Journal-Name:Journal O ADJ
of O ADP
medical O ADJ
microbiology O NOUN

However, O ADV
there O PRON
are O VERB
few O ADJ
and O CCONJ
limited O VERB
clinical O ADJ
studies. O NOUN
( O PUNCT

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

No O DET
significant O ADJ
changes O NOUN
in O ADP
HIV B-outcome NOUN
viral I-outcome ADJ
load I-outcome NOUN
, O PUNCT
CD4(+) B-outcome NOUN
or Seperator CCONJ
CD8(+) B-outcome NOUN
T I-outcome NOUN
cell I-outcome NOUN
counts E3-outcome NOUN
, O PUNCT
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
(BMI) I-outcome PUNCT
or O CCONJ
middle-upper-arm B-outcome NOUN
circumference I-outcome NOUN
(MUAC) I-outcome NUM
could O VERB
be O VERB
detected. O NOUN

One O NUM
hundred O NUM
eighty-five O ADJ
patients O NOUN
were O VERB
enrolled O VERB
in O ADP
this O DET
single-center, O NOUN
prospective, O NOUN
randomized, O NOUN
open-label O NOUN
study. O NOUN

Future O NOUN
studies O NOUN
are O VERB
still O ADV
needed O VERB
to O PART
warrant O ADJ
these O DET
results. O NOUN

A O DET
number O NOUN
was O VERB
assigned O VERB
to O PART
each O DET
eye O NOUN
drop, O NOUN
and O CCONJ
the O DET
volunteer O NOUN
was O VERB
asked O VERB
to O PART
identify O NOUN
it O PRON
by O ADP
color. O ADV

Publication O NOUN
date: O NOUN
2018/11/20 O ADJ
00:00 O NOUN
[revised] O PUNCT

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
320 O NUM
treatment-naive O ADJ
HBeAg-positive O ADJ
CHB O NOUN
patients O NOUN
who O ADP
received O VERB
randomly O ADV
a O DET
single O ADJ
regimen O NOUN
of O ADP
either O CCONJ
entecavir O NOUN
capsule O NOUN
(ETV) O NOUN
(n O NOUN
= O SYM
160) O NOUN
or O CCONJ
tenofovir O NOUN
disoproxil O NOUN
fumarate O NOUN
capsule O NOUN
(TDF) O NOUN
(n O NOUN
= O SYM
160) O NOUN
for O ADP
144 O NUM
weeks O NOUN
were O VERB
consecutively O ADV
enrolled O VERB
from O ADP
14 O NUM
tertiary O ADJ
hospitals O NOUN
or O CCONJ
university O NOUN
hospitals O NOUN
in O ADP
China O NOUN
between O ADP
January O NOUN
2012 O NUM
and O CCONJ
December O NOUN
2014. O NUM

Overall, O NOUN
the O DET
103 O NUM
enrolled O VERB
participants O NOUN
were O VERB
>/=85th O NOUN
percentile O ADJ
of O ADP
age O NOUN
and O CCONJ
sex-specific O ADJ
body O NOUN
mass O NOUN
index O NOUN
(BMI). O PUNCT

Findings O NOUN
reveal O VERB
that O ADP
respondents O NOUN
(N O PUNCT
= O SYM
205) O NOUN
are O VERB
not O ADV
averse B-outcome ADJ
to I-outcome PART
bitter I-outcome NOUN
taste I-outcome NOUN
; O PUNCT
while, O NOUN
socio-demographic O ADJ
traits O NOUN
influence O NOUN
bitter B-outcome NOUN
acceptance I-outcome NOUN
, O PUNCT
as O ADP
higher O ADJ
education O NOUN
level O NOUN
and O CCONJ
gender O NOUN
(female) O NOUN
positively O ADV
affect O NOUN
preferences B-outcome NOUN
, O PUNCT
together O ADV
with O ADP
specific O ADJ
individual O ADJ
characteristics O NOUN
as O ADP
high O ADJ
compensatory O ADJ
health O NOUN
beliefs. O NOUN

Journal-Name:Pediatric O ADJ
physical O ADJ
therapy O NOUN
: O PUNCT
the O DET
official O ADJ
publication O NOUN
of O ADP
the O DET
Section O NOUN
on O ADP
Pediatrics O NOUN
of O ADP
the O DET
American O ADJ
Physical O ADJ
Therapy O NOUN
Association O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
['2019/10/17 O NOUN
06:00' O NUM

In O ADP
Study O NOUN
1, O NOUN
this O DET
effect O NOUN
was O VERB
observed O VERB
in O ADP
end-of-day B-outcome NOUN
positive I-outcome ADJ
affect I-outcome NOUN
. O PUNCT
In O ADP
Study O NOUN
2, O NOUN
this O DET
effect O NOUN
was O VERB
found O VERB
in O ADP
both O CCONJ
end-of-day B-outcome NOUN
and Seperator CCONJ
momentary B-outcome ADJ
positive I-outcome ADJ
affect E2-outcome NOUN
outcomes. O ADJ

Publication O NOUN
date: O NOUN
2019/02/19 O NOUN
06:00 O ADP
[entrez] O ADP

Method:Ninety O NOUN
patients O NOUN
with O ADP
moderate O ADJ
and O CCONJ
severe O ADJ
OSA O NOUN
patients O NOUN
with O ADP
negative O ADJ
emotions O NOUN
diagnosed O VERB
by O ADP
PSG, O NOUN
self-rating O VERB
depression O NOUN
scale O NOUN
(SDS) O PUNCT
and O CCONJ
self-rating O VERB
anxiety O NOUN
scale O NOUN
SAS O NUM
were O VERB
selected O VERB
from O ADP
the O DET
respiratory O ADJ
department O NOUN
of O ADP
our O ADJ
hospital O NOUN
from O ADP
February O ADJ
2015 O NUM
to O PART
February O ADJ
2018. O NUM

Title: O NOUN
[Efficacy O NOUN
of O ADP
fluvoxamine O NOUN
combined O VERB
with O ADP
extended-release O NOUN
methylphenidate O NOUN
on O ADP
treatment-refractory O NOUN
obsessive-compulsive O ADJ
disorder]. O NOUN

Findings O NOUN
remained O VERB
consistent O ADJ
after O ADP
adjustment O NOUN
for O ADP
confounders O NOUN
and/or O CCONJ
in O ADP
a O DET
sensitivity O NOUN
analysis O NOUN
of O ADP
radiologically O ADV
confirmed O VERB
CAP O NOUN
(n O NOUN
= O SYM
1604, O NUM
76.1%). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Hemodynamic B-outcome ADJ
variables O NOUN
were O VERB
measured O VERB
and O CCONJ
blood O NOUN
samples O NOUN
were O VERB
drawn O VERB
before O ADP
induction O NOUN
and O CCONJ
for O ADP
15 O NUM
minutes O NOUN
afterwards. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal-Name:The O ADJ
American O ADJ
surgeon O NOUN

Material O ADJ
and O CCONJ
methods: O NOUN
A O DET
randomized, O NOUN
longitudinal O ADJ
and O CCONJ
prospective O ADJ
clinical O ADJ
study O NOUN
was O VERB
conducted. O NOUN

The O DET
participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
experimental O ADJ
(n=25) O PUNCT
and O CCONJ
control O NOUN
(n=25) O PUNCT
groups. O NOUN

METHODS: O NOUN
Patients O NOUN
who O ADP
were O VERB
referred O VERB
to O PART
Veterans O NOUN
Affairs O NOUN
(VA) O NOUN
gastroenterology O NOUN
clinics O NOUN
for O ADP
PPI-refractory O ADJ
heartburn O ADP
received O VERB
20 O NUM
mg O NOUN
of O ADP
omeprazole O NOUN
twice O ADV
daily O ADJ
for O ADP
2 O NUM
weeks, O NOUN
and O CCONJ
those O DET
with O ADP
persistent O ADJ
heartburn O ADP
underwent O VERB
endoscopy, O ADP
esophageal O ADJ
biopsy, O ADP
esophageal O ADJ
manometry, O NOUN
and O CCONJ
multichannel O NOUN
intraluminal O ADJ
impedance-pH O NOUN
monitoring. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

The O DET
addition O NOUN
of O ADP
SPOC O NOUN
scores O NOUN
to O PART
an O DET
adjusted O VERB
regression O NOUN
model O NOUN
to O PART
predict O VERB
persistent B-outcome ADJ
pain I-outcome NOUN
improved O VERB
the O DET
concordance O NOUN
statistic O ADJ
from O ADP
0.66 O NUM
to O PART
0.74, O NOUN
and O CCONJ
found O VERB
the O DET
greatest O ADV
risk O NOUN
was O VERB
associated O VERB
with O ADP
high O ADJ
(>/=74) O PUNCT
SPOC O NOUN
scores O NOUN
[odds O NOUN
ratio: O NOUN
5.63; O NOUN
99% O ADV
confidence O NOUN
interval O NOUN
(CI): O NOUN
3.59-8.84; O NOUN
absolute O ADJ
risk O NOUN
increase O NOUN
40.6%; O ADJ
99% O ADV
CI: O NOUN
30.8%, O NUM
48.6%]. O NOUN
Thirty-eight O NUM
per O ADP
cent O NUM
(484 O PUNCT
of O ADP
1277) O ADP
reported O VERB
moderate O ADJ
to O PART
extreme O NOUN
pain B-outcome NOUN
interference I-outcome NOUN
at O ADP
1 O NUM
yr. O PUNCT

Title: O NOUN
Mindfulness O ADV
mechanisms O NOUN
and O CCONJ
psychological B-outcome ADJ
effects O NOUN
for O ADP
aMCI O NOUN
patients: O NOUN
A O DET
comparison O NOUN
with O ADP
psychoeducation. O ADV

Randomisation O NOUN
was O VERB
stratified O VERB
according O ADJ
to O PART
centre O NOUN
and O CCONJ
disease O NOUN
risk. O NOUN

Secondary O ADJ
outcomes O NOUN
included O VERB
MRSA B-outcome NOUN
infection I-outcome NOUN
determined O VERB
on O ADP
the O DET
basis O NOUN
of O ADP
clinical O ADJ
judgment, O NOUN
infection O NOUN
from O ADP
any O DET
cause, O NOUN
and O CCONJ
infection-related O VERB
hospitalization. O NOUN

Patients O NOUN
received O VERB
concomitant O ADJ
palonosetron O NOUN
(0.75 O NUM
mg O NOUN
intravenously O ADV
[i.v.] O PUNCT

Preoperative O ADJ
analgesia O NOUN
group O NOUN
received O VERB
celecoxib O NOUN
before O ADP
and O CCONJ
post O ADV
operation; O NOUN
postoperative O ADJ
analgesia O NOUN
group O NOUN
received O VERB
celecoxib O NOUN
post O ADV
operation, O NOUN
all O DET
patients O NOUN
received O VERB
TKA O NOUN
and O CCONJ
intravenous O ADJ
patient-controlled O VERB
analgesia O NOUN
(PCA) O PUNCT
post O ADV
operation. O ADV

The O DET
primary O ADJ
outcome O NOUN
was O VERB
full-term B-outcome NOUN
(>/=37 X NOUN
weeks' X ADP
gestational X ADJ
age) X NOUN
livebirth I-outcome ADJ
, O PUNCT
which O ADP
was O VERB
assessed O VERB
in O ADP
all O DET
eligible O ADJ
couples O NOUN
who O ADP
completed O VERB
follow-up. O PUNCT

To O PART
objectify O NOUN
the O DET
treatment O NOUN
outcomes O NOUN
in O ADP
both O CCONJ
groups O NOUN
before O ADP
and O CCONJ
after O ADP
the O DET
treatment, O NOUN
we O PRON
measured O VERB
myostatin O NOUN
concentration O NOUN
and O CCONJ
performed O VERB
the O DET
urinary B-outcome ADJ
incontinence I-outcome NOUN
severity I-outcome NOUN
assessment O NOUN
( O NOUN
The O DET
Revised O VERB
Urinary B-outcome ADJ
Incontinence I-outcome NOUN
Scale]), O NOUN
perceived O VERB
self-efficacy B-outcome NOUN
assessment O NOUN
(General O ADJ
Self-Efficacy B-outcome NOUN
Scale), O NOUN
and O CCONJ
depression B-outcome NOUN
severity O NOUN
assessment O NOUN
( O NOUN
Beck O NOUN
Depression B-outcome NOUN
Inventory]). O ADJ

In O ADP
this O DET
study, O NOUN
we O PRON
compared O VERB
the O DET
effects O NOUN
of O ADP
no O DET
NMBD O NOUN
and O CCONJ
continuous O ADJ
rocuronium O NOUN
infusion O NOUN
on O ADP
the O DET
incidence O NOUN
of O ADP
patient O NOUN
involuntary B-outcome ADJ
movement I-outcome NOUN
and O CCONJ
motor B-outcome NOUN
evoked I-outcome VERB
potential I-outcome ADJ
(MEP) I-outcome PUNCT
monitoring. O NOUN

The O DET
incidence O NOUN
of O ADP
radiation-induced O VERB
complications B-outcome NOUN
was O VERB
similar O ADJ
in O ADP
these O DET
two O NUM
groups. O NOUN

Objective: O NOUN
To O PART
investigate O NOUN
effects O NOUN
of O ADP
two O NUM
anesthesia O NOUN
methods O NOUN
on O ADP
the O DET
first O ADV
night O NOUN
sleep B-outcome NOUN
quality I-outcome NOUN
in O ADP
middle-aged O NOUN
and O CCONJ
elderly O NOUN
patients O NOUN
after O ADP
surgery. O VERB

CONCLUSION: O NOUN
Preoperative O ADJ
low-dose O NOUN
MDCT O NOUN
should O VERB
be O VERB
used O VERB
for O ADP
diagnosis O NOUN
of O ADP
uncontrolled O VERB
chronic O ADJ
rhinosinusitis O NOUN
for O ADP
decision O NOUN
making O VERB
of O ADP
sinus O NOUN
surgeries. O NUM

Journal O ADJ
ID: O NOUN
2985248R O NOUN

As O ADP
well O ADV
as O ADP
having O VERB
important O ADJ
development O NOUN
benefits, O NOUN
interventions O NOUN
that O ADP
address O NOUN
the O DET
upstream O ADJ
structural O ADJ
and O CCONJ
gender-norms O NOUN
based O VERB
determinants O NOUN
of O ADP
poor O ADJ
mental O ADJ
health, O NOUN
and O CCONJ
provide O VERB
adolescent O NOUN
services O NOUN
for O ADP
girls O NOUN
who O ADP
require O VERB
treatment O NOUN
and O CCONJ
support, O NOUN
should O VERB
have O VERB
important O ADJ
benefits O NOUN
for O ADP
girls' O NOUN
psychological O ADJ
wellbeing. O NOUN

Overweight O NOUN
and O CCONJ
obesity O NOUN
are O VERB
a O DET
global O ADJ
concern. O NOUN

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
an O DET
early O ADJ
clinical B-outcome ADJ
response I-outcome NOUN
at O ADP
48 O NUM
to O PART
72 O NUM
hours, O NOUN
defined O VERB
as O ADP
survival B-outcome NOUN
with O ADP
a O DET
reduction O NOUN
in O ADP
lesion B-outcome NOUN
size I-outcome NOUN
of O ADP
at O ADP
least O ADV
20% O NUM
without O ADP
rescue B-outcome NOUN
antibacterial I-outcome ADJ
therapy I-outcome NOUN
. O PUNCT
A O DET
secondary O ADJ
end O NOUN
point O NOUN
was O VERB
an O DET
investigator-assessed O VERB
clinical B-outcome ADJ
response I-outcome NOUN
at O ADP
the O DET
post-treatment O NOUN
evaluation O NOUN
7 O NUM
to O PART
14 O NUM
days O NOUN
after O ADP
the O DET
last O NOUN
dose, O NOUN
with O ADP
clinical O ADJ
response O NOUN
defined O VERB
as O ADP
survival B-outcome NOUN
with O ADP
resolution O NOUN
or O CCONJ
improvement O NOUN
in O ADP
signs B-outcome NOUN
or Seperator CCONJ
symptoms I-outcome NOUN
of I-outcome ADP
infection I-outcome NOUN
to O PART
the O DET
extent O NOUN
that O ADP
further O ADV
antibacterial O ADJ
therapy O NOUN
was O VERB
unnecessary. O VERB

Participants O NOUN
were O VERB
recruited O VERB
from O ADP
the O DET
Institute O NOUN
of O ADP
Dentistry, O PUNCT
Barts O NOUN
and O CCONJ
the O DET
London O PROPN
School O NOUN
of O ADP
Medicine O NOUN
and O CCONJ
Dentistry, O PUNCT
London, O NOUN
United O VERB
Kingdom, O NOUN
and O CCONJ
recalled O VERB
at O ADP
6- O NUM
to O PART
8-week O NOUN
intervals. O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
Corneal O ADJ
Epithelial O ADJ
Remodeling O VERB
Over O ADP
2 O NUM
Years O NOUN
in O ADP
LASIK O NOUN
Versus O CCONJ
SMILE: O NOUN
A O DET
Contralateral O ADJ
Eye O NOUN
Study. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

The O DET
intervention O NOUN
group O NOUN
inhaled O VERB
2% O NUM
lavender O NOUN
essential O ADJ
oil O NOUN
every O DET
night O NOUN
before O ADP
bedtime O NOUN
for O ADP
20 O NUM
minutes O NOUN
during O ADP
one O NUM
month. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

BACKGROUND: O NOUN
We O PRON
assessed O VERB
the O DET
effect O NOUN
of O ADP
equivalent O ADJ
weight O NOUN
loss O NOUN
with O ADP
or O CCONJ
without O ADP
exercise O NOUN
on O ADP
(intra-) O NOUN
abdominal B-outcome ADJ
fat I-outcome NOUN
in O ADP
postmenopausal O ADJ
women O NOUN
in O ADP
the O DET
SHAPE-2 O NOUN
study. O NOUN

Conclusion: O NOUN
Children O NOUN
with O ADP
HIV O NOUN
were O VERB
found O VERB
to O PART
have O VERB
the O DET
most O DET
difficulty O NOUN
on O ADP
Test O NOUN
of O ADP
Playfulness B-outcome ADV
(ToP) O ADV
items O NOUN
relating O VERB
to O PART
the O DET
play B-outcome VERB
elements O NOUN
of O ADP
internal B-outcome ADJ
control I-outcome NOUN
and O CCONJ
freedom B-outcome NOUN
from I-outcome ADP
constraints I-outcome NOUN
of I-outcome ADP
reality I-outcome NOUN
. O PUNCT
The O DET
PICIHBI O NOUN
did O VERB
not O ADV
significantly O ADV
improve O VERB
children's O NOUN
play B-outcome VERB
and O CCONJ
was O VERB
not O ADV
more O ADV
effective O ADJ
than O ADP
the O DET
conventional O ADJ
intervention. O NOUN

Journal O ADJ
ID: O NOUN
2985213R O NOUN

Independent O ADJ
research O NOUN
on O ADP
the O DET
experiences O NOUN
and O CCONJ
behavioral O ADJ
aspects O NOUN
of O ADP
using O VERB
IQOS(TM), O NUM
and O CCONJ
how O ADP
it O PRON
compares O NOUN
to O PART
e-cigarettes, O NOUN
is O VERB
largely O ADV
lacking. O NOUN

No O DET
patients O NOUN
experienced O VERB
a O DET
deterioration O NOUN
in O ADP
disease B-outcome NOUN
activity I-outcome NOUN
scores O NOUN
during O ADP
the O DET
exercise O NOUN
intervention. O NOUN

Title: O NOUN
Does O VERB
nifedipine O NOUN
improve O VERB
outcomes O NOUN
of O ADP
embryo O NOUN
transfer?: O NOUN

CONCLUSION: O NOUN
We O PRON
conclude O NOUN
that O ADP
yoga O NOUN
has O VERB
strong O ADJ
effects O NOUN
on O ADP
depression B-outcome NOUN
symptoms I-outcome NOUN
and O CCONJ
blood B-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
therefore O ADV
it O PRON
can O VERB
be O VERB
used O VERB
as O ADP
a O DET
complementary O ADJ
or O CCONJ
alternative O ADJ
remedy O NOUN
for O ADP
PMS O NOUN
patients. O NOUN

The O DET
children O NOUN
in O ADP
routine O ADJ
treatment O NOUN
group O NOUN
were O VERB
given O VERB
the O DET
traditional O ADJ
symptomatic O ADJ
supportive O ADJ
treatment, O NOUN
supplemented O VERB
by O ADP
drugs O NOUN
to O PART
promote O VERB
nerve O NOUN
cell O NOUN
growth. O NOUN

Journal-Name:Medicine O NOUN

Acute O ADJ
consumption O NOUN
of O ADP
RS O NOUN
at O ADP
breakfast/lunch O NOUN
significantly O ADV
reduced O VERB
the O DET
energy B-outcome NOUN
intake I-outcome NOUN
at O ADP
the O DET
ad O NOUN
libitum O ADV
dinner O NOUN
(p O PUNCT
= O SYM
0.017). O NUM

Participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
four O NUM
infusions O NOUN
of O ADP
either O CCONJ
zoledronate O ADJ
at O ADP
a O DET
dose O NOUN
of O ADP
5 O NUM
mg O NOUN
(zoledronate O NUM
group) O ADJ
or O CCONJ
normal O ADJ
saline O NOUN
(placebo O PUNCT
group) O ADJ
at O ADP
18-month O NOUN
intervals. O NOUN

Publication O NOUN
date: O NOUN
2018/10/25 O ADJ
00:00 O NOUN
[accepted] O ADV

Small O ADJ
bowel O NOUN
capsule O NOUN
endoscopy O NOUN
was O VERB
performed O VERB
before O ADP
and O CCONJ
2 O NUM
weeks O NOUN
after O ADP
low-dose O NOUN
aspirin O NOUN
administration. O ADV

Publication O NOUN
date: O NOUN
2019/01/24 O ADJ
06:00 O ADP
[entrez] O ADP

The O DET
mean O NOUN
time B-outcome NOUN
required I-outcome VERB
to I-outcome PART
complete I-outcome ADJ
test-1 I-outcome NOUN
was O VERB
84.6 O NUM
+/- O SYM
26.6 O NUM
seconds O NOUN
in O ADP
training O VERB
group O NOUN
and O CCONJ
90.7 O NUM
+/- O SYM
43.9 O NUM
seconds O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
(95% O PUNCT
CI O NOUN
-34.0 O NUM
to O PART
21.7; O NOUN
P O NOUN
= O SYM
.653); O PUNCT
in O ADP
test-2, O NOUN
the O DET
time B-outcome NOUN
required O VERB
was O VERB
56.6 O NUM
+/- O SYM
27.9 O NUM
and O CCONJ
91.2 O NUM
+/- O SYM
43.8 O NUM
seconds O NOUN
(95% O PUNCT
CI O NOUN
-63.0 O NUM
to O PART
-6.2; O NOUN
P O NOUN
= O SYM
.019), O PUNCT
respectively. O NOUN

There O PRON
were O VERB
three O NUM
non-serious O ADJ
exercise-related O VERB
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
and O CCONJ
two O NUM
exercise O NOUN
participants O NOUN
experienced O VERB
disease B-outcome NOUN
relapse I-outcome NOUN
during O ADP
follow-up. O PUNCT

Secondary O ADJ
endpoints O NOUN
were O VERB
assessed O VERB
by O ADP
estimating O VERB
serum O NOUN
aspartate B-outcome NOUN
aminotransferase I-outcome NOUN
(AST) I-outcome NOUN
, O PUNCT
alanine B-outcome NOUN
aminotransferase I-outcome NOUN
(ALT) I-outcome PUNCT
and O CCONJ
creatine B-outcome NOUN
kinase I-outcome NOUN
MM I-outcome NOUN
(CK-MM) I-outcome PUNCT
levels O NOUN
and O CCONJ
adverse B-outcome ADJ
drug I-outcome NOUN
reactions I-outcome NOUN
(ADRs) I-outcome NUM
. O PUNCT
RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
61 O NUM
patients O NOUN
were O VERB
enrolled O VERB
of O ADP
which O ADP
46 O NUM
completed O VERB
the O DET
study O NOUN
(24 O NOUN
in O ADP
DR O NOUN
vs O CCONJ
22 O NUM
in O ADP
EODR O NOUN
group). O NOUN

CONCLUSION: O NOUN
Compared O VERB
with O ADP
AGS, O ADV
SHM O NOUN
could O VERB
decrease O NOUN
the O DET
blood B-outcome NOUN
loss I-outcome NOUN
during O ADP
hemostatic O ADJ
process O NOUN
and O CCONJ
the O DET
postoperative O ADJ
drainage B-outcome NOUN
volume I-outcome NOUN
in O ADP
posterior O ADJ
operation O NOUN
of O ADP
lumbar O ADJ
degenerative O ADJ
disease. O NOUN

PMID: O NOUN
31619437 O NUM

By O ADP
day O NOUN
28, O NUM
74 O NUM
patients O NOUN
(34.9%) O NUM
in O ADP
the O DET
peripheral O ADJ
perfusion O NOUN
group O NOUN
and O CCONJ
92 O NUM
patients O NOUN
(43.4%) O NUM
in O ADP
the O DET
lactate O VERB
group O NOUN
had O VERB
died B-outcome VERB
(hazard O PUNCT
ratio, O NOUN
0.75 O NUM
[95% O NOUN
CI, O NOUN
0.55 O NUM
to O PART
1.02]; O NOUN
P O NOUN
= O SYM
.06; O NOUN
risk O NOUN
difference, O NOUN
-8.5% O NUM
[95% O NOUN
CI, O NOUN
-18.2% O NUM
to O PART
1.2%]). O NOUN

Other O ADJ
parameters O NOUN
evaluated O VERB
were O VERB
apolipoprotein B-outcome NOUN
B I-outcome NOUN
(Apo I-outcome NUM
B) I-outcome NOUN
, O PUNCT
apolipoprotein B-outcome NOUN
A1 I-outcome NOUN
(Apo I-outcome NUM
A1) I-outcome NOUN
, O PUNCT
Coenzyme B-outcome NOUN
Q10 I-outcome NOUN
(CoQ10) I-outcome PUNCT
, O PUNCT
high-sensitive B-outcome ADJ
C-reactive I-outcome ADJ
protein I-outcome NOUN
(hsCRP) I-outcome NOUN
, O PUNCT
fasting B-outcome VERB
blood I-outcome NOUN
sugar I-outcome NOUN
(FBS) I-outcome PUNCT
, O PUNCT
homocysteine B-outcome NOUN
and O CCONJ
thyroid B-outcome NOUN
stimulating I-outcome VERB
hormone I-outcome NOUN
(TSH) I-outcome ADJ
. O PUNCT
RESULTS: O NOUN
In O ADP
12 O NUM
weeks, O NOUN
the O DET
major O ADJ
lipids B-outcome NOUN
such O ADJ
as O ADP
total O ADJ
cholesterol B-outcome NOUN
(TC) O NOUN
(p O PUNCT
= O SYM
0.0003), O NUM
triglyceride B-outcome NOUN
(TG) I-outcome NOUN
(p O PUNCT
= O SYM
0.0003), O NUM
low B-outcome ADJ
density I-outcome NOUN
lipoprotein I-outcome NOUN
cholesterol I-outcome NOUN
(LDL-C) I-outcome NOUN
(p O PUNCT
= O SYM
0.0064) O NUM
and O CCONJ
very B-outcome ADV
low I-outcome ADJ
density I-outcome NOUN
lipoprotein I-outcome NOUN
cholesterol I-outcome NOUN
(VLDL-C) I-outcome NOUN
(p O PUNCT
= O SYM
0.0001) O NUM
were O VERB
significantly O ADV
lower O ADJ
in O ADP
amla O NOUN
group O NOUN
as O ADP
compared O VERB
to O PART
placebo O NOUN
group. O VERB

No O DET
additional O ADJ
significant O ADJ
benefit O NUM
could O VERB
be O VERB
shown O VERB
from O ADP
the O DET
intervention O NOUN
compared O VERB
to O PART
standard O ADJ
management. O NOUN

The O DET
median O ADJ
overall B-outcome ADJ
survival I-outcome NOUN
was O VERB
69.2 O NUM
months O NOUN
in O ADP
the O DET
no-lymphadenectomy O NOUN
group O NOUN
and O CCONJ
65.5 O NUM
months O NOUN
in O ADP
the O DET
lymphadenectomy O NOUN
group O NOUN
(hazard O PUNCT
ratio O NOUN
for O ADP
death O NOUN
in O ADP
the O DET
lymphadenectomy O NOUN
group, O NOUN
1.06; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.83 O NUM
to O PART
1.34; O NOUN
P O NOUN
= O SYM
0.65), O NUM
and O CCONJ
median O ADJ
progression-free B-outcome ADJ
survival I-outcome NOUN
was O VERB
25.5 O NUM
months O NOUN
in O ADP
both O CCONJ
groups O NOUN
(hazard O PUNCT
ratio O NOUN
for O ADP
progression O NOUN
or O CCONJ
death O NOUN
in O ADP
the O DET
lymphadenectomy O NOUN
group, O NOUN
1.11; O NOUN
95% O NOUN
CI, O NOUN
0.92 O NUM
to O PART
1.34; O NOUN
P O NOUN
= O SYM
0.29). O NOUN

Journal O ADJ
ID: O NOUN
8900488 O NUM

In O ADP
both O CCONJ
studies, O NOUN
end-of-day B-outcome NOUN
and Seperator CCONJ
momentary B-outcome ADJ
positive I-outcome ADJ
affect E2-outcome NOUN
and O CCONJ
negative B-outcome ADJ
affect I-outcome NOUN
were O VERB
measured O VERB
in O ADP
daily O ADJ
life O NOUN
for O ADP
3 O NUM
days O NOUN
pre- O ADJ
and O CCONJ
post-intervention O NOUN
using O VERB
ambulatory O ADJ
assessments. O NOUN

Publication O NOUN
date: O NOUN
2019/01/15 O NOUN
06:00 O ADP
[medline] O NOUN

PARTICIPANTS: O NOUN
180 O NUM
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain, O NOUN
previous O ADJ
disc O NOUN
herniation, O NOUN
and O CCONJ
type O NOUN
1 O NUM
(n=118) O NOUN
or O CCONJ
type O NOUN
2 O NUM
(n=62) O NOUN
Modic O NOUN
changes O NOUN
enrolled O VERB
from O ADP
June O NOUN
2015 O NUM
to O PART
September O NOUN
2017. O NUM

BACKGROUND: O NOUN
Oscillatory O ADJ
positive O ADJ
expiratory O ADJ
pressure O NOUN
(OPEP) O PUNCT
training O VERB
is O VERB
a O DET
kind O NOUN
of O ADP
breathing O VERB
exercise O NOUN
with O ADP
Acapella. O NOUN

Publication O NOUN
date: O NOUN
2018/12/15 O NOUN
06:00 O ADP
[entrez] O ADP

Journal-Name:The O ADJ
international O ADJ
journal O ADJ
of O ADP
behavioral O ADJ
nutrition O NOUN
and O CCONJ
physical O ADJ
activity O NOUN

Journal-Name:Taiwanese O NOUN
journal O ADJ
of O ADP
obstetrics O NOUN
& O CCONJ
gynecology O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
showed O VERB
significantly O ADV
better O ADJ
treatment B-outcome NOUN
responses I-outcome NOUN
than O ADP
those O DET
in O ADP
the O DET
control O NOUN
group O NOUN
(P O NUM
&lt; O NOUN
0.05 O NUM
or O CCONJ
0.01). O NOUN

To O PART
date, O VERB
methohexital O ADJ
has O VERB
not O ADV
been O VERB
compared O VERB
with O ADP
the O DET
most O DET
commonly O ADV
used O VERB
induction O NOUN
agent, O NOUN
propofol. O NOUN

Objective: O NOUN
To O PART
evaluate O VERB
the O DET
feasibility B-outcome NOUN
and O CCONJ
safety O NOUN
of O ADP
supraglottic O ADJ
tracheal O ADJ
tube O NOUN
ventilation O NOUN
by O ADP
comparing O VERB
with O ADP
modified O VERB
laryngeal O ADJ
mask O NOUN
airway O NOUN
ventilation O NOUN
during O ADP
painless O NOUN
fiberbronchoscopy. O NOUN

Enrollment O NOUN
was O VERB
September O NOUN
2015 O NUM
to O PART
April O NOUN
2018, O NUM
with O ADP
follow-up O NOUN
ending O VERB
in O ADP
April O NOUN
2019. O NUM

OBJECTIVE: O NOUN
To O PART
evaluate O VERB
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
selective O ADJ
brain O NOUN
hypothermia O NOUN
(SBH) O NUM
in O ADP
the O DET
treatment O NOUN
of O ADP
neonates O NOUN
with O ADP
moderate O ADJ
or O CCONJ
severe O ADJ
neonatal O ADJ
hypoxic-ischemic O ADJ
encephalopathy O NOUN
(HIE), O NUM
and O CCONJ
the O DET
effect O NOUN
of O ADP
SBH O NOUN
treatment O NOUN
on O ADP
serum O NOUN
levels O NOUN
of O ADP
neuron-specific B-outcome ADJ
enolase I-outcome NOUN
(NSE) I-outcome NOUN
and O CCONJ
central B-outcome ADJ
nervous I-outcome ADJ
specific I-outcome ADJ
protein I-outcome NOUN
S100 I-outcome NOUN
. O PUNCT
METHODS: O NOUN
A O DET
prospective O ADJ
randomized O VERB
controlled O VERB
trial O NOUN
was O VERB
conducted. O NOUN

In O ADP
CLA O NOUN
group, O NOUN
93 O NUM
patients O NOUN
were O VERB
treated O VERB
with O ADP
the O DET
same O ADJ
regimen O NOUN
except O ADP
FZD O NOUN
was O VERB
replaced O VERB
by O ADP
CLA. O NOUN

METHODS: O NOUN
This O DET
parallel, O ADV
two-group, O NOUN
randomised O VERB
trial O NOUN
included O VERB
couples O NOUN
undergoing O VERB
an O DET
ICSI O NOUN
procedure O NOUN
with O ADP
fresh O ADJ
embryo O NOUN
transfer O NOUN
at O ADP
16 O NUM
assisted O VERB
conception O NOUN
units O NOUN
in O ADP
the O DET
UK. O NOUN

Secondary O ADJ
outcomes O NOUN
included O VERB
delirium B-outcome NOUN
duration I-outcome NOUN
, O PUNCT
cognitive B-outcome ADJ
decline I-outcome NOUN
, O PUNCT
breakthrough O NOUN
analgesia B-outcome NOUN
within O ADP
the O DET
first O ADV
48 O NUM
hours, O NOUN
and O CCONJ
ICU B-outcome NOUN
and Seperator CCONJ
hospital I-outcome NOUN
length I-outcome NOUN
of I-outcome ADP
stay I-outcome NOUN
. O PUNCT
Results: O NOUN
Among O ADP
121 O NUM
patients O NOUN
randomized O VERB
(median O PUNCT
age, O NOUN
69 O NUM
years; O NOUN
19 O NUM
women O NOUN
[15.8%]), O ADJ
120 O NUM
completed O VERB
the O DET
trial. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Common O ADJ
adverse B-outcome ADJ
events I-outcome NOUN
included O VERB
nasopharyngitis B-outcome NOUN
, O PUNCT
abdominal B-outcome ADJ
pain I-outcome NOUN
, O PUNCT
and O CCONJ
diarrhea B-outcome NOUN
. O PUNCT
Serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
occurred O VERB
in O ADP
6 O NUM
patients O NOUN
who O ADP
received O VERB
givosiran O NOUN
in O ADP
parts O NOUN
A O DET
through O ADP
C O NOUN
combined. O NOUN

CONCLUSIONS: O NOUN
The O DET
results O NOUN
of O ADP
the O DET
present O ADJ
study O NOUN
demonstrated O VERB
that O ADP
8 O NUM
weeks O NOUN
of O ADP
PrimaVie(R) O NOUN
Shilajit O ADJ
supplementation O NOUN
at O ADP
500 O NUM
mg.d(- O NOUN
1) O NUM
promoted O VERB
the O DET
retention O NOUN
of O ADP
maximal B-outcome ADJ
muscular I-outcome ADJ
strength I-outcome NOUN
following O VERB
the O DET
fatiguing O VERB
protocol O NOUN
and O CCONJ
decreased O VERB
baseline O NOUN
HYP. O NOUN

Two O NUM
blinded O VERB
and O CCONJ
standardized O VERB
evaluators O NOUN
assessed O VERB
the O DET
radiographic O ADJ
outcomes. O ADJ

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
recovery B-outcome NOUN
perceived O VERB
by O ADP
the O DET
patient. O NOUN

BACKGROUND: O NOUN
Health O NOUN
education O NOUN
has O VERB
been O VERB
considered O VERB
as O ADP
the O DET
effectiveness O NOUN
method O NOUN
to O PART
increase O NOUN
the O DET
self-care O NOUN
skills O NOUN
of O ADP
diabetes O NOUN
patients. O NOUN

Anti-HA B-outcome NOUN
virus I-outcome NOUN
(HAV) I-outcome PUNCT
immunoglobulin I-outcome NOUN
(Ig) I-outcome NUM
G I-outcome NOUN
was O VERB
measured O VERB
to O PART
assess O NOUN
geometric O ADJ
mean O NOUN
concentrations O NOUN
(GMCs) O ADV
and O CCONJ
seropositvity O NOUN
rates O NOUN
(>/=20 O PUNCT
mIU/mL O NOUN
anti-HAV O NOUN
IgG). O ADP

Of O ADP
the O DET
841 O NUM
patients O NOUN
who O ADP
underwent O VERB
randomization, O NOUN
the O DET
primary O ADJ
end O NOUN
point O NOUN
occurred O VERB
in O ADP
25 O NUM
of O ADP
420 O NUM
patients O NOUN
(6.0%) O NOUN
in O ADP
the O DET
rivaroxaban O ADJ
group O NOUN
and O CCONJ
in O ADP
37 O NUM
of O ADP
421 O NUM
(8.8%) O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
0.66; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.40 O NUM
to O PART
1.09; O NOUN
P O NOUN
= O SYM
0.10) O NUM
in O ADP
the O DET
period O NOUN
up O ADP
to O PART
day O NOUN
180. O NOUN

BACKGROUOND: O NOUN
The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
examine O NOUN
resting O VERB
the O DET
metabolic O ADJ
response O NOUN
to O PART
the O DET
ingestion B-outcome NOUN
of O ADP
a O DET
complex O NOUN
containing O VERB
Citrus O NOUN
Aurantium O NOUN
+ O SYM
Caffeine O NOUN
(CA O NOUN
+ O SYM
C) O NOUN
and O CCONJ
if O ADP
its O ADJ
consumption O NOUN
influences O NOUN
metabolic B-outcome ADJ
recovery I-outcome NOUN
following O VERB
a O DET
high-intensity O NOUN
anaerobic O ADJ
exercise O NOUN
bout O NOUN
in O ADP
habitual O ADJ
caffeine O NOUN
users. O NOUN

Journal-Name:British O NOUN
journal O ADJ
of O ADP
anaesthesia O NOUN

Achaogen, O VERB
South O NOUN
San O NOUN
Francisco, O ADV
CA. O NOUN

Journal-Name:Health O ADJ
and O CCONJ
quality O NOUN
of O ADP
life O NOUN
outcomes O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study O NOUN

Conclusion: O NOUN
The O DET
protocol O NOUN
for O ADP
changing O VERB
the O DET
attribution O NOUN
to O PART
unintentional O ADJ
injury O NOUN
and O CCONJ
negative O ADJ
information O NOUN
transmission O NOUN
for O ADP
risk O NOUN
behavior O NOUN
consequences O NOUN
was O VERB
proved O VERB
to O PART
effectively O ADV
reduce O VERB
children's O NOUN
unintentional O ADJ
injury O NOUN
risk B-outcome NOUN
behaviors I-outcome NOUN
and O CCONJ
relevant O ADJ
events. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Finally, O NOUN
18 O NUM
children O NOUN
of O ADP
each O DET
group O NOUN
were O VERB
enrolled O VERB
in O ADP
the O DET
analysis. O NOUN

The O DET
incidence O NOUN
of O ADP
new O ADJ
opacity B-outcome NOUN
on O ADP
chest O NOUN
radiography O NOUN
in O ADP
the O DET
48 O NUM
hours O NOUN
after O ADP
tracheal O ADJ
intubation O NOUN
was O VERB
16.4% O NUM
and O CCONJ
14.8%, O NUM
respectively O ADV
(P O NUM
= O SYM
0.73). O NUM

Neuromuscular O ADJ
monitoring O VERB
is O VERB
usually O ADV
used O VERB
to O PART
evaluate O VERB
neuromuscular O ADJ
recovery O NOUN
in O ADP
patients O NOUN
undergoing O VERB
general O ADJ
anesthesia. O NOUN

CONCLUSION: O NOUN
Music O ADJ
therapy O NOUN
had O VERB
a O DET
significant O ADJ
and O CCONJ
positive O ADJ
impact O NOUN
on O ADP
anxiety B-outcome NOUN
and O CCONJ
depression B-outcome NOUN
, O PUNCT
acting O VERB
on O ADP
prevention O NOUN
of O ADP
cardiovascular O ADJ
diseases, O NOUN
major O ADJ
threats O NOUN
to O PART
modern O NOUN
society. O NOUN

T O NOUN
Ober O NOUN
test], O NUM
the O DET
Thomas O NOUN
test], O NUM
and O CCONJ
transabdominal O ADJ
pelvic B-outcome ADJ
floor I-outcome NOUN
muscles I-outcome NOUN
(PFM) I-outcome PUNCT
ultrasound O NOUN
measurements O NOUN
were O VERB
performed O VERB
in O ADP
both O CCONJ
groups. O NOUN

30582753_PD.tx O ADP

Publication O NOUN
date: O NOUN
2019/01/09 O NOUN
06:00 O ADP
[entrez] O ADP

Compared O VERB
with O ADP
the O DET
Sham O NOUN
group, O NOUN
OSTAP O NOUN
block O VERB
reduced O VERB
the O DET
VAS O NOUN
scores O NOUN
at O ADP
all O DET
time O NOUN
points O NOUN
during O ADP
movement. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Secondary O ADJ
outcomes O NOUN
included O VERB
components O NOUN
of O ADP
the O DET
primary O ADJ
outcome, O ADJ
confirmed O VERB
or O CCONJ
suspected O VERB
late-onset O NOUN
sepsis B-outcome NOUN
, O PUNCT
necrotizing B-outcome VERB
enterocolitis I-outcome NOUN
, O PUNCT
and O CCONJ
cerebral B-outcome ADJ
palsy I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
Among O ADP
2804 O NUM
infants O NOUN
who O ADP
underwent O VERB
randomization, O NOUN
the O DET
primary O ADJ
outcome O NOUN
could O VERB
be O VERB
assessed O VERB
in O ADP
1224 O NUM
(87.4%) O NUM
assigned O VERB
to O PART
the O DET
faster O ADJ
increment O NOUN
and O CCONJ
1246 O NUM
(88.7%) O NUM
assigned O VERB
to O PART
the O DET
slower O NOUN
increment. O NOUN

Advanced O VERB
colorectal O ADJ
cancer O NOUN
patients O NOUN
with O ADP
2 O NUM
or O CCONJ
fewer O ADJ
metastatic O ADJ
sites O NOUN
experienced O VERB
longer O ADJ
progression-free B-outcome ADJ
survival I-outcome NOUN
than O ADP
those O DET
with O ADP
more O ADV
than O ADP
2 O NUM
sites. O NOUN

CONCLUSION: O NOUN
Serum O NOUN
levels O NOUN
of O ADP
APN O NOUN
and O CCONJ
AdipoR1 O VERB
are O VERB
significantly O ADV
lower O ADJ
in O ADP
T2DM O NOUN
group O NOUN
and O CCONJ
T2DM O NOUN
+ O SYM
MVC O NOUN
group, O NOUN
showing O VERB
lowest O ADV
value O NOUN
in O ADP
T2DM O NOUN
+ O SYM
MVC O NOUN
group. O VERB

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Success O NOUN
rate O NOUN
of O ADP
spinal B-outcome ADJ
deformity I-outcome NOUN
correction I-outcome NOUN
following O VERB
surgical O ADJ
procedure O NOUN
regardless O ADV
of O ADP
type O NOUN
of O ADP
administered O VERB
rod O NOUN
was O VERB
86.76 O NUM
+/- O SYM
11.30 O NUM
percent O NOUN
(62.5-100%). O ADV

Secondary O ADJ
outcomes O NOUN
will O VERB
include O VERB
vaccine O NOUN
hesitation B-outcome NOUN
and O CCONJ
intention B-outcome NOUN
scores, O NOUN
mother's O NOUN
knowledge B-outcome NOUN
, O PUNCT
attitudes B-outcome NOUN
and O CCONJ
beliefs B-outcome NOUN
about O ADV
immunization, O NOUN
and O CCONJ
psychosocial B-outcome ADJ
determinants O NOUN
of O ADP
intention O NOUN
to O PART
vaccinate. O NOUN

Omadacycline, O NOUN
an O DET
aminomethylcycline O NOUN
antibiotic O ADJ
that O ADP
can O VERB
be O VERB
administered O VERB
once O ADP
daily O ADJ
either O CCONJ
orally O ADV
or O CCONJ
intravenously, O NOUN
is O VERB
active O ADJ
against O ADP
pathogens O NOUN
that O ADP
commonly O ADV
cause O ADP
such O ADJ
infections, O NOUN
including O VERB
antibiotic-resistant O ADJ
strains. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/03/08 O ADV
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

A O DET
simple O NOUN
population O NOUN
pharmacokinetic O ADJ
model O NOUN
was O VERB
developed O VERB
to O PART
visualize O NOUN
measured O VERB
and O CCONJ
predicted O VERB
belatacept O ADV
serum O NOUN
concentrations. O NUM

Journal O ADJ
ID: O NOUN
7501160 O NUM

They O PRON
were O VERB
randomly O ADV
assigned O VERB
to O PART
an O DET
experimental O ADJ
group O NOUN
and O CCONJ
a O DET
control O NOUN
group O NOUN
(14 O NOUN
individuals O NOUN
in O ADP
each O DET
group) O ADJ
and O CCONJ
then O ADV
were O VERB
post-tested O VERB
after O ADP
two O NUM
months. O NOUN

The O DET
outcome O NOUN
parameters O NOUN
were O VERB
recession B-outcome NOUN
depth I-outcome NOUN
/ X NOUN
width S1-outcome NOUN
, O PUNCT
root B-outcome NOUN
coverage I-outcome NOUN
percentage, O ADP
and O CCONJ
root B-outcome NOUN
coverage I-outcome NOUN
aesthetic I-outcome ADJ
score O NOUN
(RES). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

RESULTS: O NOUN
A O DET
statistically O ADV
significant O ADJ
difference O NOUN
was O VERB
observed O VERB
between O ADP
the O DET
mean O NOUN
self-efficacy B-outcome NOUN
indices O NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
(p=0.001). O NOUN

Givosiran O NOUN
is O VERB
an O DET
investigational O ADJ
RNA O NOUN
interference O NOUN
therapeutic O ADJ
agent O NOUN
that O ADP
inhibits O NOUN
hepatic O ADJ
ALAS1 O NOUN
synthesis. O NOUN

RESULTS: O NOUN
A O DET
significant O ADJ
difference O NOUN
was O VERB
found O VERB
in O ADP
the O DET
median O ADJ
number O NOUN
[range] O NOUN
of O ADP
small B-outcome ADJ
intestinal I-outcome ADJ
lesions I-outcome NOUN
between O ADP
baseline O NOUN
and O CCONJ
two O NUM
weeks O NOUN
after O ADP
low-dose O NOUN
aspirin O NOUN
administration O NOUN
in O ADP
group O NOUN
A O DET
(baseline: O PUNCT
1 O NUM
[0-5], O PUNCT
after: O NOUN
5 O NUM
[1-11]; O NOUN
p O NOUN
= O SYM
0.0059) O NUM
but O CCONJ
not O ADV
in O ADP
group O NOUN
B O NOUN
(baseline: O PUNCT
0.5 O NUM
[0-9], O NUM
after: O NOUN
3 O NUM
[0-23]; O NOUN
p O NOUN
= O SYM
0.0586). O NUM

For O ADP
the O DET
majority, O NOUN
the O DET
provision O NOUN
of O ADP
education O NOUN
and O CCONJ
positive O ADJ
interventions O NOUN
aimed O VERB
at O ADP
promoting O VERB
healthy O ADJ
exercise O NOUN
and O CCONJ
self-management O ADJ
was O VERB
associated O VERB
with O ADP
significant O ADJ
benefit O NUM
without O ADP
the O DET
need O NOUN
for O ADP
more O ADV
complex O NOUN
interventions. O NOUN

There O PRON
were O VERB
56 O NUM
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
in O ADP
total, O ADJ
including O VERB
31 O NUM
in O ADP
the O DET
PICSI O NOUN
group O NOUN
and O CCONJ
25 O NUM
in O ADP
the O DET
ICSI O NOUN
group; O ADJ
most O DET
were O VERB
congenital B-outcome ADJ
abnormalities I-outcome NOUN
and O CCONJ
none O NUM
were O VERB
attributed O VERB
to O PART
treatment. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
The O DET
original O ADJ
trial O NOUN
was O VERB
retrospectively O ADV
registered O VERB
under O ADP
ClinicalTrials.gov O NOUN
Identifier O NOUN
NCT01660204 O NOUN
on O ADP
August O NOUN
8th, O NOUN
2012. O NUM

BACKGROUND: O NOUN
Shoulder O ADV
pain O NOUN
syndrome O NOUN
(SPS) O PUNCT
is O VERB
frequent O ADJ
and O CCONJ
management O NOUN
in O ADP
primary O ADJ
care O NOUN
is O VERB
precarious, O NOUN
with O ADP
a O DET
high O ADJ
rate O NOUN
of O ADP
referral O ADJ
without O ADP
adequate O ADJ
treatment, O NOUN
overloading O VERB
rehabilitation O NOUN
and O CCONJ
orthopedic O ADJ
services. O NOUN

Journal O ADJ
ID: O NOUN
101643584 O NUM

It O PRON
scavenges O NOUN
free O ADJ
radicals O NOUN
and O CCONJ
reactive O ADJ
oxygen O NOUN
species O NOUN
(ROS), O NUM
which O ADP
are O VERB
produced O VERB
during O ADP
metabolic O ADJ
pathways. O NOUN

CONCLUSION: O NOUN
the O DET
early O ADJ
stimulation O NOUN
is O VERB
a O DET
therapy O NOUN
with O ADP
bidirectional O ADJ
effect, O NOUN
because O ADP
it O PRON
has O VERB
favorable O ADJ
effects O NOUN
on O ADP
the O DET
person O NOUN
who O ADP
administers O NOUN
it; O NOUN
promotes O NOUN
health O NOUN
and O CCONJ
prevents O NOUN
illness O NOUN
in O ADP
the O DET
process O NOUN
of O ADP
adaptation O NOUN
to O PART
birth; O NOUN
especially O ADV
in O ADP
contexts O NOUN
of O ADP
vulnerability. O NOUN

Additional O ADJ
research, O NOUN
including O VERB
comparison O NOUN
of O ADP
IV O NUM
vs O CCONJ
oral O ADJ
acetaminophen O ADV
and O CCONJ
other O ADJ
potentially O ADV
opioid-sparing O VERB
analgesics, O ADJ
on O ADP
the O DET
incidence O NOUN
of O ADP
postoperative O ADJ
delirium O NOUN
is O VERB
warranted. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Journal O ADJ
ID: O NOUN
7501160 O NUM

Journal-Name:Medicine O NOUN

This O DET
study O NOUN
was O VERB
conducted O VERB
on O ADP
240 O NUM
patients O NOUN
of O ADP
dyslipidemia O NOUN
(as O PUNCT
per O ADP
ACC/AHA O NOUN
2013 O NUM
lipid O NOUN
guidelines) O NOUN
attending O VERB
the O DET
OPD/wards/CCU O NOUN
of O ADP
department O NOUN
of O ADP
cardiology, O NOUN
Sir O NOUN
Ganga O NOUN
Ram O NOUN
Hospital. O NOUN

CONCLUSIONS: O NOUN
Postdischarge O NOUN
MRSA O NOUN
decolonization O NOUN
with O ADP
chlorhexidine O NOUN
and O CCONJ
mupirocin O NOUN
led O VERB
to O PART
a O DET
30% O NOUN
lower O ADJ
risk O NOUN
of O ADP
MRSA B-outcome NOUN
infection I-outcome NOUN
than O ADP
education O NOUN
alone. O NOUN
( O PUNCT

Conclusions: O NOUN
Resin O NOUN
infiltration O NOUN
and O CCONJ
fluoride O NOUN
varnish O NOUN
are O VERB
clinically O ADV
feasible B-outcome ADJ
and O CCONJ
efficacious O ADJ
methods O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
anterior O ADJ
white B-outcome ADP
spot I-outcome NOUN
lesions I-outcome NOUN
. O PUNCT
The O DET
inhibition O NOUN
of O ADP
caries O NOUN
progression O NOUN
by O ADP
resin O NOUN
infiltration O NOUN
should O VERB
now O ADV
be O VERB
considered O VERB
an O DET
alternative O ADJ
to O PART
fluoride O NOUN
treatment. O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
493 O NUM
patients O NOUN
with O ADP
resected O VERB
pancreatic O ADJ
ductal O ADJ
adenocarcinoma O NOUN
to O PART
receive O VERB
a O DET
modified O VERB
FOLFIRINOX O NOUN
regimen O NOUN
(oxaliplatin O NOUN
[85 O NOUN
mg O NOUN
per O ADP
square O VERB
meter O NOUN
of O ADP
body-surface O NOUN
area], O NOUN
irinotecan O NOUN
[180 O PUNCT
mg O NOUN
per O ADP
square O VERB
meter, O NOUN
reduced O VERB
to O PART
150 O NUM
mg O NOUN
per O ADP
square O VERB
meter O NOUN
after O ADP
a O DET
protocol-specified O VERB
safety O NOUN
analysis], O NUM
leucovorin O NOUN
[400 O ADV
mg O NOUN
per O ADP
square O VERB
meter], O NUM
and O CCONJ
fluorouracil O NOUN
[2400 O ADP
mg O NOUN
per O ADP
square O VERB
meter O NOUN
every O DET
2 O NUM
weeks) O NOUN
or O CCONJ
gemcitabine O NOUN
(1000 O NUM
mg O NOUN
per O ADP
square O VERB
meter O NOUN
on O ADP
days O NOUN
1, O NOUN
8, O NOUN
and O CCONJ
15 O NUM
every O DET
4 O NUM
weeks) O NOUN
for O ADP
24 O NUM
weeks. O NOUN

After O ADP
the O DET
exacerbation, O NOUN
mean O NOUN
FEV1 B-outcome NOUN
improved O VERB
but O CCONJ
did O VERB
not O ADV
return O NOUN
to O PART
pre-exacerbation O NOUN
levels O NOUN
(mean O NUM
Days O NOUN
36-56 O NUM
after O ADP
the O DET
exacerbation, O NOUN
0.875 O NUM
L). O NOUN

Journal O ADJ
ID: O NOUN
101471610 O NUM

Title: O NOUN
Cost-effectiveness O NOUN
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
of O ADP
a O DET
diet O NOUN
intervention O NOUN
postpartum: O NOUN
2-year O NOUN
results O NOUN
from O ADP
a O DET
randomized O VERB
controlled O VERB
trial. O NOUN

There O PRON
were O VERB
no O DET
statistically O ADV
significant O ADJ
regression-adjusted O VERB
effects O NOUN
on O ADP
other O ADJ
outcomes, O NOUN
although O ADP
the O DET
direction O NOUN
of O ADP
change O NOUN
was O VERB
consistent O ADJ
with O ADP
improvements. O NOUN

Trial O NOUN
Registration: O NOUN
isrctn.com O NOUN
Identifier: O NOUN
ISRCTN89898870. O NOUN

RESULTS: O NOUN
The O DET
daily O ADJ
administration O NOUN
of O ADP
250 O NUM
mg O NOUN
of O ADP
elemental O ADJ
Mg O NOUN
indicated O VERB
a O DET
significant O ADJ
improvement O NOUN
in O ADP
HbA1C B-outcome NOUN
(8.32 O NOUN
to O PART
7.96%, O NUM
p O NOUN
< O SYM
0.001), O NUM
insulin B-outcome NOUN
levels O NOUN
(IL) O NOUN
(15.56 O PUNCT
to O PART
12.18 O NUM
muIU/mL, O NOUN
p O NOUN
< O SYM
0.001), O NUM
C-peptide B-outcome ADJ
(2.28 O PUNCT
to O PART
1.90 O NUM
ng/mL, O NOUN
p O NOUN
= O SYM
0.001), O NUM
HOMA.IR B-outcome NOUN
(6.16 O NOUN
to O PART
4.44, O NOUN
p O NOUN
< O SYM
0.001) O NUM
and O CCONJ
HOMA.beta B-outcome NOUN
% O SYM
(59.99 O PUNCT
to O PART
52.37, O NUM
p O NOUN
= O SYM
0.036) O NUM
of O ADP
the O DET
intervention O NOUN
group O NOUN
when O ADP
compared O VERB
with O ADP
the O DET
control O NOUN
group O NOUN
after O ADP
three O NUM
months O NOUN
of O ADP
intervention. O NOUN

To O PART
test O NOUN
this O DET
hypothesis, O NOUN
a O DET
randomized O VERB
double-blind O ADJ
placebo-controlled O VERB
study O NOUN
was O VERB
performed. O NOUN

These O DET
results O NOUN
indicate O VERB
that O ADP
EMDs O NOUN
contribute O NOUN
to O PART
the O DET
healing B-outcome VERB
of O ADP
soft O NOUN
tissue O NOUN
without O ADP
scarring. O ADV

Title: O NOUN
Effect O NOUN
of O ADP
infant O NOUN
stimulation O NOUN
on O ADP
the O DET
adaptation B-outcome NOUN
to I-outcome PART
birth I-outcome NOUN
: O PUNCT
a O DET
randomized O VERB
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/01/22 O ADJ
06:00 O ADP
[entrez] O ADP

However, O ADV
the O DET
benefit O NUM
of O ADP
thromboprophylaxis O NOUN
in O ADP
these O DET
patients O NOUN
is O VERB
uncertain. O NOUN

Title: O NOUN
Analgesic O ADP
effect O NOUN
of O ADP
trigger O ADP
point O NOUN
injection O NOUN
and O CCONJ
EMLA O NOUN
for O ADP
shoulder B-outcome NOUN
pain I-outcome NOUN
in O ADP
patients O NOUN
undergoing O VERB
total O ADJ
laparoscopic O ADJ
hysterectomy: O NOUN
A O DET
randomized O VERB
controlled O VERB
study. O NOUN

The O DET
average O NOUN
age O NOUN
was O VERB
65.41 O NUM
years O NOUN
(+/-SD O NOUN
4.08). O NOUN

RESULTS: O NOUN
Analysis O NOUN
identified O VERB
different O ADJ
views O NOUN
and O CCONJ
considerations O NOUN
for O ADP
engaging O VERB
in O ADP
a O DET
weight O NOUN
loss O NOUN
intervention O NOUN
at O ADP
the O DET
workplace. O ADV

The O DET
outcome O NOUN
was O VERB
stroke B-outcome NOUN
recurrence O NOUN
within O ADP
one-year O NOUN
follow-up. O PUNCT

The O DET
human O NOUN
immunodeficiency O NOUN
virus O NOUN
(HIV) O PUNCT
and O CCONJ
resulting O VERB
progressive O ADJ
HIV O NOUN
encephalopathy O NOUN
(PHE) O PUNCT
is O VERB
a O DET
pandemic O NOUN
in O ADP
this O DET
area, O NOUN
associated O VERB
with O ADP
development O NOUN
delays O NOUN
that O ADP
are O VERB
not O ADV
addressed O VERB
by O ADP
highly O ADV
active O ADJ
antiretroviral O ADJ
treatment O NOUN
(HAART). O NUM

Journal-Name:Nutrients O NOUN

METHODS: O NOUN
Ninety-three O NUM
infertile O NOUN
women O NOUN
were O VERB
recruited O VERB
into O ADP
1 O NUM
of O ADP
2 O NUM
groups: O NOUN
placebo O NOUN
(n O NOUN
= O SYM
47) O NOUN
or O CCONJ
nifedipine O NOUN
20 O NUM
mg O NOUN
(n O NOUN
= O SYM
46). O NOUN

The O DET
mean O NOUN
(+/-SD) O NOUN
Unified O VERB
Parkinson's B-outcome NOUN
Disease I-outcome NOUN
Rating O VERB
Scale O NOUN
(UPDRS) O NUM
score O NOUN
at O ADP
baseline O NOUN
was O VERB
28.1+/-11.4 O NOUN
points O NOUN
in O ADP
the O DET
early-start O NOUN
group O NOUN
and O CCONJ
29.3+/-12.1 O NOUN
points O NOUN
in O ADP
the O DET
delayed-start O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2019/03/06 O ADJ
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
2019/01/16 O NOUN
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
101521595 O NUM

Approved O VERB
by O ADP
the O DET
Ethics O NOUN
Committee O NOUN
of O ADP
Lower O ADJ
Austria O NOUN
(GS4-EK-4/107-2010). O NOUN

Complete-case, O NOUN
per-protocol, O NOUN
and O CCONJ
sensitivity O NOUN
analyses O NOUN
supported O VERB
this O DET
result. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

However, O ADV
randomized O VERB
clinical O ADJ
trials O NOUN
on O ADP
krill O NOUN
powder O NOUN
are O VERB
scarce O NOUN
and O CCONJ
systematic O ADJ
data O NOUN
of O ADP
krill O NOUN
meal O ADJ
on O ADP
human O NOUN
safety O NOUN
is O VERB
limited. O NOUN

For O ADP
creatine B-outcome NOUN
kinase I-outcome NOUN
, O PUNCT
SuperPATH O NOUN
group O NOUN
at O ADP
1 O NUM
and O CCONJ
3 O NUM
days O NOUN
were O VERB
lower O ADJ
than O ADP
control O NOUN
group O NOUN
( O PUNCT
P<0.05), O NOUN
while O ADP
no O DET
significant O ADJ
difference O NOUN
was O VERB
found O VERB
between O ADP
2 O NUM
groups O NOUN
before O ADP
operation O NOUN
and O CCONJ
at O ADP
14 O NUM
days O NOUN
after O ADP
operation O NOUN
( O PUNCT
P>0.05). O NOUN

Lancet O NOUN
2019;393:2213-21.This O NOUN
project O NOUN
was O VERB
funded O VERB
by O ADP
the O DET
NIHR O NOUN
Health O NOUN
Services O NOUN
and O CCONJ
Delivery O NOUN
Research O NOUN
Programme O NOUN
(project O NOUN
number O NOUN
12/5005/10).To O NUM
read O VERB
the O DET
full O ADJ
NIHR O NOUN
Signal, O ADJ
go O VERB
to O PART
https://discover.dc.nihr.ac.uk/content/signal-000789/national-quality-improvement O NOUN
-programmes-need-time-and-resources-to-have-impact. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

We O PRON
aimed O VERB
to O PART
assess O NOUN
the O DET
effects O NOUN
of O ADP
training O VERB
with O ADP
N95 O NOUN
or O CCONJ
higher O ADJ
filter O NOUN
respirators O NOUN
on O ADP
the O DET
protection B-outcome NOUN
performance O NOUN
of O ADP
respirators O NOUN
among O ADP
healthcare O NOUN
providers O NOUN
in O ADP
the O DET
emergency O NOUN
medical O ADJ
center O NOUN
(EMC). O NOUN

Additional O ADJ
arterial O ADJ
or O CCONJ
vein O NOUN
grafts O NOUN
were O VERB
used O VERB
as O ADP
indicated. O NOUN

Title: O NOUN
Moderate-intensity O NOUN
aerobic O ADJ
and O CCONJ
resistance O NOUN
exercise O NOUN
is O VERB
safe O ADJ
and O CCONJ
favorably O ADV
influences O NOUN
body B-outcome NOUN
composition I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
quiescent O ADJ
Inflammatory O ADJ
Bowel O NOUN
Disease: O NOUN
a O DET
randomized O VERB
controlled O VERB
cross-over O NOUN
trial. O NOUN

However, O ADV
there O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
for O ADP
median O ADJ
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
(5.0 O PUNCT
vs. O CCONJ
4.0 O NUM
months; O NOUN
HR O NOUN
= O SYM
1.03; O NOUN
95% O NOUN
CI, O NOUN
0.56-1.90; O NOUN
P O NOUN
= O SYM
.914). O PUNCT

Subjects O NOUN
completed O VERB
the O DET
demographic O ADJ
and O CCONJ
Beck O NOUN
Depression O NOUN
Inventory-II O NOUN
(BDI-II) O NUM
questionnaires O NOUN
before O ADP
and O CCONJ
after O ADP
intervention. O NOUN

Title: O NOUN
The O DET
impact O NOUN
of O ADP
an O DET
exercise O NOUN
program O NOUN
on O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
in O ADP
older O ADJ
breast O NOUN
cancer O NOUN
survivors O NOUN
undergoing O VERB
aromatase O NOUN
inhibitor O NOUN
therapy: O NOUN
a O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
A O DET
multicenter, O NOUN
parallel-group, O NOUN
cluster-randomized O VERB
clinical O ADJ
trial O NOUN
with O ADP
integrated O VERB
economic O ADJ
and O CCONJ
process O NOUN
evaluations O NOUN
conducted O VERB
in O ADP
24 O NUM
ICUs O NOUN
in O ADP
the O DET
United O VERB
Kingdom. O NOUN

METHODS: O NOUN
A O DET
stratified O VERB
case O NOUN
study O NOUN
was O VERB
conducted. O NOUN

Objective: O NOUN
To O PART
determine O NOUN
whether O ADP
removing O VERB
co-payment O NOUN
barriers O NOUN
increases O NOUN
P2Y12 B-outcome NOUN
inhibitor I-outcome NOUN
persistence I-outcome NOUN
and O CCONJ
lowers O NOUN
risk O NOUN
of O ADP
major B-outcome ADJ
adverse I-outcome ADJ
cardiovascular I-outcome ADJ
events I-outcome NOUN
(MACE) I-outcome PUNCT
. O PUNCT
Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Cluster O NOUN
randomized O VERB
clinical O ADJ
trial O NOUN
among O ADP
301 O NUM
hospitals O NOUN
enrolling O VERB
adult O NOUN
patients O NOUN
with O ADP
acute O ADJ
MI O NOUN
(June O PUNCT
5, O ADJ
2015, O NUM
through O ADP
September O NOUN
30, O NUM
2016); O NOUN
patients O NOUN
were O VERB
followed O VERB
up O ADP
for O ADP
1 O NUM
year O NOUN
after O ADP
discharge O NOUN
(final O NUM
date O NOUN
of O ADP
follow-up O NOUN
was O VERB
October O ADJ
23, O NUM
2017), O ADP
with O ADP
blinded O VERB
adjudication O NOUN
of O ADP
major B-outcome ADJ
adverse I-outcome ADJ
cardiovascular I-outcome ADJ
events I-outcome NOUN
(MACE) I-outcome PUNCT
; O PUNCT
choice O NOUN
of O ADP
P2Y12 O NOUN
inhibitor O NOUN
was O VERB
per O ADP
clinician O NOUN
discretion. O NOUN

Journal-Name:Pediatric O ADJ
rheumatology O NOUN
online O ADP
journal O ADJ

Introduction: O NOUN
Peri- O NOUN
and O CCONJ
postmenopausal O ADJ
women O NOUN
frequently O ADV
suffer O NOUN
from O ADP
urinary O ADJ
incontinence O NOUN
(UI). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODOLOGY/PRINCIPAL O ADP
FINDINGS: O ADJ
An O DET
open-label, O ADV
non-comparative O ADJ
randomized O VERB
trial O NOUN
of O ADP
AmBisome O NOUN
(30 O NOUN
mg/kg) O NOUN
with O ADP
miltefosine O NOUN
(100 O NUM
mg/day O NOUN
for O ADP
28 O NUM
days), O NOUN
and O CCONJ
AmBisome O NOUN
monotherapy O NOUN
(40 O NOUN
mg/kg) O NOUN
was O VERB
conducted O VERB
in O ADP
Ethiopian O NOUN
VL O NOUN
patients O NOUN
co-infected O VERB
with O ADP
HIV O NOUN
(NCT02011958). O NUM

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
a O DET
mixture O NOUN
of O ADP
two O NUM
Lactobacillus O NOUN
strains O NOUN
in O ADP
decreasing O VERB
infant B-outcome NOUN
cry I-outcome NOUN
and Seperator CCONJ
fuss S1-outcome NOUN
in O ADP
this O DET
population. O ADV

Importance: O NOUN
Whether O ADP
using O VERB
magnetic O ADJ
resonance O NOUN
imaging O VERB
(MRI) O PUNCT
to O PART
guide O NOUN
treatment O NOUN
in O ADP
patients O NOUN
with O ADP
rheumatoid O ADJ
arthritis O NOUN
(RA) O NOUN
improves O NOUN
disease O NOUN
activity O NOUN
and O CCONJ
slows O NOUN
joint O NOUN
damage O NOUN
progression O NOUN
is O VERB
unknown. O NOUN

Journal-Name:Journal O ADJ
of O ADP
cancer O NOUN
research O NOUN
and O CCONJ
therapeutics O NOUN

The O DET
investigated O VERB
program O NOUN
can O VERB
be O VERB
improved O VERB
by O ADP
considering O VERB
the O DET
following O VERB
suggestions: O NOUN
The O DET
quality O NOUN
of O ADP
the O DET
implementation O NOUN
process O NOUN
should O VERB
be O VERB
monitored O VERB
during O ADP
the O DET
implementation O NOUN
phase, O NOUN
and O CCONJ
regular O ADJ
feedback O NOUN
loops O NOUN
and O CCONJ
learning O VERB
opportunities O NOUN
for O ADP
teachers O NOUN
should O VERB
accompany O DET
a O DET
program. O NOUN

Mean O NOUN
+/- O SYM
SD O NOUN
central O ADJ
ECD O NOUN
at O ADP
baseline O NOUN
was O VERB
2453 O NUM
+/- O SYM
359 O NUM
cells/mm, O NOUN
decreasing O VERB
by O ADP
10% O ADP
+/- O SYM
14% O NOUN
to O PART
2195 O NUM
+/- O SYM
517 O NUM
cells/mm O NOUN
at O ADP
3 O NUM
months O NOUN
(P O NUM
< O SYM
0.001) O NUM
but O CCONJ
stabilizing O VERB
thereafter O ADV
with O ADP
mean O NOUN
endothelial B-outcome ADJ
cell I-outcome NOUN
loss O NOUN
(ECL) O ADV
from O ADP
baseline O NOUN
to O PART
24 O NUM
months O NOUN
of O ADP
9% O NOUN
+/- O SYM
13% O ADJ
(P O NUM
< O SYM
0.001). O NUM

201404134736 O NUM
N6 O NOUN
. O PUNCT

METHOD/DESIGN: O NOUN
This O DET
is O VERB
a O DET
multicenter, O NOUN
open-label, O ADV
randomized, O NOUN
controlled, O NOUN
and O CCONJ
equivalence O NOUN
trial O NOUN
with O ADP
2 O NUM
parallel O ADJ
arms. O ADJ

Journal O ADJ
ID: O NOUN
8216186 O NUM

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
06:00 O ADP
[medline] O NOUN

Similarly, O NOUN
fewer O ADJ
physical B-outcome ADJ
activity I-outcome NOUN
breaks I-outcome NOUN
in O ADP
combination O NOUN
with O ADP
other O ADJ
conditions O NOUN
impeded O VERB
the O DET
program's O NOUN
success. O NOUN

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
Green O NOUN
tea O NOUN
was O VERB
an O DET
effective O ADJ
adjunct O ADP
to O PART
trimethoprim-sulfamethoxazole O NOUN
to O PART
treat O NOUN
acute O ADJ
uncomplicated O VERB
cystitis O NOUN
in O ADP
women. O NOUN

There O PRON
were O VERB
no O DET
improvements O NOUN
in O ADP
the O DET
control O NOUN
group. O VERB

RESULTS: O NOUN
Both O CCONJ
groups O NOUN
heat B-outcome NOUN
acclimated I-outcome VERB
similarly O ADV
(p>0.05) O PUNCT
evidenced O VERB
by O ADP
lower O ADJ
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
thermoregulatory, B-outcome NOUN
physiological, B-outcome ADJ
and Seperator CCONJ
perceptual B-outcome ADJ
responses E1-outcome NOUN
( O PUNCT
perceived B-outcome VERB
exertion I-outcome NOUN
, O PUNCT
fatigue B-outcome NOUN
, O PUNCT
thermal B-outcome ADJ
sensation I-outcome NOUN
) O PUNCT
Pre O NOUN
HA O NOUN
vs. O CCONJ
Post O ADV
HA O NOUN
(p</=0.05). O NOUN

Except O ADP
that O ADP
the O DET
Oswestry O NOUN
disability B-outcome NOUN
index O NOUN
(ODI) O NOUN
score O NOUN
of O ADP
the O DET
control O NOUN
group O NOUN
was O VERB
significantly O ADV
higher O ADJ
than O ADP
that O ADP
of O ADP
the O DET
treatment O NOUN
group O NOUN
at O ADP
last O NOUN
follow-up O NOUN
( O PUNCT
P<0.05), O NOUN
there O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
VAS O NOUN
score O NOUN
and O CCONJ
Oswestry O NOUN
disability B-outcome NOUN
index O NOUN
(ODI) O NOUN
score O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
at O ADP
the O DET
other O ADJ
time O NOUN
points O NOUN
( O PUNCT
P>0.05). O NOUN

There O PRON
is O VERB
a O DET
paucity O NOUN
of O ADP
research O NOUN
on O ADP
the O DET
determinants O NOUN
of O ADP
psychological O ADJ
distress, O ADJ
particularly O ADV
among O ADP
the O DET
poorest O ADV
girls O NOUN
in O ADP
the O DET
poorest O ADV
communities. O NOUN

DESIGN: O NOUN
Randomized O VERB
control O NOUN
trial. O NOUN

These O DET
occurred O VERB
in O ADP
11 O NUM
of O ADP
207 O NUM
(5.3%), O NOUN
18 O NUM
of O ADP
250 O NUM
(7.2%), O NOUN
and O CCONJ
31 O NUM
of O ADP
277 O NUM
(11.2%) O NUM
patients O NOUN
exposed O VERB
to O PART
azithromycin, O ADV
clarithromycin, O NOUN
and O CCONJ
erythromycin O NOUN
for O ADP
at O ADP
least O ADV
one O NUM
day, O ADP
and O CCONJ
in O ADP
9 O NUM
of O ADP
234 O NUM
(3.8%), O NOUN
5 O NUM
of O ADP
194 O NUM
(2.6%), O PUNCT
and O CCONJ
23 O NUM
of O ADP
566 O NUM
(4.1%) O NOUN
exposed O VERB
to O PART
ciprofloxacin, O NOUN
levofloxacin, O ADV
and O CCONJ
moxifloxacin, O NOUN
respectively. O NOUN

Journal-Name: O NOUN
The O DET
International O ADJ
journal O ADJ
of O ADP
periodontics O NOUN
& O CCONJ
restorative O ADJ
dentistry O NOUN

RESULTS: O NOUN
The O DET
results O NOUN
revealed O VERB
that O ADP
there O PRON
was O VERB
a O DET
statistically O ADV
significant O ADJ
reduction O NOUN
in O ADP
plaque B-outcome NOUN
index O NOUN
(PI) O NOUN
and O CCONJ
probing B-outcome VERB
depth I-outcome NOUN
in O ADP
the O DET
test O NOUN
group O NOUN
when O ADP
compared O VERB
with O ADP
the O DET
control O NOUN
group. O VERB

BACKGROUND: O NOUN
To O PART
identify O NOUN
baseline O NOUN
patient O NOUN
characteristics O NOUN
associated O VERB
with O ADP
early O ADJ
clinically O ADV
significant O ADJ
visual B-outcome ADJ
acuity I-outcome NOUN
(VA) I-outcome NOUN
improvements O NOUN
within O ADP
3 O NUM
months O NOUN
of O ADP
treatment O NOUN
initiation O NOUN
in O ADP
ranibizumab-treated O VERB
patients O NOUN
with O ADP
retinal O ADJ
vein O NOUN
occlusion O NOUN
(RVO) O PUNCT
in O ADP
the O DET
SHORE O DET
study. O NOUN

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[entrez] O ADP

In O ADP
the O DET
group O NOUN
of O ADP
participants O NOUN
diagnosed O VERB
with O ADP
asthma, O NOUN
percentage O NOUN
differences O NOUN
of O ADP
participants O NOUN
with O ADP
good O ADJ
body O NOUN
posture O ADJ
(without O ADV
postural O ADJ
defects) O NOUN
were O VERB
statistically O ADV
significant. O NOUN

Compared O VERB
to O PART
the O DET
control O NOUN
group, O NOUN
the O DET
patients O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
had O VERB
lesser O ADJ
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
[47(26, O VERB
120) O NOUN
mg/g O ADV
vs O CCONJ
68(28, O PUNCT
158) O NOUN
mg/g, O VERB
P=0.039], O NOUN
and O CCONJ
lower O ADJ
serum O NOUN
cystatin B-outcome NOUN
C I-outcome NOUN
[(0.83+/-0.30) O NOUN
mg/L O NOUN
vs O CCONJ
(0.96+/-0.30)mg/L, O NOUN
P=0.041]. O NOUN
Berberine O NOUN
had O VERB
no O DET
obvious O ADJ
adverse B-outcome ADJ
effects I-outcome NOUN
. O PUNCT
Multiple O ADJ
linear O ADJ
regression O NOUN
analysis O NOUN
revealed O VERB
that O ADP
the O DET
berberine O NOUN
administration O NOUN
was O VERB
independently O ADV
associated O VERB
with O ADP
the O DET
reduction O NOUN
of O ADP
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
(beta=-0.051, O PUNCT
P=0.041) O NOUN
and O CCONJ
cystatin B-outcome NOUN
C I-outcome NOUN
(beta=-0.068, O NUM
P=0.033) O NOUN
in O ADP
T2DM O NOUN
patients. O NOUN

Title: O NOUN
Live O ADJ
Music O ADJ
Therapy O NOUN
During O ADP
Rehabilitation O NOUN
After O ADP
Total O ADJ
Knee O NOUN
Arthroplasty: O NOUN
A O DET
Randomized O VERB
Controlled O VERB
Trial. O NOUN

Journal-Name:Medicine O NOUN

Participants O NOUN
who O ADP
were O VERB
lost O VERB
to O PART
follow-up O NOUN
or O CCONJ
did O VERB
not O ADV
provide O VERB
biochemical O ADJ
validation O NOUN
were O VERB
considered O VERB
to O PART
not O ADV
be O VERB
abstinent. O NOUN

Infant O NOUN
colic O ADJ
is O VERB
a O DET
common O ADJ
condition O NOUN
of O ADP
unknown O VERB
pathogenesis O NOUN
that O ADP
brings O NOUN
frustration O NOUN
to O PART
families O NOUN
seeking O VERB
for O ADP
effective O ADJ
management. O NOUN

Primary O ADJ
outcome O NOUN
was O VERB
incidence O NOUN
of O ADP
active O ADJ
bleeding B-outcome VERB
control I-outcome NOUN
and O CCONJ
secondary O ADJ
outcomes O NOUN
were O VERB
incidence O NOUN
of O ADP
six O NUM
weeks O NOUN
rebleeding B-outcome VERB
, O PUNCT
complications B-outcome NOUN
, O PUNCT
and O CCONJ
mortality B-outcome NOUN
among O ADP
the O DET
studied O VERB
patients. O NOUN

We O PRON
investigated O VERB
the O DET
effects O NOUN
of O ADP
intraduodenally O ADV
administered O VERB
L-valine O NOUN
on O ADP
antropyloroduodenal B-outcome ADJ
pressures I-outcome NOUN
, O PUNCT
plasma O NOUN
cholecystokinin B-outcome NOUN
, O PUNCT
blood B-outcome NOUN
glucose I-outcome NOUN
and O CCONJ
energy B-outcome NOUN
intake I-outcome NOUN
. O PUNCT
Twelve O NUM
healthy O ADJ
lean O ADJ
men O NOUN
(age: O NOUN
29 O NUM
+/- O SYM
2 O NUM
years, O NOUN
BMI: O NOUN
22.5 O NUM
+/- O SYM
0.7 O NUM
kg/m(2)) O NOUN
were O VERB
studied O VERB
on O ADP
3 O NUM
separate O ADJ
occasions O NOUN
in O ADP
randomised, O NOUN
double-blind O ADJ
order. O NOUN

The O DET
primary O ADJ
endpoint O NOUN
of O ADP
overall O ADJ
(0-120 O NOUN
h O NOUN
after O ADP
chemotherapy O NOUN
administration) O NOUN
complete B-outcome ADJ
response I-outcome NOUN
(CR) I-outcome NOUN
rate O NOUN
(no O PUNCT
emesis, O NOUN
no O DET
rescue O NOUN
medication) O NOUN
was O VERB
64.2%, O NUM
60.0% O NUM
and O CCONJ
54.9% O NUM
in O ADP
the O DET
30-, O NOUN
100- O NUM
and O CCONJ
300-mg O NUM
arms, O NOUN
respectively, O NOUN
without O ADP
statistical O ADJ
significance O NOUN
for O ADP
dose-response. O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

BACKGROUND: O NOUN
Heartburn O NOUN
that O ADP
persists O NOUN
despite O ADP
proton-pump O NOUN
inhibitor O NOUN
(PPI) O NOUN
treatment O NOUN
is O VERB
a O DET
frequent O ADJ
clinical O ADJ
problem O ADP
with O ADP
multiple O ADJ
potential O ADJ
causes. O NOUN

RESULTS: O NOUN
Patients' O NOUN
main B-outcome ADJ
curve I-outcome NOUN
correction I-outcome NOUN
after O ADP
surgical O ADJ
procedure O NOUN
regardless O ADV
type O NOUN
of O ADP
rod O NOUN
was O VERB
48.95+/-11.04 O NUM
(13-75) O NOUN
degree. O NOUN

Journal-Name:The O ADJ
Lancet. O NOUN

The O DET
LBW O NOUN
patients O NOUN
(n O NOUN
= O SYM
278) O NOUN
were O VERB
injected O VERB
with O ADP
679 O NUM
mg O NOUN
iodine/kg O DET
(men) O ADV
or O CCONJ
762 O NUM
mg O NOUN
iodine/kg O DET
(women). O NOUN

Parents O NOUN
and O CCONJ
caregivers O NOUN
of O ADP
children O NOUN
6 O NUM
to O PART
40 O NUM
months O NOUN
age O NOUN
group O NOUN
in O ADP
intervention O NOUN
villages O NOUN
received O VERB
intensive O ADJ
education O NOUN
on O ADP
hand O NOUN
hygiene. O NOUN

Journal-Name:Medicine O NOUN

In O ADP
the O DET
SSD O NOUN
(n O NOUN
= O SYM
37) O NOUN
and O CCONJ
NPWT O NOUN
(n O NOUN
= O SYM
36) O NOUN
cohorts, O NOUN
the O DET
superficial O ADJ
surgical B-outcome ADJ
site I-outcome NOUN
infection I-outcome NOUN
(SSI) I-outcome NOUN
, O PUNCT
deep B-outcome ADJ
surgical I-outcome ADJ
site I-outcome NOUN
infection I-outcome NOUN
(SSI) I-outcome NOUN
, O PUNCT
seroma B-outcome NOUN
, O PUNCT
and O CCONJ
dehiscence B-outcome NOUN
rates O NOUN
were O VERB
16 O NUM
per O ADP
cent O NUM
and O CCONJ
14 O NUM
per O ADP
cent O NUM
(P O NUM
> O SYM
0.99), O NUM
5 O NUM
per O ADP
cent O NUM
and O CCONJ
8 O NUM
per O ADP
cent O NUM
(P O NUM
= O SYM
0.67), O NUM
16 O NUM
per O ADP
cent O NUM
and O CCONJ
11 O NUM
per O ADP
cent O NUM
(P O NUM
= O SYM
0.74), O NUM
and O CCONJ
5 O NUM
per O ADP
cent O NUM
and O CCONJ
3 O NUM
per O ADP
cent O NUM
(P O NUM
>/= O NOUN
0.99), O NUM
respectively. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

T O NOUN
Lund-Mackay O NOUN
score], O NUM
modified O VERB
Lund-Mackay O NOUN
score], O NUM
estimated B-outcome VERB
radiation I-outcome NOUN
exposure I-outcome NOUN
, O PUNCT
and O CCONJ
surgical B-outcome ADJ
complications I-outcome NOUN
were O VERB
evaluated O VERB
for O ADP
each O DET
patient. O NOUN

BACKGROUND: O NOUN
To O PART
evaluate O VERB
the O DET
safety O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
a O DET
bandage O NOUN
contact O NOUN
lens O NOUN
for O ADP
alleviating O VERB
dry B-outcome ADJ
eye I-outcome NOUN
discomfort I-outcome NOUN
after O ADP
phacoemulsification. O NOUN

Serum O NOUN
APN O NOUN
levels O NOUN
were O VERB
positively O ADV
correlated O VERB
with O ADP
FINS O NOUN
and O CCONJ
TG O NOUN
(r O NUM
= O SYM
0.412, O NOUN
0.316, O NUM
respectively; O NOUN
both O CCONJ
P<0.05), O NOUN
and O CCONJ
negatively O ADV
correlated O VERB
with O ADP
SBP, O NOUN
DBP O NOUN
and O CCONJ
LDL-C O NOUN
(r O NUM
= O SYM
-0.292, O NOUN
-0.383, O SYM
-0.334, O NOUN
respectively; O NOUN
all O DET
P<0.05). O NOUN

The O DET
median O ADJ
time B-outcome NOUN
to I-outcome PART
an Seperator DET
objective I-outcome ADP
response I-outcome NOUN
among O ADP
patients O NOUN
who O ADP
had O VERB
a O DET
response O NOUN
was O VERB
9.6 O NUM
months O NOUN
(interquartile O NUM
range, O VERB
6.6 O NUM
to O PART
16.7) O NOUN
in O ADP
the O DET
sorafenib O NOUN
group O NOUN
and O CCONJ
13.3 O NUM
months O NOUN
(interquartile O NUM
range, O VERB
11.2 O NUM
to O PART
31.1) O ADJ
in O ADP
the O DET
placebo O NOUN
group. O VERB

Journal-Name: O NOUN
Journal O ADJ
of O ADP
computer O NOUN
assisted O VERB
tomography O NOUN

Publication O NOUN
date: O NOUN
2018/11/14 O ADJ
00:00 O NOUN
[accepted] O ADV

BACKGROUND: O NOUN
Riociguat O ADP
is O VERB
a O DET
soluble O ADJ
guanylate O NOUN
cyclase O NOUN
stimulator O NOUN
approved O VERB
for O ADP
pulmonary O ADJ
arterial O ADJ
hypertension O NOUN
(PAH) O PUNCT
and O CCONJ
chronic O ADJ
thromboembolic O ADJ
pulmonary O ADJ
hypertension O NOUN
(CTPEH). O NOUN

The O DET
CMFCs O NOUN
were O VERB
defined O VERB
as O ADP
having O VERB
emergency B-outcome NOUN
C-section I-outcome NOUN
, O PUNCT
perineal B-outcome ADJ
trauma I-outcome NOUN
, O PUNCT
pregnancy-induced B-outcome VERB
hypertension I-outcome NOUN
and Seperator CCONJ
preeclampsia I-outcome NOUN
, O PUNCT
prematurity B-outcome NOUN
, O PUNCT
large-for-gestational-age B-outcome NOUN
, O PUNCT
and/or O CCONJ
small-for-gestational-age B-outcome NOUN
. O PUNCT
A O DET
total O ADJ
of O ADP
874 O NUM
women O NOUN
were O VERB
stratified O VERB
into O ADP
three O NUM
groups O NOUN
according O ADJ
to O PART
late O ADJ
first-trimester O NOUN
compliance O NOUN
with O ADP
six O NUM
food O NOUN
targets: O NOUN
>12 O NOUN
servings/week O NOUN
of O ADP
vegetables, O NOUN
>12 O NOUN
servings/week O NOUN
of O ADP
fruits, O NOUN
<2 O NOUN
servings/week O NOUN
of O ADP
juice, O NOUN
>3 O NOUN
servings/week O NOUN
of O ADP
nuts, O NOUN
>6 O NOUN
days/week O NOUN
consumption O NOUN
of O ADP
extra O ADJ
virgin O PUNCT
olive O ADJ
oil O NOUN
(EVOO), O NOUN
and O CCONJ
>/=40 O ADJ
mL/day O NOUN
of O ADP
EVOO. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

RESULTS: O NOUN
Fifty-two O NUM
residents O NOUN
participated O VERB
in O ADP
the O DET
study O NOUN
(Group O PUNCT
C: O NOUN
n O NOUN
= O SYM
27, O NUM
Group O NOUN
3D: O NOUN
n O NOUN
= O SYM
25). O NOUN

Participants O NOUN
viewed O VERB
promotional O ADJ
videos O NOUN
and O CCONJ
news O NOUN
stories O NOUN
about O ADV
an O DET
upcoming O VERB
international, O PUNCT
multi-sport O NOUN
event O NOUN
(with O PUNCT
sponsor O ADP
content O NOUN
edited O VERB
to O PART
reflect O NOUN
each O DET
condition), O NOUN
completed O VERB
a O DET
distractor O NOUN
task, O NOUN
and O CCONJ
then O ADV
answered O VERB
questions O NOUN
assessing O VERB
the O DET
response O NOUN
variables. O NUM

No O DET
major O ADJ
complications B-outcome NOUN
were O VERB
noted. O NOUN

Although O ADP
there O PRON
was O VERB
a O DET
general O ADJ
trend O NOUN
of O ADP
fasting B-outcome VERB
blood I-outcome NOUN
sugar I-outcome NOUN
(FBS) I-outcome PUNCT
reduction, O NOUN
the O DET
numbers O NOUN
of O ADP
participants O NOUN
who O ADP
may O VERB
be O VERB
classified O VERB
as O ADP
pre-diabetes O NOUN
and O CCONJ
diabetes O NOUN
groups O NOUN
( O PUNCT
fasting B-outcome VERB
blood I-outcome NOUN
sugar I-outcome NOUN
(FBS) I-outcome PUNCT
100 O NUM
mg/dl) O NOUN
in O ADP
the O DET
amla O NOUN
group O NOUN
were O VERB
only O ADV
8. O NUM

CONCLUSIONS: O NOUN
The O DET
WHO O NOUN
ACE O NOUN
approach O NOUN
supported O VERB
development O NOUN
and O CCONJ
sustainment O ADP
of O ADP
a O DET
network O NOUN
of O ADP
organizations O NOUN
linking O VERB
health O NOUN
care O NOUN
and O CCONJ
social O ADJ
services O NOUN
across O ADP
East O ADV
Baltimore. O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

Both O CCONJ
groups O NOUN
were O VERB
treated O VERB
and O CCONJ
followed O VERB
up O ADP
for O ADP
six O NUM
months. O NOUN

Schools O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
the O DET
treatment O NOUN
group O NOUN
to O PART
receive O VERB
free O ADJ
vision O NOUN
care O NOUN
and O CCONJ
eyeglasses, O NOUN
if O ADP
needed, O NOUN
or O CCONJ
control O NOUN
group, O NOUN
who O ADP
received O VERB
glasses O NOUN
only O ADV
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
study. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
is O VERB
to O PART
evaluate O VERB
the O DET
benefits O NOUN
of O ADP
treating O VERB
the O DET
donor O NOUN
liver O NOUN
with O ADP
Simvastatin O NOUN
compared O VERB
with O ADP
the O DET
standard O ADJ
transplant O NOUN
procedure. O NOUN

Plazomicin O NOUN
is O VERB
an O DET
aminoglycoside O NOUN
with O ADP
bactericidal O ADJ
activity O NOUN
against O ADP
multidrug-resistant O ADJ
(including O PUNCT
carbapenem-resistant) O NOUN
Enterobacteriaceae. O NOUN

These O DET
results O NOUN
confirm O NOUN
retrospective O ADJ
studies O NOUN
and O CCONJ
add O NOUN
that O ADP
histopathology O NOUN
subtype O NOUN
is O VERB
a O DET
strong O ADJ
determinant O NOUN
of O ADP
disease-free B-outcome ADJ
survival I-outcome NOUN
(DFS) I-outcome NOUN
in O ADP
resected O VERB
MAGE-A3-positive O ADJ
NSCLC. O NOUN

Publication O NOUN
date: O NOUN
2019/02/16 O NOUN
06:00 O ADP
[medline] O NOUN

Title: O NOUN
The O DET
Effect O NOUN
of O ADP
a O DET
Multidisciplinary O ADJ
Lifestyle O NOUN
Intervention O NOUN
on O ADP
Obesity B-outcome NOUN
Status, O NOUN
Body B-outcome NOUN
Composition I-outcome NOUN
, O PUNCT
Physical B-outcome ADJ
Fitness I-outcome ADV
, O PUNCT
and O CCONJ
Cardiometabolic B-outcome ADJ
Risk O NOUN
Markers O NOUN
in O ADP
Children O NOUN
and O CCONJ
Adolescents O NOUN
with O ADP
Obesity. O ADP

No O DET
difference O NOUN
of O ADP
adverse B-outcome ADJ
event I-outcome NOUN
incidences O NOUN
between O ADP
2 O NUM
groups O NOUN
was O VERB
observed. O NOUN

Conclusions: O NOUN
CBT-i O NOUN
for O ADP
chronic O ADJ
insomnia O NOUN
is O VERB
effective O ADJ
in O ADP
both O CCONJ
CBT-i O NOUN
alone O ADJ
and O CCONJ
combination O NOUN
with O ADP
tapered O VERB
hypnotic O ADJ
agents. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Overall, B-outcome NOUN
abdominal, B-outcome ADJ
and Seperator CCONJ
shoulder B-outcome NOUN
pains E1-outcome NOUN
were O VERB
evaluated O VERB
at O ADP
rest O NOUN
and O CCONJ
in O ADP
motion O NOUN
on O ADP
postoperative O ADJ
day O NOUN
3. O NUM

Title: O NOUN
Therapeutic O ADJ
effects O NOUN
of O ADP
dimethyldiguanide O NOUN
combined O VERB
with O ADP
clomifene O NOUN
citrate O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
polycystic O ADJ
ovary O NOUN
syndrome. O NOUN

CONCLUSIONS: O NOUN
Once-daily O NOUN
plazomicin O NOUN
was O VERB
noninferior O ADJ
to O PART
meropenem O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
complicated O VERB
UTIs O NOUN
and O CCONJ
acute O ADJ
pyelonephritis O NOUN
caused O VERB
by O ADP
Enterobacteriaceae, O NOUN
including O VERB
multidrug-resistant O ADJ
strains. O NUM
( O PUNCT

Potential O NOUN
for O ADP
skin O NOUN
irritation O NOUN
and O CCONJ
dryness, O NOUN
as O ADP
well O ADV
as O ADP
pigmentary O NOUN
changes O NOUN
are O VERB
key O ADJ
concerns. O NOUN

The O DET
PICIHBI O NOUN
group O NOUN
demonstrated O VERB
a O DET
significant O ADJ
increase O NOUN
in O ADP
one O NUM
Test O NOUN
of O ADP
Playfulness B-outcome ADV
(ToP) O ADV
item O NOUN
score O NOUN
at O ADP
midassessment. O NOUN

RESULTS: O NOUN
Total O ADJ
30-min O NOUN
time-trial B-outcome ADJ
distance I-outcome NOUN
significantly O ADV
increased O VERB
from O ADP
T1-T3 O NOUN
within O ADP
betaA1 O NOUN
only O ADV
(7397 O NOUN
+/- O SYM
195 O NUM
m O NOUN
to O PART
7580 O NUM
+/- O SYM
171 O NUM
m, O NOUN
P O NOUN
= O SYM
0.002, O NUM
np(2) O ADJ
= O SYM
0.196), O NUM
including O VERB
absolute O ADJ
average O NOUN
power B-outcome NOUN
(194.8 O ADP
+/- O SYM
18.3 O NUM
W O NOUN
to O PART
204.2 O NUM
+/- O SYM
15.5 O NUM
W, O NOUN
P O NOUN
= O SYM
0.04, O NUM
np(2) O ADJ
= O SYM
0.115) O NOUN
and O CCONJ
relative O ADJ
average O NOUN
power B-outcome NOUN
output I-outcome NOUN
(2.28 O PUNCT
+/- O SYM
0.15 O NUM
W.kg(- O NOUN
1) O NUM
to O PART
2.41 O NUM
+/- O SYM
0.12 O NUM
W.kg(- O NOUN
1), O NUM
P O NOUN
= O SYM
0.031, O NUM
np(2) O ADJ
= O SYM
0.122). O NUM

METHODS: O NOUN
The O DET
phase O NOUN
3, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
TOURMALINE-MM3 O PUNCT
study O NOUN
took O VERB
place O NOUN
in O ADP
167 O NUM
clinical O ADJ
or O CCONJ
hospital O NOUN
sites O NOUN
in O ADP
30 O NUM
countries O NOUN
in O ADP
Europe, O NOUN
the O DET
Middle O ADJ
East, O NOUN
Africa, O NOUN
Asia, O ADV
and O CCONJ
North O NOUN
and O CCONJ
South O NOUN
America. O ADV

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Materials O NOUN
and O CCONJ
Methods: O NOUN
In O ADP
this O DET
prospective O ADJ
study, O NOUN
80 O NUM
patients O NOUN
that O ADP
underwent O VERB
radical O NOUN
resection O NOUN
for O ADP
colorectal O ADJ
cancer O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
four O NUM
groups: O NOUN
(1) O PUNCT
the O DET
parecoxib O NOUN
group, O NOUN
with O ADP
preintravenous O ADJ
injection O NOUN
of O ADP
parecoxib O NOUN
and O CCONJ
postoperative O ADJ
PCIA O NOUN
after O ADP
surgery; O NOUN
(2) O PUNCT
the O DET
TAP O NOUN
group, O NOUN
with O ADP
TAP O NOUN
block O VERB
and O CCONJ
postoperative O ADJ
PCIA; O NOUN
(3) O PUNCT
the O DET
parecoxib O NOUN
+ O SYM
TAP O NOUN
group, O NOUN
with O ADP
parecoxib O NOUN
combined O VERB
with O ADP
TAP O NOUN
block O VERB
and O CCONJ
postoperative O ADJ
PCIA; O NOUN
and O CCONJ
(4) O PUNCT
the O DET
control O NOUN
group, O NOUN
with O ADP
only O ADV
postoperative O ADJ
PCIA O NOUN
and O CCONJ
preinjection O NOUN
of O ADP
normal O ADJ
saline. O NOUN

Twenty O NUM
minutes O NOUN
before O ADP
the O DET
end O NOUN
of O ADP
surgery, O NOUN
single O ADJ
bolus O NOUN
injection O NOUN
of O ADP
fentanyl, O NOUN
50 O NUM
mug O NUM
(fentanyl O PUNCT
group O NOUN
[group O NOUN
F], O NOUN
n O NOUN
= O SYM
23) O NUM
or O CCONJ
oxycodone, O ADV
4 O NUM
mg O NOUN
(oxycodone O NUM
group O NOUN
[group O NOUN
O], O NOUN
n O NOUN
= O SYM
23) O NUM
was O VERB
administered O VERB
intravenously. O NOUN
[ O PUNCT

Title: O NOUN
When O ADP
color O NOUN
helps. O NOUN

RESULTS: O NOUN
Women O NOUN
in O ADP
the O DET
green O ADV
tea O NOUN
group O NOUN
showed O VERB
a O DET
statistically O ADV
significant O ADJ
decrease O NOUN
in O ADP
the O DET
prevalence O NOUN
of O ADP
cystitis B-outcome NOUN
symptoms I-outcome NOUN
and O CCONJ
a O DET
statistically O ADV
significant O ADJ
improvement O NOUN
in O ADP
the O DET
urinalysis B-outcome ADV
results O NOUN
except O ADP
for O ADP
hematuria O NOUN
after O ADP
3 O NUM
days O NOUN
of O ADP
treatment. O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

The O DET
inflammatory O ADJ
response O NOUN
indicators O NOUN
( O PUNCT
C-reactive B-outcome ADJ
protein I-outcome NOUN
, O PUNCT
erythrocyte B-outcome NOUN
sedimentation I-outcome NOUN
rate I-outcome NOUN
) O PUNCT
and O CCONJ
muscle B-outcome NOUN
damage I-outcome NOUN
index O NOUN
( O PUNCT
creatine B-outcome NOUN
kinase I-outcome NOUN
) O PUNCT
were O VERB
recorded O VERB
in O ADP
both O CCONJ
groups. O NOUN

INTERVENTION(S): O NOUN
We O PRON
randomly O ADV
assigned O VERB
participants O NOUN
to O PART
1 O NUM
of O ADP
4 O NUM
groups: O NOUN
rigid O NOUN
taping, O NOUN
Kinesio O NOUN
taping, O NOUN
placebo, O NOUN
or O CCONJ
control O NOUN
(no O PUNCT
taping). O ADJ

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Journal-Name:Journal O ADJ
of O ADP
ethnopharmacology O NOUN

Conclusion: O NOUN
Foot O NOUN
and O CCONJ
ankle O NOUN
characteristics O NOUN
were O VERB
different O ADJ
in O ADP
individuals O NOUN
with O ADP
PFOA O NOUN
compared O VERB
to O PART
control O NOUN
participants, O NOUN
however O ADV
there O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
dynamic O ADJ
knee O NOUN
valgus O NOUN
during O ADP
single O ADJ
leg O NOUN
squat. O NOUN

Journal-Name: O NOUN
Lin O NOUN
chuang O NOUN
er O NOUN
bi O ADP
yan O NOUN
hou O VERB
tou O NOUN
jing O VERB
wai O CCONJ
ke O NOUN
za O ADP
zhi O NUM
= O SYM
Journal O ADJ
of O ADP
clinical O ADJ
otorhinolaryngology, O NOUN
head, O ADJ
and O CCONJ
neck O NOUN
surgery O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Title: O NOUN
Why O NOUN
people O NOUN
engage O NOUN
in O ADP
a O DET
weight O NOUN
loss O NOUN
intervention O NOUN
at O ADP
their O ADJ
workplace O ADJ
- O PUNCT
a O DET
stratified O VERB
case O NOUN
study. O NOUN

RESULTS: O NOUN
TXA O NOUN
significantly O ADV
reduced O VERB
perioperative O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
compared O VERB
with O ADP
placebo O NOUN
(p O PUNCT
< O SYM
0.001); O NUM
the O DET
mean O NOUN
differences O NOUN
were O VERB
525.3 O NUM
ml O NOUN
(short-TXA O PUNCT
vs O CCONJ
placebo) O NOUN
and O CCONJ
550.1 O NUM
ml O NOUN
(long-TXA O PUNCT
vs O CCONJ
placebo). O NOUN

Efficacy O NOUN
assessments O NOUN
included O VERB
changes O NOUN
in O ADP
baseline O NOUN
inflammatory O ADJ
and O CCONJ
noninflammatory O ADJ
lesions B-outcome NOUN
and O CCONJ
treatment B-outcome NOUN
success I-outcome NOUN
(at O NUM
least O ADV
2-grade O NOUN
reduction O NOUN
in O ADP
Evaluator's O NOUN
Global O NOUN
Severity O NOUN
Score O NOUN
(EGSS) O PUNCT
and O CCONJ
clear/almost O NOUN
clear). O NOUN

The O DET
proportion O NOUN
of O ADP
patients O NOUN
with O ADP
SAEs B-outcome NOUN
in O ADP
groups O NOUN
receiving O VERB
IBU O NOUN
was O VERB
15%, O NUM
and O CCONJ
in O ADP
the O DET
PCM-alone O NOUN
group, O NOUN
was O VERB
11%. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Secondary O ADJ
outcomes O NOUN
include O VERB
the O DET
difference O NOUN
in O ADP
cure B-outcome NOUN
rate O NOUN
and O CCONJ
intensity B-outcome NOUN
reduction O NOUN
rate O NOUN
between O ADP
the O DET
intense O ADJ
and O CCONJ
standard O ADJ
treatment O NOUN
groups O NOUN
as O ADP
measured O VERB
by O ADP
the O DET
other O ADJ
diagnostic O ADJ
tests, O NOUN
as O ADP
well O ADV
as O ADP
the O DET
accuracy O NOUN
of O ADP
the O DET
different O ADJ
diagnostic O ADJ
tests, O NOUN
and O CCONJ
the O DET
safety O NOUN
of O ADP
PZQ. O NOUN

The O DET
visual O ADJ
analog O NOUN
score O NOUN
was O VERB
used O VERB
to O PART
measure O NOUN
the O DET
pain B-outcome NOUN
. O PUNCT
The O DET
mean O NOUN
operative B-outcome ADJ
time I-outcome NOUN
, O PUNCT
patient-controlled O VERB
intravenous O ADJ
analgesia B-outcome NOUN
pressing I-outcome VERB
time I-outcome NOUN
, O PUNCT
time B-outcome NOUN
for Seperator ADP
first I-outcome ADV
out-of-bed I-outcome VERB
activity I-outcome NOUN
, O PUNCT
first B-outcome ADV
anus I-outcome NOUN
exhaust I-outcome ADV
time I-outcome NOUN
, O PUNCT
hospital B-outcome NOUN
stay I-outcome NOUN
duration I-outcome NOUN
, O PUNCT
and O CCONJ
complications B-outcome NOUN
were O VERB
recorded. O NOUN

METHODS: O NOUN
65 O NUM
randomly O ADV
selected O VERB
patients O NOUN
undergoing O VERB
elective O ADJ
complex O NOUN
percutaneous O ADJ
coronary O ADJ
intervention O NOUN
(PCI) O PUNCT
procedures O NOUN
from O ADP
January O NOUN
2017 O NUM
to O PART
2017 O NUM
were O VERB
randomized O VERB
in O ADP
a O DET
1:1 O ADJ
pattern O NOUN
with O ADP
or O CCONJ
without O ADP
the O DET
RADPAD. O NOUN

Journal-Name:Medicine O NOUN

Compared O VERB
with O ADP
the O DET
routine O ADJ
treatment O NOUN
group, O NOUN
the O DET
28-day O NOUN
neonatal B-outcome ADJ
behavioral I-outcome ADJ
neurological I-outcome ADJ
assessment O NOUN
score O NOUN
of O ADP
the O DET
SBH O NOUN
treatment O NOUN
group O NOUN
was O VERB
increased O VERB
by O ADP
2.9 O NUM
[95% O NOUN
confidence O NOUN
interval O NOUN
(95%CI) O NOUN
= O SYM
1.0-4.8], O NOUN
Bayley O PROPN
scales O NOUN
of O ADP
infant B-outcome NOUN
development I-outcome NOUN
(BSID) O NUM
score O NOUN
at O ADP
15 O NUM
months O NOUN
of O ADP
age O NOUN
was O VERB
improved O VERB
significantly, O NOUN
mental B-outcome ADJ
development I-outcome NOUN
index O NOUN
(MDI) O NOUN
score O NOUN
was O VERB
increased O VERB
by O ADP
11.8 O NUM
(95%CI O PUNCT
= O SYM
4.3-19.3), O NOUN
and O CCONJ
psychomotor B-outcome NOUN
development I-outcome NOUN
index O NOUN
(PDI) O NOUN
score O NOUN
was O VERB
increased O VERB
by O ADP
12.4 O NUM
(95%CI O PUNCT
= O SYM
2.5-22.3), O NOUN
with O ADP
significant O ADJ
differences O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
(all O PUNCT
P O NOUN
< O SYM
0.05). O NOUN

Fifty O NUM
participants O NOUN
(male O PUNCT
and O CCONJ
female O NOUN
aged O VERB
20 O NUM
to O PART
50 O NUM
years) O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
two O NUM
groups. O NOUN

Hyaluronan-selected O VERB
sperm O NOUN
have O VERB
reduced O VERB
levels O NOUN
of O ADP
DNA O NOUN
damage O NOUN
and O CCONJ
aneuploidy. O NOUN

Journal-Name:Medicine O NOUN

Small O ADJ
differences O NOUN
in O ADP
the O DET
effects O NOUN
seen O VERB
between O ADP
genders O NOUN
may O VERB
be O VERB
attributed O VERB
to O PART
the O DET
different O ADJ
sizes O NOUN
of O ADP
the O DET
two O NUM
groups O NOUN
and O CCONJ
need O NOUN
to O PART
be O VERB
further O ADV
evaluated O VERB
in O ADP
randomized O VERB
trials O NOUN
that O ADP
are O VERB
appropriately O ADV
powered O VERB
for O ADP
gender O NOUN
analysis. O NOUN

Adverse B-outcome ADJ
events I-outcome NOUN
that O ADP
emerged O VERB
after O ADP
treatment O NOUN
initiation O NOUN
were O VERB
reported O VERB
in O ADP
41.1% O NOUN
of O ADP
the O DET
patients O NOUN
in O ADP
the O DET
omadacycline O NOUN
group O NOUN
and O CCONJ
48.5% O NOUN
of O ADP
the O DET
patients O NOUN
in O ADP
the O DET
moxifloxacin O NOUN
group; O ADJ
the O DET
most O DET
frequent O ADJ
events O NOUN
were O VERB
gastrointestinal B-outcome ADJ
(10.2% O VERB
and O CCONJ
18.0%, O NUM
respectively), O NOUN
and O CCONJ
the O DET
largest O ADV
difference O NOUN
was O VERB
for O ADP
diarrhea B-outcome NOUN
(1.0% O NOUN
and O CCONJ
8.0%). O NOUN

Recruitment O NOUN
was O VERB
from O ADP
January O NOUN
2015 O NUM
to O PART
May O NOUN
2018, O NUM
with O ADP
follow-up O NOUN
until O ADP
July O NOUN
2018. O NUM

Among O ADP
patients O NOUN
who O ADP
received O VERB
sorafenib, O NOUN
the O DET
most O DET
frequently O ADV
reported O VERB
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
grade O NOUN
1 O NUM
or O CCONJ
2 O NUM
events O NOUN
of O ADP
rash B-outcome NOUN
(73%), O NOUN
fatigue B-outcome NOUN
(67%), O NOUN
hypertension B-outcome NOUN
(55%), O NOUN
and O CCONJ
diarrhea B-outcome NOUN
(51%). O PUNCT

Small B-outcome ADJ
for Seperator ADP
gestational I-outcome ADJ
age I-outcome NOUN
at Seperator ADP
birth I-outcome NOUN
was O VERB
significantly O ADV
more O ADV
often O ADV
detected O VERB
in O ADP
the O DET
intervention O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
usual O ADJ
care O NOUN
group O NOUN
(179 O PUNCT
of O ADP
556 O NUM
(32%) O NUM
v O NUM
78 O NUM
of O ADP
407 O NUM
(19%), O NOUN
P<0.001). O NUM

Results O NOUN
demonstrated O VERB
both O CCONJ
subjective O ADJ
and O CCONJ
objective O ADP
functional B-outcome ADJ
mobility I-outcome NOUN
improvements O NOUN
after O ADP
treatment O NOUN
in O ADP
participants O NOUN
receiving O VERB
hippotherapy O NOUN
and O CCONJ
standard O ADJ
outpatient O ADJ
PT, O NOUN
as O ADP
determined O VERB
by O ADP
the O DET
Peabody O NOUN
Developmental B-outcome ADJ
Motor I-outcome NOUN
Scales-2], O NOUN
the O DET
Pediatric O ADJ
Evaluation O NOUN
of O ADP
Disability B-outcome NOUN
Inventory], O NOUN
and O CCONJ
the O DET
Goal B-outcome NOUN
Attainment I-outcome NOUN
Scaling]. O NOUN
STATEMENT O NOUN
OF O ADP
CONCLUSION O NOUN
AND O CCONJ
RECOMMENDATIONS O NOUN
FOR O ADP
CLINICAL O ADJ
PRACTICE:: O NOUN
When O ADP
compared O VERB
with O ADP
standard O ADJ
outpatient O ADJ
PT, O NOUN
hippotherapy O NOUN
appears O NOUN
to O PART
be O VERB
a O DET
viable O ADJ
treatment O NOUN
strategy O NOUN
for O ADP
children O NOUN
aged O VERB
2 O NUM
to O PART
5 O NUM
years O NOUN
with O ADP
neurological O ADJ
impairments O NOUN
and O CCONJ
gross O ADJ
motor O NOUN
delays, O NOUN
but O CCONJ
additional O ADJ
research O NOUN
in O ADP
this O DET
area O NOUN
is O VERB
needed O VERB
to O PART
validate O NOUN
findings. O NOUN

FUNDING: O NOUN
Neovii O NOUN
Biotech. O NOUN

CONCLUSIONS: O NOUN
Inhalation O NOUN
aromatherapy O NOUN
using O VERB
lavender O NOUN
essential O ADJ
oil O NOUN
can O VERB
improve O VERB
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
of O ADP
postmenopausal O ADJ
women O NOUN
with O ADP
a O DET
reduction O NOUN
in O ADP
the O DET
severity O NOUN
of O ADP
complications B-outcome NOUN
and O CCONJ
physical-psychological B-outcome ADJ
symptoms I-outcome NOUN
. O PUNCT

Patients O NOUN
in O ADP
group O NOUN
A O DET
received O VERB
Garlicin O NOUN
Capsules O NOUN
1/time, O NOUN
3 O NUM
times/d, O VERB
combined O VERB
with O ADP
Kangfuxin O NOUN
liquid O ADV
10 O NUM
mL O NOUN
to O PART
gargle O NOUN
3 O NUM
times/d; O NUM
patients O NOUN
in O ADP
group O NOUN
B O NOUN
only O ADV
received O VERB
Kangfuxin O NOUN
liquid O ADV
10 O NUM
mL O NOUN
gargle O NOUN
5 O NUM
min, O NOUN
3/d. O NUM

24 O NUM
+/- O SYM
4 O NUM
kg/m(2)) O NOUN
males O NOUN
(n O NOUN
= O SYM
13) O DET
and O CCONJ
females O NOUN
(n O NOUN
= O SYM
13) O DET
after O ADP
exercise-induced O VERB
dehydration O NOUN
(~ O PUNCT
2.0%DeltaBody O NUM
Weight O NOUN
[BW]) O PUNCT
in O ADP
the O DET
heat O NOUN
(30 O NOUN
degrees O NOUN
C, O NOUN
50% O NUM
relative O ADJ
humidity O NOUN
[RH]). O NUM

Funded O VERB
by O ADP
Alnylam O NOUN
Pharmaceuticals; O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02452372 O NOUN
.). O NOUN

Saliva O ADJ
cortisol B-outcome NOUN
, O PUNCT
a O DET
marker O NOUN
of O ADP
the O DET
endocrine B-outcome ADJ
stress I-outcome NOUN
response I-outcome NOUN
system, O ADV
was O VERB
not O ADV
significantly O ADV
different O ADJ
between O ADP
the O DET
two O NUM
groups. O NOUN

Spearman O NOUN
rank O NOUN
correlation O NOUN
analysis O NOUN
was O VERB
performed O VERB
to O PART
determine O NOUN
correlations O NOUN
between O ADP
grip B-outcome NOUN
strength I-outcome NOUN
and O CCONJ
TOFr. O NOUN

The O DET
duration B-outcome NOUN
of I-outcome ADP
sensory I-outcome ADJ
block I-outcome VERB
was O VERB
120.5 O NUM
+/- O SYM
37.0 O NUM
minutes O NOUN
in O ADP
Dex O NOUN
group O NOUN
and O CCONJ
70.5 O NUM
+/- O SYM
34.5 O NUM
minutes O NOUN
in O ADP
Control O NOUN
group, O NOUN
respectively O ADV
(P O NUM
< O SYM
.05). O NUM

All O DET
participants O NOUN
received O VERB
allotments O NOUN
of O ADP
extra-virgin O NOUN
olive O ADJ
oil O NOUN
(1 O NOUN
L/mo) O NOUN
and O CCONJ
nuts O NOUN
(125 O NUM
g/mo) O ADP
for O ADP
free. O NOUN

Title: O NOUN
Vitamin O NOUN
D O NOUN
Daily O ADJ
versus O CCONJ
Monthly O ADV
Administration: O NOUN
Bone B-outcome NOUN
Turnover I-outcome ADV
and O CCONJ
Adipose B-outcome ADJ
Tissue I-outcome NOUN
Influences. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Results: O NOUN
Among O ADP
6874 O NUM
randomized O VERB
participants O NOUN
(mean O NUM
[SD] O PUNCT
age, O NOUN
65.0 O NUM
[4.9] O ADV
years; O NOUN
3406 O NUM
[52%] O NUM
men), O NOUN
6583 O NUM
(96%) O ADV
completed O VERB
the O DET
12-month O NOUN
follow-up O NOUN
and O CCONJ
were O VERB
included O VERB
in O ADP
the O DET
main O ADJ
analysis. O NOUN

Publication O NOUN
Type: O NOUN
Observational O ADJ
Study O NOUN

Whether O ADP
hybrid O NOUN
minimally O ADV
invasive O ADJ
esophagectomy O NOUN
results O NOUN
in O ADP
lower O ADJ
morbidity O NOUN
than O ADP
open O ADJ
esophagectomy O NOUN
is O VERB
unclear. O NOUN

The O DET
toxicity B-outcome NOUN
were O VERB
evaluated O VERB
in O ADP
all O DET
patients O NOUN
this O DET
study O NOUN
according O ADJ
to O PART
the O DET
National O ADJ
Cancer O NOUN
Institute O NOUN
Common O ADJ
Toxicity O NOUN
Criteria O NOUN
4 O NUM
(NCI O NOUN
CTC O NOUN
version O NOUN
4.0).A O PUNCT
total O ADJ
of O ADP
53 O NUM
well-matched O VERB
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
were O VERB
retrospectively O ADV
analyzed. O NOUN

Publication O NOUN
date: O NOUN
2018/05/26 O NOUN
00:00 O NOUN
[accepted] O ADV

Facilitators: O NOUN
peer O NOUN
influence, O NOUN
teacher O NOUN
influence, O NOUN
staggered O VERB
implementation, O ADP
incentives, O ADP
rewards, O NOUN
challenges O NOUN
and O CCONJ
competition, O NOUN
flexibility O NOUN
and O CCONJ
adaptability, O ADJ
child O NOUN
ownership, O NOUN
routine. O SYM

Publication O NOUN
date: O NOUN
2019/02/15 O NOUN
06:00 O ADP
[medline] O NOUN

Barriers: O NOUN
time O NOUN
within O ADP
an O DET
intense O ADJ
curriculum, O NOUN
space, O NOUN
sustaining O VERB
child O NOUN
interest, O NOUN
parental O ADJ
support, O NOUN
school O NOUN
policies. O NOUN

The O DET
current O ADJ
study O NOUN
protocol O NOUN
aims O NOUN
at O ADP
scaling O VERB
up O ADP
these O DET
results O NOUN
at O ADP
a O DET
provincial O ADJ
level O NOUN
using O VERB
a O DET
randomized O VERB
controlled O VERB
trial O NOUN
design. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
probabilities O NOUN
of O ADP
decompression O NOUN
being O VERB
cost-effective O ADJ
compared O VERB
with O ADP
no O DET
treatment O NOUN
at O ADP
a O DET
willingness-to-pay O NOUN
threshold O NOUN
of O ADP
pound20 O NOUN
000 O NUM
per O ADP
QALY O NOUN
were O VERB
close O ADJ
to O PART
0% O NOUN
at O ADP
six O NUM
months O NOUN
and O CCONJ
approximately O ADV
50% O NUM
at O ADP
one O NUM
year, O ADV
with O ADP
this O DET
probability O NOUN
potentially O ADV
increasing O VERB
for O ADP
the O DET
extrapolation O NOUN
to O PART
two O NUM
years. O NOUN

Journal-Name:Medicine O NOUN

Genotypes O NOUN
were O VERB
associated O VERB
with O ADP
plasma O NOUN
arachidonic B-outcome ADJ
acid I-outcome NOUN
levels O NOUN
and, O NOUN
if O ADP
considered O VERB
together O ADV
with O ADP
the O DET
levels O NOUN
of O ADP
the O DET
precursor O NOUN
alpha-linolenic O ADJ
acid, O NOUN
also O ADV
with O ADP
DHA B-outcome NOUN
. O PUNCT
Functional B-outcome ADJ
outcomes O NOUN
and O CCONJ
supplementation O NOUN
effects O NOUN
were O VERB
not O ADV
significantly O ADV
associated O VERB
with O ADP
genotype. O NOUN

The O DET
Schirmer O NOUN
test O NOUN
results O NOUN
did O VERB
not O ADV
significantly O ADV
change O NOUN
postoperatively. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
regarding O VERB
the O DET
incidences O NOUN
of O ADP
postoperative O ADJ
agitation B-outcome NOUN
and O CCONJ
oxygen B-outcome NOUN
saturation I-outcome NOUN
(SpO2) I-outcome ADV
. O PUNCT
Compared O VERB
with O ADP
control O NOUN
group, O NOUN
the O DET
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
of O ADP
DEX O NOUN
group O NOUN
was O VERB
decreased O VERB
after O ADP
20 O NUM
minutes O NOUN
of O ADP
drug O NOUN
administration O NOUN
[(97.13+/-12.93) O NOUN
beats/min O NOUN
vs.(104.53+/-11.97) O NOUN
beats/min, O NOUN
P<0.05]. O NOUN
The O DET
changes O NOUN
of O ADP
the O DET
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
and O CCONJ
oxygen B-outcome NOUN
saturation I-outcome NOUN
(SpO2) I-outcome ADV
in O ADP
the O DET
two O NUM
groups O NOUN
were O VERB
within O ADP
the O DET
normal O ADJ
range. O ADJ

CONCLUSION: O NOUN
The O DET
local O ADJ
application O NOUN
of O ADP
curcumin O NOUN
gel O NOUN
when O ADP
used O VERB
in O ADP
conjunction O NOUN
with O ADP
SRP O NOUN
showed O VERB
a O DET
significant O ADJ
improvement O NOUN
in O ADP
periodontal O ADJ
parameters O NOUN
and O CCONJ
has O VERB
a O DET
beneficial O ADJ
effect O NOUN
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
periodontitis. O NOUN

Journal O ADJ
ID: O NOUN
101213819 O NUM

All O DET
patients O NOUN
received O VERB
sufentanil O NOUN
(0.3 O NOUN
mug/kg) O NOUN
30 O NUM
min O NOUN
before O ADP
the O DET
end O NOUN
of O ADP
the O DET
operation O NOUN
and O CCONJ
then O ADV
received O VERB
intravenous O ADJ
analgesia O NOUN
pump O NOUN
for O ADP
postoperative O ADJ
patient O NOUN
controlled O VERB
analgesia(PCA). O NOUN

L-valine O NOUN
did O VERB
not O ADV
affect O NOUN
antral, B-outcome ADJ
pyloric B-outcome ADJ
(mean X NOUN
number; X NOUN
control: X NOUN
14 X NUM
+/- X SYM
5; X NOUN
L-Val-0.15: X NOUN
21 X NUM
+/- X SYM
9; X NOUN
L-Val-0.45: X NOUN
11 X NUM
+/- X SYM
4) X NUM
or Seperator CCONJ
duodenal B-outcome ADJ
pressures E1-outcome NOUN
, O PUNCT
plasma O NOUN
cholecystokinin B-outcome NOUN
(mean O NUM
concentration, O NOUN
pmol/L; O NOUN
control: O NOUN
3.1 O NUM
+/- O SYM
0.3; O NUM
L-Val-0.15: O NOUN
3.2 O NUM
+/- O SYM
0.3; O NUM
L-Val-0.45: O NOUN
3.0 O NUM
+/- O SYM
0.3), O NUM
blood B-outcome NOUN
glucose I-outcome NOUN
, O PUNCT
appetite B-outcome NOUN
perceptions I-outcome NOUN
, O PUNCT
symptoms B-outcome NOUN
or O CCONJ
energy B-outcome NOUN
intake I-outcome NOUN
(kcal; O NOUN
control: O NOUN
1040 O NUM
+/- O SYM
73; O NUM
L-Val-0.15: O NOUN
1040 O NUM
+/- O SYM
81; O NUM
L-Val-0.45: O NOUN
1056 O NUM
+/- O SYM
100), O NOUN
at O ADP
either O CCONJ
load O NOUN
(p O PUNCT
> O SYM
0.05 O NUM
for O ADP
all). O NOUN

CONCLUSIONS: O NOUN
TPI O NOUN
and O CCONJ
EMLA O NOUN
with O ADP
occlusive O ADJ
dressing O VERB
effectively O ADV
reduced O VERB
the O DET
shoulder B-outcome NOUN
pain I-outcome NOUN
after O ADP
total O ADJ
laparoscopic O ADJ
hysterectomy. O NOUN

The O DET
experimental O ADJ
sets O NOUN
were O VERB
performed O VERB
to O PART
momentary O ADJ
muscular O ADJ
failure. O NOUN

The O DET
data O NOUN
of O ADP
age, O NOUN
sex, O NOUN
and O CCONJ
laterality O NOUN
were O VERB
analyzed O VERB
through O ADP
pairwise O NOUN
comparison. O NOUN

Furthermore, O NOUN
we O PRON
observed O VERB
a O DET
strong O ADJ
correlation O NOUN
between O ADP
noggin B-outcome NOUN
and O CCONJ
wrist B-outcome NOUN
bone I-outcome NOUN
mineral I-outcome NOUN
density I-outcome NOUN
(r O NUM
= O SYM
-0.641, O NOUN
p O NOUN
= O SYM
0.002) O NUM
only O ADV
in O ADP
the O DET
denosumab O NOUN
group. O VERB

There O PRON
were O VERB
98 O NUM
male O NOUN
and O CCONJ
131 O NUM
female O NOUN
patients, O NOUN
with O ADP
a O DET
mean O NOUN
age O NOUN
of O ADP
65.5 O NUM
years O NOUN
(32 O PUNCT
to O PART
91). O NOUN

1.6% O ADP
reported O VERB
sexual O ADJ
abuse, O NOUN
8.0% O NOUN
recent O ADJ
eve O VERB
teasing O VERB
and O CCONJ
6.3% O ADJ
having O VERB
no O DET
parental O ADJ
emotional O ADJ
support. O NOUN

All O DET
local B-outcome ADJ
solicited I-outcome VERB
and Seperator CCONJ
unsolicited I-outcome VERB
AEs I-outcome NOUN
were O VERB
grade O NOUN
1 O NUM
or O CCONJ
2. O NUM

Limitations: O NOUN
This O DET
post O ADV
hoc O NOUN
analysis O NOUN
was O VERB
limited O VERB
to O PART
patients O NOUN
with O ADP
moderate-to-severe O ADV
plaque O NOUN
psoriasis O NOUN
with O ADP
IGA O NOUN
>/=3 O NOUN
and O CCONJ
BSA O NOUN
involvement O NOUN
(3%-12%). O PUNCT

Journal-Name: O NOUN
BMJ O NOUN
(Clinical O ADJ
research O NOUN
ed.) O NOUN

RESULTS: O NOUN
Initial O ADJ
bleeding B-outcome VERB
control I-outcome NOUN
was O VERB
significantly O ADV
higher O ADJ
in O ADP
cyanoacrylate O VERB
versus O CCONJ
sclerotherapy O NOUN
groups O NOUN
(98.25, O PUNCT
83.93% O PUNCT
respectively, O NOUN
P O NOUN
= O SYM
0.007). O NUM

Objective: O NOUN
The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
investigate O NOUN
the O DET
effect O NOUN
of O ADP
preintravenous O ADJ
injection O NOUN
of O ADP
parecoxib, O NOUN
combined O VERB
with O ADP
transversus O NOUN
abdominis O NOUN
plane O ADJ
(TAP) O PUNCT
block O VERB
and O CCONJ
postoperative O ADJ
patient-controlled O VERB
intravenous O ADJ
analgesia O NOUN
(PCIA) O PUNCT
pump, O NOUN
in O ADP
strategy O NOUN
of O ADP
enhanced O VERB
recovery B-outcome NOUN
after O ADP
surgery O NOUN
for O ADP
patients O NOUN
with O ADP
radical O NOUN
resection O NOUN
of O ADP
colorectal O ADJ
cancer. O NOUN

Participants O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
were O VERB
tested O VERB
again O ADV
after O ADP
1 O NUM
week O NOUN
(test-2). O PUNCT

BACKGROUND: O NOUN
Hypoxemia O NOUN
is O VERB
the O DET
most O DET
common O ADJ
complication O NOUN
during O ADP
tracheal O ADJ
intubation O NOUN
of O ADP
critically O ADV
ill O ADJ
adults O NOUN
and O CCONJ
may O VERB
increase O NOUN
the O DET
risk O NOUN
of O ADP
cardiac O ADJ
arrest O NOUN
and O CCONJ
death. O ADP

The O DET
significance O NOUN
level O NOUN
adopted O VERB
was O VERB
of O ADP
0.05. O PUNCT

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
We O PRON
examined O VERB
baseline O NOUN
characteristics O NOUN
associated O VERB
with O ADP
disease-free B-outcome ADJ
survival I-outcome NOUN
(DFS) I-outcome NOUN
and O CCONJ
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
among O ADP
757 O NUM
patients O NOUN
with O ADP
resected, O NOUN
histologically O ADV
proven, O NOUN
MAGE-A3-positive O ADJ
Stage O NOUN
IB-IIIA O NOUN
NSCLC O NOUN
assigned O VERB
to O PART
placebo O NOUN
in O ADP
the O DET
MAGRIT O NOUN
study O NOUN
(NCT00480025). O NUM

Plasma O NOUN
fentanyl O NOUN
levels O NOUN
were O VERB
measured O VERB
at O ADP
admission, O NOUN
1, O NOUN
6, O NOUN
12, O NUM
24, O NUM
and O CCONJ
48 O NUM
h O NOUN
postoperatively. O NOUN

CONCLUSION: O NOUN
The O DET
SPT O NOUN
intervention O NOUN
can O VERB
improve O VERB
functional O ADJ
outcomes O NOUN
of O ADP
upper O ADJ
extremity O NOUN
in O ADP
people O NOUN
after O ADP
stroke. O NOUN

Journal-Name:BMC O NOUN
infectious O ADJ
diseases O NOUN

CONCLUSION: O NOUN
Pharmacotherapeutic O ADJ
education O NOUN
of O ADP
patients O NOUN
with O ADP
T2DM O NOUN
can O VERB
significantly O ADV
improve O VERB
30-day O NOUN
post-discharge O NOUN
medication O NOUN
adherence B-outcome NOUN
, O PUNCT
without O ADP
a O DET
significant O ADJ
reduction O NOUN
in O ADP
adverse B-outcome ADJ
clinical I-outcome ADJ
outcomes I-outcome NOUN
. O PUNCT
ClinicalTrial.gov O NOUN
identification O NOUN
number: O NOUN
NCT03438162. O NOUN

The O DET
Monitoring O VERB
+ O SYM
Acceptance O ADV
Theory O ADJ
(MAT) O NOUN
postulates O NOUN
that O ADP
MBI O NOUN
improves O NOUN
cognition O NOUN
through O ADP
monitoring, O NOUN
and O CCONJ
psychological O ADJ
well-being, O NOUN
through O ADP
acceptance. O NOUN

METHODS: O NOUN
This O DET
prospective, O NOUN
interventional, O ADJ
randomized O VERB
clinical O ADJ
study O NOUN
was O VERB
done O NOUN
at O ADP
Alpha O NOUN
Vision O NOUN
Center, O NOUN
Zagazig, O ADJ
Egypt. O NOUN

The O DET
difference O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
treatment O NOUN
success O NOUN
between O ADP
the O DET
active O ADJ
medical O ADJ
group O NOUN
and O CCONJ
the O DET
control O NOUN
medical O ADJ
group O NOUN
was O VERB
16 O NUM
percentage O NOUN
points O NOUN
(95% O PUNCT
confidence O NOUN
interval, O ADP
-5 O NUM
to O PART
38; O NOUN
P O NOUN
= O SYM
0.17). O NUM

Several O ADJ
studies O NOUN
have O VERB
linked O VERB
increased O VERB
intake O NOUN
of O ADP
dietary O ADJ
fibre O NOUN
to O PART
improvement O NOUN
in O ADP
the O DET
management O NOUN
of O ADP
body O NOUN
weight. O NOUN

Publication O NOUN
date: O NOUN
2019/02/20 O ADJ
06:00 O ADP
[entrez] O ADP

The O DET
primary O ADJ
outcome O NOUN
was O VERB
total O ADJ
induction B-outcome NOUN
time I-outcome NOUN
based O VERB
on O ADP
the O DET
order O NOUN
of O ADP
remifentanil O NOUN
administration. O ADV

The O DET
aim O ADP
of O ADP
this O DET
large O ADJ
randomised O VERB
controlled O VERB
trial O NOUN
was O VERB
to O PART
collect O NOUN
data O NOUN
to O PART
enhance O NOUN
the O DET
validity O NOUN
and O CCONJ
applicability O NOUN
of O ADP
the O DET
evidence O NOUN
from O ADP
previous O ADJ
trials O NOUN
to O PART
inform O NOUN
practice. O NOUN

This O DET
study O NOUN
explored O VERB
the O DET
efficacy O NOUN
of O ADP
WPI O NOUN
for O ADP
improving O VERB
cognitive B-outcome ADJ
function I-outcome NOUN
via O ADP
delivery O NOUN
of O ADP
vitamin O NOUN
B12. O NOUN

Further O ADV
studies O NOUN
are O VERB
required O VERB
to O PART
demonstrate O VERB
the O DET
clinical O ADJ
benefits O NOUN
and O CCONJ
risks O NOUN
of O ADP
nifedipine O NOUN
usage O NOUN
in O ADP
embryo O NOUN
transfer. O NOUN

Both O CCONJ
groups O NOUN
received O VERB
brief O ADJ
advice O NOUN
about O ADV
healthy O ADJ
eating O VERB
and O CCONJ
physical O ADJ
activity. O NOUN

November O NOUN
27, O NUM
2013. O NUM

Changes O NOUN
in O ADP
QOL O NOUN
were O VERB
measured O VERB
using O VERB
the O DET
36-item O NOUN
Short O NOUN
Form O NOUN
Health B-outcome NOUN
Survey O NOUN
and O CCONJ
EQ-5D]. O VERB
The O DET
analysis O NOUN
of O ADP
cost-effectiveness O NOUN
was O VERB
a O DET
cost-utility O NOUN
analysis O NOUN
with O ADP
a O DET
health O NOUN
care O NOUN
perspective O ADJ
and O CCONJ
included O VERB
costs B-outcome NOUN
of I-outcome ADP
intervention I-outcome NOUN
for O ADP
stakeholder, O NOUN
quality-adjusted O VERB
life-years O NOUN
(QALYs) O NOUN
gained O VERB
and O CCONJ
savings B-outcome NOUN
in Seperator ADP
health I-outcome NOUN
care I-outcome NOUN
. O PUNCT
The O DET
likelihood O NOUN
of O ADP
cost-effectiveness O NOUN
was O VERB
examined O VERB
using O VERB
the O DET
net O ADJ
monetary O ADJ
benefit O NUM
method. O NOUN

Title: O NOUN
Intrathecal O ADJ
dexmedetomidine O NOUN
can O VERB
decrease O NOUN
the O DET
95% O NOUN
effective O ADJ
dose O NOUN
of O ADP
bupivacaine O NOUN
in O ADP
spinal O ADJ
anesthesia O NOUN
for O ADP
cesarean O NOUN
section: O NOUN
A O DET
prospective, O NOUN
double-blinded, O NOUN
randomized O VERB
study. O NOUN

Yi O NOUN
xue O NOUN
ban O NOUN
= O SYM
Journal O ADJ
of O ADP
Central O ADJ
South O NOUN
University. O NOUN

RESULTS: O NOUN
The O DET
incidence O NOUN
of O ADP
shoulder B-outcome NOUN
pain I-outcome NOUN
was O VERB
significantly O ADV
reduced O VERB
in O ADP
EMLA O NOUN
group O NOUN
(56%) O NOUN
compared O VERB
to O PART
control O NOUN
(88%) O NOUN
or O CCONJ
TPI O NOUN
(88%) O NOUN
groups O NOUN
(P O NUM
= O SYM
.025 O NUM
in O ADP
both); O NOUN
the O DET
severity O NOUN
of O ADP
shoulder B-outcome NOUN
pain I-outcome NOUN
was O VERB
mitigated O VERB
in O ADP
EMLA O NOUN
and O CCONJ
TPI O NOUN
groups O NOUN
compared O VERB
to O PART
control O NOUN
group O NOUN
(P O NUM
< O SYM
.001, O PUNCT
each). O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

BACKGROUND: O NOUN
Myelomeningocele O NOUN
is O VERB
a O DET
congenital O ADJ
anomaly O NOUN
of O ADP
Central O ADJ
Nervous O ADJ
System O NOUN
(CNS) O NOUN
leading O VERB
to O PART
serious O ADJ
sequels O NOUN
related O VERB
to O PART
various O ADJ
systems O NOUN
and O CCONJ
organs O NOUN
of O ADP
the O DET
affected O VERB
patient. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Fracture O NOUN
Prevention O NOUN
with O ADP
Zoledronate O NOUN
in O ADP
Older O ADJ
Women O NOUN
with O ADP
Osteopenia. O NOUN

CONCLUSIONS: O NOUN
Among O ADP
critically O ADV
ill O ADJ
adults O NOUN
undergoing O VERB
tracheal O ADJ
intubation, O NOUN
patients O NOUN
receiving O VERB
bag-mask O ADJ
ventilation O NOUN
had O VERB
higher O ADJ
oxygen B-outcome NOUN
saturations I-outcome NOUN
and O CCONJ
a O DET
lower O ADJ
incidence O NOUN
of O ADP
severe B-outcome ADJ
hypoxemia I-outcome NOUN
than O ADP
those O DET
receiving O VERB
no O DET
ventilation. O ADV
( O PUNCT

The O DET
efficacy O NOUN
of O ADP
tafenoquine O NOUN
was O VERB
not O ADV
shown O VERB
to O PART
be O VERB
noninferior O ADJ
to O PART
that O ADP
of O ADP
primaquine O NOUN
(odds O NOUN
ratio O NOUN
for O ADP
recurrence, O NOUN
1.81; O NOUN
95% O NOUN
CI, O NOUN
0.82 O NUM
to O PART
3.96). O NOUN

Nd:YAG O NOUN
laser O NOUN
goniopuncture O NOUN
was O VERB
done O NOUN
in O ADP
cases O NOUN
where O ADP
the O DET
intraocular O ADJ
pressure O NOUN
(IOP) O ADV
was O VERB
elevated O VERB
above O ADP
21 O NUM
mmHg O NOUN
after O ADP
discontinuation O NOUN
of O ADP
corticosteroid O NOUN
eye O NOUN
drops O NOUN
at O ADP
any O DET
follow-up O NOUN
visit. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

RESULTS: O NOUN
The O DET
repeated O VERB
measures O NOUN
ANOVA O NOUN
between O ADP
the O DET
GCAF O NOUN
and O CCONJ
GCON O NOUN
groups O NOUN
revealed O VERB
statistically O ADV
significant O ADJ
differences O NOUN
in O ADP
2 O NUM
variables. O NUM

OBJECTIVE: O NOUN
To O PART
observe O NOUN
the O DET
clinical O ADJ
efficacy O NOUN
of O ADP
dopamine O NOUN
modulator O NOUN
methylphenidate O NOUN
(MPH) O PUNCT
of O ADP
extended-release O NOUN
formulations O NOUN
(MPH-ER) O PUNCT
augmentation O NOUN
of O ADP
ongoing O VERB
fluvoxamine O NOUN
treatment O NOUN
in O ADP
refractory O ADJ
obsessive-compulsive O ADJ
disorder O ADP
(OCD) O NOUN
and O CCONJ
its O ADJ
effects O NOUN
on O ADP
patient's O NOUN
anxiety B-outcome NOUN
and O CCONJ
sleep B-outcome NOUN
quality I-outcome NOUN
. O PUNCT
Methods: O NOUN
A O DET
pilot O NOUN
randomized, O NOUN
placebo-controlled, O NOUN
and O CCONJ
double-blind O ADJ
trial O NOUN
was O VERB
conducted O VERB
at O ADP
an O DET
outpatient, O ADP
single-center O NOUN
academic O ADJ
setting. O NOUN

Post-hoc O NOUN
tests O NOUN
demonstrated O VERB
statistically O ADV
significant O ADJ
differences O NOUN
in O ADP
time B-outcome NOUN
under Seperator ADP
tension I-outcome NOUN
(TUT) I-outcome PUNCT
when O ADP
comparing O VERB
the O DET
group O NOUN
supplemented O VERB
with O ADP
caffeine O NOUN
(13.689 O NOUN
s O NOUN
GCAF) O NOUN
to O PART
the O DET
one O NUM
ingesting O VERB
a O DET
placebo O NOUN
(15.332 O PUNCT
s O NOUN
GCON) O NOUN
at O ADP
p O NOUN
= O SYM
0.002. O NUM

RESULTS: O NOUN
An O DET
overall O ADJ
treatment O NOUN
effect O NOUN
(p O PUNCT
= O SYM
0.019) O NUM
was O VERB
evident O ADJ
for O ADP
increased O VERB
hits B-outcome NOUN
with O ADP
PSE O NOUN
on O ADP
the O DET
stationary O ADJ
test O NOUN
with O ADP
footplates, O NOUN
with O ADP
between O ADP
group O NOUN
differences O NOUN
at O ADP
Day O NOUN
30 O NUM
(PSE O NUM
vs. O CCONJ
PLA: O NOUN
28.96 O NUM
+/- O SYM
2.08 O NUM
vs. O CCONJ
28.09 O NUM
+/- O SYM
1.92 O NUM
hits; O NOUN
p O NOUN
= O SYM
0.040) O NOUN
and O CCONJ
Day O NOUN
90 O NUM
(PSE O NUM
vs. O CCONJ
PLA: O NOUN
28.42 O NUM
+/- O SYM
2.54 O NUM
vs. O CCONJ
27.02 O NUM
+/- O SYM
3.55 O NUM
hits; O NOUN
p O NOUN
= O SYM
0.002). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
Clinical O ADJ
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
apatinib O ADP
in O ADP
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
as O ADP
the O DET
late-line O NOUN
treatment. O NOUN

At O ADP
the O DET
3-month O NOUN
follow-up O NOUN
visit, O NOUN
there O PRON
were O VERB
improvements O NOUN
in O ADP
adherence B-outcome NOUN
to O PART
the O DET
MD O NOUN
and O CCONJ
diet B-outcome NOUN
quality I-outcome NOUN
of O ADP
2.2 O NUM
and O CCONJ
2.5 O NUM
points, O NOUN
compared O VERB
to O PART
the O DET
baseline O NOUN
visit, O NOUN
respectively, O NOUN
in O ADP
favour O NOUN
of O ADP
the O DET
IG. O NOUN

Only O ADV
PPI O NOUN
therapy O NOUN
significantly O ADV
decreased O VERB
the O DET
VAS O NOUN
scores, O NOUN
suggesting O VERB
the O DET
improvement O NOUN
of O ADP
taste B-outcome NOUN
perception I-outcome NOUN
. O PUNCT
Moreover, O NOUN
PPI O NOUN
therapy O NOUN
significantly O ADV
decreased O VERB
recognition O NOUN
thresholds O NOUN
for O ADP
bitter B-outcome NOUN
taste I-outcome NOUN
in O ADP
the O DET
anterior O ADJ
tongue O NOUN
(chorda O NUM
tympani O NOUN
nerve O NOUN
area) O NOUN
and O CCONJ
the O DET
thresholds O NOUN
in O ADP
the O DET
posterior O ADJ
tongue O NOUN
(glossopharyngeal O PUNCT
nerve O NOUN
area) O NOUN
for O ADP
salty, B-outcome ADJ
sour, B-outcome NOUN
and Seperator CCONJ
bitter B-outcome NOUN
tastes E1-outcome NOUN
. O PUNCT
By O ADP
contrast, O NOUN
H2-blocker O NOUN
therapy O NOUN
caused O VERB
no O DET
significant O ADJ
changes O NOUN
of O ADP
thresholds O NOUN
in O ADP
the O DET
anterior O ADJ
tongue, O ADV
but O CCONJ
improved O VERB
the O DET
threshold O NOUN
{only} O NOUN
for O ADP
bitter B-outcome NOUN
in O ADP
the O DET
posterior O ADJ
tongue, O ADV
the O DET
value O NOUN
of O ADP
which O ADP
was O VERB
however O ADV
significantly O ADV
higher O ADJ
than O ADP
that O ADP
in O ADP
PPI O NOUN
group. O VERB

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
role O NOUN
of O ADP
0.2% O NOUN
bio-adhesive O ADJ
chlorhexidine O NOUN
gel O NOUN
in O ADP
reducing O VERB
incidence O NOUN
of O ADP
alveolar B-outcome ADJ
osteitis I-outcome NOUN
after O ADP
surgical O ADJ
removal O NOUN
of O ADP
mandibular O ADJ
third O ADJ
molars O NOUN
which O ADP
causes O NOUN
extra O ADJ
monetary O ADJ
burden O NOUN
on O ADP
the O DET
patients O NOUN
in O ADP
the O DET
form O NOUN
of O ADP
several O ADJ
follow O VERB
up O ADP
visits.. O NOUN
METHODS: O NOUN
A O DET
randomized O VERB
clinical O ADJ
trial O NOUN
was O VERB
performed O VERB
in O ADP
the O DET
Dental O ADJ
Section, O NOUN
Ayub O ADP
Medical O ADJ
College, O PUNCT
Abbottabad. O NOUN

Publication O NOUN
date: O NOUN
2019/02/13 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
effect O NOUN
of O ADP
groups O NOUN
and O CCONJ
health B-outcome NOUN
education I-outcome NOUN
duration I-outcome NOUN
times O NOUN
was O VERB
found O VERB
on O ADP
reduced O VERB
HbA1c B-outcome NOUN
concentration O NOUN
and O CCONJ
increased O VERB
the O DET
total O ADJ
score O NOUN
of O ADP
Self-Efficacy B-outcome NOUN
(P O NUM
<.05). O NOUN

In B-outcome ADP
vitro I-outcome ADV
fertilization I-outcome NOUN
(IVF) I-outcome NOUN
/ O SYM
intracytoplasmic B-outcome ADJ
sperm I-outcome NOUN
injection I-outcome NOUN
(ICSI) I-outcome NUM
outcomes O NOUN
were O VERB
compared O VERB
between O ADP
groups. O NOUN

Journal-Name:Zhong O ADJ
nan O VERB
da O NOUN
xue O NOUN
xue O NOUN
bao. O ADP

This O DET
assessment, O NOUN
part O NOUN
of O ADP
the O DET
BabyGel O NOUN
Pilot O NOUN
study, O NOUN
evaluated O VERB
the O DET
acceptability O NOUN
of O ADP
the O DET
'Newborn O NUM
Moments O NOUN
for O ADP
Hand O NOUN
Hygiene O NOUN
in O ADP
the O DET
Home' O NOUN
poster. O NOUN

Publication O NOUN
Type: O NOUN
Clinical O ADJ
Trial, O NOUN
Phase O NOUN
III O NUM

The O DET
conventional O ADJ
pulmonary O ADJ
rehabilitation O NOUN
treatments, O ADV
including O VERB
pursed O VERB
lips O NOUN
breathing O VERB
(PLB) O NOUN
and O CCONJ
abdominal O ADJ
breathing O VERB
training, O NOUN
were O VERB
applied O VERB
in O ADP
the O DET
control O NOUN
group. O VERB

Title: O NOUN
Citrus O NOUN
Aurantium O NOUN
and O CCONJ
caffeine O NOUN
complex O NOUN
versus O CCONJ
placebo O NOUN
on O ADP
biomarkers O NOUN
of O ADP
metabolism B-outcome NOUN
: O PUNCT
a O DET
double O ADV
blind O PUNCT
crossover O NOUN
design. O NOUN

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

BACKGROUND: O NOUN
The O DET
burden O NOUN
of O ADP
chronic O ADJ
obstructive O ADJ
lung O NOUN
disease O NOUN
(COPD) O NUM
is O VERB
increasing O VERB
in O ADP
women, O NOUN
with O ADP
recent O ADJ
evidence O NOUN
suggesting O VERB
gender O NOUN
differences O NOUN
in O ADP
disease O NOUN
characteristics O NOUN
and O CCONJ
potentially O ADV
in O ADP
treatment O NOUN
outcomes. O ADJ

METHODS: O NOUN
In O ADP
2 O NUM
similarly O ADV
designed O VERB
studies O NOUN
of O ADP
patients O NOUN
with O ADP
episodic O NOUN
migraine O NOUN
(6 O ADV
months) O NOUN
and O CCONJ
1 O NUM
study O NOUN
of O ADP
patients O NOUN
with O ADP
chronic O ADJ
migraine O NOUN
(3 O NOUN
months), O NOUN
patients O NOUN
randomized O VERB
in O ADP
a O DET
1:1:2 O NOUN
ratio O NOUN
received O VERB
a O DET
subcutaneous O ADJ
injection O NOUN
of O ADP
galcanezumab O NOUN
120 O NUM
mg/month O ADV
(after O PUNCT
an O DET
initial O ADJ
loading O VERB
dose O NOUN
of O ADP
240 O NUM
mg) O NOUN
or O CCONJ
240 O NUM
mg/month O ADV
or O CCONJ
placebo. O NOUN

The O DET
cumulative O ADJ
opioid B-outcome NOUN
requirement I-outcome NOUN
was O VERB
significantly O ADV
less O ADV
in O ADP
group O NOUN
O O NOUN
at O ADP
6, O NOUN
12, O NUM
24, O NUM
and O CCONJ
48 O NUM
hours O NOUN
after O ADP
surgery. O VERB
( O PUNCT

BACKGROUND: O NOUN
Neonatal O ADJ
sepsis O NOUN
is O VERB
a O DET
major O ADJ
cause O ADP
of O ADP
mortality O NOUN
worldwide, O NOUN
with O ADP
most O DET
deaths O NOUN
occurring O VERB
in O ADP
low-income O NOUN
countries. O NUM

Funded O VERB
by O ADP
the O DET
French O NOUN
National O ADJ
Cancer O NOUN
Institute; O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT00937456 O NOUN
.). O NOUN

RESULTS: O NOUN
L-Methylfolate O NOUN
was O VERB
well O ADV
tolerated B-outcome VERB
, O PUNCT
with O ADP
no O DET
significant O ADJ
effect O NOUN
over O ADP
placebo O NOUN
except O ADP
improvement O NOUN
from O ADP
abnormal O ADJ
measures O NOUN
on O ADP
the O DET
mean O NOUN
adaptive O ADJ
dimension O NOUN
of O ADP
the O DET
Adult O NOUN
ADHD B-outcome NOUN
Self-report O NOUN
scale O NOUN
(chi O PUNCT
= O SYM
4.36, O ADP
P O NOUN
= O SYM
0.04). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Additionally, O NOUN
both O CCONJ
groups O NOUN
had O VERB
similar O ADJ
safety O NOUN
profile. O NOUN

We O PRON
investigated O VERB
the O DET
effects O NOUN
of O ADP
negative O ADJ
pressure O NOUN
wound O NOUN
therapy O NOUN
(NPWT) O PUNCT
on O ADP
short- O NOUN
and O CCONJ
long-term O NOUN
wound O NOUN
outcomes O NOUN
in O ADP
patients O NOUN
undergoing O VERB
pancreatectomy. O NOUN

METHODS: O NOUN
A O DET
clinical O ADJ
trial O NOUN
cross-over O NOUN
study O NOUN
was O VERB
carried O VERB
out O ADP
on O ADP
premature O ADJ
infants O NOUN
in O ADP
NICU. O NOUN

Journal-Name:Medicine O NOUN

The O DET
direct O ADJ
and O CCONJ
video O ADJ
groups O NOUN
performed O VERB
2 O NUM
handling B-outcome VERB
activities O NOUN
significantly O ADV
better O ADJ
than O ADP
the O DET
written-pictorial O ADJ
group. O VERB

Journal-Name:BMC O NOUN
gastroenterology O NOUN

Title: O NOUN
Omadacycline O NOUN
for O ADP
Community-Acquired O VERB
Bacterial O ADJ
Pneumonia. O NOUN

However, O ADV
significant O ADJ
differences O NOUN
between O ADP
the O DET
groups O NOUN
were O VERB
not O ADV
observed O VERB
in O ADP
terms O NOUN
of O ADP
total O ADJ
RES O NOUN
and O CCONJ
complete O ADJ
root B-outcome NOUN
coverage I-outcome NOUN
rate O NOUN
(p O PUNCT
> O SYM
0.05). O NOUN

All O DET
patients O NOUN
received O VERB
tramadol O NOUN
patient-controlled O VERB
analgesia O NOUN
for O ADP
the O DET
first O ADV
24th O ADJ
hour. O NOUN

The O DET
mRNA B-outcome NOUN
expression I-outcome NOUN
was O VERB
measured O VERB
at O ADP
baseline O NOUN
and O CCONJ
12 O NUM
weeks O NOUN
by O ADP
TaqMan(R) O PUNCT
Low O ADJ
Density O NOUN
Array. O NOUN

Control O NOUN
ICUs O NOUN
(n O NOUN
= O SYM
12; O NUM
789 O NUM
participants) O NOUN
delivered O VERB
usual O ADJ
care O NOUN
in O ADP
both O CCONJ
baseline O NOUN
and O CCONJ
intervention O NOUN
periods. O NOUN

Publication O NOUN
date: O NOUN
2019/02/27 O NOUN
06:00 O ADP
[medline] O NOUN

Only O ADV
4 O NUM
children O NOUN
in O ADP
each O DET
arm O NOUN
were O VERB
found O VERB
to O PART
have O VERB
heart B-outcome NOUN
diseases I-outcome NOUN
, O PUNCT
with O ADP
prevalence O NOUN
of O ADP
(0.17/1000 O PUNCT
and O CCONJ
0.16/1000), O NUM
respectively, O NOUN
after O ADP
clinical O ADJ
and O CCONJ
echocardiography O NOUN
evaluation. O ADV

RESULTS: O NOUN
In O ADP
the O DET
PAR-G O NOUN
and O CCONJ
1PO-G, O NOUN
respectively O ADV
there O PRON
were O VERB
significant O ADJ
reductions O NOUN
in O ADP
slow B-outcome ADJ
vital I-outcome ADJ
capacity I-outcome NOUN
(SVC) I-outcome PUNCT
(p=0.0007 O PUNCT
vs. O CCONJ
p<0.0001), O NOUN
inspiratory B-outcome ADJ
reserve I-outcome NOUN
volume I-outcome NOUN
(IRV) I-outcome NUM
(p=0.0016 O NOUN
vs. O CCONJ
p=0.0026), O NOUN
and O CCONJ
forced B-outcome VERB
vital I-outcome ADJ
capacity I-outcome NOUN
(FVC) I-outcome PUNCT
(p=0.0013 O NOUN
vs. O CCONJ
p<0.0001) O NOUN
and O CCONJ
expiratory B-outcome ADJ
reserve I-outcome NOUN
volume I-outcome NOUN
(ERV) I-outcome NUM
was O VERB
maintained O VERB
only O ADV
for O ADP
the O DET
PAR-G O NOUN
(p=0.4446 O PUNCT
vs. O CCONJ
p=0.0191). O NOUN

The O DET
percentage O NOUN
of O ADP
patients O NOUN
with O ADP
a O DET
composite O NOUN
outcome O NOUN
event O NOUN
was O VERB
74% O NUM
lower O ADJ
with O ADP
caplacizumab O NOUN
than O ADP
with O ADP
placebo O NOUN
(12% O NUM
vs. O CCONJ
49%, O NOUN
P<0.001). O NUM

The O DET
difference O NOUN
between O ADP
groups O NOUN
was O VERB
significant O ADJ
(p=.045). O NOUN

Additionally, O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
also O ADV
documented O VERB
during O ADP
the O DET
period O NOUN
of O ADP
the O DET
treatment. O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study, O NOUN
Journal O ADJ
Article, O ADJ
Multicenter O NOUN
Study, O NOUN
Randomized O VERB
Controlled O VERB
Trial, O NOUN
Research O NOUN
Support, O NOUN
Non-U.S. O NOUN
Gov't, O NOUN

Department O NOUN
of O ADP
Pharmacy O NOUN
Practice, O NOUN
Sri O NOUN
Adichunchanagiri O NOUN
College O NOUN
of O ADP
Pharmacy, O NOUN
B. O NOUN
G. O NOUN
Nagara, O NOUN
Karnataka, O NOUN
India. O NOUN

Publication O NOUN
date: O NOUN
2019/01/25 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
correlations O NOUN
anxiety B-outcome NOUN
versus O CCONJ
heart B-outcome NOUN
variables O NOUN
and O CCONJ
depression B-outcome NOUN
versus O CCONJ
heart B-outcome NOUN
variables O NOUN
were O VERB
established O VERB
using O VERB
Spearman O NOUN
correlation O NOUN
test. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Comparison O NOUN
the O DET
efficacy O NOUN
of O ADP
hemorrhage O NOUN
control O NOUN
of O ADP
Surgiflo O NOUN
Haemostatic O ADJ
Matrix O NOUN
and O CCONJ
absorbable O ADJ
gelatin O NOUN
sponge O NOUN
in O ADP
posterior O ADJ
lumbar O ADJ
surgery: O NOUN
A O DET
randomized O VERB
controlled O VERB
study. O NOUN

Maintenance O NOUN
of O ADP
effect O NOUN
during O ADP
the O DET
double-blind O ADJ
phase O NOUN
was O VERB
evaluated O VERB
based O VERB
on O ADP
a O DET
comparison O NOUN
of O ADP
the O DET
percentages O NOUN
of O ADP
galcanezumab- O NOUN
and O CCONJ
placebo-treated O VERB
patients O NOUN
with O ADP
maintenance O NOUN
of O ADP
30, O NUM
50, O NOUN
75, O NUM
and O CCONJ
100% O NOUN
response B-outcome NOUN
(defined O NUM
as O ADP
>/=30, O NOUN
>/=50, O ADP
>/=75, O NOUN
and O CCONJ
100% O NOUN
reduction O NOUN
from O ADP
baseline O NOUN
in O ADP
monthly O ADV
migraine O NOUN
headache O NOUN
days O NOUN
[MHD]) O NOUN
at O ADP
an O DET
individual O ADJ
patient O NOUN
level. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Magnetic O ADJ
Resonance O NOUN
Imaging O VERB
vs O CCONJ
Conventional O ADJ
Treat-to-Target O NOUN
Strategies O NOUN
on O ADP
Disease B-outcome NOUN
Activity I-outcome NOUN
Remission I-outcome NOUN
and O CCONJ
Radiographic B-outcome ADJ
Progression I-outcome NOUN
in O ADP
Rheumatoid O NOUN
Arthritis: O NOUN
The O DET
IMAGINE-RA O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

Journal-Name:Lipids O NOUN
in O ADP
health O NOUN
and O CCONJ
disease O NOUN

There O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
the O DET
amount O NOUN
of O ADP
blood B-outcome NOUN
loss I-outcome NOUN
and O CCONJ
autologous O ADJ
blood B-outcome NOUN
transfusion I-outcome NOUN
between O ADP
the O DET
2 O NUM
groups, O NOUN
and O CCONJ
there O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
the O DET
operation B-outcome NOUN
time I-outcome NOUN
between O ADP
the O DET
2 O NUM
groups. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Medicine O NOUN

FINDINGS: O ADJ
We O PRON
recruited O VERB
2203 O NUM
participants O NOUN
between O ADP
May O NOUN
7, O NUM
2014, O NUM
and O CCONJ
Sept O ADV
28, O NUM
2017, O NUM
of O ADP
whom O ADP
1099 O NUM
were O VERB
assigned O VERB
to O PART
the O DET
lactoferrin O NOUN
group O NOUN
and O CCONJ
1104 O NUM
to O PART
the O DET
control O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2018/12/20 O ADJ
06:00 O ADP
[entrez] O ADP

CONCLUSION: O NOUN
The O DET
1 O NUM
year O NOUN
MACE B-outcome NOUN
rates O NOUN
are O VERB
comparable O ADJ
in O ADP
patients O NOUN
who O ADP
underwent O VERB
elective O ADJ
coronary O ADJ
revascularization O NOUN
using O VERB
sirolimus O NOUN
eluting O VERB
polymer-free O ADJ
and O CCONJ
biodegradable O ADJ
polymer O NOUN
stents. O NOUN

The O DET
prevalence O NOUN
of O ADP
low B-outcome ADJ
birth I-outcome NOUN
weight I-outcome NOUN
(LBW) I-outcome NUM
was O VERB
also O ADV
lower O ADJ
in O ADP
three-dose O NOUN
(3.5%) O NOUN
than O ADP
in O ADP
two-dose O NOUN
(12.2%) O NUM
group O NOUN
(aOR, O ADV
0.15; O NOUN
95% O NOUN
CI, O NOUN
0.04-0.63); O NUM
however, O ADV
the O DET
prevalence O NOUN
of O ADP
maternal B-outcome ADJ
anaemia I-outcome NOUN
, O PUNCT
pre-term B-outcome NOUN
births I-outcome NOUN
, O PUNCT
clinical B-outcome ADJ
malaria I-outcome NOUN
and O CCONJ
SP O NOUN
adverse B-outcome ADJ
effects I-outcome NOUN
were O VERB
similar O ADJ
between O ADP
the O DET
two O NUM
arms O NOUN
of O ADP
treatment. O NOUN

Title: O NOUN
The O DET
addition O NOUN
of O ADP
simvastatin O NOUN
administration O NOUN
to O PART
cold O NOUN
storage O NOUN
solution O NOUN
of O ADP
explanted O VERB
whole O ADJ
liver O NOUN
grafts O NOUN
for O ADP
facing O VERB
ischemia/reperfusion O NOUN
injury O NOUN
in O ADP
an O DET
area O NOUN
with O ADP
a O DET
low O ADJ
rate O NOUN
of O ADP
deceased O VERB
donation: O NOUN
a O DET
monocentric O ADP
randomized O VERB
controlled O VERB
double-blinded O VERB
phase O NOUN
2 O NUM
study. O NOUN

Daily O ADJ
vitD(3) O NOUN
+ O SYM
PBA O NOUN
for O ADP
16 O NUM
weeks O NOUN
was O VERB
well-tolerated O VERB
and O CCONJ
effectively O ADV
improved O VERB
vitD(3) B-outcome NOUN
status O NOUN
but O CCONJ
did O VERB
not O ADV
reduce O VERB
viral B-outcome ADJ
load I-outcome NOUN
, O PUNCT
restore O VERB
peripheral B-outcome ADJ
T I-outcome NOUN
cell I-outcome NOUN
counts I-outcome NOUN
or O CCONJ
improve O VERB
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
(BMI) I-outcome PUNCT
or O CCONJ
middle-upper-arm B-outcome NOUN
circumference I-outcome NOUN
(MUAC) I-outcome NUM
in O ADP
HIV O NOUN
patients O NOUN
with O ADP
slow O ADJ
progressive O ADJ
disease. O NOUN

Publication O NOUN
date: O NOUN
2019/03/06 O ADJ
06:00 O ADP
[medline] O NOUN

This O DET
study O NOUN
aimed O VERB
to O PART
determine O NOUN
whether O ADP
two O NUM
intravenous O ADJ
(IV) O NUM
TXA O NOUN
regimens O NOUN
(a O PUNCT
three-hour O NOUN
two-dose O NOUN
(short-TXA) O PUNCT
and O CCONJ
11-hour O NOUN
four-dose O NOUN
(long-TXA)) O PUNCT
were O VERB
more O ADV
effective O ADJ
than O ADP
placebo O NOUN
in O ADP
reducing O VERB
perioperative O ADJ
real O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(RBL, O NOUN
between O ADP
baseline O NOUN
and O CCONJ
day O NOUN
3 O NUM
postoperatively) O NOUN
in O ADP
patients O NOUN
undergoing O VERB
THA O NOUN
who O ADP
receive O VERB
rivaroxaban O ADJ
as O ADP
thromboprophylaxis. O NOUN

On O ADP
the O DET
first O ADV
day O NOUN
before O ADP
surgery, O NOUN
the O DET
patient's O NOUN
general O ADJ
data O NOUN
were O VERB
collected O VERB
and O CCONJ
the O DET
Pittsburgh O NOUN
sleep B-outcome NOUN
quality I-outcome NOUN
index O NOUN
(PSQI) O NOUN
was O VERB
used O VERB
to O PART
assess O NOUN
the O DET
patient's O NOUN
sleep B-outcome NOUN
status I-outcome NOUN
in O ADP
the O DET
past O NOUN
month. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Australian O ADJ
and O CCONJ
New O ADJ
Zealand O NOUN
Clinical O ADJ
Trials O NOUN
Registry O NOUN
( O PUNCT
ACTRN12616001434482 O NOUN
). O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

RESULTS: O NOUN
The O DET
assay O NOUN
range O NOUN
was O VERB
0.9-30 O NUM
mg/L O NOUN
with O ADP
accuracy O NOUN
within O ADP
91%-99% O NOUN
and O CCONJ
coefficients O NOUN
of O ADP
variation O NOUN
ranging O VERB
from O ADP
1.2% O NOUN
to O PART
3.6%. O NUM

Journal O ADJ
ID: O NOUN
7807333 O NUM

Title: O NOUN
Combined O VERB
phacoemulsification O NOUN
and O CCONJ
viscocanalostomy O NOUN
with O ADP
Ologen O NOUN
implant O NOUN
versus O CCONJ
combined O VERB
phacoemulsification O NOUN
and O CCONJ
viscocanalostomy. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

In O ADP
this O DET
study, O NOUN
for O ADP
the O DET
first O ADV
time, O NOUN
it O PRON
was O VERB
presented O VERB
that O ADP
pelvic B-outcome ADJ
floor I-outcome NOUN
muscles I-outcome NOUN
(PFM) I-outcome PUNCT
asymmetry I-outcome NOUN
visible O ADJ
in O ADP
ultrasonography O NOUN
may O VERB
be O VERB
corrected O VERB
by O ADP
this O DET
specific O ADJ
exercise. O NOUN

Compared O VERB
with O ADP
group O NOUN
C, O NOUN
serum O NOUN
norepinephrines B-outcome NOUN
in O ADP
group O NOUN
D O NOUN
was O VERB
significantly O ADV
less O ADV
(t=13.276, O NUM
16.027, O NUM
14.319, O NUM
12.771, O NOUN
12.296, O NOUN
respectively; O NOUN
all O DET
P<0.05) O NOUN
at O ADP
T(1), O NOUN
T(2), O NOUN
T(3), O NOUN
T(4), O NOUN
T(5).And O NOUN
there O PRON
were O VERB
no O DET
difference O NOUN
between O ADP
these O DET
two O NUM
groups O NOUN
at O ADP
T(0), O NOUN
T(6), O NOUN
T(7), O NOUN
T(8)(all O NOUN
P>0.05). O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Patients O NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
treated O VERB
for O ADP
a O DET
total O ADJ
of O ADP
12 O NUM
weeks. O NOUN

Patients O NOUN
were O VERB
randomized O VERB
into O ADP
2 O NUM
groups. O NOUN

Compared O VERB
with O ADP
the O DET
control O NOUN
group, O NOUN
the O DET
operation B-outcome NOUN
time I-outcome NOUN
of O ADP
the O DET
SuperPATH O NOUN
group O NOUN
was O VERB
longer O ADJ
( O PUNCT
t=4.470, O NOUN
P=0.000), O NOUN
and O CCONJ
the O DET
incision B-outcome NOUN
was O VERB
shorter O ADJ
( O PUNCT
t=-2.168, O NOUN
P=0.041). O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

As O ADP
hydrogen O NOUN
gas O NOUN
was O VERB
recently O ADV
reported O VERB
to O PART
activate O VERB
PGC1alpha, O NOUN
the O DET
present O ADJ
study O NOUN
investigated O VERB
whether O ADP
it O PRON
restores O NOUN
exhausted O VERB
CD8+ B-outcome NOUN
T I-outcome NOUN
cells I-outcome NOUN
to O PART
improve O VERB
prognosis O NOUN
in O ADP
patients O NOUN
with O ADP
stage O NOUN
IV O NUM
colorectal O ADJ
cancer. O NOUN

Wohlfert O ADP
TM, O NOUN
Miller O NOUN
KC. O NOUN

PMID: O NOUN
31615781 O NUM

Title: O NOUN
[Effect O ADJ
of O ADP
dexmedetomidine O NOUN
on O ADP
perioperative O ADJ
stress B-outcome NOUN
and O CCONJ
postoperative O ADJ
pain B-outcome NOUN
in O ADP
patients O NOUN
with O ADP
radical O NOUN
resection O NOUN
of O ADP
esophageal O ADJ
cancer O NOUN
under O ADP
combined O VERB
thoracoscope O NOUN
and O CCONJ
laparoscope]. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

This O DET
aims O NOUN
to O PART
investigate O NOUN
the O DET
effect O NOUN
of O ADP
combined O VERB
use O NOUN
of O ADP
radial O ADJ
extracorporeal O ADJ
shock O NOUN
wave O NOUN
therapy O NOUN
(rESWT) O NOUN
and O CCONJ
conventional O ADJ
rehabilitation O NOUN
therapy O NOUN
on O ADP
postoperative O ADJ
rehabilitation O NOUN
of O ADP
children O NOUN
with O ADP
spastic O ADJ
cerebral O ADJ
palsy. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Title: O NOUN
Cardiometabolic B-outcome ADJ
Health I-outcome NOUN
in O ADP
Relation O NOUN
to O PART
Lifestyle O NOUN
and O CCONJ
Body O NOUN
Weight O NOUN
Changes O NOUN
3(-)8 O ADJ
Years O NOUN
Earlier. O NOUN

The O DET
patients O NOUN
received O VERB
dry O ADJ
needling O VERB
using O VERB
sterile O ADJ
stainless-steel O NOUN
acupuncture O NOUN
needles O NOUN
of O ADP
0.25 O NUM
x O SYM
40 O NUM
mm O NOUN
and O CCONJ
0.25 O NUM
x O SYM
25 O NUM
mm O NOUN
dimensions. O NOUN

After O ADP
30 O NUM
days O NOUN
of O ADP
dark O ADJ
chocolate O NOUN
intake, O NOUN
an O DET
increased O VERB
antioxidant B-outcome NOUN
power I-outcome NOUN
was O VERB
found O VERB
in O ADP
elite O ADP
athletes O NOUN
assuming O VERB
dark O ADJ
chocolate. O NOUN

CONCLUSIONS: O NOUN
Gua O NOUN
Sha O NOUN
appears O NOUN
to O PART
be O VERB
an O DET
acceptable B-outcome ADJ
, O PUNCT
safe, O NOUN
and O CCONJ
effective O ADJ
treatment O NOUN
for O ADP
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain. O NOUN

CONCLUSION: O NOUN
The O DET
findings O NOUN
indicated O VERB
the O DET
pilates O NOUN
exercises O NOUN
can O VERB
be O VERB
valuable O ADJ
for O ADP
improvement O NOUN
of O ADP
CKD O NOUN
patients' O NOUN
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
. O PUNCT

Publication O NOUN
date: O NOUN
2019/02/13 O NOUN
06:00 O ADP
[medline] O NOUN

Compared O VERB
with O ADP
noninvasive O ADJ
breathing O VERB
unit O NOUN
after O ADP
treatment, O NOUN
rhodiola+noninvasive O ADJ
breathing O VERB
unit O NOUN
after O ADP
treatment O NOUN
in O ADP
patients O NOUN
with O ADP
elevated O VERB
levels O NOUN
of O ADP
serum O NOUN
SOD B-outcome NOUN
, O PUNCT
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
level O NOUN
decreased O VERB
P<0.05, O NOUN
and O CCONJ
for O ADP
the O DET
treatment O NOUN
group O NOUN
after O ADP
treatment O NOUN
in O ADP
patients O NOUN
with O ADP
serum O NOUN
SOD B-outcome NOUN
levels O NOUN
drop, O NOUN
the O DET
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
levels O NOUN
P<0.05, O NOUN
and O CCONJ
the O DET
after O ADP
rhodiola O NOUN
rosea O NOUN
treatment O NOUN
group O NOUN
compared, O NOUN
rhodiola+noninvasive O ADJ
breathing O VERB
unit O NOUN
after O ADP
treatment O NOUN
in O ADP
patients O NOUN
with O ADP
elevated O VERB
levels O NOUN
of O ADP
serum O NOUN
SOD B-outcome NOUN
, O PUNCT
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
level O NOUN
decreased O VERB
P<0.05. O NOUN

Efficacy O NOUN
and O CCONJ
safety O NOUN
results O NOUN
in O ADP
the O DET
Japanese O NOUN
subgroup O NOUN
and O CCONJ
the O DET
East O ADV
Asian O ADJ
subgroup O NOUN
(which O ADV
included O VERB
patients O NOUN
from O ADP
Japan, O NOUN
Taiwan, O DET
and O CCONJ
South O NOUN
Korea) O ADJ
were O VERB
consistent O ADJ
with O ADP
the O DET
overall O ADJ
study O NOUN
population. O ADV

Eligible O ADJ
adults O NOUN
from O ADP
132 O NUM
sites O NOUN
in O ADP
17 O NUM
countries O NOUN
with O ADP
previously O ADV
untreated O VERB
CD30-positive O ADJ
peripheral O ADJ
T-cell O NOUN
lymphomas O NOUN
(targeting O VERB
75% O NUM
with O ADP
systemic O ADJ
anaplastic O ADJ
large O ADJ
cell O NOUN
lymphoma) O NOUN
were O VERB
randomly O ADV
assigned O VERB
1:1 O ADJ
to O PART
receive O VERB
either O CCONJ
A+CHP O ADV
or O CCONJ
CHOP O VERB
for O ADP
six O NUM
or O CCONJ
eight O NUM
21-day O NOUN
cycles. O NUM

FUNDING: O NOUN
Bristol-Myers O NOUN
Squibb. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
German O NOUN
register O NOUN
of O ADP
clinical O ADJ
studies: O NOUN
DRKS00000622 O NOUN
. O PUNCT

Echocardiography O NOUN
was O VERB
analysed O VERB
off-line O NOUN
at O ADP
baseline, O NOUN
after O ADP
3, O NOUN
6 O NUM
and O CCONJ
12 O NUM
months O NOUN
by O ADP
investigators O NOUN
who O ADP
were O VERB
blinded O VERB
to O PART
clinical O ADJ
data. O NOUN

METHODS: O NOUN
A O DET
sample O NOUN
of O ADP
2262 O NUM
male O NOUN
truckers O NOUN
registered O VERB
in O ADP
the O DET
North O NOUN
Star O NOUN
Alliance O NOUN
electronic O ADJ
health O NOUN
record O NOUN
system O NOUN
who, O NOUN
based O VERB
on O ADP
these O DET
records, O NOUN
were O VERB
not O ADV
testing O VERB
for O ADP
HIV O NOUN
regularly O ADV
were O VERB
randomized O VERB
to O PART
one O NUM
of O ADP
three O NUM
study O NOUN
groups O NOUN
in O ADP
which O ADP
they O PRON
were O VERB
sent O ADJ
text O VERB
messages O NOUN
about O ADV
the O DET
availability O NOUN
of O ADP
(1) O PUNCT
oral O ADJ
HIV O NOUN
self-test O NOUN
kits O NOUN
at O ADP
all O DET
8 O NUM
North O NOUN
Star O NOUN
Alliance O NOUN
Kenya O PROPN
clinics O NOUN
that O ADP
was O VERB
sent O ADJ
three O NUM
times O NOUN
(intervention), O NOUN
(2) O PUNCT
HIV O NOUN
testing O VERB
in O ADP
general O ADJ
(not O ADV
self-testing) O NOUN
at O ADP
all O DET
North O NOUN
Star O NOUN
Alliance O NOUN
clinics O NOUN
sent O ADJ
three O NUM
times O NOUN
(enhanced O VERB
standard O ADJ
of O ADP
care O NOUN
[SOC]), O ADJ
or O CCONJ
(3) O PUNCT
HIV O NOUN
testing O VERB
in O ADP
general O ADJ
(not O ADV
self-testing) O NOUN
at O ADP
all O DET
North O NOUN
Star O NOUN
Alliance O NOUN
clinics O NOUN
sent O ADJ
one O NUM
time O NOUN
(SOC). O ADV

These O DET
reductions O NOUN
were O VERB
associated O VERB
with O ADP
a O DET
79% O NUM
lower O ADJ
mean O NOUN
annualized O VERB
attack B-outcome NOUN
rate O NOUN
than O ADP
that O ADP
observed O VERB
with O ADP
placebo O NOUN
(exploratory O NUM
efficacy O NOUN
end O NOUN
point). O NOUN

Complete O ADJ
diet O NOUN
collections O NOUN
were O VERB
analyzed O VERB
for O ADP
nitrogen O NOUN
(for O PUNCT
protein), O NOUN
fat, O ADP
energy, O NOUN
and O CCONJ
carbohydrate O NOUN
by O ADP
difference. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Objective: O NOUN
To O PART
further O ADV
define O NOUN
the O DET
role O NOUN
of O ADP
a O DET
fixed O VERB
combination O NOUN
halobetasol O NOUN
propionate O NOUN
0.01% O NOUN
and O CCONJ
tazarotene O NOUN
0.045% O NUM
(HP/TAZ) O PUNCT
lotion O NOUN
in O ADP
moderate-to-severe O ADV
plaque O NOUN
psoriasis O NOUN
using O VERB
the O DET
IGAxBSA O NOUN
composite O NOUN
tool. O NOUN

The O DET
secondary O ADJ
outcome O NOUN
was O VERB
clinical B-outcome ADJ
response I-outcome NOUN
. O PUNCT
For O ADP
the O DET
safety O NOUN
assessment, O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
recorded O VERB
during O ADP
the O DET
study O NOUN
period. O NOUN

FINDINGS: O ADJ
Between O ADP
May O NOUN
12, O NUM
2015, O NUM
and O CCONJ
Aug O NOUN
4, O NOUN
2016, O NUM
184 O NUM
overweight O NUM
or O CCONJ
obese O NOUN
patients O NOUN
with O ADP
non-alcoholic O ADJ
steatohepatitis O NOUN
were O VERB
screened O VERB
for O ADP
study O NOUN
inclusion. O NOUN

This O DET
indicates O NOUN
that O ADP
changing O VERB
lifestyle B-outcome NOUN
is O VERB
an O DET
important O ADJ
first O ADV
step, O NOUN
but O CCONJ
maintaining O VERB
this O DET
change O NOUN
is O VERB
needed O VERB
for O ADP
improving O VERB
cardiometabolic B-outcome ADJ
health I-outcome NOUN
in O ADP
the O DET
long-term. O NOUN

Superoxide B-outcome NOUN
dismutase I-outcome NOUN
activity O NOUN
was O VERB
significantly O ADV
elevated O VERB
after O ADP
exercise O NOUN
(p O PUNCT
= O SYM
0.002) O NUM
in O ADP
placebo O NOUN
but O CCONJ
not O ADV
AA. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Title: O NOUN
The O DET
effect O NOUN
of O ADP
different O ADJ
sources O NOUN
of O ADP
fish O NOUN
and O CCONJ
camelina O NOUN
sativa O NOUN
oil O NOUN
on O ADP
immune O ADJ
cell O NOUN
and O CCONJ
adipose O ADJ
tissue O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
in O ADP
subjects O NOUN
with O ADP
abnormal O ADJ
fasting O VERB
glucose O NOUN
metabolism: O NOUN
a O DET
randomized O VERB
controlled O VERB
trial. O NOUN

The O DET
plasma O NOUN
concentrations O NOUN
of O ADP
netupitant B-outcome ADJ
and Seperator CCONJ
its X NUM
metabolites S1-outcome NOUN
increased O VERB
with O ADP
the O DET
dose O NOUN
increase O NOUN
from O ADP
30 O NUM
mg O NOUN
to O PART
300 O NUM
mg. O NOUN

RESULTS: O NOUN
At O ADP
all O DET
time O NOUN
points, O NOUN
tramadol B-outcome NOUN
consumption O NOUN
of O ADP
the O DET
OSTAP O NOUN
group O NOUN
remained O VERB
significantly O ADV
lower O ADJ
when O ADP
compared O VERB
with O ADP
Sham O NOUN
group. O VERB

The O DET
basic O ADJ
antianginal O ADJ
therapy O NOUN
was O VERB
allowed O VERB
to O PART
use O NOUN
in O ADP
both O CCONJ
groups: O NOUN
beta-blockers, O NOUN
calcium O NOUN
antagonists, O NOUN
ATE O NOUN
inhibitors O NOUN
/ O SYM
angiotensin O NOUN
II O NUM
receptor O NOUN
blockers, O NOUN
statins, O NOUN
acetylsalicylic O ADJ
acid, O NOUN
blockers O NOUN
of O ADP
P2Y12 O NOUN
receptor O NOUN
platelets. O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
We O PRON
included O VERB
88 O NUM
patients O NOUN
with O ADP
a O DET
stable O ADJ
form O NOUN
of O ADP
CHD, O NUM
who O ADP
were O VERB
going O VERB
to O PART
pass O NOUN
the O DET
elective O ADJ
PCI, O NOUN
in O ADP
the O DET
study. O NOUN

Title: O NOUN
Use O PUNCT
of O ADP
a O DET
robotic O ADJ
walking O VERB
aid O VERB
in O ADP
rehabilitation O NOUN
to O PART
reduce O VERB
fear B-outcome ADJ
of I-outcome ADP
falling I-outcome VERB
is O VERB
feasible B-outcome ADJ
and O CCONJ
acceptable B-outcome ADJ
from O ADP
the O DET
end O NOUN
user's O ADJ
perspective: O NOUN
A O DET
randomised O VERB
comparative O ADJ
study. O NOUN

PC O NOUN
significantly O ADV
lowered O VERB
sweat B-outcome NOUN
rate O NOUN
(PC O NOUN
= O SYM
1.02 O NUM
+/- O SYM
0.31 O NUM
L O NOUN
. O PUNCT

No O DET
significant O ADJ
differences O NOUN
were O VERB
found O VERB
between O ADP
the O DET
direct O ADJ
and O CCONJ
video O ADJ
groups. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
NCT, O NOUN
NCT03134690. O NOUN

Journal O ADJ
ID: O NOUN
101476450 O NUM

RESULTS: O NOUN
Non-esterified B-outcome VERB
fatty I-outcome ADJ
acid I-outcome NOUN
net O ADJ
area O NOUN
under O ADP
curve O NOUN
(AUC) O NOUN
was O VERB
increased O VERB
by O ADP
97 O NUM
+/- O SYM
38 O NUM
mumol/Lx270 O NOUN
min O NOUN
(p O PUNCT
= O SYM
0.024) O NOUN
after O ADP
breakfast O NOUN
but O CCONJ
reduced O VERB
by O ADP
141 O NUM
+/- O SYM
33 O NUM
mumol/Lx180 O NOUN
min O NOUN
(p O PUNCT
< O SYM
0.001) O NUM
after O ADP
lunch O NOUN
on O ADP
the O DET
CRHP O NOUN
compared O VERB
with O ADP
CD O NOUN
diet. O NOUN

A O DET
total O ADJ
of O ADP
40 O NUM
eligible O ADJ
patients O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
a O DET
treatment O NOUN
group O NOUN
(received O PUNCT
BZSF O NOUN
and O CCONJ
ceftriaxone) O NOUN
or O CCONJ
a O DET
control O NOUN
group O NOUN
(received O PUNCT
ceftriaxone O NOUN
alone). O NOUN

Publication O NOUN
date: O NOUN
2018/03/27 O ADV
00:00 O NOUN
[accepted] O ADV

CM O NOUN
had O VERB
a O DET
more O ADV
positive O ADJ
effect O NOUN
on O ADP
strength B-outcome NOUN
development O NOUN
and O CCONJ
should O VERB
be O VERB
considered O VERB
an O DET
appropriate O ADJ
post-exercise O NOUN
recovery O NOUN
supplement O NOUN
for O ADP
adolescents. O NOUN

An O DET
equivalent O ADJ
volume O NOUN
of O ADP
normal O ADJ
saline O NOUN
was O VERB
administered O VERB
in O ADP
patients O NOUN
in O ADP
the O DET
control O NOUN
group. O VERB

Fifty-five O ADJ
women O NOUN
in O ADP
5 O NUM
village O NOUN
clusters O NOUN
received O VERB
the O DET
ABHR O NOUN
and O CCONJ
used O VERB
it O PRON
from O ADP
birth O NOUN
to O PART
3 O NUM
months O NOUN
postnatally, O NOUN
with O ADP
use O NOUN
guided O VERB
by O ADP
the O DET
new O ADJ
poster. O NOUN

Journal O ADJ
ID: O NOUN
101643584 O NUM

BACKGROUND: O NOUN
Ascorbic O ADJ
acid O NOUN
is O VERB
a O DET
water-soluble O ADJ
chain O NOUN
breaking O VERB
antioxidant. O NOUN

Publication O NOUN
date: O NOUN
2018/10/28 O NOUN
00:00 O NOUN
[accepted] O ADV

The O DET
160 O NUM
patients O NOUN
fulfilled O VERB
the O DET
study O NOUN
requirements. O NOUN

PsycINFO O NOUN
Database O NOUN
Record O NOUN
(c) O PUNCT
2018 O NUM
APA, O NOUN
all O DET
rights O NOUN
reserved). O NOUN

Preoperatively, O ADJ
all O DET
patients O NOUN
were O VERB
evaluated O VERB
clinically O ADV
( O NOUN
Kujala O NOUN
score O NOUN
questionnaire]) O ADP
and O CCONJ
radiologically. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
consumption B-outcome NOUN
of O ADP
postoperative O ADJ
rescued O NOUN
sufentanil O NOUN
was O VERB
significantly O ADV
lower O ADJ
in O ADP
Dex O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
Control O NOUN
group O NOUN
(56.3 O NOUN
+/- O SYM
9.4 O NUM
vs O CCONJ
65.9 O NUM
+/- O SYM
10.7 O NUM
mug). O ADJ

Journal O ADJ
ID: O NOUN
101273480 O NUM

The O DET
mean O NOUN
value O NOUN
of O ADP
all O DET
measured O VERB
hematology B-outcome NOUN
variables O NOUN
remained O VERB
within O ADP
the O DET
reference O NOUN
values O NOUN
in O ADP
all O DET
study O NOUN
subject O NOUN
and O CCONJ
no O DET
significant O ADJ
changes O NOUN
were O VERB
observed O VERB
in O ADP
blood B-outcome NOUN
pressure I-outcome NOUN
or O CCONJ
lipid B-outcome NOUN
values. O NUM

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
100 O NUM
children O NOUN
with O ADP
chronic O ADJ
constipation O NOUN
were O VERB
included O VERB
in O ADP
this O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study, O NOUN
Journal O ADJ
Article, O ADJ
Multicenter O NOUN
Study, O NOUN
Randomized O VERB
Controlled O VERB
Trial, O NOUN
Research O NOUN
Support, O NOUN
U.S. O PROPN
Gov't, O NOUN
Non-P.H.S., O VERB

METHODS: O NOUN
Seventy O NOUN
non-dialysis O NOUN
CKD-MBD O NOUN
patients O NOUN
with O ADP
kidney O NOUN
deficiency O NOUN
and O CCONJ
dampness-heat O NOUN
syndrome O NOUN
were O VERB
randomized O VERB
into O ADP
control O NOUN
group O NOUN
(n=35) O PUNCT
and O CCONJ
treatment O NOUN
group O NOUN
(n=35). O NOUN

CONCLUSIONS: O NOUN
In O ADP
high-risk O NOUN
ambulatory O ADJ
patients O NOUN
with O ADP
cancer, O NOUN
treatment O NOUN
with O ADP
rivaroxaban O ADJ
did O VERB
not O ADV
result O VERB
in O ADP
a O DET
significantly O ADV
lower O ADJ
incidence O NOUN
of O ADP
venous B-outcome ADJ
thromboembolism I-outcome NOUN
or O CCONJ
death B-outcome NOUN
due I-outcome ADJ
to I-outcome PART
venous I-outcome ADJ
thromboembolism I-outcome NOUN
in O ADP
the O DET
180-day O NOUN
trial O NOUN
period. O NOUN

Patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
undergo O NOUN
transthoracic O ADJ
open O ADJ
esophagectomy O NOUN
(open O NUM
procedure) O NOUN
or O CCONJ
hybrid O NOUN
minimally O ADV
invasive O ADJ
esophagectomy O NOUN
(hybrid O NOUN
procedure). O NOUN

After O ADP
the O DET
intervention, O ADP
only O ADV
the O DET
exercise O NOUN
group O NOUN
had O VERB
a O DET
significantly O ADV
lower O ADJ
BMI B-outcome NOUN
z-score O NOUN
than O ADP
the O DET
baseline O NOUN
score O NOUN
by O ADP
about O ADV
0.1 O NUM
(p O PUNCT
= O SYM
0.03), O NUM
but O CCONJ
no O DET
significant O ADJ
group O NOUN
by O ADP
time O NOUN
interaction O NOUN
effects O NOUN
were O VERB
observed. O NOUN

A O DET
masked O VERB
evaluator O NOUN
assessed O VERB
parent O NOUN
performance B-outcome NOUN
, O PUNCT
and O CCONJ
parents O NOUN
rated O VERB
instructional B-outcome ADJ
effectiveness. O NOUN

CONCLUSION: O NOUN
Despite O ADP
the O DET
decrease O NOUN
in O ADP
the O DET
number O NOUN
of O ADP
some O DET
cytotoxic B-outcome ADJ
cells I-outcome NOUN
(CTLs) I-outcome NUM
and O CCONJ
an O DET
increase O NOUN
in O ADP
the O DET
proportion O NOUN
of O ADP
T B-outcome NOUN
regulatory I-outcome ADJ
lymphocytes I-outcome NOUN
(Tregs) I-outcome NUM
to I-outcome PART
cytotoxic I-outcome ADJ
lymphocytes I-outcome NOUN
(CTLs) I-outcome NUM
, O PUNCT
supplementation O NOUN
with O ADP
LTE O NOUN
seems O NOUN
to O PART
exert O NOUN
a O DET
beneficial O ADJ
effect O NOUN
on O ADP
a O DET
disrupted O VERB
Th1/Th2 O NOUN
balance O NOUN
in O ADP
elite O ADP
athletes, O NOUN
as O ADP
shown O VERB
by O ADP
the O DET
decrease O NOUN
in O ADP
interleukin B-outcome NOUN
10 I-outcome NUM
(IL-10) I-outcome PUNCT
concentration. O NOUN

Journal O ADJ
ID: O NOUN
100968555 O NUM

METHODS: O NOUN
Utilizing O VERB
a O DET
randomized, O NOUN
double-blind, O NOUN
placebo-controlled, O NOUN
parallel O ADJ
design, O NOUN
healthy, O NOUN
recreationally-active O ADJ
men O NOUN
and O CCONJ
women O NOUN
(n O NOUN
= O SYM
142) O NOUN
received O VERB
900 O NUM
mg O NOUN
of O ADP
PSE O NOUN
or O CCONJ
placebo O NOUN
(PLA) O PUNCT
daily O ADJ
for O ADP
90 O NUM
days. O NOUN

Publication O NOUN
date: O NOUN
2019/01/22 O ADJ
06:00 O ADP
[medline] O NOUN

The O DET
Harris O ADV
and O CCONJ
VAS O NOUN
scores O NOUN
of O ADP
SuperPATH O NOUN
group O NOUN
at O ADP
1 O NUM
and O CCONJ
3 O NUM
days O NOUN
after O ADP
operation O NOUN
were O VERB
better O ADJ
than O ADP
those O DET
of O ADP
control O NOUN
group O NOUN
( O PUNCT
P<0.05). O NOUN

However, O ADV
few O ADJ
studies O NOUN
have O VERB
explored O VERB
the O DET
application O NOUN
of O ADP
OPEP O NOUN
in O ADP
surgery O NOUN
lung O NOUN
cancer O NOUN
patients O NOUN
underwent O VERB
lobectomy. O NOUN

After O ADP
a O DET
10-min O NOUN
rest, O NOUN
they O PRON
exercised O VERB
to O PART
a O DET
Trec O ADV
of O ADP
39.5 O NUM
degrees O NOUN
C. O NOUN
Subsequently, O NOUN
they O PRON
underwent O VERB
CWI O NOUN
(9.99 O PUNCT
+/- O SYM
0.03 O NUM
degrees O NOUN
C) O NOUN
until O ADP
Trec O ADV
reached O VERB
38 O NUM
degrees O NOUN
C. O NOUN
On O ADP
control O NOUN
(CON) O NOUN
days, O NOUN
the O DET
same O ADJ
procedures O NOUN
occurred O VERB
without O ADP
the O DET
15-min O NOUN
PC O NOUN
intervention. O NOUN

BACKGROUND: O NOUN
To O PART
study O NOUN
the O DET
efficacy O NOUN
of O ADP
the O DET
biodegradable O ADJ
collagen O NOUN
implant O NOUN
Ologen(R) O NOUN
as O ADP
an O DET
adjuvant O NOUN
in O ADP
phaco-viscocanalostomy O NOUN
in O ADP
patients O NOUN
with O ADP
coexisting O VERB
cataract O NOUN
and O CCONJ
primary O ADJ
open O ADJ
angle O NOUN
glaucoma. O NOUN

Among O ADP
the O DET
108 O NUM
participants O NOUN
enrolled, O NOUN
37, O NUM
34, O NUM
and O CCONJ
37 O NUM
received O VERB
Avaxim, O NOUN
Epaxal, O NOUN
and O CCONJ
Havrix, O NOUN
respectively. O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

The O DET
intervention O NOUN
period O NOUN
lasted O VERB
30 O NUM
days O NOUN
(1 O NOUN
session O NOUN
every O DET
10 O NUM
days). O NOUN

BACKGROUND: O NOUN
Micronutrient O NOUN
deficiencies O NOUN
are O VERB
common O ADJ
during O ADP
pregnancy, O NOUN
especially O ADV
in O ADP
pregnant O ADJ
women O NOUN
from O ADP
economically O ADV
disadvantaged O NOUN
settings O NOUN
where O ADP
diets O NOUN
with O ADP
low O ADJ
content O NOUN
of O ADP
minerals O NOUN
and O CCONJ
vitamins O NOUN
are O VERB
consumed. O NOUN

Comparison O NOUN
of O ADP
percentage O NOUN
of O ADP
respondents O NOUN
fitting O VERB
into O ADP
body O NOUN
posture O ADJ
norms O NOUN
clearly O ADV
indicates O NOUN
higher O ADJ
value O NOUN
in O ADP
the O DET
group O NOUN
classified O VERB
as O ADP
active. O ADJ

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
This O DET
was O VERB
a O DET
prospective, O NOUN
randomized, O NOUN
unblinded O VERB
study. O NOUN

In O ADP
this O DET
open-label, O ADV
randomized, O NOUN
prospective, O NOUN
multicenter O NOUN
study, O NOUN
108 O NUM
children O NOUN
were O VERB
enrolled O VERB
and O CCONJ
randomized O VERB
to O PART
receive O VERB
a O DET
pediatric O ADJ
form O NOUN
of O ADP
Avaxim, O NOUN
Epaxal, O NOUN
or O CCONJ
Havrix. O NOUN

Journal-Name:Lancet O NOUN
(London, O PUNCT
England) O NOUN

BACKGROUND: O NOUN
This O DET
study O NOUN
aimed O VERB
to O PART
evaluate O VERB
the O DET
effectiveness O NOUN
of O ADP
neuromuscular O ADJ
electrical O ADJ
stimulation O NOUN
(NMES) O NUM
therapy O NOUN
in O ADP
patients O NOUN
with O ADP
urinary O ADJ
incontinence O NOUN
after O ADP
stroke O NOUN
(UIAS). O NOUN

As O ADP
shown O VERB
by O ADP
subjective O ADJ
symptoms B-outcome NOUN
, O PUNCT
the O DET
results O NOUN
in O ADP
95% O NOUN
of O ADP
patients O NOUN
were O VERB
rated O VERB
as O ADP
good O ADJ
or O CCONJ
very O ADV
good. O NOUN

RESULTS: O NOUN
PC O NOUN
lowered O VERB
body B-outcome NOUN
heat I-outcome NOUN
storage I-outcome NOUN
and O CCONJ
rectal B-outcome ADJ
temperature I-outcome NOUN
by O ADP
15.7 O NUM
+/- O SYM
15.0 O NUM
W O NOUN
. O PUNCT

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
A O DET
randomized, O NOUN
controlled, O NOUN
clinical O ADJ
trial O NOUN
was O VERB
conducted O VERB
on O ADP
62 O NUM
postmenopausal O ADJ
women O NOUN
referred O VERB
to O PART
health O NOUN
centers O NOUN
of O ADP
Isfahan, O CCONJ
Iran. O NOUN

Oxidant/antioxidant B-outcome NOUN
status O NOUN
and O CCONJ
markers O NOUN
of O ADP
muscle B-outcome NOUN
damage I-outcome NOUN
were O VERB
evaluated O VERB
in O ADP
24 O NUM
elite O ADP
football O NOUN
players O NOUN
and O CCONJ
15 O NUM
controls. O NOUN

The O DET
primary O ADJ
endpoint O NOUN
was O VERB
lung B-outcome NOUN
function I-outcome NOUN
, O PUNCT
as O ADP
measured O VERB
by O ADP
forced B-outcome VERB
expiratory I-outcome ADJ
volume I-outcome NOUN
in Seperator ADP
1 I-outcome NUM
second I-outcome ADJ
(FEV1) I-outcome NOUN
and O CCONJ
ratio B-outcome NOUN
between Seperator ADP
FEV1 I-outcome NOUN
and Seperator CCONJ
forced I-outcome VERB
vital I-outcome ADJ
capacity I-outcome NOUN
(FEV1/FVC) I-outcome PUNCT
. O PUNCT
The O DET
secondary O ADJ
endpoints O NOUN
included O VERB
the O DET
symptom B-outcome NOUN
improvements, O NOUN
as O ADP
measured O VERB
by O ADP
clinical B-outcome ADJ
assessment I-outcome NOUN
score, O NOUN
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QoL) I-outcome NOUN
, O PUNCT
as O ADP
assessed O VERB
with O ADP
Paediatric O ADJ
Allergic B-outcome ADJ
Disease I-outcome NOUN
Quality I-outcome NOUN
of I-outcome ADP
Life I-outcome NOUN
Questionnaire O PROPN
(PADQLQ) O NUM
scores. O NOUN

Funded O VERB
by O ADP
Achaogen O NOUN
and O CCONJ
the O DET
Biomedical O ADJ
Advanced O VERB
Research O NOUN
and O CCONJ
Development O NOUN
Authority; O NOUN
EPIC O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02486627.). O NOUN

Further O ADV
evaluation O NOUN
of O ADP
long-term O NOUN
cardiovascular O ADJ
effects O NOUN
is O VERB
needed. O NOUN

BACKGROUND: O NOUN
Precooling O VERB
(PC) O PUNCT
before O ADP
exercise O NOUN
may O VERB
help O VERB
prevent O NOUN
severe O ADJ
hyperthermia O NOUN
and O CCONJ
exertional O ADJ
heatstroke O NOUN
(EHS). O PUNCT

Muscular B-outcome ADJ
strength I-outcome NOUN
was O VERB
significantly O ADV
different O ADJ
between O ADP
limbs O NOUN
at O ADP
the O DET
start O NOUN
of O ADP
the O DET
intervention O NOUN
(p O PUNCT
= O SYM
0.02). O NOUN

Journal O ADJ
ID: O NOUN
101307187 O NUM

Patients O NOUN
with O ADP
clinical O ADJ
stage O NOUN
I-II O NUM
gastric O ADJ
cancer O NOUN
with O ADP
a O DET
body O NOUN
mass O NOUN
index O NOUN
of O ADP
25 O NUM
and O CCONJ
over, O NOUN
who O ADP
undergo O NOUN
laparoscopic O ADJ
subtotal O ADJ
gastrectomy O NOUN
will O VERB
be O VERB
eligible O ADJ
for O ADP
trial O NOUN
inclusion. O NOUN

h(-1), O NOUN
CON O NOUN
= O SYM
1.22 O NUM
+/- O SYM
0.39 O NUM
L O NOUN
. O PUNCT

BACKGROUND: O NOUN
Sperm O NOUN
selection O NOUN
strategies O NOUN
aimed O VERB
at O ADP
improving O VERB
success O NOUN
rates O NOUN
of O ADP
intracytoplasmic O ADJ
sperm O NOUN
injection O NOUN
(ICSI) O NUM
include O VERB
binding O VERB
to O PART
hyaluronic O ADJ
acid O NOUN
(herein O NUM
termed O VERB
hyaluronan). O NOUN

Publication O NOUN
date: O NOUN
2019/01/09 O NOUN
06:00 O ADP
[medline] O NOUN

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
60 O NUM
patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
1 O NUM
of O ADP
2 O NUM
groups: O NOUN
Pre-administered O VERB
with O ADP
remifentanil O NOUN
before O ADP
propofol O NOUN
infusion O NOUN
(Group O PUNCT
R, O NOUN
n O NOUN
= O SYM
30) O NOUN
and O CCONJ
co-administered O VERB
with O ADP
remifentanil O NOUN
with O ADP
propofol O NOUN
(Group O PUNCT
N, O NOUN
n O NOUN
= O SYM
30). O NOUN

Results O NOUN
will O VERB
be O VERB
adapted O VERB
and O CCONJ
shared O VERB
with O ADP
all O DET
stakeholders. O NOUN

Title: O NOUN
Rehabilitation O NOUN
treatment O NOUN
of O ADP
spastic O ADJ
cerebral O ADJ
palsy O NOUN
with O ADP
radial O ADJ
extracorporeal O ADJ
shock O NOUN
wave O NOUN
therapy O NOUN
and O CCONJ
rehabilitation O NOUN
therapy. O NOUN

Results O NOUN
suggest O VERB
there O PRON
is O VERB
value O NOUN
in O ADP
further O ADV
methodologically O ADV
rigorous O ADJ
investigations O NOUN
into O ADP
improving O VERB
community-based O VERB
health O NOUN
system O NOUN
functioning O VERB
through O ADP
a O DET
similar O ADJ
approach O NOUN
to O PART
community O NOUN
engagement. O NOUN

Introduction: O NOUN
Most O DET
medical O ADJ
schools O NOUN
teach O NOUN
cardiopulmonary O ADJ
resuscitation O NOUN
(CPR) O ADV
during O ADP
the O DET
final O ADJ
year O NOUN
in O ADP
course O NOUN
curriculum O NOUN
to O PART
prepare O NOUN
students O NOUN
to O PART
manage O NOUN
the O DET
first O ADV
minutes O NOUN
of O ADP
clinical O ADJ
emergencies. O ADP

Title: O NOUN
EYE O NOUN
LENS O NOUN
RADIATION O NOUN
EXPOSURE O NOUN
OF O ADP
WORKERS O NOUN
DURING O ADP
MEDICAL O VERB
INTERVENTIONAL O ADJ
PROCEDURES O NOUN
AND O CCONJ
SURGERY. O NOUN

The O DET
results O NOUN
were O VERB
analyzed O VERB
using O VERB
descriptive O ADJ
and O CCONJ
inferential O ADJ
statistical O ADJ
tests O NOUN
in O ADP
SPSS O ADV
software. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ISRCTN67852437 O NOUN
, O PUNCT
registered O VERB
02/03/2015. O NUM

At O ADP
10 O NUM
minutes O NOUN
after O ADP
the O DET
beginning O VERB
of O ADP
atomization, O NOUN
the O DET
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
monitored O VERB
by O ADP
ventilator O NOUN
in O ADP
different O ADJ
preset O NOUN
VT O NOUN
groups O NOUN
was O VERB
significantly O ADV
lower O ADJ
than O ADP
tidal B-outcome DET
volume I-outcome NOUN
showed O VERB
by O ADP
simulated O VERB
water O NOUN
lung O NOUN
(mL: O PUNCT
649.67+/-5.03 O NOUN
vs. O CCONJ
840.00+/-10.00 O NOUN
at O ADP
650 O NUM
mL O NOUN
of O ADP
preset O NOUN
VT O NOUN
and O CCONJ
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
P O NOUN
< O SYM
0.05), O NUM
and O CCONJ
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
was O VERB
significantly O ADV
higher O ADJ
than O ADP
tidal B-outcome DET
volume I-outcome NOUN
showed O VERB
by O ADP
simulated O VERB
water O NOUN
lung O NOUN
(mL: O PUNCT
1 O NUM
270.33+/-11.06 O NOUN
vs. O CCONJ
840.00+/-10.00 O NOUN
at O ADP
650 O NUM
mL O NOUN
of O ADP
preset O NOUN
VT O NOUN
and O CCONJ
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
P O NOUN
< O SYM
0.05). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

BACKGROUND: O NOUN
Residual O ADJ
postoperative O ADJ
neuromuscular O ADJ
blockade O NOUN
is O VERB
an O DET
important O ADJ
clinical O ADJ
issue. O NOUN

Publication O NOUN
date: O NOUN
2019/03/08 O ADV
06:00 O ADP
[medline] O NOUN

At O ADP
enrolment, O NOUN
90 O NUM
women O NOUN
will O VERB
be O VERB
randomly O ADV
assigned O VERB
into O ADP
each O DET
intervention O NOUN
arm O NOUN
to O PART
receive O VERB
either O CCONJ
a O DET
daily O ADJ
tablet O NOUN
of O ADP
200 O NUM
mug O NUM
elemental O ADJ
selenium O NOUN
or O CCONJ
placebo. O NOUN

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
who O ADP
were O VERB
scheduled O VERB
for O ADP
CABG O NOUN
and O CCONJ
had O VERB
been O VERB
randomly O ADV
assigned O VERB
to O PART
undergo O NOUN
bilateral O ADJ
or O CCONJ
single O ADJ
internal-thoracic-artery O ADV
grafting, O NOUN
there O PRON
was O VERB
no O DET
significant O ADJ
between-group O NOUN
difference O NOUN
in O ADP
the O DET
rate O NOUN
of O ADP
death B-outcome NOUN
from I-outcome ADP
any Seperator DET
cause I-outcome ADP
at O ADP
10 O NUM
years O NOUN
in O ADP
the O DET
intention-to-treat O NOUN
analysis. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

At O ADP
the O DET
same O ADJ
time, O NOUN
both O CCONJ
groups O NOUN
showed O VERB
no O DET
difference O NOUN
in O ADP
terms O NOUN
of O ADP
the O DET
serologic O ADJ
and O CCONJ
biochemical O ADJ
response B-outcome NOUN
. O PUNCT
Of O ADP
all O DET
patients, O NOUN
2 O NUM
dropped O VERB
out O ADP
due O ADJ
to O PART
adverse B-outcome ADJ
events I-outcome NOUN
and O CCONJ
5 O NUM
experienced O VERB
serious B-outcome ADJ
adverse I-outcome ADJ
reactions I-outcome NOUN
. O PUNCT
CONCLUSION: O NOUN
Both O CCONJ
capsules O NOUN
(ETV O NUM
or O CCONJ
TDF) O NOUN
were O VERB
equally O ADV
effective O ADJ
in O ADP
nucleos(t)ide-naive O ADJ
CHB O NOUN
patients O NOUN
with O ADP
a O DET
comparable O ADJ
side-effect B-outcome NOUN
profile O NOUN
even O ADV
in O ADP
a O DET
long-term O NOUN
of O ADP
144 O NUM
weeks. O NOUN

Infants O NOUN
aged O VERB
4(-)12 O NUM
weeks O NOUN
received O VERB
L. O NOUN
rhamnosus O NOUN
19070-2 O NUM
and O CCONJ
L. O NOUN
reuteri O NOUN
12246 O NUM
in O ADP
a O DET
daily O ADJ
dose O NOUN
of O ADP
250 O NUM
x O SYM
10(6) O NOUN
CFU, O NOUN
3.33 O NUM
mg O NOUN
of O ADP
fructooligosaccharide, O DET
and O CCONJ
200 O NUM
IU O NOUN
of O ADP
vitamin O NOUN
D(3) O NOUN
(84 O PUNCT
infants, O NOUN
probiotic O ADJ
group) O ADJ
or O CCONJ
just O ADV
vitamin O NOUN
D(3) O NOUN
(84 O PUNCT
infants, O NOUN
control O NOUN
group) O ADJ
for O ADP
28 O NUM
days. O NOUN

Journal O ADJ
ID: O NOUN
0373125 O NUM

Repeated O VERB
measures O NOUN
ANOVA O NOUN
was O VERB
used O VERB
to O PART
compare O NOUN
the O DET
groups O NOUN
over O ADP
time. O NOUN

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
Supplementation O NOUN
with O ADP
ascorbic O ADJ
acid O NOUN
prior O ADJ
exercise O NOUN
improves O NOUN
antioxidant B-outcome NOUN
power O NOUN
but O CCONJ
does O VERB
not O ADV
prevent O NOUN
muscle B-outcome NOUN
damage I-outcome NOUN
. O PUNCT

BACKGROUND: O NOUN
This O DET
study O NOUN
evaluated O VERB
the O DET
impact O NOUN
of O ADP
an O DET
exercise O NOUN
program O NOUN
on O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
in O ADP
older O ADJ
breast O NOUN
cancer O NOUN
survivors O NOUN
undergoing O VERB
aromatase O NOUN
inhibitor O NOUN
therapy. O NOUN

The O DET
main O ADJ
objective O ADP
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
feasibility B-outcome NOUN
of O ADP
the O DET
Borg O ADJ
rating O VERB
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
at O ADP
grading O VERB
functional B-outcome ADJ
training I-outcome VERB
intensity I-outcome NOUN
of O ADP
the O DET
affected O VERB
upper O ADJ
limb O NOUN
in O ADP
older O ADJ
adults O NOUN
with O ADP
a O DET
chronic O ADJ
stroke O NOUN
and O CCONJ
secondarily O ADV
to O PART
explore O ADP
the O DET
clinical O ADJ
changes O NOUN
between O ADP
FT O NOUN
and O CCONJ
ST O NOUN
when O ADP
the O DET
intensity O NOUN
is O VERB
regulated O VERB
with O ADP
Borg O ADJ
rating O VERB
of O ADP
perceived O VERB
exertion]. O NOUN
Patients O NOUN
and O CCONJ
methods: O NOUN
Twelve O NUM
participants O NOUN
were O VERB
randomized O VERB
into O ADP
a O DET
FT O NOUN
or O CCONJ
ST O NOUN
group O NOUN
and O CCONJ
trained O VERB
their O ADJ
affected O VERB
upper O ADJ
limb O NOUN
(3 O NOUN
times/week O DET
for O ADP
4 O NUM
weeks) O NOUN
with O ADP
the O DET
intensity O NOUN
standardized O VERB
with O ADP
Borg O ADJ
rating O VERB
of O ADP
perceived O VERB
exertion]. O NOUN
Feasibility B-outcome NOUN
was O VERB
assessed O VERB
by O ADP
adherence B-outcome NOUN
, O PUNCT
occurrence O NOUN
of O ADP
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
and O CCONJ
comparison O NOUN
of O ADP
Borg O ADJ
rating O VERB
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
ratings O NOUN
between O ADP
groups. O NOUN

Title: O NOUN
[Comparison O NOUN
of O ADP
effects O NOUN
of O ADP
two O NUM
anesthesia O NOUN
methods O NOUN
on O ADP
the O DET
first O ADV
night O NOUN
sleep B-outcome NOUN
quality I-outcome NOUN
in O ADP
middle-aged O NOUN
and O CCONJ
elderly O NOUN
patients O NOUN
undergoing O VERB
surgery O NOUN
for O ADP
lower O ADJ
extremity O NOUN
varicose O ADJ
vein]. O NOUN

RESULTS: O NOUN
(1) O PUNCT
Clinical O ADJ
research O NOUN
results: O NOUN
all O DET
77 O NUM
patients O NOUN
were O VERB
enrolled O VERB
in O ADP
the O DET
final O ADJ
analysis, O NOUN
including O VERB
20 O NUM
patients O NOUN
with O ADP
7 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow O NOUN
under O ADP
VCV O NOUN
mode, O NOUN
18 O NUM
patients O NOUN
with O ADP
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow, O NOUN
and O CCONJ
21 O NUM
patients O NOUN
with O ADP
7 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow O NOUN
under O ADP
PCV O NOUN
mode O NOUN
and O CCONJ
18 O NUM
patients O NOUN
with O ADP
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow. O NOUN

Journal O ADJ
ID: O NOUN
2985213R O NOUN

DISCUSSION: O NOUN
The O DET
evidence O NOUN
for O ADP
cost-effectiveness O NOUN
at O ADP
12 O NUM
months O NOUN
was O VERB
inconclusive. O ADJ

Title: O NOUN
The O DET
effect O NOUN
of O ADP
Baduanjin O NOUN
qigong O ADJ
combined O VERB
with O ADP
CBT O NOUN
on O ADP
physical B-outcome ADJ
fitness I-outcome ADP
and O CCONJ
psychological B-outcome ADJ
health I-outcome NOUN
of O ADP
elderly O NOUN
housebound. O NOUN

Journal O ADJ
ID: O NOUN
0014162 O NUM

A O DET
total O ADJ
of O ADP
45 O NUM
menopausal O ADJ
participants O NOUN
were O VERB
recruited O VERB
in O ADP
this O DET
study. O NOUN

Background: O NOUN
Acne O NOUN
vulgaris O NOUN
(acne) O NUM
is O VERB
the O DET
most O DET
common O ADJ
dermatologic O ADJ
disease O NOUN
seen O VERB
in O ADP
a O DET
racially, O NOUN
geographically, O NOUN
politically, O NOUN
culturally, O NOUN
and O CCONJ
socioeconomically O ADV
diverse O ADJ
Hispanic O ADJ
population. O ADV

Journal O ADJ
ID: O NOUN
101090633 O NUM

Three O NUM
group O NOUN
patients O NOUN
were O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
serum O NOUN
SOD B-outcome NOUN
and O CCONJ
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
before O ADP
treatment O NOUN
P>0.05. O NOUN

Title: O NOUN
Increased O VERB
self-care B-outcome NOUN
activities O NOUN
and O CCONJ
glycemic B-outcome ADJ
control I-outcome NOUN
rate O NOUN
in O ADP
relation O NOUN
to O PART
health O NOUN
education O NOUN
via O ADP
Wechat O ADP
among O ADP
diabetes O NOUN
patients: O NOUN
A O DET
randomized O VERB
clinical O ADJ
trial. O NOUN

PURPOSE: O NOUN
The O DET
primary O ADJ
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
investigate O NOUN
the O DET
effectiveness O NOUN
of O ADP
3 O NUM
different O ADJ
methods O NOUN
for O ADP
delivering O VERB
instruction O NOUN
on O ADP
infant O NOUN
handling O VERB
to O PART
parents O NOUN
in O ADP
the O DET
neonatal O ADJ
intensive O ADJ
care O NOUN
unit O NOUN
(NICU). O NOUN

Eighty-three O NUM
patients O NOUN
with O ADP
pulmonary O ADJ
bullae O NOUN
(American O NUM
Society O NOUN
of O ADP
Anesthesiologists O NOUN
(ASA) O NOUN
I-III) O ADP
undergoing O VERB
lobectomy, O NOUN
with O ADP
general O ADJ
anaesthesia, O NOUN
were O VERB
included. O NOUN

We O PRON
developed O VERB
a O DET
moderate-intensity O NOUN
intervention O NOUN
program O NOUN
that O ADP
can O VERB
be O VERB
sustained O VERB
in O ADP
the O DET
real-world O NOUN
setting O VERB
and O CCONJ
is O VERB
practically O ADV
applicable O ADJ
to O PART
both O CCONJ
moderate O ADJ
and O CCONJ
severe O ADJ
obesity. O ADP

Journal-Name:The O ADJ
International O ADJ
journal O ADJ
of O ADP
oral O ADJ
& O CCONJ
maxillofacial O ADJ
implants O NOUN

RESULTS: O NOUN
At O ADP
a O DET
median O ADJ
follow-up O NOUN
of O ADP
33.6 O NUM
months, O NOUN
the O DET
median O ADJ
disease-free B-outcome ADJ
survival I-outcome NOUN
was O VERB
21.6 O NUM
months O NOUN
in O ADP
the O DET
modified-FOLFIRINOX O NOUN
group O NOUN
and O CCONJ
12.8 O NUM
months O NOUN
in O ADP
the O DET
gemcitabine O NOUN
group O NOUN
(stratified O PUNCT
hazard O NOUN
ratio O NOUN
for O ADP
cancer-related B-outcome VERB
event I-outcome NOUN
, O PUNCT
second B-outcome ADJ
cancer I-outcome NOUN
, O PUNCT
or O CCONJ
death B-outcome NOUN
, O PUNCT
0.58; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.46 O NUM
to O PART
0.73; O NOUN
P<0.001). O NUM

The O DET
mean O NOUN
time B-outcome NOUN
for Seperator ADP
completing I-outcome VERB
the Seperator DET
task I-outcome NOUN
during O ADP
the O DET
stabilization O NOUN
period O NOUN
was O VERB
significantly O ADV
different O ADJ
between O ADP
group O NOUN
I O NUM
and O CCONJ
group O NOUN
III O NUM
and O CCONJ
group O NOUN
II O NUM
and O CCONJ
group O NOUN
III, O NOUN
which O ADP
means O NOUN
that O ADP
the O DET
independent O ADJ
training O VERB
method O NOUN
was O VERB
inferior O ADJ
to O PART
the O DET
other O ADJ
methods O NOUN
(group O PUNCT
I O NUM
vs. O CCONJ
group O NOUN
II O NUM
vs. O CCONJ
group O NOUN
III: O NOUN
187.38 O NUM
vs. O CCONJ
187.07 O NUM
vs. O CCONJ
253.47 O NUM
seconds, O NOUN
P O NOUN
< O SYM
.001). O PUNCT

OBJECTIVE: O NOUN
To O PART
develop O VERB
an O DET
intervention O NOUN
protocol O NOUN
for O ADP
children's O NOUN
unintentional O ADJ
injury O NOUN
risk O NOUN
behaviors, O NOUN
and O CCONJ
to O PART
evaluate O VERB
the O DET
feasibility B-outcome NOUN
of O ADP
the O DET
protocol. O NOUN

Publication O NOUN
date: O NOUN
2018/11/13 O NOUN
00:00 O NOUN
[accepted] O ADV

No O DET
complications B-outcome NOUN
were O VERB
observed O VERB
during O ADP
the O DET
study. O NOUN

Journal-Name:Nutrients O NOUN

The O DET
most O DET
preferred B-outcome VERB
respirator O NOUN
type O NOUN
was O VERB
the O DET
valve-type O NOUN
(10 O NOUN
persons, O NOUN
45.5%). O NUM

In O ADP
addition, O NOUN
they O PRON
also O ADV
underwent O VERB
verum O NOUN
or O CCONJ
sham O NOUN
TENS O NOUN
30 O NUM
min O NOUN
daily, O NOUN
3 O NUM
times O NOUN
weekly O ADV
for O ADP
4 O NUM
weeks. O NOUN

METHODS: O NOUN
Patients O NOUN
received O VERB
either O CCONJ
60 O NUM
mg O NOUN
denosumab O NOUN
(n O NOUN
= O SYM
32) O NOUN
or O CCONJ
placebo O NOUN
(n O NOUN
= O SYM
31) O NOUN
every O DET
6 O NUM
months O NOUN
for O ADP
12 O NUM
months. O NOUN

PMID: O NOUN
31597637 O NUM

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
8900488 O NUM

Poor O ADJ
nutritional O ADJ
status O NOUN
is O VERB
common O ADJ
among O ADP
human O NOUN
immunodeficiency O NOUN
virus O NOUN
(HIV)-infected O VERB
patients O NOUN
including O VERB
vitamin O NOUN
D O NOUN
(vitD(3)) O NOUN
deficiency. O NOUN

Subgroup O NOUN
analysis O NOUN
revealed O VERB
that O ADP
there O PRON
were O VERB
no O DET
differences O NOUN
in O ADP
mean O NOUN
maximum O NOUN
grip O NOUN
value O NOUN
recovery O NOUN
between O ADP
patients O NOUN
treated O VERB
with O ADP
rocuronium O NOUN
and O CCONJ
those O DET
treated O VERB
with O ADP
cisatracurium O NOUN
when O ADP
TOFr O NOUN
was O VERB
0.7, O NUM
0.8, O NOUN
and O CCONJ
0.9 O NUM
or O CCONJ
when O ADP
the O DET
TOFr O NOUN
was O VERB
0.25 O NUM
after O ADP
60 O NUM
minutes O NOUN
(all O PUNCT
P O NOUN
>.05). O NUM

In O ADP
the O DET
2nd O ADJ
group O NOUN
of O ADP
patients O NOUN
which O ADP
also O ADV
contained O VERB
22 O NUM
children O NOUN
and O CCONJ
autologous O ADJ
gracilis O NOUN
graft O NOUN
was O VERB
used. O NOUN

Publication O NOUN
date: O NOUN
2019/03/09 O NOUN
06:00 O ADP
[medline] O NOUN

FINDINGS: O ADJ
Between O ADP
July O NOUN
31, O NUM
2014, O NUM
and O CCONJ
March O NOUN
14, O NUM
2016, O NUM
656 O NUM
patients O NOUN
were O VERB
enrolled O VERB
and O CCONJ
randomly O ADV
assigned O VERB
to O PART
receive O VERB
ixazomib O NOUN
maintenance O NOUN
therapy O NOUN
(n=395) O NOUN
or O CCONJ
placebo O NOUN
(n=261). O NOUN

Journal-Name:Nutrition O NOUN
& O CCONJ
diabetes O NOUN

Employees O NOUN
aged O VERB
18-65 O NUM
years O NOUN
with O ADP
no O DET
self-reported O VERB
medical O ADJ
contraindications O NOUN
to O PART
physical O ADJ
activity O NOUN
were O VERB
included. O NOUN

A O DET
primary O ADJ
school O NOUN
in O ADP
Changsha O ADV
city O NOUN
was O VERB
selected O VERB
by O ADP
random O NOUN
cluster O NOUN
sampling. O VERB

RESULTS: O NOUN
A O DET
protocol-defined O VERB
decrease O NOUN
in O ADP
the O DET
hemoglobin B-outcome NOUN
level O NOUN
occurred O VERB
in O ADP
4 O NUM
of O ADP
166 O NUM
patients O NOUN
(2.4%; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.9 O NUM
to O PART
6.0) O ADP
in O ADP
the O DET
tafenoquine O NOUN
group O NOUN
and O CCONJ
in O ADP
1 O NUM
of O ADP
85 O NUM
patients O NOUN
(1.2%; O NOUN
95% O NOUN
CI, O NOUN
0.2 O NUM
to O PART
6.4) O ADP
in O ADP
the O DET
primaquine O NOUN
group, O NOUN
for O ADP
a O DET
between-group O NOUN
difference O NOUN
of O ADP
1.2 O NUM
percentage O NOUN
points O NOUN
(95% O PUNCT
CI, O NOUN
-4.2 O NUM
to O PART
5.0). O NOUN

T O NOUN
Self-rating O VERB
depression B-outcome NOUN
scale O NOUN
(SDS) O PUNCT
and O CCONJ
self-rating O VERB
anxiety B-outcome NOUN
scale O NOUN
SAS O NUM
scores O NOUN
of O ADP
patients O NOUN
in O ADP
the O DET
rhodiola O NOUN
rosea+non-invasive O ADJ
ventilator O NOUN
group O NOUN
decreased O VERB
after O ADP
treatment O NOUN
P<0.05 O NOUN
compared O VERB
with O ADP
those O DET
in O ADP
the O DET
non-invasive O ADJ
ventilator O NOUN
group. O VERB
[ O PUNCT

Title: O NOUN
[Effects O NOUN
of O ADP
rhodiola O NOUN
rosea O NOUN
on O ADP
oxidative B-outcome ADJ
stress I-outcome NOUN
and O CCONJ
negative B-outcome ADJ
emotional I-outcome ADJ
states I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
obstructive O ADJ
sleep O NOUN
apnea]. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

In O ADP
the O DET
present O ADJ
post O ADV
hoc O NOUN
analysis, O NOUN
patients O NOUN
who O ADP
continued O NOUN
to O PART
perform O NOUN
daily O ADJ
home O NOUN
spirometry O NOUN
and O CCONJ
completed O VERB
at O ADP
least O ADV
one O NUM
measurement O NOUN
per O ADP
week O NOUN
for O ADP
a O DET
56-day O NOUN
period O NOUN
before O ADP
and O CCONJ
after O ADP
the O DET
start O NOUN
of O ADP
a O DET
moderate O ADJ
or O CCONJ
severe O ADJ
exacerbation O NOUN
were O VERB
included. O NOUN

Further O ADV
studies O NOUN
are O VERB
needed O VERB
to O PART
validate O NOUN
the O DET
current O ADJ
observations. O NOUN

Randomisation O NOUN
was O VERB
stratified O VERB
by O ADP
induction O NOUN
regimen, O NOUN
pre-induction O NOUN
disease O NOUN
stage, O VERB
and O CCONJ
response O NOUN
post-transplantation. O NOUN

Supplementation O NOUN
with O ADP
oral O ADJ
vitamin O NOUN
D O NOUN
can O VERB
favor O NOUN
the O DET
state O NOUN
of O ADP
iron O NOUN
metabolism, O VERB
and O CCONJ
testosterone O NOUN
and O CCONJ
cortisol O NOUN
as O ADP
an O DET
indicator O NOUN
of O ADP
muscle O NOUN
recovery O NOUN
of O ADP
the O DET
athlete O NOUN
with O ADP
a O DET
deficiency. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
(p=0.3). O PUNCT

Most O DET
studies O NOUN
assessing O VERB
PZQ O NOUN
efficacy O NOUN
have O VERB
used O VERB
relatively O ADV
insensitive O ADJ
parasitological O ADJ
diagnostics, O ADJ
such O ADJ
as O ADP
the O DET
Kato-Katz O NOUN
(KK) O NOUN
and O CCONJ
urine-filtration O NOUN
methods, O NOUN
thereby O ADV
overestimating O VERB
cure O NOUN
rates O NOUN
(CRs). O PUNCT

The O DET
intervention O NOUN
arm O NOUN
received O VERB
a O DET
single O ADJ
mass O NOUN
drug O NOUN
administration O NOUN
of O ADP
azithromycin. O NOUN

Journal-Name:Nigerian O NOUN
journal O ADJ
of O ADP
clinical O ADJ
practice O NOUN

Study O NOUN
2 O NUM
tested O VERB
2-week O NOUN
smartphone-based O VERB
Monitor O NOUN
+ O SYM
Accept O ADV
and O CCONJ
Monitor O NOUN
Only O ADV
interventions O NOUN
compared O VERB
with O ADP
an O DET
active O ADJ
control O NOUN
training. O NOUN

Journal O ADJ
ID: O NOUN
101238455 O NUM

Journal O ADJ
ID: O NOUN
100968562 O NUM

Injecting O VERB
a O DET
long O ADV
acting O VERB
steroid O NOUN
is O VERB
a O DET
common O ADJ
practice O NOUN
to O PART
alleviate O NOUN
the O DET
symptoms O NOUN
of O ADP
osteoarthritic O ADJ
knee. O NOUN

EG O NOUN
patients O NOUN
completed O VERB
ExMI O NOUN
therapy. O NOUN

Data O NOUN
were O VERB
from O ADP
review O NOUN
of O ADP
notes O NOUN
and O CCONJ
minutes O NOUN
from O ADP
meetings, O NOUN
and O CCONJ
discussions O NOUN
with O ADP
each O DET
CBO O NOUN
on O ADP
value O NOUN
added O VERB
by O ADP
intervention O NOUN
elements O NOUN
and O CCONJ
on O ADP
impact O NOUN
of O ADP
the O DET
project. O NOUN

Medical O ADJ
sciences O NOUN

BACKGROUND: O NOUN
Research O NOUN
has O VERB
demonstrated O VERB
that O ADP
low O ADJ
fermentable O ADJ
oligiosaccharide, O NOUN
disaccharide, O NOUN
monosaccharide O NOUN
and O CCONJ
polyol O NOUN
(FODMAP) O PUNCT
diets O NOUN
improve O VERB
gastrointestinal O ADJ
(GI) O NOUN
symptoms O NOUN
in O ADP
irritable O ADJ
bowel O NOUN
syndrome O NOUN
sufferers. O NOUN

Importance: O NOUN
Multimodal O ADP
postoperative O ADJ
analgesia O NOUN
is O VERB
widely O ADV
used O VERB
but O CCONJ
lacks O NOUN
evidence O NOUN
of O ADP
benefit. O NOUN

Journal O ADJ
ID: O NOUN
0374675 O NUM

Journal O ADJ
ID: O NOUN
0374675 O NUM

At O ADP
2 O NUM
years O NOUN
follow-up, O ADP
the O DET
mean O NOUN
intraocular B-outcome ADJ
pressure(IOP) I-outcome NOUN
level O NOUN
was O VERB
statistically O ADV
significantly O ADV
decreased O VERB
in O ADP
the O DET
OloPhacovisco O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.02) O NUM
and O CCONJ
complete O ADJ
success B-outcome NOUN
occurred O VERB
in O ADP
23 O NUM
eyes O NOUN
(59.0%) O PUNCT
in O ADP
the O DET
Phacovisco O NOUN
group O NOUN
and O CCONJ
in O ADP
32 O NUM
eyes O NOUN
(80.0%) O NOUN
in O ADP
the O DET
OloPhacovisco O NOUN
group. O VERB

The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
examine O NOUN
the O DET
feasibility B-outcome NOUN
and O CCONJ
potential O ADJ
effectiveness O NOUN
of O ADP
an O DET
active, O ADJ
music-instruction O NOUN
intervention O NOUN
in O ADP
improving O VERB
psychological B-outcome ADJ
health I-outcome NOUN
and O CCONJ
social B-outcome ADJ
functioning I-outcome VERB
among O ADP
Veterans O NOUN
suffering O VERB
from O ADP
moderate O ADJ
to O PART
severe O ADJ
PTSD. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Journal O ADJ
ID: O NOUN
101266132 O NUM

Most O DET
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
mild; O NOUN
the O DET
most O DET
common O ADJ
events O NOUN
were O VERB
diarrhoea B-outcome NOUN
in O ADP
eight O NUM
(16%) O PUNCT
of O ADP
49 O NUM
patients O NOUN
treated O VERB
with O ADP
pegbelfermin O NOUN
and O CCONJ
two O NUM
(8%) O NOUN
of O ADP
26 O NUM
patients O NOUN
treated O VERB
with O ADP
placebo O NOUN
and O CCONJ
nausea B-outcome NOUN
in O ADP
seven O NUM
(14%) O PUNCT
patients O NOUN
treated O VERB
with O ADP
pegbelfermin O NOUN
and O CCONJ
two O NUM
(8%) O NOUN
patients O NOUN
treated O VERB
with O ADP
placebo. O NOUN

Publication O NOUN
date: O NOUN
2018/11/19 O NOUN
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
date: O NOUN
2019/02/09 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[entrez] O ADP

METHODS: O NOUN
The O DET
present O ADJ
double-blind O ADJ
randomized O VERB
controlled O VERB
trial O NOUN
included O VERB
women O NOUN
who O ADP
underwent O VERB
home O NOUN
deliveries O NOUN
in O ADP
Chitral O ADJ
district, O NOUN
Khyber O NOUN
Pakhtunkhwa O NOUN
province, O NOUN
Pakistan, O NOUN
after O ADP
presenting O VERB
at O ADP
healthcare O NOUN
facilities O NOUN
during O ADP
the O DET
third O ADJ
trimester O NOUN
of O ADP
pregnancy O NOUN
between O ADP
May O NOUN
28, O NUM
2012, O NUM
and O CCONJ
November O NOUN
27, O NUM
2014. O NUM

In O ADP
the O DET
dry O ADJ
needling O VERB
group, O NOUN
all O DET
the O DET
effect O NOUN
sizes O NOUN
for O ADP
headache O NOUN
variables O NOUN
were O VERB
large. O NOUN

Journal O ADJ
ID: O NOUN
101281800 O NUM

Journal O ADJ
ID: O NOUN
100968562 O NUM

Publication O NOUN
date: O NOUN
2019/02/14 O NOUN
06:00 O ADP
[entrez] O ADP

Fifty-three O NUM
patients O NOUN
undergoing O VERB
spine O NOUN
surgery O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
2 O NUM
groups: O NOUN
control O NOUN
group O NOUN
(group O PUNCT
C, O NOUN
n O NOUN
= O SYM
26) O NOUN
and O CCONJ
transcutaneous O ADJ
electrical O ADJ
acupoint O NOUN
stimulation O NOUN
group O NOUN
(group O PUNCT
TEAS, O NOUN
n O NOUN
= O SYM
27). O NOUN

There O PRON
is O VERB
a O DET
paucity O NOUN
of O ADP
evidence O NOUN
on O ADP
interventions O NOUN
that O ADP
might O VERB
provide O VERB
cardio-protection. O ADV

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

RESULTS: O NOUN
Between O ADP
September O NOUN
2014 O NUM
and O CCONJ
October O ADJ
2015, O NUM
we O PRON
recruited O VERB
and O CCONJ
randomly O ADV
assigned O VERB
37 O NUM
clusters O NOUN
(from O PUNCT
nine O NUM
organisations; O NOUN
mean O NOUN
clusters O NOUN
per O ADP
organisation O NOUN
= O SYM
four) O NOUN
and O CCONJ
853 O NUM
participants O NOUN
to O PART
the O DET
intervention O NOUN
(n O NOUN
= O SYM
19 O NUM
with O ADP
457 O NUM
participants) O NOUN
or O CCONJ
control O NOUN
group O NOUN
(n O NOUN
= O SYM
18 O NUM
with O ADP
396 O NUM
participants). O NOUN

Journal-Name:Nutrients O NOUN

Title: O NOUN
Alcohol O NOUN
pictorial O ADJ
health O NOUN
warning O VERB
labels: O NOUN
the O DET
impact O NOUN
of O ADP
self-affirmation O NOUN
and O CCONJ
health O NOUN
warning O VERB
severity. O DET

Journal-Name:Medicine O NOUN

Data O NOUN
were O VERB
analyzed O VERB
using O VERB
1-way O NOUN
repeated-measures O NOUN
analysis O NOUN
of O ADP
variance O NOUN
for O ADP
each O DET
outcome O NOUN
measure. O NOUN

FUNDING: O NOUN
UK O PROPN
National O ADJ
Institute O NOUN
for O ADP
Health O NOUN
Research O NOUN
Health O NOUN
Technology O NOUN
Assessment O NOUN
programme O NOUN
(10/57/49). O NUM

TRIAL O NOUN
REGISTRATION: O NOUN
current O ADJ
controlled O VERB
trials O NOUN
PHRC/HC/32/15. O NOUN

BACKGROUND: O NOUN
Complications O NOUN
related O VERB
to O PART
concurrent O ADJ
chemoradiotherapy O NOUN
(CCRT) O NUM
such O ADJ
as O ADP
acute O ADJ
radiation-induced O VERB
esophagitis O NOUN
(ARIE) O NUM
may O VERB
cause O ADP
significant O ADJ
morbidity O NOUN
and O CCONJ
unplanned O VERB
treatment O NOUN
delays O NOUN
in O ADP
patients O NOUN
with O ADP
advanced O VERB
non-small O ADJ
cell O NOUN
lung O NOUN
cancer O NOUN
(NSCLC). O PUNCT

Title: O NOUN
Seafood O NOUN
Consumption, O NOUN
Omega-3 O NOUN
Fatty O ADJ
Acids O NOUN
Intake, O NOUN
and O CCONJ
Life-Time O NOUN
Prevalence O NOUN
of O ADP
Depression B-outcome NOUN
in O ADP
the O DET
PREDIMED-Plus O NOUN
Trial. O NOUN

These O DET
contextual O ADJ
factors O NOUN
interacted O VERB
with O ADP
the O DET
implemented O VERB
training O VERB
to O PART
influence O NOUN
knowledge O NOUN
about O ADV
pharmacological O ADJ
treatments O NOUN
and O CCONJ
symptoms O NOUN
of O ADP
mental O ADJ
illness, O NOUN
confidence O NOUN
in O ADP
providing O VERB
treatment, O NOUN
negative O ADJ
beliefs O NOUN
about O ADV
certain O ADJ
mental O ADJ
health O NOUN
conditions, O NOUN
and O CCONJ
the O DET
understanding O VERB
of O ADP
the O DET
role O NOUN
of O ADP
PCPs O NOUN
in O ADP
mental O ADJ
health O NOUN
care O NOUN
delivery. O VERB

Journal O ADJ
ID: O NOUN
0313225 O NUM

Journal-Name: O NOUN
BMJ O NOUN
(Clinical O ADJ
research O NOUN
ed.) O NOUN

Journal-Name:Respiratory O NUM
research O NOUN

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT02571361. O NOUN

Journal-Name:International O ADJ
journal O ADJ
of O ADP
environmental O ADJ
research O NOUN
and O CCONJ
public O ADJ
health O NOUN

Title: O NOUN
[A O PUNCT
comparison O NOUN
study O NOUN
of O ADP
cognitive-behavioral O ADJ
therapy O NOUN
alone O ADJ
versus O CCONJ
combination O NOUN
with O ADP
tapered O VERB
hypnotic O ADJ
agents O NOUN
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
insomnia]. O NOUN

Functional B-outcome ADJ
outcome O NOUN
was O VERB
significantly O ADV
improved O VERB
compared O VERB
to O PART
baseline O NOUN
in O ADP
both O CCONJ
the O DET
groups O NOUN
until O ADP
six O NUM
weeks O NOUN
however, O ADV
in O ADP
the O DET
triamcinolone O NOUN
group, O NOUN
it O PRON
was O VERB
significant O ADJ
until O ADP
twelve O NUM
weeks. O NOUN

Generally, O NOUN
UI O NOUN
becomes O NOUN
more O ADV
severe O ADJ
with O ADP
age. O ADJ

Methods: O NOUN
This O DET
was O VERB
a O DET
prospective O ADJ
study. O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
patients O NOUN
with O ADP
acute O ADJ
STEMI O NOUN
presenting O VERB
within O ADP
6 O NUM
hours O NOUN
of O ADP
symptoms, O NOUN
adjunctive O ADJ
low-dose O NOUN
intracoronary O ADJ
alteplase O NOUN
given O VERB
during O ADP
the O DET
primary O ADJ
percutaneous O ADJ
intervention O NOUN
did O VERB
not O ADV
reduce O VERB
microvascular B-outcome ADJ
obstruction I-outcome NOUN
. O PUNCT
The O DET
study O NOUN
findings O NOUN
do O VERB
not O ADV
support O NOUN
this O DET
treatment. O NOUN

All O DET
children O NOUN
returned O VERB
to O PART
full B-outcome ADJ
activity I-outcome NOUN
. O PUNCT
Similar O ADJ
results O NOUN
were O VERB
obtained O VERB
in O ADP
patients O NOUN
in O ADP
2nd O ADJ
group, O NOUN
where O ADP
MPFL O NOUN
was O VERB
reconstructed O VERB
with O ADP
ipsilateral O ADJ
gracilis O NOUN
tendon. O ADV
[ O PUNCT

Eligible O ADJ
women O NOUN
(aged O PUNCT
18-43 O NUM
years) O NOUN
had O VERB
a O DET
body-mass O NOUN
index O NOUN
of O ADP
19-35 O NUM
kg/m(2) O NOUN
and O CCONJ
a O DET
follicle-stimulating O VERB
hormone O NOUN
(FSH) O PUNCT
concentration O NOUN
of O ADP
3.0-20.0 O NUM
mIU/mL O NOUN
or, O NOUN
if O ADP
no O DET
FSH O NOUN
measurement O NOUN
was O VERB
available, O NOUN
an O DET
anti-mullerian O ADJ
hormone O NOUN
concentration O NOUN
of O ADP
at O ADP
least O ADV
1.5 O NUM
pmol/L. O NOUN
Eligible O ADJ
men O NOUN
(aged O PUNCT
18-55 O NUM
years) O NOUN
had O VERB
not O ADV
had O VERB
a O DET
vasovasostomy O NOUN
or O CCONJ
been O VERB
treated O VERB
for O ADP
cancer O NOUN
in O ADP
the O DET
24 O NUM
months O NOUN
before O ADP
recruitment O NOUN
and O CCONJ
were O VERB
able, O NOUN
after O ADP
at O ADP
least O ADV
3 O NUM
days O NOUN
of O ADP
sexual O ADJ
abstinence, O NOUN
to O PART
produce O VERB
freshly O ADV
ejaculated O VERB
sperm O NOUN
for O ADP
the O DET
treatment O NOUN
cycle. O NOUN

END O NOUN
POINTS: O NOUN
Primary O ADJ
end O NOUN
point O NOUN
was O VERB
MACE B-outcome NOUN
at O ADP
1 O NUM
year O NOUN
and O CCONJ
secondary O ADJ
end O NOUN
points O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
1 O NUM
year O NOUN
were O VERB
cardiac B-outcome ADJ
death I-outcome NOUN
, O PUNCT
urgent O ADJ
target O NOUN
lesion B-outcome NOUN
revascularization I-outcome NOUN
, O PUNCT
acute B-outcome ADJ
coronary I-outcome ADJ
syndrome I-outcome NOUN
, O PUNCT
stroke B-outcome NOUN
and O CCONJ
in-stent B-outcome NOUN
re-stenosis I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
204 O NUM
patients O NOUN
were O VERB
enrolled O VERB
between O ADP
January O NOUN
2013 O NUM
to O PART
July O NOUN
2014, O NUM
91 O NUM
in O ADP
the O DET
polymer-free O ADJ
group O NOUN
and O CCONJ
113 O NUM
in O ADP
the O DET
biodegradable O ADJ
polymer O NOUN
group. O VERB

Handgrip B-outcome NOUN
strength I-outcome NOUN
increase O NOUN
was O VERB
also O ADV
observed O VERB
after O ADP
HIIT O NOUN
(p=.002), O PUNCT
but O CCONJ
no O DET
differences O NOUN
were O VERB
observed O VERB
with O ADP
MIIT O NOUN
and O CCONJ
CG. O NOUN

Patients O NOUN
with O ADP
coexisting O VERB
cataract O NOUN
and O CCONJ
glaucoma O NOUN
were O VERB
randomized O VERB
to O PART
receive O VERB
either O CCONJ
phaco-viscocanalostomy O NOUN
(Phacovisco O PUNCT
group) O ADJ
(39 O ADV
eyes) O NOUN
or O CCONJ
phaco-viscocanalostomy O NOUN
with O ADP
Ologen(R) O NOUN
implant O NOUN
(OloPhacovisco O NUM
group) O ADJ
(40 O NOUN
eyes). O ADJ

The O DET
OSTAP O NOUN
block O VERB
is O VERB
a O DET
promising O VERB
technique O NOUN
for O ADP
producing O VERB
effective O ADJ
and O CCONJ
prolonged O VERB
postoperative O ADJ
analgesia O NOUN
in O ADP
patients O NOUN
undergoing O VERB
laparoscopic O ADJ
hysterectomy O NOUN
surgeries. O NUM

Secondary O ADJ
outcomes O NOUN
included O VERB
health B-outcome NOUN
, O PUNCT
mental B-outcome ADJ
wellbeing I-outcome VERB
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
work B-outcome NOUN
absenteeism I-outcome NOUN
and Seperator CCONJ
presenteeism S1-outcome NOUN
, O PUNCT
and O CCONJ
use B-outcome NOUN
of I-outcome ADP
healthcare I-outcome NOUN
resources I-outcome NOUN
. O PUNCT
Cost-effectiveness, O NOUN
cost-benefit O NOUN
and O CCONJ
mediation O NOUN
analyses O NOUN
were O VERB
conducted. O NOUN

RESULTS: O NOUN
Thirty-five O ADJ
patients O NOUN
were O VERB
assigned O VERB
to O PART
the O DET
AG O NOUN
and O CCONJ
thirty-four O NOUN
patients O NOUN
were O VERB
assigned O VERB
to O PART
the O DET
CG. O NOUN

Journal-Name:Anticancer O NOUN
research O NOUN

Primary O ADJ
endpoint: O NOUN
the O DET
change O NOUN
in O ADP
plasma O NOUN
HIV-1 B-outcome NOUN
comparing O VERB
week O NOUN
0 O NUM
to O PART
16 O NUM
using O VERB
modified O VERB
intention-to-treat O NOUN
(mITT, O NOUN
n O NOUN
= O SYM
197) O NOUN
and O CCONJ
per-protocol O NOUN
(n O NOUN
= O SYM
173) O NOUN
analyses. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

intrauterine B-outcome ADJ
adhesions I-outcome NOUN
were O VERB
staged O VERB
as O ADP
mild O ADJ
in O ADP
4 O NUM
patients O NOUN
(14.28%) O PUNCT
and O CCONJ
moderate O ADJ
in O ADP
2 O NUM
patients O NOUN
(7.14%) O NUM
in O ADP
group O NOUN
2 O NUM
according O ADJ
to O PART
the O DET
American O ADJ
Fertility O NOUN
Society O NOUN
classification O NOUN
of O ADP
IUAs. O NOUN

Stroke B-outcome NOUN
volume I-outcome NOUN
index O NOUN
(SVI) O PUNCT
and O CCONJ
cardiac B-outcome ADJ
cycle I-outcome NOUN
efficiency O NOUN
(CCE) O PUNCT
showed O VERB
an O DET
increase O NOUN
in O ADP
Group O NOUN
SM O NOUN
but O CCONJ
a O DET
decrease O NOUN
in O ADP
Group O NOUN
S O NOUN
(Ptime*group<0.0001). O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

SHORE O DET
data O NOUN
were O VERB
retrospectively O ADV
analyzed O VERB
to O PART
identify O NOUN
baseline O NOUN
patient O NOUN
characteristics O NOUN
associated O VERB
with O ADP
early O ADJ
clinically O ADV
significant O ADJ
improvements O NOUN
in O ADP
visual B-outcome ADJ
acuity I-outcome NOUN
(VA) I-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
improvement O NOUN
to O PART
a O DET
Snellen O NOUN
equivalent O ADJ
of O ADP
20/40 O NOUN
or O CCONJ
better O ADJ
vision B-outcome NOUN
(>/= O PUNCT
69 O NUM
Early O ADJ
Treatment O NOUN
Diabetic B-outcome ADJ
Retinopathy I-outcome NOUN
Study O NOUN
(ETDRS) O NOUN
letters) O NOUN
or O CCONJ
an O DET
increase O NOUN
in O ADP
best-corrected B-outcome VERB
visual I-outcome ADJ
acuity I-outcome NOUN
(BCVA) I-outcome NUM
of O ADP
15 O NUM
or O CCONJ
more O ADV
ETDRS O NOUN
letters O NOUN
from O ADP
baseline O NOUN
within O ADP
3 O NUM
months O NOUN
of O ADP
treatment O NOUN
initiation. O ADV

Journal O ADJ
ID: O NOUN
9812598 O NUM

Conclusion: O NOUN
Peer O NOUN
support O NOUN
for O ADP
education O NOUN
intervention O NOUN
seemed O VERB
beneficial O ADJ
for O ADP
diabetic B-outcome ADJ
control I-outcome NOUN
. O PUNCT
The O DET
combination O NOUN
of O ADP
education O NOUN
and O CCONJ
effect O NOUN
evaluation O NOUN
was O VERB
important O ADJ
in O ADP
the O DET
evaluation O NOUN
of O ADP
diabetes B-outcome NOUN
prevention I-outcome NOUN
and Seperator CCONJ
control S1-outcome NOUN
. O PUNCT
Peer O NOUN
support O NOUN
education O NOUN
also O ADV
benefited O VERB
the O DET
blood B-outcome NOUN
glucose I-outcome NOUN
control I-outcome NOUN
in O ADP
general O ADJ
population. O ADV

CONCLUSIONS: O NOUN
Rather O ADV
than O ADP
being O VERB
a O DET
time O NOUN
of O ADP
optimism, O ADV
a O DET
third O ADJ
of O ADP
low O ADJ
caste O NOUN
girls O NOUN
in O ADP
rural O ADJ
north, O NOUN
Karnataka O NOUN
have O VERB
limited O VERB
hope O NOUN
for O ADP
the O DET
future, O NOUN
with O ADP
some O DET
contemplating O VERB
suicide. O NOUN

In O ADP
the O DET
treatment O NOUN
arm O NOUN
there O PRON
was O VERB
a O DET
significant O ADJ
reduction O NOUN
of O ADP
ocular B-outcome ADJ
infection I-outcome NOUN
12 O NUM
months O NOUN
after O ADP
treatment O NOUN
(p O PUNCT
= O SYM
0.004) O NOUN
but O CCONJ
no O DET
change O NOUN
in O ADP
the O DET
control O NOUN
arm. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

The O DET
primary O ADJ
efficacy O NOUN
end O NOUN
point O NOUN
was O VERB
0.6% O NOUN
in O ADP
both O CCONJ
the O DET
conventional O ADJ
60 O NUM
mg O NOUN
loading O VERB
dose O NOUN
(LD) O NOUN
and O CCONJ
lower O ADJ
30 O NUM
mg O NOUN
LD O NOUN
groups O NOUN
(p O PUNCT
= O SYM
not O ADV
significant). O NOUN

INTRODUCTION: O NOUN
The O DET
purpose O NOUN
of O ADP
this O DET
research O NOUN
was O VERB
to O PART
compare O NOUN
the O DET
effects O NOUN
of O ADP
Herbst O NOUN
appliance O NOUN
therapy O NOUN
using O VERB
incremental O ADJ
vs O CCONJ
maximum O NOUN
advancement O ADJ
in O ADP
late O ADJ
adolescent O NOUN
and O CCONJ
young O ADJ
adult O NOUN
patients O NOUN
with O ADP
Class O NOUN
II O NUM
skeletal O ADJ
malocclusion. O NOUN

PURPOSE: O NOUN
To O PART
evaluate O VERB
3-dimensional O ADJ
epithelial O ADJ
remodeling O VERB
in O ADP
patients O NOUN
undergoing O VERB
myopic O ADJ
laser O NOUN
in O ADP
situ O ADV
keratomileusis O NOUN
(LASIK) O PUNCT
versus O CCONJ
small O ADJ
incision O NOUN
lenticule O NOUN
extraction O NOUN
(SMILE). O NOUN

We O PRON
previously O ADV
conducted O VERB
a O DET
regional O ADJ
study O NOUN
in O ADP
the O DET
Quebec's O NOUN
Eastern O NOUN
Townships O NOUN
region, O NOUN
the O DET
PromoVac O NOUN
Study, O NOUN
to O PART
test O NOUN
a O DET
new O ADJ
educational O ADJ
intervention, O ADP
based O VERB
on O ADP
motivational O ADJ
interviewing O VERB
techniques, O NOUN
aimed O VERB
at O ADP
promoting O VERB
infant B-outcome NOUN
vaccination I-outcome NOUN
. O PUNCT
This O DET
first O ADV
study O NOUN
evidenced O VERB
that O ADP
the O DET
intervention O NOUN
led O VERB
to O PART
a O DET
marked O VERB
increase O NOUN
in O ADP
mothers' O ADJ
intention B-outcome NOUN
to O PART
vaccinate, O ADP
and O CCONJ
vaccine B-outcome NOUN
coverage O NOUN
in O ADP
their O ADJ
infants. O NOUN

MAIN O ADJ
OUTCOME O NOUN
MEASURES: O NOUN
The O DET
primary O ADJ
outcome O NOUN
measure O NOUN
was O VERB
a O DET
composite O NOUN
of O ADP
severe B-outcome ADJ
adverse I-outcome ADJ
perinatal I-outcome ADJ
outcomes I-outcome NOUN
: O PUNCT
perinatal B-outcome ADJ
death I-outcome NOUN
, O PUNCT
Apgar B-outcome PROPN
score I-outcome NOUN
<4, O NOUN
impaired B-outcome VERB
consciousness I-outcome NOUN
, O PUNCT
asphyxia B-outcome NOUN
, O PUNCT
seizures B-outcome NOUN
, O PUNCT
assisted B-outcome VERB
ventilation I-outcome NOUN
, O PUNCT
septicaemia B-outcome NOUN
, O PUNCT
meningitis B-outcome NOUN
, O PUNCT
bronchopulmonary B-outcome ADJ
dysplasia I-outcome NOUN
, O PUNCT
intraventricular B-outcome ADJ
haemorrhage I-outcome NOUN
, O PUNCT
periventricular B-outcome ADJ
leukomalacia I-outcome NOUN
, O PUNCT
or O CCONJ
necrotising B-outcome VERB
enterocolitis I-outcome NOUN
. O PUNCT
Secondary O ADJ
outcomes O NOUN
were O VERB
two O NUM
composite O NOUN
measures O NOUN
of O ADP
severe B-outcome ADJ
maternal I-outcome ADJ
morbidity I-outcome NOUN
, O PUNCT
and O CCONJ
spontaneous B-outcome ADJ
labour I-outcome NOUN
and Seperator CCONJ
birth I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
Between O ADP
1 O NUM
February O ADJ
2015 O NUM
and O CCONJ
29 O NUM
February O ADJ
2016, O NUM
60 O NUM
midwifery O NOUN
practices O NOUN
enrolled O VERB
13 O NUM
520 O NUM
women O NOUN
in O ADP
mid-pregnancy O NOUN
(mean O NUM
22.8 O NUM
(SD O NOUN
2.4) O NUM
weeks' O ADP
gestation). O NOUN

Postoperative O ADJ
intravenous O ADJ
patient-controlled O VERB
analgesia(PCA) O ADV
was O VERB
performed O VERB
in O ADP
all O DET
patients, O NOUN
with O ADP
background O NOUN
doses O NOUN
of O ADP
sufentanil O NOUN
0.04 O NUM
mug. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Combination O NOUN
of O ADP
Paracetamol O NOUN
(Acetaminophen) O ADV
and O CCONJ
Ibuprofen O NOUN
vs O CCONJ
Either O CCONJ
Alone O ADJ
on O ADP
Patient-Controlled O VERB
Morphine B-outcome NOUN
Consumption I-outcome NOUN
in O ADP
the O DET
First O ADV
24 O NUM
Hours O NOUN
After O ADP
Total O ADJ
Hip O NOUN
Arthroplasty: O NOUN
The O DET
PANSAID O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

The O DET
proposed O VERB
trial O NOUN
aims O NOUN
to O PART
provide O VERB
evidence O NOUN
for O ADP
the O DET
effectiveness O NOUN
of O ADP
repellent O NOUN
distributed O VERB
through O ADP
VHVs O NOUN
in O ADP
reducing O VERB
malaria B-outcome NOUN
. O PUNCT
METHODS: O NOUN
The O DET
study O NOUN
is O VERB
an O DET
open O ADJ
stepped-wedge O NOUN
cluster-randomised O VERB
controlled O VERB
trial O NOUN
randomised O VERB
at O ADP
the O DET
village O NOUN
level. O NOUN

For O ADP
SAT, O NOUN
39 O NUM
samples O NOUN
(n O NOUN
= O SYM
8, O NOUN
n O NOUN
= O SYM
10, O NUM
n O NOUN
= O SYM
9, O NOUN
n O NOUN
= O SYM
12, O NUM
respectively) O NOUN
were O VERB
available. O NOUN

Devices O NOUN
that O ADP
promote O VERB
interaction O NOUN
with O ADP
tasks O NOUN
on O ADP
computers O NOUN
can O VERB
enhance O NOUN
performance O NOUN
and O CCONJ
lead O NOUN
to O PART
greater O ADJ
independence O NOUN
and O CCONJ
utilization O NOUN
of O ADP
technology. O NOUN

METHODS: O NOUN
Cross-sectional O ADJ
survey O NOUN
of O ADP
1191 O NUM
low O ADJ
caste O NOUN
girls O NOUN
in O ADP
two O NUM
districts O NOUN
in O ADP
north O NOUN
Karnataka, O NOUN
conducted O VERB
as O ADP
part O NOUN
of O ADP
a O DET
cluster O NOUN
randomised-control O NOUN
trial. O NOUN

Journal-Name:Croatian O NOUN
medical O ADJ
journal O ADJ

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
with O ADP
progressive, O NOUN
refractory, O ADV
or O CCONJ
symptomatic O ADJ
desmoid O NOUN
tumors, O NOUN
sorafenib O NOUN
significantly O ADV
prolonged O VERB
progression-free B-outcome ADJ
survival I-outcome NOUN
and O CCONJ
induced O VERB
durable O ADJ
responses. O NOUN
( O PUNCT

Publication O NOUN
date: O NOUN
2019/02/26 O VERB
06:00 O ADP
[medline] O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
Tumor O NOUN
specimens O NOUN
and O CCONJ
clinical O ADJ
information O NOUN
were O VERB
collected O VERB
from O ADP
patients O NOUN
enrolled O VERB
in O ADP
CLASSIC O ADJ
trial, O NOUN
a O DET
randomized O VERB
controlled O VERB
study O NOUN
of O ADP
capecitabine O NOUN
plus O CCONJ
oxaliplatin-based O VERB
adjuvant O NOUN
chemotherapy. O NOUN

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
46 O NUM
eligible O ADJ
patients O NOUN
with O ADP
acute O ADJ
tinnitus O NOUN
were O VERB
entered O VERB
and O CCONJ
included O VERB
in O ADP
this O DET
randomized O VERB
controlled O VERB
trial. O NOUN

The O DET
IRSN O NOUN
dosemeter O NOUN
model O NOUN
was O VERB
considered O VERB
the O DET
most O DET
convenient B-outcome ADJ
. O PUNCT

The O DET
intervention O NOUN
group O NOUN
was O VERB
on O ADP
250 O NUM
mg/day O NOUN
of O ADP
elemental O ADJ
Mg O NOUN
for O ADP
three O NUM
months O NOUN
while O ADP
the O DET
control O NOUN
group O NOUN
did O VERB
not O ADV
receive O VERB
any O DET
type O NOUN
of O ADP
supplements O NOUN
throughout O ADV
the O DET
intervention O NOUN
period. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

CONCLUSIONS: O NOUN
Ologen(R) O NOUN
implant O NOUN
improved O VERB
the O DET
success B-outcome NOUN
rate O NOUN
of O ADP
phaco-viscocanalostomy. O NOUN

BACKGROUND: O NOUN
Ovarian O ADJ
hyperstimulation O NOUN
syndrome O NOUN
remains O NOUN
a O DET
serious O ADJ
complication O NOUN
during O ADP
in O ADP
vitro O ADV
fertilization O NOUN
cycles O NOUN
if O ADP
high O ADJ
dose O NOUN
human O NOUN
chorionic O ADJ
gonadotropin O NOUN
(hCG) O PUNCT
is O VERB
used O VERB
to O PART
trigger O ADP
ovulation O NOUN
in O ADP
high O ADJ
responder O VERB
patients. O NOUN

BACKGROUND: O NOUN
Dexmedetomidine O NOUN
(Dex), O NOUN
as O ADP
an O DET
adjuvant, O NOUN
has O VERB
been O VERB
reported O VERB
to O PART
prolong O NOUN
the O DET
duration O NOUN
of O ADP
spinal O ADJ
analgesia O NOUN
when O ADP
adding O VERB
to O PART
local O ADJ
anesthetic. O NOUN

Results O NOUN
indicate O VERB
that O ADP
WPI O NOUN
itself O PRON
did O VERB
not O ADV
result O VERB
in O ADP
improved O VERB
cognitive B-outcome ADJ
function I-outcome NOUN
but O CCONJ
some O DET
evidence O NOUN
of O ADP
benefit O NUM
of O ADP
SPI O NOUN
for O ADP
females O NOUN
was O VERB
found. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
[Effectiveness O ADV
of O ADP
a O DET
self-administered O VERB
rehabilitation O NOUN
program O NOUN
for O ADP
shoulder O NOUN
pain O NOUN
syndrome O NOUN
in O ADP
primary O ADJ
health O NOUN
care]. O NOUN

The O DET
main O ADJ
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
influence O NOUN
of O ADP
eight O NUM
weeks O NOUN
of O ADP
supplementation O NOUN
with O ADP
3000 O NUM
IU/day O NOUN
of O ADP
vitamin O NOUN
D O NOUN
on O ADP
the O DET
hematological B-outcome ADJ
and O CCONJ
iron B-outcome NOUN
metabolism I-outcome NOUN
profile, O NOUN
as O ADP
well O ADV
as O ADP
on O ADP
the O DET
analytical O ADJ
values O NOUN
of O ADP
testosterone B-outcome NOUN
and O CCONJ
cortisol B-outcome NOUN
on O ADP
elite O ADP
male O NOUN
traditional O ADJ
rowers. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

The O DET
average O NOUN
duration B-outcome NOUN
of I-outcome ADP
operating I-outcome VERB
procedure I-outcome NOUN
was O VERB
1 O NUM
hour O NOUN
and O CCONJ
35 O NUM
minutes. O ADJ

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
A O DET
randomized, O NOUN
single-blind O NOUN
clinical O ADJ
trial O NOUN
(evaluators) O NUM
with O ADP
an O DET
experimental O ADJ
group O NOUN
(self-administered O VERB
rehabilitation) O NOUN
and O CCONJ
a O DET
control O NOUN
group O NOUN
(standard O PUNCT
physical O ADJ
therapy) O NOUN
was O VERB
carried O VERB
out O ADP
in O ADP
271 O NUM
adult O NOUN
patients O NOUN
aged O VERB
18 O NUM
or O CCONJ
older O ADJ
with O ADP
unilateral O ADJ
shoulder O NOUN
pain O NOUN
lasting O VERB
more O ADV
than O ADP
six O NUM
weeks O NOUN
and O CCONJ
less O ADV
than O ADP
three O NUM
months. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
ETView O NOUN
tracheoscopic O ADJ
ventilation O NOUN
tube O NOUN
(TVT) O NOUN
is O VERB
a O DET
tracheal O ADJ
tube O NOUN
(TT) O NOUN
incorporating O VERB
a O DET
video O ADJ
camera O NOUN
and O CCONJ
a O DET
light O NOUN
source O NOUN
in O ADP
its O ADJ
tip. O NOUN

Mindfulness O ADV
meditation O NOUN
interventions-which O NOUN
train O NOUN
skills O NOUN
in O ADP
monitoring O VERB
present-moment O ADJ
experiences O NOUN
with O ADP
a O DET
lens O NOUN
of O ADP
acceptance-have O VERB
shown O VERB
promise O NOUN
for O ADP
increasing O VERB
positive O ADJ
emotions. O NOUN

PURPOSE: O NOUN
Clinical O ADJ
implications O NOUN
of O ADP
single O ADJ
patient O NOUN
classifier O NOUN
(SPC) O NUM
and O CCONJ
microsatellite O NOUN
instability O NOUN
(MSI) O NOUN
in O ADP
stage O NOUN
II/III O NOUN
gastric O ADJ
cancer O NOUN
have O VERB
been O VERB
reported. O NOUN

Title: O NOUN
A O DET
Double-Blind O ADJ
Placebo-Controlled O VERB
Randomized O VERB
Trial O NOUN
Evaluating O VERB
the O DET
Effect O NOUN
of O ADP
Polyphenol-Rich O ADV
Herbal O ADJ
Congee O ADP
on O ADP
Bone B-outcome NOUN
Turnover I-outcome ADV
Markers O NOUN
of O ADP
the O DET
Perimenopausal O ADJ
and O CCONJ
Menopausal O ADJ
Women. O NOUN

Journal-Name:Journal O ADJ
of O ADP
strength O NOUN
and O CCONJ
conditioning O VERB
research O NOUN

Responding O VERB
patients O NOUN
received O VERB
decitabine O NOUN
as O ADP
consolidation O NOUN
therapy O NOUN
on O ADP
a O DET
5-day O NOUN
schedule O NOUN
for O ADP
up O ADP
to O PART
24 O NUM
cycles. O NUM

METHODS: O NOUN
Forty-two O NUM
patients O NOUN
with O ADP
skeletal O ADJ
Class O NOUN
II O NUM
malocclusion O NOUN
were O VERB
treated O VERB
with O ADP
cast-splint O NOUN
Herbst O NOUN
appliances. O NUM

Similarly, O NOUN
no O DET
clinical O ADJ
or O CCONJ
statistical O ADJ
differences O NOUN
were O VERB
noted O VERB
for O ADP
skeletal B-outcome ADJ
changes: O NOUN
ANB B-outcome NOUN
angle I-outcome NOUN
(PT, O NOUN
-1.51 O NUM
degrees O NOUN
; O PUNCT
FT, O NOUN
-1.25 O NUM
degrees O NOUN
; O PUNCT
P O NOUN
= O SYM
0.828; O NOUN
95% O NOUN
CI, O NOUN
-0.68, O ADP
0.849), O NUM
pogonion-sella B-outcome NOUN
vertical I-outcome ADJ
(PT, O NOUN
3.25 O NUM
mm; O NOUN
FT, O NOUN
3.35 O NUM
mm) O NOUN
or O CCONJ
A-sella B-outcome ADP
vertical I-outcome ADJ
(PT, O NOUN
1.28 O NUM
mm; O NOUN
FT, O NOUN
1.06 O NUM
mm). O NOUN

We O PRON
have O VERB
developed O VERB
a O DET
drug-capture O NOUN
assay O NOUN
(using O VERB
drug O NOUN
target) O NOUN
to O PART
measure O NOUN
belatacept O ADV
in O ADP
serum O NOUN
and O CCONJ
applied O VERB
this O DET
assay O NOUN
in O ADP
a O DET
pharmacokinetic O ADJ
study O NOUN
in O ADP
renal O ADJ
transplant O NOUN
recipients. O NOUN

PURPOSE: O NOUN
To O PART
study O NOUN
the O DET
effect O NOUN
of O ADP
Kangfuxin O NOUN
liquid O ADV
combined O VERB
with O ADP
Garlicin O NOUN
Capsules O NOUN
in O ADP
treatment O NOUN
of O ADP
children O NOUN
with O ADP
recurrent O ADP
oral O ADJ
ulcer O NOUN
(ROU) O NUM
and O CCONJ
on O ADP
immunological B-outcome ADJ
regulation I-outcome NOUN
. O PUNCT
METHODS: O NOUN
This O DET
randomized O VERB
controlled O VERB
clinical O ADJ
study O NOUN
prospectively O ADV
enrolled O VERB
204 O NUM
patients O NOUN
with O ADP
ROU O NOUN
who O ADP
were O VERB
randomly O ADV
divided O VERB
into O ADP
2 O NUM
groups. O NOUN

Title: O NOUN
Enteral O ADJ
lactoferrin O NOUN
supplementation O NOUN
for O ADP
very O ADV
preterm O NOUN
infants: O NOUN
a O DET
randomised O VERB
placebo-controlled O VERB
trial. O NOUN

In O ADP
conclusion, O NOUN
the O DET
multifactorial O ADJ
intervention O NOUN
performed O VERB
could O VERB
improve O VERB
adherence B-outcome NOUN
to O PART
the O DET
MD O NOUN
and O CCONJ
diet B-outcome NOUN
quality I-outcome NOUN
among O ADP
patients O NOUN
with O ADP
T2DM. O NOUN

Therefore, O NOUN
evidence O NOUN
is O VERB
scarce O NOUN
on O ADP
what O DET
conditions O NOUN
play O VERB
a O DET
role O NOUN
in O ADP
successful O ADJ
implementation O NOUN
and O CCONJ
how O ADP
they O PRON
interact. O NOUN

Publication O NOUN
date: O NOUN
2019/03/08 O ADV
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

We O PRON
hope O NOUN
to O PART
show O VERB
the O DET
oncologic O ADJ
benefits O NOUN
of O ADP
deep O ADJ
NMB O NOUN
compared O VERB
with O ADP
moderate O ADJ
NMB O NOUN
during O ADP
subtotal O ADJ
gastrectomy. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
A O DET
Multifactorial O ADJ
Intervention O NOUN
in O ADP
Increasing O VERB
Adherence B-outcome NOUN
to O PART
the O DET
Mediterranean O NOUN
Diet O NOUN
among O ADP
Patients O NOUN
with O ADP
Diabetes O NOUN
Mellitus O NOUN
Type O NOUN
2: O NUM
A O DET
Controlled O VERB
and O CCONJ
Randomized O VERB
Study O NOUN
(EMID O PUNCT
Study). O NOUN

Registered O VERB
August O NOUN
7, O NUM
2015 O NUM
- O PUNCT
retrospectively O ADV
registered. O NOUN

MEASUREMENTS: O NOUN
Peak B-outcome NOUN
muscle I-outcome NOUN
activation I-outcome NOUN
(in O NUM
percentage O NOUN
of O ADP
maximal O ADJ
voluntary O ADJ
isometric O ADJ
contraction O NOUN
[%MVIC]) O ADP
in O ADP
the O DET
lower O ADJ
limbs O NOUN
during O ADP
gait O NOUN
was O VERB
measured O VERB
by O ADP
means O NOUN
of O ADP
surface O NOUN
electromyography, O NOUN
electrogoniometry, O NOUN
and O CCONJ
foot O NOUN
contact O NOUN
switches. O NUM

BACKGROUND/OBJECTIVES: O NOUN
Molecular O ADJ
mechanisms O NOUN
linking O VERB
fish O NOUN
and O CCONJ
vegetable O ADJ
oil O NOUN
intakes O NOUN
to O PART
their O ADJ
healthy O ADJ
metabolic O ADJ
effects O NOUN
may O VERB
involve O NOUN
attenuation O NOUN
of O ADP
inflammation. O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
fit O NOUN
factors O NOUN
among O ADP
healthcare O NOUN
providers O NOUN
working O VERB
in O ADP
the O DET
Emergency O NOUN
Department O NOUN
Center O NOUN
before O ADP
and O CCONJ
after O ADP
training O VERB
with O ADP
three O NUM
types O NOUN
of O ADP
N95 O NOUN
and O CCONJ
higher O ADJ
filter O NOUN
respirators. O NOUN

There O PRON
were O VERB
no O DET
statistical O ADJ
differences O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
on O ADP
the O DET
other O ADJ
outcome O NOUN
measures. O NOUN

RES O NOUN
was O VERB
evaluated O VERB
by O ADP
two O NUM
calibrated O VERB
blind O PUNCT
periodontists O NOUN
one O NUM
year O NOUN
after O ADP
the O DET
treatment. O NOUN

Therefore, O NOUN
this O DET
study O NOUN
determined O VERB
if O ADP
PC O NOUN
affected O VERB
rectal B-outcome ADJ
temperature I-outcome NOUN
(Trec) I-outcome NOUN
, O PUNCT
body B-outcome NOUN
heat I-outcome NOUN
storage I-outcome NOUN
, O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
ratings O NOUN
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
(RPE), O NOUN
thermal B-outcome ADJ
sensation I-outcome NOUN
, O PUNCT
sweat B-outcome NOUN
rate, O NOUN
and O CCONJ
postexercise O NOUN
cold-water O NOUN
immersion O NOUN
(CWI) O NUM
rectal B-outcome ADJ
temperature I-outcome NOUN
cooling O VERB
rates. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Two O NUM
hundred O NUM
patients O NOUN
with O ADP
RA O NOUN
in O ADP
clinical O ADJ
remission O NOUN
(disease O NUM
activity O NOUN
score O NOUN
in O ADP
28 O NUM
joints-C-reactive O NOUN
protein O NOUN
[DAS28-CRP] O NOUN
<3.2 O ADJ
and O CCONJ
no O DET
swollen O NOUN
joints) O NOUN
were O VERB
enrolled O VERB
between O ADP
April O NOUN
2012 O NUM
and O CCONJ
June O NOUN
2015. O NUM

The O DET
most O DET
relevant O ADJ
combination O NOUN
was O VERB
good O ADJ
quality O NOUN
implementation O NOUN
of O ADP
physical B-outcome ADJ
activity I-outcome NOUN
breaks I-outcome NOUN
, O PUNCT
implemented O VERB
by O ADP
teachers O NOUN
with O ADP
a O DET
high O ADJ
self-efficacy B-outcome NOUN
, O PUNCT
and O CCONJ
a O DET
good O ADJ
previous O ADJ
knowledge B-outcome NOUN
about O ADV
the O DET
intervention. O NOUN

All O DET
patients O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
two O NUM
groups O NOUN
according O ADJ
to O PART
the O DET
order O NOUN
of O ADP
treatment, O NOUN
27 O NUM
cases O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
were O VERB
treated O VERB
with O ADP
short-segment O ADP
fixation O NOUN
combined O VERB
with O ADP
vertebral O ADJ
reconstruction, O NOUN
26 O NUM
cases O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
were O VERB
treated O VERB
with O ADP
short-segment O ADP
fixation. O ADV

Journal O ADJ
ID: O NOUN
100968551 O NUM

The O DET
response O NOUN
was O VERB
independent O ADJ
of O ADP
the O DET
degree O NOUN
of O ADP
hypermobility. O NUM

As O ADP
a O DET
comparison O NOUN
control, O NOUN
26 O NUM
advanced O VERB
colorectal O ADJ
cancer O NOUN
patients O NOUN
with O ADP
comparable O ADJ
clinical O ADJ
baseline O NOUN
characteristics O NOUN
including O VERB
age, O NOUN
sex, O NOUN
Eastern O NOUN
Cooperative O ADJ
Oncology O NOUN
Group O NOUN
(ECOG) O NOUN
score, O NOUN
pathological O ADJ
type, O NOUN
carcinoembryonic O ADJ
antigen O NOUN
(CEA) O NOUN
level, O NOUN
tumor O NOUN
location, O NOUN
number O NOUN
and O CCONJ
location(s) O NOUN
of O ADP
metastasis, O NOUN
and O CCONJ
previous O ADJ
chemotherapies O NOUN
were O VERB
subject O NOUN
to O PART
observation. O ADV

Journal-Name:Journal O ADJ
of O ADP
personality O NOUN
and O CCONJ
social O ADJ
psychology O NOUN

RESULTS: O NOUN
By O ADP
December O NOUN
31, O NUM
2017, O NUM
a O DET
total O ADJ
of O ADP
261 O NUM
of O ADP
the O DET
347 O NUM
men O NOUN
in O ADP
the O DET
radical-prostatectomy O NOUN
group O NOUN
and O CCONJ
292 O NUM
of O ADP
the O DET
348 O NUM
men O NOUN
in O ADP
the O DET
watchful-waiting O VERB
group O NOUN
had O VERB
died B-outcome VERB
; O PUNCT
71 O NUM
deaths B-outcome NOUN
in X PUNCT
the X DET
radical-prostatectomy X NOUN
group X NOUN
and X CCONJ
110 X NUM
in X ADP
the X DET
watchful-waiting X VERB
group X NOUN
were X NOUN
due I-outcome ADJ
to I-outcome PART
prostate I-outcome NOUN
cancer I-outcome NOUN
(relative O ADJ
risk, O NOUN
0.55; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.41 O NUM
to O PART
0.74; O NOUN
P<0.001; O ADJ
absolute O ADJ
difference O NOUN
in O ADP
risk, O NOUN
11.7 O NUM
percentage O NOUN
points; O NOUN
95% O NOUN
CI, O NOUN
5.2 O NUM
to O PART
18.2). O NUM

ClinicalTrials.gov:NCT01485562. O VERB

Journal O ADJ
ID: O NOUN
0404312 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

BACKGROUND: O NOUN
Counterforce O NOUN
orthoses O NOUN
are O VERB
used O VERB
to O PART
manage O NOUN
lateral O ADJ
elbow O NOUN
tendinopathy, O ADJ
and O CCONJ
their O ADJ
effectiveness O NOUN
in O ADP
improving O VERB
motor O NOUN
function O NOUN
has O VERB
been O VERB
documented. O NOUN

RESULTS: O NOUN
The O DET
two O NUM
groups O NOUN
of O ADP
patients O NOUN
were O VERB
comparable O ADJ
for O ADP
preoperative O ADJ
SAI O NOUN
scores O NOUN
(P&gt;0.05); O NOUN
The O DET
patients O NOUN
in O ADP
the O DET
sedation O NOUN
group O NOUN
appeared O VERB
to O PART
have O VERB
lower O ADJ
intraoprative O ADJ
SAI O NOUN
scores, O NOUN
but O CCONJ
this O DET
difference O NOUN
was O VERB
not O ADV
statistically O ADV
significant O ADJ
(P=0.05). O NOUN

Transcutaneous O ADJ
electrical O ADJ
acupoint O NOUN
stimulation O NOUN
(TEAS) O NUM
is O VERB
a O DET
emerging O VERB
treatment O NOUN
which O ADP
combines O NOUN
transcutaneous O ADJ
electrical O ADJ
nerve O NOUN
stimulation O NOUN
with O ADP
traditional O ADJ
acupoint O NOUN
therapy. O NOUN

Prevention O NOUN
of O ADP
body O NOUN
posture O ADJ
abnormalities O NOUN
is O VERB
worth O ADP
promoting O VERB
in O ADP
groups O NOUN
of O ADP
children, O NOUN
also O ADV
with O ADP
various O ADJ
diseases O NOUN
including O VERB
asthma O NOUN
and O CCONJ
allergies O NOUN
symptoms. O NOUN

Whey O NOUN
protein O NOUN
is O VERB
rich O ADJ
in O ADP
the O DET
branched-chain O NOUN
amino O ADJ
acids, O NOUN
L-leucine, O ADJ
L-isoleucine O NOUN
and O CCONJ
L-valine. O NOUN

Title: O NOUN
Dark O NOUN
Chocolate O NOUN
Intake O NOUN
Positively O ADV
Modulates O NOUN
Redox B-outcome NOUN
Status O NOUN
and O CCONJ
Markers O NOUN
of O ADP
Muscular B-outcome ADJ
Damage I-outcome NOUN
in O ADP
Elite O ADP
Football O NOUN
Athletes: O ADJ
A O DET
Randomized O VERB
Controlled O VERB
Study. O NOUN

METHODS: O NOUN
Sixty O NUM
patients O NOUN
scheduled O VERB
to O PART
undergo O NOUN
elective O ADJ
ileostomy O NOUN
closure O NOUN
under O ADP
epidural O ADJ
anesthesia O NOUN
were O VERB
randomized O VERB
into O ADP
propofol O NOUN
sedation O NOUN
group O NOUN
and O CCONJ
control O NOUN
group O NOUN
(n=30). O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
sedation O NOUN
group O NOUN
received O VERB
a O DET
loading O VERB
dose O NOUN
of O ADP
propofol O NOUN
of O ADP
0.6 O NUM
mg.kg(- O NOUN
1). O NOUN

Journal-Name:Medicine O NOUN

DESIGN: O NOUN
Double O ADV
blind, O NOUN
parallel O ADJ
group, O NOUN
placebo O NOUN
controlled, O NOUN
multicentre O NOUN
trial. O NOUN

Title: O NOUN
Yoga O NOUN
positively O ADV
affected O VERB
depression B-outcome NOUN
and O CCONJ
blood B-outcome NOUN
pressure I-outcome NOUN
in O ADP
women O NOUN
with O ADP
premenstrual O NOUN
syndrome O NOUN
in O ADP
a O DET
randomized O VERB
controlled O VERB
clinical O ADJ
trial. O NOUN

The O DET
secondary O ADJ
outcomes O NOUN
included O VERB
visual O ADJ
analog O NOUN
scale O NOUN
(VAS) O PUNCT
scores O NOUN
during O ADP
movement, O NOUN
the O DET
tramadol B-outcome NOUN
consumption O NOUN
at O ADP
the O DET
1st, O NUM
4th, O NUM
and O CCONJ
12th O ADJ
postoperative O ADJ
hours, O NOUN
and O CCONJ
nausea B-outcome NOUN
scores O NOUN
at O ADP
the O DET
24th O ADJ
hour O NOUN
postoperatively. O NOUN

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Main O ADJ
outcome O NOUN
measures O NOUN
were O VERB
best-corrected B-outcome VERB
visual I-outcome ADJ
acuity I-outcome NOUN
(BCVA) I-outcome NUM
gain O VERB
of O ADP
15 O NUM
or O CCONJ
more O ADV
ETDRS O NOUN
letters O NOUN
from O ADP
baseline, O NOUN
Snellen O NOUN
equivalent O ADJ
of O ADP
20/40 O NOUN
or O CCONJ
better O ADJ
vision B-outcome NOUN
, O PUNCT
and O CCONJ
baseline O NOUN
factors O NOUN
associated O VERB
with O ADP
early O ADJ
clinically O ADV
significant O ADJ
improvement O NOUN
in O ADP
best-corrected B-outcome VERB
visual I-outcome ADJ
acuity I-outcome NOUN
(BCVA) I-outcome NUM
. O PUNCT
RESULTS: O NOUN
The O DET
median O ADJ
time B-outcome NOUN
for Seperator ADP
patients I-outcome NOUN
to I-outcome PART
achieve I-outcome NOUN
a Seperator DET
best-corrected I-outcome VERB
visual I-outcome ADJ
acuity I-outcome NOUN
(BCVA) I-outcome NUM
of O ADP
20/40 O NOUN
or O CCONJ
better O ADJ
was O VERB
59 O NUM
days O NOUN
and O CCONJ
the O DET
median O ADJ
time O NOUN
for O ADP
patients O NOUN
to O PART
gain O VERB
15 O NUM
or O CCONJ
more O ADV
{ O NOUN
Early O ADJ
Treatment O NOUN
Diabetic B-outcome ADJ
Retinopathy I-outcome NOUN
Study O NOUN
(ETDRS)]} O PUNCT
letters O NOUN
was O VERB
63 O NUM
days. O NOUN

SIM O NOUN
group O NOUN
learned O VERB
the O DET
AHA O NOUN
guidelines O NOUN
for O ADP
high-quality O NOUN
CPR O NOUN
via O ADP
an O DET
hour O NOUN
session O NOUN
that O ADP
included O VERB
a O DET
PowerPoint O NOUN
lecture O ADJ
with O ADP
training O VERB
on O ADP
a O DET
high-fidelity O NOUN
simulator. O NOUN

Clinical O ADJ
and O CCONJ
radiographic O ADJ
assessments O NOUN
of O ADP
abutments B-outcome NOUN
and O CCONJ
crowns B-outcome VERB
, O PUNCT
peri-implant B-outcome ADJ
mucosa I-outcome NOUN
, O PUNCT
and O CCONJ
marginal B-outcome ADJ
bone I-outcome NOUN
levels O NOUN
were O VERB
recorded. O NOUN

The O DET
secondary O ADJ
outcomes O NOUN
were O VERB
serum O NOUN
levels O NOUN
of O ADP
neuron-specific B-outcome ADJ
enolase I-outcome NOUN
and O CCONJ
S100 B-outcome NOUN
protein I-outcome NOUN
. O PUNCT
The O DET
occurrences O NOUN
of O ADP
adverse B-outcome ADJ
events I-outcome NOUN
in O ADP
the O DET
two O NUM
groups O NOUN
were O VERB
recorded. O NOUN

DISCUSSION: O NOUN
In O ADP
the O DET
case O NOUN
results O NOUN
of O ADP
this O DET
Provincial O ADJ
RCT O NOUN
be O VERB
confirmed, O NOUN
serious O ADJ
consideration O NOUN
should O VERB
then O ADV
be O VERB
given O VERB
by O ADP
Ministry O NOUN
of O ADP
Health O NOUN
authorities O NOUN
to O PART
the O DET
possible O ADJ
implementation O NOUN
of O ADP
MI-based O VERB
strategies O NOUN
across O ADP
provincial O ADJ
maternity O NOUN
wards. O NOUN

Journal O ADJ
ID: O NOUN
8008349 O NUM

SAEs B-outcome NOUN
after O ADP
the O DET
1st O ADJ
and O CCONJ
2nd O ADJ
doses O NOUN
were O VERB
reported O VERB
in O ADP
2 O NUM
participants O NOUN
and O CCONJ
1 O NUM
participant, O NOUN
respectively, O NOUN
but O CCONJ
none O NUM
was O VERB
assessed O VERB
as O ADP
being O VERB
related O VERB
to O PART
vaccination. O ADV

METHODS: O NOUN
Single O NOUN
centre O NOUN
prospective O ADJ
open O ADJ
labeled O VERB
randomised O VERB
controlled O VERB
clinical O ADJ
trial. O NOUN

METHODS: O NOUN
A O DET
cervical O ADJ
spine O NOUN
phantom O NOUN
was O VERB
prepared O VERB
using O VERB
a O DET
cervical O ADJ
spine O NOUN
model O NOUN
immersed O VERB
in O ADP
a O DET
mixture O NOUN
of O ADP
gelatin O NOUN
and O CCONJ
psyllium O NOUN
husk. O NOUN

Group O NOUN
B O NOUN
(scleral O ADJ
group) O ADJ
included O VERB
124 O NUM
cases O NOUN
(127 O NUM
eyes), O NOUN
using O VERB
the O DET
sclera O NOUN
as O ADP
allograft. O NOUN

The O DET
e-cigarette O NOUN
group O NOUN
reported O VERB
greater O ADJ
declines O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
cough B-outcome NOUN
and O CCONJ
phlegm B-outcome NOUN
production I-outcome NOUN
from O ADP
baseline O NOUN
to O PART
52 O NUM
weeks O NOUN
than O ADP
did O VERB
the O DET
nicotine-replacement O ADJ
group O NOUN
(relative O ADJ
risk O NOUN
for O ADP
cough, O ADV
0.8; O NUM
95% O NOUN
CI, O NOUN
0.6 O NUM
to O PART
0.9; O NUM
relative O ADJ
risk O NOUN
for O ADP
phlegm, O NOUN
0.7; O NUM
95% O NOUN
CI, O NOUN
0.6 O NUM
to O PART
0.9). O NUM

The O DET
study O NOUN
was O VERB
aimed O VERB
to O PART
observe O NOUN
the O DET
curative O ADJ
effect O NOUN
of O ADP
device-guided O VERB
rehabilitation O NOUN
on O ADP
respiratory O ADJ
functions O NOUN
in O ADP
stable O ADJ
COPD O NOUN
patients. O NOUN

Title: O NOUN
Effects O NOUN
of O ADP
Grape O NOUN
Pomace O NOUN
Polyphenolic O ADJ
Extract O NOUN
(Taurisolo((R))) O PUNCT
in O ADP
Reducing O VERB
Trimethylamine B-outcome NOUN
N-oxide I-outcome NOUN
(TMAO) I-outcome NOUN
Serum O NOUN
Levels O NOUN
in O ADP
Humans: O NOUN
Preliminary O ADJ
Results O NOUN
from O ADP
a O DET
Randomized, O NOUN
Placebo-Controlled, O NOUN
Cross-Over O NOUN
Study. O NOUN

Title: O NOUN
[Effects O NOUN
of O ADP
berberine O NOUN
on O ADP
the O DET
serum O NOUN
cystatin B-outcome NOUN
C I-outcome NOUN
levels O NOUN
and O CCONJ
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
mellitus]. O NOUN

The O DET
relationship O NOUN
between O ADP
serum O NOUN
25(OH)vitamin O NOUN
D3 O NOUN
concentration O NOUN
and O CCONJ
waist B-outcome NOUN
circumference I-outcome NOUN
supports O NOUN
vitamin O NOUN
D O NOUN
having O VERB
a O DET
protective O ADJ
role O NOUN
in O ADP
the O DET
current O ADJ
setting, O ADV
since O ADP
waist O NOUN
size O NOUN
is O VERB
directly O ADV
associated O VERB
with O ADP
the O DET
risk O NOUN
of O ADP
cardiovascular O ADJ
and O CCONJ
metabolic O ADJ
diseases. O NOUN

The O DET
ergogenic O ADJ
effect O NOUN
of O ADP
betaA O NOUN
has O VERB
also O ADV
been O VERB
demonstrated O VERB
for O ADP
2000-m O NUM
rowing O VERB
performance O NOUN
prompting O VERB
interest O NOUN
in O ADP
whether O ADP
betaA O NOUN
may O VERB
be O VERB
beneficial O ADJ
for O ADP
sustained O VERB
aerobic O ADJ
exercise. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Journal-Name:Reproductive O ADJ
health O NOUN

Survival O NOUN
analyses O NOUN
were O VERB
performed O VERB
via O ADP
the O DET
Kaplan-Meier O NOUN
method. O NOUN

Differences O NOUN
between O ADP
treatment O NOUN
arms, O NOUN
based O VERB
on O ADP
the O DET
intention-to-treat O NOUN
principle, O NOUN
were O VERB
adjusted O VERB
for O ADP
covariates O NOUN
and O CCONJ
missing O VERB
data O NOUN
were O VERB
handled O VERB
using O VERB
multiple O ADJ
imputation. O ADV

Journal O ADJ
ID: O NOUN
0374675 O NUM

BACKGROUND: O NOUN
Post-traumatic O ADJ
Stress O NOUN
Disorder O NOUN
(PTSD) O ADV
is O VERB
a O DET
common O ADJ
sequelae O NOUN
of O ADP
severe O ADJ
combat-related O VERB
emotional O ADJ
trauma O NOUN
that O ADP
is O VERB
often O ADV
associated O VERB
with O ADP
significantly O ADV
reduced O VERB
quality O NOUN
of O ADP
life O NOUN
in O ADP
afflicted O VERB
veterans. O NUM

Proton O NOUN
pump O NOUN
inhibitor O NOUN
(PPI) O NOUN
is O VERB
a O DET
useful O ADJ
drug O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
LPR, O VERB
but O CCONJ
its O ADJ
effect O NOUN
on O ADP
hypogeusia O NOUN
is O VERB
not O ADV
known. O NOUN

An O DET
in O ADP
vitro O ADV
study O NOUN
also O ADV
confirmed O VERB
that O ADP
polyphenol O NOUN
extracts O NOUN
significantly O ADV
decreased O VERB
oxidative O ADJ
stress O NOUN
in O ADP
murine O ADJ
myoblast O NOUN
cell O NOUN
line O NOUN
C2C12-derived. O NOUN

RESULTS: O NOUN
We O PRON
randomized O VERB
210 O NUM
participants, O NOUN
and O CCONJ
197 O NUM
completed O VERB
the O DET
trial. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
aim O ADP
of O ADP
his O ADJ
study O NOUN
is O VERB
to O PART
test O NOUN
our O ADJ
hypothesis O NOUN
that O ADP
5 O NUM
mug O NUM
Dex O NOUN
could O VERB
enhance O NOUN
the O DET
efficiency O NOUN
of O ADP
intrathecal O ADJ
bupivacaine O NOUN
and O CCONJ
reduce O VERB
the O DET
dose B-outcome NOUN
requirement O NOUN
of O ADP
spinal O ADJ
bupivacaine O NOUN
for O ADP
patients O NOUN
undergoing O VERB
cesarean O NOUN
section. O NOUN

Containing O VERB
dominantly O ADV
EPA, O NOUN
it O PRON
is O VERB
considered O VERB
to O PART
be O VERB
effective O ADJ
in O ADP
lowering O VERB
lipids, O NOUN
foremost O ADJ
serum O NOUN
triglycerides O NOUN
and O CCONJ
LDL O NOUN
cholesterol. O NOUN

PARTICIPANTS: O NOUN
Twenty-five O NUM
children O NOUN
with O ADP
DCD O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
the O DET
KT O NOUN
group O NOUN
(mean O NUM
age O NOUN
= O SYM
7.97 O NUM
years) O NOUN
and O CCONJ
24 O NUM
to O PART
the O DET
control O NOUN
group O NOUN
(mean O NUM
age O NOUN
= O SYM
8.04 O NUM
years). O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
Role O NOUN
Of O ADP
0.2% O NOUN
Bio-Adhesive O ADJ
Chlorhexidine O NOUN
Gel O NOUN
In O ADP
Reducing O VERB
Incidence O NOUN
Of O ADP
Alveolar B-outcome ADJ
Osteitis I-outcome NOUN
. O PUNCT

Adjuvant O NOUN
chemotherapy O NOUN
using O VERB
S-1 O NOUN
was O VERB
administered O VERB
for O ADP
6 O NUM
months O NOUN
to O PART
patients O NOUN
with O ADP
curative O ADJ
resection O NOUN
who O ADP
fully O ADV
recovered O VERB
within O ADP
10 O NUM
weeks O NOUN
after O ADP
surgery O NOUN
in O ADP
both O CCONJ
arms. O ADJ

BACKGROUND: O NOUN
We O PRON
aimed O VERB
to O PART
investigate O NOUN
how O ADP
high-dose O NOUN
ecabet O NOUN
sodium O NOUN
affects O NOUN
low-dose O NOUN
aspirin-induced O VERB
small O ADJ
intestinal O ADJ
mucosal O ADJ
injury O NOUN
in O ADP
healthy O ADJ
volunteers. O ADV

Publication O NOUN
date: O NOUN
2018/11/13 O NOUN
00:00 O NOUN
[accepted] O ADV

A O DET
administration O NOUN
of O ADP
GLN O NOUN
was O VERB
associated O VERB
with O ADP
a O DET
decrease O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
grade O NOUN
2 O NUM
or O CCONJ
3 O NUM
acute O ADJ
radiation-induced O VERB
esophagitis B-outcome NOUN
(ARIE) O NUM
(6.7% O NUM
vs O CCONJ
53.4% O NUM
for O ADP
Gln+ O NOUN
vs O CCONJ
Gln-; O NOUN
P O NOUN
= O SYM
.004). O ADP

The O DET
BMI B-outcome NOUN
z-score O NOUN
of O ADP
the O DET
overall O ADJ
completers O NOUN
decreased O VERB
by O ADP
about O ADV
0.05 O NUM
after O ADP
the O DET
16-week O NOUN
intervention O NOUN
(p O PUNCT
= O SYM
0.02). O NOUN

The O DET
deadline O NOUN
for O ADP
follow-up O NOUN
was O VERB
June O NOUN
2017 O NUM
and O CCONJ
the O DET
incidence O NOUN
of O ADP
thromboembolism B-outcome NOUN
events O NOUN
within O ADP
6 O NUM
months O NOUN
after O ADP
operation O NOUN
was O VERB
counted. O NOUN

A O DET
transition O NOUN
to O PART
oral O ADJ
omadacycline O NOUN
(300 O PUNCT
mg O NOUN
every O DET
24 O NUM
hours) O NOUN
or O CCONJ
oral O ADJ
linezolid O NOUN
(600 O NUM
mg O NOUN
every O DET
12 O NUM
hours) O NOUN
was O VERB
allowed O VERB
after O ADP
3 O NUM
days; O NOUN
the O DET
total O ADJ
treatment O NOUN
duration O NOUN
was O VERB
7 O NUM
to O PART
14 O NUM
days. O NOUN

Title: O NOUN
[Evaluation O NOUN
of O ADP
intervention O NOUN
program O NOUN
for O ADP
risk O NOUN
behaviors O NOUN
of O ADP
unintentional O ADJ
injury O NOUN
among O ADP
school O NOUN
age O NOUN
children]. O NOUN

Journal-Name:National O ADJ
Bureau O PROPN
of O ADP
Economic O ADJ
Research O NOUN
bulletin O NOUN
on O ADP
aging O VERB
and O CCONJ
health O NOUN

Main O ADJ
parameters O NOUN
setting O VERB
of O ADP
respirator: O NOUN
the O DET
predetermined O VERB
tidal O DET
volume O NOUN
(VT) O NOUN
was O VERB
set O NOUN
at O ADP
500 O NUM
mL O NOUN
in O ADP
the O DET
VCV O NOUN
group; O ADJ
the O DET
preset O NOUN
pressure O NOUN
was O VERB
regulated, O NOUN
so O ADV
that O ADP
when O ADP
the O DET
atomizer O NOUN
was O VERB
connected O VERB
to O PART
the O DET
atomization O NOUN
device, O NOUN
the O DET
VT O NOUN
was O VERB
nearly O ADV
equal O ADJ
to O PART
or O CCONJ
slightly O ADV
larger O ADJ
than O ADP
500 O NUM
mL O NOUN
in O ADP
the O DET
PCV O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Blood O NOUN
samples O NOUN
were O VERB
obtained O VERB
from O ADP
the O DET
antecubital O ADJ
vein O NOUN
before O ADP
each O DET
exercise O NOUN
test, O NUM
1 O NUM
min O NOUN
after O ADP
completing O VERB
the O DET
test, O NUM
and O CCONJ
after O ADP
a O DET
24-h O NOUN
recovery. O NOUN

Title: O NOUN
Medial O ADJ
patellofemoral O ADJ
ligament O NOUN
reconstruction O NOUN
in O ADP
children: O NOUN
A O DET
comparative O ADJ
randomized O VERB
short-term O NOUN
study O NOUN
of O ADP
fascia O NOUN
lata O NOUN
allograft O NOUN
and O CCONJ
gracilis O NOUN
tendon O NOUN
autograft O NOUN
reconstruction. O NOUN

Publication O NOUN
date: O NOUN
2018/12/22 O NOUN
06:00 O ADP
[entrez] O ADP

Journal-Name:Respiratory O NUM
research O NOUN

Results: O NOUN
The O DET
glycemic B-outcome ADJ
control I-outcome NOUN
rate O NOUN
of O ADP
intervention O NOUN
group O NOUN
for O ADP
patients O NOUN
and O CCONJ
people O NOUN
with O ADP
impaired O VERB
glucose O NOUN
tolerance O NOUN
(72.2% O NOUN
and O CCONJ
71.4%) O NUM
were O VERB
higher O ADJ
than O ADP
control O NOUN
group O NOUN
(43.6% O PUNCT
and O CCONJ
26.7%), O NOUN
but O CCONJ
the O DET
unchanged B-outcome VERB
rate O NOUN
of O ADP
intervention O NOUN
group O NOUN
(13.9% O NOUN
and O CCONJ
0.0%) O NUM
were O VERB
lower O ADJ
than O ADP
control O NOUN
group O NOUN
(42.3% O PUNCT
and O CCONJ
73.3%). O NUM

respectively O ADV
(p O PUNCT
= O SYM
0.450). O NUM

RESULTS: O NOUN
In O ADP
the O DET
methylene O NOUN
blue O ADJ
localization O NOUN
group, O NOUN
3 O NUM
patients O NOUN
had O VERB
localization B-outcome NOUN
failure O NOUN
due O ADJ
to O PART
the O DET
intrathoracic O NOUN
diffusion O NOUN
of O ADP
methylene O NOUN
blue, O ADP
and O CCONJ
the O DET
success B-outcome NOUN
rate O NOUN
was O VERB
93.61%. O NOUN

BACKGROUND: O NOUN
Scorpion O NOUN
envenomation O NOUN
and O CCONJ
its O ADJ
consequences O NOUN
represented O VERB
a O DET
serious O ADJ
healthcare O NOUN
problem O ADP
in O ADP
Upper O NOUN
Egypt O NOUN
and O CCONJ
considered O VERB
to O PART
be O VERB
an O DET
important O ADJ
cause O ADP
of O ADP
life-threatening O VERB
emergency O NOUN
particularly O ADV
in O ADP
children. O NOUN

RESULTS: O NOUN
No O DET
significant O ADJ
operative O ADJ
or O CCONJ
postoperative O ADJ
complications B-outcome NOUN
(other O PUNCT
than O ADP
failure) O NOUN
were O VERB
encountered O VERB
in O ADP
either O CCONJ
group. O VERB

All O DET
outcomes O NOUN
were O VERB
measured O VERB
at O ADP
baseline, O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
6-week, O NUM
and O CCONJ
12-week O NOUN
treatment. O NOUN

Journal-Name:Medicine O NOUN

OBJECTIVE: O NOUN
Primary O ADJ
objective O ADP
was O VERB
to O PART
compare O NOUN
the O DET
effects O NOUN
of O ADP
atorvastatin O NOUN
40mg O NOUN
vs O CCONJ
80mg O NOUN
on O ADP
LDL-C B-outcome NOUN
in O ADP
Indian O NOUN
patients O NOUN
with O ADP
atherosclerotic O ADJ
dyslipidemia. O NOUN

Following O VERB
baseline O NOUN
measures, O NOUN
two O NUM
study O NOUN
intervals O NOUN
occurred O VERB
with O ADP
the O DET
intervention O NOUN
group O NOUN
receiving O VERB
live O ADJ
music O ADJ
for O ADP
the O DET
first O ADV
interval O NOUN
followed O VERB
by O ADP
no O DET
music O ADJ
during O ADP
the O DET
second O ADJ
interval; O NOUN
the O DET
control O NOUN
group O NOUN
received O VERB
no O DET
music O ADJ
during O ADP
both O CCONJ
intervals. O NOUN

For O ADP
the O DET
statistical O ADJ
analyses, O NOUN
the O DET
IBM O NOUN
SPSS O ADV
Statistics O NOUN
22 O NUM
(IBM O NUM
SPSS, O ADJ
Turkey) O NOUN
program O NOUN
was O VERB
used O VERB
to O PART
assess O NOUN
the O DET
findings O NOUN
of O ADP
the O DET
study. O NOUN

Women O NOUN
with O ADP
premenstrual O NOUN
syndrome O NOUN
(PMS) O NOUN
often O ADV
complain O NOUN
about O ADV
depression O NOUN
when O ADP
their O ADJ
menstrual O ADJ
cycle O NOUN
begins. O NUM

Journal O ADJ
ID: O NOUN
100968555 O NUM

CONCLUSIONS: O NOUN
The O DET
traditional O ADJ
respiratory O ADJ
training O VERB
combined O VERB
with O ADP
device-guided O VERB
pulmonary O ADJ
rehabilitation O NOUN
can O VERB
improve O VERB
the O DET
respiratory B-outcome ADJ
muscle I-outcome NOUN
function I-outcome NOUN
and O CCONJ
athletic B-outcome ADJ
ability I-outcome NOUN
in O ADP
stable O ADJ
COPD O NOUN
patients. O NOUN

Following O VERB
a O DET
review O NOUN
of O ADP
the O DET
information, O NOUN
attendees O NOUN
proposed O VERB
actions O NOUN
to O PART
strengthen O ADV
community-based O VERB
health O NOUN
services O NOUN
in O ADP
their O ADJ
community. O ADJ

RESULTS: O NOUN
Forty-four O NUM
individuals O NOUN
under O ADP
hazardous O ADJ
or O CCONJ
harmful O ADJ
alcohol O NOUN
use O NOUN
completed O VERB
all O DET
phases O NOUN
of O ADP
the O DET
research. O NOUN

We O PRON
investigated O VERB
whether O ADP
oral O ADJ
antibiotic O ADJ
therapy O NOUN
is O VERB
noninferior O ADJ
to O PART
intravenous O ADJ
antibiotic O ADJ
therapy O NOUN
for O ADP
this O DET
indication. O ADV

BACKGROUND: O NOUN
Magnesium O NOUN
(Mg) O NOUN
supplementation O NOUN
may O VERB
help O VERB
control O NOUN
glycemic O ADJ
response O NOUN
among O ADP
type O NOUN
2 O NUM
diabetes O NOUN
(T2D) O NOUN
patients. O NOUN

Although O ADP
the O DET
reductions O NOUN
in O ADP
weight B-outcome NOUN
and O CCONJ
body B-outcome NOUN
fat I-outcome NOUN
were O VERB
comparable O ADJ
in O ADP
IS O VERB
and O CCONJ
IR O NOUN
groups, O NOUN
only O ADV
women O NOUN
with O ADP
IR O NOUN
showed O VERB
a O DET
significant O ADJ
increase O NOUN
in O ADP
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
concentration O NOUN
as O ADP
a O DET
result O VERB
of O ADP
all O DET
interventions. O NOUN

Journal O ADJ
ID: O NOUN
9433361 O NUM

Twenty O NUM
seven O NUM
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
who O ADP
had O VERB
failed O VERB
at O ADP
least O ADV
2 O NUM
lines O NOUN
chemotherapy O NOUN
were O VERB
treated O VERB
with O ADP
apatinib O ADP
(500 O PUNCT
mg/day). O NOUN

The O DET
levels O NOUN
of O ADP
interleukin B-outcome NOUN
2 I-outcome NUM
(IL-2) I-outcome NOUN
, O PUNCT
interleukin B-outcome NOUN
4 I-outcome NUM
(IL-4) I-outcome PUNCT
, O PUNCT
interleukin B-outcome NOUN
10 I-outcome NUM
(IL-10) I-outcome PUNCT
, O PUNCT
interferon B-outcome NOUN
gamma I-outcome NOUN
(INF-) I-outcome PUNCT
and O CCONJ
total O ADJ
antioxidant B-outcome NOUN
capacity O NOUN
(TAC) O ADP
were O VERB
determined O VERB
with O ADP
commercially O ADV
available O ADJ
diagnostic O ADJ
kits. O NOUN

No O DET
therapeutic O ADJ
intervention O NOUN
was O VERB
applied O VERB
to O PART
the O DET
CG. O NOUN

BACKGROUND: O NOUN
We O PRON
aimed O VERB
to O PART
assess O NOUN
whether O ADP
an O DET
ultrasound O NOUN
(US)-guided O PUNCT
oblique O ADJ
subcostal O ADJ
transversus O NOUN
abdominis O NOUN
plane O ADJ
(OSTAP) O PUNCT
block O VERB
would O VERB
improve O VERB
the O DET
postoperative O ADJ
pain B-outcome NOUN
scores O NOUN
and O CCONJ
decrease O NOUN
the O DET
tramadol B-outcome NOUN
consumption O NOUN
after O ADP
a O DET
laparoscopic O ADJ
hysterectomy. O NOUN

In O ADP
the O DET
15th O NOUN
day O NOUN
after O ADP
surgery, O NOUN
drainage O NOUN
by O ADP
the O DET
incision O NOUN
was O VERB
1.53 O NUM
and O CCONJ
the O DET
traditional O ADJ
chest O NOUN
drainage O NOUN
was O VERB
2.11 O NUM
(p=0.440), O PUNCT
30th O ADV
days O NOUN
after O ADP
drainage O NOUN
by O ADP
incision O NOUN
was O VERB
0.71 O NUM
and O CCONJ
traditional O ADJ
chest O NOUN
drainage O NOUN
was O VERB
0.84 O NUM
(p=0.787). O PUNCT

FINDINGS: O ADJ
Between O ADP
Feb O NOUN
28, O NUM
2013, O NUM
and O CCONJ
April O NOUN
12, O NUM
2018, O NUM
71 O NUM
patients O NOUN
were O VERB
enrolled. O NOUN

As O ADP
obesity O NOUN
is O VERB
recognised O VERB
as O ADP
a O DET
contributing O VERB
factor O NOUN
when O ADP
developing O VERB
various O ADJ
health O NOUN
threatening O VERB
chronic O ADJ
diseases, O NOUN
prevention O NOUN
initiatives O NOUN
focusing O VERB
on O ADP
weight O NOUN
loss O NOUN
are O VERB
becoming O VERB
more O ADV
important. O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Randomized, O NOUN
placebo-controlled, O NOUN
factorial O ADJ
clinical O ADJ
trial O NOUN
among O ADP
120 O NUM
patients O NOUN
aged O VERB
60 O NUM
years O NOUN
or O CCONJ
older O ADJ
undergoing O VERB
on-pump O NOUN
coronary O ADJ
artery O NOUN
bypass O NOUN
graft O NOUN
(CABG) O PUNCT
surgery O NOUN
or O CCONJ
combined O VERB
CABG/valve O NUM
surgeries O NOUN
at O ADP
a O DET
US O PROPN
center. O NOUN

Operator-reported O VERB
aspiration B-outcome NOUN
occurred O VERB
during O ADP
2.5% O NOUN
of O ADP
intubations O NOUN
in O ADP
the O DET
bag-mask O ADJ
ventilation O NOUN
group O NOUN
and O CCONJ
during O ADP
4.0% O NOUN
in O ADP
the O DET
no-ventilation O NOUN
group O NOUN
(P O NUM
= O SYM
0.41). O NOUN

Journal-Name:Medicine O NOUN

The O DET
composite O NOUN
of O ADP
death B-outcome NOUN
from I-outcome ADP
any Seperator DET
cause I-outcome ADP
, O PUNCT
myocardial B-outcome ADJ
infarction I-outcome NOUN
, O PUNCT
or O CCONJ
stroke B-outcome NOUN
was O VERB
a O DET
secondary O ADJ
outcome. O NOUN

Journal-Name:Respiratory O NUM
research O NOUN

In O ADP
the O DET
SHM O NOUN
group, O NOUN
it O PRON
was O VERB
22, O NUM
3, O NOUN
and O CCONJ
5 O NUM
cases O NOUN
respectively. O NOUN

Journal O ADJ
ID: O NOUN
101474849 O NUM

Title: O NOUN
Prospective, O NOUN
randomized, O NOUN
double-blinded, O NOUN
placebo-controlled O VERB
study O NOUN
on O ADP
safety O NOUN
and O CCONJ
tolerability B-outcome NOUN
of O ADP
the O DET
krill O NOUN
powder O NOUN
product O NOUN
in O ADP
overweight O NUM
subjects O NOUN
with O ADP
moderately O ADV
elevated O VERB
blood O NOUN
pressure. O NOUN

Title: O NOUN
Induction O NOUN
chronomodulated O VERB
chemotherapy O NOUN
plus O CCONJ
radiotherapy O NOUN
for O ADP
nasopharyngeal O ADJ
carcinoma: O NOUN
A O DET
Phase O NOUN
II O NUM
prospective O ADJ
randomized O VERB
study. O NOUN

There O PRON
were O VERB
no O DET
incidences O NOUN
of O ADP
bradycardia B-outcome NOUN
and O CCONJ
hypoxemia B-outcome NOUN
in O ADP
either O CCONJ
of O ADP
the O DET
groups O NOUN
during O ADP
study O NOUN
observation. O ADV

The O DET
World O NOUN
Health O NOUN
Organisation O NOUN
(WHO) O NOUN
'5 O PUNCT
Moments O NOUN
for O ADP
Hand O NOUN
Hygiene' O NUM
poster O NOUN
has O VERB
been O VERB
used O VERB
to O PART
reduce O VERB
hospital-acquired O VERB
infections, O NOUN
but O CCONJ
there O PRON
is O VERB
no O DET
similar O ADJ
tool O NOUN
to O PART
prevent O NOUN
community-acquired O VERB
newborn O NOUN
infections O NOUN
in O ADP
low-resource O ADJ
settings. O NOUN

Safety, O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
(AEs), O PUNCT
and O CCONJ
cutaneous O ADJ
tolerability B-outcome NOUN
were O VERB
evaluated O VERB
throughout O ADV
using O VERB
a O DET
4-point O NOUN
scale O NOUN
where O ADP
0=none O ADJ
and O CCONJ
3=severe. O NOUN

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
2019/01/27 O NOUN
06:00 O ADP
[entrez] O ADP

Differences O NOUN
between O ADP
two O NUM
groups O NOUN
each O DET
time O NOUN
showed O VERB
no O DET
statistical O ADJ
significance O NOUN
(p O PUNCT
> O SYM
0.05). O NOUN

The O DET
drug O NOUN
Simvastatin O NOUN
may O VERB
help O VERB
to O PART
protect O VERB
donor O NOUN
livers O NOUN
against O ADP
this O DET
damage O NOUN
and O CCONJ
improve O VERB
outcomes O NOUN
for O ADP
transplant O NOUN
recipients. O NOUN

BACKGROUND: O NOUN
The O DET
ability O NOUN
to O PART
generate O NOUN
high O ADJ
levels O NOUN
of O ADP
power O NOUN
is O VERB
one O NUM
of O ADP
the O DET
key O ADJ
factors O NOUN
determining O VERB
success O NOUN
in O ADP
many O DET
sport O ADJ
disciplines. O ADJ

Registered O VERB
5 O NUM
October O ADJ
2015. O NUM

CONCLUSION: O NOUN
The O DET
use O NOUN
of O ADP
colorings O NOUN
in O ADP
eye O NOUN
drops O NOUN
can O VERB
help O VERB
distinguishing O VERB
the O DET
vials O NOUN
and O CCONJ
preventing O VERB
misidentification B-outcome NOUN
. O PUNCT

Journal-Name:Zhonghua O NOUN
nei O ADV
ke O NOUN
za O ADP
zhi O NUM

Publication O NOUN
date: O NOUN
2018/12/19 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
KT O NOUN
group O NOUN
demonstrated O VERB
26.87%MVIC O NOUN
(95% O PUNCT
CI O NOUN
= O SYM
26.87, O NOUN
7.11) O NUM
higher O ADJ
gastrocnemius O NOUN
medialis O NOUN
muscle O NOUN
peak O NOUN
activation O NOUN
during O ADP
mid O NOUN
stance O NOUN
phase O NOUN
at O ADP
post-test O NOUN
when O ADP
compared O VERB
with O ADP
the O DET
control O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
101266132 O NUM

SETTING: O NOUN
People's O NOUN
Hospital O NOUN
of O ADP
Guanghan, O NOUN
China. O NOUN

RESULTS: O NOUN
Among O ADP
the O DET
1054 O NUM
participants O NOUN
(527 O NUM
in O ADP
each O DET
group), O NOUN
end-point O NOUN
data O NOUN
were O VERB
available O ADJ
for O ADP
1015 O NUM
(96.3%). O NUM

Pain B-outcome NOUN
severity I-outcome NOUN
was O VERB
measured O VERB
by O ADP
the O DET
visual O ADJ
scale O NOUN
before O ADP
treatment, O NOUN
1 O NUM
h O NOUN
after O ADP
consuming O VERB
the O DET
drug O NOUN
(for O PUNCT
24 O NUM
h) O ADV
and O CCONJ
48 O NUM
h O NOUN
after O ADP
the O DET
onset O NOUN
of O ADP
drug. O NOUN

To O PART
compare O NOUN
students' O NOUN
MCF O NOUN
experiences O NOUN
we O PRON
sent O ADJ
out O ADP
an O DET
electronic O ADJ
survey O NOUN
afterward O ADJ
to O PART
assess O NOUN
the O DET
following O VERB
using O VERB
a O DET
0-100 O NUM
sliding O VERB
scale: O NOUN
overall O ADJ
satisfaction B-outcome NOUN
with O ADP
the O DET
meeting; O ADJ
the O DET
effectiveness O NOUN
of O ADP
communication B-outcome NOUN
; O PUNCT
the O DET
helpfulness O ADV
of O ADP
the O DET
meeting; O ADJ
their O ADJ
stress B-outcome NOUN
levels, O NOUN
and O CCONJ
the O DET
convenience B-outcome NOUN
of O ADP
their O ADJ
meeting O VERB
location. O ADV

The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
examine O NOUN
the O DET
effects O NOUN
of O ADP
8 O NUM
weeks O NOUN
of O ADP
Shilajit O ADJ
supplementation O NOUN
at O ADP
250 O NUM
mg.d(- O NOUN
1) O NUM
(low O PUNCT
dose) O ADJ
and O CCONJ
500 O NUM
mg.d(- O NOUN
1) O NUM
(high O PUNCT
dose) O ADJ
versus O CCONJ
placebo O NOUN
on O ADP
maximal B-outcome ADJ
voluntary I-outcome ADJ
isometric I-outcome ADJ
contraction I-outcome NOUN
(MVIC) I-outcome NOUN
strength, O NOUN
concentric B-outcome ADJ
peak I-outcome NOUN
torque I-outcome ADV
, O PUNCT
fatigue-induced O VERB
percent O NOUN
decline O NOUN
in O ADP
strength B-outcome NOUN
, O PUNCT
and O CCONJ
serum O NOUN
hydroxyproline B-outcome NOUN
(HYP) I-outcome NOUN
. O PUNCT
METHODS: O NOUN
Sixty-three O NUM
recreationally-active O ADJ
men O NOUN
([Formula: O PUNCT
see O NOUN
text O NOUN
+/- O SYM
SD: O NOUN
21.2 O NUM
+/- O SYM
2.4 O NUM
yr.; O NOUN

The O DET
administration O NOUN
of O ADP
NMES O NOUN
or O CCONJ
sham O NOUN
NMES, O NOUN
as O ADP
intervention, O ADP
was O VERB
performed O VERB
for O ADP
an O DET
8-week O NOUN
period O NOUN
treatment, O NOUN
and O CCONJ
4-week O NOUN
period O NOUN
follow-up. O PUNCT

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
The O DET
use B-outcome NOUN
of I-outcome ADP
resources I-outcome NOUN
, O PUNCT
costs B-outcome NOUN
, O PUNCT
and O CCONJ
quality-adjusted O VERB
life-years O NOUN
(QALYs) O NOUN
were O VERB
assessed O VERB
in O ADP
the O DET
trial O NOUN
at O ADP
six O NUM
months O NOUN
and O CCONJ
one O NUM
year. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

In O ADP
the O DET
control O NOUN
group, O NOUN
the O DET
patients O NOUN
received O VERB
the O DET
routine O ADJ
care. O NOUN

These O DET
findings O NOUN
will O VERB
inform O NOUN
future O NOUN
mass O NOUN
drug O NOUN
administration O NOUN
policy O NOUN
and O CCONJ
shed O ADJ
light O NOUN
on O ADP
position O NOUN
of O ADP
novel O ADJ
diagnostic O ADJ
tools O NOUN
to O PART
evaluate O VERB
schistosomiasis O NOUN
control O NOUN
strategies. O NOUN

Title: O NOUN
The O DET
influence O NOUN
of O ADP
high-dose O NOUN
intraoperative O ADJ
remifentanil O NOUN
on O ADP
postoperative B-outcome ADJ
sore I-outcome ADV
throat I-outcome NOUN
: O PUNCT
a O DET
prospective O ADJ
randomized O VERB
study: O NOUN
A O DET
CONSORT O NOUN
compliant O ADJ
article. O NOUN

Publication O NOUN
date: O NOUN
2019/02/13 O NOUN
06:00 O ADP
[entrez] O ADP

Studies O NOUN
have O VERB
reported O VERB
that O ADP
uterine O ADJ
contractions O NOUN
(UC) O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
embryo O NOUN
transfer O NOUN
(ET) O NOUN
were O VERB
inversely O ADV
related O VERB
to O PART
implantation O NOUN
and O CCONJ
pregnancy O NOUN
rate, O NOUN
hence O ADV
reducing O VERB
the O DET
success O NOUN
of O ADP
IVF O NOUN
treatments. O NOUN

Hyperpigmentation B-outcome NOUN
severity I-outcome NOUN
reduced O VERB
progressively O ADV
with O ADP
treatment. O NOUN

Conclusion: O NOUN
Berberine O NOUN
improves O NOUN
diabetic O ADJ
kidney O NOUN
disease O NOUN
by O ADP
reducing O VERB
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
serum O NOUN
cystatin B-outcome NOUN
C I-outcome NOUN
and O CCONJ
serum O NOUN
cystatin B-outcome NOUN
C I-outcome NOUN
in O ADP
T2DM O NOUN
patients, O NOUN
and O CCONJ
it O PRON
was O VERB
safe. O NOUN

Day O NOUN
1) O NUM
and O CCONJ
dexamethasone O NOUN
(9.9 O PUNCT
mg O NOUN
i.v. O NOUN

Saliva O ADJ
3-methoxy-4-hydroxyphenylglycol B-outcome NOUN
(MHPG) I-outcome NOUN
, O PUNCT
a O DET
major O ADJ
product O NOUN
of O ADP
noradrenaline O NOUN
breakdown O NOUN
and O CCONJ
a O DET
representative O ADJ
marker O NOUN
of O ADP
sympathetic B-outcome ADJ
nerve I-outcome NOUN
activity I-outcome NOUN
, O PUNCT
was O VERB
significantly O ADV
lower O ADJ
just O ADV
after O ADP
the O DET
TSST O NOUN
in O ADP
the O DET
active O ADJ
group O NOUN
compared O VERB
with O ADP
the O DET
placebo O NOUN
group. O VERB

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Objective: O NOUN
To O PART
investigate O NOUN
the O DET
effects O NOUN
of O ADP
berberine O NOUN
on O ADP
urine O NOUN
albumin/creatine B-outcome NOUN
ratio I-outcome NOUN
(UACR) I-outcome PUNCT
and O CCONJ
serum O NOUN
cystatin B-outcome NOUN
C I-outcome NOUN
(Cys I-outcome NOUN
C) I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
mellitus O NOUN
(T2DM). O VERB

Interventions: O NOUN
Patients O NOUN
were O VERB
randomized O VERB
1:1 O ADJ
(stratified O PUNCT
by O ADP
cardiac O ADJ
vs O CCONJ
noncardiac O ADJ
surgery O NOUN
and O CCONJ
positive O ADJ
vs O CCONJ
negative O ADJ
recent O ADJ
fall O NOUN
history) O NOUN
to O PART
receive O VERB
EEG-guided O VERB
anesthetic O ADJ
administration O NOUN
(n O NOUN
= O SYM
614) O NUM
or O CCONJ
usual O ADJ
anesthetic O ADJ
care O NOUN
(n O NOUN
= O SYM
618). O NOUN

Methods: O NOUN
Fifty-one O NUM
participants O NOUN
with O ADP
PFOA O NOUN
(66% O NOUN
women, O NOUN
mean O NOUN
+/- O SYM
SD O NOUN
age O NOUN
57 O NUM
+/- O SYM
10 O NUM
years, O NOUN
body O NOUN
mass O NOUN
index O NOUN
(BMI) O PUNCT
27 O NUM
+/- O SYM
6 O NUM
kg/m(2)), O NUM
and O CCONJ
23 O NUM
controls O NOUN
(56% O PUNCT
women, O NOUN
age O NOUN
56 O NUM
+/- O SYM
9 O NUM
years, O NOUN
BMI O NOUN
24 O NUM
+/- O SYM
4 O NUM
kg/m(2)) O NOUN
had O VERB
ankle O NOUN
dorsiflexion O NOUN
measured O VERB
using O VERB
the O DET
knee-to-wall O NOUN
test, O NUM
foot O NOUN
mobility, O NOUN
calculated O VERB
as O ADP
the O DET
difference O NOUN
in O ADP
midfoot O NOUN
height O NOUN
or O CCONJ
width O NOUN
between O ADP
non-weightbearing O VERB
and O CCONJ
weightbearing, O NOUN
and O CCONJ
static O ADJ
foot O NOUN
posture O ADJ
characterized O VERB
utilizing O VERB
the O DET
Foot O NOUN
Posture O ADJ
Index. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

The O DET
subjects O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
the O DET
high O ADJ
dose, O NOUN
low O ADJ
dose, O NOUN
or O CCONJ
placebo O NOUN
group O NOUN
(each O PUNCT
group: O NOUN
n O NOUN
= O SYM
21). O ADJ

SETTING: O NOUN
University O NOUN
hospital O NOUN
between O ADP
2010 O NUM
and O CCONJ
2014. O NUM

But O CCONJ
in O ADP
practice, O NOUN
we O PRON
found O VERB
a O DET
lot O NOUN
of O ADP
problems O NOUN
in O ADP
using O VERB
the O DET
ointment. O NOUN

DISCUSSION: O NOUN
This O DET
project O NOUN
will O VERB
contribute O NOUN
much O DET
needed O VERB
evidence O NOUN
on O ADP
the O DET
efficacy O NOUN
of O ADP
an O DET
electronic O ADJ
wellbeing O VERB
intervention O NOUN
for O ADP
Indigenous O ADJ
people O NOUN
with O ADP
ESKD O NOUN
- O PUNCT
a O DET
group O NOUN
in O ADP
which O ADP
distress O NOUN
is O VERB
likely O ADV
to O PART
be O VERB
unacceptably O ADV
high, O ADP
yet O ADV
relatively O ADV
untreated. O NOUN

Journal O ADJ
ID: O NOUN
101604552 O NUM

2018;17(12):1290-1296. O NOUN

Journal-Name:Medicine O NOUN

Title: O NOUN
Impact O NOUN
of O ADP
pharmacotherapeutic O ADJ
education O NOUN
on O ADP
medication O NOUN
adherence B-outcome NOUN
and O CCONJ
adverse B-outcome ADJ
outcomes I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
mellitus: O NOUN
a O DET
prospective, O NOUN
randomized O VERB
study. O NOUN

However, O ADV
the O DET
employees O NOUN
were O VERB
influenced O VERB
by O ADP
several O ADJ
factors, O NOUN
such O ADJ
as O ADP
their O ADJ
own O ADJ
health O NOUN
and O CCONJ
weight O NOUN
loss, O NOUN
the O DET
pressure O NOUN
from O ADP
the O DET
environment O NOUN
and O CCONJ
their O ADJ
struggle O NOUN
for O ADP
recognition. O ADV

BACKGROUND: O NOUN
Pegbelfermin O NOUN
(BMS-986036), O PUNCT
a O DET
PEGylated O VERB
human O NOUN
fibroblast O NOUN
growth O NOUN
factor O NOUN
21 O NUM
(FGF21) O PUNCT
analogue, O NOUN
has O VERB
previously O ADV
been O VERB
shown O VERB
to O PART
improve O VERB
markers O NOUN
of O ADP
metabolism O NOUN
and O CCONJ
liver O NOUN
fibrosis O NOUN
in O ADP
obese O NOUN
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes. O NOUN

Registered O VERB
1 O NUM
May O NOUN
2017 O NUM
- O PUNCT
Retrospectively O ADV
registered, O VERB
http://www.clinicaltrial.gov O NOUN
/ O SYM
NCT03134690. O NOUN

Patients O NOUN
with O ADP
laryngopharyngeal O ADJ
reflux O NOUN
(LPR) O ADV
were O VERB
reported O VERB
to O PART
suffer O NOUN
from O ADP
hypogeusia O NOUN
that O ADP
affects O NOUN
quality O NOUN
of O ADP
life. O NOUN

Journal-Name:Kathmandu O NOUN
University O NOUN
medical O ADJ
journal O ADJ
(KUMJ) O NOUN

Among O ADP
participants O NOUN
with O ADP
1-year O NOUN
abstinence, O NOUN
those O DET
in O ADP
the O DET
e-cigarette O NOUN
group O NOUN
were O VERB
more O ADV
likely O ADV
than O ADP
those O DET
in O ADP
the O DET
nicotine-replacement O ADJ
group O NOUN
to O PART
use B-outcome NOUN
their Seperator ADJ
assigned I-outcome VERB
product I-outcome NOUN
at O ADP
52 O NUM
weeks O NOUN
(80% O PUNCT
[63 O NOUN
of O ADP
79 O NUM
participants O NOUN
vs. O CCONJ
9% O NOUN
[4 O PUNCT
of O ADP
44 O NUM
participants]). O ADJ

Title: O NOUN
Is O VERB
the O DET
transdermal O ADJ
fentanyl O NOUN
patch O NOUN
an O DET
efficient O ADJ
way O NOUN
to O PART
achieve O NOUN
acute O ADJ
postoperative O ADJ
pain B-outcome NOUN
control I-outcome NOUN
?: O ADJ

INTERVENTION: O NOUN
KT O NOUN
group O NOUN
received O VERB
KT O NOUN
application O NOUN
to O PART
the O DET
quadriceps O NOUN
and O CCONJ
gastrocnemius O NOUN
muscles O NOUN
whereas O ADP
the O DET
control O NOUN
group O NOUN
received O VERB
no O DET
intervention. O NOUN

Clinical O ADJ
data O NOUN
and O CCONJ
biological O ADJ
parameters O NOUN
were O VERB
detected O VERB
and O CCONJ
recorded. O NOUN

The O DET
resulting O VERB
data O NOUN
were O VERB
used O VERB
to O PART
calculate O NOUN
the O DET
metabolizable O ADJ
energy O NOUN
of O ADP
cashews O NOUN
and O CCONJ
the O DET
digestibility O NOUN
of O ADP
macronutrients. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
iso-caloric O ADJ
CRHP/CD O NOUN
diets O NOUN
contained O VERB
31/54 O NOUN
E% O NOUN
from O ADP
carbohydrate, O ADP
29/16 O NOUN
E% O NOUN
energy O NOUN
from O ADP
protein O NOUN
and O CCONJ
40/30 O NOUN
E% O NOUN
from O ADP
fat, O ADP
respectively. O NOUN

Either O CCONJ
low-dose O NOUN
or O CCONJ
standard-dose O NOUN
MDCT O NOUN
protocol O NOUN
was O VERB
performed, O NOUN
the O DET
experience O NOUN
of O ADP
otolaryngologist O NOUN
had O VERB
decreased O VERB
complication B-outcome NOUN
after O ADP
surgeries. O NUM

Journal-Name:The O ADJ
heart O NOUN
surgery O NOUN
forum O NOUN

At O ADP
3 O NUM
years, O NOUN
the O DET
mean O NOUN
marginal B-outcome ADJ
bone I-outcome NOUN
level O NOUN
(MBL) O NOUN
change O NOUN
at O ADP
CI, O NOUN
FI, O NOUN
and O CCONJ
PS O NOUN
implants O NOUN
was O VERB
-0.12, O NOUN
-1.02, O NOUN
and O CCONJ
-1.04 O NUM
mm, O NOUN
respectively O ADV
(P O NUM
= O SYM
.014). O PUNCT
" O PUNCT

APN O NOUN
and O CCONJ
AdipoR1 O VERB
levels O NOUN
may O VERB
influence O NOUN
glucose O NOUN
and O CCONJ
lipid O NOUN
metabolism O NOUN
in O ADP
T2DM O NOUN
patients. O NOUN

2) O NOUN
Methods: O NOUN
a O DET
prospective, O NOUN
randomized, O NOUN
parallel O ADJ
pilot O NOUN
study O NOUN
of O ADP
4.5 O NUM
g O NOUN
administration O NOUN
of O ADP
Spirulina O NOUN
maxima O NOUN
or O CCONJ
placebo O NOUN
for O ADP
12 O NUM
weeks O NOUN
in O ADP
16 O NUM
patients O NOUN
with O ADP
systemic O ADJ
arterial O ADJ
hypertension O NOUN
(SAH) O PUNCT
undergoing O VERB
treatment O NOUN
with O ADP
angiotensin-converting O VERB
enzyme O NOUN
(ACE) O NOUN
inhibitors O NOUN
was O VERB
performed O VERB
to O PART
assess O NOUN
the O DET
effects O NOUN
on O ADP
endothelial B-outcome ADJ
damage I-outcome NOUN
and O CCONJ
oxidative B-outcome ADJ
stress I-outcome NOUN
indicators. O NOUN

Taking O VERB
effective O ADJ
preventive O ADJ
measures O NOUN
is O VERB
particularly O ADV
important O ADJ
for O ADP
control O NOUN
of O ADP
HFMD O NOUN
infection. O NOUN

Vitamin O NOUN
D O NOUN
and O CCONJ
probiotic O ADJ
co-supplementation O NOUN
was O VERB
associated O VERB
with O ADP
a O DET
significant O ADJ
reduction O NOUN
in O ADP
total O ADJ
testosterone B-outcome NOUN
(beta O NUM
- O PUNCT
0.19 O NUM
ng/mL; O NOUN
95% O NOUN
CI, O NOUN
- O PUNCT
0.28, O NUM
- O PUNCT
0.10; O NOUN
P O NOUN
< O SYM
0.001), O NUM
hirsutism B-outcome NOUN
(beta O NUM
- O PUNCT
0.95; O NOUN
95% O NOUN
CI, O NOUN
- O PUNCT
1.39, O NUM
- O PUNCT
0.51; O ADP
P O NOUN
< O SYM
0.001), O NUM
high-sensitivity B-outcome NOUN
C-reactive I-outcome ADJ
protein I-outcome NOUN
(hs-CRP) I-outcome NOUN
(beta O NUM
- O PUNCT
0.67 O NUM
mg/L; O NOUN
95% O NOUN
CI, O NOUN
- O PUNCT
0.97, O NUM
- O PUNCT
0.38; O NOUN
P O NOUN
< O SYM
0.001) O NUM
and O CCONJ
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
levels O NOUN
(beta O NUM
- O PUNCT
0.25 O NUM
mumol/L; O NOUN
95% O NOUN
CI, O NOUN
- O PUNCT
0.40, O NUM
- O PUNCT
0.10; O NOUN
P O NOUN
= O SYM
0.001), O NUM
and O CCONJ
a O DET
significant O ADJ
increase O NOUN
in O ADP
total O ADJ
antioxidant B-outcome NOUN
capacity O NOUN
(TAC) O ADP
(beta O NUM
82.81 O NUM
mmol/L; O NOUN
95% O NOUN
CI, O NOUN
42.86, O ADP
122.75; O NOUN
P O NOUN
< O SYM
0.001) O NUM
and O CCONJ
total O ADJ
glutathione B-outcome NOUN
(GSH) I-outcome PUNCT
levels O NOUN
(beta O NUM
40.42 O NUM
mumol/L; O NOUN
95% O NOUN
CI, O NOUN
4.69, O ADJ
76.19; O NOUN
P O NOUN
= O SYM
0.02), O NUM
compared O VERB
with O ADP
the O DET
placebo. O NOUN

There O PRON
were O VERB
no O DET
deaths B-outcome NOUN
, O PUNCT
discontinuations B-outcome NOUN
due I-outcome ADJ
to I-outcome PART
adverse I-outcome ADJ
events I-outcome NOUN
, O PUNCT
or O CCONJ
treatment-related O VERB
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
. O PUNCT
INTERPRETATION: O CCONJ
Treatment O NOUN
with O ADP
subcutaneously O ADV
administered O VERB
pegbelfermin O NOUN
for O ADP
16 O NUM
weeks O NOUN
was O VERB
generally O ADV
well O ADV
tolerated O VERB
and O CCONJ
significantly O ADV
reduced O VERB
hepatic B-outcome ADJ
fat I-outcome NOUN
fraction I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
non-alcoholic O ADJ
steatohepatitis. O NOUN

In O ADP
a O DET
prespecified O VERB
supportive O ADJ
analysis O NOUN
involving O VERB
the O DET
same O ADJ
population, O NOUN
the O DET
same O ADJ
end O NOUN
point O NOUN
was O VERB
assessed O VERB
during O ADP
the O DET
intervention O NOUN
period O NOUN
(first O PUNCT
receipt O NOUN
of O ADP
trial O NOUN
agent O NOUN
to O PART
last O NOUN
dose O NOUN
plus O CCONJ
2 O NUM
days). O NOUN

Results: O NOUN
: O PUNCT
Among O ADP
207 O NUM
cases O NOUN
followed O VERB
till O ADV
delivery, O NOUN
the O DET
prevalence O NOUN
of O ADP
parasitaemia B-outcome NOUN
was O VERB
lower O ADJ
in O ADP
three-dose O NOUN
group O NOUN
than O ADP
in O ADP
two-dose O NOUN
group O NOUN
for O ADP
both O CCONJ
peripheral B-outcome ADJ
(9.3% X NOUN
versus X CCONJ
27.8%) X NOUN
and Seperator CCONJ
placental B-outcome ADJ
(10.6% X NOUN
versus X CCONJ
25.6%) X NOUN
parasitaemia E1-outcome NOUN
. O PUNCT
The O DET
adjusted O VERB
odds O NOUN
ratios O NOUN
(aOR) O NOUN
were O VERB
0.15 O NUM
[95% O NOUN
confidence O NOUN
interval O NOUN
(CI), O ADJ
0.05 O NUM
- O PUNCT
0.45 O NUM
and O CCONJ
0.17 O NUM
(95% O PUNCT
CI, O NOUN
0.06-0.51), O NOUN
respectively. O NOUN

Fourteen O NUM
performed O VERB
a O DET
16-week O NOUN
resistance O NOUN
training O VERB
(RT) O NOUN
intervention, O ADP
9 O NUM
were O VERB
assigned O VERB
to O PART
a O DET
usual O ADJ
care O NOUN
waitlist O ADJ
control O NOUN
group. O VERB

Title: O NOUN
Efficacy O NOUN
of O ADP
a O DET
New O ADJ
Crosslinked O VERB
Hyaluronan O NOUN
Gel O NOUN
in O ADP
the O DET
Prevention O NOUN
of O ADP
Intrauterine B-outcome NOUN
Adhesions I-outcome NOUN
. O PUNCT

The O DET
aim O ADP
of O ADP
the O DET
present O ADJ
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
efficacy O NOUN
of O ADP
green O ADV
tea O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
standard O ADJ
antimicrobial O ADJ
treatment O NOUN
in O ADP
women O NOUN
with O ADP
acute O ADJ
uncomplicated O VERB
cystitis. O NOUN

Publication O NOUN
date: O NOUN
2019/02/27 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
2019/01/17 O ADP
06:00 O ADP
[medline] O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
Two O NUM
co-primary O ADJ
outcomes: O NOUN
24-hour O NOUN
morphine B-outcome NOUN
consumption I-outcome NOUN
using O VERB
patient-controlled O VERB
analgesia O NOUN
in O ADP
pairwise O NOUN
comparisons O NOUN
between O ADP
the O DET
4 O NUM
groups O NOUN
(multiplicity-adjusted O PUNCT
thresholds O NOUN
for O ADP
statistical O ADJ
significance, O NOUN
P O NOUN
< O SYM
.0042; O NUM
minimal O ADJ
clinically O ADV
important O ADJ
difference, O NOUN
10 O NUM
mg), O NOUN
and O CCONJ
proportion O NOUN
of O ADP
patients O NOUN
with O ADP
1 O NUM
or O CCONJ
more O ADV
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
(SAEs) I-outcome NOUN
within O ADP
90 O NUM
days O NOUN
(multiplicity-adjusted O PUNCT
thresholds O NOUN
for O ADP
statistical O ADJ
significance, O NOUN
P O NOUN
< O SYM
.025). O PUNCT

The O DET
"shell" B-outcome NOUN
phenomenon I-outcome NOUN
and O CCONJ
surgery O NOUN
complications B-outcome NOUN
were O VERB
observed O VERB
at O ADP
the O DET
same O ADJ
time. O NOUN

One O NUM
group O NOUN
underwent O VERB
thoracic O ADJ
drainage O NOUN
by O ADP
the O DET
same O ADJ
intercostal O ADJ
space O NOUN
of O ADP
thoracotomy O NOUN
and O CCONJ
the O DET
other O ADJ
by O ADP
traditional O ADJ
chest O NOUN
drainage O NOUN
approach. O NOUN

OBJECTIVE: O NOUN
To O PART
explore O ADP
the O DET
effects O NOUN
of O ADP
propofol O NOUN
sedation O NOUN
on O ADP
psychological B-outcome ADJ
stress I-outcome NOUN
in O ADP
patients O NOUN
undergoing O VERB
surgery O NOUN
under O ADP
epidural O ADJ
anesthesia. O NOUN

Patients O NOUN
from O ADP
the O DET
1st O ADJ
group O NOUN
were O VERB
to O PART
take O NOUN
nicorandil O NOUN
2 O NUM
days O NOUN
and O CCONJ
1 O NUM
day O NOUN
before O ADP
the O DET
PCI O NOUN
at O ADP
the O DET
30 O NUM
mg/day O NOUN
dose, O NOUN
then O ADV
20 O NUM
mg O NOUN
orally O ADV
2 O NUM
hours O NOUN
just O ADV
before O ADP
PCI, O NOUN
and O CCONJ
one O NUM
more O ADV
time O NOUN
6 O NUM
hours O NOUN
after O ADP
the O DET
PCI O NOUN
- O PUNCT
10 O NUM
mg O NOUN
nicorandil. O NOUN

RESULTS: O NOUN
The O DET
preoperative O ADJ
MDCT O NOUN
images O NOUN
for O ADP
standard-dose O NOUN
protocol O NOUN
had O VERB
better O ADJ
quality B-outcome NOUN
than O ADP
low-dose O NOUN
protocol O NOUN
(P O NUM
< O SYM
.001, O PUNCT
q O NOUN
= O SYM
4.57). O NOUN

Funded O VERB
by O ADP
Paratek O NOUN
Pharmaceuticals; O NOUN
OASIS-1 O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02378480 O NOUN
.). O NOUN

Publication O NOUN
date: O NOUN
2018/11/26 O NOUN
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
date: O NOUN
2018/11/20 O ADJ
00:00 O NOUN
[accepted] O ADV

Household B-outcome NOUN
food I-outcome NOUN
purchasing I-outcome VERB
behaviour I-outcome NOUN
, O PUNCT
three O NUM
24-h O NOUN
food B-outcome NOUN
recalls, O NOUN
Tucker's O NOUN
semi-quantitative O ADJ
food B-outcome NOUN
frequency I-outcome NOUN
questionnaire O NOUN
(FFQ)], O NOUN
and O CCONJ
weight B-outcome NOUN
were O VERB
assessed O VERB
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
8 O NUM
weeks. O NOUN

No O DET
differences O NOUN
in O ADP
the O DET
evolution O NOUN
of O ADP
the O DET
other O ADJ
scores O NOUN
assessed O VERB
were O VERB
observed O VERB
between O ADP
groups. O NOUN

RESULTS: O NOUN
Totally, O NOUN
135 O NUM
infants O NOUN
in O ADP
three O NUM
groups O NOUN
were O VERB
studied O VERB
and O CCONJ
the O DET
results O NOUN
showed O VERB
that O ADP
minimum O NOUN
and O CCONJ
maximum O NOUN
gastric B-outcome ADJ
residual I-outcome ADJ
volumes I-outcome NOUN
were O VERB
in O ADP
prone O NOUN
(6.49 O NOUN
+/- O SYM
8.25 O NUM
ML) O NOUN
and O CCONJ
supine O NOUN
(12.59 O NUM
+/- O SYM
11.9 O NUM
ML) O NOUN
positions, O NOUN
respectively. O NOUN

TRIAL O NOUN
FUNDING: O NOUN
Medical O ADJ
Research O NOUN
Council/ O NOUN
Wellcome O ADP
Trust/ O NOUN
DfID O NOUN
(Global O NUM
Health O NOUN
Trials O NOUN
Scheme). O NOUN

METHODS/DESIGN: O NOUN
Eligible O ADJ
and O CCONJ
consenting O VERB
women O NOUN
will O VERB
be O VERB
randomly O ADV
assigned O VERB
to O PART
one O NUM
of O ADP
two O NUM
treatments O NOUN
(one O NOUN
cycle O NOUN
of O ADP
a O DET
GnRH O NOUN
agonist O NOUN
or O CCONJ
two O NUM
cycles O NOUN
of O ADP
a O DET
GnRH O NOUN
agonist) O NOUN
prior O ADJ
to O PART
IVF/ICSI O NOUN
using O VERB
a O DET
table O ADJ
of O ADP
random O NOUN
numbers. O NOUN

This O DET
interaction O NOUN
is O VERB
capable O ADJ
of O ADP
creating O VERB
toxic O ADJ
species O NOUN
that O ADP
generate O NOUN
cell O NOUN
death. O ADP

Helicobacter O NOUN
pylori O NOUN
(Hp) O NUM
drug O NOUN
resistant O ADJ
rate O NOUN
to O PART
clarithromycin O NOUN
(CLA) O PUNCT
has O VERB
increased O VERB
to O PART
20% O NUM
to O PART
50%, O NOUN
which O ADP
cause O ADP
concerns O NOUN
regarding O VERB
its O ADJ
effectiveness O NOUN
in O ADP
eradicating O VERB
Hp, O NOUN
we O PRON
aim O ADP
to O PART
evaluate O VERB
the O DET
cost-effectiveness O NOUN
of O ADP
CLA-based O VERB
versus O CCONJ
furazolidone O NOUN
(FZD)-based O VERB
quadruple O ADJ
therapy, O NOUN
and O CCONJ
assess O NOUN
factors O NOUN
that O ADP
affect O NOUN
anti-Hp O ADP
efficacy. O NOUN

It O PRON
is O VERB
recommended O VERB
its O ADJ
teaching O VERB
to O PART
mothers O NOUN
and O CCONJ
its O ADJ
application O NOUN
in O ADP
the O DET
home O NOUN
environment. O NOUN

METHODOLOGY: O NOUN
In O ADP
total, O ADJ
237 O NUM
samples O NOUN
were O VERB
analysed O VERB
from O ADP
28 O NUM
DFUs, O NOUN
collected O VERB
at O ADP
fortnightly O ADV
intervals O NOUN
for O ADP
6 O NUM
months O NOUN
or O CCONJ
until O ADP
healing. O NOUN

Journal-Name:Medicine O NOUN

The O DET
findings O NOUN
do O VERB
not O ADV
support O NOUN
routine O ADJ
ultrasonography O NOUN
in O ADP
the O DET
third O ADJ
trimester O NOUN
for O ADP
low O ADJ
risk O NOUN
pregnancies. O NOUN

Vitamin O NOUN
D O NOUN
is O VERB
involved O VERB
in O ADP
bone O NOUN
metabolism O NOUN
and O CCONJ
in O ADP
many O DET
various O ADJ
extra-skeletal O ADJ
diseases O NOUN
such O ADJ
as O ADP
malabsorption O NOUN
syndromes, O NOUN
cardiovascular O ADJ
and O CCONJ
metabolic O ADJ
diseases, O NOUN
cancer, O NOUN
and O CCONJ
autoimmune O ADJ
and O CCONJ
neurological O ADJ
diseases. O NOUN

Journal O ADJ
ID: O NOUN
100968547 O NUM

No O DET
significant O ADJ
effects O NOUN
were O VERB
found O VERB
for O ADP
sprint B-outcome NOUN
variables O NOUN
(P O NUM
> O SYM
0.05) O NUM
with O ADP
comparable O ADJ
values O NOUN
at O ADP
T3 O NOUN
for O ADP
mean O NOUN
distance B-outcome NOUN
(betaA1: O NOUN
163.9 O NUM
+/- O SYM
3.8 O NUM
m; O NOUN
betaA2: O NOUN
161.2 O NUM
+/- O SYM
3.5 O NUM
m; O NOUN
PL: O NOUN
162.7 O NUM
+/- O SYM
3.6 O NUM
m), O NOUN
average O NOUN
power B-outcome NOUN
(betaA1: O NOUN
352.7 O NUM
+/- O SYM
14.5 O NUM
W; O ADP
betaA2: O NOUN
342.2 O NUM
+/- O SYM
13.5 O NUM
W; O ADP
PL: O NOUN
348.2 O NUM
+/- O SYM
13.9 O NUM
W) O NOUN
and O CCONJ
lactate B-outcome VERB
(betaA1: O NOUN
10.0 O NUM
+/- O SYM
0.9 O NUM
mmol. O NOUN

Journal-Name:BMC O NOUN
ophthalmology O NOUN

A O DET
randomized, O NOUN
placebo-controlled, O NOUN
cross-over O NOUN
trial O NOUN
was O VERB
carried O VERB
out O ADP
to O PART
evaluate O VERB
the O DET
Trimethylamine B-outcome NOUN
N-oxide I-outcome NOUN
(TMAO) I-outcome NOUN
-reducing O VERB
effect O NOUN
of O ADP
Taurisolo((R)). O NOUN

The O DET
differences O NOUN
between O ADP
the O DET
preoperative O ADJ
and O CCONJ
postoperative O ADJ
changes O NOUN
were O VERB
found O VERB
statistically O ADV
significant, O NOUN
but O CCONJ
not O ADV
different O ADJ
between O ADP
the O DET
2 O NUM
techniques O NOUN
at O ADP
any O DET
given O VERB
time O NOUN
studied. O NOUN

All O DET
canals O NOUN
were O VERB
cleaned O VERB
and O CCONJ
shaped O VERB
with O ADP
Reciproc O NOUN
instruments, O NOUN
and O CCONJ
were O VERB
used O VERB
with O ADP
a O DET
micro O ADJ
motor O NOUN
(VDW, O PUNCT
Munich O ADJ
Germany). O NOUN

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
with O ADP
CAP O NOUN
hospitalized O VERB
to O PART
non-ICU O NOUN
wards, O NOUN
erythromycin O NOUN
use O NOUN
was O VERB
associated O VERB
with O ADP
a O DET
68% O NUM
increased O VERB
risk O NOUN
of O ADP
hospital-acquired O VERB
cardiac B-outcome ADJ
events I-outcome NOUN
, O PUNCT
mainly O ADV
heart B-outcome NOUN
failure I-outcome NOUN
. O PUNCT
Levofloxacin B-outcome NOUN
and O CCONJ
moxifloxacin B-outcome NOUN
were O VERB
associated O VERB
with O ADP
a O DET
lower O ADJ
risk O NOUN
of O ADP
heart B-outcome NOUN
failure I-outcome NOUN
. O PUNCT
Although O ADP
our O ADJ
study O NOUN
does O VERB
not O ADV
fully O ADV
exclude O NOUN
confounding O VERB
bias, O NOUN
findings O NOUN
remained O VERB
largely O ADV
unchanged O VERB
in O ADP
crude, O NOUN
adjusted, O NOUN
and O CCONJ
sensitivity O NOUN
analyses. O NOUN

Journal-Name: O NOUN
BMJ O NOUN
(Clinical O ADJ
research O NOUN
ed.) O NOUN

Publication O NOUN
date: O NOUN
2018/12/06 O NOUN
00:00 O NOUN
[accepted] O ADV

Title: O NOUN
Effect O NOUN
of O ADP
a O DET
Nurse-Led O NOUN
Preventive O ADJ
Psychological O ADJ
Intervention O NOUN
on O ADP
Symptoms O NOUN
of O ADP
Posttraumatic B-outcome ADJ
Stress I-outcome NOUN
Disorder O NOUN
Among O ADP
Critically O ADV
Ill O NOUN
Patients: O NOUN
A O DET
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

Objective:The O NOUN
aim O ADP
of O ADP
this O DET
study O NOUN
is O VERB
to O PART
investigate O NOUN
the O DET
effects O NOUN
of O ADP
rhodiola O NOUN
rosea O NOUN
on O ADP
oxidative B-outcome ADJ
stress I-outcome NOUN
, O PUNCT
anxiety B-outcome NOUN
and O CCONJ
depression B-outcome NOUN
in O ADP
patients O NOUN
with O ADP
OSA. O NOUN

This O DET
study O NOUN
was O VERB
conducted O VERB
to O PART
assess O NOUN
the O DET
safety O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
sclerotherapy O NOUN
versus O CCONJ
cyanoacrylate O VERB
injection O NOUN
for O ADP
management O NOUN
of O ADP
actively O ADV
bleeding O VERB
esophageal O ADJ
varices O NOUN
in O ADP
cirrhotic O ADJ
patients. O NOUN

The O DET
efficacy O NOUN
was O VERB
evaluated O VERB
by O ADP
Pittsburgh O NOUN
sleep B-outcome NOUN
quality I-outcome NOUN
index O NOUN
(PSQI)], O NOUN
Beck O NOUN
depression B-outcome NOUN
index O NOUN
(BDI) O NOUN
, O PUNCT
Beck O NOUN
anxiety B-outcome NOUN
inventory O ADJ
(BAI) O NOUN
and O CCONJ
sleep B-outcome NOUN
diary O ADP
variables O NOUN
at O ADP
baseline, O NOUN
middle O ADJ
and O CCONJ
end O NOUN
of O ADP
treatment. O NOUN

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
investigate O NOUN
how O ADP
body O NOUN
posture O ADJ
is O VERB
shaped O VERB
in O ADP
children O NOUN
diagnosed O VERB
with O ADP
asthma O NOUN
symptoms O NOUN
and O CCONJ
whether O ADP
body O NOUN
posture O ADJ
is O VERB
associated O VERB
with O ADP
PA. O NOUN

OBJECTIVE: O NOUN
To O PART
determine O NOUN
and O CCONJ
compare O NOUN
the O DET
short-term O NOUN
effects O NOUN
of O ADP
rigid O NOUN
and O CCONJ
Kinesio O NOUN
taping O VERB
on O ADP
scapular B-outcome ADJ
dyskinesis I-outcome NOUN
, O PUNCT
scapular B-outcome ADJ
upward I-outcome ADJ
rotation I-outcome NOUN
, O PUNCT
and O CCONJ
pectoralis B-outcome NOUN
minor I-outcome ADJ
length I-outcome NOUN
in O ADP
asymptomatic O ADJ
overhead O ADP
athletes. O ADV

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

A O DET
dietary O ADJ
calcium O NOUN
intake O NOUN
of O ADP
1 O NUM
g O NOUN
per O ADP
day O NOUN
was O VERB
advised, O NOUN
but O CCONJ
calcium O NOUN
supplements O NOUN
were O VERB
not O ADV
provided. O NOUN

CONCLUSIONS: O NOUN
Mean O NOUN
lung B-outcome NOUN
function I-outcome NOUN
starts O NOUN
to O PART
decline O NOUN
prior O ADJ
to O PART
the O DET
first O ADV
reported O VERB
symptoms O NOUN
of O ADP
an O DET
exacerbation, O NOUN
and O CCONJ
does O VERB
not O ADV
recover O NOUN
to O PART
pre-exacerbation O NOUN
levels O NOUN
8 O NUM
weeks O NOUN
after O ADP
the O DET
event. O NOUN

CONCLUSION: O NOUN
In O ADP
Indian O NOUN
patients, O NOUN
30 O NUM
mg O NOUN
of O ADP
prasugrel O NOUN
loading O VERB
is O VERB
as O ADP
effective O ADJ
as O ADP
60 O NUM
mg O NOUN
of O ADP
prasugrel O NOUN
with O ADP
significantly O ADV
less O ADV
minor B-outcome ADJ
bleeding I-outcome VERB
. O PUNCT

Vanderbilt O NOUN
University O NOUN
Medical O ADJ
Center, O NOUN
Nashville, O NOUN
TN. O NOUN

Low O ADJ
DHA O NOUN
intakes O NOUN
might O VERB
explain O NOUN
subtle O ADJ
neurological B-outcome ADJ
deficits I-outcome NOUN
in O ADP
PKU. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Journal O ADJ
ID: O NOUN
101654770 O NUM

Journal-Name:BMC O NOUN
neurology O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
a O DET
Resuscitation O NOUN
Strategy O NOUN
Targeting O VERB
Peripheral O ADJ
Perfusion O NOUN
Status O NOUN
vs O CCONJ
Serum O NOUN
Lactate O NOUN
Levels O NOUN
on O ADP
28-Day O ADP
Mortality B-outcome NOUN
Among O ADP
Patients O NOUN
With O ADP
Septic O ADJ
Shock: O NOUN
The O DET
ANDROMEDA-SHOCK O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

The O DET
elbow O NOUN
sleeve O NOUN
yielded O VERB
better O ADJ
scores O NOUN
than O ADP
no O DET
orthosis O NOUN
for O ADP
the O DET
following O VERB
outcomes: O NOUN
joint B-outcome NOUN
position I-outcome NOUN
reproduction I-outcome NOUN
score O NOUN
at O ADP
110 O NUM
degrees O NOUN
(P O NUM
< O SYM
.001), O PUNCT
pain B-outcome NOUN
(P O NUM
< O SYM
.001), O PUNCT
and O CCONJ
grip B-outcome NOUN
strength I-outcome NOUN
(P O NUM
= O SYM
.012). O PUNCT

For O ADP
the O DET
safety O NOUN
evaluation, O NOUN
laboratory O NOUN
examinations O NOUN
including O VERB
complete B-outcome ADJ
blood I-outcome NOUN
count I-outcome NOUN
, O PUNCT
liver B-outcome NOUN
function I-outcome NOUN
test, O NUM
renal B-outcome ADJ
function I-outcome NOUN
test, O NUM
blood B-outcome NOUN
coagulation I-outcome NOUN
test, O NUM
inflammation B-outcome NOUN
test, O NUM
and O CCONJ
urine B-outcome NOUN
analysis I-outcome NOUN
will O VERB
be O VERB
conducted O VERB
before O ADP
and O CCONJ
after O ADP
taking O VERB
the O DET
medications. O NOUN

At O ADP
the O DET
test-of-cure O NOUN
visit, O NOUN
composite O NOUN
cure B-outcome NOUN
was O VERB
observed O VERB
in O ADP
81.7% O NUM
(156 O NUM
of O ADP
191 O NUM
patients) O NOUN
and O CCONJ
70.1% O NUM
(138 O NOUN
of O ADP
197 O NUM
patients), O NOUN
respectively O ADV
(difference, O ADV
11.6 O NUM
percentage O NOUN
points; O NOUN
95% O NOUN
CI, O NOUN
2.7 O NUM
to O PART
20.3). O PUNCT

Clinicians O NOUN
may O VERB
find O ADP
these O DET
helpful O ADJ
when O ADP
considering O VERB
the O DET
likelihood O NOUN
of O ADP
achieving O VERB
early O ADJ
clinically O ADV
significant O ADJ
visual B-outcome ADJ
acuity I-outcome NOUN
(VA) I-outcome NOUN
improvements O NOUN
with O ADP
ranibizumab O ADJ
in O ADP
patients O NOUN
with O ADP
RVO. O NOUN

Serious B-outcome ADJ
adverse I-outcome ADJ
reactions I-outcome NOUN
such O ADJ
as O ADP
acute B-outcome ADJ
appendicitis I-outcome NOUN
and O CCONJ
acute B-outcome ADJ
viral I-outcome ADJ
gastroenteritis I-outcome NOUN
were O VERB
observed O VERB
in O ADP
the O DET
BT-11 O NOUN
group4 O NOUN
and O CCONJ
the O DET
placebo O NOUN
group, O NOUN
respectively. O NOUN

The O DET
operation B-outcome NOUN
time I-outcome NOUN
, O PUNCT
length B-outcome NOUN
of I-outcome ADP
stay I-outcome NOUN
, O PUNCT
length B-outcome NOUN
of I-outcome ADP
incision I-outcome NOUN
, O PUNCT
and O CCONJ
perioperative O ADJ
complications B-outcome NOUN
related O VERB
to O PART
operation O NOUN
were O VERB
recorded. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

METHODS: O NOUN
In O ADP
a O DET
crossover O NOUN
design O NOUN
with O ADP
a O DET
1 O NUM
wk. O DET

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

It O PRON
may O VERB
be O VERB
a O DET
more O ADV
acceptable O ADJ
and O CCONJ
viable O ADJ
option O NOUN
for O ADP
the O DET
common O ADJ
man. O NOUN

Satisfactory O ADJ
compliance B-outcome NOUN
with O ADP
mask O NOUN
application O NOUN
was O VERB
40% O NUM
in O ADP
control O NOUN
group O NOUN
vs. O CCONJ
73.3% O NUM
in O ADP
DEX O NOUN
group O NOUN
(P<0.05). O NOUN

Title: O NOUN
Cluster O NOUN
randomized O VERB
evaluation O NOUN
of O ADP
the O DET
Nia O NOUN
Project: O NOUN
study O NOUN
protocol. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

white B-outcome ADP
spot I-outcome NOUN
lesions I-outcome NOUN
were O VERB
assessed O VERB
using O VERB
a O DET
laser O NOUN
fluorescence O NOUN
device O NOUN
( O NOUN
DIAGNOdent O ADJ
pen], O NOUN
Kavo, O NOUN
Germany) O NOUN
and O CCONJ
were O VERB
characterized O VERB
at O ADP
baseline, O NOUN
immediately O ADV
following O VERB
resin O NOUN
infiltration O NOUN
application O NOUN
and O CCONJ
at O ADP
a O DET
6-month O NOUN
follow-up. O PUNCT

Journal-Name:International O ADJ
journal O ADJ
of O ADP
gynaecology O NOUN
and O CCONJ
obstetrics: O NOUN
the O DET
official O ADJ
organ O NOUN
of O ADP
the O DET
International O ADJ
Federation O NOUN
of O ADP
Gynaecology O NOUN
and O CCONJ
Obstetrics O NOUN

The O DET
tear O NUM
levels O NOUN
of O ADP
matrix B-outcome NOUN
metalloproteinase I-outcome NOUN
(MMP)-9 I-outcome PUNCT
and O CCONJ
serotonin B-outcome NOUN
were O VERB
measured O VERB
before O ADP
and O CCONJ
at O ADP
1 O NUM
month O NOUN
after O ADP
injection. O ADV

Last O ADV
and O CCONJ
baseline O NOUN
observation O NOUN
carried O VERB
forward O ADV
method O NOUN
(LOCF, O PUNCT
BOCF) O NOUN
were O VERB
performed O VERB
as O ADP
sensitivity O NOUN
analysis. O NOUN

CONCLUSION: O NOUN
CART O NOUN
showed O VERB
significant O ADJ
improvement O NOUN
in O ADP
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
(HRV) I-outcome NUM
parameters O NOUN
indicating O VERB
vagal O ADJ
dominance O NOUN
in O ADP
middle-aged O NOUN
hypertensive O ADJ
women. O NOUN

We O PRON
observed O VERB
no O DET
differences O NOUN
among O ADP
groups O NOUN
for O ADP
the O DET
change O NOUN
in O ADP
the O DET
pectoralis B-outcome NOUN
minor I-outcome ADJ
index O NOUN
(P O NUM
> O SYM
.05). O NUM

The O DET
safety O NOUN
profile O NOUN
of O ADP
netupitant O ADJ
was O VERB
comparable O ADJ
in O ADP
the O DET
three O NUM
arms. O ADJ

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Relevant O ADJ
participants' O NOUN
data O NOUN
will O VERB
be O VERB
collected O VERB
at O ADP
enrolment O ADJ
and O CCONJ
at O ADP
delivery. O VERB

BACKGROUND: O NOUN
Exacerbations O NOUN
of O ADP
chronic O ADJ
obstructive O ADJ
pulmonary O ADJ
disease O NOUN
(COPD) O NUM
are O VERB
associated O VERB
with O ADP
loss O NOUN
of O ADP
lung O NOUN
function O NOUN
and O CCONJ
poor O ADJ
outcomes O NOUN
for O ADP
patients. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
[Effects O NOUN
of O ADP
aerosol O NOUN
inhalation O NOUN
on O ADP
respiratory B-outcome ADJ
mechanical I-outcome ADJ
parameters O NOUN
under O ADP
different O ADJ
ventilation O NOUN
patterns O NOUN
and O CCONJ
ventilator O NOUN
parameters]. O NOUN

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
1548 O NUM
patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
undergo O NOUN
bilateral O ADJ
internal-thoracic-artery O ADV
grafting O VERB
(the O NOUN
bilateral-graft O NOUN
group) O ADJ
and O CCONJ
1554 O NUM
to O PART
undergo O NOUN
single O ADJ
internal-thoracic-artery O ADV
grafting O VERB
(the O NOUN
single-graft O NOUN
group). O NOUN

Publication O NOUN
date: O NOUN
2019/02/28 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:Japanese O NOUN
journal O ADJ
of O ADP
clinical O ADJ
oncology O NOUN

Journal-Name:Medicine O NOUN

Journal-Name:Panminerva O NOUN
medica O NOUN

Emphasis O NOUN
has O VERB
been O VERB
placed O VERB
on O ADP
TKA O NOUN
pain O NOUN
management O NOUN
for O ADP
postoperative O ADJ
care O NOUN
and O CCONJ
during O ADP
rehabilitation. O ADV

OBJECTIVE:: O NOUN
With O ADP
increasing O VERB
incorporation O NOUN
of O ADP
MRI O NOUN
in O ADP
radiotherapy, O NOUN
we O PRON
investigate O NOUN
two O NUM
MRI O NOUN
sequences O NOUN
for O ADP
prostate O NOUN
delineation O NOUN
in O ADP
radiographer-led O VERB
image O NOUN
guidance. O NOUN

BACKGROUND: O NOUN
Crohn's O NOUN
disease O NOUN
(CD) O NOUN
is O VERB
a O DET
highly O ADV
prevalent O ADJ
inflammatory O ADJ
bowel O NOUN
disease O NOUN
(IBD), O PUNCT
characterized O VERB
by O ADP
recurring O VERB
flares O NOUN
altered O VERB
by O ADP
periods O NOUN
of O ADP
inactive O ADJ
disease O NOUN
and O CCONJ
remission, O NOUN
affecting O VERB
physical O ADJ
and O CCONJ
psychological O ADJ
aspects O NOUN
and O CCONJ
quality O NOUN
of O ADP
life O NOUN
(QoL). O NOUN

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
445 O NUM
patients O NOUN
were O VERB
randomly O ADV
assigned: O NOUN
222 O NUM
to O PART
the O DET
early-start O NOUN
group O NOUN
and O CCONJ
223 O NUM
to O PART
the O DET
delayed-start O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
100968567 O NUM

METHODS: O NOUN
This O DET
multicenter, O NOUN
double-blind, O NOUN
double-dummy, O NOUN
parallel O ADJ
group, O NOUN
randomized, O NOUN
placebo-controlled O VERB
trial O NOUN
was O VERB
conducted O VERB
in O ADP
Ethiopia, O ADV
Peru, O ADP
Brazil, O NOUN
Cambodia, O NOUN
Thailand, O NOUN
and O CCONJ
the O DET
Philippines. O NOUN

Title: O NOUN
School-based O VERB
surveillance O NOUN
for O ADP
detection O NOUN
of O ADP
children O NOUN
with O ADP
acute B-outcome ADJ
pharyngitis I-outcome NOUN
, O PUNCT
rheumatic B-outcome ADJ
fever/rheumatic I-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
in O ADP
Shimla O NOUN
district, O NOUN
Himachal O NOUN
Pradesh, O NOUN
India-A O NOUN
cluster O NOUN
randomized O VERB
controlled O VERB
trial. O NOUN

Implementation O NOUN
methods: O NOUN
how O ADP
and O CCONJ
when O ADP
the O DET
components O NOUN
were O VERB
implemented B-outcome VERB
in O ADP
schools. O NOUN

Nonetheless, O NOUN
the O DET
positive O ADJ
results O NOUN
achieved O NOUN
in O ADP
the O DET
area O NOUN
of O ADP
functionality O NOUN
of O ADP
the O DET
CHW O NOUN
intervention O NOUN
and O CCONJ
community O NOUN
structure O NOUN
capacity O NOUN
are O VERB
encouraging. O NOUN

Including O VERB
men O NOUN
in O ADP
preconception O NOUN
health O NOUN
policy O NOUN
guidelines O NOUN
and O CCONJ
identifying O VERB
suitable O ADJ
actors O NOUN
for O ADP
care O NOUN
provision O NOUN
would O VERB
be O VERB
important O ADJ
first O ADV
steps. O NOUN

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
Initially, O NOUN
56 O NUM
patients O NOUN
were O VERB
randomized O VERB
into O ADP
four O NUM
groups; O NOUN
control O NOUN
group O NOUN
(n=12), O PUNCT
single-dose O NOUN
(n=16), O NOUN
repeated-dose O NOUN
(n=12) O PUNCT
and O CCONJ
continuous O ADJ
infusion O NOUN
(n=16) O PUNCT
RSB O NOUN
analgesia O NOUN
groups. O NOUN

Local O ADJ
cutaneous O ADJ
safety O NOUN
and O CCONJ
tolerability B-outcome NOUN
assessments O NOUN
were O VERB
generally O ADV
mild-to-moderate O ADJ
at O ADP
baseline O NOUN
and O CCONJ
improved O VERB
by O ADP
week O NOUN
12. O NUM

To O PART
combat O NOUN
this O DET
problem, O NOUN
investigators O NOUN
have O VERB
attempted O VERB
to O PART
withhold O ADV
angiotensin-converting O VERB
enzyme O NOUN
inhibitors O NOUN
(ACEi) O NUM
and O CCONJ
angiotensin O NOUN
receptor O NOUN
blockers O NOUN
(ARB) O NOUN
preoperatively, O ADJ
or O CCONJ
evaluated O VERB
the O DET
effects O NOUN
of O ADP
different O ADJ
induction O NOUN
agents O NOUN
in O ADP
conferring O VERB
greater O ADJ
hemodynamic O ADJ
stability. O NOUN

Repeated O VERB
measures O NOUN
analysis O NOUN
of O ADP
variance O NOUN
(RMANOVA) O PUNCT
demonstrated O VERB
significant O ADJ
differences O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
over O ADP
time O NOUN
for O ADP
the O DET
Schirmer O NOUN
I O NUM
test O NOUN
(p O PUNCT
= O SYM
0.002), O NUM
corneal B-outcome ADJ
fluorescein I-outcome NOUN
staining I-outcome VERB
(p O PUNCT
= O SYM
0.025), O NUM
ocular B-outcome ADJ
surface I-outcome NOUN
disease I-outcome NOUN
index](p O NOUN
= O SYM
0.020), O NUM
and O CCONJ
frequency O NOUN
of O ADP
lubricants B-outcome NOUN
(p O PUNCT
= O SYM
0.029). O NUM

When O ADP
the O DET
patient O NOUN
left O ADV
the O DET
postanesthesia O NOUN
care O NOUN
unit, O ADP
all O DET
had O VERB
sore B-outcome ADV
throat I-outcome NOUN
and O CCONJ
26/15/25 O VERB
patients O NOUN
in O ADP
VDT/VST/DT O NOUN
group O NOUN
had O VERB
hoarseness B-outcome VERB
. O PUNCT
All O DET
had O VERB
good O ADJ
outcomes B-outcome NOUN
of I-outcome ADP
the Seperator DET
surgical I-outcome ADJ
operations I-outcome NOUN
.We O PUNCT
found O VERB
the O DET
ETView O NOUN
tube O NOUN
to O PART
be O VERB
helpful B-outcome ADJ
in O ADP
the O DET
endotracheal O ADJ
intubation O NOUN
and O CCONJ
continuous O ADJ
surveillance O NOUN
of O ADP
tube O NOUN
position O NOUN
in O ADP
patients O NOUN
with O ADP
video-assisted O VERB
thoracoscopic O ADJ
lobectomy. O NOUN

A O DET
total O ADJ
of O ADP
159 O NUM
American O ADJ
Society O NOUN
of O ADP
Anesthesiologists O NOUN
(ASA) O NOUN
physical O ADJ
status O NOUN
I O NUM
to O PART
III O NUM
patients O NOUN
scheduled O VERB
for O ADP
primary O ADJ
TKA O NOUN
were O VERB
randomized O VERB
to O PART
one O NUM
of O ADP
three O NUM
study O NOUN
groups. O NOUN

METHODS: O NOUN
In O ADP
a O DET
double-blind O ADJ
trial, O NOUN
we O PRON
randomly O ADV
assigned O VERB
(in O NUM
a O DET
1:1 O ADJ
ratio) O NOUN
adults O NOUN
with O ADP
community-acquired O VERB
bacterial O ADJ
pneumonia O NOUN
(Pneumonia O NOUN
Severity O NOUN
Index O NOUN
risk O NOUN
class O NOUN
II, O NOUN
III, O NOUN
or O CCONJ
IV) O NUM
to O PART
receive O VERB
omadacycline O NOUN
(100 O NUM
mg O NOUN
intravenously O ADV
every O DET
12 O NUM
hours O NOUN
for O ADP
two O NUM
doses, O ADJ
then O ADV
100 O NUM
mg O NOUN
intravenously O ADV
every O DET
24 O NUM
hours), O NOUN
or O CCONJ
moxifloxacin O NOUN
(400 O NUM
mg O NOUN
intravenously O ADV
every O DET
24 O NUM
hours). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

PMID: O NOUN
31618286 O NUM

After O ADP
an O DET
anesthetic O ADJ
induction, O NOUN
bolus O NOUN
of O ADP
rocuronium O NOUN
0.1 O NUM
mg/kg O NOUN
was O VERB
injected O VERB
when O ADP
it O PRON
was O VERB
needed O VERB
(for O PUNCT
patient O NOUN
involuntary B-outcome ADJ
movement I-outcome NOUN
or O CCONJ
at O ADP
the O DET
request O NOUN
of O ADP
the O DET
surgeon) O NOUN
in O ADP
group O NOUN
B, O NOUN
and O CCONJ
5 O NUM
mcg/kg/min O NOUN
of O ADP
rocuronium O NOUN
were O VERB
infused O VERB
in O ADP
group O NOUN
I O NUM
study O NOUN
participants. O NOUN

The O DET
primary O ADJ
endpoint O NOUN
is O VERB
defined O VERB
as O ADP
the O DET
number O NOUN
of O ADP
individuals O NOUN
positive O ADJ
for O ADP
Plasmodium B-outcome NOUN
falciparum I-outcome NOUN
and Seperator CCONJ
Plasmodium B-outcome NOUN
vivax I-outcome NOUN
infections E1-outcome NOUN
diagnosed O VERB
by O ADP
a O DET
rapid O ADJ
diagnostic O ADJ
test. O NOUN

RESULTS: O NOUN
Data O NOUN
from O ADP
55 O NUM
of O ADP
the O DET
62 O NUM
participants O NOUN
were O VERB
analyzed. O NOUN

There O PRON
were O VERB
no O DET
instances O NOUN
of O ADP
urgent O ADJ
target O NOUN
lesion B-outcome NOUN
re-vascularisation I-outcome NOUN
or O CCONJ
definite O ADP
stent B-outcome NOUN
thrombosis I-outcome NOUN
in O ADP
either O CCONJ
groups. O NOUN

This O DET
study O NOUN
aimed O VERB
to O PART
develop O VERB
a O DET
multidisciplinary O ADJ
lifestyle O NOUN
intervention O NOUN
program O NOUN
targeted O VERB
at O ADP
children O NOUN
and O CCONJ
adolescents O NOUN
with O ADP
moderate O ADJ
to O PART
severe O ADJ
obesity, O ADJ
and O CCONJ
assess O NOUN
the O DET
additional O ADJ
effects O NOUN
of O ADP
exercise O NOUN
intervention O NOUN
when O ADP
compared O VERB
to O PART
usual O ADJ
care. O NOUN

There O PRON
was O VERB
a O DET
statistically O ADV
significant O ADJ
improvement O NOUN
in O ADP
the O DET
post O ADV
procedure O NOUN
creatinine B-outcome NOUN
values O NOUN
at O ADP
24h O NOUN
(p=0.013), O NOUN
48h O NOUN
(p=0.015), O PUNCT
2 O NUM
weeks O NOUN
(p=0.003), O NOUN
6 O NUM
weeks O NOUN
(p=0.003) O NOUN
and O CCONJ
post O ADV
procedure O NOUN
glomerular B-outcome ADJ
filtration I-outcome NOUN
rate I-outcome NOUN
(eGFR) I-outcome NOUN
values O NOUN
at O ADP
24h O NOUN
(p=0.026), O NOUN
48h O NOUN
(p=0.044), O PUNCT
2 O NUM
weeks O NOUN
(p=0.015) O NUM
and O CCONJ
6 O NUM
weeks O NOUN
(p=0.011) O NOUN
in O ADP
study O NOUN
group O NOUN
compared O VERB
to O PART
control O NOUN
group. O VERB

There O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
the O DET
proportions O NOUN
of O ADP
participants O NOUN
reporting O VERB
local B-outcome ADJ
solicited I-outcome VERB
AEs I-outcome NOUN
, O PUNCT
systemic B-outcome ADJ
solicited I-outcome VERB
AEs I-outcome NOUN
, O PUNCT
unsolicited B-outcome VERB
AEs I-outcome NOUN
, O PUNCT
and O CCONJ
SAEs B-outcome NOUN
among O ADP
the O DET
3 O NUM
vaccine O NOUN
groups O NOUN
after O ADP
the O DET
1st O ADJ
and O CCONJ
2nd O ADJ
doses. O NOUN

RESULTS: O NOUN
Eleven O NUM
out O ADP
of O ADP
fifty O NUM
patients O NOUN
in O ADP
the O DET
study O NOUN
group O NOUN
developed O VERB
contrast B-outcome NOUN
induced I-outcome VERB
nephropathy I-outcome NOUN
(CIN) I-outcome NOUN
(22%) O PUNCT
compared O VERB
to O PART
eighteen O NUM
out O ADP
of O ADP
the O DET
fifty O NUM
control O NOUN
patients O NOUN
(36%) O NOUN
(p=0.123). O PUNCT

CONCLUSIONS: O NOUN
Systematic O ADJ
pelvic O ADJ
and O CCONJ
paraaortic O ADJ
lymphadenectomy O NOUN
in O ADP
patients O NOUN
with O ADP
advanced O VERB
ovarian O ADJ
cancer O NOUN
who O ADP
had O VERB
undergone O VERB
intraabdominal O ADJ
macroscopically O ADV
complete O ADJ
resection O NOUN
and O CCONJ
had O VERB
normal O ADJ
lymph O NOUN
nodes O NOUN
both O CCONJ
before O ADP
and O CCONJ
during O ADP
surgery O NOUN
was O VERB
not O ADV
associated O VERB
with O ADP
longer O ADJ
overall B-outcome ADJ
or Seperator CCONJ
progression-free B-outcome ADJ
survival E1-outcome NOUN
than O ADP
no O DET
lymphadenectomy O NOUN
and O CCONJ
was O VERB
associated O VERB
with O ADP
a O DET
higher O ADJ
incidence O NOUN
of O ADP
postoperative O ADJ
complications B-outcome NOUN
. O PUNCT
(Funded O PUNCT
by O ADP
Deutsche O NOUN
Forschungsgemeinschaft O NOUN
and O CCONJ
the O DET
Austrian O ADJ
Science O NOUN
Fund; O NOUN
LION O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT00712218.). O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Importance: O NOUN
There O PRON
are O VERB
currently O ADV
no O DET
proven O VERB
treatments O NOUN
to O PART
reduce O VERB
the O DET
risk O NOUN
of O ADP
mild O ADJ
cognitive O ADJ
impairment O NOUN
and O CCONJ
dementia. O NOUN

All O DET
primary O ADJ
and O CCONJ
secondary O ADJ
outcomes O NOUN
were O VERB
measured O VERB
at O ADP
baseline, O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
8-week O NOUN
treatment, O NOUN
and O CCONJ
4-week O NOUN
follow-up. O PUNCT

Regarding O VERB
the O DET
composite O NOUN
outcome O NOUN
of O ADP
death B-outcome NOUN
, O PUNCT
myocardial B-outcome ADJ
infarction I-outcome NOUN
, O PUNCT
or O CCONJ
stroke B-outcome NOUN
, O PUNCT
there O PRON
were O VERB
385 O NUM
patients O NOUN
(24.9%) O PUNCT
with O ADP
an O DET
event O NOUN
in O ADP
the O DET
bilateral-graft O NOUN
group O NOUN
and O CCONJ
425 O NUM
patients O NOUN
(27.3%) O NOUN
with O ADP
an O DET
event O NOUN
in O ADP
the O DET
single-graft O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
0.90; O NOUN
95% O NOUN
CI, O NOUN
0.79 O NUM
to O PART
1.03). O ADP

TRIAL O NOUN
REGISTRATION: O NOUN
ISRCTN10894523 O NOUN
. O PUNCT

Title: O NOUN
Iodoform O NOUN
Vs O NUM
Calcium O NOUN
Hydroxide/Zinc O NOUN
Oxide O NOUN
based O VERB
pastes: O ADJ
12-month O NOUN
findings O NOUN
of O ADP
a O DET
Randomized O VERB
Controlled O VERB
Trial. O NOUN

Journal O ADJ
ID: O NOUN
9206499 O NUM

The O DET
relative O ADJ
risk O NOUN
of O ADP
SAE B-outcome ADP
was O VERB
1.44 O NUM
(97.5% O NUM
CI, O NOUN
0.79 O NUM
to O PART
2.64; O NOUN
P O NOUN
= O SYM
.18). O NUM

Retrospectively O ADV
registered: O NOUN
December O NOUN
3, O NOUN
2010, O NUM
( O PUNCT
http://www.drks.de/drks_web/setLocale_EN.do O NOUN
). O NOUN

Results: O NOUN
Recruitment O NOUN
stopped O VERB
on O ADP
December O NOUN
21, O NUM
2017, O NUM
because O ADP
conditional O ADJ
power O NOUN
for O ADP
the O DET
primary O ADJ
outcome O NOUN
based O VERB
on O ADP
a O DET
prespecified O VERB
analysis O NOUN
of O ADP
the O DET
first O ADV
267 O NUM
randomized O VERB
participants O NOUN
was O VERB
less O ADV
than O ADP
30% O NOUN
in O ADP
both O CCONJ
treatment O NOUN
groups O NOUN
(futility O NOUN
criterion). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
findings O NOUN
provide O VERB
new O ADJ
insights O NOUN
on O ADP
the O DET
effects O NOUN
and O CCONJ
mechanisms O NOUN
of O ADP
a O DET
MBI O NOUN
on O ADP
aMCI O NOUN
symptoms. O NOUN

No O DET
robotic O ADJ
rehabilitation O NOUN
session O NOUN
had O VERB
to O PART
be O VERB
replaced B-outcome VERB
by O ADP
conventional O ADJ
rehabilitation. O ADV

Journal-Name:Zhongguo O NOUN
xiu O NOUN
fu O ADP
chong O ADJ
jian O NOUN
wai O CCONJ
ke O NOUN
za O ADP
zhi O NUM
= O SYM
Zhongguo O NOUN
xiufu O VERB
chongjian O NOUN
waike O ADP
zazhi O NOUN
= O SYM
Chinese O NOUN
journal O ADJ
of O ADP
reparative O ADJ
and O CCONJ
reconstructive O ADJ
surgery O NOUN

Registered O VERB
19.7.2018. O NOUN

RESULTS: O NOUN
At O ADP
a O DET
median O ADJ
follow-up O NOUN
of O ADP
7.5 O NUM
years O NOUN
(range, O NOUN
1.3-9.6 O NUM
years), O NOUN
7-year O NOUN
biochemical B-outcome ADJ
failure-free I-outcome ADJ
survival I-outcome NOUN
(BCFFS) I-outcome NUM
was O VERB
76.2% O NUM
for O ADP
the O DET
MHF O NOUN
group O NOUN
and O CCONJ
46.2% O NUM
for O ADP
the O DET
EHF O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.005). O NUM

School O NOUN
physical O ADJ
education O NOUN
(PE) O NOUN
is O VERB
an O DET
important O ADJ
existing O VERB
network O NOUN
in O ADP
which O ADP
participation O NOUN
in O ADP
physical O ADJ
activity O NOUN
beyond O ADP
school O NOUN
can O VERB
be O VERB
promoted O VERB
to O PART
the O DET
captive O ADJ
young O ADJ
people. O NOUN

We O PRON
will O VERB
compare O NOUN
3-month, O NUM
6-month, O NUM
and O CCONJ
12-month O NOUN
graft B-outcome NOUN
survival I-outcome NOUN
after O ADP
LT, O NOUN
in O ADP
order O NOUN
to O PART
identify O NOUN
a O DET
significant O ADJ
relation O NOUN
between O ADP
the O DET
two O NUM
homogenous O ADJ
groups O NOUN
of O ADP
LT O NOUN
patients. O NOUN

The O DET
outcomes O NOUN
were O VERB
evaluated O VERB
clinically O ADV
and O CCONJ
radiographically O ADV
according O ADJ
to O PART
specific O ADJ
criteria. O NOUN

This O DET
study O NOUN
therefore O ADV
investigated O VERB
the O DET
effect O NOUN
of O ADP
two O NUM
betaA O NOUN
dosing O VERB
strategies O NOUN
on O ADP
30-min O NOUN
rowing B-outcome VERB
and Seperator CCONJ
subsequent X NOUN
sprint B-outcome NOUN
performance E1-outcome NOUN
. O PUNCT
METHODS: O NOUN
Following O VERB
University O NOUN
Ethics O NOUN
approval, O NOUN
twenty-seven O VERB
healthy, O NOUN
male O NOUN
rowers O NOUN
(age: O NOUN
24 O NUM
+/- O SYM
2 O NUM
years; O NOUN
body-height: O NOUN
1.81 O NUM
+/- O SYM
0.02 O NUM
m; O NOUN
body-mass: O NOUN
82.3 O NUM
+/- O SYM
2.5 O NUM
kg; O NOUN
body-fat: O NOUN
14.2 O NUM
+/- O SYM
1.0%) O NUM
were O VERB
randomised O VERB
in O ADP
a O DET
double-blind O ADJ
manner O NOUN
to O PART
4 O NUM
weeks O NOUN
of: O NOUN
i) O ADJ
betaA O NOUN
(2.4 O NOUN
g.d(- O NOUN
1), O NUM
betaA1); O NOUN
ii) O ADP
matched O VERB
total O ADJ
betaA O NOUN
(4.8 O NOUN
g O NOUN
on O ADP
alternate O VERB
days, O NOUN
betaA2); O VERB
or O CCONJ
iii) O NOUN
cornflour O NOUN
placebo O NOUN
(2.4 O NOUN
g.d(- O NOUN
1), O NUM
PL). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
The O DET
effect O NOUN
of O ADP
progressive O ADJ
muscle O NOUN
relaxation O NOUN
on O ADP
cancer O NOUN
patients' O NOUN
self-efficacy B-outcome NOUN
. O PUNCT

This O DET
sample O NOUN
size O NOUN
achieves O NOUN
90% O VERB
power O NOUN
to O PART
detect O VERB
a O DET
difference O NOUN
of O ADP
14.6% O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
survival O NOUN
using O VERB
a O DET
one-sided O VERB
binomial O ADJ
test. O NOUN

Publication O NOUN
date: O NOUN
2018/12/17 O NOUN
00:00 O NOUN
[accepted] O ADV

Injection B-outcome NOUN
pain I-outcome NOUN
was O VERB
reported O VERB
by O ADP
11 O NUM
of O ADP
28 O NUM
(39%) O NOUN
in O ADP
the O DET
Group O NOUN
N O NOUN
and O CCONJ
in O ADP
2 O NUM
of O ADP
28 O NUM
(7%) O NUM
in O ADP
the O DET
Group O NOUN
R O NOUN
(difference O NOUN
in O ADP
proportion: O ADJ
32%, O NOUN
95% O NOUN
CI: O NOUN
10-51%, O NOUN
P O NOUN
= O SYM
.01). O PUNCT

Title: O NOUN
Low O ADJ
dose O NOUN
human O NOUN
chorionic O ADJ
gonadotropin O NOUN
administration O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
gonadotropin O NOUN
releasing-hormone O NOUN
agonist O NOUN
trigger O ADP
versus O CCONJ
35 O NUM
h O NOUN
later O ADV
in O ADP
women O NOUN
at O ADP
high O ADJ
risk O NOUN
of O ADP
developing O VERB
ovarian O ADJ
hyperstimulation O NOUN
syndrome O NOUN
- O PUNCT
a O DET
prospective O ADJ
randomized O VERB
double-blind O ADJ
clinical O ADJ
trial. O NOUN

Title: O NOUN
Acute O ADJ
GVHD O NOUN
prophylaxis O NOUN
plus O CCONJ
ATLG O NOUN
after O ADP
myeloablative O ADJ
allogeneic O ADJ
haemopoietic O ADJ
peripheral O ADJ
blood O NOUN
stem-cell O NOUN
transplantation O NOUN
from O ADP
HLA-identical O ADJ
siblings O NOUN
in O ADP
patients O NOUN
with O ADP
acute O ADJ
myeloid O NOUN
leukaemia O NOUN
in O ADP
remission: O NOUN
final O ADJ
results O NOUN
of O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
and O CCONJ
long-term O NOUN
outcome O NOUN
analysis O NOUN
of O ADP
a O DET
phase O NOUN
3 O NUM
randomised O VERB
study. O NOUN

Dipirona O NOUN
and O CCONJ
tramadol O NOUN
doses O NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
groups O NOUN
(p=0.201 O NOUN
and O CCONJ
p=0.341). O NOUN

Registered O VERB
on O ADP
3rd O ADJ
September O NOUN
2018, O NUM
https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=3571. O ADV

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

The O DET
patients O NOUN
will O VERB
be O VERB
randomized O VERB
into O ADP
a O DET
deep O ADJ
NMB O NOUN
group O NOUN
or O CCONJ
a O DET
moderate O ADJ
NMB O NOUN
group O NOUN
with O ADP
a O DET
1:1 O ADJ
ratio. O NOUN

Impressions B-outcome NOUN
from O ADP
the O DET
counselling O VERB
were O VERB
also O ADV
assessed O VERB
at O ADP
follow-up. O PUNCT

Journal O ADJ
ID: O NOUN
2985248R O NOUN

There O PRON
was O VERB
a O DET
decrease O NOUN
in O ADP
albumin B-outcome NOUN
levels O NOUN
in O ADP
both O CCONJ
groups O NOUN
(p O PUNCT
? O PUNCT

Journal-Name:Terapevticheskii O NOUN
arkhiv O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ISRCTN27083228 O NOUN

Treatment B-outcome NOUN
success I-outcome NOUN
was O VERB
achieved O NOUN
by O ADP
19.6% O NOUN
of O ADP
subjects O NOUN
by O ADP
week O NOUN
12, O NUM
compared O VERB
with O ADP
12.7% O NUM
on O ADP
vehicle O NOUN
(P=0.015). O NUM

CONCLUSION: O NOUN
The O DET
prevention O NOUN
of O ADP
the O DET
complications O NOUN
during O ADP
the O DET
percutaneous O ADJ
myocardial O ADJ
revascularization O NOUN
should O VERB
be O VERB
considered O VERB
with O ADP
the O DET
position O NOUN
of O ADP
the O DET
most O DET
suitable O ADJ
pharmacological O ADJ
support. O NOUN

The O DET
primary O ADJ
objective O ADP
was O VERB
to O PART
show O VERB
the O DET
noninferiority O NOUN
of O ADP
plazomicin O NOUN
to O PART
meropenem O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
complicated O VERB
UTIs, O ADP
including O VERB
acute O ADJ
pyelonephritis, O NOUN
with O ADP
a O DET
noninferiority O NOUN
margin O ADP
of O ADP
15 O NUM
percentage O NOUN
points. O NOUN

Publication O NOUN
date: O NOUN
2018/07/01 O NOUN
00:00 O NOUN
[accepted] O ADV

We O PRON
observed O VERB
a O DET
significant O ADJ
decrease O NOUN
in O ADP
absolute O ADJ
hepatic B-outcome ADJ
fat I-outcome NOUN
fraction I-outcome NOUN
in O ADP
the O DET
group O NOUN
receiving O VERB
10 O NUM
mg O NOUN
pegbelfermin O NOUN
daily O ADJ
(-6.8% O PUNCT
vs O CCONJ
-1.3%; O NOUN
p=0.0004) O ADV
and O CCONJ
in O ADP
the O DET
group O NOUN
receiving O VERB
20 O NUM
mg O NOUN
pegbelfermin O NOUN
weekly O ADV
(-5.2% O NUM
vs O CCONJ
-1.3%; O NOUN
p=0.008) O NUM
compared O VERB
with O ADP
the O DET
placebo O NOUN
group. O VERB

BACKGROUND: O NOUN
and O CCONJ
purpose: O NOUN
Different O ADJ
in O ADP
vitro O ADV
studies O NOUN
have O VERB
reported O VERB
the O DET
antimicrobial O ADJ
effects O NOUN
of O ADP
green O ADV
tea O NOUN
catechins O NOUN
and O CCONJ
also O ADV
their O ADJ
synergistic O ADJ
effects O NOUN
with O ADP
trimethoprim-sulfamethoxazole O NOUN
against O ADP
E. O NOUN
coli. O NOUN

These O DET
findings O NOUN
do O VERB
not O ADV
support O NOUN
the O DET
use O NOUN
of O ADP
this O DET
psychological O ADJ
intervention. O NOUN

There O PRON
was O VERB
no O DET
difference O NOUN
for O ADP
compression B-outcome NOUN
rate O NOUN
or O CCONJ
recoil B-outcome NOUN
between O ADP
groups. O NOUN

The O DET
participants O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
received O VERB
lactulose, O NOUN
while O ADP
the O DET
subjects O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
received O VERB
placebo O NOUN
intervention. O NOUN

CONCLUSIONS: O NOUN
Lacunar O ADV
infarction O NOUN
of O ADP
SAI O NOUN
have O VERB
lower O ADJ
risk O NOUN
of O ADP
stroke B-outcome NOUN
recurrence O NOUN
than O ADP
MAIs, O ADP
while O ADP
non-lacunar O NOUN
infarction O NOUN
of O ADP
SAI O NOUN
might O VERB
have O VERB
similar O ADJ
risk O NOUN
as O ADP
MAIs. O NOUN

METHODS: O NOUN
The O DET
SHAPE-2 O NOUN
study O NOUN
is O VERB
a O DET
three-armed O VERB
randomised O VERB
controlled O VERB
trial O NOUN
conducted O VERB
in O ADP
2012-2013 O NUM
in O ADP
the O DET
Netherlands. O NOUN

Title: O NOUN
A O DET
randomized O VERB
comparative O ADJ
study O NOUN
between O ADP
intravenous O ADJ
and O CCONJ
intramuscular O ADJ
scorpion O NOUN
antivenom O NOUN
regimens O NOUN
in O ADP
children. O NOUN

In O ADP
part O NOUN
A O DET
of O ADP
the O DET
trial, O NOUN
patients O NOUN
without O ADP
recent O ADJ
porphyria O NOUN
attacks O NOUN
(i.e., O PUNCT
no O DET
attacks O NOUN
in O ADP
the O DET
6 O NUM
months O NOUN
before O ADP
baseline) O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
a O DET
single O ADJ
subcutaneous O ADJ
injection O NOUN
of O ADP
one O NUM
of O ADP
five O NUM
ascending O VERB
doses O NOUN
of O ADP
givosiran O NOUN
(0.035, O NOUN
0.10, O NUM
0.35, O NUM
1.0, O NOUN
or O CCONJ
2.5 O NUM
mg O NOUN
per O ADP
kilogram O NOUN
of O ADP
body O NOUN
weight) O VERB
or O CCONJ
placebo. O NOUN

RESULTS: O NOUN
Both O CCONJ
the O DET
ALS O NOUN
and O CCONJ
control O NOUN
group O NOUN
(CG) O NOUN
showed O VERB
better O ADJ
performance B-outcome NOUN
on O ADP
the O DET
computer O NOUN
task O NOUN
when O ADP
using O VERB
the O DET
touchscreen O NUM
device, O NOUN
but O CCONJ
there O PRON
was O VERB
limited O VERB
transfer B-outcome NOUN
of O ADP
performance O NOUN
onto O ADP
the O DET
task O NOUN
performed O VERB
on O ADP
the O DET
Finger O NOUN
Motion O NOUN
control O NOUN
or O CCONJ
motion O NOUN
tracking. O NOUN

The O DET
sample O NOUN
had O VERB
180 O NUM
individuals O NOUN
with O ADP
a O DET
pattern O NOUN
of O ADP
hazardous O ADJ
or O CCONJ
harmful O ADJ
alcohol O NOUN
use, O NOUN
recruited O VERB
in O ADP
a O DET
Basic O ADJ
Health O NOUN
Unit O NOUN
in O ADP
the O DET
city O NOUN
of O ADP
Sao O NOUN
Paulo. O NOUN

All O DET
patients O NOUN
had O VERB
intravenous O ADJ
patient-controlled O VERB
analgesia O NOUN
(PCA) O PUNCT
with O ADP
10 O NUM
mug/kg O NOUN
of O ADP
fentanyl O NOUN
for O ADP
48 O NUM
hours. O DET

Compared O VERB
with O ADP
those O DET
in O ADP
the O DET
rhodiola O NOUN
treatment O NOUN
group, O NOUN
Self-rating O VERB
depression B-outcome NOUN
scale O NOUN
(SDS) O PUNCT
and O CCONJ
self-rating O VERB
anxiety B-outcome NOUN
scale O NOUN
SAS O NUM
scores O NOUN
of O ADP
patients O NOUN
in O ADP
the O DET
rhodiola+non-invasive O ADJ
breathing O VERB
group O NOUN
decreased O VERB
after O ADP
treatment O NOUN
P<0.05. O NOUN

RESULTS: O NOUN
Better O ADJ
scores O NOUN
were O VERB
observed O VERB
with O ADP
the O DET
forearm O NOUN
band, O NOUN
as O ADP
compared O VERB
with O ADP
no O DET
orthosis, O NUM
for O ADP
multiple O ADJ
outcomes O NOUN
including O VERB
joint B-outcome NOUN
position I-outcome NOUN
reproduction I-outcome NOUN
score O NOUN
at O ADP
70 O NUM
degrees O NOUN
of O ADP
elbow O NOUN
flexion O NOUN
(P O NUM
= O SYM
.006), O PUNCT
pain B-outcome NOUN
(P O NUM
< O SYM
.001), O PUNCT
grip B-outcome NOUN
strength I-outcome NOUN
(P O NUM
= O SYM
.01), O PUNCT
and O CCONJ
dexterity B-outcome NOUN
(P O NUM
< O SYM
.001). O PUNCT

Pain B-outcome NOUN
severity I-outcome NOUN
and O CCONJ
adverse B-outcome ADJ
effects I-outcome NOUN
were O VERB
evaluated O VERB
too. O NOUN

The O DET
number O NOUN
needed O VERB
to O PART
treat O NOUN
to O PART
avert O NOUN
one O NUM
death B-outcome NOUN
from I-outcome ADP
any Seperator DET
cause I-outcome ADP
was O VERB
8.4. O NOUN

Thus, O NOUN
branched-chain O NOUN
amino O ADJ
acids O NOUN
may, O NOUN
at O ADP
least O ADV
in O ADP
part, O NOUN
mediate O VERB
the O DET
effects O NOUN
of O ADP
whey O NOUN
to O PART
reduce O VERB
energy O NOUN
intake O NOUN
and/or O CCONJ
blood O NOUN
glucose. O NOUN

RESULTS: O NOUN
After O ADP
treatment, O NOUN
NES O NOUN
showed O VERB
greater O ADJ
effectiveness O NOUN
in O ADP
reducing O VERB
the O DET
severity O NOUN
of O ADP
nausea B-outcome NOUN
(P O NUM
= O SYM
.02), O PUNCT
and O CCONJ
vomiting B-outcome VERB
(P O NUM
= O SYM
.04), O NOUN
as O ADP
well O ADV
as O ADP
the O DET
appetite B-outcome NOUN
improvement O NOUN
(P O NUM
= O SYM
.02), O PUNCT
compared O VERB
with O ADP
the O DET
sham O NOUN
NES. O NOUN

BACKGROUND: O NOUN
Maintenance O NOUN
therapy O NOUN
following O VERB
autologous O ADJ
stem O NOUN
cell O NOUN
transplantation O NOUN
(ASCT) O PUNCT
can O VERB
delay O NOUN
disease O NOUN
progression O NOUN
and O CCONJ
prolong O NOUN
survival O NOUN
in O ADP
patients O NOUN
with O ADP
multiple O ADJ
myeloma. O ADV

Journal O ADJ
ID: O NOUN
0255562 O NUM

Journal-Name:Nan O NOUN
fang O NOUN
yi O ADP
ke O NOUN
da O NOUN
xue O NOUN
xue O NOUN
bao O NOUN
= O SYM
Journal O ADJ
of O ADP
Southern O NOUN
Medical O ADJ
University O NOUN

There O PRON
were O VERB
5 O NUM
cases O NOUN
of O ADP
"shell" B-outcome NOUN
phenomenon I-outcome NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
and O CCONJ
4 O NUM
cases O NOUN
of O ADP
nonunion B-outcome NOUN
at O ADP
last O NOUN
follow-up, O ADP
23 O NUM
cases O NOUN
of O ADP
"shell" B-outcome NOUN
phenomenon I-outcome NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
and O CCONJ
19 O NUM
cases O NOUN
of O ADP
nonunion B-outcome NOUN
at O ADP
last O NOUN
follow-up; O ADP
there O PRON
was O VERB
a O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
( O PUNCT
P<0.05). O NOUN

Title: O NOUN
Novel O ADJ
Tretinoin O NOUN
0.05% O NUM
Lotion O NOUN
for O ADP
Once-Daily O NOUN
Treatment O NOUN
of O ADP
Moderate-to-Severe O NOUN
Acne O NOUN
Vulgaris O NOUN
in O ADP
a O DET
Hispanic O ADJ
Population O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
date: O NOUN
2019/01/29 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2018/12/15 O NOUN
06:00 O ADP
[entrez] O ADP

Conclusion O NOUN
Intra-articular O ADJ
injection O NOUN
of O ADP
Triamcinolone O NOUN
acetenoid O NOUN
is O VERB
effective O ADJ
in O ADP
symptoms B-outcome NOUN
control I-outcome NOUN
and O CCONJ
improving O VERB
functional B-outcome ADJ
outcome O NOUN
in O ADP
clinically O ADV
diagnosed O VERB
osteoarthritis O NOUN
of O ADP
knees O NOUN
in O ADP
community O NOUN
set O NOUN
up O ADP
during O ADP
health O NOUN
camps. O NOUN

Title: O NOUN
Single O NOUN
Patient O NOUN
Classifier O NOUN
Assay, O NOUN
Microsatellite O NOUN
Instability, O ADJ
and O CCONJ
Epstein-Barr O NOUN
Virus O NOUN
Status O NOUN
Predict O NOUN
Clinical O ADJ
Outcomes O NOUN
in O ADP
Stage O NOUN
II/III O NOUN
Gastric O ADJ
Cancer: O NOUN
Results O NOUN
from O ADP
CLASSIC O ADJ
Trial. O NOUN

The O DET
time B-outcome NOUN
to I-outcome PART
achieve I-outcome NOUN
1-lung I-outcome ADV
ventilation I-outcome NOUN
with O ADP
the O DET
VDT O NOUN
was O VERB
58.5 O NUM
+/- O SYM
21.5 O NUM
(mean O NUM
+/- O SYM
SD) O NOUN
seconds, O NOUN
the O DET
VST O NOUN
was O VERB
38.2 O NUM
+/- O SYM
10.1 O NUM
(mean O NUM
+/- O SYM
SD) O NOUN
seconds, O NOUN
and O CCONJ
the O DET
DT O NOUN
group O NOUN
was O VERB
195.5 O NUM
+/- O SYM
40.3 O NUM
(mean O NUM
+/- O SYM
SD) O NOUN
seconds. O NOUN

All O DET
patients O NOUN
received O VERB
3 O NUM
sessions O NOUN
per O ADP
week O NOUN
of O ADP
SPT O NOUN
for O ADP
8 O NUM
weeks. O NOUN

The O DET
effectiveness O NOUN
is O VERB
satisfactory. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal O ADJ
ID: O NOUN
101213729 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

A O DET
total O ADJ
of O ADP
82 O NUM
older O ADJ
adults O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
3 O NUM
groups: O NOUN
a O DET
HIIT O NOUN
group O NOUN
(n=28), O NOUN
a O DET
continuous O ADJ
intensity O NOUN
training O VERB
group O NOUN
(MIIT O NOUN
group, O NOUN
n=27), O NOUN
or O CCONJ
a O DET
control O NOUN
group O NOUN
(CG, O NOUN
n=27). O NOUN

Funded O VERB
by O ADP
the O DET
Department O NOUN
of O ADP
Veterans O NOUN
Affairs O NOUN
Cooperative O ADJ
Studies O NOUN
Program; O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT01265550.). O NOUN

Journal-Name:Nan O NOUN
fang O NOUN
yi O ADP
ke O NOUN
da O NOUN
xue O NOUN
xue O NOUN
bao O NOUN
= O SYM
Journal O ADJ
of O ADP
Southern O NOUN
Medical O ADJ
University O NOUN

Publication O NOUN
date: O NOUN
2018/09/01 O NOUN
00:00 O NOUN
[accepted] O ADV

Participants O NOUN
underwent O VERB
anxiety B-outcome NOUN
and O CCONJ
depression B-outcome NOUN
evaluation, O NOUN
as O ADP
well O ADV
as O ADP
measurements O NOUN
of O ADP
the O DET
intervals B-outcome NOUN
between Seperator ADP
consecutive I-outcome ADJ
heartbeats I-outcome NOUN
or O CCONJ
RR B-outcome NOUN
intervals I-outcome NOUN
for O ADP
the O DET
analysis O NOUN
of O ADP
HRV B-outcome NOUN
at O ADP
the O DET
first O ADV
and O CCONJ
the O DET
last O NOUN
weeks O NOUN
of O ADP
hospitalization O NOUN
of O ADP
their O ADJ
preterms. O NOUN

The O DET
therapeutic O ADJ
benefits O NOUN
of O ADP
LOWFODMAP O NOUN
diets O NOUN
in O ADP
recreational O ADJ
and O CCONJ
trained O VERB
athletes O NOUN
during O ADP
sustained O VERB
training O VERB
periods O NOUN
warrants O NOUN
further O ADV
investigation. O NOUN

Journal-Name:JSLS O NOUN
: O PUNCT
Journal O ADJ
of O ADP
the O DET
Society O NOUN
of O ADP
Laparoendoscopic O ADJ
Surgeons O NOUN

Publication O NOUN
date: O NOUN
2019/01/01 O NOUN
06:00 O ADP
[medline] O NOUN

When O ADP
the O DET
endometrium B-outcome NOUN
thickness I-outcome NOUN
reached O VERB
>/=7 O ADJ
mm, O NOUN
embryo O NOUN
transfer O NOUN
was O VERB
done. O NOUN

OBJECTIVE: O NOUN
To O PART
test O NOUN
the O DET
efficacy O NOUN
of O ADP
Gua O NOUN
Sha O NOUN
therapy O NOUN
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain. O NOUN

Publication O NOUN
date: O NOUN
2019/02/27 O NOUN
06:00 O ADP
[medline] O NOUN

BACKGROUND: O NOUN
Mental O ADJ
health O NOUN
disorders O NOUN
among O ADP
adolescents O NOUN
have O VERB
emerged O VERB
as O ADP
a O DET
major O ADJ
public O ADJ
health O NOUN
issue O NOUN
in O ADP
many O DET
low O ADJ
and O CCONJ
middle-income O NOUN
countries, O NOUN
including O VERB
India. O NOUN

LESSONS O NOUN
LEARNED: O NOUN
It O PRON
is O VERB
feasible O ADJ
to O PART
engage O NOUN
and O CCONJ
maintain O NOUN
a O DET
network O NOUN
of O ADP
CBOs O NOUN
linked O VERB
with O ADP
a O DET
local O ADJ
health O NOUN
system. O NOUN

RESULTS: O NOUN
The O DET
Numeric O ADJ
rating O VERB
scale O NOUN
of O ADP
group O NOUN
O O NOUN
in O ADP
the O DET
PACU O NOUN
was O VERB
significantly O ADV
lower O ADJ
(P O NUM
<.05); O NOUN
fewer O ADJ
patients O NOUN
in O ADP
group O NOUN
O O NOUN
required O VERB
additional O ADJ
fentanyl B-outcome NOUN
boluses I-outcome NOUN
in O ADP
the O DET
PACU O NOUN
(P O NUM
<.05). O NOUN

BACKGROUND: O NOUN
Treatment O NOUN
of O ADP
Plasmodium O NOUN
vivax O NOUN
malaria O NOUN
requires O NOUN
the O DET
clearing O VERB
of O ADP
asexual O ADJ
parasites, O NOUN
but O CCONJ
relapse O NOUN
can O VERB
be O VERB
prevented O VERB
only O ADV
if O ADP
dormant O ADJ
hypnozoites O NOUN
are O VERB
cleared O VERB
from O ADP
the O DET
liver O NOUN
(a O PUNCT
treatment O NOUN
termed O VERB
"radical O ADJ
cure"). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal O ADJ
ID: O NOUN
101303164 O NUM

Patient O NOUN
survival O NOUN
of O ADP
SPC-prognosis O NOUN
was O VERB
well O ADV
stratified O VERB
regardless O ADV
of O ADP
EBV O NOUN
status O NOUN
and O CCONJ
in O ADP
microsatellite O NOUN
stable O ADJ
(MSS) O PUNCT
group, O NOUN
but O CCONJ
not O ADV
in O ADP
MSI-high O NOUN
group. O VERB

Appropriate O ADJ
interim O ADJ
analyses O NOUN
will O VERB
be O VERB
conducted O VERB
by O ADP
a O DET
data O NOUN
monitoring O VERB
and O CCONJ
ethics O NOUN
committee O NOUN
(DMEC), O PUNCT
and O CCONJ
the O DET
final O ADJ
test O NOUN
will O VERB
be O VERB
an O DET
intention-to-treat O NOUN
analysis. O NOUN

Title: O NOUN
Resin-modified O VERB
glass O NOUN
ionomer O NOUN
cement O NOUN
vs O CCONJ
composite O NOUN
for O ADP
orthodontic O ADJ
bonding: O NOUN
A O DET
multicenter, O NOUN
single-blind, O NOUN
randomized O VERB
controlled O VERB
trial. O NOUN

BACKGROUND: O NOUN
Head O NOUN
to O PART
head O NOUN
trials O NOUN
of O ADP
clinical O ADJ
outcomes O NOUN
of O ADP
sirolimus O NOUN
eluting O VERB
polymer O NOUN
free O ADJ
vs. O CCONJ
biodegradable O ADJ
polymer O NOUN
stents O NOUN
are O VERB
lacking. O NOUN

Publication O NOUN
Type: O NOUN
Equivalence O NOUN
Trial O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Exhausted O VERB
cluster O NOUN
of O ADP
differentiation O NOUN
(CD)8+ O NOUN
T O NOUN
cells O NOUN
lose O NOUN
immunological O ADJ
activity O NOUN
due O ADJ
to O PART
mitochondrial O ADJ
dysfunction O NOUN
caused O VERB
by O ADP
peroxisome O NOUN
proliferatoractivated O VERB
receptor O NOUN
gamma O NOUN
coactivator O NOUN
1alpha O NOUN
(PGC1alpha) O NOUN
inactivation, O NOUN
resulting O VERB
in O ADP
a O DET
poor O ADJ
prognosis O NOUN
in O ADP
patients O NOUN
with O ADP
cancer. O NOUN

PURPOSE: O NOUN
Trachoma, O ADP
caused O VERB
by O ADP
repeated O VERB
ocular O ADJ
infection O NOUN
with O ADP
Chlamydia O NOUN
trachomatis, O NOUN
is O VERB
the O DET
leading O VERB
infectious O ADJ
cause O ADP
of O ADP
blindness O NOUN
worldwide O ADJ
and O CCONJ
is O VERB
targeted O VERB
for O ADP
elimination O NOUN
as O ADP
a O DET
public O ADJ
health O NOUN
problem. O NOUN

Secondary O ADJ
objectives O NOUN
were O VERB
to O PART
compare O NOUN
the O DET
effects O NOUN
of O ADP
atorvastatin O NOUN
40mg O NOUN
vs O CCONJ
80mg O NOUN
on O ADP
HDL-C B-outcome NOUN
and O CCONJ
triglycerides B-outcome NOUN
and O CCONJ
also O ADV
comparing O VERB
of O ADP
side B-outcome NOUN
effects I-outcome NOUN
( O PUNCT
myopathy B-outcome NOUN
, O PUNCT
hepatotoxicity B-outcome NOUN
and O CCONJ
new B-outcome ADJ
onset I-outcome NOUN
diabetes I-outcome NOUN
mellitus I-outcome NOUN
) O PUNCT
of O ADP
both O CCONJ
doses. O NOUN

2015;35(3): O NUM
R17-R34). O NOUN

CONCLUSIONS: O NOUN
The O DET
main O ADJ
finding O VERB
of O ADP
the O DET
study O NOUN
is O VERB
that O ADP
CAF O NOUN
ingestion O NOUN
increases O NOUN
movement B-outcome NOUN
velocity I-outcome NOUN
of O ADP
the O DET
bar O CCONJ
in O ADP
the O DET
eccentric O ADJ
phase O NOUN
of O ADP
the O DET
movement, O NOUN
what O DET
results O NOUN
in O ADP
shortening O VERB
of O ADP
the O DET
time B-outcome NOUN
under Seperator ADP
tension I-outcome NOUN
(TUT) I-outcome PUNCT
needed O VERB
for O ADP
performing O VERB
a O DET
specific O ADJ
number O NOUN
of O ADP
repetitions, O NOUN
without O ADP
decreasing O VERB
power B-outcome NOUN
and O CCONJ
velocity B-outcome NOUN
in O ADP
the O DET
CON O NOUN
phase O NOUN
of O ADP
the O DET
movement. O NOUN

J O NOUN
Drugs O NOUN
Dermatol. O NOUN

Results: O NOUN
Among O ADP
559 O NUM
randomized O VERB
participants O NOUN
(mean O NUM
age, O NOUN
67 O NUM
years; O NOUN
277 O NUM
[50%] O NUM
women), O NOUN
556 O NUM
(99.5%) O NOUN
completed O VERB
the O DET
trial O NOUN
and O CCONJ
were O VERB
included O VERB
in O ADP
the O DET
analysis. O NOUN

The O DET
mean O NOUN
blood B-outcome NOUN
pressure I-outcome NOUN
(MBP), O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
SpO2 B-outcome NOUN
, O PUNCT
Observer's O NOUN
Assessment O NOUN
of O ADP
Alertness B-outcome ADP
/ O SYM
Sedation B-outcome NOUN
(OAA/S)], O NOUN
and O CCONJ
the O DET
indicators O NOUN
of O ADP
psychological B-outcome ADJ
stress I-outcome NOUN
of O ADP
brain O NOUN
functional O ADJ
state O NOUN
of O ADP
the O DET
patients O NOUN
(including O PUNCT
the O DET
wavelet B-outcome NOUN
index O NOUN
[WLi], O NOUN
anxiety B-outcome NOUN
index O NOUN
[ANXi], O NOUN
comfortable B-outcome ADJ
index O NOUN
[CFi] O PUNCT
and O CCONJ
pain B-outcome NOUN
index O NOUN
[Pi]) O NOUN
were O VERB
recorded O VERB
at O ADP
5 O NUM
min O NOUN
after O ADP
entering O VERB
the O DET
operating O VERB
room O NOUN
(T0), O PUNCT
at O ADP
the O DET
time O NOUN
of O ADP
lumbar O ADJ
puncture O NOUN
(T1) O NOUN
and O CCONJ
change O NOUN
to O PART
supine O NOUN
position O NOUN
after O ADP
the O DET
puncture O NOUN
(T2), O PUNCT
at O ADP
20 O NUM
s O NOUN
(T3), O PUNCT
40 O NUM
s O NOUN
(T4), O PUNCT
and O CCONJ
60 O NUM
s O NOUN
(T5) O NUM
after O ADP
intravenous O ADJ
administration, O NOUN
and O CCONJ
at O ADP
2 O NUM
min O NOUN
(T6), O PUNCT
4 O NUM
min O NOUN
(T5), O PUNCT
6 O NUM
min O NOUN
(T8), O PUNCT
8 O NUM
min O NOUN
(T9), O PUNCT
10 O NUM
min O NOUN
(T10) O NUM
and O CCONJ
40 O NUM
min O NOUN
(T11) O ADP
after O ADP
skin O NOUN
incision. O ADV

Repeated-measures O NOUN
ANOVA O NOUN
with O ADP
group O NOUN
factor O NOUN
(GC O NOUN
and O CCONJ
GVD3) O NOUN
were O VERB
used O VERB
to O PART
examine O NOUN
if O ADP
the O DET
interaction O NOUN
of O ADP
the O DET
different O ADJ
values O NOUN
was O VERB
the O DET
same O ADJ
or O CCONJ
different O ADJ
between O ADP
the O DET
groups O NOUN
throughout O ADV
the O DET
study O NOUN
(time O NOUN
x O SYM
group) O ADJ
after O ADP
vitamin O NOUN
D3 O NOUN
treatment. O NOUN

This O DET
study O NOUN
was O VERB
conducted O VERB
to O PART
evaluate O VERB
the O DET
Effectiveness O NOUN
of O ADP
Mindfulness-Based O VERB
Cognitive O ADJ
Therapy O NOUN
(MBCT) O NUM
on O ADP
the O DET
Illness B-outcome NOUN
Perception I-outcome NOUN
(IP) I-outcome NOUN
and O CCONJ
Psychological B-outcome ADJ
Symptoms I-outcome NOUN
(PS) I-outcome NOUN
for O ADP
Patients O NOUN
in O ADP
primary O ADJ
care O NOUN
with O ADP
an O DET
active O ADJ
symptom O NOUN
of O ADP
Rheumatoid O NOUN
Arthritis O NOUN
(RA). O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
the O DET
long-term O NOUN
efficacy O NOUN
of O ADP
tenofovir O NOUN
and O CCONJ
entecavir O NOUN
in O ADP
nucleos(t)ide O NOUN
analogue-naive O ADJ
HBeAg-positive O ADJ
patients O NOUN
with O ADP
chronic O ADJ
hepatitis O NOUN
B: O NOUN
A O DET
large, O ADV
multicentre, O NOUN
randomized O VERB
controlled O VERB
trials. O NOUN

RESULTS: O NOUN
menthol O NOUN
chewing O VERB
gum O NOUN
significantly O ADV
reduced O VERB
the O DET
intensity O NOUN
(p O PUNCT
<0.001), O NOUN
with O ADP
Cohen's O NOUN
medium-effect O NOUN
d, O NOUN
and O CCONJ
thirst B-outcome ADV
discomfort I-outcome NOUN
(p O PUNCT
<0.001), O NOUN
with O ADP
a O DET
large-effect O NOUN
Cohen's O NOUN
d. O NOUN
CONCLUSION: O NOUN
menthol O NOUN
chewing O VERB
gum O NOUN
was O VERB
effective O ADJ
in O ADP
reducing O VERB
the O DET
intensity B-outcome NOUN
and Seperator CCONJ
discomfort B-outcome NOUN
of I-outcome ADP
preoperative I-outcome ADJ
thirst E3-outcome ADV
. O PUNCT
The O DET
strategy O NOUN
proved O VERB
to O PART
be O VERB
an O DET
innovative, O NOUN
feasible B-outcome ADJ
and O CCONJ
safe O ADJ
option O NOUN
in O ADP
the O DET
use O NOUN
for O ADP
the O DET
surgical O ADJ
patient, O NOUN
in O ADP
the O DET
management O NOUN
of O ADP
the O DET
preoperative O ADJ
thirst, O NOUN
in O ADP
elective O ADJ
surgeries. O NUM

Also O ADV
the O DET
frequency O NOUN
of O ADP
the O DET
troponin B-outcome NOUN
increase O NOUN
above O ADP
the O DET
UNL(upper O ADP
normal O ADJ
level) O NOUN
in O ADP
the O DET
nicorandal O ADJ
group, O NOUN
was O VERB
significantly O ADV
(p O PUNCT
= O SYM
0.03) O NUM
lower O ADJ
(in O NUM
62% O NUM
of O ADP
cases O NOUN
compared O VERB
to O PART
85% O NOUN
of O ADP
the O DET
control O NOUN
group). O NOUN

Title: O NOUN
"We O NOUN
have O VERB
to O PART
clean O NOUN
ourselves O NOUN
to O PART
ensure O NOUN
that O ADP
our O ADJ
children O NOUN
are O VERB
healthy O ADJ
and O CCONJ
beautiful": O ADJ
findings O NOUN
from O ADP
a O DET
qualitative O ADJ
assessment O NOUN
of O ADP
a O DET
hand O NOUN
hygiene O NOUN
poster O NOUN
in O ADP
rural O ADJ
Uganda. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

METHODS: O NOUN
In O ADP
a O DET
prospective O ADJ
randomized O VERB
contralateral O ADJ
eye O NOUN
study O NOUN
of O ADP
LASIK O NOUN
versus O CCONJ
SMILE O NOUN
procedures, O NOUN
21 O NUM
consecutive O ADJ
patients O NOUN
(42 O VERB
eyes) O NOUN
were O VERB
evaluated O VERB
with O ADP
corneal O ADJ
epithelial O ADJ
mapping O VERB
by O ADP
anterior O ADJ
segment O NOUN
optical O ADJ
coherence O NOUN
tomography O NOUN
for O ADP
up O ADP
to O PART
2 O NUM
years. O NOUN

The O DET
subjects O NOUN
in O ADP
D1 O NOUN
and O CCONJ
D2 O NOUN
groups O NOUN
must O VERB
consume O NOUN
the O DET
congee O ADP
containing O VERB
the O DET
combined O VERB
extract O NOUN
of O ADP
M. O NOUN
alba O NOUN
and O CCONJ
P. O NOUN
odoratum O NOUN
leaves O NOUN
at O ADP
doses O NOUN
of O ADP
50 O NUM
and O CCONJ
1500 O NUM
mg/day, O NOUN
respectively. O NOUN

Single-step O NUM
advancement O ADJ
was O VERB
achieved O NOUN
in O ADP
the O DET
MA O NOUN
group O NOUN
until O ADP
an O DET
edge-to-edge O NOUN
incisor O NOUN
relationship O NOUN
or O CCONJ
an O DET
overcorrected O VERB
Class O NOUN
I O NUM
molar O ADJ
relationship O NOUN
was O VERB
obtained. O NOUN

Publication O NOUN
date: O NOUN
2019/01/22 O ADJ
06:00 O ADP
[medline] O NOUN

Respiratory O ADJ
mechanical O ADJ
indices O NOUN
[ O PUNCT
peak B-outcome NOUN
airway I-outcome NOUN
pressure I-outcome NOUN
(Ppeak) I-outcome ADP
, O PUNCT
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
(VTi) I-outcome NOUN
, O PUNCT
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
(VTe) I-outcome NOUN
were O VERB
recorded O VERB
before O ADP
atomization O NOUN
(atomized O VERB
oxygen O NOUN
flow O NOUN
was O VERB
0) O NOUN
and O CCONJ
10 O NUM
minutes O NOUN
after O ADP
the O DET
beginning O VERB
of O ADP
atomization O NOUN
under O ADP
the O DET
condition O NOUN
of O ADP
7 O NUM
L/min O NOUN
and O CCONJ
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow O NOUN
respectively. O NOUN
( O PUNCT

RESULTS: O NOUN
Among O ADP
all O DET
the O DET
250 O NUM
patients O NOUN
examined O VERB
156 O NUM
women O NOUN
were O VERB
eligible O ADJ
for O ADP
study O NOUN
and O CCONJ
finally O ADV
120 O NUM
patients O NOUN
were O VERB
allocated O VERB
to O PART
intervention O NOUN
(n O NOUN
= O SYM
60) O ADP
and O CCONJ
control O NOUN
(n O NOUN
= O SYM
60) O ADP
groups. O NOUN

The O DET
between-group O NOUN
difference O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
was O VERB
not O ADV
significant O ADJ
(146 O PUNCT
of O ADP
527 O NUM
participants O NOUN
[27.7%] O NOUN
in O ADP
the O DET
intravenous O ADJ
group O NOUN
and O CCONJ
138 O NUM
of O ADP
527 O NUM
[26.2%] O NOUN
in O ADP
the O DET
oral O ADJ
group; O ADJ
P=0.58). O NOUN

TRIAL O NOUN
REGISTRATION O NOUN
NUMBER: O NOUN
www.clinicaltrials.gov O NOUN
NCT02011958. O NOUN

Data O NOUN
collection O NOUN
instruments O NOUN
consisted O VERB
of O ADP
demographic O ADJ
information O NOUN
and O CCONJ
Strategies O NOUN
Used O VERB
by O ADP
People O NOUN
to O PART
Promote O NOUN
Health O NOUN
questionnaires. O ADP

Journal-Name:Zhongguo O NOUN
fei O ADV
ai O NOUN
za O ADP
zhi O NUM
= O SYM
Chinese O NOUN
journal O ADJ
of O ADP
lung O NOUN
cancer O NOUN

MAIN O ADJ
OUTCOME O NOUN
MEASURES: O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
Roland-Morris O NOUN
Disability B-outcome NOUN
Questionnaire O PROPN
(RMDQ) O NOUN
score O NOUN
(range O PUNCT
0-24) O NOUN
at O ADP
one O NUM
year O NOUN
follow-up O NOUN
in O ADP
the O DET
intention O NOUN
to O PART
treat O NOUN
population. O ADV

PMID: O NOUN
31609293 O NUM

BACKGROUND: O NOUN
The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
analyze O NOUN
the O DET
response O NOUN
of O ADP
selected O VERB
components O NOUN
of O ADP
the O DET
immune O ADJ
system O NOUN
in O ADP
rowers O NOUN
to O PART
maximal O ADJ
physical O ADJ
exercise, O NOUN
and O CCONJ
to O PART
verify O NOUN
if O ADP
this O DET
response O NOUN
could O VERB
be O VERB
modulated O VERB
by O ADP
supplementation O NOUN
with O ADP
L-theanine. O NUM

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

This O DET
trial O NOUN
is O VERB
registered O VERB
with O ADP
NCT03288623. O NOUN

The O DET
appointment O ADJ
of O ADP
the O DET
oral O ADJ
form O NOUN
of O ADP
nicorandil O NOUN
(Cordinic, O PUNCT
PIQ-FHARMA O NOUN
LLC) O NOUN
for O ADP
2 O NUM
days O NOUN
and O CCONJ
1 O NUM
day O NOUN
before O ADP
PCI O NOUN
30 O NUM
mg/day, O NOUN
then O ADV
20 O NUM
mg O NOUN
2 O NUM
hours O NOUN
before O ADP
the O DET
PCI O NOUN
and O CCONJ
10 O NUM
mg O NOUN
after O ADP
6 O NUM
hours O NOUN
after O ADP
the O DET
surgery O NOUN
reduces O NOUN
the O DET
risk O NOUN
of O ADP
intraoperative O ADJ
myocardial B-outcome ADJ
damage I-outcome NOUN
. O PUNCT
The O DET
obtained O VERB
data O NOUN
give O ADJ
an O DET
opportunity O NOUN
to O PART
extend O NOUN
the O DET
indications O NOUN
for O ADP
nicorandil's O NOUN
appointment O ADJ
in O ADP
the O DET
drug O NOUN
support O NOUN
during O ADP
PCI O NOUN
in O ADP
patients O NOUN
with O ADP
stable O ADJ
coronary O ADJ
artery O NOUN
disease. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

However, O ADV
individuals O NOUN
who O ADP
met O VERB
in-person O NOUN
with O ADP
a O DET
faculty O NOUN
member O NOUN
rated O VERB
effectiveness O NOUN
of O ADP
communication B-outcome NOUN
higher O ADJ
than O ADP
those O DET
who O ADP
met O VERB
via O ADP
videoconference O NOUN
(p=0.0002), O PUNCT
while O ADP
those O DET
who O ADP
met O VERB
online O ADP
rated O VERB
convenience B-outcome NOUN
higher O ADJ
than O ADP
those O DET
who O ADP
met O VERB
in-person O NOUN
(p<0.0001). O PUNCT

There O PRON
was O VERB
not O ADV
significantly O ADV
different O ADJ
in O ADP
the O DET
patient O NOUN
satisfaction B-outcome NOUN
of O ADP
analgesia, O NOUN
incidence O NOUN
of O ADP
side B-outcome NOUN
effects I-outcome NOUN
, O PUNCT
neonatal B-outcome ADJ
outcomes O NOUN
and O CCONJ
neurological B-outcome ADJ
deficit I-outcome ADP
between O ADP
the O DET
2 O NUM
groups. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHOD: O NOUN
Thirty O NUM
individuals O NOUN
with O ADP
ALS O NOUN
(18 O NOUN
men O NOUN
and O CCONJ
12 O NUM
women, O NOUN
mean O NOUN
age O NOUN
59 O NUM
years, O NOUN
range O NOUN
44-74 O NUM
years) O NOUN
with O ADP
a O DET
mean O NOUN
score O NOUN
of O ADP
26, O NUM
(minimum O NUM
score O NOUN
of O ADP
14 O NUM
and O CCONJ
maximum O NOUN
41) O NOUN
on O ADP
the O DET
Revised O VERB
Amyotrophic O ADJ
Lateral O ADJ
Sclerosis O NOUN
Functional O ADJ
Rating O VERB
Scale O NOUN
(ALSFRS-R) O NUM
and O CCONJ
30 O NUM
healthy O ADJ
controls O NOUN
matched O VERB
for O ADP
age O NOUN
and O CCONJ
gender, O NOUN
participated. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

At O ADP
+25d, O NUM
post-exercise O NOUN
heart B-outcome NOUN
rate I-outcome NOUN
(p=0.01) O PUNCT
and O CCONJ
physiological B-outcome ADJ
strain I-outcome NOUN
index O NOUN
(p<0.05) O NOUN
but O CCONJ
neither O CCONJ
Tre B-outcome PUNCT
(p=0.18) O NOUN
nor O CCONJ
sweat B-outcome NOUN
rate O NOUN
(p=0.44) O NOUN
were O VERB
lower O ADJ
in O ADP
IHE O NOUN
vs. O CCONJ
CON. O NOUN

Sixty O NUM
patients, O NOUN
aged O VERB
50-70, O NOUN
undergoing O VERB
elective O ADJ
surgery O NOUN
for O ADP
unilateral O ADJ
lower O ADJ
extremity O NOUN
varicose O ADJ
vein O NOUN
at O ADP
Ningbo O NOUN
No.2 O NOUN
Hospital, O ADJ
with O ADP
American O ADJ
Society O NOUN
of O ADP
Anesthesiologists O NOUN
(ASA) O NOUN
grade O NOUN
or O CCONJ
, O PUNCT
were O VERB
enrolled O VERB
and O CCONJ
randomly O ADV
allocated O VERB
to O PART
two O NUM
groups O NOUN
(n=30), O NOUN
general O ADJ
anesthesia O NOUN
group O NOUN
and O CCONJ
spinal O ADJ
anesthesia O NOUN
group. O VERB

A O DET
representative O ADJ
from O ADP
the O DET
municipality, O ADJ
the O DET
manager O NOUN
at O ADP
a O DET
home-care O NOUN
centre, O NOUN
the O DET
project O NOUN
manager O NOUN
of O ADP
the O DET
weight O NOUN
loss O NOUN
intervention O NOUN
and O CCONJ
six O NUM
health-care O NOUN
workers O NOUN
were O VERB
interviewed O VERB
at O ADP
the O DET
end O NOUN
of O ADP
a O DET
one-year O NOUN
weight O NOUN
loss O NOUN
intervention O NOUN
at O ADP
the O DET
workplace. O ADV

A O DET
total O ADJ
of O ADP
360 O NUM
patients O NOUN
were O VERB
required O VERB
after O ADP
considering O VERB
ineligible O ADJ
cases. O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

PMID: O NOUN
31597020 O NUM

Journal O ADJ
ID: O NOUN
101238455 O NUM

Funded O VERB
by O ADP
GlaxoSmithKline O NOUN
and O CCONJ
Medicines O NOUN
for O ADP
Malaria O NOUN
Venture; O NOUN
GATHER O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02216123 O NOUN
.). O NOUN

Journal-Name:Reproductive O ADJ
biology O NOUN
and O CCONJ
endocrinology O NOUN
: O PUNCT
RB&E O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Ginger O NOUN
and O CCONJ
Novafen O NOUN
on O ADP
menstrual B-outcome ADJ
pain I-outcome NOUN
: O PUNCT
A O DET
cross-over O NOUN
trial. O NOUN

Nausea B-outcome NOUN
scores O NOUN
at O ADP
the O DET
24th O ADJ
postoperative O ADJ
hour O NOUN
were O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
OSTAP O NOUN
group O NOUN
compared O VERB
with O ADP
the O DET
Sham O NOUN
group O NOUN
CONCLUSION:: O ADJ
We O PRON
concluded O VERB
that O ADP
bilateral O ADJ
US-guided O VERB
OSTAP O NOUN
blocks O NOUN
reduced O VERB
24th O ADJ
hour O NOUN
tramadol B-outcome NOUN
requirements O NOUN
and O CCONJ
VAS O NOUN
scores O NOUN
after O ADP
laparoscopic O ADJ
hysterectomy. O NOUN

Publication O NOUN
date: O NOUN
2019/02/19 O NOUN
00:00 O NOUN
[accepted] O ADV

A O DET
randomized, O NOUN
controlled O VERB
trial O NOUN
has O VERB
begun O NOUN
to O PART
compare O NOUN
neoadjuvant O ADJ
chemotherapy O NOUN
using O VERB
gemcitabine O NOUN
and O CCONJ
S-1 O NOUN
with O ADP
upfront O ADP
surgery O NOUN
for O ADP
patients O NOUN
planned O VERB
resection O NOUN
of O ADP
pancreatic O ADJ
cancer. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Comparing O VERB
the O DET
groups, O NOUN
the O DET
slow B-outcome ADJ
vital I-outcome ADJ
capacity I-outcome NOUN
(p=0.0027) O ADP
and O CCONJ
forced B-outcome VERB
vital I-outcome ADJ
capacity I-outcome NOUN
(p=0.0028) O NOUN
showed O VERB
a O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
treatments, O ADV
while O ADP
the O DET
PAR-G O NOUN
showed O VERB
smaller O ADJ
declines O NOUN
in O ADP
these O DET
capacities. O NUM

Journal O ADJ
ID: O NOUN
101627676 O NUM

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
pain B-outcome NOUN
intensity I-outcome NOUN
, O PUNCT
measured O VERB
by O ADP
the O DET
visual O ADJ
analog O NOUN
scale O NOUN
(VAS). O NOUN

Journal O ADJ
ID: O NOUN
101088661 O NUM

Results: O NOUN
One O NUM
month O NOUN
after O ADP
induction O NOUN
chemotherapy, O NOUN
the O DET
overall O ADJ
response B-outcome NOUN
rate O NOUN
was O VERB
96.7% O NUM
in O ADP
the O DET
CC O NOUN
group O NOUN
versus O CCONJ
73.3% O NUM
in O ADP
the O DET
RC O NOUN
group O NOUN
(P O NUM
= O SYM
0.011). O NUM

CONCLUSIONS: O NOUN
There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
survival B-outcome NOUN
without O ADP
moderate O ADJ
or O CCONJ
severe O ADJ
neurodevelopmental B-outcome ADJ
disability I-outcome NOUN
at O ADP
24 O NUM
months O NOUN
in O ADP
very O ADV
preterm O NOUN
or O CCONJ
very-low-birth-weight O NOUN
infants O NOUN
with O ADP
a O DET
strategy O NOUN
of O ADP
advancing O VERB
milk O NOUN
feeding O VERB
volumes O NOUN
in O ADP
daily O ADJ
increments O NOUN
of O ADP
30 O NUM
ml O NOUN
per O ADP
kilogram O NOUN
as O ADP
compared O VERB
with O ADP
18 O NUM
ml O NOUN
per O ADP
kilogram. O NOUN
( O PUNCT

Less O ADV
onerous O ADJ
PT O NOUN
wear O ADJ
regimens O NOUN
may O VERB
therefore O ADV
be O VERB
a O DET
viable O ADJ
alternative O ADJ
to O PART
FT O NOUN
wear O ADJ
of O ADP
removable O ADJ
functional O ADJ
appliances. O NUM

Publication O NOUN
date: O NOUN
2018/11/04 O PUNCT
00:00 O NOUN
[accepted] O ADV

Journal-Name:Medicine O NOUN

Postmenopausal O NOUN
overweight O NUM
women O NOUN
were O VERB
randomized O VERB
to O PART
a O DET
diet O NOUN
(n O NOUN
= O SYM
97), O NOUN
exercise O NOUN
plus O CCONJ
diet O NOUN
(n O NOUN
= O SYM
98) O NOUN
or O CCONJ
control O NOUN
group O NOUN
(n O NOUN
= O SYM
48). O NOUN

Title: O NOUN
Randomized O VERB
study O NOUN
of O ADP
the O DET
impact O NOUN
of O ADP
a O DET
therapeutic O ADJ
education O NOUN
program O NOUN
on O ADP
patients O NOUN
suffering O VERB
from O ADP
chronic O ADJ
low-back O NOUN
pain O NOUN
who O ADP
are O VERB
treated O VERB
with O ADP
transcutaneous O ADJ
electrical O ADJ
nerve O NOUN
stimulation. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Journal O ADJ
ID: O NOUN
2985213R O NOUN

The O DET
intervention O NOUN
strategy O NOUN
showed O VERB
a O DET
higher O ADJ
incidence O NOUN
of O ADP
induction B-outcome NOUN
of I-outcome ADP
labour I-outcome NOUN
(1.16, O NOUN
1.04 O NUM
to O PART
1.30) O NUM
and O CCONJ
a O DET
lower O ADJ
incidence O NOUN
of O ADP
augmentation B-outcome NOUN
of I-outcome ADP
labour I-outcome NOUN
(0.78, O NOUN
0.71 O NUM
to O PART
0.85). O NOUN

Journal O ADJ
ID: O NOUN
9308586 O NUM

Publication O NOUN
date: O NOUN
2019/03/07 O ADV
06:00 O ADP
[medline] O NOUN

RESULTS: O NOUN
After O ADP
10-week O NOUN
treatment, O NOUN
the O DET
patients O NOUN
received O VERB
NMES O NOUN
therapy O NOUN
showed O VERB
better O ADJ
efficacy O NOUN
in O ADP
primary O ADJ
endpoints O NOUN
of O ADP
urodynamic B-outcome ADJ
values O NOUN
(P O NUM
<.01) O NOUN
and O CCONJ
Overactive B-outcome ADJ
Bladder I-outcome NOUN
Symptom I-outcome NOUN
Score O NOUN
(P O NUM
<.01), O PUNCT
and O CCONJ
secondary O ADJ
endpoints O NOUN
of O ADP
International O ADJ
Consultation O NOUN
on O ADP
Incontinence B-outcome NOUN
Questionnaire-Short O NOUN
Form O NOUN
(ICIQ-SF) O NUM
(P O NUM
<.01) O NOUN
and O CCONJ
Barthel O PROPN
Index O NOUN
(BI) O NOUN
(P O NUM
<.01), O PUNCT
compared O VERB
with O ADP
patients O NOUN
who O ADP
underwent O VERB
sham O NOUN
NMES. O NOUN

These O DET
patients O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
2 O NUM
groups: O NOUN
methylene O NOUN
blue O ADJ
localization O NOUN
group O NOUN
(n O NOUN
= O SYM
47), O NUM
and O CCONJ
modified O VERB
localization O NOUN
group O NOUN
(n O NOUN
= O SYM
32), O NUM
where O ADP
the O DET
patients O NOUN
received O VERB
preoperative O ADJ
localization O NOUN
of O ADP
the O DET
small O ADJ
nodules O NOUN
by O ADP
CT-guided O VERB
placing O VERB
wire O NOUN
and O CCONJ
intrapleural O ADJ
fibrin O NOUN
glue O ADJ
near O ADV
the O DET
nodule O NOUN
at O ADP
3 O NUM
days O NOUN
before O ADP
the O DET
operation. O ADV

The O DET
primary O ADJ
outcome O NOUN
was O VERB
MRSA B-outcome NOUN
infection I-outcome NOUN
as O ADP
defined O VERB
according O ADJ
to O PART
Centers O NOUN
for O ADP
Disease O NOUN
Control O NOUN
and O CCONJ
Prevention O NOUN
(CDC) O NUM
criteria. O NOUN

The O DET
wider O ADP
use O NOUN
of O ADP
PICSI, O NOUN
therefore, O NOUN
is O VERB
not O ADV
recommended O VERB
at O ADP
present. O NOUN

Journal O ADJ
ID: O NOUN
0372541 O NUM

Publication O NOUN
date: O NOUN
2018/12/22 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study O NOUN

The O DET
primary O ADJ
endpoint O NOUN
of O ADP
the O DET
study O NOUN
was O VERB
between O ADP
group O NOUN
difference O NOUN
in O ADP
child O NOUN
reported O VERB
pain B-outcome NOUN
from O ADP
baseline O NOUN
to O PART
12 O NUM
months O NOUN
as O ADP
assessed O VERB
using O VERB
the O DET
Wong O ADP
Baker O NOUN
faces O NOUN
pain B-outcome NOUN
scale]. O NOUN
Secondary O ADJ
endpoints O NOUN
were O VERB
parent O NOUN
reported O VERB
pain B-outcome NOUN
(100 O NUM
mm O NOUN
visual O ADJ
analogue O NOUN
scale), O NOUN
parent O NOUN
reported O VERB
function B-outcome NOUN
( O NOUN
child O NOUN
health B-outcome NOUN
assessment O NOUN
questionnaire]), O ADP
child O NOUN
reported O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
( O NOUN
child O NOUN
health B-outcome NOUN
utility O NOUN
9-dimensional O ADJ
assessment]), O NOUN
coordination B-outcome NOUN
( O NOUN
movement B-outcome NOUN
assessment O NOUN
battery O NOUN
for O ADP
children O NOUN
version O NOUN
2]) O ADJ
and O CCONJ
grip B-outcome NOUN
strength I-outcome NOUN
(handheld O NUM
dynamometer). O NOUN

To O PART
study O NOUN
the O DET
effect O NOUN
of O ADP
rural O ADJ
county O NOUN
hospital O NOUN
vision O NOUN
centers O NOUN
(VC) O NOUN
on O ADP
self-reported O VERB
glasses B-outcome NOUN
ownership I-outcome NOUN
and O CCONJ
wearing B-outcome VERB
behavior I-outcome NOUN
(primary O PUNCT
outcome) O PUNCT
among O ADP
rural O ADJ
children O NOUN
in O ADP
China, O NOUN
we O PRON
conducted O VERB
a O DET
cluster-randomized O VERB
controlled O VERB
trial O NOUN
at O ADP
a O DET
VC O NOUN
in O ADP
the O DET
government O NOUN
hospital O NOUN
of O ADP
Qinan O ADP
County, O NOUN
a O DET
nationally-designated O VERB
poor O ADJ
county. O ADJ

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

The O DET
2nd O ADJ
dose O NOUN
was O VERB
administered O VERB
after O ADP
an O DET
interval O NOUN
of O ADP
6 O NUM
months. O NOUN

Journal-Name:Lancet O NOUN
(London, O PUNCT
England) O NOUN

Having O VERB
no O DET
hope O NOUN
for O ADP
the O DET
future O NOUN
was O VERB
independently O ADV
associated O VERB
with O ADP
a O DET
range O NOUN
of O ADP
factors, O NOUN
including O VERB
recent O ADJ
"eve-teasing" O PUNCT
(AOR O NUM
1.5 O NUM
(1.0-2.4)), O NUM
being O VERB
engaged O VERB
(AOR O NUM
2.9 O NUM
(0.9-9.7)), O PUNCT
not O ADV
participating O VERB
in O ADP
groups O NOUN
(AOR O NUM
0.5 O NUM
(0.4-0.6)) O NOUN
and O CCONJ
a O DET
lack O NOUN
of O ADP
emotional O ADJ
support O NOUN
(AOR O NUM
0.6 O NUM
(0.4-0.7)). O NUM

Title: O NOUN
Oral O ADJ
glutamine O NOUN
supplements O NOUN
reduce O VERB
concurrent O ADJ
chemoradiotherapy-induced O VERB
esophagitis O NOUN
in O ADP
patients O NOUN
with O ADP
advanced O VERB
non-small O ADJ
cell O NOUN
lung O NOUN
cancer. O NOUN

BACKGROUND: O NOUN
Pre- O NOUN
and O CCONJ
co-administration O NOUN
of O ADP
remifentanil O NOUN
in O ADP
target-controlled O VERB
propofol O NOUN
and O CCONJ
remifentanil O NOUN
anesthesia O NOUN
are O VERB
the O DET
most O DET
common O ADJ
methods O NOUN
in O ADP
clinical O ADJ
practice. O NOUN

METHODS: O NOUN
In O ADP
the O DET
study, O NOUN
60 O NUM
children O NOUN
of O ADP
American O ADJ
Society O NOUN
of O ADP
Anesthesiology O NOUN
classification O NOUN
(ASA O PUNCT
I-II), O ADJ
aged O VERB
2-9 O NUM
years, O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
one O NUM
of O ADP
two O NUM
equal O ADJ
groups. O NOUN

After O ADP
the O DET
self-affirmation O NOUN
manipulation O NOUN
was O VERB
administered, O NOUN
we O PRON
tracked O VERB
participants' O NOUN
eye B-outcome NOUN
movements I-outcome NOUN
while O ADP
they O PRON
viewed O VERB
images O NOUN
of O ADP
six O NUM
moderately-severe O ADV
and O CCONJ
six O NUM
highly-severe O ADJ
pictorial O ADJ
health O NOUN
warning O VERB
labels O NOUN
presented O VERB
on O ADP
large O ADJ
beer O NOUN
cans. O NUM

The O DET
optimal O ADJ
duration O NOUN
of O ADP
maintenance O NOUN
of O ADP
the O DET
ACB O NOUN
is O VERB
still O ADV
questionable. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
This O DET
study O NOUN
is O VERB
registered O VERB
at O ADP
ClinicalTrials.gov, O NOUN
no. O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

As O ADP
a O DET
result O VERB
of O ADP
better O ADJ
wound O NOUN
healing B-outcome VERB
, O PUNCT
the O DET
EMD-added O VERB
group O NOUN
exhibited O VERB
better O ADJ
results O NOUN
in O ADP
terms O NOUN
of O ADP
the O DET
harmony B-outcome NOUN
of I-outcome ADP
the Seperator DET
mucogingival I-outcome NOUN
junction I-outcome NOUN
between Seperator ADP
adjacent I-outcome ADJ
teeth I-outcome NOUN
. O PUNCT
This O DET
paper O NOUN
is O VERB
the O DET
first O ADV
split-mouth O NOUN
study O NOUN
in O ADP
which O ADP
SCTG+CAF O NUM
and O CCONJ
SCTG+CAF+EMD O NOUN
were O VERB
compared O VERB
using O VERB
RES O NOUN
in O ADP
bilateral O ADJ
canines. O NOUN

Quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
was O VERB
assessed O VERB
by O ADP
the O DET
questionnaires O NOUN
SF36, O NOUN
EORTC O ADJ
QLQ-C30, O ADV
and O CCONJ
EORTC O ADJ
QLQ-BR23 O NOUN
at O ADP
baseline, O NOUN
and O CCONJ
at O ADP
three, O NOUN
six, O ADV
and O CCONJ
nine O NUM
months. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
objectively O ADV
measured O VERB
mean O NOUN
steps/day B-outcome NOUN
at O ADP
6 O NUM
months O NOUN
using O VERB
a O DET
validated O VERB
pedometer O NOUN
(Yamax O NOUN
Digi-Walker O NOUN
CW-701) O NOUN
over O ADP
7 O NUM
days, O NOUN
assessed O VERB
with O ADP
intention O NOUN
to O PART
treat O NOUN
analysis. O NOUN

Journal O ADJ
ID: O NOUN
100968551 O NUM

Journal O ADJ
ID: O NOUN
101474849 O NUM

AIMS: O VERB
Cementless O NOUN
primary O ADJ
total O ADJ
hip O NOUN
arthroplasty O NOUN
(THA) O NUM
is O VERB
associated O VERB
with O ADP
risks O NOUN
of O ADP
bleeding O VERB
and O CCONJ
thromboembolism. O NOUN

Result:There O NOUN
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
SDS O NOUN
and O CCONJ
SAS O NOUN
scores O NOUN
between O ADP
the O DET
three O NUM
groups O NOUN
P>0.05. O NOUN
[ O PUNCT

Similarly, O NOUN
there O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
between O ADP
the O DET
groups O NOUN
with O ADP
respect O NOUN
to O PART
resting B-outcome VERB
pain I-outcome NOUN
scores O NOUN
(P O NUM
= O SYM
.94 O PUNCT
for O ADP
back O ADP
pain O NOUN
and O CCONJ
P O NOUN
= O SYM
.16 O NUM
for O ADP
leg O NOUN
pain) O NOUN
and O CCONJ
movement B-outcome NOUN
pain I-outcome NOUN
scores O NOUN
(P O NUM
= O SYM
.52 O PUNCT
for O ADP
back O ADP
pain O NOUN
and O CCONJ
P O NOUN
= O SYM
.56 O NUM
for O ADP
leg O NOUN
pain). O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Publication O NOUN
date: O NOUN
2019/01/04 O VERB
00:00 O NOUN
[accepted] O ADV

The O DET
dry O ADJ
needling O VERB
was O VERB
applied O VERB
in O ADP
active O ADJ
trigger O ADP
points O NOUN
located O VERB
in O ADP
the O DET
musculature O NOUN
of O ADP
the O DET
head O NOUN
and O CCONJ
the O DET
neck. O NOUN

Title: O NOUN
Music O ADJ
therapy O NOUN
intervention O NOUN
in O ADP
cardiac B-outcome ADJ
autonomic I-outcome ADJ
modulation I-outcome NOUN
, O PUNCT
anxiety B-outcome NOUN
, O PUNCT
and O CCONJ
depression B-outcome NOUN
in O ADP
mothers O NOUN
of O ADP
preterms: O NOUN
randomized O VERB
controlled O VERB
trial. O NOUN

Palo O NOUN
Alto, O NOUN
CA, O NOUN
USA. O NOUN

RESULTS: O NOUN
The O DET
mean O NOUN
performance B-outcome NOUN
score O NOUN
in O ADP
test-1 O NOUN
was O VERB
62.5 O NUM
+/- O SYM
10.1 O NUM
points O NOUN
in O ADP
the O DET
training O VERB
group O NOUN
and O CCONJ
62.3 O NUM
+/- O SYM
4.1 O NUM
points O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
[95% O NOUN
confidence O NOUN
interval O NOUN
(95% O PUNCT
CI) O NOUN
-5.5 O VERB
to O PART
5.8; O NOUN
P O NOUN
= O SYM
.954]. O PUNCT
In O ADP
test-2, O NOUN
the O DET
mean O NOUN
score O NOUN
was O VERB
86.8 O NUM
+/- O SYM
6.5 O NUM
points O NOUN
and O CCONJ
59.9 O NUM
+/- O SYM
4.4 O NUM
points O NOUN
in O ADP
the O DET
training O VERB
and O CCONJ
control O NOUN
groups, O NOUN
respectively O ADV
(95% O PUNCT
CI O NOUN
21.9-31.8; O NUM
P O NOUN
< O SYM
.001). O PUNCT

Journal O ADJ
ID: O NOUN
2985248R O NOUN

METHODS: O NOUN
In O ADP
this O DET
24-week, O NUM
randomized, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
phase O NOUN
3 O NUM
study, O NOUN
225 O NUM
patients, O NOUN
142 O NUM
of O ADP
which O ADP
were O VERB
East O ADV
Asian O ADJ
(63.4%), O NOUN
were O VERB
enrolled: O NOUN
Japan O ADP
(n O NOUN
= O SYM
114), O NOUN
South O NOUN
Korea O NOUN
(n O NOUN
= O SYM
20), O NUM
Taiwan O NOUN
(n O NOUN
= O SYM
8), O NUM
the O DET
Czech O NOUN
Republic O ADJ
(n O NOUN
= O SYM
42), O NUM
and O CCONJ
Poland O NOUN
(n O NOUN
= O SYM
40). O NOUN

PSE O NOUN
was O VERB
well O ADV
tolerated B-outcome VERB
as O ADP
evidenced O VERB
by O ADP
no O DET
effects O NOUN
observed O VERB
in O ADP
the O DET
blood B-outcome NOUN
safety O NOUN
panels. O NOUN

Journal-Name:Medicine O NOUN

Publication O NOUN
date: O NOUN
2018/12/28 O NUM
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2019/01/03 O ADJ
00:00 O NOUN
[accepted] O ADV

PARTICIPANTS: O NOUN
A O DET
total O ADJ
of O ADP
twenty-eight O NOUN
hypertensive O ADJ
(Stage O NOUN
1 O NUM
and O CCONJ
2) O NOUN
sedentary O ADJ
women O NOUN
(Age O PUNCT
40.54+/-4.2 O NOUN
yrs; O NOUN
Height O NOUN
155.14+/-5.4cm; O NOUN
Weight O NOUN
70.96+/-10.2kg; O NUM
BMI O NOUN
29.6+/-4.4; O NUM
Duration O NOUN
of O ADP
HTN: O NOUN
6.43+/-2.5 O ADP
yrs) O NOUN
were O VERB
recruited O VERB
for O ADP
the O DET
study. O NOUN

Of O ADP
these, O NOUN
64 O NUM
(85%) O NOUN
vs O CCONJ
83 O NUM
(88%), O NOUN
respectively, O NOUN
reached O VERB
the O DET
primary O ADJ
clinical O ADJ
end O NOUN
point O NOUN
(risk O NOUN
difference, O NOUN
-4.8% O NUM
[1-sided O VERB
95% O NOUN
CI, O NOUN
-13.6% O NOUN
to O PART
+ O SYM
infinity; O NOUN
1-sided O VERB
P O NOUN
= O SYM
.19]) O PUNCT
and O CCONJ
49 O NUM
(66%) O ADV
vs O CCONJ
58 O NUM
(62%), O NOUN
respectively, O NOUN
reached O VERB
the O DET
primary O ADJ
radiographic O ADJ
end O NOUN
point O NOUN
(risk O NOUN
difference, O NOUN
4.7% O NOUN
[1-sided O VERB
95% O NOUN
CI, O NOUN
-7.0% O NUM
to O PART
+ O SYM
infinity; O NOUN
1-sided O VERB
P O NOUN
= O SYM
.25). O PUNCT

BACKGROUND: O NOUN
Among O ADP
patients O NOUN
with O ADP
metastatic O ADJ
pancreatic O ADJ
cancer, O NOUN
combination O NOUN
chemotherapy O NOUN
with O ADP
fluorouracil, O NOUN
leucovorin, O NOUN
irinotecan, O NOUN
and O CCONJ
oxaliplatin O NOUN
(FOLFIRINOX) O NUM
leads O NOUN
to O PART
longer O ADJ
overall O ADJ
survival O NOUN
than O ADP
gemcitabine O NOUN
therapy. O NOUN

Future O NOUN
randomized O VERB
trials O NOUN
with O ADP
longer-term O NOUN
outcomes O NOUN
that O ADP
include O VERB
sensorimotor O NOUN
mechanisms O NOUN
might O VERB
enhance O NOUN
our O ADJ
understanding O VERB
of O ADP
the O DET
comparative O ADJ
effectiveness. O NOUN

BACKGROUND: O NOUN
This O DET
study O NOUN
aimed O VERB
to O PART
investigate O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
lactulose O ADV
for O ADP
the O DET
treatment O NOUN
of O ADP
Chinese O NOUN
children O NOUN
with O ADP
chronic O ADJ
constipation. O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/02/14 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Title: O NOUN
Pre-administration O NOUN
of O ADP
remifentanil O NOUN
in O ADP
target-controlled O VERB
propofol O NOUN
and O CCONJ
remifentanil O NOUN
anesthesia O NOUN
prolongs O NOUN
anesthesia B-outcome NOUN
induction I-outcome NOUN
in O ADP
neurosurgical O ADJ
patients: O NOUN
A O DET
double-blind O ADJ
randomized O VERB
controlled O VERB
trial. O NOUN

Importance: O NOUN
High-quality O NOUN
dietary O ADJ
patterns O NOUN
may O VERB
help O VERB
prevent O NOUN
chronic O ADJ
disease, O NOUN
but O CCONJ
limited O VERB
data O NOUN
exist O VERB
from O ADP
randomized O VERB
trials O NOUN
about O ADV
the O DET
effects O NOUN
of O ADP
nutritional O ADJ
and O CCONJ
behavioral O ADJ
interventions O NOUN
on O ADP
dietary O ADJ
changes. O NOUN

Title: O NOUN
Preventive O ADJ
effects O NOUN
of O ADP
galcanezumab O NOUN
in O ADP
adult O NOUN
patients O NOUN
with O ADP
episodic O NOUN
or O CCONJ
chronic O ADJ
migraine O NOUN
are O VERB
persistent: O NOUN
data O NOUN
from O ADP
the O DET
phase O NOUN
3, O NOUN
randomized, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
EVOLVE-1, O NOUN
EVOLVE-2, O NOUN
and O CCONJ
REGAIN O NOUN
studies. O NOUN

Interestingly, O NOUN
the O DET
main O ADJ
determinant O NOUN
of O ADP
vitamin O NOUN
D O NOUN
at O ADP
baseline O NOUN
was O VERB
the O DET
waist O NOUN
circumference. O NOUN

METHODS: O NOUN
This O DET
randomized O VERB
clinical O ADJ
trial O NOUN
was O VERB
conducted O VERB
at O ADP
infertility O NOUN
department O NOUN
of O ADP
Royan O NOUN
Institute O NOUN
from O ADP
January O NOUN
2017 O NUM
to O PART
June O NOUN
2018. O NUM

CONCLUSIONS: O NOUN
Moderate-intensity O NOUN
combined O VERB
aerobic O ADJ
and O CCONJ
resistance O NOUN
training O VERB
is O VERB
safe O ADJ
in O ADP
physically O ADV
unfit O ADP
patients O NOUN
with O ADP
quiescent O ADJ
Inflammatory O ADJ
Bowel O NOUN
Disease O NOUN
and O CCONJ
can O VERB
quickly O NOUN
achieve O NOUN
favourable O ADJ
body B-outcome NOUN
compositional I-outcome ADJ
changes O NOUN
without O ADP
adverse B-outcome ADJ
effects I-outcome NOUN
. O PUNCT
TRIAL O NOUN
REGISTRATION: O NOUN
The O DET
study O NOUN
was O VERB
registered O VERB
at O ADP
ClinicalTrials.gov; O NOUN
Trial O NOUN
number: O NOUN
NCT02463916 O NOUN
. O PUNCT

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

In O ADP
addition, O NOUN
there O PRON
is O VERB
good O ADJ
concordance O NOUN
between O ADP
radiographers O NOUN
across O ADP
all O DET
imaging O VERB
modalities. O NOUN

Metabolic B-outcome ADJ
pathways O NOUN
involving O VERB
lysine B-outcome NOUN
, O PUNCT
and O CCONJ
phytochemicals B-outcome NOUN
were O VERB
also O ADV
modulated O VERB
by O ADP
navy O ADJ
bean O NOUN
intake O NOUN
in O ADP
CRC O NOUN
survivors. O NOUN

Journal-Name:Cornea O NOUN

BACKGROUND: O NOUN
Levodopa O NOUN
is O VERB
the O DET
main O ADJ
treatment O NOUN
for O ADP
symptoms O NOUN
of O ADP
Parkinson's O NOUN
disease. O NOUN

Patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
3 O NUM
groups, O NOUN
based O VERB
on O ADP
the O DET
tube O NOUN
ETView O NOUN
double-lumen O NOUN
tube O NOUN
(VDT), O NUM
ETView O NOUN
single-lumen O NOUN
tube O NOUN
(VST), O PUNCT
or O CCONJ
traditional O ADJ
double O ADV
lumen O NOUN
tube O NOUN
(DT).All O PUNCT
83 O NUM
patients' O NOUN
intubations O NOUN
were O VERB
successful O ADJ
to O PART
achieve B-outcome NOUN
1-lung I-outcome ADV
ventilation I-outcome NOUN
: O PUNCT
74 O NUM
patients O NOUN
at O ADP
the O DET
first O ADV
attempt O NOUN
(22/26 O NOUN
in O ADP
VDT, O NUM
26/28 O NOUN
in O ADP
VST, O NUM
26/29 O NOUN
in O ADP
DT O NOUN
group) O ADJ
and O CCONJ
9 O NUM
patients O NOUN
at O ADP
the O DET
second O ADJ
attempt. O NOUN

The O DET
changes O NOUN
in O ADP
respiratory B-outcome ADJ
mechanical I-outcome ADJ
indexes O NOUN
were O VERB
observed O VERB
under O ADP
different O ADJ
ventilation O NOUN
patterns O NOUN
and O CCONJ
ventilator O NOUN
parameters O NOUN
of O ADP
0 O NUM
(only O ADV
connected O VERB
with O ADP
atomizing O VERB
device), O NOUN
5, O ADJ
7, O NUM
9 O NUM
L/min O NOUN
atomizing O VERB
oxygen O NOUN
flow. O NOUN

Publication O NOUN
date: O NOUN
2019/02/26 O VERB
06:00 O ADP
[entrez] O ADP

Results: O NOUN
At O ADP
week O NOUN
12, O NUM
mean O NOUN
percent O NOUN
reduction O NOUN
in O ADP
inflammatory O ADJ
and O CCONJ
noninflammatory O ADJ
lesion B-outcome NOUN
counts O NOUN
were O VERB
60.1% O NUM
and O CCONJ
53.0%, O NUM
respectively, O NOUN
compared O VERB
with O ADP
51.1% O NUM
and O CCONJ
38.7% O NUM
with O ADP
vehicle O NOUN
(P</=0.001) O PUNCT
in O ADP
the O DET
Hispanic O ADJ
population. O ADV

The O DET
population O NOUN
pharmacokinetic O ADJ
model O NOUN
visualized O VERB
both O CCONJ
measured O VERB
and O CCONJ
predicted O VERB
concentrations. O NUM

Publication O NOUN
date: O NOUN
2018/12/31 O NOUN
06:00 O ADP
[entrez] O ADP

Title: O NOUN
Multivitamin O NOUN
and O CCONJ
Mineral O NOUN
Supplementation O NOUN
Containing O VERB
Phytonutrients O NOUN
Scavenges O NOUN
Reactive O ADJ
Oxygen O NOUN
Species O NOUN
in O ADP
Healthy O NOUN
Subjects: O NOUN
A O DET
Randomized, O NOUN
Double-Blinded, O NOUN
Placebo-Controlled O VERB
Trial. O NOUN

Journal O ADJ
ID: O NOUN
100967802 O NUM

Finally, O NOUN
participants O NOUN
reported O VERB
their O ADJ
self-efficacy B-outcome NOUN
to O PART
drink O NOUN
less O ADV
and O CCONJ
their O ADJ
alcohol B-outcome NOUN
use I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
There O PRON
was O VERB
no O DET
clear O ADJ
evidence O NOUN
that O ADP
enhancing O VERB
self-affirmation O NOUN
influenced O VERB
any O DET
outcome. O NOUN

No O DET
significant O ADJ
effect O NOUN
over O ADP
24 O NUM
h O NOUN
or O CCONJ
qualitative O ADJ
feelings O NOUN
of O ADP
satiety B-outcome NOUN
were O VERB
observed. O NOUN

BACKGROUND: O NOUN
Unhealthy O NOUN
foods O NOUN
are O VERB
promoted O VERB
heavily, O NOUN
through O ADP
food O NOUN
company O DET
sponsorship O NOUN
of O ADP
elite O ADP
sport, O NOUN
resulting O VERB
in O ADP
extensive O ADJ
exposure O NOUN
among O ADP
young O ADJ
adults O NOUN
who O ADP
are O VERB
avid O NOUN
sport O ADJ
spectators. O NOUN

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[entrez] O ADP

Study O NOUN
design O NOUN
20 O NUM
participants O NOUN
with O ADP
psychomotor O NOUN
disadaptation O NOUN
admitted O VERB
to O PART
an O DET
academic O ADJ
rehabilitation O NOUN
ward O NOUN
were O VERB
randomised O VERB
to O PART
receive O VERB
physiotherapist O NOUN
care O NOUN
supported O VERB
by O ADP
the O DET
SafeWalker(R) O ADV
robotic O ADJ
walking O VERB
aid O VERB
or O CCONJ
standard O ADJ
care O NOUN
only, O NOUN
for O ADP
ten O NUM
days. O NOUN

Publication O NOUN
date: O NOUN
2018/01/25 O VERB
00:00 O NOUN
[accepted] O ADV

Journal O ADJ
ID: O NOUN
0255562 O NUM

METHODS: O NOUN
We O PRON
conducted O VERB
a O DET
phase O NOUN
1 O NUM
trial O NOUN
of O ADP
givosiran O NOUN
in O ADP
patients O NOUN
with O ADP
acute O ADJ
intermittent O ADJ
porphyria. O NOUN

DISCUSSION: O NOUN
The O DET
study O NOUN
will O VERB
make O VERB
a O DET
unique O ADJ
contribution O NOUN
to O PART
the O DET
literature O NOUN
by O ADP
testing O VERB
a O DET
theory-based O VERB
intervention O NOUN
delivered O VERB
by O ADP
PE O NOUN
teachers O NOUN
to O PART
promote O VERB
school O NOUN
students' O NOUN
participation B-outcome NOUN
in O ADP
out-of-school O NOUN
physical O ADJ
activity. O NOUN

The O DET
results O NOUN
showed O VERB
that O ADP
the O DET
menopausal O ADJ
women O NOUN
in O ADP
D2 O NOUN
group O NOUN
increased O VERB
serum O NOUN
alkaline B-outcome ADJ
phosphatase I-outcome NOUN
, O PUNCT
osteocalcin B-outcome NOUN
, O PUNCT
and O CCONJ
total O ADJ
phenolic B-outcome NOUN
compounds O NOUN
content O NOUN
but O CCONJ
decreased O VERB
CTX B-outcome NOUN
level. O NOUN

Both O CCONJ
groups O NOUN
completed O VERB
+25d O NOUN
in O ADP
the O DET
hot O ADJ
condition. O NOUN

The O DET
exercise O NOUN
session O NOUN
attendance B-outcome NOUN
rate O NOUN
was O VERB
62% O NUM
for O ADP
HIIT O NOUN
(288/465) O NOUN
and O CCONJ
75% O NUM
for O ADP
MICT O NOUN
(320/429), O NOUN
with O ADP
62% O NUM
of O ADP
HIIT O NOUN
participants O NOUN
(8/13) O ADP
and O CCONJ
67% O ADJ
of O ADP
MICT O NOUN
participants O NOUN
(8/12) O PUNCT
completing O VERB
at O ADP
least O ADV
24 O NUM
of O ADP
36 O NUM
sessions. O NOUN

Publication O NOUN
date: O NOUN
2018/12/20 O ADJ
06:00 O ADP
[entrez] O ADP

CONCLUSION: O NOUN
Muscle O NOUN
relaxation O NOUN
can O VERB
enhance O NOUN
self-efficacy B-outcome NOUN
of O ADP
cancer O NOUN
patients. O NOUN

METHODS: O NOUN
A O DET
randomized, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
trial O NOUN
involving O VERB
confirmed O VERB
HIV-positive O ADJ
pregnant O ADJ
women O NOUN
at O ADP
the O DET
Lagos O NOUN
University O NOUN
Teaching O VERB
Hospital O NOUN
(LUTH) O NUM
between O ADP
September O NOUN
2018 O NUM
and O CCONJ
February O ADJ
2019. O NUM

The O DET
test O NOUN
group O NOUN
had O VERB
significantly O ADV
better O ADJ
results O NOUN
than O ADP
the O DET
control O NOUN
according O ADJ
to O PART
the O DET
soft B-outcome NOUN
tissue I-outcome NOUN
texture I-outcome NOUN
and O CCONJ
mucogingival B-outcome NOUN
junction I-outcome NOUN
alignment I-outcome ADP
results O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

CONCLUSIONS: O NOUN
Our O ADJ
results O NOUN
suggest O VERB
that O ADP
the O DET
efficacy O NOUN
of O ADP
EHF O NOUN
is O VERB
potentially O ADV
inferior O ADJ
to O PART
that O ADP
of O ADP
MHF O NOUN
and O CCONJ
that O ADP
further O ADV
studies O NOUN
are O VERB
warranted, O VERB
therefore, O NOUN
to O PART
confirm O NOUN
these O DET
findings. O NOUN

PURPOSE: O NOUN
To O PART
evaluate O VERB
corneal B-outcome ADJ
endothelial I-outcome ADJ
cell I-outcome NOUN
density I-outcome NOUN
(ECD) I-outcome NOUN
and Seperator CCONJ
morphology S3-outcome NOUN
2 O NUM
years O NOUN
after O ADP
phacoemulsification O NOUN
in O ADP
subjects O NOUN
from O ADP
the O DET
COMPASS O NOUN
trial O NOUN
(ClinicalTrials.gov, O PUNCT
NCT01085357) O NOUN
who O ADP
had O VERB
mild-to-moderate O ADJ
primary O ADJ
open-angle O NOUN
glaucoma O NOUN
and O CCONJ
visually O ADV
significant O ADJ
cataracts. O VERB

The O DET
incidence O NOUN
of O ADP
treatment B-outcome NOUN
success I-outcome NOUN
with O ADP
surgery O NOUN
(18 O NOUN
of O ADP
27 O NUM
patients, O NOUN
67%) O NUM
was O VERB
significantly O ADV
superior O ADJ
to O PART
that O ADP
with O ADP
active O ADJ
medical O ADJ
treatment O NOUN
(7 O NOUN
of O ADP
25 O NUM
patients, O NOUN
28%; O NUM
P O NOUN
= O SYM
0.007) O NOUN
or O CCONJ
control O NOUN
medical O ADJ
treatment O NOUN
(3 O NOUN
of O ADP
26 O NUM
patients, O NOUN
12%; O NUM
P<0.001). O NUM

CONCLUSIONS: O NOUN
Whilst O ADP
daily O ADJ
betaA O NOUN
may O VERB
confer O VERB
individual O ADJ
benefits, O NOUN
these O DET
results O NOUN
demonstrate O VERB
limited O VERB
impact O NOUN
of O ADP
betaA O NOUN
(irrespective O PUNCT
of O ADP
dosing O VERB
strategy) O NOUN
on O ADP
30-min O NOUN
rowing B-outcome VERB
or Seperator CCONJ
subsequent X NOUN
sprint B-outcome NOUN
performance E1-outcome NOUN
. O PUNCT
Further O ADV
investigation O NOUN
of O ADP
betaA O NOUN
dosage O NOUN
> O SYM
2.4 O NUM
g.d(- O NOUN
1) O NUM
and/or O CCONJ
chronic O ADJ
intervention O NOUN
periods O NOUN
(> O PUNCT
4-8 O NUM
weeks) O NOUN
may O VERB
be O VERB
warranted O VERB
based O VERB
on O ADP
within-group O NOUN
observations. O NOUN

Title: O NOUN
Effects O NOUN
of O ADP
ascorbic O ADJ
acid O NOUN
supplementation O NOUN
on O ADP
oxidative B-outcome ADJ
stress I-outcome NOUN
markers O NOUN
in O ADP
healthy O ADJ
women O NOUN
following O VERB
a O DET
single O ADJ
bout O NOUN
of O ADP
exercise. O NOUN

Selenium O NOUN
is O VERB
a O DET
non-metallic O ADJ
chemical O ADJ
element O NOUN
of O ADP
great O ADJ
importance O NOUN
to O PART
human O NOUN
health. O NOUN

This O DET
study O NOUN
aimed O VERB
to O PART
evaluate O VERB
the O DET
influence O NOUN
of O ADP
music O ADJ
therapy O NOUN
intervention O NOUN
on O ADP
the O DET
autonomic O ADJ
control O NOUN
of O ADP
heart B-outcome NOUN
rate I-outcome NOUN
, O PUNCT
anxiety B-outcome NOUN
, O PUNCT
and O CCONJ
depression B-outcome NOUN
in O ADP
mothers. O NOUN

Omadacycline O NOUN
was O VERB
noninferior O ADJ
to O PART
moxifloxacin O NOUN
for O ADP
early O ADJ
clinical B-outcome ADJ
response I-outcome NOUN
(81.1% O PUNCT
and O CCONJ
82.7%, O NUM
respectively; O NOUN
difference, O NOUN
-1.6 O ADJ
percentage O NOUN
points; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
-7.1 O NUM
to O PART
3.8), O NUM
and O CCONJ
the O DET
rates O NOUN
of O ADP
investigator-assessed O VERB
clinical B-outcome ADJ
response I-outcome NOUN
at O ADP
the O DET
post-treatment O NOUN
evaluation O NOUN
were O VERB
87.6% O NUM
and O CCONJ
85.1%, O NUM
respectively O ADV
(difference, O ADV
2.5 O NUM
percentage O NOUN
points; O NOUN
95% O NOUN
CI, O NOUN
-2.4 O NOUN
to O PART
7.4). O NOUN

Several O ADJ
small O ADJ
trials O NOUN
have O VERB
suggested O VERB
that O ADP
supplementing O VERB
the O DET
enteral O ADJ
diet O NOUN
of O ADP
very O ADV
preterm O NOUN
infants O NOUN
with O ADP
lactoferrin, O NOUN
an O DET
antimicrobial O ADJ
protein O NOUN
processed O VERB
from O ADP
cow's O NOUN
milk, O NOUN
prevents O NOUN
infections O NOUN
and O CCONJ
associated O VERB
complications. O NOUN

At O ADP
6 O NUM
months O NOUN
of O ADP
follow O VERB
up, O NOUN
few O ADJ
patients O NOUN
reported O VERB
myalgia B-outcome NOUN
(2 O PUNCT
in O ADP
group O NOUN
A O DET
and O CCONJ
7 O NUM
in O ADP
Group O NOUN
B). O NOUN

It O PRON
has O VERB
been O VERB
reported O VERB
that O ADP
the O DET
intensity B-outcome NOUN
of I-outcome ADP
pain I-outcome NOUN
from O ADP
dysmenorrhea O ADJ
decreased O VERB
in O ADP
the O DET
Novafen O NOUN
and O CCONJ
Ginger O NOUN
groups. O NOUN

The O DET
admission O NOUN
of O ADP
prolonged O VERB
form O NOUN
of O ADP
nitrates O NOUN
before O ADP
the O DET
PCI O NOUN
was O VERB
allowed O VERB
in O ADP
the O DET
second O ADJ
group. O VERB

A O DET
transition O NOUN
to O PART
oral O ADJ
omadacycline O NOUN
(300 O PUNCT
mg O NOUN
every O DET
24 O NUM
hours) O NOUN
or O CCONJ
moxifloxacin O NOUN
(400 O NUM
mg O NOUN
every O DET
24 O NUM
hours), O NOUN
respectively, O NOUN
was O VERB
allowed O VERB
after O ADP
3 O NUM
days; O NOUN
the O DET
total O ADJ
treatment O NOUN
duration O NOUN
was O VERB
7 O NUM
to O PART
14 O NUM
days. O NOUN

But O CCONJ
persistent O ADJ
CNLDO O NOUN
in O ADP
older O ADJ
children O NOUN
makes O NOUN
the O DET
success O NOUN
rate O NOUN
rapidly O ADV
decreased O VERB
due O ADJ
to O PART
long-term O NOUN
chronic O ADJ
inflammation. O NOUN

Group O NOUN
receiving O VERB
placebo O NOUN
had O VERB
pain B-outcome NOUN
relief I-outcome NOUN
only O ADV
for O ADP
first O ADV
two O NUM
weeks. O NOUN

METHODS: O NOUN
This O DET
was O VERB
a O DET
prospective O ADJ
single O ADJ
blind O PUNCT
randomized O VERB
sham O NOUN
controlled O VERB
trial O NOUN
where O ADP
patients O NOUN
undergoing O VERB
coronary O ADJ
angioplasty O NOUN
with O ADP
stage O NOUN
III O NUM
chronic O ADJ
kidney O NOUN
disease O NOUN
were O VERB
randomized O VERB
into O ADP
sham O NOUN
preconditioning O VERB
and O CCONJ
remote O ADV
ischemic O ADJ
preconditioning. O NOUN

Journal-Name:Medicine O NOUN

However, O ADV
the O DET
underlying O VERB
mechanisms O NOUN
and O CCONJ
effective O ADJ
therapeutic O ADJ
targets O NOUN
are O VERB
still O ADV
unclear. O NOUN

They O PRON
were O VERB
equally O ADV
and O CCONJ
randomly O ADV
allocated O VERB
to O PART
a O DET
treatment O NOUN
group O NOUN
(n O NOUN
= O SYM
50) O NOUN
and O CCONJ
a O DET
placebo O NOUN
group O NOUN
(n O NOUN
= O SYM
50). O NOUN

Title: O NOUN
A O DET
Randomized O VERB
Trial O NOUN
of O ADP
Lymphadenectomy O NOUN
in O ADP
Patients O NOUN
with O ADP
Advanced O VERB
Ovarian O ADJ
Neoplasms. O NOUN

This O DET
study O NOUN
aims O NOUN
to O PART
determine O NOUN
the O DET
efficacy O NOUN
of O ADP
repeated O VERB
PZQ O NOUN
treatments O NOUN
against O ADP
Schistosoma B-outcome NOUN
mansoni I-outcome NOUN
infection I-outcome NOUN
in O ADP
school-aged O VERB
children O NOUN
in O ADP
Cote O NOUN
d'Ivoire O NOUN
using O VERB
the O DET
traditional O ADJ
KK O NOUN
technique, O ADV
as O ADP
well O ADV
as O ADP
more O ADV
sensitive O ADJ
antigen- O NOUN
and O CCONJ
DNA-detection O NOUN
methods. O NOUN

Tafenoquine O NOUN
is O VERB
a O DET
single-dose O NOUN
8-aminoquinoline O NOUN
that O ADP
has O VERB
recently O ADV
been O VERB
registered O VERB
for O ADP
the O DET
radical O NOUN
cure O NOUN
of O ADP
P. O NOUN
vivax. O NOUN

A O DET
total O ADJ
of O ADP
312 O NUM
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
were O VERB
recorded O VERB
in O ADP
110 O NUM
patients. O NOUN

RESULTS: O NOUN
The O DET
multivariate O ADJ
analysis O NOUN
showed O VERB
that O ADP
lower O ADJ
nodal O NOUN
stage, O VERB
the O DET
presence O NOUN
of O ADP
squamous O ADJ
cell O NOUN
carcinoma O NOUN
(SCC), O NUM
a O DET
broader O ADJ
surgical O ADJ
resection O NOUN
in O ADP
patients O NOUN
with O ADP
SCC, O NUM
and O CCONJ
being O VERB
female O NOUN
with O ADP
non-SCC O CCONJ
were O VERB
significantly O ADV
associated O VERB
with O ADP
longer O ADJ
disease-free B-outcome ADJ
survival I-outcome NOUN
(DFS) I-outcome NOUN
. O PUNCT
Lower O ADJ
nodal O NOUN
stage O NOUN
and O CCONJ
smaller O ADJ
tumor O NOUN
size O NOUN
were O VERB
significantly O ADV
associated O VERB
with O ADP
an O DET
improved O VERB
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
. O PUNCT
Compared O VERB
to O PART
Other O ADJ
International, O PUNCT
enrollment O NOUN
in O ADP
East O ADV
Asia O PROPN
was O VERB
associated O VERB
with O ADP
an O DET
improved O VERB
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
non-SCC. O NOUN

Publication O NOUN
date: O NOUN
2019/01/01 O NOUN
06:00 O ADP
[medline] O NOUN

For O ADP
both O CCONJ
end O NOUN
points, O NOUN
the O DET
noninferiority O NOUN
margin O ADP
was O VERB
10 O NUM
percentage O NOUN
points. O NOUN

These O DET
findings O NOUN
were O VERB
true O ADJ
irrespective O ADJ
of O ADP
the O DET
type O NOUN
of O ADP
resection O NOUN
performed. O NOUN

After O ADP
6 O NUM
months, O NOUN
RA B-outcome NOUN
and Seperator CCONJ
RV B-outcome NOUN
area E1-outcome NOUN
, O PUNCT
RV B-outcome NOUN
thickness I-outcome NOUN
tricuspid I-outcome NOUN
regurgitation I-outcome NOUN
velocity I-outcome NOUN
showed O VERB
a O DET
significant O ADJ
reduction. O NOUN

Late O ADJ
first-trimester O NOUN
high O ADJ
adherence O NOUN
to O PART
the O DET
predefined O VERB
six O NUM
food O NOUN
targets O NOUN
is O VERB
associated O VERB
with O ADP
a O DET
reduction O NOUN
in O ADP
the O DET
risk O NOUN
of O ADP
gestational B-outcome ADJ
diabetes I-outcome NOUN
mellitus I-outcome NOUN
(GDM) I-outcome NOUN
, O PUNCT
emergency B-outcome NOUN
C-section I-outcome NOUN
, O PUNCT
perineal B-outcome ADJ
trauma I-outcome NOUN
, O PUNCT
pregnancy-induced B-outcome VERB
hypertension I-outcome NOUN
and Seperator CCONJ
preeclampsia I-outcome NOUN
, O PUNCT
prematurity B-outcome NOUN
, O PUNCT
large-for-gestational-age B-outcome NOUN
, O PUNCT
and/or O CCONJ
small-for-gestational-age B-outcome NOUN
, O PUNCT
urinary B-outcome ADJ
tract I-outcome NOUN
infections I-outcome NOUN
(UTI) I-outcome NUM
, O PUNCT
prematurity B-outcome NOUN
, O PUNCT
and O CCONJ
small-for-gestational-age B-outcome NOUN
(SGA) I-outcome PUNCT
newborns. O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
the O DET
effectiveness O NOUN
of O ADP
two-dose O NOUN
versus O CCONJ
three-dose O NOUN
sulphadoxine-pyrimethamine O NOUN
in O ADP
preventing O VERB
adverse B-outcome ADJ
pregnancy I-outcome NOUN
outcomes I-outcome NOUN
in O ADP
Nigeria. O NOUN

In O ADP
group O NOUN
B, O NOUN
although O ADP
the O DET
median O ADJ
number O NOUN
[range] O NOUN
of O ADP
lesions B-outcome NOUN
in O ADP
the O DET
first O ADV
tertile O ADJ
of O ADP
the O DET
small O ADJ
intestine O NOUN
did O VERB
not O ADV
increase O NOUN
two O NUM
weeks O NOUN
after O ADP
low-dose O NOUN
aspirin O NOUN
administration O NOUN
(baseline: O PUNCT
0 O NUM
[0-4], O NOUN
after: O NOUN
1.5 O NUM
[0-8]; O PUNCT
p O NOUN
= O SYM
0.2969), O NOUN
the O DET
number O NOUN
of O ADP
lesions B-outcome NOUN
in O ADP
the O DET
second O ADJ
and O CCONJ
third O ADJ
tertiles O NOUN
of O ADP
the O DET
small O ADJ
intestine O NOUN
increased O VERB
significantly O ADV
(baseline: O PUNCT
0 O NUM
[0-5], O PUNCT
after: O NOUN
2 O NUM
[0-15]; O NOUN
p O NOUN
= O SYM
0.0469). O NUM

Journal-Name:JAMA O NOUN

SUMMARY O NOUN
OF O ADP
KEY O NOUN
POINTS: O NOUN
This O DET
is O VERB
a O DET
case-series O NOUN
report O NOUN
using O VERB
data O NOUN
previously O ADV
collected O VERB
for O ADP
a O DET
discontinued O VERB
randomized O VERB
controlled O VERB
trial, O NOUN
in O ADP
which O ADP
participants O NOUN
received O VERB
hippotherapy O NOUN
or O CCONJ
standard O ADJ
outpatient O ADJ
clinic O ADJ
PT O NOUN
for O ADP
a O DET
12-week O NOUN
treatment O NOUN
period. O NOUN

BACKGROUND: O NOUN
Large O ADJ
scale O NOUN
administration O NOUN
of O ADP
the O DET
anthelminthic O ADJ
drug O NOUN
praziquantel O NOUN
(PZQ) O NOUN
to O PART
at-risk O NOUN
populations O NOUN
is O VERB
the O DET
cornerstone O NOUN
of O ADP
schistosomiasis O NOUN
control, O NOUN
although O ADP
persisting O VERB
high O ADJ
prevalence O NOUN
of O ADP
infections O NOUN
in O ADP
some O DET
areas O NOUN
and O CCONJ
growing O VERB
concerns O NOUN
of O ADP
PZQ O NOUN
resistance O NOUN
have O VERB
revealed O VERB
the O DET
limitations O NOUN
of O ADP
this O DET
strategy. O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

Participants O NOUN
who O ADP
were O VERB
not O ADV
already O ADV
taking O VERB
vitamin O NOUN
D O NOUN
supplements O NOUN
received O VERB
cholecalciferol O NOUN
before O ADP
the O DET
trial O NOUN
began O VERB
(a O PUNCT
single O ADJ
dose O NOUN
of O ADP
2.5 O NUM
mg) O NOUN
and O CCONJ
during O ADP
the O DET
trial O NOUN
(1.25 O NOUN
mg O NOUN
per O ADP
month). O NOUN

Jitter O NOUN
plots O NOUN
of O ADP
the O DET
individual O ADJ
SFS24 O ADJ
values O NOUN
versus O CCONJ
plasma O NOUN
NT O NOUN
concentrations O NOUN
were O VERB
significantly O ADV
correlated O VERB
in O ADP
benign O ADJ
and O CCONJ
cancer O NOUN
patients O NOUN
(r=-0.284, O NUM
p=0.028). O NOUN

Moderately O ADV
vitamin O NOUN
B12-deficient O NOUN
participants O NOUN
aged O VERB
between O ADP
45 O NUM
and O CCONJ
75 O NUM
years O NOUN
(n O NOUN
= O SYM
56) O NOUN
were O VERB
recruited O VERB
into O ADP
this O DET
randomised O VERB
controlled O VERB
crossover O NOUN
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
['2019/10/18 O NOUN
06:00' O NUM

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

They O PRON
were O VERB
randomly O ADV
divided O VERB
into O ADP
2 O NUM
groups O NOUN
of O ADP
120 O NUM
each. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
date: O NOUN
2018/12/03 O ADJ
00:00 O NOUN
[accepted] O ADV

Outcomes O NOUN
were O VERB
performed O VERB
on O ADP
a O DET
simulated O VERB
cardiac O ADJ
arrest O NOUN
case O NOUN
adapted O VERB
from O ADP
the O DET
AHA O NOUN
Advanced O VERB
Cardiac O ADJ
Life O NOUN
Support O NOUN
(ACLS) O PUNCT
SimMan(R) O ADV
Scenario O NOUN
manual. O NOUN

The O DET
patients O NOUN
inhaled O VERB
hydrogen O NOUN
gas O NOUN
for O ADP
3 O NUM
h/day O NOUN
at O ADP
their O ADJ
own O ADJ
homes O NOUN
and O CCONJ
received O VERB
chemotherapy O NOUN
at O ADP
the O DET
Tamana O NOUN
Regional O ADJ
Health O NOUN
Medical O ADJ
Center O NOUN
(Tamana, O NUM
Kumamoto, O ADJ
Japan). O NOUN

Objective:To O NOUN
investigate O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
LOPasparaginase O NOUN
+ O SYM
vincristine O ADV
+ O SYM
dexamethasone O NOUN
chemotherapy O NOUN
combined O VERB
with O ADP
radiotherapy O NOUN
in O ADP
patients O NOUN
with O ADP
nasal O ADJ
NK/T O NOUN
cell O NOUN
lymphoma. O NOUN

RESULTS: O NOUN
The O DET
mean O NOUN
+/- O SYM
SD O NOUN
of O ADP
total O ADJ
induction B-outcome NOUN
time I-outcome NOUN
was O VERB
180.5 O NUM
+/- O SYM
49.0 O NUM
s O NOUN
in O ADP
Group O NOUN
N O NOUN
and O CCONJ
246.3 O NUM
+/- O SYM
64.7 O NUM
s O NOUN
in O ADP
Group O NOUN
R O NOUN
(mean O NUM
difference: O NOUN
65.8 O NUM
seconds; O NOUN
95% O NOUN
CI: O NOUN
35.0-96.5 O NUM
s, O NOUN
P O NOUN
< O SYM
.01). O PUNCT

Compared O VERB
with O ADP
group O NOUN
C, O NOUN
the O DET
number O NOUN
of O ADP
patients O NOUN
with O ADP
postoperative O ADJ
pain B-outcome NOUN
(VAS O PUNCT
score>/=4) O NOUN
in O ADP
group O NOUN
D O NOUN
was O VERB
obviously O ADV
less O ADV
at O ADP
T(6), O NOUN
T(7), O NOUN
T(8)(10 O NOUN
vs O CCONJ
20, O NUM
4 O NUM
vs O CCONJ
12, O NUM
3 O NUM
vs O CCONJ
10; O NUM
chi(2)=4.762, O NOUN
4.762, O NOUN
4.332, O PUNCT
respectively; O NOUN
all O DET
P<0.05). O NOUN

Journal-Name:Beijing O VERB
da O NOUN
xue O NOUN
xue O NOUN
bao. O ADP

RBR-3x7gz8 O NOUN
). O NOUN

Time B-outcome NOUN
to I-outcome PART
Bispectral I-outcome ADJ
index I-outcome NOUN
(BIS) I-outcome PUNCT
60 I-outcome NUM
and O CCONJ
rocuronium B-outcome NOUN
onset I-outcome NOUN
time I-outcome NOUN
were O VERB
longer O ADJ
in O ADP
the O DET
Group O NOUN
R O NOUN
(P O NUM
< O SYM
.01 O NUM
and O CCONJ
P O NOUN
< O SYM
.01, O PUNCT
respectively). O NOUN

+25d O NOUN
post-exercise O NOUN
epinephrine B-outcome NOUN
was O VERB
higher O ADJ
in O ADP
CON O NOUN
vs. O CCONJ
IHE O NOUN
(p=0.04). O PUNCT

Title: O NOUN
The O DET
Effects O NOUN
of O ADP
Tai O NOUN
Chi O NOUN
on O ADP
Heart B-outcome NOUN
Rate I-outcome NOUN
Variability I-outcome NOUN
in O ADP
Older O ADJ
Chinese O NOUN
Individuals O NOUN
with O ADP
Depression. O NOUN

On O ADP
the O DET
same O ADJ
task, O NOUN
average O NOUN
reaction B-outcome NOUN
time I-outcome NOUN
improved O VERB
(treatment O NUM
effect, O NOUN
p O NOUN
= O SYM
0.036) O NUM
with O ADP
PSE O NOUN
at O ADP
Day O NOUN
7 O NUM
(PSE O NUM
vs. O CCONJ
PLA: O NOUN
0.5896 O NUM
+/- O SYM
0.060 O NUM
vs. O CCONJ
0.6141 O NUM
+/- O SYM
0.073 O NUM
s; O ADP
p O NOUN
= O SYM
0.049) O NOUN
and O CCONJ
Day O NOUN
30 O NUM
(PSE O NUM
vs. O CCONJ
PLA: O NOUN
0.5811 O NUM
+/- O SYM
0.068 O NUM
vs. O CCONJ
0.6033 O NUM
+/- O SYM
0.055 O NUM
s; O ADP
p O NOUN
= O SYM
0.049). O NUM

Publication O NOUN
date: O NOUN
['2019/10/10 O PUNCT
06:00' O NUM

The O DET
remifentanil O NOUN
effective O ADJ
concentration B-outcome NOUN
(EC50) O PUNCT
of O ADP
that O ADP
suppressed O VERB
responses O NOUN
to O PART
extubation O NOUN
during O ADP
anesthetic O ADJ
emergence O NOUN
was O VERB
1.20 O NUM
ng/mL O NOUN
in O ADP
group O NOUN
TEAS, O NOUN
a O DET
value O NOUN
that O ADP
was O VERB
significantly O ADV
lower O ADJ
than O ADP
the O DET
1.64 O NUM
ng/mL O NOUN
needed O VERB
by O ADP
patients O NOUN
in O ADP
group O NOUN
C.The O ADJ
TEAS O NOUN
can O VERB
enhance O NOUN
the O DET
efficacy O NOUN
of O ADP
remifentanil O NOUN
on O ADP
suppressing O VERB
responses B-outcome NOUN
to O PART
tracheal O ADJ
extubation O NOUN
in O ADP
elderly O NOUN
patients, O NOUN
the O DET
effective O ADJ
concentration B-outcome NOUN
(EC50) O PUNCT
of O ADP
remifentanil O NOUN
can O VERB
reduce O VERB
approximately O ADV
27% O NUM
compared O VERB
with O ADP
group O NOUN
C. O NOUN

Zero" O NOUN
marginal B-outcome ADJ
bone I-outcome NOUN
level O NOUN
(MBL) O NOUN
loss O NOUN
or O CCONJ
gain O VERB
was O VERB
measured O VERB
over O ADP
the O DET
3-year O NOUN
period O NOUN
at O ADP
72.1% O NUM
CI, O NOUN
3.0% O NOUN
FI, O NOUN
and O CCONJ
16.6% O NUM
PS O NOUN
implants. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Journal-Name:Journal O ADJ
of O ADP
ovarian O ADJ
research O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
reduction O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
contrast B-outcome NOUN
induced I-outcome VERB
nephropathy I-outcome NOUN
(CIN) I-outcome NOUN
. O PUNCT
The O DET
secondary O ADJ
outcomes O NOUN
were O VERB
the O DET
maximum O NOUN
improvement O NOUN
in O ADP
eGFR B-outcome NOUN
, O PUNCT
maximum O NOUN
reduction O NOUN
in O ADP
serum O NOUN
creatinine B-outcome NOUN
and O CCONJ
composite O NOUN
of O ADP
requirement O NOUN
of O ADP
hemodialysis B-outcome NOUN
, O PUNCT
death B-outcome NOUN
and O CCONJ
rehospitalization B-outcome NOUN
for Seperator ADP
heart I-outcome NOUN
failure I-outcome NOUN
up O ADP
to O PART
6 O NUM
weeks O NOUN
after O ADP
PCI. O NOUN

In O ADP
this O DET
study O NOUN
a O DET
total O ADJ
of O ADP
98 O NUM
patients O NOUN
with O ADP
MMC O NOUN
and O CCONJ
hydrocephalus O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
two O NUM
equal O ADJ
groups. O NOUN

METHODS: O NOUN
We O PRON
conducted O VERB
a O DET
randomized O VERB
controlled O VERB
trial O NOUN
on O ADP
46 O NUM
patients O NOUN
scheduled O VERB
to O PART
undergo O NOUN
THR. O NOUN

Treatments O NOUN
for O ADP
PPI-refractory O ADJ
heartburn O ADP
are O VERB
of O ADP
unproven O VERB
efficacy O NOUN
and O CCONJ
focus O NOUN
on O ADP
controlling O VERB
gastroesophageal O ADJ
reflux O NOUN
with O ADP
reflux-reducing O VERB
medication O NOUN
(e.g., O NOUN
baclofen) O NOUN
or O CCONJ
antireflux O NOUN
surgery O NOUN
or O CCONJ
on O ADP
dampening O VERB
visceral O ADJ
hypersensitivity O NOUN
with O ADP
neuromodulators O NOUN
(e.g., O NOUN
desipramine). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Tranexamic O ADJ
acid O NOUN
(TXA) O NOUN
is O VERB
an O DET
efficient O ADJ
antifibrinolytic O ADJ
agent, O NOUN
but O CCONJ
the O DET
mode O NOUN
and O CCONJ
timing O VERB
of O ADP
its O ADJ
administration O NOUN
remain O VERB
controversial. O NOUN

Further, O NOUN
amongst O ADP
all O DET
views, O NOUN
LAO O NOUN
views O NOUN
have O VERB
significantly O ADV
higher O ADJ
emitted O VERB
radiation O NOUN
as O ADP
compared O VERB
to O PART
Non O NOUN
LAO O NOUN
views O NOUN
and O CCONJ
need O NOUN
more O ADV
radiation O NOUN
protection. O NOUN

Moreover, O NOUN
gastrocnemius B-outcome NOUN
medialis I-outcome NOUN
and Seperator CCONJ
biceps B-outcome VERB
femoris I-outcome NOUN
muscle I-outcome NOUN
peak I-outcome NOUN
activation E3-outcome NOUN
during O ADP
loading O VERB
response O NOUN
decreased O VERB
by O ADP
8.36%MVIC O NUM
(95% O PUNCT
CI O NOUN
= O SYM
2.71, O NUM
14.02) O ADJ
and O CCONJ
3.54%MVIC O NUM
(95% O PUNCT
CI O NOUN
= O SYM
1.08, O NUM
6.01), O ADP
respectively, O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
overtime. O ADJ

Work-related B-outcome VERB
fear I-outcome ADJ
of I-outcome ADP
pain I-outcome NOUN
was O VERB
reduced O VERB
in O ADP
both O CCONJ
the O DET
Combined- O NOUN
(p O PUNCT
= O SYM
0.003) O NUM
and O CCONJ
Exercise-arm O NUM
(p O PUNCT
= O SYM
0.002). O NUM

A O DET
diet O NOUN
enriched O VERB
in O ADP
CSO, O NOUN
a O DET
rich O ADJ
source O NOUN
of O ADP
alpha-linolenic O ADJ
acid O NOUN
(ALA), O PUNCT
decreased O VERB
PBMC O NOUN
IFNG O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
(P O NUM
< O SYM
0.01). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Medicine O NOUN

The O DET
incidence O NOUN
of O ADP
new O ADJ
demineralized B-outcome VERB
lesions I-outcome NOUN
was O VERB
24%; O NUM
but O CCONJ
when O ADP
the O DET
esthetic B-outcome ADJ
impact O NOUN
was O VERB
taken O VERB
into O ADP
account, O NOUN
this O DET
was O VERB
considerably O ADV
lower O ADJ
(9%). O NUM

Title: O NOUN
Rivaroxaban O NOUN
for O ADP
Thromboprophylaxis O NOUN
in O ADP
High-Risk O NOUN
Ambulatory O ADJ
Patients O NOUN
with O ADP
Cancer. O ADV

CONCLUSIONS: O NOUN
Oral O ADJ
antibiotic O ADJ
therapy O NOUN
was O VERB
noninferior O ADJ
to O PART
intravenous O ADJ
antibiotic O ADJ
therapy O NOUN
when O ADP
used O VERB
during O ADP
the O DET
first O ADV
6 O NUM
weeks O NOUN
for O ADP
complex O NOUN
orthopedic O ADJ
infection, O NOUN
as O ADP
assessed O VERB
by O ADP
treatment B-outcome NOUN
failure I-outcome NOUN
at O ADP
1 O NUM
year. O NOUN
( O PUNCT

Prot. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

The O DET
results O NOUN
have O VERB
contributed O VERB
to O PART
the O DET
establishing O VERB
of O ADP
an O DET
HA O NOUN
vaccination O NOUN
policy O NOUN
in O ADP
Korea O NOUN
and O CCONJ
will O VERB
be O VERB
informative O NOUN
to O PART
countries O NOUN
that O ADP
plan O NOUN
to O PART
initiate O VERB
vaccination O NOUN
programs O NOUN
against O ADP
HAV. O NOUN

ATLG O NOUN
was O VERB
descriptively O ADV
superior O ADJ
to O PART
non-ATLG O NOUN
at O ADP
24 O NUM
months O NOUN
for O ADP
physical B-outcome ADJ
function I-outcome NOUN
(points O NOUN
estimate O ADP
-14.8 O NUM
[95% O NOUN
CI O NOUN
-26.4 O NUM
to O PART
-3.1]; O NUM
p=0.014) O NOUN
and O CCONJ
social B-outcome ADJ
function I-outcome NOUN
(-19.1 O NOUN
[-38.0 O NOUN
to O PART
-0.2]; O NUM
p=0.047), O NOUN
gastrointestinal B-outcome ADJ
side-effects I-outcome NOUN
(8.8 O PUNCT
[2.5-15.1]; O NOUN
p=0.008) O NUM
and O CCONJ
effect O NOUN
on O ADP
family O NOUN
(13.5 O NUM
[1.2-25.8]; O SYM
p=0.032). O NOUN

CONCLUSION: O NOUN
In O ADP
patients O NOUN
undergoing O VERB
primary O ADJ
cementless O NOUN
THA, O NOUN
using O VERB
a O DET
posterior O ADJ
approach, O NOUN
who O ADP
are O VERB
treated O VERB
with O ADP
rivaroxaban O ADJ
for O ADP
thromboembolic O ADJ
prophylaxis, O NOUN
short- O NOUN
and O CCONJ
long-TXA O NOUN
IV O NUM
protocols O NOUN
are O VERB
significantly O ADV
more O ADV
effective O ADJ
than O ADP
placebo O NOUN
in O ADP
reducing O VERB
perioperative O ADJ
real O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(RBL), O PUNCT
without O ADP
any O DET
thromboembolic B-outcome ADJ
complications I-outcome NOUN
. O PUNCT
Non-inferiority O NOUN
of O ADP
a O DET
short- O NOUN
versus O CCONJ
a O DET
long-TXA O NOUN
protocol O NOUN
in O ADP
reducing O VERB
perioperative O ADJ
real O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(RBL) O PUNCT
was O VERB
supported O VERB
in O ADP
a O DET
secondary O ADJ
analysis. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
posttraumatic B-outcome ADJ
stress I-outcome NOUN
disorder I-outcome ADP
(PTSD) I-outcome ADV
symptom I-outcome NOUN
severity I-outcome NOUN
at O ADP
6 O NUM
months O NOUN
(treatment O NUM
effect O NOUN
estimate O ADP
[difference O ADP
in O ADP
differences O NOUN
of O ADP
-0.03 O NUM
[95% O NOUN
CI, O NOUN
-2.58 O NUM
to O PART
2.52]; O NUM
P O NOUN
= O SYM
.98). O NUM

METHODS: O NOUN
Baltimore O NOUN
CONNECT O NOUN
involved O VERB
22 O NUM
CBOs O NOUN
in O ADP
East O ADV
Baltimore O NOUN
randomized O VERB
to O PART
a O DET
co-developed O VERB
intervention O NOUN
bundle O NOUN
versus O CCONJ
control. O NOUN

Title: O NOUN
Piloting O VERB
a O DET
participatory, O ADJ
community-based O VERB
health O NOUN
information O NOUN
system O NOUN
for O ADP
strengthening O VERB
community-based O VERB
health O NOUN
services: O NOUN
findings O NOUN
of O ADP
a O DET
cluster-randomized O VERB
controlled O VERB
trial O NOUN
in O ADP
the O DET
slums O NOUN
of O ADP
Freetown, O NOUN
Sierra O NOUN
Leone. O NOUN

RESULTS: O NOUN
The O DET
mean O NOUN
age O NOUN
of O ADP
participants O NOUN
was O VERB
21.83 O NUM
+/- O SYM
2.07 O NUM
years. O NOUN

Publication O NOUN
date: O NOUN
2019/03/05 O NOUN
06:00 O ADP
[medline] O NOUN

Title: O NOUN
Clinical O ADJ
research O NOUN
on O ADP
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
Bosinji O NOUN
for O ADP
low O ADJ
back O ADP
pain O NOUN
with O ADP
radiculopathy O ADJ
caused O VERB
by O ADP
herniated O VERB
intervertebral O ADJ
disc O NOUN
of O ADP
the O DET
lumbar O ADJ
spine: O NOUN
A O DET
protocol O NOUN
for O ADP
a O DET
multicenter, O NOUN
randomized, O NOUN
controlled O VERB
equivalence O NOUN
trial. O NOUN

In O ADP
the O DET
control O NOUN
group, O NOUN
19 O NUM
cases O NOUN
were O VERB
successfully O ADV
hemostatic B-outcome ADJ
in O ADP
3 O NUM
minutes, O NOUN
4 O NUM
cases O NOUN
were O VERB
successful O ADJ
in O ADP
5 O NUM
minutes, O NOUN
and O CCONJ
7 O NUM
cases O NOUN
were O VERB
combined O VERB
with O ADP
hemostasis. O NOUN

Title: O NOUN
Intraduodenal O ADJ
Administration O NOUN
of O ADP
L-Valine O NOUN
Has O NOUN
No O DET
Effect O NOUN
on O ADP
Antropyloroduodenal B-outcome ADJ
Pressures I-outcome NOUN
, O PUNCT
Plasma O NOUN
Cholecystokinin B-outcome NOUN
Concentrations O NOUN
or O CCONJ
Energy B-outcome NOUN
Intake I-outcome NOUN
in O ADP
Healthy, O NOUN
Lean O ADJ
Men. O NOUN

Amnestic O ADJ
mild O ADJ
cognitive O ADJ
impairment O NOUN
(aMCI), O ADJ
an O DET
Alzheimer's O NOUN
disease O NOUN
prodrome, O ADJ
is O VERB
characterized O VERB
by O ADP
cognitive O ADJ
and O CCONJ
psychological O ADJ
symptoms, O NOUN
the O DET
latter O NOUN
aggravating O VERB
prognosis. O NOUN

Results: O NOUN
Overall, O NOUN
402 O NUM
patients O NOUN
(30 O NOUN
mg: O ADV
134; O NUM
100 O NUM
mg: O ADV
135; O NUM
300 O NUM
mg: O ADV
133) O NOUN
were O VERB
treated O VERB
and O CCONJ
evaluable O ADJ
for O ADP
efficacy O NOUN
and O CCONJ
safety. O ADJ

Journal-Name:Lancet O NOUN
(London, O PUNCT
England) O NOUN

BACKGROUND: O NOUN
Congenital O ADJ
nasolacrimal O ADJ
duct O NOUN
obstruction O NOUN
(CNLDO) O PUNCT
is O VERB
common O ADJ
and. O NOUN

After O ADP
in O ADP
vitro O ADV
GI O NOUN
digestion, O NOUN
intestinal O ADJ
bioaccessibility O NOUN
of O ADP
RSV O NOUN
was O VERB
92.3%. O NOUN

In O ADP
intervention O NOUN
arm, O ADJ
one O NUM
child O NOUN
had O VERB
rheumatic B-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
(RHD) I-outcome PUNCT
while O ADP
three O NUM
had O VERB
congenital B-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
; O PUNCT
in O ADP
control O NOUN
arm, O ADJ
one O NUM
child O NOUN
had O VERB
congenital B-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
and O CCONJ
three O NUM
had O VERB
rheumatic B-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
(RHD) I-outcome PUNCT
. O PUNCT
CONCLUSIONS: O NOUN
School O NOUN
based O VERB
surveillance O NOUN
had O VERB
higher O ADJ
rate O NOUN
of O ADP
suspecting O VERB
children O NOUN
with O ADP
acute B-outcome ADJ
pharyngitis I-outcome NOUN
and O CCONJ
or O CCONJ
rheumatic B-outcome ADJ
fever/rheumatic I-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
(RF/RHD) I-outcome NOUN
although O ADP
with O ADP
low O ADJ
specificity. O NOUN

RESULTS: O NOUN
There O PRON
were O VERB
positive O ADJ
associations O NOUN
among O ADP
SPC, O NOUN
MSI, O ADV
and O CCONJ
EBV O NOUN
statuses O NOUN
among O ADP
586 O NUM
patients. O NOUN

METHODS: O NOUN
We O PRON
used O VERB
data O NOUN
from O ADP
the O DET
Fluid O NOUN
Lavage O NOUN
of O ADP
Open O ADJ
Wounds O NOUN
trial O NOUN
to O PART
determine, O NOUN
in O ADP
1560 O NUM
open O ADJ
fracture O NOUN
patients O NOUN
undergoing O VERB
surgical O ADJ
repair, O ADJ
the O DET
association O NOUN
between O ADP
Somatic O ADJ
PreOccupation O NOUN
and O CCONJ
Coping O VERB
(captured O PUNCT
by O ADP
the O DET
SPOC O NOUN
questionnaire) O NOUN
and O CCONJ
recovery O NOUN
at O ADP
1 O NUM
yr. O PUNCT

The O DET
increase O NOUN
in O ADP
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
was O VERB
parallel O ADJ
to O PART
the O DET
improvement O NOUN
of O ADP
insulin B-outcome NOUN
resistance I-outcome NOUN
parameters. O NOUN

No O DET
additional O ADJ
side B-outcome NOUN
effect I-outcome NOUN
was O VERB
observed O VERB
by O ADP
adding O VERB
spinal O ADJ
Dex. O NOUN

All O DET
groups O NOUN
perceived O VERB
the O DET
instruction O NOUN
as O ADP
effective. O ADJ

RESULTS: O NOUN
The O DET
general O ADJ
score O NOUN
of O ADP
the O DET
depression B-outcome NOUN
after O ADP
yoga O NOUN
intervention O NOUN
was O VERB
statistically O ADV
significant O ADJ
compared O VERB
to O PART
the O DET
control O NOUN
group O NOUN
(P<0.036) O NUM
and O CCONJ
yoga O NOUN
group O NOUN
before O ADP
intervention O NOUN
(P<0.001). O NOUN

CONCLUSION: O NOUN
In O ADP
second-line O NOUN
treatment O NOUN
for O ADP
metastatic O ADJ
colorectal O ADJ
cancer, O NOUN
mFOLFOX6 O NOUN
or O CCONJ
FOLFIRI O NOUN
with O ADP
erlotinib O NOUN
in O ADP
a O DET
sequence-dependent O ADJ
fashion O NOUN
is O VERB
not O ADV
feasible O ADJ
despite O ADP
potential O ADJ
promising O VERB
activity. O NOUN

Findings O NOUN
may O VERB
also O ADV
be O VERB
used O VERB
by O ADP
decision-makers O NOUN
interested O VERB
in O ADP
implementing O VERB
the O DET
mhGAP-IG O NOUN
training O VERB
in O ADP
other O ADJ
LMICs. O VERB

The O DET
secondary O ADJ
end O NOUN
points O NOUN
were O VERB
also O ADV
comparable O ADJ
between O ADP
the O DET
two O NUM
groups- O NOUN
Death B-outcome NOUN
- O PUNCT
1 O NUM
of O ADP
85(1.17%) O NUM
vs. O CCONJ
2 O NUM
of O ADP
98(2.04%), O NOUN
p O NOUN
= O SYM
0.646, O NUM
Stroke B-outcome NOUN
0 O NUM
of O ADP
85 O NUM
vs. O CCONJ
2 O NUM
of O ADP
98(2.04%), O NOUN
p O NOUN
= O SYM
0.185 O NUM
and O CCONJ
acute B-outcome ADJ
coronary I-outcome ADJ
syndrome I-outcome NOUN
- O PUNCT
2 O NUM
of O ADP
85(2.35%) O NUM
vs. O CCONJ
1 O NUM
of O ADP
98(1.02%), O NOUN
p O NOUN
= O SYM
0.204. O NUM

L(- O NOUN
1)) O NOUN
was O VERB
monitored O VERB
pre-post O NOUN
time-trial O ADJ
and O CCONJ
following O VERB
maximal O ADJ
sprint O NOUN
efforts. O NOUN

Patients O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
found O VERB
that O ADP
the O DET
rehabilitation O NOUN
sessions O NOUN
were O VERB
easier B-outcome NOUN
(p O PUNCT
= O SYM
0.048). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Funded O VERB
by O ADP
the O DET
Health O NOUN
Technology O NOUN
Assessment O NOUN
Programme O NOUN
of O ADP
the O DET
National O ADJ
Institute O NOUN
for O ADP
Health O NOUN
Research; O NOUN
SIFT O NOUN
Current O ADJ
Controlled O VERB
Trials O NOUN
number, O ADV
ISRCTN76463425.). O NUM

Journal-Name:Nutrients O NOUN

The O DET
APPAC O NOUN
II O NUM
trial O NOUN
aims O NOUN
to O PART
add O NOUN
clinical O ADJ
evidence O NOUN
on O ADP
the O DET
debated O VERB
role O NOUN
of O ADP
antibiotics O NOUN
as O ADP
the O DET
first-line O NOUN
treatment O NOUN
for O ADP
a O DET
CT-confirmed O VERB
uncomplicated O VERB
acute O ADJ
appendicitis O NOUN
as O ADP
well O ADV
as O ADP
to O PART
optimise O NOUN
the O DET
non-operative O ADJ
treatment O NOUN
for O ADP
uncomplicated O VERB
acute O ADJ
appendicitis. O NOUN

CONCLUSION: O NOUN
These O DET
results O NOUN
suggest O VERB
that O ADP
toric O ADJ
contact O NOUN
lenses O NOUN
provided O ADJ
improved O VERB
objective O ADP
measures O NOUN
of O ADP
vision B-outcome NOUN
in O ADP
a O DET
low-to-moderate O NOUN
astigmatic O ADJ
population. O ADV

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

The O DET
patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
1 O NUM
of O ADP
2 O NUM
groups: O NOUN
Group O NOUN
1 O NUM
patients O NOUN
received O VERB
curettage O NOUN
plus O CCONJ
NCH O NOUN
gel O NOUN
(intervention O PUNCT
group), O NOUN
and O CCONJ
group O NOUN
2 O NUM
patients O NOUN
received O VERB
curettage O NOUN
alone O ADJ
(control O PUNCT
group). O NOUN

Publication O NOUN
date: O NOUN
2019/02/16 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
2019/02/07 O ADJ
06:00 O ADP
[entrez] O ADP

We O PRON
calculated O VERB
cause-specific O ADJ
hazard O NOUN
ratio's O NOUN
(HR's) O NUM
for O ADP
effects O NOUN
of O ADP
time-dependent O ADJ
macrolide B-outcome NOUN
and O CCONJ
fluoroquinolone B-outcome ADJ
exposure O NOUN
as O ADP
compared O VERB
to O PART
beta-lactam O NOUN
monotherapy O NOUN
on O ADP
cardiac B-outcome ADJ
events I-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
new O ADJ
or O CCONJ
worsening O VERB
heart B-outcome NOUN
failure, I-outcome NOUN
arrhythmia, B-outcome NOUN
or Seperator CCONJ
myocardial B-outcome ADJ
ischemia I-outcome NOUN
during I-outcome ADP
hospitalization E2-outcome NOUN
. O PUNCT
RESULTS: O NOUN
Cardiac B-outcome ADJ
events I-outcome NOUN
occurred O VERB
in O ADP
146 O NUM
(6.9%) O NUM
of O ADP
2107 O NUM
patients, O NOUN
including O VERB
heart B-outcome NOUN
failure I-outcome NOUN
(n O NOUN
= O SYM
101, O NOUN
4.8%), O NOUN
arrhythmia B-outcome NOUN
(n O NOUN
= O SYM
53, O NOUN
2.5%), O NUM
and O CCONJ
myocardial B-outcome ADJ
ischemia I-outcome NOUN
(n O NOUN
= O SYM
14, O NUM
0.7%). O NUM

This O DET
study O NOUN
explores O NOUN
the O DET
effects O NOUN
of O ADP
sponsorship O NOUN
of O ADP
an O DET
elite O ADP
sporting O VERB
event O NOUN
by: O NOUN
(A) O PUNCT
non-food O NOUN
brands O NOUN
(control), O PUNCT
(B) O PUNCT
unhealthy O NOUN
food O NOUN
brands, O NOUN
(C) O NOUN
healthier O ADJ
food O NOUN
brands, O NOUN
or O CCONJ
(D) O NOUN
an O DET
obesity O NOUN
prevention O NOUN
public O ADJ
health O NOUN
campaign O ADV
on O ADP
young O ADJ
adults' O NOUN
brand B-outcome NOUN
awareness I-outcome ADV
, O PUNCT
attitudes B-outcome NOUN
, O PUNCT
image B-outcome NOUN
perceptions I-outcome NOUN
, O PUNCT
event-sponsor B-outcome NOUN
fit I-outcome NOUN
perceptions I-outcome NOUN
, O PUNCT
and O CCONJ
preference B-outcome NOUN
for O ADP
food O NOUN
sponsors' O ADJ
products. O NOUN

BACKGROUND: O NOUN
Total O ADJ
knee O NOUN
arthroplasty O NOUN
(TKA) O ADV
is O VERB
a O DET
surgical O ADJ
procedure O NOUN
to O PART
replace O NOUN
the O DET
weight-bearing O VERB
surfaces O NOUN
of O ADP
the O DET
knee O NOUN
joint O NOUN
to O PART
relieve O NOUN
pain O NOUN
and O CCONJ
disability. O NOUN

It O PRON
aims O NOUN
to O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
a O DET
late O ADJ
first-trimester O NOUN
(>12 O NOUN
gestational O ADJ
weeks) O NOUN
degree O NOUN
of O ADP
adherence O NOUN
to O PART
a O DET
MedDiet O NOUN
pattern-based O VERB
on O ADP
six O NUM
food O NOUN
targets-on O NOUN
a O DET
composite O NOUN
of O ADP
materno-foetal O ADJ
outcomes O NOUN
(CMFCs). O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
ambulatory O ADJ
adults O NOUN
with O ADP
hypertension, O NOUN
treating O VERB
to O PART
a O DET
systolic O ADJ
blood O NOUN
pressure O NOUN
goal O NOUN
of O ADP
less O ADV
than O ADP
120 O NUM
mm O NOUN
Hg O NOUN
compared O VERB
with O ADP
a O DET
goal O NOUN
of O ADP
less O ADV
than O ADP
140 O NUM
mm O NOUN
Hg O NOUN
did O VERB
not O ADV
result O VERB
in O ADP
a O DET
significant O ADJ
reduction O NOUN
in O ADP
the O DET
risk O NOUN
of O ADP
probable O ADJ
dementia B-outcome NOUN
. O PUNCT
Because O ADP
of O ADP
early O ADJ
study O NOUN
termination O NOUN
and O CCONJ
fewer O ADJ
than O ADP
expected O VERB
cases O NOUN
of O ADP
dementia, O NOUN
the O DET
study O NOUN
may O VERB
have O VERB
been O VERB
underpowered O VERB
for O ADP
this O DET
end O NOUN
point. O NOUN

However, O ADV
these O DET
results O NOUN
can O AUX
not O ADV
be O VERB
representative O ADJ
of O ADP
a O DET
heavy O ADJ
workload O ADP
or O CCONJ
incident O ADJ
situations O NOUN
for O ADP
which O ADP
radiation O NOUN
exposure O NOUN
to O PART
the O DET
eye-lens O NOUN
could O VERB
exceed O NOUN
this O DET
limit. O NOUN

As O ADP
we O PRON
now O ADV
know O NOUN
that O ADP
antibiotic O ADJ
therapy O NOUN
for O ADP
uncomplicated O VERB
acute O ADJ
appendicitis O NOUN
is O VERB
feasible O ADJ
and O CCONJ
safe, O NOUN
further O ADV
studies O NOUN
evaluating O VERB
optimisation O NOUN
of O ADP
the O DET
antibiotic O ADJ
treatment O NOUN
regarding O VERB
both O CCONJ
antibiotic O ADJ
spectrum O NOUN
and O CCONJ
shorter O ADJ
hospital O NOUN
stay O NOUN
are O VERB
needed O VERB
to O PART
evaluate O VERB
antibiotics O NOUN
as O ADP
the O DET
first-line O NOUN
treatment O NOUN
for O ADP
uncomplicated O VERB
acute O ADJ
appendicitis. O NOUN

INTERVENTIONS: O NOUN
60 O NUM
midwifery O NOUN
practices O NOUN
offered O VERB
usual O ADJ
care O NOUN
(serial O ADJ
fundal O ADJ
height O NOUN
measurements O NOUN
with O ADP
clinically O ADV
indicated O VERB
ultrasonography). O NUM

Total O ADJ
treatment B-outcome NOUN
times I-outcome NOUN
were O VERB
9.7 O NUM
+/- O SYM
1.1 O NUM
months O NOUN
for O ADP
the O DET
IA O NOUN
group O NOUN
and O CCONJ
9.5 O NUM
+/- O SYM
1.1 O NUM
months O NOUN
for O ADP
the O DET
MA O NOUN
group. O VERB

Biochemical B-outcome ADJ
failure I-outcome NOUN
tended O ADP
to O PART
be O VERB
a O DET
late O ADJ
event O NOUN
with O ADP
a O DET
median O ADJ
time O NOUN
to O PART
occurrence O NOUN
of O ADP
5 O NUM
years. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

Also, O ADJ
compared O VERB
to O PART
the O DET
control O NOUN
group, O NOUN
LF O NOUN
decreased O VERB
ICAM1 O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
(P O NUM
< O SYM
0.05). O NOUN

Journal-Name:Revista O NOUN
da O NOUN
Associacao O NOUN
Medica O NOUN
Brasileira O NOUN
(1992) O PUNCT

CONCLUSIONS: O NOUN
Our O ADJ
evidence O NOUN
showed O VERB
that O ADP
the O DET
brief O ADJ
group O NOUN
intervention O NOUN
performed O VERB
by O ADP
the O DET
nurse O ADJ
in O ADP
the O DET
primary O ADJ
health O NOUN
care O NOUN
context O NOUN
was O VERB
effective O ADJ
to O PART
reduce O VERB
alcohol B-outcome NOUN
consumption I-outcome NOUN
in O ADP
individuals O NOUN
with O ADP
patterns O NOUN
of O ADP
hazardous O ADJ
or O CCONJ
harmful O ADJ
use. O PUNCT

Operation B-outcome NOUN
time I-outcome NOUN
and O CCONJ
difficulty B-outcome NOUN
of O ADP
finding O VERB
the O DET
specimen O NOUN
was O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
modified O VERB
localization O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
methylene O NOUN
blue O ADJ
localization O NOUN
group O NOUN
(P O NUM
< O SYM
.05). O NUM

We O PRON
randomly O ADV
assigned O VERB
clusters O NOUN
(1:1) O NOUN
using O VERB
a O DET
computer O NOUN
generated O VERB
random O NOUN
sequence. O NOUN

The O DET
overarching O VERB
study O NOUN
aim O ADP
was O VERB
to O PART
understand O ADP
how O ADP
schools O NOUN
implemented B-outcome VERB
the O DET
AS:Sk O NUM
intervention, O ADP
with O ADP
a O DET
specific O ADJ
focus O NOUN
on O ADP
the O DET
frequency O NOUN
of O ADP
intervention B-outcome NOUN
component I-outcome NOUN
implementation I-outcome NOUN
, O PUNCT
and O CCONJ
how O ADP
the O DET
components O NOUN
were O VERB
incorporated B-outcome VERB
into O ADP
the O DET
school O NOUN
day. O NOUN

BACKGROUND: O NOUN
The O DET
prevalence O NOUN
of O ADP
obesity O NOUN
has O VERB
increased O VERB
significantly O ADV
worldwide O ADJ
within O ADP
the O DET
last O NOUN
decade. O NOUN

The O DET
patients' O NOUN
preoperative O ADJ
and O CCONJ
intraoperative O ADJ
anxiety B-outcome NOUN
scores O NOUN
were O VERB
assessed O VERB
with O ADP
the O DET
State O NOUN
Anxiety B-outcome NOUN
Inventory O ADJ
(SAI) O NUM
on O ADP
the O DET
day O NOUN
before O ADP
and O CCONJ
on O ADP
the O DET
first O ADV
day O NOUN
after O ADP
the O DET
surgery, O NOUN
respectively. O NOUN

Background O NOUN
Knee O NOUN
pain O NOUN
is O VERB
one O NUM
of O ADP
the O DET
common O ADJ
complaints O NOUN
patients O NOUN
present O ADJ
with O ADP
in O ADP
any O DET
community O NOUN
based O VERB
health O NOUN
camps O NOUN
and O CCONJ
Osteoarthritis O NOUN
of O ADP
knee O NOUN
is O VERB
a O DET
usual O ADJ
diagnosis. O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study O NOUN

Twenty-three O NUM
survivors O NOUN
of O ADP
BC O NOUN
were O VERB
included O VERB
in O ADP
this O DET
analysis. O NOUN

2) O NOUN
Compared O VERB
with O ADP
the O DET
results O NOUN
at O ADP
baseline, O NOUN
subjective O ADJ
sleep B-outcome NOUN
quality I-outcome NOUN
(SQ) I-outcome ADV
, O PUNCT
sleep B-outcome NOUN
onset I-outcome NOUN
latency I-outcome NOUN
(SOL) I-outcome NOUN
, O PUNCT
sleep B-outcome NOUN
efficiency I-outcome NOUN
(SE) I-outcome NOUN
, O PUNCT
sleep B-outcome NOUN
disturbance I-outcome NOUN
(SD) I-outcome NOUN
and O CCONJ
used O VERB
sleep B-outcome NOUN
medication I-outcome NOUN
(USM) O PUNCT
in O ADP
PSQI O NOUN
in O ADP
combination O NOUN
group O NOUN
significantly O ADV
decreased O VERB
at O ADP
week O NOUN
4 O NUM
and O CCONJ
8 O NUM
(all O PUNCT
P<0.05) O NOUN
. O PUNCT

Palo O NOUN
Alto, O NOUN
CA, O NOUN
USA. O NOUN

METHODS: O NOUN
This O DET
2-arm O NOUN
randomized O VERB
controlled O VERB
trial O NOUN
(RCT) O NUM
enrolled O VERB
86 O NUM
eligible O ADJ
patients O NOUN
with O ADP
CUR O NOUN
following O VERB
TBI. O NOUN

In O ADP
addition, O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
also O ADV
recorded O VERB
during O ADP
the O DET
study O NOUN
period. O NOUN

Recent O ADJ
studies O NOUN
have O VERB
demonstrated O VERB
that O ADP
the O DET
energy O NOUN
provided O ADJ
by O ADP
several O ADJ
tree O NOUN
nuts O NOUN
is O VERB
less O ADV
than O ADP
that O ADP
predicted O VERB
by O ADP
the O DET
Atwater O ADV
factors, O NOUN
though O ADP
energy O NOUN
available O ADJ
from O ADP
cashews O NOUN
has O VERB
never O ADV
been O VERB
assessed. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Registration O NOUN
name: O NOUN
Virtual O ADJ
Task O NOUN
in O ADP
Amyotrophic O ADJ
Lateral O ADJ
Sclerosis; O NOUN
Registration O NOUN
number: O NOUN
NCT03113630 O NOUN
; O PUNCT
retrospectively O ADV
registered O VERB
on O ADP
04/13/2017. O NUM

The O DET
capacity O NOUN
of O ADP
HMCs O NOUN
and O CCONJ
WDCs O NOUN
to O PART
engage O NOUN
with O ADP
the O DET
local O ADJ
health O NOUN
system O NOUN
was O VERB
also O ADV
measured O VERB
at O ADP
baseline O NOUN
and O CCONJ
endline. O NOUN

Title: O NOUN
Combined O VERB
intravenous O ADJ
and O CCONJ
intra-articular O ADJ
tranexamic O ADJ
acid O NOUN
administration O NOUN
in O ADP
total O ADJ
knee O NOUN
arthroplasty O NOUN
for O ADP
preventing O VERB
blood B-outcome NOUN
loss I-outcome NOUN
and O CCONJ
hyperfibrinolysis B-outcome NOUN
: O PUNCT
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

No O DET
adverse B-outcome ADJ
events I-outcome NOUN
occurred. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

A O DET
series O NOUN
of O ADP
multivariable O ADJ
analyses O NOUN
will O VERB
also O ADV
be O VERB
carried O VERB
out O ADP
to O PART
identify O NOUN
and O CCONJ
control O NOUN
for O ADP
several O ADJ
possible O ADJ
confounders O NOUN
of O ADP
the O DET
major O ADJ
pregnancy B-outcome NOUN
outcomes I-outcome NOUN
and O CCONJ
HIV B-outcome NOUN
disease I-outcome NOUN
progression I-outcome NOUN
. O PUNCT
Statistical O ADJ
significance O NOUN
will O VERB
be O VERB
defined O VERB
as O ADP
P O NOUN
< O SYM
.05. O PUNCT

GnRH-agonist O NOUN
trigger O ADP
and O CCONJ
adjuvant O NOUN
low O ADJ
dose O NOUN
hCG O NOUN
has O VERB
been O VERB
proposed O VERB
to O PART
improve O VERB
birth O NOUN
rates, O NOUN
but O CCONJ
timing O VERB
of O ADP
this O DET
hCG O NOUN
support O NOUN
to O PART
corpus O NOUN
luteum O NOUN
function O NOUN
has O VERB
never O ADV
been O VERB
fully O ADV
described. O NOUN

The O DET
hypothesis O NOUN
was O VERB
that O ADP
PFM O NOUN
asymmetry O NOUN
may O VERB
have O VERB
a O DET
functional O ADJ
reason O NOUN
related O VERB
to O PART
lumbopelvic O NOUN
complex O NOUN
misalignment. O NOUN

Secondary O ADJ
outcomes O NOUN
included O VERB
participant-reported O VERB
treatment B-outcome NOUN
usage I-outcome NOUN
and O CCONJ
respiratory B-outcome ADJ
symptoms I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
886 O NUM
participants O NOUN
underwent O VERB
randomization. O NOUN

Journal-Name:BMC O NOUN
psychology O NOUN

RESULTS: O NOUN
Most O DET
mothers O NOUN
reported O VERB
that O ADP
they O PRON
understood B-outcome VERB
the O DET
message O NOUN
in O ADP
the O DET
poster O NOUN
("The O ADJ
picture O NOUN
shows O NOUN
me O NOUN
you O NOUN
must O VERB
use O NOUN
these O DET
drugs O NOUN
to O PART
keep O NOUN
your O ADP
baby O NOUN
healthy") O DET
and O CCONJ
that O ADP
they O PRON
could O VERB
adhere B-outcome ADV
to O PART
the O DET
moments O NOUN
from O ADP
the O DET
poster. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

The O DET
duration O NOUN
of O ADP
treatment O NOUN
lasted O VERB
for O ADP
8 O NUM
weeks. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Anxiety B-outcome NOUN
and O CCONJ
depression B-outcome NOUN
levels O NOUN
were O VERB
measured O VERB
at O ADP
the O DET
beginning O VERB
of O ADP
the O DET
study. O NOUN

After O ADP
the O DET
operation, O NOUN
intravenous O ADJ
fentanyl O NOUN
infusion O NOUN
(25 O NOUN
mug/h) O NOUN
was O VERB
begun O NOUN
with O ADP
loading O VERB
dose O NOUN
25 O NUM
mug O NUM
in O ADP
the O DET
IV O NUM
group O NOUN
and O CCONJ
only O ADV
normal O ADJ
saline O NOUN
in O ADP
the O DET
TFP O NOUN
group. O VERB

The O DET
diastolic B-outcome ADJ
pressure I-outcome NOUN
decreased O VERB
significantly O ADV
after O ADP
yoga O NOUN
intervention O NOUN
(P<0.029). O NOUN

Grip B-outcome NOUN
strength I-outcome NOUN
was O VERB
tested O VERB
in O ADP
all O DET
patients O NOUN
using O VERB
an O DET
electronic O ADJ
device O NOUN
before O ADP
anesthesia O NOUN
and O CCONJ
when O ADP
TOFr O NOUN
values O NOUN
of O ADP
0.7, O NUM
0.8, O NOUN
and O CCONJ
0.9, O NUM
and O CCONJ
an O DET
hour O NOUN
later O ADV
of O ADP
TOFr O NOUN
value O NOUN
of O ADP
0.25. O NUM

Retrospectively O ADV
registered O VERB
on O ADP
November O NOUN
17, O NUM
2017. O NUM

TPI O NOUN
or O CCONJ
EMLA O NOUN
treatments O NOUN
decreased O VERB
shoulder O NOUN
pain O NOUN
irrespective O ADJ
of O ADP
exercise O NOUN
habit O NOUN
(P O NUM
= O SYM
.001 O NUM
and O CCONJ
P O NOUN
< O SYM
.001, O PUNCT
respectively), O NOUN
but O CCONJ
decreased O VERB
overall B-outcome ADJ
pain I-outcome NOUN
only O ADV
in O ADP
patients O NOUN
without O ADP
exercise O NOUN
habit O NOUN
(P O NUM
= O SYM
.019). O PUNCT

Methods: O NOUN
A O DET
child O NOUN
survival O NOUN
project O NOUN
was O VERB
implemented O VERB
in O ADP
10 O NUM
slum O NOUN
communities, O NOUN
which O ADP
were O VERB
then O ADV
randomly O ADV
allocated O VERB
to O PART
intervention O NOUN
(PCBHIS) O NUM
and O CCONJ
comparison O NOUN
areas. O NOUN

The O DET
statistical O ADJ
analysis O NOUN
showed O VERB
that O ADP
there O PRON
were O VERB
significant O ADJ
differences O NOUN
between O ADP
groups O NOUN
regarding O VERB
the O DET
total O ADJ
dose B-outcome NOUN
of O ADP
used O VERB
gonadotropins O NOUN
(P O NUM
< O SYM
0.001), O NUM
stimulation B-outcome NOUN
duration I-outcome NOUN
(P O NUM
< O SYM
0.001), O NUM
number O NOUN
of O ADP
retrieved B-outcome VERB
oocytes I-outcome NOUN
(P O NUM
= O SYM
0.01) O NUM
and O CCONJ
top O ADV
quality O NOUN
embryo B-outcome NOUN
(P O NUM
< O SYM
0.001) O NUM
and O CCONJ
also O ADV
cancellation B-outcome NOUN
(P O NUM
= O SYM
0.002) O NUM
and O CCONJ
fertilization B-outcome NOUN
rates O NOUN
(P O NUM
= O SYM
0.002). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Journal-Name:JAMA O NOUN

In O ADP
the O DET
bilateral-graft O NOUN
group, O NOUN
13.9% O NUM
of O ADP
the O DET
patients O NOUN
received O VERB
only O ADV
a O DET
single O ADJ
internal-thoracic-artery O ADV
graft, O NOUN
and O CCONJ
in O ADP
the O DET
single-graft O NOUN
group, O NOUN
21.8% O NUM
of O ADP
the O DET
patients O NOUN
also O ADV
received O VERB
a O DET
radial-artery O NOUN
graft. O VERB

CONCLUSION: O NOUN
The O DET
poster O NOUN
was O VERB
well-received B-outcome VERB
, O PUNCT
and O CCONJ
participants O NOUN
reported O VERB
compliance B-outcome NOUN
with O ADP
the O DET
moments O NOUN
for O ADP
hand O NOUN
hygiene O NOUN
(although O NUM
the O DET
full O ADJ
body O NOUN
wipe O NOUN
of O ADP
the O DET
baby O NOUN
has O VERB
since O ADP
been O VERB
removed). O ADP

CONCLUSIONS: O NOUN
Our O ADJ
findings O NOUN
suggest O VERB
that O ADP
the O DET
active, O ADJ
music-instruction O NOUN
program O NOUN
holds O NOUN
promise O NOUN
as O ADP
a O DET
complementary O ADJ
means O NOUN
of O ADP
ameliorating O VERB
PTSD B-outcome NOUN
and O CCONJ
depressive B-outcome ADJ
symptoms I-outcome NOUN
among O ADP
this O DET
population. O ADV

METHODS: O NOUN
CD80 O NOUN
was O VERB
used O VERB
to O PART
trap O NOUN
belatacept O ADV
onto O ADP
streptavidin-coated O VERB
wells. O NOUN

Background: O NOUN
Although O ADP
community O NOUN
engagement O NOUN
has O VERB
been O VERB
promoted O VERB
as O ADP
a O DET
strategy O NOUN
for O ADP
health O NOUN
systems O NOUN
strengthening, O ADP
there O PRON
is O VERB
need O NOUN
for O ADP
more O ADV
evidence O NOUN
for O ADP
effectiveness O NOUN
of O ADP
this O DET
approach. O NOUN

These O DET
effects O NOUN
were O VERB
absent O ADJ
in O ADP
AA O NOUN
cohort. O NOUN

Predilution O NOUN
extended O VERB
the O DET
measurement O NOUN
range O NOUN
to O PART
130 O NUM
mg/L O NOUN
with O ADP
an O DET
accuracy O NOUN
of O ADP
90% O VERB
and O CCONJ
coefficients O NOUN
of O ADP
variation O NOUN
of O ADP
3.8%. O NUM

Title: O NOUN
Comparison O NOUN
of O ADP
lower O ADJ
loading O VERB
dose O NOUN
of O ADP
prasugrel O NOUN
with O ADP
conventional O ADJ
loading O VERB
dose O NOUN
of O ADP
prasugrel O NOUN
in O ADP
Indian O NOUN
patients O NOUN
undergoing O VERB
percutaneous O ADJ
coronary O ADJ
interventions. O NOUN

Journal-Name:Zhonghua O NOUN
wei O NUM
zhong O PUNCT
bing O VERB
ji O ADP
jiu O NOUN
yi O ADP
xue O NOUN

Moderate O ADP
intake O NOUN
of O ADP
total O ADJ
LC O ADP
omega-3 O NOUN
PUFA O NOUN
(approximately O ADV
0.5(-)1 O NUM
g/day) O NOUN
was O VERB
significantly O ADV
associated O VERB
with O ADP
a O DET
lower O ADJ
prevalence O NOUN
of O ADP
depression B-outcome NOUN
. O PUNCT
CONCLUSION: O NOUN
In O ADP
our O ADJ
study, O NOUN
moderate O ADJ
fish O NOUN
and O CCONJ
LC O ADP
omega-3 O NOUN
PUFA O NOUN
intake, O NOUN
but O CCONJ
not O ADV
high O ADJ
intake, O NOUN
was O VERB
associated O VERB
with O ADP
lower O ADJ
odds O NOUN
of O ADP
depression B-outcome NOUN
suggesting O VERB
a O DET
U-shaped O NOUN
relationship. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

RESULTS: O NOUN
The O DET
mean O NOUN
age O NOUN
(+/-SD) O NOUN
of O ADP
the O DET
60 O NUM
participants O NOUN
was O VERB
27.5+/-5.0 O NUM
years, O NOUN
spherical O ADJ
refractive O ADJ
error O NOUN
was O VERB
-3.68+/-2.01 O NUM
D, O ADJ
and O CCONJ
cylinder O NOUN
was O VERB
-1.28+/-0.36 O ADJ
D. O NOUN
High- O ADV
and O CCONJ
low-contrast O NOUN
visual B-outcome ADJ
acuities I-outcome NOUN
with O ADP
toric O ADJ
lenses O NOUN
were O VERB
better O ADJ
than O ADP
with O ADP
spherical O ADJ
lenses O NOUN
at O ADP
both O CCONJ
fitting O VERB
(toric O ADJ
high-contrast: O PUNCT
-0.065+/-0.078 O NUM
and O CCONJ
low-contrast: O NOUN
0.133+/-0.103 O NUM
vs. O CCONJ
spherical O ADJ
high-contrast: O PUNCT
0.001+/-0.104 O NUM
and O CCONJ
low-contrast: O NOUN
0.224+/-0.107) O NOUN
and O CCONJ
follow-up O NOUN
(toric O ADJ
high-contrast: O PUNCT
-0.083+/-0.087 O NOUN
and O CCONJ
low-contrast: O NOUN
0.108+/-0.107 O NUM
vs. O CCONJ
spherical O ADJ
high-contrast: O PUNCT
-0.015+/-0.095 O VERB
and O CCONJ
low-contrast: O NOUN
0.211+/-0.104) O NOUN
(all O PUNCT
P<0.0001). O NOUN

All O DET
the O DET
cases O NOUN
of O ADP
OHSS O ADP
in O ADP
Group O NOUN
2 O NUM
were O VERB
moderate O ADJ
while O ADP
the O DET
one O NUM
case O NOUN
of O ADP
OHSS O ADP
in O ADP
Group O NOUN
1 O NUM
was O VERB
mild. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrials.gov, O NOUN
NCT03112083 O NOUN
, O PUNCT
retrospectively O ADV
registered. O NOUN

The O DET
subjects O NOUN
were O VERB
randomly O ADV
allocated O VERB
into O ADP
2 O NUM
groups O NOUN
according O ADJ
to O PART
activation O NOUN
type: O NOUN
incremental O ADJ
advancement O ADJ
(IA) O NOUN
and O CCONJ
maximum O NOUN
advancement O ADJ
(MA). O PUNCT

METHODS: O NOUN
This O DET
randomized O VERB
controlled O VERB
study O NOUN
included O VERB
409 O NUM
subjects O NOUN
(496 O PUNCT
eyes) O NOUN
older O ADJ
than O ADP
1-year-old O NOUN
with O ADP
persistent O ADJ
CNLDO O NOUN
in O ADP
southwest O NOUN
China, O NOUN
and O CCONJ
classified O VERB
into O ADP
3 O NUM
groups: O NOUN
96 O NUM
cases O NOUN
(123 O PUNCT
eyes) O NOUN
were O VERB
the O DET
tobramycin/dexamethasone O NOUN
eye O NOUN
drops O NOUN
group O NOUN
(drops O PUNCT
group), O NOUN
88 O NUM
cases O NOUN
(104 O NUM
eyes) O NOUN
were O VERB
the O DET
tobramycin/dexamethasone O NOUN
ointment O NOUN
group O NOUN
(ointment O NUM
group), O NOUN
and O CCONJ
225 O NUM
cases O NOUN
(269 O PUNCT
eyes) O NOUN
were O VERB
control O NOUN
group O NOUN
which O ADP
probing O VERB
with O ADP
normal O ADJ
saline O NOUN
(NS O PUNCT
group). O NOUN

Title: O NOUN
The O DET
Mitochondria-Targeted O VERB
Metabolic O ADJ
Tubular O ADJ
Injury O NOUN
in O ADP
Diabetic O ADJ
Kidney O NOUN
Disease. O NOUN

In O ADP
the O DET
5 O NUM
PCBHIS O NOUN
communities, O NOUN
the O DET
findings O NOUN
from O ADP
monthly O ADV
reports O NOUN
submitted O VERB
by O ADP
community O NOUN
health O NOUN
workers O NOUN
(CHWs) O PUNCT
and O CCONJ
verbal O ADV
autopsy O NOUN
findings O NOUN
for O ADP
deaths O NOUN
of O ADP
children O NOUN
who O ADP
died O VERB
before O ADP
reaching O VERB
5 O NUM
years O NOUN
of O ADP
age, O NOUN
were O VERB
processed O VERB
and O CCONJ
shared O VERB
at O ADP
bimonthly O ADV
meetings O NOUN
in O ADP
each O DET
community. O ADJ

SHM O NOUN
is O VERB
a O DET
safe O ADJ
and O CCONJ
effective O ADJ
hemostatic B-outcome ADJ
agent O NOUN
in O ADP
lumbar O ADJ
posterior O ADJ
surgery. O VERB

Data O NOUN
was O VERB
collected O VERB
by O ADP
semi-structured O VERB
interviews O NOUN
between O ADP
March O NOUN
and O CCONJ
April O NOUN
2016. O NUM

Interventions: O NOUN
Patients O NOUN
were O VERB
randomized O VERB
to O PART
a O DET
step-by-step O NOUN
resuscitation O NOUN
protocol O NOUN
aimed O VERB
at O ADP
either O CCONJ
normalizing O VERB
capillary O NOUN
refill O NOUN
time O NOUN
(n O NOUN
= O SYM
212) O NOUN
or O CCONJ
normalizing O VERB
or O CCONJ
decreasing O VERB
lactate O VERB
levels O NOUN
at O ADP
rates O NOUN
greater O ADJ
than O ADP
20% O NUM
per O ADP
2 O NUM
hours O NOUN
(n O NOUN
= O SYM
212), O NUM
during O ADP
an O DET
8-hour O NOUN
intervention O NOUN
period. O NOUN

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[entrez] O ADP

Four O NUM
of O ADP
the O DET
6 O NUM
care-seeking O VERB
behaviors O NOUN
judged O VERB
to O PART
be O VERB
amenable O ADJ
to O PART
promotion O NOUN
by O ADP
CHWs O NOUN
improved O VERB
more O ADV
in O ADP
the O DET
intervention O NOUN
area O NOUN
than O ADP
in O ADP
the O DET
comparison O NOUN
area, O NOUN
and O CCONJ
1 O NUM
was O VERB
statistically O ADV
significant O ADJ
(treatment O NUM
of O ADP
diarrhea O NOUN
with O ADP
ORS O NOUN
and O CCONJ
zinc). O NUM

BACKGROUND: O NOUN
Shilajit O ADJ
is O VERB
a O DET
safe, O NOUN
fluvic O NOUN
mineral O NOUN
complex O NOUN
exudate O NOUN
that O ADP
is O VERB
common O ADJ
to O PART
Ayurvedic O NOUN
medicine O NOUN
and O CCONJ
is O VERB
composed O VERB
of O ADP
fulvic O NOUN
acids, O NOUN
dibenzo-alpha-pyrones, O NOUN
proteins, O NOUN
and O CCONJ
minerals. O NOUN

INTRODUCTION: O NOUN
The O DET
aim O ADP
of O ADP
this O DET
2-arm O NOUN
parallel O ADJ
study O NOUN
was O VERB
to O PART
compare O NOUN
the O DET
dentoalveolar B-outcome ADJ
and O CCONJ
skeletal B-outcome ADJ
changes O NOUN
achieved O NOUN
with O ADP
Twin-block O NOUN
appliance O NOUN
therapy O NOUN
prescribed O VERB
on O ADP
either O CCONJ
a O DET
part- O NOUN
or O CCONJ
full-time O NOUN
basis O NOUN
for O ADP
12 O NUM
months. O NOUN

AIM: O NOUN
To O PART
evaluate O VERB
the O DET
impact O NOUN
of O ADP
pharmacotherapeutic O ADJ
education O NOUN
on O ADP
30-day O NOUN
post-discharge O NOUN
medication O NOUN
adherence B-outcome NOUN
and O CCONJ
adverse B-outcome ADJ
outcomes I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
mellitus O NOUN
(T2DM). O VERB

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[medline] O NOUN

Title: O NOUN
Action O NOUN
of O ADP
antimicrobial O ADJ
photodynamic O ADJ
therapy O NOUN
with O ADP
red O ADJ
leds O NOUN
in O ADP
microorganisms O NOUN
related O VERB
to O PART
halitose: O NOUN
Controlled O VERB
and O CCONJ
randomized O VERB
clinical O ADJ
trial. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

SETTING: O NOUN
Athletic O ADJ
training O VERB
rooms. O NOUN

Amla O NOUN
extract O NOUN
(500 O PUNCT
mg) O NOUN
or O CCONJ
a O DET
matching O VERB
placebo O NOUN
capsule O NOUN
was O VERB
administered O VERB
twice O ADV
daily O ADJ
for O ADP
12 O NUM
weeks O NOUN
to O PART
the O DET
respective O ADJ
group O NOUN
of O ADP
patients. O NOUN

Therefore, O NOUN
we O PRON
investigated O VERB
the O DET
induction B-outcome NOUN
time I-outcome NOUN
of O ADP
anesthesia O NOUN
based O VERB
on O ADP
type O NOUN
of O ADP
remifentanil O NOUN
administration O NOUN
in O ADP
target-controlled O VERB
anesthesia. O NOUN

In O ADP
the O DET
prespecified O VERB
intervention-period O NOUN
analysis, O NOUN
the O DET
primary O ADJ
end O NOUN
point O NOUN
occurred O VERB
in O ADP
11 O NUM
patients O NOUN
(2.6%) O PUNCT
in O ADP
the O DET
rivaroxaban O ADJ
group O NOUN
and O CCONJ
in O ADP
27 O NUM
(6.4%) O NUM
in O ADP
the O DET
placebo O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
0.40; O NOUN
95% O NOUN
CI, O NOUN
0.20 O NUM
to O PART
0.80). O NOUN

The O DET
first O ADV
40 O NUM
patients O NOUN
were O VERB
allocated O VERB
equally O ADV
to O PART
the O DET
two O NUM
treatment O NOUN
groups O NOUN
by O ADP
computer-generated O VERB
block O VERB
randomisation O NOUN
(block O NOUN
size O NOUN
40), O NOUN
after O ADP
which O ADP
a O DET
response-adaptive O ADJ
randomisation O NOUN
algorithm O NOUN
used O VERB
all O DET
previous O ADJ
patients' O NOUN
treatment O NOUN
and O CCONJ
response O NOUN
data O NOUN
to O PART
decide O NOUN
the O DET
allocation O NOUN
of O ADP
each O DET
following O VERB
patient O NOUN
favouring O VERB
the O DET
group O NOUN
with O ADP
superior O ADJ
response. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ISRCTN17975376 O ADJ
(Registered O PUNCT
19/09/2014). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Caplacizumab, O NOUN
an O DET
anti-von O NOUN
Willebrand O NOUN
factor O NOUN
humanized, O NOUN
bivalent O ADJ
variable-domain-only O ADV
immunoglobulin O NOUN
fragment, O NOUN
inhibits O NOUN
interaction O NOUN
between O ADP
von O ADP
Willebrand O NOUN
factor O NOUN
multimers O NOUN
and O CCONJ
platelets. O NOUN

Publication O NOUN
date: O NOUN
2019/02/16 O NOUN
06:00 O ADP
[medline] O NOUN

METHODS: O NOUN
FLAME O NOUN
was O VERB
a O DET
52-week O NOUN
randomized O VERB
controlled O VERB
trial O NOUN
in O ADP
patients O NOUN
with O ADP
severe-to-very-severe O NOUN
COPD O NOUN
and O CCONJ
a O DET
history O NOUN
of O ADP
exacerbations. O NOUN

This O DET
anatomically O ADV
high-fidelity O NOUN
simulator O NOUN
did O VERB
not O ADV
have O VERB
any O DET
advantages O NOUN
compared O VERB
with O ADP
conventional O ADJ
dry O ADJ
simulators. O NOUN

METHODS: O NOUN
This O DET
study O NOUN
was O VERB
part O NOUN
of O ADP
an O DET
effectiveness O NOUN
and O CCONJ
process O NOUN
evaluation O NOUN
including O VERB
24 O NUM
intervention O NOUN
and O CCONJ
27 O NUM
control O NOUN
classes. O NOUN

Title: O NOUN
Intermittent O ADJ
exercise-heat O NOUN
exposures O NOUN
and O CCONJ
intense O ADJ
physical O ADJ
activity O NOUN
sustain O NOUN
heat B-outcome NOUN
acclimation I-outcome NOUN
adaptations. O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
NES O NOUN
group O NOUN
received O VERB
NES O NOUN
intervention, O ADP
while O ADP
the O DET
subjects O NOUN
in O ADP
the O DET
sham O NOUN
group O NOUN
underwent O VERB
sham O NOUN
NES. O NOUN

Title: O NOUN
Pathways O NOUN
leading O VERB
to O PART
success O NOUN
and O CCONJ
non-success: O NOUN
a O DET
process O NOUN
evaluation O NOUN
of O ADP
a O DET
cluster O NOUN
randomized O VERB
physical O ADJ
activity O NOUN
health O NOUN
promotion O NOUN
program O NOUN
applying O VERB
fuzzy-set O ADP
qualitative O ADJ
comparative O ADJ
analysis. O NOUN

BACKGROUND/AIMS: O NOUN
Diabetic O ADJ
kidney O NOUN
disease O NOUN
(DKD) O PUNCT
is O VERB
a O DET
leading O VERB
cause O ADP
of O ADP
end-stage O NOUN
renal O ADJ
disease O NOUN
(ESRD) O NOUN
worldwide, O NOUN
and O CCONJ
the O DET
importance O NOUN
of O ADP
tubular O ADJ
injury O NOUN
has O VERB
been O VERB
highlighted O VERB
in O ADP
recent O ADJ
years. O NOUN

OBJECTIVES: O NOUN
To O PART
investigate O NOUN
the O DET
effectiveness O NOUN
of O ADP
routine O ADJ
ultrasonography O NOUN
in O ADP
the O DET
third O ADJ
trimester O NOUN
in O ADP
reducing O VERB
adverse B-outcome ADJ
perinatal I-outcome ADJ
outcomes O NOUN
in O ADP
low O ADJ
risk O NOUN
pregnancies O NOUN
compared O VERB
with O ADP
usual O ADJ
care O NOUN
and O CCONJ
the O DET
effect O NOUN
of O ADP
this O DET
policy O NOUN
on O ADP
maternal B-outcome ADJ
outcomes O NOUN
and O CCONJ
obstetric B-outcome ADP
interventions I-outcome NOUN
. O PUNCT
DESIGN: O NOUN
Pragmatic, O NOUN
multicentre, O NOUN
stepped O VERB
wedge O NOUN
cluster O NOUN
randomised O VERB
trial. O NOUN

Objective: O NOUN
To O PART
determine O NOUN
if O ADP
a O DET
peripheral O ADJ
perfusion-targeted O VERB
resuscitation O NOUN
during O ADP
early O ADJ
septic O ADJ
shock O NOUN
in O ADP
adults O NOUN
is O VERB
more O ADV
effective O ADJ
than O ADP
a O DET
lactate O VERB
level-targeted O VERB
resuscitation O NOUN
for O ADP
reducing O VERB
mortality B-outcome NOUN
. O PUNCT
Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Multicenter, O NOUN
randomized O VERB
trial O NOUN
conducted O VERB
at O ADP
28 O NUM
intensive O ADJ
care O NOUN
units O NOUN
in O ADP
5 O NUM
countries. O NUM

The O DET
most O DET
common O ADJ
grade O NOUN
3-4 O NUM
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
neutropenic B-outcome ADJ
fever I-outcome NOUN
(seven O PUNCT
patients O NOUN
[25%] O NUM
in O ADP
the O DET
5-day O NOUN
group O NOUN
and O CCONJ
14 O NUM
[33%] O NUM
in O ADP
the O DET
10-day O NOUN
group) O ADJ
and O CCONJ
infection B-outcome NOUN
(five O NUM
[18%] O NUM
and O CCONJ
16 O NUM
[37%], O ADV
respectively). O NOUN

The O DET
sham O NOUN
dry O ADJ
needling O VERB
procedure O NOUN
was O VERB
applied O VERB
into O ADP
the O DET
adipose O ADJ
tissue O NOUN
located O VERB
at O ADP
any O DET
area O NOUN
where O ADP
an O DET
active O ADJ
trigger O ADP
point O NOUN
was O VERB
absent. O NOUN

Journal-Name:Journal O ADJ
of O ADP
athletic O ADJ
training O VERB

Conclusions: O NOUN
This O DET
study O NOUN
was O VERB
implemented O VERB
in O ADP
challenging O VERB
circumstances. O NOUN

Journal-Name:Medicine O NOUN

Title: O NOUN
Once-Daily O NOUN
Plazomicin O NOUN
for O ADP
Complicated O VERB
Urinary O ADJ
Tract O NOUN
Infections. O ADV

Purpose: O NOUN
Intensity O NOUN
of O ADP
a O DET
training O VERB
program O NOUN
is O VERB
a O DET
critical O ADJ
variable O ADJ
in O ADP
treatment O NOUN
gains O NOUN
poststroke, O NOUN
but O CCONJ
there O PRON
are O VERB
no O DET
guidelines O NOUN
to O PART
adequately O ADV
dose O NOUN
the O DET
intensity O NOUN
of O ADP
functional O ADJ
training O VERB
(FT); O NOUN
the O DET
recommended O VERB
type O NOUN
of O ADP
training O VERB
to O PART
promote O VERB
poststroke O NOUN
recovery. O NOUN

RESULTS: O NOUN
Plazomicin O NOUN
was O VERB
noninferior O ADJ
to O PART
meropenem O NOUN
with O ADP
respect O NOUN
to O PART
the O DET
primary O ADJ
efficacy O NOUN
end O NOUN
points. O NOUN

Web-based O VERB
randomisation O NOUN
minimised O VERB
for O ADP
recruitment O NOUN
site, O NOUN
gestation O NOUN
(completed O VERB
weeks), O NOUN
sex, O NOUN
and O CCONJ
single O ADJ
versus O CCONJ
multifetal O ADJ
pregnancy. O NOUN

AIMS: O VERB
Adductor O NOUN
canal O NOUN
block O VERB
(ACB) O PUNCT
has O VERB
emerged O VERB
as O ADP
an O DET
alternative O ADJ
to O PART
femoral O ADJ
nerve O NOUN
block O VERB
(FNB) O PUNCT
for O ADP
analgesia O NOUN
after O ADP
total O ADJ
knee O NOUN
arthroplasty O NOUN
(TKA). O NOUN

No O DET
major O ADJ
safety O NOUN
concerns O NOUN
related O VERB
to O PART
the O DET
study O NOUN
medication O NOUN
were O VERB
identified. O NOUN

Title: O NOUN
Brentuximab O NOUN
vedotin O NOUN
with O ADP
chemotherapy O NOUN
for O ADP
CD30-positive O ADJ
peripheral O ADJ
T-cell O NOUN
lymphoma O NOUN
(ECHELON-2): O NUM
a O DET
global, O ADJ
double-blind, O NOUN
randomised, O NOUN
phase O NOUN
3 O NUM
trial. O NOUN

INTERPRETATION: O CCONJ
The O DET
addition O NOUN
of O ADP
ATLG O NOUN
to O PART
standard O ADJ
GVHD O NOUN
prophylaxis O NOUN
improves O NOUN
the O DET
probability O NOUN
of O ADP
surviving B-outcome VERB
without O ADP
disease B-outcome NOUN
relapse I-outcome NOUN
and O CCONJ
cGVHD B-outcome ADP
after O ADP
myeloablative O ADJ
peripheral O ADJ
blood O NOUN
stem-cell O NOUN
transplantation O NOUN
from O ADP
an O DET
HLA-identical O ADJ
sibling O VERB
donor O NOUN
for O ADP
patients O NOUN
with O ADP
acute O ADJ
leukaemia O NOUN
in O ADP
remission. O ADV

There O PRON
was O VERB
a O DET
slightly O ADV
higher O ADJ
incidence O NOUN
of O ADP
ovarian B-outcome ADJ
hyperstimulation I-outcome NOUN
syndrome I-outcome NOUN
(OHSS) I-outcome NUM
in O ADP
Group O NOUN
2 O NUM
compared O VERB
to O PART
Group O NOUN
1 O NUM
although O ADP
the O DET
difference O NOUN
was O VERB
not O ADV
statistically O ADV
significant O ADJ
(3/31, O NOUN
9.7% O NOUN
versus O CCONJ
1/26, O NOUN
3.8%). O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

One O NUM
hundred O NUM
and O CCONJ
fourteen O NUM
obese O NOUN
women O NOUN
aged O VERB
from O ADP
18 O NUM
to O PART
40 O NUM
years O NOUN
were O VERB
divided O VERB
into O ADP
insulin O NOUN
sensitive O ADJ
(IS) O NOUN
and O CCONJ
insulin O NOUN
resistant O ADJ
(IR) O PUNCT
groups O NOUN
and O CCONJ
received O VERB
a O DET
low O ADJ
calorie O NOUN
diet O NOUN
(LC), O NUM
or O CCONJ
an O DET
isocaloric O ADJ
diet O NOUN
and O CCONJ
500 O NUM
mg O NOUN
metformin O NOUN
twice O ADV
daily O ADJ
(IM), O PUNCT
or O CCONJ
isocaloric O ADJ
diet O NOUN
with O ADP
120 O NUM
mg O NOUN
orlistat O NOUN
three O NUM
times O NOUN
daily O ADJ
(IO). O PUNCT

Title: O NOUN
The O DET
periprocedural O ADJ
myocardial B-outcome ADJ
damage I-outcome NOUN
prevention O NOUN
during O ADP
elective O ADJ
percutaneous O ADJ
coronary O ADJ
intervention O NOUN
as O ADP
a O DET
result O VERB
of O ADP
pharmacological O ADJ
preconditioning O VERB
with O ADP
an O DET
oral O ADJ
form O NOUN
of O ADP
nicorandil O NOUN
in O ADP
patients O NOUN
with O ADP
stable O ADJ
coronary O ADJ
artery O NOUN
disease. O NOUN

Results: O NOUN
A O DET
total O ADJ
of O ADP
194 O NUM
children O NOUN
were O VERB
included O VERB
in O ADP
the O DET
study: O NOUN
98 O NUM
in O ADP
the O DET
intervention O NOUN
group; O ADJ
96 O NUM
in O ADP
the O DET
control O NOUN
group; O ADJ
96 O NUM
(49.5%) O NOUN
boys O NOUN
and O CCONJ
98 O NUM
(50.5%) O PUNCT
girls O NOUN
between O ADP
7 O NUM
and O CCONJ
8 O NUM
years O NOUN
old. O NUM

In O ADP
the O DET
analyses O NOUN
of O ADP
the O DET
experimental O ADJ
differences O NOUN
in O ADP
each O DET
group O NOUN
the O DET
Wilcoxon O NOUN
test O NOUN
will O VERB
be O VERB
used. O NOUN

Method:Sixty O NUM
patients O NOUN
with O ADP
nasal O ADJ
NK/T O NOUN
cell O NOUN
lymphoma O NOUN
admitted O VERB
to O PART
our O ADJ
hospital O NOUN
from O ADP
February O ADJ
2012 O NUM
to O PART
February O ADJ
2016 O NUM
were O VERB
selected O VERB
as O ADP
the O DET
study O NOUN
subject. O NOUN

Journal-Name:Anticancer O NOUN
research O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Patients O NOUN
received O VERB
triple O NOUN
therapy O NOUN
(long-acting O VERB
muscarinic O ADJ
antagonist O NOUN
and O CCONJ
long-acting O VERB
beta2-agonist/inhaled O VERB
corticosteroid O NOUN
[ICS]) O NOUN
for O ADP
6 O NUM
weeks, O NOUN
and O CCONJ
were O VERB
randomized O VERB
to O PART
continue O NOUN
triple O NOUN
therapy O NOUN
or O CCONJ
stepwise O ADV
withdrawal O NOUN
of O ADP
the O DET
ICS O NOUN
(dual O PUNCT
bronchodilator O NOUN
group). O NOUN

Mean O NOUN
compression B-outcome NOUN
fraction I-outcome NOUN
was O VERB
0.724 O NUM
(95% O PUNCT
CI O NOUN
[0.699-0.751]) O PUNCT
for O ADP
SIM O NOUN
group O NOUN
and O CCONJ
0.679 O NUM
(95% O PUNCT
CI O NOUN
[0.655-0.702]) O PUNCT
for O ADP
STD, O NUM
p=0.01. O NOUN

A O DET
general O ADJ
linear O ADJ
mixed O VERB
model O NOUN
was O VERB
applied O VERB
to O PART
test O NOUN
the O DET
intervention O NOUN
effect O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
16-week O NOUN
intervention O NOUN
(T2, O NUM
n O NOUN
= O SYM
338) O NOUN
and O CCONJ
at O ADP
three-month O NOUN
follow-up O NOUN
(T3, O NOUN
n O NOUN
= O SYM
311). O NOUN

RESULTS: O NOUN
At O ADP
the O DET
end O NOUN
of O ADP
8-week O NOUN
treatment, O NOUN
the O DET
patients O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
did O VERB
not O ADV
achieve O NOUN
better O ADJ
outcomes O NOUN
in O ADP
post-voiding B-outcome VERB
residual I-outcome ADJ
urine I-outcome NOUN
volume I-outcome NOUN
(PV-VRU) I-outcome PUNCT
(P O NUM
= O SYM
.66), O PUNCT
voided B-outcome VERB
volume I-outcome NOUN
(P O NUM
= O SYM
.59), O PUNCT
maximum B-outcome NOUN
urinary I-outcome ADJ
flow I-outcome NOUN
rate O NOUN
(Qmax) O PUNCT
(P O NUM
= O SYM
.53), O ADP
and O CCONJ
Barthel O PROPN
Index O NOUN
(BI) O NOUN
scores O NOUN
(P O NUM
= O SYM
.67), O NOUN
than O ADP
patients O NOUN
in O ADP
the O DET
control O NOUN
group. O VERB

During O ADP
the O DET
16-week O NOUN
intervention, O ADP
intervention O NOUN
participants O NOUN
watched O VERB
ten O NUM
video O ADJ
lessons O NOUN
at O ADP
home O NOUN
and O CCONJ
joined O VERB
ten O NUM
peer O NOUN
support O NOUN
group O NOUN
teleconferences. O NOUN

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[entrez] O ADP

Title: O NOUN
A O DET
high-fidelity O NOUN
simulator O NOUN
for O ADP
needle O NOUN
cricothyroidotomy O NOUN
training O VERB
is O VERB
not O ADV
associated O VERB
with O ADP
increased O VERB
proficiency B-outcome NOUN
compared O VERB
with O ADP
conventional O ADJ
simulators: O NOUN
A O DET
randomized O VERB
controlled O VERB
study. O NOUN

All O DET
patients O NOUN
received O VERB
a O DET
3-day O NOUN
course O NOUN
of O ADP
chloroquine O NOUN
(total O ADJ
dose O NOUN
of O ADP
1500 O NUM
mg). O ADJ

Journal O ADJ
ID: O NOUN
9422756 O NUM

A O DET
total O ADJ
of O ADP
196 O NUM
patients O NOUN
(98 O NOUN
per O ADP
group) O ADJ
are O VERB
required. O NOUN

Methods O NOUN
Forty-Four O NOUN
children O NOUN
(2.3+/-0.9 O NUM
years) O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
two O NUM
groups O NOUN
to O PART
receive O VERB
either O CCONJ
intravenous O ADJ
sufentanil O NOUN
(1 O NOUN
mug/kg) O NOUN
and O CCONJ
midazolam O NOUN
(0.2 O NOUN
mg/kg) O NOUN
(Group O PUNCT
SM) O NOUN
or O CCONJ
2.0 O NUM
minimal O ADJ
alveolar O ADJ
concentration O NOUN
(MAC) O NOUN
sevoflurane O NOUN
(Group O PUNCT
S) O ADV
to O PART
complete O ADJ
induction O NOUN
after O ADP
sedation O NOUN
was O VERB
obtained O VERB
with O ADP
2.0 O NUM
MAC O NOUN
sevoflurane. O NOUN

METHODS: O NOUN
Cricothyroidotomy-naive O ADJ
residents O NOUN
were O VERB
recruited O VERB
and O CCONJ
randomly O ADV
assigned O VERB
to O PART
2 O NUM
groups, O NOUN
including O VERB
simulation O NOUN
training O VERB
with O ADP
a O DET
conventional O ADJ
simulator O NOUN
(Group O PUNCT
C) O NOUN
and O CCONJ
with O ADP
a O DET
high-fidelity O NOUN
simulator O NOUN
(Group O PUNCT
3D). O NUM

Publication O NOUN
date: O NOUN
2018/10/17 O NOUN
00:00 O NOUN
[accepted] O ADV

Journal-Name:BMC O NOUN
surgery O NOUN

There O PRON
was O VERB
significant O ADJ
difference O NOUN
in O ADP
blood B-outcome NOUN
loss I-outcome NOUN
during O ADP
hemostatic O ADJ
process O NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
(P O NUM
<.001). O NUM

Title: O NOUN
Mothers O NOUN
In O ADP
Motion O NOUN
intervention O NOUN
effect O NOUN
on O ADP
psychosocial B-outcome ADJ
health I-outcome NOUN
in O ADP
young, O NOUN
low-income O NOUN
women O NOUN
with O ADP
overweight O NUM
or O CCONJ
obesity. O ADP

Patients O NOUN
in O ADP
clinical O ADJ
remission O NOUN
and O CCONJ
physically O ADV
inactive O ADJ
with O ADP
a O DET
mean O NOUN
age O NOUN
of O ADP
25 O NUM
+/- O SYM
6.5 O NUM
years O NOUN
and O CCONJ
Body O NOUN
Mass O NOUN
Index O NOUN
of O ADP
28.9 O NUM
+/- O SYM
3.8 O NUM
were O VERB
recruited O VERB
from O ADP
a O DET
dedicated O VERB
Inflammatory O ADJ
Bowel O NOUN
Disease O NOUN
clinic. O ADJ

BACKGROUND: O NOUN
Recently, O NOUN
a O DET
novel O ADJ
approach O NOUN
with O ADP
delaying O VERB
the O DET
start O NOUN
of O ADP
controlled O VERB
ovarian O ADJ
stimulation O NOUN
along O ADV
with O ADP
gonadotropin-releasing O VERB
hormone O NOUN
(GnRH) O NUM
antagonist O NOUN
pretreatment O NOUN
for O ADP
7 O NUM
days O NOUN
after O ADP
estrogen O NOUN
priming O VERB
for O ADP
further O ADV
suppression O NOUN
of O ADP
endogenous O ADJ
follicle O NOUN
stimulating O VERB
hormone O NOUN
(FSH) O PUNCT
during O ADP
the O DET
early O ADJ
follicular O ADJ
phase, O NOUN
resulting O VERB
in O ADP
more O ADV
FSH-responsive O ADJ
follicles O NOUN
and O CCONJ
thus O ADV
improving O VERB
synchronous O NOUN
follicular O ADJ
development O NOUN
was O VERB
introduced. O NOUN

RESULTS: O NOUN
The O DET
number O NOUN
of O ADP
adherent B-outcome ADJ
patients O NOUN
was O VERB
significantly O ADV
higher O ADJ
in O ADP
the O DET
intervention O NOUN
group O NOUN
(57/64 O NOUN
[89.9%] O NOUN
vs O CCONJ
41/61 O NOUN
[67.2%]; O ADP
chi2 O NOUN
test, O NUM
P=0.003]. O NOUN
There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
groups O NOUN
in O ADP
the O DET
number O NOUN
of O ADP
patients O NOUN
who O ADP
experienced O VERB
adverse B-outcome ADJ
outcomes I-outcome NOUN
(31/64 O NOUN
[48.4%] O NOUN
vs O CCONJ
36/61 O NOUN
[59.0%]; O NOUN
chi2 O NOUN
test, O NUM
P=0.236). O NOUN

However, O ADV
most O DET
studies O NOUN
assessing O VERB
implementation O NOUN
success O NOUN
focus O NOUN
on O ADP
only O ADV
one O NUM
condition, O NOUN
although O ADP
more O ADV
conditions O NOUN
influence O NOUN
this O DET
process. O NOUN

METHODS: O NOUN
One O NUM
hundred O NUM
patients O NOUN
presented O VERB
to O PART
the O DET
emergency O NOUN
department O NOUN
of O ADP
Assiut O NOUN
University O NOUN
Children O NOUN
Hospital O NOUN
with O ADP
a O DET
history O NOUN
of O ADP
scorpion O NOUN
sting O VERB
aged O VERB
less O ADV
than O ADP
18 O NUM
years O NOUN
were O VERB
included O VERB
in O ADP
our O ADJ
randomized O VERB
comparative O ADJ
trial O NOUN
during O ADP
2016. O NUM

The O DET
degree O NOUN
to O PART
which O ADP
individuals O NOUN
change O NOUN
their O ADJ
lifestyle B-outcome NOUN
in O ADP
response O NOUN
to O PART
interventions O NOUN
differs O NOUN
and O CCONJ
this O DET
variation O NOUN
could O VERB
affect O NOUN
cardiometabolic B-outcome ADJ
health I-outcome NOUN
. O PUNCT
We O PRON
examined O VERB
if O ADP
changes O NOUN
in O ADP
dietary B-outcome ADJ
intake I-outcome NOUN
, O PUNCT
physical B-outcome ADJ
activity I-outcome NOUN
and O CCONJ
weight B-outcome NOUN
of O ADP
obese O NOUN
infertile O NOUN
women O NOUN
during O ADP
the O DET
first O ADV
six O NUM
months O NOUN
of O ADP
the O DET
LIFEstyle O NOUN
trial O NOUN
were O VERB
associated O VERB
with O ADP
cardiometabolic B-outcome ADJ
health I-outcome NOUN
3(-)8 O ADJ
years O NOUN
later O ADV
(N O PUNCT
= O SYM
50(-)78). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Significant O ADJ
treatment O NOUN
x O SYM
time O NOUN
effects O NOUN
were O VERB
found O VERB
for O ADP
postprandial O ADJ
glucose B-outcome NOUN
(p O PUNCT
= O SYM
0.004) O NOUN
for O ADP
RS O NOUN
compared O VERB
to O PART
placebo, O NOUN
with O ADP
a O DET
trend O NOUN
for O ADP
higher O ADJ
C-peptide B-outcome ADJ
concentrations O NOUN
following O VERB
RS. O NOUN

Publication O NOUN
date: O NOUN
2019/02/14 O NOUN
06:00 O ADP
[entrez] O ADP

There O PRON
were O VERB
significant O ADJ
differences O NOUN
in O ADP
the O DET
24 O NUM
hours O NOUN
increment O NOUN
in O ADP
highly B-outcome ADV
sensitive I-outcome ADJ
troponin I-outcome NOUN
(HS-Tp) I-outcome NOUN
in O ADP
the O DET
control O NOUN
group, O NOUN
it O PRON
was O VERB
higher O ADJ
(112 O NUM
ng/l) O NOUN
than O ADP
in O ADP
the O DET
nicorandil O NOUN
group O NOUN
(67 O PUNCT
ng/l), O NOUN
p O NOUN
= O SYM
0.03. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

DFUs O NOUN
which O ADP
failed O VERB
to O PART
heal O NOUN
during O ADP
the O DET
study O NOUN
period O NOUN
(20/28, O PUNCT
71.4 O NUM
%) O PUNCT
were O VERB
more O ADV
likely O ADV
to O PART
be O VERB
persistently O ADV
colonized O VERB
with O ADP
a O DET
heterogeneous O ADJ
community O NOUN
of O ADP
micro-organisms O NOUN
including O VERB
anaerobes O NOUN
and O CCONJ
Enterobacteriaceae O NOUN
(log-likelihood O NUM
ratio O NOUN
9.56, O NOUN
P=0.008). O NOUN

BACKGROUND: O NOUN
Visceral O ADJ
leishmaniasis O NOUN
(VL) O PUNCT
in O ADP
human O NOUN
immunodeficiency O NOUN
virus O NOUN
(HIV) O PUNCT
co-infected O VERB
patients O NOUN
requires O NOUN
special O ADJ
case O NOUN
management. O NOUN

Eligible O ADJ
women O NOUN
were O VERB
undergoing O VERB
IVF O NOUN
(fresh-embryo O NUM
or O CCONJ
frozen-embryo O NOUN
transfer), O NOUN
with O ADP
no O DET
recent O ADJ
exposure O NOUN
to O PART
disruptive O ADJ
intrauterine O ADJ
instrumentation O NOUN
(e.g., O NOUN
hysteroscopy). O NOUN

In O ADP
our O ADJ
adjusted O VERB
multivariable O ADJ
regression O NOUN
models, O NOUN
SPOC O NOUN
scores O NOUN
at O ADP
6 O NUM
weeks O NOUN
post-surgery O NOUN
accounted O VERB
for O ADP
10% O ADP
of O ADP
the O DET
variation O NOUN
in O ADP
short O ADJ
form-12 O NOUN
physical B-outcome ADJ
component O NOUN
summary O NOUN
scores O NOUN
and O CCONJ
14% O NOUN
of O ADP
short O ADJ
form-12 O NOUN
mental B-outcome ADJ
component O NOUN
summary O NOUN
scores O NOUN
at O ADP
1 O NUM
yr. O PUNCT

Journal O ADJ
ID: O NOUN
101599229 O NUM

Journal O ADJ
ID: O NOUN
2985248R O NOUN

BACKGROUND: O NOUN
Health O NOUN
promotion O NOUN
programs O NOUN
can O VERB
only O ADV
lead O NOUN
to O PART
improvements O NOUN
in O ADP
health O NOUN
outcomes O NOUN
if O ADP
they O PRON
are O VERB
effectively O ADV
implemented. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
a O DET
Nutritional O ADJ
and O CCONJ
Behavioral O ADJ
Intervention O NOUN
on O ADP
Energy-Reduced O VERB
Mediterranean O NOUN
Diet O NOUN
Adherence B-outcome NOUN
Among O ADP
Patients O NOUN
With O ADP
Metabolic O ADJ
Syndrome: O NOUN
Interim O NOUN
Analysis O NOUN
of O ADP
the O DET
PREDIMED-Plus O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

Extended O VERB
follow-up O NOUN
(median O PUNCT
5.9 O NUM
years O NOUN
[IQR O PUNCT
1.7-7.9]) O NUM
confirmed O VERB
a O DET
lower O ADJ
5-year O ADJ
chronic B-outcome ADJ
graft-versus-host I-outcome ADV
disease I-outcome NOUN
(cGVHD) I-outcome NOUN
incidence O NOUN
(30.0% O PUNCT
[95% O NOUN
CI O NOUN
21.4-41.9 O NOUN
vs O CCONJ
69.1% O PUNCT
[59.1-80.1]; O NOUN
analysis O NOUN
for O ADP
entire O ADJ
follow-up, O ADP
p<0.001), O NOUN
no O DET
increase O NOUN
in O ADP
relapses B-outcome NOUN
(35.4% O NUM
[26.4-47.5] O NOUN
vs O CCONJ
22.5% O NUM
[14.6-34.7]; O NOUN
p=0.09), O ADJ
improved O VERB
cGVHD-free B-outcome ADJ
and Seperator CCONJ
relapse-free I-outcome ADJ
survival I-outcome NOUN
(cGRFS) I-outcome SYM
(34.3% O PUNCT
[24.2-44.5] O NOUN
vs O CCONJ
13.9% O NUM
[7.1-22.9]; O NOUN
p=0.005), O NOUN
and O CCONJ
fewer O ADJ
patients O NOUN
still O ADV
in O ADP
immunosuppression B-outcome NOUN
(9.6% O NOUN
vs O CCONJ
28.3%; O NOUN
p=0.017) O NOUN
in O ADP
the O DET
ATLG O NOUN
group O NOUN
compared O VERB
with O ADP
the O DET
non-ATLG O NOUN
group. O VERB

RESULTS: O NOUN
The O DET
RSB O NOUN
analgesia O NOUN
significantly O ADV
enhanced O VERB
the O DET
SFS24 O ADJ
scores O NOUN
in O ADP
the O DET
study O NOUN
groups O NOUN
(p=0.001). O NOUN

BACKGROUND: O NOUN
Schools O NOUN
have O VERB
been O VERB
identified O VERB
as O ADP
key O ADJ
environments O NOUN
to O PART
promote O VERB
child O NOUN
physical O ADJ
activity O NOUN
(PA). O NUM

Survival B-outcome NOUN
without O ADP
moderate O ADJ
or O CCONJ
severe O ADJ
neurodevelopmental B-outcome ADJ
disability I-outcome NOUN
at O ADP
24 O NUM
months O NOUN
occurred O VERB
in O ADP
802 O NUM
of O ADP
1224 O NUM
infants O NOUN
(65.5%) O PUNCT
assigned O VERB
to O PART
the O DET
faster O ADJ
increment O NOUN
and O CCONJ
848 O NUM
of O ADP
1246 O NUM
(68.1%) O PUNCT
assigned O VERB
to O PART
the O DET
slower O NOUN
increment O NOUN
(adjusted O PUNCT
risk O NOUN
ratio, O NOUN
0.96; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.92 O NUM
to O PART
1.01; O NOUN
P O NOUN
= O SYM
0.16). O NOUN

Journal O ADJ
ID: O NOUN
101566341 O NUM

Quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QoL) I-outcome NOUN
, O PUNCT
assessed O VERB
using O VERB
European O NOUN
Organisation O NOUN
for O ADP
Research O NOUN
and O CCONJ
Treatment O NOUN
of O ADP
Cancer O NOUN
QLQ-C30 O NOUN
and O CCONJ
QLQ-HDC29 O NOUN
questionnaires, O NOUN
was O VERB
an O DET
unpublished O VERB
secondary O ADJ
endpoint, O VERB
which O ADP
we O PRON
now O ADV
report O NOUN
here. O NOUN

The O DET
rowers O NOUN
were O VERB
subjected O VERB
to O PART
blood O NOUN
tests O NOUN
at O ADP
the O DET
beginning O VERB
of O ADP
the O DET
study O NOUN
(T1) O NOUN
and O CCONJ
after O ADP
eight O NUM
weeks O NOUN
of O ADP
treatment O NOUN
(T2), O PUNCT
for O ADP
the O DET
analysis O NOUN
of O ADP
haematological B-outcome ADJ
and O CCONJ
hormonal B-outcome ADJ
values. O NUM

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

These O DET
data O NOUN
do O VERB
not O ADV
support O NOUN
its O ADJ
routine O ADJ
use O NOUN
to O PART
prevent O NOUN
late-onset O NOUN
infection O NOUN
and O CCONJ
associated O VERB
morbidity O NOUN
or O CCONJ
mortality O NOUN
in O ADP
very O ADV
preterm O NOUN
infants. O NOUN

The O DET
present O ADJ
study O NOUN
aimed O VERB
to O PART
investigate O NOUN
the O DET
short-term O NOUN
effects O NOUN
of O ADP
RS O NOUN
on O ADP
appetite B-outcome NOUN
, O PUNCT
satiety B-outcome NOUN
and O CCONJ
postprandial O ADJ
metabolism B-outcome NOUN
in O ADP
overweight/obese O NOUN
subjects. O NOUN

The O DET
mechanism O NOUN
behind O NOUN
this O DET
second-meal O ADJ
phenomenon O NOUN
of O ADP
CRHP O NOUN
diet O NOUN
on O ADP
important O ADJ
risk O NOUN
factors O NOUN
for O ADP
aggravating O VERB
T2DM O NOUN
and O CCONJ
cardiovascular O ADJ
disease O NOUN
awaits O NOUN
further O ADV
investigation. O NOUN

We O PRON
sought O NOUN
to O PART
determine O NOUN
whether O ADP
a O DET
one-time O NOUN
azithromycin O NOUN
mass O NOUN
treatment O NOUN
would O VERB
reduce O VERB
trachomatous B-outcome ADJ
inflammation-follicular I-outcome ADJ
(TF) I-outcome NOUN
levels O NOUN
below O ADP
the O DET
elimination O NOUN
threshold O NOUN
of O ADP
5% O NOUN
in O ADP
communities O NOUN
with O ADP
disease O NOUN
prevalence O NOUN
between O ADP
5 O NUM
and O CCONJ
9.9%. O NUM

The O DET
primary O ADJ
endpoint O NOUN
was O VERB
achieved O NOUN
in O ADP
similar O ADJ
proportions O NOUN
of O ADP
patients O NOUN
in O ADP
the O DET
two O NUM
treatment O NOUN
groups O NOUN
(12 O PUNCT
[43%] O NUM
of O ADP
28 O NUM
in O ADP
the O DET
5-day O NOUN
schedule O NOUN
group, O NOUN
95% O NOUN
credible O ADJ
interval O NOUN
26-60, O ADJ
and O CCONJ
17 O NUM
[40%] O NUM
of O ADP
43 O NUM
in O ADP
the O DET
10-day O NOUN
schedule O NOUN
group, O NOUN
26-54, O NOUN
p=0.78; O NOUN
difference O NOUN
3%, O NOUN
-21 O NUM
to O PART
27). O NOUN

TRIAL O NOUN
REGISTRATION O NOUN
NUMBER: O NOUN
ClinicalTrials.gov O NOUN
(NCT03196791), O NOUN
date O NOUN
of O ADP
registration: O NOUN
October O ADJ
10, O NUM
2017. O NUM

The O DET
present O ADJ
design O NOUN
is O VERB
a O DET
clinical O ADJ
trial O NOUN
that O ADP
uses O NOUN
the O DET
pre-test O NOUN
and O CCONJ
post-test O NOUN
design O NOUN
with O ADP
a O DET
control O NOUN
group. O VERB

No O DET
venous B-outcome ADJ
or Seperator CCONJ
arterial I-outcome ADJ
thromboembolic I-outcome ADJ
complications I-outcome NOUN
were O VERB
reported. O NOUN

Vital O ADJ
status O NOUN
was O VERB
not O ADV
known O VERB
for O ADP
2.3% O NOUN
of O ADP
the O DET
patients O NOUN
at O ADP
10 O NUM
years. O NOUN

There O PRON
were O VERB
no O DET
significant O ADJ
between-group O NOUN
differences O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
wheezing B-outcome VERB
or O CCONJ
shortness B-outcome ADV
of I-outcome ADP
breath I-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
E-cigarettes O NOUN
were O VERB
more O ADV
effective O ADJ
for O ADP
smoking B-outcome VERB
cessation I-outcome NOUN
than O ADP
nicotine-replacement O ADJ
therapy, O NOUN
when O ADP
both O CCONJ
products O NOUN
were O VERB
accompanied O VERB
by O ADP
behavioral O ADJ
support. O NOUN
( O PUNCT

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[medline] O NOUN

Conclusion: O NOUN
The O DET
treatment O NOUN
of O ADP
thoracolumbar O ADV
fracture O NOUN
with O ADP
short-segment O ADP
fixation O NOUN
combined O VERB
with O ADP
injured O VERB
vertebral O ADJ
reconstruction O NOUN
can O VERB
effectively O ADV
prevent O NOUN
the O DET
"shell" B-outcome NOUN
phenomenon I-outcome NOUN
, O PUNCT
which O ADP
is O VERB
conducive O ADJ
to O PART
maintaining O VERB
the O DET
height O NOUN
of O ADP
injured O VERB
vertebral O ADJ
and O CCONJ
improving O VERB
the O DET
long-term O NOUN
function. O ADJ

At O ADP
baseline, O NOUN
the O DET
ultrasonographic O ADJ
evaluation O NOUN
of O ADP
pelvic B-outcome ADJ
floor I-outcome NOUN
muscles I-outcome NOUN
(PFM) I-outcome PUNCT
performed O VERB
during O ADP
resting O VERB
and O CCONJ
during O ADP
voluntary O ADJ
pelvic O ADJ
muscles O NOUN
contraction O NOUN
showed O VERB
the O DET
right-left O NOUN
length O NOUN
asymmetry. O VERB

Title: O NOUN
Tobramycin/dexamethasone O NOUN
eye O NOUN
drops O NOUN
as O ADP
a O DET
better O ADJ
choice O NOUN
for O ADP
lacrimal O ADJ
duct O NOUN
probing O VERB
in O ADP
persistent O ADJ
congenital O ADJ
nasolacrimal O ADJ
duct O NOUN
obstruction: O NOUN
A O DET
consort O NOUN
study. O NOUN

CONCLUSION: O NOUN
We O PRON
developed O VERB
a O DET
high-fidelity O NOUN
simulator O NOUN
for O ADP
cricothyroidotomy O NOUN
from O ADP
3D O NOUN
computed O VERB
tomography O NOUN
data O NOUN
using O VERB
a O DET
3D O NOUN
printer. O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
Bazhengsan O NOUN
formula O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
ceftriaxone O NOUN
for O ADP
female O NOUN
patients O NOUN
with O ADP
uncomplicated O VERB
gonorrhea: O NOUN
A O DET
pilot O NOUN
study. O NOUN

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

The O DET
children O NOUN
have O VERB
good O ADJ
recovery B-outcome NOUN
conditions I-outcome NOUN
, O PUNCT
and O CCONJ
no O DET
obvious O ADJ
postoperative O ADJ
agitation B-outcome NOUN
and O CCONJ
respiratory B-outcome ADJ
depression I-outcome NOUN
after O ADP
DEX O NOUN
administration. O ADV

METHOD: O NOUN
This O DET
Study O NOUN
is O VERB
A O DET
Prospective, O NOUN
randomized, O NOUN
open-label, O ADV
comparative O ADJ
study. O NOUN

Participants O NOUN
redeemed O VERB
only O ADV
39% O NUM
(SD O NOUN
43%) O NOUN
of O ADP
their O ADJ
earned O VERB
points. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

The O DET
LOP O NOUN
regimen O NOUN
was O VERB
used O VERB
in O ADP
group O NOUN
A O DET
and O CCONJ
the O DET
CHOPcyclophosphamide O NOUN
+ O SYM
pirarubicin O NOUN
+ O SYM
vincristine O ADV
+ O SYM
dexamethasone O NOUN
regimen O NOUN
was O VERB
used O VERB
in O ADP
group O NOUN
B. O NOUN
The O DET
short-term O NOUN
efficacy, O NOUN
long-term O NOUN
efficacy O NOUN
and O CCONJ
adverse B-outcome ADJ
reactions I-outcome NOUN
of O ADP
the O DET
two O NUM
groups O NOUN
were O VERB
compared. O NOUN

Title: O NOUN
Partial O ADJ
thickness O NOUN
cornea O NOUN
tissue O NOUN
from O ADP
small O ADJ
incision O NOUN
lenticule O NOUN
extraction: O NOUN
A O DET
novel O ADJ
patch O NOUN
graft O NOUN
in O ADP
glaucoma O NOUN
drainage O NOUN
implant O NOUN
surgery. O VERB

The O DET
success B-outcome NOUN
rate O NOUN
in O ADP
the O DET
group O NOUN
of O ADP
colored O VERB
eye O NOUN
drops O NOUN
was O VERB
88% O VERB
and, O NOUN
in O ADP
the O DET
group O NOUN
of O ADP
transparent, O ADJ
24%. O NUM

Among O ADP
the O DET
men O NOUN
who O ADP
underwent O VERB
radical O NOUN
prostatectomy, O NOUN
extracapsular O ADJ
extension O NOUN
was O VERB
associated O VERB
with O ADP
a O DET
risk O NOUN
of O ADP
death B-outcome NOUN
from I-outcome ADP
prostate I-outcome NOUN
cancer I-outcome NOUN
that O ADP
was O VERB
5 O NUM
times O NOUN
as O ADP
high O ADJ
as O ADP
that O ADP
among O ADP
men O NOUN
without O ADP
extracapsular O ADJ
extension, O NOUN
and O CCONJ
a O DET
Gleason O PROPN
score O NOUN
higher O ADJ
than O ADP
7 O NUM
was O VERB
associated O VERB
with O ADP
a O DET
risk O NOUN
that O ADP
was O VERB
10 O NUM
times O NOUN
as O ADP
high O ADJ
as O ADP
that O ADP
with O ADP
a O DET
score O NOUN
of O ADP
6 O NUM
or O CCONJ
lower O ADJ
(scores O NOUN
range O NOUN
from O ADP
2 O NUM
to O PART
10, O NUM
with O ADP
higher O ADJ
scores O NOUN
indicating O VERB
more O ADV
aggressive O ADJ
cancer). O NOUN

No O DET
significant O ADJ
difference O NOUN
of O ADP
fasting B-outcome VERB
plasma I-outcome NOUN
glucose I-outcome NOUN
and O CCONJ
2-hour B-outcome NOUN
plasma I-outcome NOUN
glucose I-outcome NOUN
concentrations O NOUN
were O VERB
found O VERB
between O ADP
intervention O NOUN
and O CCONJ
control O NOUN
groups O NOUN
at O ADP
6 O NUM
months O NOUN
and O CCONJ
12 O NUM
months O NOUN
(P O NUM
>.05). O NUM

CTs O NOUN
were O VERB
performed O VERB
due O ADJ
to O PART
caries O NOUN
lesions O NOUN
in O ADP
70.4% O NUM
of O ADP
the O DET
cases O NOUN
and O CCONJ
due O ADJ
to O PART
trauma O NOUN
in O ADP
29.6%. O NUM

RS O NOUN
may O VERB
indeed O ADV
have O VERB
short-term O NOUN
beneficial O ADJ
effects O NOUN
in O ADP
obese O NOUN
individuals. O NOUN

No O DET
increase O NOUN
in O ADP
second B-outcome ADJ
malignancies I-outcome NOUN
was O VERB
noted O VERB
with O ADP
ixazomib O NOUN
therapy O NOUN
(12 O PUNCT
[3%] O NOUN
patients) O NOUN
compared O VERB
with O ADP
placebo O NOUN
(eight O NUM
[3%] O NOUN
patients) O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
this O DET
analysis. O NOUN

The O DET
IV O NUM
group O NOUN
(n O NOUN
= O SYM
30) O NOUN
received O VERB
a O DET
placebo O NOUN
patch. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Decolonization O NOUN
involved O VERB
chlorhexidine O NOUN
mouthwash, O NOUN
baths O NOUN
or O CCONJ
showers O NOUN
with O ADP
chlorhexidine, O NOUN
and O CCONJ
nasal O ADJ
mupirocin O NOUN
for O ADP
5 O NUM
days O NOUN
twice O ADV
per O ADP
month O NOUN
for O ADP
6 O NUM
months. O NOUN

Patients O NOUN
were O VERB
divided O VERB
into O ADP
two O NUM
groups O NOUN
of O ADP
20 O NUM
patients. O NOUN

METHODS: O NOUN
We O PRON
conducted O VERB
a O DET
multicenter, O NOUN
randomized, O NOUN
controlled O VERB
trial O NOUN
of O ADP
postdischarge O NOUN
hygiene O NOUN
education, O VERB
as O ADP
compared O VERB
with O ADP
education O NOUN
plus O CCONJ
decolonization, O NOUN
in O ADP
patients O NOUN
colonized O VERB
with O ADP
MRSA O NOUN
(carriers). O NOUN

Journal-Name:Medicine O NOUN

CONCLUSIONS: O NOUN
Men O NOUN
with O ADP
clinically O ADV
detected, O NOUN
localized O VERB
prostate O NOUN
cancer O NOUN
and O CCONJ
a O DET
long O ADV
life O NOUN
expectancy O NOUN
benefited O VERB
from O ADP
radical O NOUN
prostatectomy, O NOUN
with O ADP
a O DET
mean O NOUN
of O ADP
2.9 O NUM
years O NOUN
of O ADP
life O NOUN
gained. O NOUN

BACKGROUND: O NOUN
Hypomethylating O VERB
agents, O NOUN
such O ADJ
as O ADP
decitabine, O NOUN
are O VERB
the O DET
standard O ADJ
of O ADP
care O NOUN
for O ADP
older O ADJ
patients O NOUN
with O ADP
newly O ADV
diagnosed O VERB
acute O ADJ
myeloid O NOUN
leukaemia. O NOUN

Methylphenidate B-outcome NOUN
dosing I-outcome VERB
was O VERB
significantly O ADV
higher O ADJ
in O ADP
individuals O NOUN
on O ADP
L-methylfolate O NOUN
over O ADP
time O NOUN
(chi O PUNCT
= O SYM
7.35, O NUM
P O NOUN
= O SYM
0.007). O NUM

RESULTS: O NOUN
The O DET
obtained O VERB
data O NOUN
shows O NOUN
the O DET
significant O ADJ
differences O NOUN
of O ADP
an O DET
increase O NOUN
in O ADP
highly B-outcome ADV
sensitive I-outcome ADJ
troponin I-outcome NOUN
(HS-Tp) I-outcome NOUN
in O ADP
24 O NUM
hours O NOUN
after O ADP
PCI O NOUN
in O ADP
patients O NOUN
with O ADP
no O DET
admission O NOUN
of O ADP
nicorandil O NOUN
(117 O NUM
ng/l) O NOUN
as O ADP
compared O VERB
with O ADP
the O DET
nicorandil O NOUN
group O NOUN
(73 O NOUN
ng/l), O NOUN
p O NOUN
= O SYM
0.04. O PUNCT

Full O ADJ
history, O NOUN
clinical O ADJ
examination, O NOUN
and O CCONJ
routine O ADJ
baseline O NOUN
investigations O NOUN
were O VERB
performed. O NOUN

PMID: O NOUN
31623051 O NUM

Journal O ADJ
ID: O NOUN
8410840 O NUM

Eligible O ADJ
participants O NOUN
were O VERB
adults O NOUN
with O ADP
a O DET
confirmed O VERB
diagnosis O NOUN
of O ADP
symptomatic O ADJ
multiple O ADJ
myeloma O NOUN
according O ADJ
to O PART
International O ADJ
Myeloma O NOUN
Working O VERB
Group O NOUN
criteria O NOUN
who O ADP
had O VERB
achieved O NOUN
at O ADP
least O ADV
a O DET
partial O ADJ
response O NOUN
after O ADP
undergoing O VERB
standard-of-care O NOUN
induction O NOUN
therapy O NOUN
followed O VERB
by O ADP
high-dose O NOUN
melphalan O NOUN
(200 O NUM
mg/m(2)) O NOUN
conditioning O VERB
and O CCONJ
single O ADJ
ASCT O NOUN
within O ADP
12 O NUM
months O NOUN
of O ADP
diagnosis. O NOUN

We O PRON
describe O NOUN
the O DET
first O ADV
randomised O VERB
controlled O VERB
trial O NOUN
to O PART
address O NOUN
both O CCONJ
chronic O ADJ
disease O NOUN
and O CCONJ
mental O ADJ
health O NOUN
in O ADP
Indigenous O ADJ
people O NOUN
with O ADP
ESKD, O ADJ
which O ADP
is O VERB
the O DET
first O ADV
to O PART
test O NOUN
the O DET
effectiveness O NOUN
of O ADP
a O DET
culturally O ADV
adapted O VERB
e-mental O ADJ
health O NOUN
intervention O NOUN
in O ADP
this O DET
population. O ADV

Title: O NOUN
[Clinical O ADJ
observation O NOUN
of O ADP
LOP O NOUN
chemotherapy O NOUN
combined O VERB
with O ADP
radiotherapy O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
early O ADJ
nasal O ADJ
NK/T O NOUN
cell O NOUN
lymphoma]. O NOUN

Title: O NOUN
Open-labeled O VERB
randomized O VERB
controlled O VERB
trial O NOUN
to O PART
evaluate O VERB
the O DET
1-year O NOUN
clinical O ADJ
outcomes O NOUN
of O ADP
polymer-free O ADJ
sirolimus-eluting O VERB
coronary O ADJ
stents O NOUN
as O ADP
compared O VERB
with O ADP
biodegradable O ADJ
polymer-based O VERB
sirolimus-eluting O VERB
coronary O ADJ
stents. O NOUN

BACKGROUND: O NOUN
Community-based O VERB
organizations O NOUN
(CBOs) O PUNCT
are O VERB
key O ADJ
partners O NOUN
in O ADP
supporting O VERB
care, O NOUN
but O CCONJ
health O NOUN
systems O NOUN
and O CCONJ
CBOs O NOUN
operate O NOUN
in O ADP
silos. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

RESULTS: O NOUN
Cumulative O ADJ
mean O NOUN
QALYs/mean O NOUN
costs B-outcome NOUN
of I-outcome ADP
health I-outcome NOUN
care I-outcome NOUN
service I-outcome NOUN
use I-outcome NOUN
and Seperator CCONJ
surgery I-outcome NOUN
per O ADP
patient O NOUN
from O ADP
baseline O NOUN
to O PART
12 O NUM
months O NOUN
were O VERB
estimated O VERB
as O ADP
0.640 O NUM
(standard O PUNCT
error O NOUN
(se) O NOUN
0.024)/ O NUM
pound3147 O NOUN
(se O PUNCT
166) O NOUN
in O ADP
the O DET
decompression O NOUN
arm, O ADJ
0.656 O NUM
(se O PUNCT
0.020)/ O NUM
pound2830 O NOUN
(se O PUNCT
183) O NOUN
in O ADP
the O DET
arthroscopy O NOUN
only O ADV
arm O NOUN
and O CCONJ
0.522 O NUM
(se O PUNCT
0.029)/ O NUM
pound1451 O NOUN
(se O PUNCT
151) O NOUN
in O ADP
the O DET
no O DET
treatment O NOUN
arm. O NOUN

Title: O NOUN
Halobetasol O NOUN
and O CCONJ
Tazarotene: O NOUN
Further O ADV
Defining O VERB
the O DET
Role O NOUN
of O ADP
a O DET
Unique O ADJ
Fixed O VERB
Combination O NOUN
Topical O ADJ
Lotion O NOUN
in O ADP
Moderate-to-Severe O NOUN
Plaque O NOUN
Psoriasis O NOUN

Direct O ADJ
comparison O NOUN
between O ADP
both O CCONJ
interventions O NOUN
revealed O VERB
that O ADP
the O DET
reduction O NOUN
in O ADP
subcutaneous B-outcome ADJ
fat I-outcome NOUN
was O VERB
statistically O ADV
significantly O ADV
larger O ADJ
in O ADP
the O DET
group O NOUN
that O ADP
combined O VERB
exercise O NOUN
with O ADP
diet: O NOUN
an O DET
additional O ADJ
10.6 O NUM
cm(2) O NOUN
(95%CI O PUNCT
-18.7; O NUM
- O PUNCT
2.4) O NUM
was O VERB
lost O VERB
compared O VERB
to O PART
the O DET
diet-only O ADV
group. O VERB

Publication O NOUN
date: O NOUN
2019/02/01 O ADP
06:01 O NUM
[medline] O NOUN

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[pubmed] O PUNCT

CONCLUSION: O NOUN
Premedication O NOUN
with O ADP
intranasal O ADJ
DEX O NOUN
2 O NUM
mug/kg O NOUN
for O ADP
children O NOUN
undergoing O VERB
dental O ADJ
rehabilitation O NOUN
under O ADP
general O ADJ
anesthesia O NOUN
produces O NOUN
good O ADJ
preoperative O ADJ
sedation B-outcome NOUN
. O PUNCT
The O DET
levels O NOUN
of O ADP
sedation B-outcome NOUN
, O PUNCT
scores O NOUN
of O ADP
parental B-outcome ADJ
separation I-outcome NOUN
and O CCONJ
compliance B-outcome NOUN
with O ADP
the O DET
mask O NOUN
were O VERB
satisfied. O NOUN

METHODS: O NOUN
A O DET
group O NOUN
of O ADP
34 O NUM
healthy O ADJ
volunteers O NOUN
was O VERB
presented O VERB
to O PART
two O NUM
groups O NOUN
of O ADP
four O NUM
eye O NOUN
drops O NOUN
each. O NOUN

Plasma O NOUN
malondialdehyde B-outcome NOUN
did O VERB
not O ADV
change O NOUN
after O ADP
exercise O NOUN
in O ADP
placebo O NOUN
but O CCONJ
was O VERB
significantly O ADV
decreased O VERB
in O ADP
AA O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Secondary O ADJ
outcomes O NOUN
include O VERB
any O DET
maternal O ADJ
or O CCONJ
fetal O ADJ
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
miscarriage B-outcome NOUN
, O PUNCT
pregnancy B-outcome NOUN
, O PUNCT
live B-outcome ADJ
births I-outcome NOUN
, O PUNCT
and O CCONJ
neonatal B-outcome ADJ
outcomes. O ADJ

However, O ADV
no O DET
significant O ADJ
differences O NOUN
were O VERB
found O VERB
between O ADP
groups. O NOUN

Patients O NOUN
were O VERB
randomized O VERB
to O PART
receive O VERB
equi-anesthetic O ADJ
doses O NOUN
of O ADP
either O CCONJ
propofol O NOUN
or O CCONJ
methohexital O ADJ
for O ADP
anesthetic O ADJ
induction. O NOUN

h(- O NOUN
1) O NUM
followed O VERB
by O ADP
a O DET
maintenance O NOUN
dose O NOUN
with O ADP
continuous O ADJ
infusion O NOUN
of O ADP
3 O NUM
mg.kg(- O NOUN
1). O NOUN

There O PRON
were O VERB
no O DET
differences O NOUN
in O ADP
these O DET
results O NOUN
based O VERB
on O ADP
demographic O ADJ
variables. O NUM

Interventions: O NOUN
Participants O NOUN
were O VERB
randomized O VERB
to O PART
a O DET
systolic O ADJ
blood O NOUN
pressure O NOUN
goal O NOUN
of O ADP
either O CCONJ
less O ADV
than O ADP
120 O NUM
mm O NOUN
Hg O NOUN
(intensive O NUM
treatment O NOUN
group; O ADJ
n O NOUN
= O SYM
4678) O NOUN
or O CCONJ
less O ADV
than O ADP
140 O NUM
mm O NOUN
Hg O NOUN
(standard O PUNCT
treatment O NOUN
group; O ADJ
n O NOUN
= O SYM
4683). O NOUN

Journal-Name:Nutrients O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

We O PRON
divided O VERB
45 O NUM
subjects O NOUN
into O ADP
3 O NUM
groups: O NOUN
those O DET
with O ADP
expert O NOUN
proctoring O VERB
(group O PUNCT
I), O NOUN
those O DET
who O ADP
watched O VERB
only O ADV
an O DET
educational O ADJ
video O ADJ
(group O PUNCT
II), O NOUN
and O CCONJ
those O DET
with O ADP
independent O ADJ
training O VERB
(group O PUNCT
III; O NOUN
n O NOUN
= O SYM
15 O NUM
per O ADP
group). O NOUN

Two O NUM
groups O NOUN
of O ADP
patients O NOUN
were O VERB
randomly O ADV
categorized O VERB
according O ADJ
to O PART
the O DET
route O NOUN
of O ADP
administration O NOUN
of O ADP
scorpion O NOUN
antivenom; O NOUN
intramuscular O ADJ
and O CCONJ
intravenous O ADJ
with O ADP
50 O NUM
patients O NOUN
in O ADP
each O DET
group. O VERB

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
therefore O ADV
to O PART
explore O ADP
reasons O NOUN
for O ADP
employee O NOUN
engagement O NOUN
in O ADP
weight O NOUN
loss O NOUN
projects O NOUN
at O ADP
the O DET
workplace O ADJ
and O CCONJ
the O DET
incentives O NOUN
a O DET
municipality, O ADJ
a O DET
manager O NOUN
at O ADP
a O DET
home-care O NOUN
centre, O NOUN
and O CCONJ
a O DET
project O NOUN
manager O NOUN
have O VERB
to O PART
launch O NOUN
such O ADJ
project. O NOUN

All O DET
subjects O NOUN
will O VERB
be O VERB
submitted O VERB
to O PART
microbiological O ADJ
analysis O NOUN
and O CCONJ
evaluation O NOUN
with O ADP
Oral O ADJ
ChromaTM O NOUN
before, O NOUN
immediately O ADV
after O ADP
treatment, O NOUN
7, O NUM
14, O NUM
and O CCONJ
30 O NUM
days O NOUN
after O ADP
treatment. O NOUN

The O DET
follow O VERB
up O ADP
period O NOUN
was O VERB
6 O NUM
months. O NOUN

Title: O NOUN
Determinants O NOUN
of O ADP
Plasma O NOUN
Docosahexaenoic O NOUN
Acid O NOUN
Levels O NOUN
and O CCONJ
Their O ADJ
Relationship O NOUN
to O PART
Neurological B-outcome ADJ
and Seperator CCONJ
Cognitive B-outcome ADJ
Functions E1-outcome NOUN
in O ADP
PKU O NOUN
Patients: O NOUN
A O DET
Double O ADV
Blind O NOUN
Randomized O VERB
Supplementation O NOUN
Study. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Serum O NOUN
corticosterone B-outcome NOUN
in O ADP
group O NOUN
D O NOUN
were O VERB
sharply O ADV
less O ADV
than O ADP
them O PRON
in O ADP
group O NOUN
C O NOUN
at O ADP
T(2), O NOUN
T(3), O NOUN
T(4), O NOUN
T(5) O ADJ
(t=16.364, O NUM
15.306, O NOUN
12.153, O NOUN
12.592, O NOUN
respectively; O NOUN
all O DET
P<0.05), O NOUN
but O CCONJ
at O ADP
T(0), O NOUN
T(1), O NOUN
T(6), O NOUN
T(7), O NOUN
T(8), O ADJ
there O PRON
were O VERB
no O DET
difference O NOUN
between O ADP
these O DET
two O NUM
groups O NOUN
(all O PUNCT
P>0.05). O NOUN

Further O ADV
studies O NOUN
are O VERB
still O ADV
needed O VERB
to O PART
warrant O ADJ
the O DET
results O NOUN
of O ADP
this O DET
study. O NOUN

METHODS: O NOUN
The O DET
study O NOUN
was O VERB
designed O VERB
as O ADP
a O DET
prospective, O NOUN
delayed-entry O NOUN
randomized O VERB
pilot O NOUN
trial. O NOUN

RESULTS: O NOUN
The O DET
self-administered O VERB
rehabilitation O NOUN
program O NOUN
showed O VERB
an O DET
adjusted O VERB
effectiveness O NOUN
of O ADP
51% O NUM
at O ADP
the O DET
end O NOUN
of O ADP
treatment O NOUN
compared O VERB
to O PART
54% O ADV
of O ADP
the O DET
standard O ADJ
physical O ADJ
therapy O NOUN
(p O PUNCT
> O SYM
0.05). O NOUN

CONCLUSIONS: O NOUN
Based O VERB
on O ADP
this O DET
single-center O NOUN
prospective O ADJ
study, O NOUN
both O CCONJ
of O ADP
these O DET
therapies O NOUN
appear O VERB
to O PART
have O VERB
relatively O ADV
favorable O ADJ
outcomes, O NOUN
although O ADP
cyanoacrylate O VERB
injection O NOUN
may O VERB
be O VERB
superior O ADJ
to O PART
sclerotherapy O NOUN
for O ADP
initial O ADJ
control O NOUN
of O ADP
active B-outcome ADJ
bleeding I-outcome VERB
. O PUNCT
TRIAL O NOUN
REGISTRATION: O NOUN
[ClinicalTrials.gov O NUM
Identifier: O NOUN
NCT03388125 O NOUN
]-Date O NUM
of O ADP
registration: O NOUN
January O NOUN
2, O NOUN
2018 O NUM
"Retrospectively O ADV
registered". O NOUN

CONCLUSION: O NOUN
SPC, O NOUN
MSI, O ADV
and O CCONJ
EBV O NOUN
statuses O NOUN
could O VERB
be O VERB
used O VERB
in O ADP
combination O NOUN
to O PART
predict O VERB
the O DET
prognosis O NOUN
and O CCONJ
responsiveness O NOUN
of O ADP
adjuvant O NOUN
chemotherapy O NOUN
for O ADP
stage O NOUN
II/III O NOUN
gastric O ADJ
cancer. O NOUN

Journal-Name:BMC O NOUN
neurology O NOUN

All O DET
centers O NOUN
had O VERB
to O PART
qualify O NOUN
with O ADP
regard O NOUN
to O PART
surgical O ADJ
skills O NOUN
before O ADP
participation O NOUN
in O ADP
the O DET
trial. O NOUN

METHODS: O NOUN
A O DET
single-blind O NOUN
randomized O VERB
controlled O VERB
trial O NOUN
was O VERB
performed. O NOUN

After O ADP
3, O NOUN
7, O NUM
and O CCONJ
10 O NUM
months, O NOUN
a O DET
third O ADJ
of O ADP
the O DET
practices O NOUN
were O VERB
randomised O VERB
to O PART
the O DET
intervention O NOUN
strategy. O NOUN

There O PRON
were O VERB
33 O NUM
(45%) O NOUN
female O NOUN
patients O NOUN
in O ADP
the O DET
study O NOUN
and O CCONJ
the O DET
average O NOUN
BMI O NOUN
was O VERB
27.6. O NUM

Successful B-outcome ADJ
spinal I-outcome ADJ
anesthesia I-outcome NOUN
was O VERB
defined O VERB
as O ADP
a O DET
T5 O NOUN
sensory O ADJ
level O NOUN
achieved O NOUN
within O ADP
10 O NUM
min O NOUN
after O ADP
intrathecal O ADJ
drug O NOUN
administration O NOUN
and O CCONJ
no O DET
epidural O ADJ
supplement O NOUN
was O VERB
required O VERB
during O ADP
the O DET
surgery. O VERB

The O DET
rate O NOUN
of O ADP
stroke B-outcome NOUN
recurrence O NOUN
was O VERB
7.6%, O NUM
15.1% O NUM
and O CCONJ
15.3% O NUM
in O ADP
lacunar O NOUN
infarction O NOUN
of O ADP
SAI, O NUM
non-lacunar O NOUN
infarction O NOUN
of O ADP
SAI O NOUN
and O CCONJ
MAIs O NOUN
at O ADP
one O NUM
year, O ADV
respectively. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Conclusion: O NOUN
Our O ADJ
results O NOUN
suggest O VERB
that O ADP
LCME-required O VERB
MCF O NOUN
sessions O NOUN
can O VERB
be O VERB
successfully O ADV
conducted O VERB
via O ADP
web-based O VERB
programs O NOUN
such O ADJ
as O ADP
Google O NOUN
Hangouts O NOUN
without O ADP
jeopardizing O VERB
overall O ADJ
meeting O VERB
experience B-outcome NOUN
. O PUNCT
While O ADP
the O DET
convenience B-outcome NOUN
of O ADP
the O DET
meetings O NOUN
was O VERB
improved, O NOUN
it O PRON
is O VERB
also O ADV
important O ADJ
for O ADP
clerkship O NOUN
directors O NOUN
to O PART
note O NOUN
the O DET
perceived O VERB
deficit O ADP
in O ADP
the O DET
effectiveness O NOUN
of O ADP
communication B-outcome NOUN
with O ADP
videoconferencing. O NOUN

RESULTS: O NOUN
Participants O NOUN
in O ADP
MTG O NOUN
had O VERB
an O DET
average O NOUN
of O ADP
seven O NUM
sessions O NOUN
of O ADP
music O ADJ
therapy, O NOUN
and O CCONJ
showed O VERB
improvement O NOUN
in O ADP
anxiety B-outcome NOUN
and O CCONJ
depression B-outcome NOUN
scores O NOUN
and O CCONJ
autonomic B-outcome ADJ
indexes O NOUN
of O ADP
the O DET
time O NOUN
domain O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Palo O NOUN
Alto, O NOUN
CA, O NOUN
USA. O NOUN

A O DET
total O ADJ
of O ADP
2961 O NUM
eligible O ADJ
patients O NOUN
were O VERB
identified O VERB
from O ADP
September O NOUN
2015 O NUM
to O PART
January O NOUN
2017. O NUM

Two O NUM
events O NOUN
in O ADP
the O DET
lactoferrin O NOUN
group O NOUN
(one O NOUN
case O NOUN
of O ADP
blood B-outcome NOUN
in Seperator ADP
stool I-outcome NOUN
and O CCONJ
one O NUM
death B-outcome NOUN
after O ADP
intestinal O ADJ
perforation) O NOUN
were O VERB
assessed O VERB
as O ADP
being O VERB
possibly O ADV
related O VERB
to O PART
the O DET
trial O NOUN
intervention. O NOUN

The O DET
results O NOUN
is O VERB
surprising, O NOUN
so O ADV
we O PRON
hope O NOUN
to O PART
do O VERB
some O DET
further O ADV
research O NOUN
in O ADP
order O NOUN
to O PART
prove O NOUN
it O PRON
is O VERB
worth O ADP
to O PART
clinical O ADJ
application. O NOUN

RESULTS: O NOUN
After O ADP
treatment, O NOUN
the O DET
6-minute O NOUN
walk B-outcome NOUN
test O NOUN
(6MWT)], O NOUN
chronic B-outcome ADJ
obstructive I-outcome ADJ
pulmonary I-outcome ADJ
disease I-outcome NOUN
(COPD) I-outcome NUM
assessment O NOUN
test O NOUN
(CAT)], O NOUN
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
, O PUNCT
airflow B-outcome NOUN
obstruction I-outcome NOUN
, O PUNCT
dyspnea B-outcome NOUN
, O PUNCT
and O CCONJ
exercise B-outcome NOUN
capacity I-outcome NOUN
(BODE) O NUM
index O NOUN
were O VERB
significantly O ADV
increased O VERB
compared O VERB
with O ADP
pre-treatment O NOUN
in O ADP
both O CCONJ
groups O NOUN
(P O NUM
< O SYM
.01), O PUNCT
but O CCONJ
not O ADV
FVC% O NOUN
and O CCONJ
FEVl%. O NOUN

Publication O NOUN
Type: O NOUN
Letter O NOUN

CONCLUSIONS: O NOUN
A O DET
short-term O NOUN
LOWFODMAP O NOUN
diet O NOUN
under O ADP
free-living O VERB
conditions O NOUN
reduced O VERB
exercise-related O VERB
GI B-outcome NOUN
symptoms I-outcome NOUN
and O CCONJ
improved O VERB
the O DET
perceived O VERB
ability B-outcome NOUN
to O PART
exercise O NOUN
in O ADP
otherwise O NOUN
healthy, O NOUN
recreational O ADJ
runners. O NOUN

This O DET
study O NOUN
was O VERB
registered O VERB
in O ADP
the O DET
Australian O ADJ
New O ADJ
Zealand O NOUN
Clinical O ADJ
Trial O NOUN
Registry O NOUN
(ANZCTR) O NOUN
under O ADP
protocol O NOUN
number: O NOUN
ACTRN12617000449336. O NOUN

CONCLUSION: O NOUN
Our O ADJ
study O NOUN
indicates O NOUN
that O ADP
mitochondrial B-outcome ADJ
damage I-outcome NOUN
could O VERB
be O VERB
the O DET
hallmark O NOUN
of O ADP
tubular O ADJ
injury O NOUN
in O ADP
DKD O NOUN
patients, O NOUN
and O CCONJ
this O DET
would O VERB
provide O VERB
a O DET
novel O ADJ
and O CCONJ
attractive O ADJ
therapeutic O ADJ
target O NOUN
to O PART
improve O VERB
this O DET
disease. O NOUN

RESULTS: O NOUN
The O DET
overall O ADJ
incidence O NOUN
of O ADP
postoperative B-outcome ADJ
sore I-outcome ADV
throat I-outcome NOUN
was O VERB
higher O ADJ
in O ADP
the O DET
HR O NOUN
group O NOUN
compared O VERB
with O ADP
that O ADP
in O ADP
the O DET
LR O NOUN
group O NOUN
[33 O NOUN
(72%) O PUNCT
vs O CCONJ
18 O NUM
(39%), O NOUN
P O NOUN
= O SYM
.022]. O NUM
The O DET
incidence O NOUN
of O ADP
postoperative B-outcome ADJ
sore I-outcome ADV
throat I-outcome NOUN
at O ADP
0, O NUM
2, O NOUN
and O CCONJ
24 O NUM
hours O NOUN
after O ADP
surgery O NOUN
was O VERB
higher O ADJ
in O ADP
the O DET
HR O NOUN
group O NOUN
compared O VERB
with O ADP
that O ADP
in O ADP
the O DET
LR O NOUN
group O NOUN
(P O NUM
< O SYM
.001, O PUNCT
P O NOUN
= O SYM
.001, O PUNCT
and O CCONJ
P O NOUN
= O SYM
.001, O PUNCT
respectively). O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

Therefore, O NOUN
28 O NUM
patients O NOUN
were O VERB
randomly O ADV
selected O VERB
from O ADP
the O DET
diagnostic O ADJ
group. O VERB

The O DET
paired O VERB
sample O NOUN
t-test O NOUN
or O CCONJ
Wilcoxon O NOUN
test O NOUN
were O VERB
employed O VERB
to O PART
calculate O NOUN
the O DET
differences O NOUN
between O ADP
variables O NOUN
before O ADP
and O CCONJ
after O ADP
music O ADJ
therapy O NOUN
intervention. O NOUN

However, O ADV
using O VERB
SMV O NOUN
may O VERB
have O VERB
superior O ADJ
effect O NOUN
on O ADP
improving O VERB
muscle B-outcome NOUN
tone I-outcome NOUN
after O ADP
stroke. O NOUN

Publication O NOUN
date: O NOUN
2019/02/05 O NOUN
06:00 O ADP
[medline] O NOUN

We O PRON
quantified O VERB
associations O NOUN
between O ADP
macrolide B-outcome NOUN
and O CCONJ
fluoroquinolone B-outcome ADJ
use O NOUN
and O CCONJ
cardiac B-outcome ADJ
events I-outcome NOUN
in O ADP
patients O NOUN
hospitalized O VERB
with O ADP
CAP O NOUN
in O ADP
non-ICU O NOUN
wards. O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

Microbiome O NOUN
profiles O NOUN
were O VERB
generated O VERB
by O ADP
16S O NOUN
rRNA O NOUN
gene O NOUN
sequence O NOUN
analysis, O NOUN
supplemented O VERB
by O ADP
targeted O VERB
nanopore O ADV
sequencing. O NOUN

These O DET
parameters O NOUN
were O VERB
also O ADV
examined O VERB
in O ADP
20 O NUM
healthy O ADJ
volunteers. O ADV

CONCLUSION: O NOUN
Pre-administration O NOUN
of O ADP
remifentanil O NOUN
in O ADP
target-controlled O VERB
propofol O NOUN
and O CCONJ
remifentanil O NOUN
anesthesia O NOUN
prolongs O NOUN
total O ADJ
induction B-outcome NOUN
time I-outcome NOUN
about O ADV
35% O ADP
compared O VERB
to O PART
co-administration O NOUN
of O ADP
remifentanil O NOUN
and O CCONJ
propofol O NOUN
by O ADP
decreased O VERB
CO. O NOUN

Whereas O ADP
rigid O NOUN
and O CCONJ
Kinesio O NOUN
taping O VERB
are O VERB
recommended O VERB
for O ADP
preventing O VERB
these O DET
injuries, O NOUN
high-level O NOUN
evidence O NOUN
from O ADP
clinical O ADJ
trials O NOUN
is O VERB
still O ADV
needed. O NOUN

The O DET
remaining O VERB
78 O NUM
patients O NOUN
underwent O VERB
randomization. O NOUN

All O DET
patients O NOUN
were O VERB
treated O VERB
with O ADP
combined O VERB
chemotherapy O NOUN
and O CCONJ
IMRTintensity O NOUN
modulated O VERB
conformal O ADJ
radiotherapy. O NOUN

Journal-Name:Upsala O NOUN
journal O ADJ
of O ADP
medical O ADJ
sciences O NOUN

2) O NOUN
Simulated O VERB
scuba O ADJ
test O NOUN
in O ADP
vitro: O ADP
the O DET
ventilator O NOUN
was O VERB
connected O VERB
to O PART
the O DET
simulated O VERB
scuba, O NOUN
and O CCONJ
an O DET
external O ADJ
mechanical O ADJ
ventilation O NOUN
model O NOUN
was O VERB
constructed. O NOUN

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

The O DET
control O NOUN
group O NOUN
received O VERB
an O DET
information O NOUN
leaflet O NOUN
about O ADV
issues O NOUN
related O VERB
to O PART
alcohol O NOUN
consumption. O NOUN

Journal O ADJ
ID: O NOUN
0224131 O NUM

The O DET
primary O ADJ
outcome O NOUN
was O VERB
parasite B-outcome NOUN
clearance I-outcome NOUN
at O ADP
day O NOUN
29, O NUM
after O ADP
the O DET
first O ADV
round O ADJ
of O ADP
treatment. O NOUN

During O ADP
the O DET
follow-up O NOUN
period, O NOUN
2 O NUM
children O NOUN
of O ADP
SBH O NOUN
treatment O NOUN
group O NOUN
and O CCONJ
2 O NUM
children O NOUN
of O ADP
routine O ADJ
treatment O NOUN
group O NOUN
were O VERB
lost O VERB
or O CCONJ
the O DET
outcome O NOUN
was O VERB
unknown. O NOUN

Resulting O VERB
data O NOUN
were O VERB
then O ADV
analyzed O VERB
using O VERB
t O NOUN
test, O NUM
Pearson O NOUN
chi-square O NOUN
test, O NUM
and O CCONJ
Fisher O ADV
exact O NOUN
test O NOUN
to O PART
compare O NOUN
outcomes O NOUN
between O ADP
the O DET
2 O NUM
groups. O NOUN

CONCLUSION: O NOUN
Both O CCONJ
the O DET
regimens O NOUN
achieved O NOUN
therapeutic O ADJ
goals, O NOUN
however O ADV
DR O NOUN
was O VERB
found O VERB
to O PART
be O VERB
superior O ADJ
as O ADP
it O PRON
achieved O NOUN
greater O ADJ
reduction O NOUN
in O ADP
total O ADJ
cholesterol B-outcome NOUN
(TC) O NOUN
and O CCONJ
low B-outcome ADJ
density I-outcome NOUN
lipoprotein-cholesterol I-outcome NOUN
(LDL-C) I-outcome NOUN
. O PUNCT
Further, O NOUN
these O DET
findings O NOUN
are O VERB
substantiated O VERB
by O ADP
correlation O NOUN
of O ADP
lipid B-outcome NOUN
indices O NOUN
with O ADP
serum O NOUN
hydroxymethylglutaryl-CoA B-outcome NOUN
reductase I-outcome NOUN
enzyme I-outcome NOUN
(HMGCR) I-outcome PUNCT
levels. O NOUN

CONCLUSION: O NOUN
On O ADP
the O DET
basis O NOUN
of O ADP
present O ADJ
results O NOUN
the O DET
delayed-start O NOUN
protocol O NOUN
in O ADP
poor O ADJ
responders O NOUN
can O VERB
improve O VERB
the O DET
fertilization B-outcome NOUN
rate O NOUN
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
embryos B-outcome NOUN
and O CCONJ
reduce O VERB
the O DET
cycle B-outcome NOUN
cancellation I-outcome NOUN
but O CCONJ
have O VERB
no O DET
significant O ADJ
effect O NOUN
on O ADP
clinical B-outcome ADJ
pregnancy I-outcome NOUN
rate; O NOUN
however, O ADV
larger O ADJ
randomized O VERB
clinical O ADJ
trials O NOUN
are O VERB
required O VERB
to O PART
compare O NOUN
it O PRON
with O ADP
other O ADJ
protocols. O NOUN

Noggin B-outcome NOUN
was O VERB
measured, O NOUN
for O ADP
the O DET
first O ADV
time O NOUN
in O ADP
thalassemia O ADP
patients, O NOUN
at O ADP
baseline O NOUN
and O CCONJ
at O ADP
12 O NUM
months, O NOUN
using O VERB
a O DET
recently O ADV
developed O VERB
high O ADJ
sensitivity O NOUN
fluorescent O ADJ
immunoassay. O NOUN

Title: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN
of O ADP
Simulation O NOUN
vs. O CCONJ
Standard O NOUN
Training O VERB
for O ADP
Teaching O VERB
Medical O ADJ
Students O NOUN
High-quality O NOUN
Cardiopulmonary O ADJ
Resuscitation. O NOUN

Although O ADP
there O PRON
are O VERB
studies O NOUN
confirming O VERB
ergogenic O ADJ
effects O NOUN
of O ADP
caffeine O NOUN
(CAF) O PUNCT
on O ADP
different O ADJ
physical O ADJ
and O CCONJ
mental O ADJ
abilities, O NOUN
much O DET
controversy O NOUN
remains O NOUN
about O ADV
its O ADJ
influence O NOUN
on O ADP
power. O NOUN

Interventions: O NOUN
Participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
treatment O NOUN
with O ADP
placebo O NOUN
(n O NOUN
= O SYM
151), O NOUN
alteplase O NOUN
10 O NUM
mg O NOUN
(n O NOUN
= O SYM
144), O NUM
or O CCONJ
alteplase O NOUN
20 O NUM
mg O NOUN
(n O NOUN
= O SYM
145) O NOUN
by O ADP
manual O ADJ
infusion O NOUN
over O ADP
5 O NUM
to O PART
10 O NUM
minutes. O ADJ

CrCo-Ti O NOUN
rods O NOUN
provide O VERB
significant O ADJ
and O CCONJ
stable O ADJ
spinal B-outcome ADJ
correction I-outcome NOUN
, O PUNCT
especially O ADV
in O ADP
correction B-outcome NOUN
of I-outcome ADP
main I-outcome ADJ
curve I-outcome NOUN
. O PUNCT
This O DET
rate O NOUN
was O VERB
associated O VERB
with O ADP
patients' O NOUN
age O NOUN
and O CCONJ
type O NOUN
of O ADP
rod O NOUN
administered O VERB
but O CCONJ
not O ADV
gender. O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
For O ADP
this O DET
randomized O VERB
controlled O VERB
clinical O ADJ
trial, O NOUN
we O PRON
enrolled O VERB
50 O NUM
CKD O NOUN
patients. O NOUN

Cost B-outcome NOUN
per O ADP
gained O VERB
QALY O NOUN
was O VERB
1704-7889 O NUM
USD. O ADP

Patients O NOUN
with O ADP
diabetes O NOUN
or O CCONJ
glucose O NOUN
intolerance O NOUN
in O ADP
the O DET
education O NOUN
group O NOUN
improved O VERB
significantly O ADV
in O ADP
waist-to-hip B-outcome NOUN
ratio I-outcome NOUN
, O PUNCT
uric B-outcome ADJ
acid I-outcome NOUN
, O PUNCT
total B-outcome ADJ
cholesterol I-outcome NOUN
and O CCONJ
< O SYM
P O NOUN
0> O NOUN
HDL-C O NOUN
. O PUNCT
Glycemic B-outcome ADJ
hemoglobin I-outcome NOUN
level O NOUN
also O ADV
improved O VERB
significantly O ADV
in O ADP
diabetes O NOUN
patients O NOUN
of O ADP
the O DET
education O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
101234168 O NUM

In O ADP
both O CCONJ
groups, O NOUN
the O DET
efficacy O NOUN
of O ADP
the O DET
trial O NOUN
drug O NOUN
was O VERB
similar O ADJ
for O ADP
methicillin-susceptible O ADJ
and O CCONJ
methicillin-resistant O ADJ
Staphylococcus B-outcome NOUN
aureus I-outcome NOUN
infections I-outcome NOUN
. O PUNCT
Adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
reported O VERB
in O ADP
48.3% O NUM
of O ADP
the O DET
patients O NOUN
in O ADP
the O DET
omadacycline O NOUN
group O NOUN
and O CCONJ
in O ADP
45.7% O NUM
of O ADP
those O DET
in O ADP
the O DET
linezolid O NOUN
group; O ADJ
the O DET
most O DET
frequent O ADJ
adverse B-outcome ADJ
events I-outcome NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
gastrointestinal B-outcome ADJ
(in O NUM
18.0% O NUM
and O CCONJ
15.8% O NUM
of O ADP
the O DET
patients O NOUN
in O ADP
the O DET
respective O ADJ
groups). O NOUN

Methods: O NOUN
Chemotherapy-naive O ADJ
patients O NOUN
were O VERB
randomized O VERB
(1:1:1) O NUM
to O PART
a O DET
single O ADJ
oral O ADJ
netupitant O ADJ
30-, O NOUN
100- O NUM
or O CCONJ
300-mg O NUM
dose O NOUN
before O ADP
chemotherapy O NOUN
initiation. O ADV

Methods: O NOUN
A O DET
total O ADJ
of O ADP
114 O NUM
T2DM O NOUN
inpatients O NOUN
or O CCONJ
outpatients, O ADV
including O VERB
46 O NUM
males O NOUN
and O CCONJ
68 O NUM
females O NOUN
aged O VERB
(55+/-14) O PUNCT
years O NOUN
between O ADP
January O NOUN
2015 O NUM
and O CCONJ
January O NOUN
2016 O NUM
were O VERB
randomly O ADV
divided O VERB
into O ADP
two O NUM
groups: O NOUN
the O DET
control O NOUN
group O NOUN
(n=57) O NOUN
only O ADV
with O ADP
hypoglycemic O ADJ
agents, O NOUN
and O CCONJ
the O DET
intervention O NOUN
group O NOUN
(n=57) O NOUN
with O ADP
berberine O NOUN
(0.4 O NOUN
g, O NOUN
3 O NUM
times O NOUN
a O DET
day) O NOUN
on O ADP
the O DET
basis O NOUN
of O ADP
treatment O NOUN
from O ADP
the O DET
control O NOUN
group. O VERB

Title: O NOUN
Right O NOUN
ventricular O ADJ
size O NOUN
and O CCONJ
function O NOUN
under O ADP
riociguat O NOUN
in O ADP
pulmonary O ADJ
arterial O ADJ
hypertension O NOUN
and O CCONJ
chronic O ADJ
thromboembolic O ADJ
pulmonary O ADJ
hypertension O NOUN
(the O NOUN
RIVER O NOUN
study). O NOUN

The O DET
incidence O NOUN
of O ADP
postoperative O ADJ
shivering B-outcome VERB
was O VERB
higher O ADJ
in O ADP
the O DET
HR O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
LR O NOUN
group O NOUN
[10 O NOUN
(22%) O PUNCT
vs O CCONJ
2 O NUM
(4%), O NOUN
difference O NOUN
17%, O NUM
95% O NOUN
CI O NOUN
2%-33%, O NOUN
P O NOUN
= O SYM
.027]. O PUNCT
CONCLUSION: O NOUN
A O DET
relatively O ADV
large O ADJ
dose O NOUN
of O ADP
intraoperative O ADJ
remifentanil O NOUN
increased O VERB
the O DET
incidence O NOUN
of O ADP
postoperative B-outcome ADJ
sore I-outcome ADV
throat I-outcome NOUN
in O ADP
patients O NOUN
for O ADP
orthopedic O ADJ
surgery O NOUN
under O ADP
general O ADJ
anesthesia. O NOUN

Surgical O ADJ
quality O NOUN
assurance O NOUN
was O VERB
implemented O VERB
by O ADP
the O DET
credentialing O VERB
of O ADP
surgeons, O NOUN
standardization O NOUN
of O ADP
technique, O ADV
and O CCONJ
monitoring O VERB
of O ADP
performance. O NOUN

Journal-Name:BMC O NOUN
ophthalmology O NOUN

RESULTS: O NOUN
Over O ADP
17 O NUM
months, O NOUN
53 O NUM
patients O NOUN
were O VERB
assessed O VERB
for O ADP
eligibility O NOUN
and O CCONJ
36 O NUM
(68%) O NOUN
were O VERB
randomised O VERB
(47% O NOUN
male; O NOUN
mean O NOUN
age O NOUN
36.9 O NUM
[SD O NUM
11.2 O VERB
years); O NOUN
13 O NUM
to O PART
HIIT, O NOUN
12 O NUM
to O PART
MICT, O NOUN
and O CCONJ
11 O NUM
to O PART
control. O NOUN

CONCLUSIONS: O NOUN
Exercise-heat O NOUN
exposures O NOUN
every O DET
fifth O ADJ
day O NOUN
for O ADP
25 O NUM
days O NOUN
and O CCONJ
regular O ADJ
intense O ADJ
physical O ADJ
activity O NOUN
after O ADP
HA O NOUN
sustained O VERB
heart B-outcome NOUN
rate I-outcome NOUN
and O CCONJ
Tre B-outcome PUNCT
adaptations O NOUN
and O CCONJ
reduced O VERB
perceptual B-outcome ADJ
and Seperator CCONJ
Physiological B-outcome ADJ
strain E1-outcome NOUN
during O ADP
exercise-heat O NOUN
stress O NOUN
approximately O ADV
1 O NUM
month O NOUN
later. O NOUN

Journal-Name:BMC O NOUN
infectious O ADJ
diseases O NOUN

SETTING: O NOUN
Hospital O NOUN
outpatient O ADJ
clinics O NOUN
at O ADP
six O NUM
hospitals O NOUN
in O ADP
Norway. O NOUN

Journal-Name:Medicine O NOUN

Feeling O VERB
down, O ADJ
depressed O VERB
or O CCONJ
hopeless O ADV
was O VERB
independently O ADV
associated O VERB
with O ADP
recent O ADJ
eve-teasing O VERB
(AOR O NUM
2.9 O NUM
(1.6-5.4)), O NOUN
a O DET
harassing O VERB
or O CCONJ
abusive O ADJ
school O NOUN
environment O NOUN
(AOR O NUM
3.9 O NUM
(1.8-8.2)), O NOUN
being O VERB
frequently O ADV
absent O ADJ
(AOR O NUM
2.8 O NUM
(1.5-5.5)) O PUNCT
or O CCONJ
having O VERB
dropped O VERB
out O ADP
of O ADP
school O NOUN
(AOR O NUM
2.1 O NUM
(1.0-4.3)), O NOUN
and O CCONJ
living O VERB
in O ADP
Vijayapura O NOUN
district O ADP
(AOR O NUM
2.5 O NUM
(1.6-4.1)). O NUM

Journal-Name:Medicine O NOUN

BACKGROUND: O NOUN
Induction O NOUN
of O ADP
delta O NOUN
aminolevulinic O ADJ
acid O NOUN
synthase O NOUN
1 O NUM
( O PUNCT
ALAS1) O NOUN
gene O NOUN
expression O NOUN
and O CCONJ
accumulation O NOUN
of O ADP
neurotoxic O ADJ
intermediates O NOUN
result O VERB
in O ADP
neurovisceral O ADJ
attacks O NOUN
and O CCONJ
disease O NOUN
manifestations O NOUN
in O ADP
patients O NOUN
with O ADP
acute O ADJ
intermittent O ADJ
porphyria, O ADV
a O DET
rare O ADJ
inherited O VERB
disease O NOUN
of O ADP
heme O NOUN
biosynthesis. O NOUN

Additionally O ADV
the O DET
authors O NOUN
evaluated O VERB
whether O ADP
CAF O NOUN
has O VERB
a O DET
significant O ADJ
effect O NOUN
on O ADP
velocity B-outcome NOUN
of O ADP
the O DET
bar O CCONJ
in O ADP
the O DET
eccentric O ADJ
(ECC) O PUNCT
phase O NOUN
(VEMEAN) O NUM
of O ADP
the O DET
bench O NOUN
press O NOUN
movement. O NOUN

Thus, O NOUN
PrimaVie(R) O NOUN
Shilajit O ADJ
supplementation O NOUN
at O ADP
500 O NUM
mg.d(- O NOUN
1) O NUM
elicited O VERB
favorable O ADJ
muscle B-outcome NOUN
and Seperator CCONJ
connective B-outcome ADJ
tissue E1-outcome NOUN
adaptations. O NOUN

Primary O ADJ
outcome O NOUN
data O NOUN
for O ADP
2182 O NUM
infants O NOUN
(1093 O PUNCT
[99.5%] O NOUN
of O ADP
1098 O NUM
in O ADP
the O DET
lactoferrin O NOUN
group O NOUN
and O CCONJ
1089 O NUM
[99.0] O NOUN
of O ADP
1101 O NUM
in O ADP
the O DET
control O NOUN
group) O ADJ
were O VERB
available O ADJ
for O ADP
inclusion O NOUN
in O ADP
the O DET
modified O VERB
intention-to-treat O NOUN
analyses. O NOUN

Objective: O NOUN
To O PART
explore O ADP
the O DET
surgical O ADJ
treatment O NOUN
strategy O NOUN
of O ADP
the O DET
vertebral O ADJ
"shell" O NOUN
after O ADP
thoracolumbar O ADV
fracture, O NOUN
and O CCONJ
provide O VERB
clinical O ADJ
reference O NOUN
for O ADP
the O DET
intervention O NOUN
and O CCONJ
treatment O NOUN
of O ADP
"shell". O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

On O ADP
day O NOUN
28, O NUM
mean O NOUN
cry B-outcome NOUN
and Seperator CCONJ
fuss B-outcome NOUN
time E1-outcome NOUN
became O VERB
statistically O ADV
different: O NOUN
142 O NUM
(89) O NOUN
vs. O CCONJ
199 O NUM
(72), O PUNCT
respectively O ADV
(p O PUNCT
< O SYM
0.05). O NOUN

Also, O ADJ
safety O NOUN
parameters O NOUN
were O VERB
similar O ADJ
between O ADP
the O DET
two O NUM
groups. O NOUN

Importance: O NOUN
Despite O ADP
guideline O NOUN
recommendations, O NOUN
many O DET
patients O NOUN
discontinue O NOUN
P2Y12 O NOUN
inhibitor O NOUN
therapy O NOUN
earlier O ADJ
than O ADP
the O DET
recommended O VERB
1 O NUM
year O NOUN
after O ADP
myocardial O ADJ
infarction O NOUN
(MI), O NOUN
and O CCONJ
higher-potency O NOUN
P2Y12 O NOUN
inhibitors O NOUN
are O VERB
underutilized. O NOUN

RESULTS: O NOUN
Spearman O NOUN
rank O NOUN
correlation O NOUN
analysis O NOUN
indicated O VERB
that O ADP
there O PRON
was O VERB
a O DET
significant O ADJ
correlation O NOUN
between O ADP
grip B-outcome NOUN
strength I-outcome NOUN
and O CCONJ
TOFr O NOUN
during O ADP
patient O NOUN
recovery O NOUN
from O ADP
general O ADJ
anesthesia O NOUN
(correlation O NUM
coefficient O NOUN
for O ADP
grip O NOUN
strength O NOUN
recovery O NOUN
[rs] O NOUN
= O SYM
0.886). O NUM

Postprandial O ADJ
qualitative O ADJ
appetite B-outcome NOUN
, O PUNCT
glucose B-outcome NOUN
, O PUNCT
insulin B-outcome NOUN
, O PUNCT
and O CCONJ
GLP-1 B-outcome NOUN
were O VERB
measured O VERB
every O DET
30 O NUM
min O NOUN
for O ADP
7 O NUM
h. O NOUN
Energy B-outcome NOUN
intake I-outcome NOUN
values O NOUN
from O ADP
an O DET
ad O NOUN
libitum O ADV
dinner O NOUN
and O CCONJ
for O ADP
a O DET
24-h O NOUN
period O NOUN
were O VERB
assessed. O NOUN

Title: O NOUN
White O ADP
Sweet O ADJ
Potato O NOUN
as O ADP
Meal O ADJ
Replacement O NOUN
for O ADP
Overweight O NOUN
White-Collar O ADJ
Workers: O ADJ
A O DET
Randomized O VERB
Controlled O VERB
Trial. O NOUN

We O PRON
discuss O NOUN
possible O ADJ
explanations O NOUN
for O ADP
this O DET
null O ADJ
effect, O NOUN
including O VERB
the O DET
impact O NOUN
of O ADP
participants' O NOUN
low O ADJ
perceived O VERB
susceptibility O NOUN
to O PART
the O DET
risks O NOUN
shown O VERB
on O ADP
these O DET
pictorial O ADJ
health O NOUN
warning O VERB
labels. O NOUN

To O PART
evaluate O VERB
whether O ADP
all O DET
SAI O NOUN
had O VERB
lower O ADJ
risk O NOUN
of O ADP
stroke B-outcome NOUN
recurrence O NOUN
than O ADP
MAIs O NOUN
in O ADP
minor O ADJ
stroke. O NOUN

Publication O NOUN
date: O NOUN
2019/01/17 O ADP
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
Patients O NOUN
under O ADP
long-term O NOUN
treatment O NOUN
with O ADP
riociguat O NOUN
show O VERB
significantly O ADV
reduced O VERB
right B-outcome ADJ
heart I-outcome NOUN
size I-outcome NOUN
and O CCONJ
improved O VERB
RV B-outcome NOUN
function I-outcome NOUN
in O ADP
PAH O NOUN
and O CCONJ
CTEPH. O NOUN

Journal-Name:Italian O NOUN
journal O ADJ
of O ADP
pediatrics O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

CONCLUSIONS: O NOUN
Direct O ADJ
and O CCONJ
video O ADJ
instructions O NOUN
are O VERB
equally O ADV
effective O ADJ
in O ADP
teaching O VERB
parents O NOUN
to O PART
perform O NOUN
simple O NOUN
whole B-outcome ADJ
motor I-outcome NOUN
tasks O NOUN
in O ADP
the O DET
NICU, O ADJ
and O CCONJ
parents O NOUN
welcome B-outcome NOUN
the Seperator DET
instruction I-outcome NOUN
. O PUNCT

The O DET
aortic O ADJ
and O CCONJ
hepatic O ADJ
equivalence O NOUN
margins O NOUN
were O VERB
100 O NUM
and O CCONJ
20 O NUM
Hounsfield O NOUN
units, O NOUN
respectively. O NOUN

Title: O NOUN
Endoscopic O ADJ
injection O NOUN
sclerotherapy O NOUN
versus O CCONJ
N-Butyl-2 O NOUN
Cyanoacrylate O NOUN
injection O NOUN
in O ADP
the O DET
management O NOUN
of O ADP
actively O ADV
bleeding O VERB
esophageal O ADJ
varices: O NOUN
a O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Bispectral O ADJ
index(BIS) O NOUN
was O VERB
used O VERB
to O PART
monitor O NOUN
the O DET
depth O NOUN
of O ADP
anesthesia O NOUN
and O CCONJ
maintained O VERB
between O ADP
45-60 O NUM
during O ADP
operation. O ADV

0.05). O NOUN

Study O NOUN
participants O NOUN
were O VERB
admitted O VERB
30 O NUM
minutes O NOUN
prior O ADJ
to O PART
ET O NOUN
and O CCONJ
given O VERB
either O CCONJ
tablet O NOUN
after O ADP
their O ADJ
baseline O NOUN
vital O ADJ
signs O NOUN
were O VERB
recorded. O NOUN

PURPOSE: O NOUN
To O PART
investigate O NOUN
the O DET
rehydrating B-outcome VERB
efficacy O NOUN
of O ADP
MW O NOUN
after O ADP
exercise-induced O VERB
dehydration. O ADV

Similarly, O NOUN
adjusted O VERB
depressive B-outcome ADJ
symptoms I-outcome NOUN
were O VERB
reduced O VERB
by O ADP
20.4% O NUM
(- O NOUN
6.3 O NUM
points, O NOUN
p O NOUN
= O SYM
0.02). O NOUN

Publication O NOUN
date: O NOUN
2018/12/30 O ADP
06:00 O ADP
[entrez] O ADP

Conclusions: O NOUN
Albuminemia B-outcome NOUN
levels O NOUN
decreased O VERB
significantly O ADV
in O ADP
both O CCONJ
groups, O NOUN
and O CCONJ
this O DET
decrease O NOUN
was O VERB
more O ADV
marked O VERB
in O ADP
the O DET
EEN O NOUN
group. O VERB

Journal-Name:Revista O NOUN
de O ADP
la O NOUN
Facultad O ADV
de O ADP
Ciencias O NOUN
Medicas O NOUN
(Cordoba, O NUM
Argentina) O NOUN

The O DET
primary O ADJ
safety O NOUN
outcome O NOUN
was O VERB
a O DET
protocol-defined O VERB
decrease O NOUN
in O ADP
the O DET
hemoglobin B-outcome NOUN
level O NOUN
(>3.0 O PUNCT
g O NOUN
per O ADP
deciliter O NOUN
or O CCONJ
>/=30% O NOUN
from O ADP
baseline O NOUN
or O CCONJ
to O PART
a O DET
level O NOUN
of O ADP
<6.0 O CCONJ
g O NOUN
per O ADP
deciliter). O PUNCT

METHODS: O NOUN
In O ADP
this O DET
double-blind, O NOUN
randomized O VERB
trial O NOUN
involving O VERB
high-risk O NOUN
ambulatory O ADJ
patients O NOUN
with O ADP
cancer O NOUN
(Khorana O NOUN
score O NOUN
of O ADP
>/=2, O NOUN
on O ADP
a O DET
scale O NOUN
from O ADP
0 O NUM
to O PART
6, O NOUN
with O ADP
higher O ADJ
scores O NOUN
indicating O VERB
a O DET
higher O ADJ
risk O NOUN
of O ADP
venous O ADJ
thromboembolism), O NOUN
we O PRON
randomly O ADV
assigned O VERB
patients O NOUN
without O ADP
deep-vein O NOUN
thrombosis O NOUN
at O ADP
screening O VERB
to O PART
receive O VERB
rivaroxaban O ADJ
(at O NUM
a O DET
dose O NOUN
of O ADP
10 O NUM
mg) O NOUN
or O CCONJ
placebo O NOUN
daily O ADJ
for O ADP
up O ADP
to O PART
180 O NUM
days, O NOUN
with O ADP
screening O VERB
every O DET
8 O NUM
weeks. O NOUN

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
00:00 O NOUN
[accepted] O ADV

By O ADP
week O NOUN
8, O NOUN
HP/TAZ O NOUN
lotion O NOUN
achieved O NOUN
a O DET
63.5% O NOUN
reduction O NOUN
in O ADP
mean O NOUN
IGAxBSA O NOUN
composite O NOUN
score O NOUN
(P<0.001 O PUNCT
versus O CCONJ
TAZ O NOUN
and O CCONJ
vehicle), O NOUN
that O ADP
was O VERB
sustained O VERB
four O NUM
weeks O NOUN
posttreatment O NOUN
(P<0.001 O PUNCT
versus O CCONJ
TAZ O NOUN
and O CCONJ
vehicle O NOUN
and O CCONJ
P=0.003 O NOUN
versus O CCONJ
HP). O NOUN

The O DET
tear O NUM
serotonin B-outcome NOUN
level O NOUN
in O ADP
group O NOUN
A O DET
was O VERB
reduced O VERB
from O ADP
2.76 O NUM
+/- O SYM
0.34 O NUM
to O PART
1.73 O NUM
+/- O SYM
0.14 O NUM
ng/mL O NOUN
(p O PUNCT
< O SYM
0.001). O NUM

Clinicaltrials.gov O NOUN
NCT01702974. O NOUN

MAIN O ADJ
OUTCOME O NOUN
MEASURES: O NOUN
Resting B-outcome VERB
blood I-outcome NOUN
pressure I-outcome NOUN
was O VERB
measured O VERB
and O CCONJ
standard O ADJ
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
(HRV) I-outcome NUM
indices O NOUN
were O VERB
calculated O VERB
using O VERB
time O NOUN
domain O NOUN
( O PUNCT
SDNN B-outcome NOUN
, O PUNCT
pNN50 B-outcome ADV
, O PUNCT
RMSSD B-outcome NOUN
) O PUNCT
and O CCONJ
frequency O NOUN
domain O NOUN
( O PUNCT
LFnu B-outcome ADP
, O PUNCT
HFnu B-outcome NOUN
, O PUNCT
LF/HF B-outcome ADV
and O CCONJ
TP B-outcome NOUN
) O PUNCT
analysis. O NOUN

BACKGROUND: O NOUN
To O PART
investigate O NOUN
the O DET
effectiveness O NOUN
of O ADP
Baduanjin O NOUN
qigong O ADJ
combined O VERB
with O ADP
cognitive-behavior O ADJ
therapy O NOUN
(CBT) O PUNCT
on O ADP
the O DET
physical B-outcome ADJ
fitness I-outcome ADP
and O CCONJ
psychological B-outcome ADJ
health I-outcome NOUN
of O ADP
elderly O NOUN
housebound. O NOUN

In O ADP
total, O ADJ
27 O NUM
participants, O NOUN
inexperienced O VERB
in O ADP
spinal O ADJ
ultrasonography, O ADJ
were O VERB
enrolled O VERB
and O CCONJ
allocated O VERB
to O PART
1 O NUM
of O ADP
2 O NUM
groups O NOUN
(training O VERB
group, O NOUN
n O NOUN
= O SYM
18; O NUM
control O NOUN
group, O NOUN
n O NOUN
= O SYM
9). O ADJ

A O DET
randomized O VERB
controlled O VERB
trial O NOUN
comparing O VERB
the O DET
effect O NOUN
of O ADP
NPWT O NOUN
with O ADP
standard O ADJ
surgical O ADJ
dressing O VERB
(SSD) O PUNCT
on O ADP
wounds O NOUN
was O VERB
performed O VERB
in O ADP
265 O NUM
patients O NOUN
undergoing O VERB
open O ADJ
gastrointestinal O ADJ
resections O NOUN
from O ADP
2012 O NUM
to O PART
2016. O NUM

Both O CCONJ
groups O NOUN
were O VERB
assessed O VERB
by O ADP
6-minute O NOUN
walk B-outcome NOUN
test O NOUN
(6MWT)], O NOUN
chronic B-outcome ADJ
obstructive I-outcome ADJ
pulmonary I-outcome ADJ
disease I-outcome NOUN
(COPD) I-outcome NUM
assessment O NOUN
test O NOUN
(CAT)], O NOUN
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
, O PUNCT
airflow B-outcome NOUN
obstruction I-outcome NOUN
, O PUNCT
dyspnea B-outcome NOUN
, O PUNCT
and O CCONJ
exercise B-outcome NOUN
capacity I-outcome NOUN
(BODE) O NUM
index]. O ADJ
Besides, O NOUN
the O DET
pulmonary B-outcome ADJ
function I-outcome NOUN
(FVC%, O PUNCT
FEVl%) O NOUN
were O VERB
measured O VERB
at O ADP
6 O NUM
months O NOUN
before O ADP
and O CCONJ
after O ADP
treatment. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

The O DET
appearance B-outcome NOUN
, O PUNCT
graft B-outcome NOUN
, O PUNCT
conjunctiva B-outcome ADP
melting I-outcome VERB
, O PUNCT
and O CCONJ
tube B-outcome NOUN
exposure I-outcome NOUN
were O VERB
the O DET
primary O ADJ
observation O NOUN
points. O NOUN

Patients O NOUN
with O ADP
clinical O ADJ
improvement O NOUN
but O CCONJ
without O ADP
parasite O NOUN
clearance O NOUN
at O ADP
day O NOUN
29 O NUM
received O VERB
a O DET
second O ADJ
round O ADJ
of O ADP
the O DET
allocated O VERB
treatment. O NOUN

Complete B-outcome ADJ
remission I-outcome NOUN
, O PUNCT
complete B-outcome ADJ
remission I-outcome NOUN
with Seperator ADP
incomplete I-outcome ADJ
platelet I-outcome NOUN
recovery I-outcome NOUN
(CRp) I-outcome NOUN
, O PUNCT
complete B-outcome ADJ
remission I-outcome NOUN
with Seperator ADP
incomplete I-outcome ADJ
haematological I-outcome ADJ
recovery I-outcome NOUN
(CRi) I-outcome NOUN
, O PUNCT
and O CCONJ
overall B-outcome ADJ
survival I-outcome NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
groups O NOUN
when O ADP
stratified O VERB
by O ADP
cytogenetics, O NOUN
de-novo O NOUN
versus O CCONJ
secondary O ADJ
or O CCONJ
therapy-related O VERB
acute O ADJ
myeloid O NOUN
leukaemia, O NOUN
or O CCONJ
TP53(mut) O ADJ
status. O NOUN

Title: O NOUN
[ O PUNCT
Feasibility B-outcome NOUN
of O ADP
supraglottic O ADJ
tracheal O ADJ
tube O NOUN
ventilation O NOUN
during O ADP
painless O NOUN
fiberbronchoscopy]. O NOUN

The O DET
treatment O NOUN
was O VERB
well O ADV
tolerated B-outcome VERB
, O PUNCT
without O ADP
side B-outcome NOUN
effects I-outcome NOUN
or O CCONJ
adverse B-outcome ADJ
events I-outcome NOUN
. O PUNCT
Thus, O NOUN
our O ADJ
WSP O NOUN
formula O NOUN
as O ADP
an O DET
MR O NOUN
can O VERB
facilitate O VERB
individual O ADJ
weight B-outcome NOUN
loss O NOUN
and O CCONJ
thus O ADV
has O VERB
commercial O ADJ
application O NOUN
in O ADP
the O DET
food O NOUN
industry. O VERB

RESULTS: O NOUN
The O DET
scapular B-outcome ADJ
dyskinesis I-outcome NOUN
percentage O NOUN
( O PUNCT
P O NOUN
< O SYM
.05) O NOUN
decreased O VERB
and O CCONJ
the O DET
pectoralis B-outcome NOUN
minor I-outcome ADJ
index O NOUN
( O PUNCT
P O NOUN
< O SYM
.001) O PUNCT
increased O VERB
immediately O ADV
and O CCONJ
at O ADP
60 O NUM
to O PART
72 O NUM
hours O NOUN
after O ADP
taping O VERB
in O ADP
the O DET
rigid-taping O VERB
and O CCONJ
Kinesio-taping O VERB
groups. O NOUN

The O DET
aims O NOUN
of O ADP
our O ADJ
study O NOUN
were O VERB
to O PART
analyze O NOUN
not O ADV
only O ADV
the O DET
influence O NOUN
of O ADP
daily O ADJ
vs. O CCONJ
monthly O ADV
administration O NOUN
of O ADP
vitamin O NOUN
D O NOUN
on O ADP
bone B-outcome NOUN
metabolism I-outcome NOUN
and O CCONJ
bone B-outcome NOUN
turnover I-outcome ADV
, O PUNCT
but O CCONJ
also O ADV
the O DET
effects O NOUN
of O ADP
different O ADJ
routes O NOUN
of O ADP
administration O NOUN
on O ADP
fat B-outcome NOUN
mass I-outcome NOUN
in O ADP
a O DET
cohort O NOUN
of O ADP
adults O NOUN
with O ADP
low O ADJ
levels O NOUN
of O ADP
25(OH) O NUM
vitamin O NOUN
D3 O NOUN
at O ADP
baseline. O NOUN

Journal-Name:BMC O NOUN
psychology O NOUN

BACKGROUND: O NOUN
We O PRON
previously O ADV
showed O VERB
that O ADP
human O NOUN
anti-T-lymphocyte O NOUN
globulin O NOUN
(ATLG) O ADV
plus O CCONJ
ciclosporin O NOUN
and O CCONJ
methotrexate O NOUN
given O VERB
to O PART
patients O NOUN
with O ADP
acute O ADJ
leukaemia O NOUN
in O ADP
remission, O NOUN
having O VERB
allogeneic O ADJ
haemopoietic O ADJ
stem-cell O NOUN
transplantation O NOUN
with O ADP
peripheral O ADJ
blood O NOUN
stem O NOUN
cells O NOUN
from O ADP
an O DET
HLA-identical O ADJ
sibling O VERB
donor O NOUN
after O ADP
myeloablative O ADJ
conditioning, O NOUN
significantly O ADV
reduced O VERB
2-year O NOUN
chronic B-outcome ADJ
graft-versus-host I-outcome ADV
disease I-outcome NOUN
(cGVHD) I-outcome NOUN
incidence X NOUN
and X NOUN
severity S4-outcome NOUN
, O PUNCT
without O ADP
increasing O VERB
disease B-outcome NOUN
relapse I-outcome NOUN
and O CCONJ
infections O NOUN
, O PUNCT
and O CCONJ
improves O NOUN
cGVHD-free O ADJ
and O CCONJ
relapse-free O ADJ
survival O NOUN
(cGRFS) O SYM
. O PUNCT
The O DET
aim O ADP
of O ADP
an O DET
extended O VERB
follow-up O NOUN
study O NOUN
was O VERB
the O DET
assessment O NOUN
of O ADP
long-term O NOUN
outcomes, O NOUN
which O ADP
are, O NOUN
in O ADP
this O DET
context, O NOUN
scarcely O ADV
reported O VERB
in O ADP
the O DET
literature. O NOUN

Title: O NOUN
Randomized O VERB
Delayed-Start O NOUN
Trial O NOUN
of O ADP
Levodopa O NOUN
in O ADP
Parkinson's O NOUN
Disease. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:The O ADJ
bone O NOUN
& O CCONJ
joint O NOUN
journal O ADJ

The O DET
postinduction O NOUN
systolic B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
(P O NUM
= O SYM
.03), O PUNCT
diastolic B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
(P O NUM
< O SYM
.001) O PUNCT
and O CCONJ
heart B-outcome NOUN
rate I-outcome NOUN
(P O NUM
= O SYM
.03) O NUM
were O VERB
significantly O ADV
higher O ADJ
in O ADP
the O DET
methohexital O ADJ
group. O VERB

Title: O NOUN
FOLFIRINOX O NOUN
or O CCONJ
Gemcitabine O NOUN
as O ADP
Adjuvant O NOUN
Therapy O NOUN
for O ADP
Pancreatic O ADJ
Cancer. O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

RESULTS: O NOUN
In O ADP
1st O ADJ
group O NOUN
of O ADP
children O NOUN
operated O VERB
with O ADP
cadaver O ADV
allografts, O ADV
the O DET
Kujala O NOUN
score O ADJ
significantly O ADV
improved O VERB
from O ADP
73.91 O NUM
points O NOUN
preoperatively O ADV
to O PART
94.50 O NUM
points O NOUN
postoperatively O ADV
(P O NUM
< O SYM
.001). O PUNCT

Title: O NOUN
The O DET
effect O NOUN
of O ADP
two O NUM
beta-alanine O NOUN
dosing O VERB
strategies O NOUN
on O ADP
30-minute O NOUN
rowing B-outcome VERB
performance I-outcome NOUN
: O PUNCT
a O DET
randomized, O NOUN
controlled O VERB
trial. O NOUN

Participants, O NOUN
the O DET
study O NOUN
team O NOUN
administering O VERB
treatment, O NOUN
and O CCONJ
investigators O NOUN
analysing O VERB
outcomes O NOUN
(who O PUNCT
were O VERB
independent O ADJ
of O ADP
the O DET
study O NOUN
team O NOUN
and O CCONJ
had O VERB
no O DET
further O ADV
involvement) O NOUN
were O VERB
masked O VERB
to O PART
treatment O NOUN
groups. O NOUN

The O DET
incidence O NOUN
of O ADP
severe B-outcome ADJ
adverse I-outcome ADJ
perinatal I-outcome ADJ
outcomes I-outcome NOUN
was O VERB
1.7% O ADJ
(n=118) O NOUN
for O ADP
the O DET
intervention O NOUN
strategy O NOUN
and O CCONJ
1.8% O NOUN
(n=106) O NOUN
for O ADP
usual O ADJ
care. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
treatment B-outcome NOUN
success I-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
a O DET
decrease O NOUN
of O ADP
50% O NUM
or O CCONJ
more O ADV
in O ADP
the O DET
Gastroesophageal O NOUN
Reflux O NOUN
Disease O NOUN
(GERD)-Health O PUNCT
Related O VERB
Quality B-outcome NOUN
of I-outcome ADP
Life I-outcome NOUN
score O ADJ
(range, O NOUN
0 O NUM
to O PART
50, O NOUN
with O ADP
higher O ADJ
scores O NOUN
indicating O VERB
worse O NOUN
symptoms) O NOUN
at O ADP
1 O NUM
year. O NOUN

Title: O NOUN
Randomized O VERB
Trial O NOUN
of O ADP
Medical O ADJ
versus O CCONJ
Surgical O ADJ
Treatment O NOUN
for O ADP
Refractory O ADJ
Heartburn. O NOUN

MATERIAL O NOUN
AND O CCONJ
METHODS: O NOUN
Three O NUM
hundred O NUM
thirty-two O NUM
Indian O NOUN
patients O NOUN
undergoing O VERB
elective O ADJ
percutaneous O ADJ
coronary O ADJ
intervention O NOUN
(PCI) O PUNCT
were O VERB
enrolled O VERB
in O ADP
the O DET
study. O NOUN

Total O ADJ
follow-up O NOUN
was O VERB
38.2 O NUM
months, O NOUN
during O ADP
which O ADP
the O DET
median O ADJ
duration O NOUN
of O ADP
overall B-outcome ADJ
survival I-outcome NOUN
was O VERB
5.5 O NUM
months O NOUN
(IQR O NUM
2.1-11.7) O NUM
in O ADP
the O DET
5-day O NOUN
group O NOUN
and O CCONJ
6.0 O NUM
months O NOUN
(1.9-11.7) O PUNCT
in O ADP
the O DET
10-day O NOUN
group. O VERB

Reduction O NOUN
in O ADP
serum O NOUN
hydroxymethylglutaryl-CoA B-outcome NOUN
reductase I-outcome NOUN
enzyme I-outcome NOUN
(HMGCR) I-outcome PUNCT
levels O NOUN
was O VERB
comparable O ADJ
in O ADP
both O CCONJ
the O DET
groups O NOUN
(31.17% O PUNCT
vs O CCONJ
28.19%). O NOUN

DHA B-outcome NOUN
intakes O NOUN
up O ADP
to O PART
7 O NUM
mg/kg O NOUN
did O VERB
not O ADV
improve O VERB
neurological B-outcome ADJ
functions I-outcome NOUN
in O ADP
PKU O NOUN
children. O NOUN

Then O ADV
the O DET
3 O NUM
groups O NOUN
were O VERB
divided O VERB
into O ADP
2 O NUM
subgroups O NOUN
by O ADP
age, O NOUN
12 O NUM
to O PART
24 O NUM
months O NOUN
and O CCONJ
25 O NUM
to O PART
36 O NUM
months. O NOUN

Achaogen, O VERB
South O NOUN
San O NOUN
Francisco, O ADV
CA. O NOUN

Statistically O ADV
significant O ADJ
root B-outcome NOUN
coverage I-outcome NOUN
percentage O NOUN
was O VERB
observed O VERB
at O ADP
one O NUM
year O NOUN
post-treatment O NOUN
for O ADP
both O CCONJ
groups O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
8912748 O NUM

179.8 O NUM
+/- O SYM
6.3 O NUM
cm; O NOUN
83.1 O NUM
+/- O SYM
12.7 O NUM
kg) O NOUN
volunteered O VERB
to O PART
participate O NOUN
in O ADP
this O DET
study. O NOUN

Journal-Name:Marine O NOUN
drugs O NOUN

Some O DET
of O ADP
the O DET
earlier O ADJ
studies O NOUN
have O VERB
reported O VERB
several, O ADJ
non-serious O ADJ
adverse O ADJ
events, O NOUN
mostly O ADV
related O VERB
to O PART
gastrointestinal O ADJ
tract, O NOUN
but O CCONJ
systematic O ADJ
sufficiently O ADV
powered O VERB
study O NOUN
on O ADP
safety O NOUN
is O VERB
lacking. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

INTRODUCTION: O NOUN
Noggin O NOUN
is O VERB
an O DET
antagonist O NOUN
of O ADP
bone O NOUN
morphogenetic O ADJ
proteins O NOUN
(BMPs) O PUNCT
and O CCONJ
has O VERB
a O DET
strong O ADJ
effect O NOUN
on O ADP
osteogenesis. O NOUN

Furthermore, O NOUN
the O DET
24 O NUM
elite O ADP
football O NOUN
players O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
a O DET
dark O ADJ
chocolate O NOUN
(>85% O NOUN
cocoa) O NOUN
intake O NOUN
(n O NOUN
= O SYM
12) O NOUN
or O CCONJ
a O DET
control O NOUN
group O NOUN
(n O NOUN
= O SYM
12) O NOUN
for O ADP
30 O NUM
days O NOUN
in O ADP
a O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Journal-Name:Journal O ADJ
of O ADP
global O ADJ
health O NOUN

CONCLUSION: O NOUN
Oral O ADJ
supplementation O NOUN
with O ADP
3000 O NUM
IU/day O NOUN
of O ADP
vitamin O NOUN
D3 O NOUN
during O ADP
eight O NUM
weeks O NOUN
showed O VERB
to O PART
be O VERB
sufficient O ADJ
to O PART
prevent O NOUN
a O DET
decline O NOUN
in O ADP
hematological O ADJ
levels O NOUN
of O ADP
haemoglobin B-outcome NOUN
and O CCONJ
haematocrit B-outcome NOUN
, O PUNCT
and O CCONJ
improve O VERB
transferrin B-outcome NOUN
of O ADP
25(OH)D O NUM
levels. O NOUN

The O DET
intercostal O ADJ
drainage O NOUN
group O NOUN
had O VERB
mean O NOUN
length B-outcome NOUN
of I-outcome ADP
hospital I-outcome NOUN
stay I-outcome NOUN
(p=0.527) O NOUN
and O CCONJ
drainage O NOUN
(p=0.547) O NOUN
of O ADP
4 O NUM
days, O NOUN
and O CCONJ
the O DET
traditional O ADJ
chest O NOUN
drainage O NOUN
group O NOUN
and O CCONJ
2 O NUM
and O CCONJ
5.5 O NUM
days, O NOUN
respectively. O NOUN

METHODS: O NOUN
We O PRON
performed O VERB
a O DET
phase O NOUN
3, O NOUN
prospective, O NOUN
double-blind, O NOUN
double-dummy, O NOUN
randomized, O NOUN
controlled O VERB
trial O NOUN
to O PART
compare O NOUN
tafenoquine O NOUN
with O ADP
primaquine O NOUN
in O ADP
terms O NOUN
of O ADP
safety O NOUN
and O CCONJ
efficacy. O NOUN

With O ADP
a O DET
median O ADJ
follow-up O NOUN
of O ADP
31 O NUM
months O NOUN
(IQR O NUM
27.3-35.7), O NOUN
we O PRON
observed O VERB
a O DET
28% O NUM
reduction O NOUN
in O ADP
the O DET
risk O NOUN
of O ADP
progression B-outcome NOUN
or O CCONJ
death B-outcome NOUN
with O ADP
ixazomib O NOUN
versus O CCONJ
placebo O NOUN
(median O PUNCT
PFS O NOUN
26.5 O NUM
months O NOUN
[95% O NOUN
CI O NOUN
23.7-33.8 O ADV
vs O CCONJ
21.3 O NUM
months O NOUN
[18.0-24.7]; O NOUN
hazard O NOUN
ratio O NOUN
0.72, O NUM
95% O NOUN
CI O NOUN
0.58-0.89; O NOUN
p=0.0023). O VERB

D-group O NOUN
received O VERB
a O DET
12-wk O NOUN
diet O NOUN
intervention O NOUN
within O ADP
primary O ADJ
health O NOUN
care O NOUN
followed O VERB
by O ADP
monthly O ADV
emails O NOUN
up O ADP
to O PART
the O DET
1-y O NOUN
follow-up. O PUNCT

intrauterine B-outcome ADJ
adhesions I-outcome NOUN
were O VERB
observed O VERB
in O ADP
6 O NUM
patients O NOUN
in O ADP
group O NOUN
2, O NOUN
while O ADP
no O DET
intrauterine B-outcome ADJ
adhesions I-outcome NOUN
was O VERB
observed O VERB
in O ADP
group O NOUN
1 O NUM
(P O NUM
= O SYM
.007). O PUNCT

Title: O NOUN
[Effect O ADJ
of O ADP
Ronghuang O NOUN
Granule O NOUN
on O ADP
serum O NOUN
FGF23 B-outcome NOUN
, O PUNCT
FGFRs B-outcome NOUN
and O CCONJ
Klotho B-outcome NOUN
in O ADP
non-dialysis O NOUN
patients O NOUN
with O ADP
CKD-MBD O NOUN
and O CCONJ
kidney O NOUN
deficiency O NOUN
and O CCONJ
damp-heat O NOUN
syndrome]. O NOUN

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[medline] O NOUN

METHODS: O NOUN
This O DET
randomized, O NOUN
double-blinded, O NOUN
placebo-controlled O VERB
clinical O ADJ
trial O NOUN
was O VERB
carried O VERB
out O ADP
on O ADP
60 O NUM
subjects, O NOUN
aged O VERB
18-40 O NUM
years O NOUN
old. O NUM

Publication O NOUN
date: O NOUN
2018/11/21 O NOUN
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

RESULTS: O NOUN
The O DET
success B-outcome NOUN
rates O NOUN
in O ADP
the O DET
tobramycin/dexamethasone O NOUN
eye O NOUN
drops O NOUN
group O NOUN
in O ADP
both O CCONJ
2 O NUM
age O NOUN
subgroups O NOUN
were O VERB
significantly O ADV
higher O ADJ
than O ADP
that O ADP
in O ADP
the O DET
ointment O NOUN
group O NOUN
and O CCONJ
NS O NOUN
group O NOUN
(P O NUM
< O SYM
.05). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

CONCLUSIONS: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
clinical O ADJ
trial O NOUN
suggest O VERB
that O ADP
trigger O ADP
point O NOUN
dry O ADJ
needling O VERB
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
tension-type O NOUN
headache O NOUN
is O VERB
effective O ADJ
and O CCONJ
safe O ADJ
in O ADP
reducing O VERB
headache B-outcome NOUN
intensity I-outcome NOUN
, Seperator PUNCT
frequency X NOUN
and Seperator CCONJ
duration S1-outcome NOUN
, O PUNCT
and O CCONJ
increasing O VERB
health-related B-outcome VERB
quality I-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
. O PUNCT
TRIAL O NOUN
REGISTRATION: O NOUN
Clinical O ADJ
Trials O NOUN
NCT03500861. O NOUN

It O PRON
can O VERB
improve O VERB
anxiety B-outcome NOUN
and O CCONJ
has O VERB
no O DET
adverse B-outcome ADJ
effect I-outcome NOUN
on O ADP
sleep B-outcome NOUN
quality I-outcome NOUN
. O PUNCT

Under O ADP
PCV O NOUN
mode, O NOUN
with O ADP
the O DET
increase O NOUN
in O ADP
oxygen O NOUN
atomization O NOUN
flow, O NOUN
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
was O VERB
decreased O VERB
gradually, O NOUN
and O CCONJ
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
was O VERB
increased O VERB
gradually, O NOUN
with O ADP
significant O ADJ
difference O NOUN
as O ADP
compared O VERB
with O ADP
those O DET
before O ADP
atomization O NOUN
when O ADP
the O DET
atomized O VERB
oxygen O NOUN
flow O NOUN
was O VERB
9 O NUM
L/min O NOUN
[ O PUNCT
inspiratory B-outcome ADJ
tidal I-outcome DET
volume I-outcome NOUN
(mL): O NOUN
322.78+/-17.75 O NOUN
vs. O CCONJ
518.17+/-8.97, O NOUN
exhaled B-outcome VERB
tidal I-outcome DET
volume I-outcome NOUN
(mL): O NOUN
730.89+/-31.20 O NOUN
vs. O CCONJ
519.00+/-9.06, O NOUN
both O CCONJ
P O NOUN
< O SYM
0.05]. O NUM
There O PRON
was O VERB
no O DET
significant O ADJ
change O NOUN
in O ADP
peak B-outcome NOUN
airway I-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
and O CCONJ
no O DET
significant O ADJ
difference O NOUN
at O ADP
9 O NUM
L/min O NOUN
of O ADP
atomized O VERB
oxygen O NOUN
flow O NOUN
as O ADP
compared O VERB
with O ADP
that O ADP
before O ADP
atomization O NOUN
(cmH2O: O NOUN
21.44+/-2.23 O PUNCT
vs. O CCONJ
21.39+/-2.55, O NUM
P O NOUN
> O SYM
0.05). O NOUN
( O PUNCT

Introduction: O NOUN
Acute O ADJ
pancreatitis O NOUN
(AP) O NOUN
is O VERB
an O DET
inflammatory O ADJ
disease O NOUN
of O ADP
the O DET
pancreas O NOUN
that O ADP
spans O NOUN
a O DET
wide O ADJ
range O NOUN
ranging O VERB
from O ADP
mild O ADJ
to O PART
critical O ADJ
forms. O NOUN

Title: O NOUN
[Effect O ADJ
of O ADP
Kangfuxin O NOUN
liquid O ADV
combined O VERB
with O ADP
Garlicin O NOUN
Capsules O NOUN
in O ADP
treatment O NOUN
of O ADP
children O NOUN
with O ADP
recurrent O ADP
oral O ADJ
ulcer O NOUN
and O CCONJ
on O ADP
immune B-outcome ADJ
regulation I-outcome NOUN
]. O NOUN

METHODS: O NOUN
We O PRON
derived O VERB
data O NOUN
from O ADP
the O DET
imaging O VERB
subgroup O NOUN
of O ADP
the O DET
Clopidogrel O NOUN
in O ADP
High-risk O NOUN
Patients O NOUN
with O ADP
Acute O ADJ
Nondisabling O VERB
Cerebrovascular O ADJ
Events O NOUN
(CHANCE) O PUNCT
trial. O NOUN

OBJECTIVE: O NOUN
To O PART
verify O NOUN
the O DET
effectiveness O NOUN
of O ADP
brief O ADJ
group O NOUN
intervention, O ADP
performed O VERB
by O ADP
nurses, O NOUN
in O ADP
reducing O VERB
the O DET
hazardous B-outcome ADJ
or Seperator CCONJ
harmful I-outcome ADJ
alcohol I-outcome NOUN
use I-outcome NOUN
in O ADP
users O NOUN
of O ADP
a O DET
primary O ADJ
health O NOUN
care O NOUN
service. O NOUN

kg(-1).h(-1) O NOUN
for O ADP
patients O NOUN
in O ADP
group O NOUN
C, O NOUN
and O CCONJ
sufentanil O NOUN
0.025 O NUM
mug.kg(-1).h(-1) O NOUN
plus O CCONJ
dexmedetomidine O NOUN
0.1 O NUM
mug. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
diet O NOUN
with O ADP
or O CCONJ
without O ADP
exercise O NOUN
on O ADP
abdominal O ADJ
fat O NOUN
</> O SYM
in O ADP
postmenopausal O ADJ
women O NOUN
- O PUNCT
a O DET
randomised O VERB
trial. O NOUN

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
79 O NUM
patients O NOUN
with O ADP
POCS O NOUN
and O CCONJ
35 O NUM
healthy O ADJ
females O NOUN
were O VERB
included, O VERB
and O CCONJ
endometrial O ADJ
biopsies O NOUN
were O VERB
obtained. O NOUN

Title: O NOUN
Sorafenib O NOUN
for O ADP
Advanced O VERB
and O CCONJ
Refractory O ADJ
Desmoid O NOUN
Tumors. O NOUN

Journal O ADJ
ID: O NOUN
9301647 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Publication O NOUN
date: O NOUN
2019/02/05 O NOUN
06:00 O ADP
[medline] O NOUN

Statistical O ADJ
analysis O NOUN
were O VERB
performed O VERB
using O VERB
the O DET
Statistical O ADJ
Package O NOUN
for O ADP
the O DET
Social O ADJ
Sciences, O NOUN
version O NOUN
20. O NUM

The O DET
accumulation O NOUN
of O ADP
damaged B-outcome VERB
mtDNA I-outcome ADJ
and O CCONJ
fragmented B-outcome VERB
mitochondria I-outcome NOUN
resulted O VERB
in O ADP
increased O VERB
reactive B-outcome ADJ
oxygen I-outcome NOUN
species I-outcome NOUN
(ROS) I-outcome PUNCT
generation, O NOUN
activation O NOUN
of O ADP
apoptosis B-outcome NOUN
and O CCONJ
loss O NOUN
of O ADP
mitochondrial B-outcome ADJ
membrane I-outcome NOUN
potential I-outcome ADJ
(DeltaPsim) I-outcome NOUN
in O ADP
tubules O NOUN
and O CCONJ
PBMCs. O NOUN

This O DET
trial O NOUN
is O VERB
registered O VERB
with O ADP
ClinicalTrials.gov, O NOUN
number O NOUN
NCT01786343. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[medline] O NOUN

Respiratory B-outcome ADJ
depression I-outcome NOUN
was O VERB
not O ADV
happened O NUM
in O ADP
both O CCONJ
groups. O NOUN

Five O NUM
quasimonomorphic O ADJ
mononucleotide O NOUN
markers O NOUN
were O VERB
used O VERB
to O PART
assess O NOUN
tumor O NOUN
MSI O NOUN
status. O NOUN

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
72 O NUM
children, O NOUN
ages O NOUN
4 O NUM
to O PART
12 O NUM
years O NOUN
with O ADP
MA O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
a O DET
treatment O NOUN
group O NOUN
or O CCONJ
a O DET
control O NOUN
group O NOUN
at O ADP
a O DET
ratio O NOUN
of O ADP
1:1. O NUM

Title: O NOUN
The O DET
influence O NOUN
of O ADP
pelvis O NOUN
reposition O NOUN
exercises O NOUN
on O ADP
pelvic B-outcome ADJ
floor I-outcome NOUN
muscles I-outcome NOUN
asymmetry I-outcome NOUN
: O PUNCT
A O DET
randomized O VERB
prospective O ADJ
study. O NOUN

This O DET
effect O NOUN
may O VERB
not O ADV
be O VERB
dose O NOUN
related O VERB
within O ADP
the O DET
studied O VERB
range. O ADJ

Title: O NOUN
Patient O NOUN
coping O VERB
and O CCONJ
expectations O NOUN
predict O VERB
recovery B-outcome NOUN
after O ADP
major O ADJ
orthopaedic O ADJ
trauma. O NOUN

The O DET
percentage O NOUN
of O ADP
patients O NOUN
who O ADP
had O VERB
a O DET
recurrence B-outcome NOUN
of O ADP
TTP O NOUN
at O ADP
any O DET
time O NOUN
during O ADP
the O DET
trial O NOUN
was O VERB
67% O ADJ
lower O ADJ
with O ADP
caplacizumab O NOUN
than O ADP
with O ADP
placebo O NOUN
(12% O NUM
vs. O CCONJ
38%, O NUM
P<0.001). O NUM

Therefore, O NOUN
continuous O ADJ
investigation O NOUN
of O ADP
effective O ADJ
interventions O NOUN
for O ADP
upper O ADJ
extremity O NOUN
functions O NOUN
after O ADP
stroke O NOUN
is O VERB
a O DET
necessity. O ADJ

The O DET
participants O NOUN
performed O VERB
a O DET
2000-m O NUM
test O NOUN
on O ADP
a O DET
rowing O VERB
ergometer O NOUN
at O ADP
the O DET
beginning O VERB
(1st O NOUN
examination) O NOUN
and O CCONJ
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
supplementation O NOUN
period O NOUN
(2nd O PUNCT
examination). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/03/05 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSIONS: O NOUN
The O DET
aforementioned O VERB
results O NOUN
demonstrate O VERB
that O ADP
TKA O NOUN
is O VERB
an O DET
effective O ADJ
surgery, O NOUN
and O CCONJ
IV O NUM
plus O CCONJ
IA O NOUN
TXA O NOUN
injection O NOUN
functions O NOUN
more O ADV
effectively O ADV
in O ADP
reducing O VERB
blood B-outcome NOUN
loss I-outcome NOUN
and O CCONJ
fibrinolytic B-outcome ADJ
activity O NOUN
in O ADP
patients, O NOUN
which O ADP
is O VERB
a O DET
clinical O ADJ
factor O NOUN
of O ADP
occult O NOUN
hemorrhage. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Medicine O NOUN

The O DET
project O NOUN
manager O NOUN
and O CCONJ
the O DET
manager O NOUN
of O ADP
the O DET
home-care O NOUN
centre O NOUN
both O CCONJ
reflected O VERB
mainly O ADV
on O ADP
improvement O NOUN
of O ADP
the O DET
healthcare O NOUN
workers O NOUN
health. O NOUN

Endometriosis O NOUN
is O VERB
a O DET
classic O ADJ
indication O NOUN
for O ADP
IVF. O NUM

Group O NOUN
A O DET
(corneal O PUNCT
group) O ADJ
included O VERB
131 O NUM
cases O NOUN
(135 O ADV
eyes), O NOUN
receiving O VERB
the O DET
3 O NUM
layers O NOUN
of O ADP
allogeneic O ADJ
cornea O NOUN
slices O NOUN
as O ADP
graft. O VERB

INCLUSION O NOUN
CRITERIA: O NOUN
Patients O NOUN
with O ADP
stable O ADJ
coronary O ADJ
artery O NOUN
disease O NOUN
or O CCONJ
recent O ADJ
acute O ADJ
coronary O ADJ
syndrome O NOUN
( O PUNCT
>1 O NOUN
week O NOUN
from O ADP
the O DET
date O NOUN
of O ADP
STEMI), O NOUN
being O VERB
taken O VERB
up O ADP
for O ADP
elective O ADJ
angioplasty. O NOUN

Journal-Name:BMC O NOUN
gastroenterology O NOUN

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT02257294. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
7703942 O NUM

All O DET
students O NOUN
managed O VERB
a O DET
simulated O VERB
cardiac O ADJ
arrest O NOUN
scenario O NOUN
with O ADP
primary O ADJ
outcome O NOUN
based O VERB
on O ADP
the O DET
AHA O NOUN
guidelines O NOUN
definition O NOUN
of O ADP
high-quality O NOUN
CPR O NOUN
(specifies O NOUN
metrics O NOUN
for O ADP
compression B-outcome NOUN
rate, X NOUN
depth I-outcome NOUN
, O PUNCT
recoil B-outcome NOUN
, O PUNCT
and O CCONJ
compression B-outcome NOUN
fraction I-outcome NOUN
). O NOUN

The O DET
prevalence O NOUN
of O ADP
atelectasis O NOUN
was O VERB
10% O ADP
for O ADP
the O DET
PAR-G O NOUN
and O CCONJ
30% O NOUN
for O ADP
the O DET
1PO-G O NUM
(p=0.0027). O NOUN

Topics O NOUN
of O ADP
discussion O NOUN
in O ADP
CHDRs O NOUN
focused O VERB
primarily O ADV
on O ADP
CHW O NOUN
functionality. O NOUN

Compared O VERB
with O ADP
MIIT O NOUN
and O CCONJ
control O NOUN
groups, O NOUN
HIIT O NOUN
showed O VERB
improvements O NOUN
in O ADP
the O DET
SF-36 O NOUN
domains: O NOUN
general B-outcome ADJ
health I-outcome NOUN
(p<.001 O PUNCT
for O ADP
both) O NOUN
health B-outcome NOUN
changes O NOUN
(p<.001 O PUNCT
for O ADP
both), O NOUN
vitality B-outcome NOUN
(p=.002 O NUM
and O CCONJ
p=.001 O NUM
respectively) O NOUN
and O CCONJ
physical B-outcome ADJ
functioning I-outcome VERB
(p=.036 O PUNCT
and O CCONJ
p<.001 O NOUN
respectively). O NOUN

METHODS: O NOUN
Forty-five O ADJ
adult, O NOUN
hypertensive O ADJ
patients O NOUN
taking O VERB
ACEi O NOUN
or O CCONJ
ARB O NOUN
and O CCONJ
scheduled O VERB
for O ADP
elective, O NOUN
noncardiac O ADJ
surgery O NOUN
completed O VERB
the O DET
study. O NOUN

CONCLUSION: O NOUN
Health O NOUN
education O NOUN
of O ADP
diabetic O ADJ
individuals O NOUN
via O ADP
Wechat O ADP
platform O NOUN
in O ADP
conjunction O NOUN
with O ADP
conventional O ADJ
diabetes O NOUN
treatment O NOUN
could O VERB
improve O VERB
glycemic B-outcome ADJ
control I-outcome NOUN
and O CCONJ
positively O ADV
influence O NOUN
other O ADJ
aspects O NOUN
of O ADP
diabetes O NOUN
self-care B-outcome NOUN
skills. O NOUN

These O DET
meetings O NOUN
were O VERB
held O NOUN
over O ADP
a O DET
period O NOUN
of O ADP
20 O NUM
months O NOUN
from O ADP
July O NOUN
2015 O NUM
to O PART
March O NOUN
2017. O NUM

Therefore, O NOUN
the O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
use O NOUN
a O DET
combination O NOUN
of O ADP
methods O NOUN
to O PART
elicit O VERB
child O NOUN
and O CCONJ
teacher O NOUN
perceptions O NOUN
regarding O VERB
the O DET
feasibility B-outcome NOUN
and O CCONJ
acceptability B-outcome NOUN
of O ADP
the O DET
AS:Sk O NUM
intervention, O ADP
alongside O ADP
systematic O ADJ
researcher O ADP
observations. O NOUN

Publication O NOUN
date: O NOUN
2019/03/08 O ADV
06:00 O ADP
[medline] O NOUN

The O DET
patients O NOUN
were O VERB
divided O VERB
into O ADP
two O NUM
groups O NOUN
by O ADP
random O NOUN
allocation O NOUN
using O VERB
Ti-Ti O NOUN
rods O NOUN
(n O NOUN
= O SYM
29) O NOUN
and O CCONJ
CrCo-Ti O NOUN
rods O NOUN
(n O NOUN
= O SYM
30) O NOUN
and O CCONJ
the O DET
alone O ADJ
difference O NOUN
among O ADP
them O PRON
in O ADP
the O DET
surgical O ADJ
procedure O NOUN
was O VERB
rod O NOUN
material O ADJ
(Ti-Ti O NOUN
or O CCONJ
CrCo-Ti O NOUN
rods) O ADJ
and O CCONJ
finally, O NOUN
radiological B-outcome ADJ
outcomes O NOUN
were O VERB
compared O VERB
preoperatively, O ADJ
postoperatively O ADV
and O CCONJ
at O ADP
last O NOUN
follow-up O NOUN
for O ADP
12 O NUM
months. O NOUN

Publication O NOUN
date: O NOUN
2019/01/27 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
The O DET
therapeutic O ADJ
effect O NOUN
of O ADP
combined O VERB
treatment O NOUN
is O VERB
better O ADJ
than O ADP
clomifene O NOUN
citrate O NOUN
alone O ADJ
in O ADP
the O DET
treatment O NOUN
of O ADP
PCOS. O NOUN

However, O ADV
data O NOUN
on O ADP
the O DET
optimal O ADJ
route O NOUN
of O ADP
administration O NOUN
are O VERB
not O ADV
consistent. O NOUN

Unchanged B-outcome VERB
rate, O NOUN
transfer B-outcome NOUN
rate O NOUN
of O ADP
patients, O NOUN
rate O NOUN
of O ADP
impaired B-outcome VERB
glucose I-outcome NOUN
tolerance I-outcome NOUN
, O PUNCT
turn B-outcome NOUN
normal I-outcome ADJ
rate O NOUN
and O CCONJ
other O ADJ
biochemical O ADJ
indicators O NOUN
of O ADP
patients O NOUN
and O CCONJ
people O NOUN
with O ADP
impaired O VERB
glucose O NOUN
tolerance O NOUN
from O ADP
control O NOUN
group O NOUN
and O CCONJ
intervention O NOUN
group O NOUN
were O VERB
analyzed, O NOUN
to O PART
evaluate O VERB
the O DET
intervention O NOUN
effects O NOUN
of O ADP
peer O NOUN
support O NOUN
education O NOUN
mode. O VERB

The O DET
data O NOUN
were O VERB
collected O VERB
using O VERB
the O DET
revised O VERB
Illness B-outcome NOUN
Perception I-outcome NOUN
Questionnaire O PROPN
(IPQ-R) O NOUN
and O CCONJ
Depression B-outcome NOUN
Anxiety B-outcome NOUN
Stress B-outcome NOUN
Scales O NOUN
(DASS-21 O NOUN
scores) O NOUN
which O ADP
were O VERB
completed O VERB
by O ADP
the O DET
participants. O NOUN

No O DET
changes O NOUN
were O VERB
detected O VERB
in O ADP
weight B-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
"MyNutriCart" O NOUN
app O CCONJ
use O NOUN
led O VERB
to O PART
significant O ADJ
improvements O NOUN
in O ADP
food-related B-outcome VERB
behaviors I-outcome NOUN
compared O VERB
to O PART
baseline, O NOUN
with O ADP
no O DET
significant O ADJ
differences O NOUN
when O ADP
compared O VERB
to O PART
the O DET
Traditional O ADJ
group. O VERB

The O DET
mean O NOUN
reduction O NOUN
in O ADP
total B-outcome ADJ
cholesterol I-outcome NOUN
(TC) I-outcome NOUN
, O PUNCT
low B-outcome ADJ
density I-outcome NOUN
lipoprotein-cholesterol I-outcome NOUN
(LDL-C) I-outcome NOUN
and O CCONJ
non-high B-outcome ADJ
density I-outcome NOUN
lipoprotein-cholesterol I-outcome NOUN
(HDL-C) I-outcome NOUN
was O VERB
significantly O ADV
higher O ADJ
in O ADP
DR O NOUN
group, O NOUN
whereas O ADP
mean O NOUN
reduction O NOUN
in O ADP
triglycerides B-outcome NOUN
(TG) I-outcome NOUN
and O CCONJ
increase O NOUN
in O ADP
non-high B-outcome ADJ
density I-outcome NOUN
lipoprotein-cholesterol I-outcome NOUN
(HDL-C) I-outcome NOUN
was O VERB
similar O ADJ
in O ADP
both O CCONJ
the O DET
groups. O NOUN

The O DET
exercise O NOUN
protocol O NOUN
consisted O VERB
of O ADP
performing O VERB
the O DET
bench O NOUN
press O NOUN
movement O NOUN
with O ADP
a O DET
load O NOUN
equal O ADJ
to O PART
70%1RM O NUM
with O ADP
maximal O ADJ
possible O ADJ
velocity O NOUN
(X/0/X/0). O NOUN

Total O ADJ
knee O NOUN
arthroplasty O NOUN
(TKA) O ADV
is O VERB
a O DET
common O ADJ
orthopedic O ADJ
surgery O NOUN
known O VERB
to O PART
be O VERB
very O ADV
painful. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
This O DET
trial O NOUN
was O VERB
retrospectively O ADV
registered O VERB
on O ADP
20/12/2018 O NUM
under O ADP
the O DET
number O NOUN
( O PUNCT
NCT03782051 O NOUN
). O NOUN

Median O ADJ
24-hour O NOUN
morphine B-outcome NOUN
consumption I-outcome NOUN
was O VERB
20 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
0-148) O NOUN
in O ADP
the O DET
PCM O NOUN
+ O SYM
IBU O NOUN
group, O NOUN
36 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
0-166) O NUM
for O ADP
PCM O NOUN
alone, O NOUN
26 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
2-139) O NOUN
for O ADP
IBU O NOUN
alone, O NOUN
and O CCONJ
28 O NUM
mg O NOUN
(99.6% O PUNCT
CI, O NOUN
2-145) O NUM
for O ADP
HS-PCM O NOUN
+ O SYM
IBU. O NOUN

Hagstrom, O NOUN
AD, O NOUN
Shorter, O NOUN
KA, O NOUN
and O CCONJ
Marshall, O NOUN
PWM. O NOUN

The O DET
task O NOUN
used O VERB
in O ADP
this O DET
study O NOUN
was O VERB
the O DET
Tube O NOUN
2 O NUM
and O CCONJ
it O PRON
imitates O NOUN
a O DET
vesicourethral O ADJ
anastomosis O NOUN
in O ADP
robotic O ADJ
prostatectomy. O NOUN

CONCLUSIONS: O NOUN
Training O VERB
on O ADP
wearing O VERB
an O DET
N95 O NOUN
or O CCONJ
higher O ADJ
respirator O NOUN
improved O VERB
the O DET
protection B-outcome NOUN
performance O NOUN
of O ADP
respirators O NOUN
among O ADP
healthcare O NOUN
providers O NOUN
working O VERB
in O ADP
the O DET
EMC. O NOUN

The O DET
anti-HAV B-outcome NOUN
GMCs I-outcome NOUN
in O ADP
the O DET
Avaxim, O NOUN
Epaxal, O NOUN
and O CCONJ
Havrix O NOUN
groups O NOUN
were O VERB
5868.4 O NOUN
(95% O PUNCT
CI: O NOUN
4237.2-8126.6), O NOUN
1962.1 O NOUN
(95% O PUNCT
CI: O NOUN
1298.0-2965.9), O NOUN
and O CCONJ
2232.9 O NOUN
mIU/mL O NOUN
(95% O PUNCT
CI: O NOUN
1428.4-3490.4), O NOUN
respectively, O NOUN
after O ADP
administration O NOUN
of O ADP
2 O NUM
doses O NOUN
(P O NUM
< O SYM
.001). O PUNCT

After O ADP
simulation O NOUN
training, O NOUN
participants O NOUN
performed O VERB
cricothyroidotomy O NOUN
using O VERB
an O DET
ex O ADP
vivo O ADV
porcine O ADJ
larynx O ADJ
fitted O VERB
with O ADP
an O DET
endoscope O NOUN
to O PART
record O NOUN
the O DET
procedure. O NOUN

Journal O ADJ
ID: O NOUN
101230586 O NUM

Title: O NOUN
The O DET
influence O NOUN
of O ADP
orlistat, O NOUN
metformin O NOUN
and O CCONJ
diet O NOUN
on O ADP
serum O NOUN
levels O NOUN
of O ADP
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
in O ADP
obeses O NOUN
women O NOUN
with O ADP
and O CCONJ
without O ADP
insulin O NOUN
resistance. O NOUN

Publication O NOUN
date: O NOUN
2019/02/28 O NOUN
06:00 O ADP
[medline] O NOUN

Following O VERB
the O DET
study, O NOUN
5 O NUM
focus O NOUN
group O NOUN
discussions O NOUN
(FGDs) O PUNCT
were O VERB
conducted O VERB
consisting O VERB
of O ADP
6-8 O NUM
purposively O ADV
sampled O VERB
participants O NOUN
from O ADP
intervention O NOUN
villages. O NUM

This O DET
study O NOUN
is O VERB
designed O VERB
to O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
high-dose O NOUN
remifentanil O NOUN
on O ADP
the O DET
incidence O NOUN
of O ADP
postoperative B-outcome ADJ
sore I-outcome ADV
throat I-outcome NOUN
(POST) I-outcome NUM
in O ADP
patients O NOUN
after O ADP
general O ADJ
anesthesia. O NOUN

The O DET
data O NOUN
sources O NOUN
were O VERB
pooled O VERB
to O PART
produce O VERB
the O DET
themes O NOUN
presented O VERB
in O ADP
the O DET
results O NOUN
section. O NOUN

RESULTS: O NOUN
Two O NUM
groups O NOUN
showed O VERB
no O DET
difference O NOUN
in O ADP
baseline O NOUN
characteristics. O NOUN

Publication O NOUN
date: O NOUN
2018/12/23 O NOUN
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[medline] O NOUN

Peak O NOUN
FPPA O NOUN
was O VERB
determined O VERB
from O ADP
video O ADJ
recordings O NOUN
while O ADP
participants O NOUN
performed O VERB
5 O NUM
single-leg O ADJ
squats. O NOUN

Little O ADJ
is O VERB
known O VERB
about O ADV
the O DET
impact O NOUN
of O ADP
bracing O VERB
on O ADP
sensory O ADJ
function. O ADJ

Of O ADP
those O DET
in O ADP
the O DET
intervention O NOUN
group O NOUN
who O ADP
tested, O NOUN
64.5% O NUM
chose O NOUN
the O DET
self-test B-outcome NOUN
and O CCONJ
35.5% O NUM
chose O NOUN
the O DET
standard O ADJ
provider-administered O VERB
blood-based O VERB
HIV B-outcome NOUN
test I-outcome NOUN
. O PUNCT
Although O ADP
the O DET
intervention O NOUN
more O ADV
than O ADP
doubled O VERB
HIV B-outcome NOUN
testing I-outcome VERB
rates, O NOUN
because O ADP
HIV B-outcome NOUN
testing I-outcome VERB
rates O NOUN
were O VERB
so O ADV
low O ADJ
in O ADP
this O DET
population O NOUN
(by O NOUN
design O NOUN
as O ADP
we O PRON
selected O VERB
irregular O ADJ
testers), O NOUN
even O ADV
in O ADP
the O DET
intervention O NOUN
group O NOUN
more O ADV
than O ADP
96% O ADJ
of O ADP
participants O NOUN
did O VERB
not O ADV
test B-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
Announcing O VERB
the O DET
availability O NOUN
of O ADP
HIV O NOUN
self-testing O VERB
via O ADP
text O VERB
message O NOUN
increased O VERB
HIV B-outcome NOUN
testing I-outcome VERB
rates O NOUN
among O ADP
truckers O NOUN
who O ADP
were O VERB
not O ADV
regularly O ADV
accessing O VERB
HIV O NOUN
testing. O NOUN

T O NOUN
Self-rating O VERB
depression B-outcome NOUN
scale O NOUN
(SDS) O PUNCT
and O CCONJ
self-rating O VERB
anxiety B-outcome NOUN
scale O NOUN
SAS O NUM
scores O NOUN
of O ADP
patients O NOUN
in O ADP
the O DET
rhodiola O NOUN
treatment O NOUN
group O NOUN
increased O VERB
after O ADP
treatment O NOUN
P<0.05. O NOUN

RESULTS: O NOUN
There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
in O ADP
patient O NOUN
characteristics, O ADJ
operation B-outcome NOUN
time I-outcome NOUN
, O PUNCT
extubation B-outcome NOUN
time I-outcome NOUN
and O CCONJ
recovery B-outcome NOUN
time I-outcome NOUN
. O PUNCT
Compared O VERB
with O ADP
the O DET
children O NOUN
in O ADP
control O NOUN
group, O NOUN
those O DET
in O ADP
DEX O NOUN
group O NOUN
were O VERB
significantly O ADV
more O ADV
sedated B-outcome VERB
when O ADP
they O PRON
were O VERB
separated O VERB
from O ADP
their O ADJ
parents O NOUN
(56.7% O PUNCT
vs. O CCONJ
26.7%, O NUM
P<0.05). O NOUN

The O DET
objective O ADP
of O ADP
current O ADJ
article O NOUN
is O VERB
to O PART
present O ADJ
the O DET
protocol O NOUN
for O ADP
a O DET
PE O NOUN
teacher-delivered O VERB
theory-based O VERB
trial O NOUN
to O PART
promote O VERB
secondary O ADJ
school O NOUN
students' O NOUN
participation B-outcome NOUN
in O ADP
physical O ADJ
activity O NOUN
out-of-school O NOUN
contexts. O NOUN

Journal O ADJ
ID: O NOUN
0370522 O NUM

Journal O ADJ
ID: O NOUN
100968562 O NUM

The O DET
subjects O NOUN
were O VERB
divided O VERB
into O ADP
two O NUM
groups O NOUN
of O ADP
control O NOUN
and O CCONJ
intervention. O NOUN

Journal-Name:BMC O NOUN
infectious O ADJ
diseases O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
Efficacy O NOUN
of O ADP
RADPAD O NOUN
protection O NOUN
drape O NOUN
in O ADP
reducing O VERB
radiation B-outcome NOUN
exposure I-outcome NOUN
in O ADP
the O DET
catheterization O NOUN
laboratory-First O NOUN
Indian O NOUN
study. O NOUN

Results: O NOUN
Among O ADP
11001 O NUM
enrolled O VERB
patients O NOUN
(median O PUNCT
age, O NOUN
62 O NUM
years; O NOUN
3459 O NUM
[31%] O NUM
women), O NOUN
10102 O NUM
patients O NOUN
were O VERB
discharged O VERB
with O ADP
prescriptions O NOUN
for O ADP
clopidogrel O NOUN
or O CCONJ
ticagrelor O ADV
(clopidogrel O NUM
prescribed O VERB
to O PART
2317 O NUM
[36.0%] O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
and O CCONJ
2497 O NUM
[54.7%] O NOUN
in O ADP
the O DET
usual O ADJ
care O NOUN
group), O NOUN
4393 O NUM
of O ADP
6135 O NUM
patients O NOUN
(72%) O PUNCT
in O ADP
the O DET
intervention O NOUN
group O NOUN
used B-outcome VERB
the Seperator DET
voucher I-outcome ADV
, O PUNCT
and O CCONJ
follow-up O NOUN
data O NOUN
at O ADP
1 O NUM
year O NOUN
were O VERB
available O ADJ
for O ADP
10802 O NUM
patients O NOUN
(98.2%). O ADV

Journal O ADJ
ID: O NOUN
101307187 O NUM

There O PRON
was O VERB
no O DET
significant O ADJ
change O NOUN
in O ADP
Coenzyme B-outcome NOUN
Q10 I-outcome NOUN
(CoQ10) I-outcome PUNCT
level O NOUN
of O ADP
amla O NOUN
(p O PUNCT
= O SYM
0.2942) O NUM
or O CCONJ
placebo O NOUN
groups O NOUN
(p O PUNCT
= O SYM
0.6744). O NUM

This O DET
study O NOUN
investigated O VERB
the O DET
effects O NOUN
of O ADP
yoga O NOUN
on O ADP
women O NOUN
with O ADP
PMS O NOUN
suffering O VERB
from O ADP
depression O NOUN
during O ADP
menstrual O ADJ
cycle. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODS: O NOUN
A O DET
between-subjects O NOUN
web-based O VERB
experiment O NOUN
was O VERB
conducted, O VERB
consisting O VERB
of O ADP
four O NUM
sponsorship O NOUN
conditions O NOUN
(A O PUNCT
through O ADP
D) O NOUN
featuring O VERB
three O NUM
product O NOUN
categories O NOUN
within O ADP
each O DET
condition. O NOUN

Journal O ADJ
ID: O NOUN
7903310 O NUM

For O ADP
the O DET
first O ADV
3 O NUM
groups, O NOUN
we O PRON
applied O VERB
tape O NOUN
to O PART
the O DET
shoulder O NOUN
and O CCONJ
scapular O ADJ
region. O NOUN

RESULTS: O NOUN
Supplementation O NOUN
with O ADP
L-theanine O NOUN
contributed O VERB
to O PART
a O DET
significant O ADJ
post-exercise O NOUN
decrease O NOUN
in O ADP
IL-10 B-outcome NOUN
concentration, O NOUN
which O ADP
was O VERB
reflected O VERB
by O ADP
higher O ADJ
values O NOUN
of O ADP
IL-2 B-outcome NOUN
to I-outcome PART
IL-10 I-outcome NOUN
and Seperator CCONJ
IFN-gamma B-outcome NOUN
to I-outcome PART
IL-10 I-outcome NOUN
ratios E1-outcome NOUN
. O PUNCT
Moreover, O NOUN
a O DET
significant O ADJ
post-recovery O NOUN
decrease O NOUN
in O ADP
cytotoxic B-outcome ADJ
lymphocyte I-outcome NOUN
(CTL) I-outcome PUNCT
count, O NOUN
T B-outcome NOUN
regulatory I-outcome ADJ
lymphocyte I-outcome NOUN
(Treg) I-outcome NUM
to I-outcome PART
natural I-outcome ADJ
killer I-outcome NOUN
(NK) I-outcome ADV
and Seperator CCONJ
T B-outcome NOUN
regulatory I-outcome ADJ
lymphocyte I-outcome NOUN
(Treg) I-outcome NUM
to I-outcome PART
cytotoxic I-outcome ADJ
lymphocyte I-outcome NOUN
(CTL) I-outcome PUNCT
ratios E1-outcome NOUN
was O VERB
observed O VERB
in O ADP
the O DET
supplemented O VERB
group. O VERB

RESULTS: O NOUN
All O DET
groups O NOUN
significantly O ADV
improved O VERB
handling B-outcome VERB
performance. O NOUN

Journal O ADJ
ID: O NOUN
101238455 O NUM

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
gender, O NOUN
age, O NOUN
body O NOUN
mass O NOUN
index, O NOUN
the O DET
type O NOUN
of O ADP
disease, O NOUN
complicating O VERB
diseases, O NOUN
and O CCONJ
American O ADJ
Society O NOUN
of O ADP
Anesthesiologists O NOUN
grading O VERB
between O ADP
2 O NUM
groups O NOUN
( O PUNCT
P>0.05). O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

DESIGN: O NOUN
Randomized O VERB
controlled O VERB
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/02/05 O NOUN
06:00 O ADP
[medline] O NOUN

Mean O NOUN
daily O ADJ
FEV1 B-outcome NOUN
began O VERB
to O PART
decline O NOUN
from O ADP
approximately O ADV
2 O NUM
weeks O NOUN
before O ADP
the O DET
onset O NOUN
of O ADP
symptoms O NOUN
of O ADP
an O DET
exacerbation, O NOUN
dropping O VERB
from O ADP
0.907 O NUM
L O NOUN
(mean O NUM
Days O NOUN
- O PUNCT
56 O NUM
to O PART
- O PUNCT
36 O NUM
before O ADP
the O DET
exacerbation) O NOUN
to O PART
0.860 O NUM
L O NOUN
on O ADP
the O DET
first O ADV
day O NOUN
of O ADP
the O DET
exacerbation. O ADJ

METHODS: O NOUN
Postprandial O ADJ
non-esterified B-outcome VERB
fatty I-outcome ADJ
acid I-outcome NOUN
and O CCONJ
triglyceride B-outcome NOUN
responses O NOUN
were O VERB
assessed O VERB
in O ADP
subjects O NOUN
with O ADP
T2DM O NOUN
by O ADP
comparing O VERB
a O DET
carbohydrate-reduced O VERB
high-protein O NOUN
(CRHP) O NOUN
diet O NOUN
with O ADP
a O DET
conventional O ADJ
diabetes O NOUN
(CD) O NOUN
diet O NOUN
in O ADP
an O DET
open-label, O ADV
randomized, O NOUN
cross-over O NOUN
study. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Compared O VERB
with O ADP
MAIs, O ADP
lacunar O NOUN
infarction O NOUN
of O ADP
SAI O NOUN
had O VERB
lower O ADJ
risk O NOUN
of O ADP
stroke B-outcome NOUN
recurrence O NOUN
(hazard O PUNCT
ratio O NOUN
[HR] O NOUN
0.41, O NUM
95% O NOUN
confidence O NOUN
interval O NOUN
[CI] O ADV
0.21-0.80, O NUM
P O NOUN
= O SYM
0.009), O NUM
but O CCONJ
not O ADV
in O ADP
non-lacunar O NOUN
infarction O NOUN
of O ADP
SAI O NOUN
(HR O NOUN
1.01, O NOUN
95% O NOUN
CI O NOUN
0.60-1.69, O NUM
P O NOUN
= O SYM
0.98). O NUM

Title: O NOUN
The O DET
acute O ADJ
effects O NOUN
of O ADP
caffeine O NOUN
intake O NOUN
on O ADP
time B-outcome NOUN
under Seperator ADP
tension I-outcome NOUN
and O CCONJ
power B-outcome NOUN
generated O VERB
during O ADP
the O DET
bench O NOUN
press O NOUN
movement. O NOUN

CONCLUSIONS: O NOUN
The O DET
findings O NOUN
support O NOUN
the O DET
feasibility B-outcome NOUN
and O CCONJ
acceptability B-outcome NOUN
of O ADP
the O DET
exercise O NOUN
programmes O NOUN
and O CCONJ
trial O NOUN
procedures. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

As O ADP
well O ADV
as O ADP
receiving O VERB
usual O ADJ
care, O NOUN
women O NOUN
in O ADP
the O DET
intervention O NOUN
strategy O NOUN
were O VERB
offered O VERB
two O NUM
routine O ADJ
biometry O NOUN
scans O NOUN
at O ADP
28-30 O NUM
and O CCONJ
34-36 O NUM
weeks' O ADP
gestation. O NOUN

To O PART
assess O NOUN
safety, O ADP
local B-outcome ADJ
solicited I-outcome VERB
adverse I-outcome ADJ
events I-outcome NOUN
(AEs) I-outcome NOUN
, O PUNCT
systemic B-outcome ADJ
solicited I-outcome VERB
AEs I-outcome NOUN
, O PUNCT
unsolicited B-outcome VERB
AEs I-outcome NOUN
, O PUNCT
and O CCONJ
serious B-outcome ADJ
AEs I-outcome NOUN
(SAEs) I-outcome NOUN
were O VERB
graded. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODS: O NOUN
We O PRON
conducted O VERB
a O DET
6-year, O NUM
double-blind O ADJ
trial O NOUN
involving O VERB
2000 O NUM
women O NOUN
with O ADP
osteopenia O NOUN
(defined O NUM
by O ADP
a O DET
T O NOUN
score O NOUN
of O ADP
-1.0 O PUNCT
to O PART
-2.5 O ADP
at O ADP
either O CCONJ
the O DET
total O ADJ
hip O NOUN
or O CCONJ
the O DET
femoral O ADJ
neck O NOUN
on O ADP
either O CCONJ
side) O NOUN
who O ADP
were O VERB
65 O NUM
years O NOUN
of O ADP
age O NOUN
or O CCONJ
older. O NOUN

Moreover, O NOUN
a O DET
significant O ADJ
reduction O NOUN
in O ADP
muscle B-outcome NOUN
damage I-outcome NOUN
markers O NOUN
( O PUNCT
CK B-outcome NOUN
and O CCONJ
LDH B-outcome NOUN
, O PUNCT
p O NOUN
< O SYM
0.001) O NUM
was O VERB
observed. O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

BACKGROUND: O NOUN
Based O VERB
on O ADP
the O DET
encouraging O VERB
activity O NOUN
and O CCONJ
manageable O ADJ
safety O NOUN
profile O NOUN
observed O VERB
in O ADP
a O DET
phase O NOUN
1 O NUM
study, O NOUN
the O DET
ECHELON-2 O NOUN
trial O NOUN
was O VERB
initiated O VERB
to O PART
compare O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
brentuximab O NOUN
vedotin, O NOUN
cyclophosphamide, O NOUN
doxorubicin, O NOUN
and O CCONJ
prednisone O ADJ
(A+CHP) O NOUN
versus O CCONJ
cyclophosphamide, O NOUN
doxorubicin, O NOUN
vincristine, O NOUN
and O CCONJ
prednisone O ADJ
(CHOP) O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
CD30-positive O ADJ
peripheral O ADJ
T-cell O NOUN
lymphomas. O NOUN

The O DET
overall O ADJ
approach O NOUN
includes O NOUN
providing O VERB
universal O ADJ
access O NOUN
to O PART
diagnosis O NOUN
and O CCONJ
treatment O NOUN
of O ADP
malaria, O NOUN
and O CCONJ
sustainable O ADJ
preventive O ADJ
measures, O NOUN
including O VERB
vector O NOUN
control. O NOUN

Publication O NOUN
date: O NOUN
2019/03/07 O ADV
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Other O ADJ
outcomes O NOUN
include O VERB
gonadotrophin B-outcome NOUN
(Gn) I-outcome NUM
duration I-outcome NOUN
, O PUNCT
the O DET
total O ADJ
dose B-outcome NOUN
of I-outcome ADP
follicle-stimulating I-outcome VERB
hormone I-outcome NOUN
(FSH) I-outcome PUNCT
used, O NOUN
number O NOUN
of O ADP
oocytes B-outcome NOUN
retrieved I-outcome VERB
, O PUNCT
number O NOUN
of O ADP
embryos B-outcome NOUN
available I-outcome ADJ
for Seperator ADP
transfer I-outcome NOUN
, O PUNCT
implantation B-outcome NOUN
rate, O NOUN
the O DET
abortion B-outcome NOUN
rate, O NOUN
live B-outcome ADJ
birth I-outcome NOUN
rate, O NOUN
and O CCONJ
incidence O NOUN
of O ADP
moderate-to-severe O ADV
ovarian B-outcome ADJ
hyperstimulation I-outcome NOUN
. O PUNCT
The O DET
sample O NOUN
size O NOUN
of O ADP
this O DET
trial O NOUN
is O VERB
estimated O VERB
to O PART
be O VERB
421 O NUM
participants O NOUN
for O ADP
each O DET
of O ADP
the O DET
two O NUM
arms. O ADJ

Publication O NOUN
date: O NOUN
2019/01/11 O NOUN
06:00 O ADP
[entrez] O ADP

TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrials.gov O NOUN
NCT02666872 O NOUN
(Retrospectively O ADV
registered O VERB
as O ADP
January O NOUN
28, O NUM
2016). O NOUN

REGISTRATION: O NOUN
NCT02190630. O NOUN

The O DET
addition O NOUN
of O ADP
SPOC O NOUN
scores O NOUN
to O PART
an O DET
adjusted O VERB
regression O NOUN
model O NOUN
to O PART
predict O VERB
pain B-outcome NOUN
interference I-outcome NOUN
improved O VERB
the O DET
concordance O NOUN
statistic O ADJ
from O ADP
0.66 O NUM
to O PART
0.75, O NUM
and O CCONJ
the O DET
greatest O ADV
risk O NOUN
was O VERB
associated O VERB
with O ADP
high O ADJ
SPOC O NOUN
scores O NOUN
(odds O NOUN
ratio: O NOUN
6.06; O NOUN
99% O ADV
CI: O NOUN
3.97-9.25; O NOUN
absolute O ADJ
risk O NOUN
increase: O NOUN
18.3%; O NOUN
95% O NOUN
CI: O NOUN
11.7%, O NUM
26.7%). O NUM

Journal O ADJ
ID: O NOUN
101604552 O NUM

According O ADJ
to O PART
several O ADJ
qualitative O ADJ
studies O NOUN
in O ADP
Africa, O NOUN
such O ADJ
pressures O NOUN
are O VERB
exacerbated O VERB
by O ADP
girls' O NOUN
lack O NOUN
of O ADP
knowledge O NOUN
of O ADP
their O ADJ
bodies, O NOUN
their O ADJ
rights, O NOUN
and O CCONJ
the O DET
implications O NOUN
of O ADP
their O ADJ
decisions, O PUNCT
and O CCONJ
by O ADP
their O ADJ
inability O NOUN
to O PART
manage O NOUN
puberty O NOUN
and O CCONJ
adolescence O NOUN
safely O ADV
and O CCONJ
comfortably O ADV
with O ADP
appropriate O ADJ
menstrual O ADJ
health O NOUN
and O CCONJ
hygiene O NOUN
management O NOUN
(MHM) O NOUN
products. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
all-cause B-outcome NOUN
mortality I-outcome NOUN
at O ADP
28 O NUM
days. O NOUN

Publication O NOUN
date: O NOUN
2018/12/26 O NOUN
06:00 O ADP
[entrez] O ADP

Title: O NOUN
Metabolizable O ADJ
Energy B-outcome NOUN
from O ADP
Cashew O NOUN
Nuts O NOUN
is O VERB
Less O ADV
than O ADP
that O ADP
Predicted O VERB
by O ADP
Atwater O ADV
Factors. O NOUN

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
explore O ADP
the O DET
effects O NOUN
of O ADP
music O ADJ
therapy/physical O ADJ
therapy O NOUN
co-treatment O NOUN
using O VERB
live O ADJ
music-supported O VERB
exercise O NOUN
on O ADP
pain B-outcome NOUN
and O CCONJ
exercise O NOUN
adherence B-outcome NOUN
during O ADP
a O DET
lower O ADJ
extremity O NOUN
pedaling O VERB
exercise O NOUN
to O PART
facilitate O VERB
range B-outcome NOUN
of I-outcome ADP
motion I-outcome NOUN
(ROM) I-outcome NOUN
. O PUNCT
The O DET
researcher O ADP
randomized O VERB
32 O NUM
TKA O NOUN
inpatient O NOUN
rehabilitation O NOUN
participants O NOUN
to O PART
an O DET
intervention O NOUN
or O CCONJ
control O NOUN
group. O VERB

Conclusion: O NOUN
The O DET
combination O NOUN
of O ADP
parecoxib, O NOUN
TAP, O NOUN
and O CCONJ
PCIA O NOUN
pump O NOUN
could O VERB
significantly O ADV
reduce O VERB
patient O NOUN
postoperative O ADJ
pain B-outcome NOUN
and O CCONJ
enhance O NOUN
recovery B-outcome NOUN
. O PUNCT

The O DET
reduction O NOUN
in O ADP
6-month O NOUN
follow-up O NOUN
( O NOUN
DIAGNOdent O ADJ
pen O NOUN
values O NOUN
were O VERB
statistically O ADV
significant O ADJ
in O ADP
both O CCONJ
groups O NOUN
relative O ADJ
to O PART
baseline O NOUN
values. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
2984818R O ADV

Exacerbation O NOUN
onset O NOUN
was O VERB
the O DET
first O ADV
day O NOUN
of O ADP
a O DET
reported O VERB
symptom O NOUN
of O ADP
exacerbation. O ADJ

The O DET
baseline O NOUN
status O NOUN
of O ADP
knees O NOUN
of O ADP
two O NUM
groups O NOUN
was O VERB
comparable O ADJ
at O ADP
the O DET
start O NOUN
of O ADP
study. O NOUN

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

Publication O NOUN
date: O NOUN
2018/11/08 O ADP
00:00 O NOUN
[revised] O PUNCT

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

We O PRON
used O VERB
descriptive O ADJ
analyses O NOUN
due O ADJ
to O PART
the O DET
small O ADJ
sample O NOUN
size. O NOUN

There O PRON
was O VERB
a O DET
linear O ADJ
association O NOUN
between O ADP
high, O ADP
moderate, O NOUN
and O CCONJ
low O ADJ
adherence, O ADV
and O CCONJ
a O DET
lower O ADJ
risk O NOUN
of O ADP
gestational B-outcome ADJ
diabetes I-outcome NOUN
mellitus I-outcome NOUN
(GDM) I-outcome NOUN
, O PUNCT
emergency B-outcome NOUN
C-section I-outcome NOUN
, O PUNCT
perineal B-outcome ADJ
trauma I-outcome NOUN
, O PUNCT
pregnancy-induced B-outcome VERB
hypertension I-outcome NOUN
and O CCONJ
preeclampsia B-outcome NOUN
, O PUNCT
prematurity B-outcome NOUN
, O PUNCT
large-for-gestational-age B-outcome NOUN
, O PUNCT
and/or O CCONJ
small-for-gestational-age B-outcome NOUN
, O PUNCT
urinary B-outcome ADJ
tract I-outcome NOUN
infections I-outcome NOUN
(UTI) I-outcome NUM
, O PUNCT
prematurity B-outcome NOUN
, O PUNCT
and O CCONJ
small-for-gestational-age B-outcome NOUN
(SGA) I-outcome PUNCT
newborns O NOUN
(all O PUNCT
p O NOUN
< O SYM
0.05). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Shanghai O NUM
kou O NOUN
qiang O NOUN
yi O ADP
xue O NOUN
= O SYM
Shanghai O NOUN
journal O ADJ
of O ADP
stomatology O ADV

In O ADP
conclusion, O NOUN
reductions O NOUN
in O ADP
snack B-outcome NOUN
intake I-outcome NOUN
were O VERB
associated O VERB
with O ADP
reduced O VERB
insulin B-outcome NOUN
resistance I-outcome NOUN
3(-)8 O ADJ
years O NOUN
later, O ADV
but O CCONJ
adjustment O NOUN
for O ADP
current O ADJ
lifestyle B-outcome NOUN
reduced O VERB
these O DET
associations. O NOUN

BACKGROUND: O NOUN
Hospitalized O VERB
patients O NOUN
who O ADP
are O VERB
colonized O VERB
with O ADP
methicillin-resistant O ADJ
Staphylococcus O NOUN
aureus O NOUN
(MRSA) O NOUN
are O VERB
at O ADP
high O ADJ
risk O NOUN
for O ADP
infection O NOUN
after O ADP
discharge. O ADJ

The O DET
arterial B-outcome ADJ
carbon I-outcome NOUN
dioxide I-outcome NOUN
partial I-outcome ADJ
pressure I-outcome NOUN
PaCO(2) I-outcome ADV
), O NUM
the O DET
time B-outcome NOUN
spent I-outcome VERB
in Seperator ADP
successful I-outcome ADJ
positioning I-outcome VERB
of I-outcome ADP
the Seperator DET
tube I-outcome NOUN
, O PUNCT
the O DET
endoscope B-outcome NOUN
indwelling I-outcome VERB
duration I-outcome NOUN
, O PUNCT
operative B-outcome ADJ
time I-outcome NOUN
, O PUNCT
tube B-outcome NOUN
drawing I-outcome VERB
time I-outcome NOUN
, O PUNCT
patients' O NOUN
awakening B-outcome VERB
time I-outcome NOUN
, O PUNCT
satisfaction B-outcome NOUN
of O ADP
operators, O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
during O ADP
anesthesia, O NOUN
the O DET
numbers O NOUN
of O ADP
bucking B-outcome VERB
or O CCONJ
body B-outcome NOUN
moving I-outcome VERB
were O VERB
also O ADV
recorded. O NOUN

Title: O NOUN
Heart O NOUN
Rate O NOUN
Variability O NOUN
following O VERB
Combined O VERB
Aerobic O ADJ
and O CCONJ
Resistance O NOUN
Training O VERB
in O ADP
Sedentary O ADJ
Hypertensive O ADJ
Women: O NOUN
A O DET
Randomised O VERB
Control O NOUN
Trial. O NOUN

Patients O NOUN
in O ADP
the O DET
Sham O NOUN
group O NOUN
received O VERB
an O DET
US-guided O VERB
bilateral O ADJ
OSTAP O NOUN
with O ADP
40 O NUM
mL O NOUN
of O ADP
0.9% O NOUN
saline. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Repeated O VERB
doses O NOUN
of O ADP
Praziquantel O NOUN
in O ADP
Schistosomiasis O NOUN
Treatment O NOUN
(RePST) O NOUN
- O PUNCT
single O ADJ
versus O CCONJ
multiple O ADJ
praziquantel O NOUN
treatments O NOUN
in O ADP
school-aged O VERB
children O NOUN
in O ADP
Cote O NOUN
d'Ivoire: O PUNCT
a O DET
study O NOUN
protocol O NOUN
for O ADP
an O DET
open-label, O ADV
randomised O VERB
controlled O VERB
trial. O NOUN

Methods: O NOUN
Between O ADP
June O NOUN
2015 O NUM
and O CCONJ
January O NOUN
2017, O NUM
53 O NUM
patients O NOUN
with O ADP
high O ADJ
risk O NOUN
of O ADP
vertebral O ADJ
"shell" O NOUN
after O ADP
thoracolumbar O ADV
fracture O NOUN
surgery O NOUN
were O VERB
enrolled O VERB
in O ADP
a O DET
prospective O ADJ
study O NOUN
according O ADJ
to O PART
the O DET
selection O NOUN
criteria. O NOUN

PMID: O NOUN
31623042 O NUM

The O DET
tear B-outcome NUM
breakup I-outcome ADP
time I-outcome NOUN
(TBUT) I-outcome PUNCT
, O PUNCT
Schirmer O NOUN
test O NOUN
with O ADP
anesthesia, O NOUN
and O CCONJ
fluorescein B-outcome NOUN
staining I-outcome VERB
scores O NOUN
were O VERB
measured O VERB
preoperatively O ADV
and O CCONJ
postoperatively O ADV
on O ADP
days O NOUN
7, O NUM
14, O NUM
30 O NUM
and O CCONJ
90. O NOUN

The O DET
drug B-outcome NOUN
cost I-outcome NOUN
in O ADP
the O DET
AG O NOUN
(4,413.60+/-1,772.35) O PUNCT
yen O ADV
were O VERB
significantly O ADV
lower O ADJ
than O ADP
that O ADP
in O ADP
the O DET
CG O NOUN
(6,490.35+/-3,367.66) O PUNCT
yen O ADV
(P=0.01). O NUM

Title: O NOUN
Effects O NOUN
of O ADP
botulinum O NOUN
toxin O NOUN
type O NOUN
A O DET
on O ADP
the O DET
treatment O NOUN
of O ADP
dry O ADJ
eye O NOUN
disease O NOUN
and O CCONJ
tear O NUM
cytokines. O NUM

CONCLUSION: O NOUN
This O DET
is O VERB
the O DET
first O ADV
study O NOUN
comparing O VERB
the O DET
impact O NOUN
of O ADP
CM O NOUN
and O CCONJ
CHO O NOUN
on O ADP
athletic O ADJ
outcomes O NOUN
in O ADP
an O DET
adolescent O NOUN
population O NOUN
in O ADP
a O DET
field-based O VERB
environment. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

CONCLUSION: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
study O NOUN
showed O VERB
that O ADP
ET O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
montelukast O NOUN
may O VERB
benefit O NUM
for O ADP
children O NOUN
with O ADP
MA. O ADJ

Journal O ADJ
ID: O NOUN
9425194 O NUM

RESULTS: O NOUN
With O ADP
a O DET
median O ADJ
follow-up O NOUN
of O ADP
27.2 O NUM
months, O NOUN
the O DET
2-year O NOUN
progression-free B-outcome ADJ
survival I-outcome NOUN
rate O NOUN
was O VERB
81% O NUM
(95% O PUNCT
confidence O NOUN
interval O NOUN
[CI], O VERB
69 O NUM
to O PART
96) O NOUN
in O ADP
the O DET
sorafenib O NOUN
group O NOUN
and O CCONJ
36% O NUM
(95% O PUNCT
CI, O NOUN
22 O NUM
to O PART
57) O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
(hazard O PUNCT
ratio O NOUN
for O ADP
progression B-outcome NOUN
or O CCONJ
death B-outcome NOUN
, O PUNCT
0.13; O NOUN
95% O NOUN
CI, O NOUN
0.05 O NUM
to O PART
0.31; O NOUN
P<0.001). O NUM

CONCLUSIONS: O NOUN
There O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
either O CCONJ
dental B-outcome ADJ
or O CCONJ
skeletal B-outcome ADJ
changes O NOUN
achieved O NOUN
with O ADP
PT O NOUN
or O CCONJ
FT O NOUN
wear O ADJ
of O ADP
a O DET
Twin-block O NOUN
appliance O NOUN
over O ADP
12 O NUM
months. O NOUN

Los O NOUN
Angeles O NOUN
Biomedical O ADJ
Research O NOUN
Institute, O VERB
Los O NOUN
Angeles, O NOUN
CA O NOUN
dr.mckinnell@gmail.com. O NOUN

Title: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial O NOUN
comparing O VERB
methohexital O ADJ
and O CCONJ
propofol O NOUN
for O ADP
induction O NOUN
in O ADP
patients O NOUN
receiving O VERB
angiotensin O NOUN
axis O NOUN
blockade. O NOUN

Sterol B-outcome NOUN
regulatory I-outcome ADJ
element-binding I-outcome VERB
protein-1 I-outcome NOUN
expression I-outcome NOUN
was O VERB
inhibited O VERB
after O ADP
treatment, O NOUN
while O ADP
the O DET
inhibitory O ADJ
effects O NOUN
of O ADP
combined O VERB
treatment O NOUN
were O VERB
stronger O ADJ
than O ADP
those O DET
of O ADP
clomifene O NOUN
citrate O NOUN
alone. O NOUN

The O DET
main O ADJ
outcomes O NOUN
were O VERB
the O DET
rate O NOUN
and O CCONJ
severity B-outcome NOUN
of I-outcome ADP
intrauterine B-outcome ADJ
adhesions E2-outcome NOUN
formation, O ADP
which O ADP
were O VERB
assessed O VERB
by O ADP
follow-up O NOUN
hysteroscopy O NOUN
performed O VERB
in O ADP
the O DET
ensuing O VERB
2-6 O NUM
months. O NOUN

There O PRON
were O VERB
four O NUM
serious B-outcome ADJ
AEs I-outcome NOUN
(SAEs) I-outcome NOUN
reported O VERB
(two O NUM
each O DET
group) O ADJ
unrelated O VERB
to O PART
treatment. O NOUN

CONCLUSION: O NOUN
Our O ADJ
results O NOUN
support O NOUN
the O DET
mechanisms O NOUN
occurring O VERB
with O ADP
the O DET
use O NOUN
of O ADP
either O CCONJ
of O ADP
the O DET
described O VERB
orthotic O ADJ
interventions. O NOUN

Cost-effectiveness O NOUN
ratios O NOUN
of O ADP
FZD O NOUN
and O CCONJ
CLA O NOUN
groups O NOUN
were O VERB
0.75 O NUM
and O CCONJ
1.02, O NOUN
and O CCONJ
incremental O ADJ
cost-effectiveness O NOUN
ratio O NOUN
of O ADP
FZD O NOUN
group O NOUN
over O ADP
CLA O NOUN
group O NOUN
was O VERB
-3.62. O NUM

28 O NUM
received O VERB
decitabine O NOUN
for O ADP
5 O NUM
days O NOUN
and O CCONJ
43 O NUM
for O ADP
10 O NUM
days, O NOUN
and O CCONJ
all O DET
were O VERB
assessable O ADJ
for O ADP
efficacy O NOUN
and O CCONJ
safety. O ADJ

IQOS(TM) O NOUN
scored O VERB
higher O ADJ
in O ADP
terms O NOUN
of O ADP
subjective O ADJ
reward/satisfaction B-outcome NOUN
and O CCONJ
was O VERB
slightly O ADV
preferred O VERB
to O PART
the O DET
e-cigarette. O NOUN

Recently, O NOUN
we O PRON
revealed O VERB
that O ADP
beta-Eudesmol O NOUN
ingestion O NOUN
affected O VERB
autonomic O ADJ
nerve O NOUN
activity O NOUN
in O ADP
an O DET
animal O NOUN
model. O NOUN

Patients O NOUN
treated O VERB
with O ADP
IV O NUM
acetaminophen O ADV
had O VERB
a O DET
significant O ADJ
reduction O NOUN
in O ADP
delirium B-outcome NOUN
(10% O PUNCT
vs O CCONJ
28% O NUM
placebo; O ADV
difference, O NOUN
-18% O NOUN
[95% O NOUN
CI, O NOUN
-32% O NOUN
to O PART
-5%]; O NOUN
P O NOUN
= O SYM
.01; O PUNCT
HR, O NOUN
2.8 O NUM
[95% O NOUN
CI, O NOUN
1.1-7.8]). O ADJ

Journal-Name:Medicine O NOUN

Owing O ADJ
to O PART
the O DET
multifactorial O ADJ
nature O NOUN
of O ADP
wound O NOUN
complications, O NOUN
it O PRON
is O VERB
yet O ADV
to O PART
be O VERB
determined O VERB
which O ADP
cohorts O NOUN
of O ADP
pancreatectomy O NOUN
patients O NOUN
will O VERB
benefit O NUM
from O ADP
NPWT. O ADV

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT02546765. O NOUN

This O DET
semi-experimental O ADJ
study O NOUN
was O VERB
conducted O VERB
using O VERB
a O DET
pretest-posttest O NOUN
and O CCONJ
control O NOUN
group. O VERB

Journal-Name:Medicine O NOUN

RESULTS: O NOUN
The O DET
expression O NOUN
level O NOUN
of O ADP
sterol B-outcome NOUN
regulatory I-outcome ADJ
element-binding I-outcome VERB
protein-1 I-outcome NOUN
was O VERB
higher O ADJ
in O ADP
PCOS O NOUN
patients O NOUN
than O ADP
that O ADP
in O ADP
the O DET
healthy O ADJ
control. O NOUN

Retrospectively O ADV
registered O VERB
14th O NUM
October O ADJ
2016. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Progress O NOUN
in O ADP
community O NOUN
health O NOUN
partnerships O NOUN
: O PUNCT
research, O NOUN
education, O VERB
and O CCONJ
action O NOUN

To O PART
reach O NOUN
these O DET
goals, O NOUN
we O PRON
determined O VERB
that O ADP
we O PRON
needed O VERB
to O PART
recruit O NOUN
106 O NUM
patients. O NOUN

BACKGROUND: O NOUN
Truckers O NOUN
in O ADP
sub-Saharan O CCONJ
Africa O PROPN
are O VERB
at O ADP
higher O ADJ
risk O NOUN
of O ADP
contracting O VERB
HIV O NOUN
than O ADP
the O DET
general O ADJ
population. O ADV

Title: O NOUN
A O DET
comparative O ADJ
study O NOUN
on O ADP
the O DET
prophylactic O ADJ
effects O NOUN
of O ADP
paracetamol O NOUN
and O CCONJ
dexmedetomidine O NOUN
for O ADP
controlling O VERB
hemodynamics B-outcome NOUN
during O ADP
surgery O NOUN
and O CCONJ
postoperative O ADJ
pain B-outcome NOUN
in O ADP
patients O NOUN
with O ADP
laparoscopic O ADJ
cholecystectomy. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

METHODS: O NOUN
This O DET
randomized O VERB
controlled O VERB
clinical O ADJ
trial O NOUN
was O VERB
conducted O VERB
from O ADP
April O NOUN
to O PART
October O ADJ
2015 O NUM
in O ADP
Tabriz, O ADJ
Iran. O NOUN

Journal-Name:Nutrients O NOUN

Journal-Name:Oxidative O ADJ
medicine O NOUN
and O CCONJ
cellular O ADJ
longevity O NOUN

However, O ADV
this O DET
procedure O NOUN
is O VERB
inconvenient O ADJ
and O CCONJ
not O ADV
widely O ADV
adopted. O NOUN

Exercise O NOUN
can O VERB
produce O VERB
an O DET
imbalance O NOUN
between O ADP
ROS O NOUN
and O CCONJ
antioxidants, O NOUN
leading O VERB
to O PART
oxidative O ADJ
stress-related O VERB
tissue O NOUN
damages. O ADJ

Vaccine B-outcome NOUN
coverage O NOUN
will O VERB
be O VERB
analyzed O VERB
using O VERB
Chi-squared O NOUN
distribution O NOUN
testing O VERB
and O CCONJ
logistic O ADJ
regression O NOUN
to O PART
identify O NOUN
determinant O NOUN
factors. O NOUN

Title: O NOUN
Suspension O NOUN
Training O VERB
HIIT O NOUN
Improves O NOUN
Gait B-outcome NOUN
Speed I-outcome NOUN
, O PUNCT
Strength B-outcome NOUN
and O CCONJ
Quality B-outcome NOUN
of I-outcome ADP
Life I-outcome NOUN
in O ADP
Older O ADJ
Adults. O NOUN

To O PART
address O NOUN
the O DET
growing O VERB
interest O NOUN
in O ADP
connecting O VERB
mental O ADJ
and O CCONJ
physical O ADJ
performance, O NOUN
the O DET
present O ADJ
study O NOUN
examined O VERB
whether O ADP
the O DET
nootropic O ADJ
effects O NOUN
of O ADP
PSE O NOUN
translate O NOUN
into O ADP
changes O NOUN
in O ADP
reactive B-outcome ADJ
agility I-outcome NOUN
following O VERB
daily O ADJ
supplementation O NOUN
with O ADP
PSE. O NOUN

They O PRON
were O VERB
divided O VERB
into O ADP
VCV O NOUN
group O NOUN
and O CCONJ
PCV O NOUN
group O NOUN
according O ADJ
to O PART
ventilation O NOUN
mode. O VERB

Interestingly, O NOUN
the O DET
increase O NOUN
was O VERB
higher O ADJ
in O ADP
the O DET
placebo O NOUN
group. O VERB

The O DET
term O NOUN
livebirth B-outcome ADJ
rate O NOUN
did O VERB
not O ADV
differ O VERB
significantly O ADV
between O ADP
PICSI O NOUN
(27.4% O NUM
[379/1381]) O NOUN
and O CCONJ
ICSI O NOUN
(25.2% O PUNCT
[346/1371]) O NUM
groups O NOUN
(odds O NOUN
ratio O NOUN
1.12, O NOUN
95% O NOUN
CI O NOUN
0.95-1.34; O NUM
p=0.18). O NOUN

Pretreatment O NOUN
and O CCONJ
day-of-debond O NOUN
digital O ADJ
photographic O ADJ
images O NOUN
were O VERB
taken O VERB
of O ADP
the O DET
teeth O NOUN
and O CCONJ
assessed O VERB
by O ADP
up O ADP
to O PART
5 O NUM
clinical O ADJ
and O CCONJ
3 O NUM
lay O ADJ
assessors O NOUN
for O ADP
the O DET
presence O NOUN
or O CCONJ
absence O NOUN
of O ADP
new O ADJ
demineralized B-outcome VERB
lesions I-outcome NOUN
and O CCONJ
the O DET
esthetic B-outcome ADJ
impact. O NOUN

The O DET
level B-outcome NOUN
of I-outcome ADP
the Seperator DET
root I-outcome NOUN
canal I-outcome NOUN
filling I-outcome VERB
was O VERB
better O ADJ
in O ADP
the O DET
Calen(R)/ZO O NUM
group. O VERB

The O DET
median O ADJ
follow-up O NOUN
time O NOUN
was O VERB
6.0 O NUM
months O NOUN
(2.0-16.0 O PUNCT
months). O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
overall B-outcome ADJ
survival I-outcome NOUN
rate O NOUN
at O ADP
3 O NUM
years O NOUN
was O VERB
63.4% O NUM
in O ADP
the O DET
modified-FOLFIRINOX O NOUN
group O NOUN
and O CCONJ
48.6% O NUM
in O ADP
the O DET
gemcitabine O NOUN
group. O VERB

These O DET
findings O NOUN
may O VERB
be O VERB
explained O VERB
by O ADP
a O DET
reduction O NOUN
in O ADP
indigestible O ADJ
carbohydrates O NOUN
available O ADJ
for O ADP
fermentation O NOUN
in O ADP
the O DET
gut. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Among O ADP
2806 O NUM
eligible O ADJ
children O NOUN
with O ADP
visiual O ADJ
impairment O NOUN
(visual O ADJ
acuity O NOUN
</= O NOUN
6/12 O ADJ
in O ADP
either O CCONJ
eye), O NOUN
93 O NUM
(3.31%) O PUNCT
were O VERB
lost O VERB
to O PART
follow-up, O ADP
leaving O VERB
2713 O NUM
students O NOUN
(45.0% O NOUN
boys). O NUM

Hospitals O NOUN
randomized O VERB
to O PART
usual O ADJ
care O NOUN
(n O NOUN
= O SYM
156 O NUM
[4565 O NOUN
patients]) O NUM
did O VERB
not O ADV
provide O VERB
study O NOUN
vouchers. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

RESULTS: O NOUN
Eight O NUM
hundred O NUM
and O CCONJ
eighty-eight O NOUN
patients O NOUN
in O ADP
the O DET
WISDOM O NOUN
study O NOUN
had O VERB
a O DET
moderate/severe O ADV
exacerbation B-outcome NOUN
after O ADP
the O DET
complete O ADJ
ICS O NOUN
withdrawal O NOUN
visit; O NOUN
360 O NUM
of O ADP
them O PRON
contributed O VERB
at O ADP
least O ADV
one O NUM
FEV1 B-outcome NOUN
measure O NOUN
per O ADP
week O NOUN
for O ADP
the O DET
8 O NUM
weeks O NOUN
before O ADP
and O CCONJ
after O ADP
the O DET
event O NOUN
and O CCONJ
are O VERB
included O VERB
in O ADP
this O DET
analysis. O NOUN

The O DET
means O NOUN
and O CCONJ
CVs O NOUN
of O ADP
MEP B-outcome NOUN
amplitude I-outcome ADJ
in O ADP
all O DET
limbs O NOUN
were O VERB
significantly O ADV
lower O ADJ
in O ADP
group O NOUN
I. O NOUN
The O DET
mean O NOUN
train-of-four B-outcome ADV
(TOF) I-outcome ADV
counts I-outcome NOUN
from O ADP
30 O NUM
to O PART
80 O NUM
min O NOUN
of O ADP
operation O NOUN
were O VERB
significantly O ADV
higher O ADJ
in O ADP
group O NOUN
B. O NOUN
CONCLUSION: O NOUN
We O PRON
conclude O NOUN
that O ADP
the O DET
continuous O ADJ
infusion O NOUN
of O ADP
rocuronium O NOUN
effectively O ADV
inhibited O VERB
the O DET
involuntary B-outcome ADJ
movement I-outcome NOUN
and O CCONJ
spontaneous B-outcome ADJ
respiration I-outcome NOUN
of O ADP
the O DET
patient O NOUN
while O ADP
enabling O VERB
MEP O NOUN
monitoring. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
WISDOM O NOUN
(ClinicalTrials.gov O ADV
number, O ADV
NCT00975195 O NOUN
). O NOUN

Journal O ADJ
ID: O NOUN
101627676 O NUM

The O DET
Mediterranean O NOUN
diet O NOUN
(MD) O NOUN
is O VERB
recognized O VERB
as O ADP
one O NUM
of O ADP
the O DET
healthiest O NOUN
dietary O ADJ
patterns O NOUN
and O CCONJ
has O VERB
benefits O NOUN
such O ADJ
as O ADP
improving O VERB
glycaemic O ADJ
control O NOUN
among O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
(T2DM). O VERB

No O DET
significant O ADJ
differences O NOUN
between O ADP
sclerotherapy O NOUN
and O CCONJ
cyanoacrylate O VERB
groups O NOUN
regarding O VERB
rebleeding B-outcome VERB
(26.79, O NUM
19.30% O NOUN
respectively, O NOUN
P O NOUN
= O SYM
0.344), O NUM
complications B-outcome NOUN
, O PUNCT
hospital B-outcome NOUN
stay I-outcome NOUN
or O CCONJ
mortality B-outcome NOUN
rate O NOUN
were O VERB
observed. O NOUN

Navy O ADJ
bean O NOUN
consumption O NOUN
was O VERB
previously O ADV
shown O VERB
to O PART
modulate O NOUN
host O NOUN
and O CCONJ
microbiome O NOUN
metabolism, O VERB
and O CCONJ
this O DET
investigation O NOUN
was O VERB
performed O VERB
to O PART
assess O NOUN
the O DET
impact O NOUN
on O ADP
the O DET
human O NOUN
stool B-outcome NOUN
metabolome I-outcome NOUN
, O PUNCT
which O ADP
includes O NOUN
the O DET
presence O NOUN
of O ADP
navy B-outcome ADJ
bean I-outcome NOUN
metabolites I-outcome NOUN
. O PUNCT
This O DET
4-week, O NUM
randomized-controlled O VERB
trial O NOUN
with O ADP
overweight O NUM
and O CCONJ
obese O NOUN
CRC O NOUN
survivors O NOUN
involved O VERB
consumption O NOUN
of O ADP
1 O NUM
meal O ADJ
and O CCONJ
1 O NUM
snack O NOUN
daily. O NOUN

Muscular B-outcome ADJ
strength I-outcome NOUN
was O VERB
significantly O ADV
different O ADJ
between O ADP
limbs O NOUN
in O ADP
the O DET
RT O NOUN
group O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
intervention O NOUN
(p O PUNCT
= O SYM
0.01). O NOUN

We O PRON
aimed O VERB
to O PART
investigate O NOUN
the O DET
efficacy O NOUN
of O ADP
PICSI O NOUN
versus O CCONJ
standard O ADJ
ICSI O NOUN
for O ADP
improving O VERB
livebirth B-outcome ADJ
rates O NOUN
among O ADP
couples O NOUN
undergoing O VERB
fertility O NOUN
treatment. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

In O ADP
light O NOUN
of O ADP
this, O ADV
the O DET
present O ADJ
paper O NOUN
is O VERB
an O DET
attempt O NOUN
to O PART
determine O NOUN
the O DET
effects O NOUN
of O ADP
different O ADJ
positioning O VERB
on O ADP
gastric B-outcome ADJ
residual I-outcome ADJ
volume I-outcome NOUN
in O ADP
premature O ADJ
infants O NOUN
in O ADP
NICU. O NOUN

Journal-Name:Medicine O NOUN

Perceived O VERB
ability B-outcome NOUN
to O PART
exercise B-outcome NOUN
(frequency, X NOUN
intensity I-outcome NOUN
and Seperator CCONJ
duration S1-outcome NOUN
) O PUNCT
in O ADP
relation O NOUN
to O PART
each O DET
dietary O ADJ
period O NOUN
was O VERB
also O ADV
rated O VERB
using O VERB
a O DET
visual O ADJ
analogue O NOUN
scale. O ADJ

Dietary O ADJ
fibre O NOUN
from O ADP
resistant O ADJ
starch O NOUN
(RS) O NOUN
has O VERB
been O VERB
shown O VERB
to O PART
have O VERB
an O DET
impact O NOUN
on O ADP
food O NOUN
intake O NOUN
in O ADP
normal O ADJ
weight O NOUN
individuals, O ADJ
but O CCONJ
its O ADJ
role O NOUN
in O ADP
obesity O NOUN
is O VERB
unknown. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Process O NOUN
evaluations O NOUN
can O VERB
provide O VERB
information O NOUN
on O ADP
which O ADP
aspects O NOUN
of O ADP
an O DET
intervention O NOUN
were O VERB
delivered O VERB
and O CCONJ
how. O NOUN

Title: O NOUN
Randomized O VERB
Evaluation O NOUN
of O ADP
Videoconference O NOUN
Meetings O NOUN
for O ADP
Medical O ADJ
Students' O NUM
Mid-clerkship O NOUN
Feedback O NOUN
Sessions. O NOUN

Publication O NOUN
date: O NOUN
2018/08/13 O ADJ
00:00 O NOUN
[accepted] O ADV

OBJECTIVE: O NOUN
To O PART
compare O NOUN
the O DET
hemostatic B-outcome ADJ
effect O NOUN
of O ADP
hematostatic O ADJ
agent O NOUN
Surgiflo O NOUN
and O CCONJ
absorbable O ADJ
gelatin O NOUN
sponge O NOUN
(AGS) O NOUN
in O ADP
posterior O ADJ
lumbar O ADJ
surgery. O VERB

Journal O ADJ
ID: O NOUN
9415084 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

1-year O NOUN
overall B-outcome ADJ
survival I-outcome NOUN
was O VERB
25% O NUM
in O ADP
both O CCONJ
groups. O NOUN

Objectives O NOUN
To O PART
determine O NOUN
the O DET
acceptability B-outcome NOUN
and O CCONJ
feasibility B-outcome NOUN
of O ADP
the O DET
use O NOUN
of O ADP
a O DET
robotic O ADJ
walking O VERB
aid O VERB
to O PART
support O NOUN
the O DET
work O NOUN
of O ADP
physiotherapists O NOUN
in O ADP
reducing O VERB
fear B-outcome ADJ
of I-outcome ADP
falling I-outcome VERB
in O ADP
the O DET
rehabilitation O NOUN
of O ADP
elderly O NOUN
patients O NOUN
with O ADP
'psychomotor O NOUN
disadaptation' O NOUN
(the O NOUN
most O DET
severe O ADJ
form O NOUN
of O ADP
post-fall O NOUN
syndrome). O NOUN

One-quarter O NOUN
were O VERB
African O ADV
American O ADJ
or O CCONJ
Black. O NOUN

Meanwhile, O NOUN
the O DET
correlation O NOUN
analysis O NOUN
and O CCONJ
multiple O ADJ
stepwise O ADV
regression O NOUN
analysis O NOUN
were O VERB
used O VERB
to O PART
analyze O NOUN
the O DET
association O NOUN
of O ADP
APN O NOUN
and O CCONJ
AdipoR1 O VERB
with O ADP
clinical O ADJ
factors. O NOUN

RESULTS: O NOUN
Myocarditis B-outcome NOUN
, O PUNCT
encephalopathy B-outcome NOUN
, O PUNCT
cardiogenic B-outcome ADJ
shock I-outcome NOUN
, O PUNCT
ICU B-outcome NOUN
admission I-outcome NOUN
, O PUNCT
need B-outcome NOUN
for Seperator ADP
mechanical I-outcome ADJ
ventilation I-outcome NOUN
, O PUNCT
mean O NOUN
hospital B-outcome NOUN
stay I-outcome NOUN
and O CCONJ
mortality B-outcome NOUN
were O VERB
significantly O ADV
lower O ADJ
in O ADP
those O DET
received O VERB
intravenous O ADJ
antivenom O NOUN
compared O VERB
with O ADP
those O DET
received O VERB
intramuscular O ADJ
one. O PUNCT

Surgical O ADJ
site O NOUN
infection O NOUN
(SSI) O NOUN
and O CCONJ
incisional O ADJ
hernia O NOUN
are O VERB
common O ADJ
complications O NOUN
after O ADP
major O ADJ
pancreatectomy. O NOUN

Journal-Name:Lipids O NOUN
in O ADP
health O NOUN
and O CCONJ
disease O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
AG O NOUN
received O VERB
oscillating O VERB
positive O ADJ
expiratory O ADJ
pressure O NOUN
training O VERB
and O CCONJ
the O DET
CG O NOUN
underwent O VERB
standard O ADJ
perioperative O ADJ
treatment. O NOUN

The O DET
development O NOUN
of O ADP
complex O NOUN
communities, O NOUN
particularly O ADV
involving O VERB
Enterobacteriaceae O NOUN
and O CCONJ
strict O ADJ
anaerobes, O NOUN
may O VERB
be O VERB
contributing O VERB
to O PART
poor O ADJ
outcomes O NOUN
in O ADP
DFUs O NOUN
and O CCONJ
requires O NOUN
further O ADV
investigation. O NOUN

Journal-Name: O NOUN
The O DET
journal O ADJ
of O ADP
contemporary O ADJ
dental O ADJ
practice O NOUN

However, O ADV
the O DET
effect O NOUN
of O ADP
PICSI O NOUN
on O ADP
livebirth O ADJ
rates O NOUN
is O VERB
uncertain. O NOUN

Publication O NOUN
date: O NOUN
['2019/10/17 O NOUN
06:00' O NUM

In O ADP
this O DET
single-blind O NOUN
randomized O VERB
crossover O NOUN
study, O NOUN
overweight/obese O NOUN
healthy O ADJ
males O NOUN
consumed O VERB
a O DET
test O NOUN
breakfast O NOUN
and O CCONJ
lunch O NOUN
containing O VERB
either O CCONJ
48 O NUM
g O NOUN
RS O NOUN
or O CCONJ
a O DET
placebo. O NOUN

One O NUM
eye O NOUN
needed O VERB
repair B-outcome NOUN
surgery I-outcome NOUN
. O PUNCT
There O PRON
was O VERB
no O DET
statistical O ADJ
difference O NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
(P O NUM
> O SYM
.05). O NUM

Publication O NOUN
date: O NOUN
2019/01/01 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:Nutrients O NOUN

AIM: O NOUN
The O DET
aim O ADP
of O ADP
the O DET
present O ADJ
study O NOUN
is O VERB
to O PART
evaluate O VERB
the O DET
efficacy O NOUN
of O ADP
curcumin O NOUN
gel O NOUN
as O ADP
local O ADJ
drug O NOUN
delivery O NOUN
post-scaling O VERB
and O CCONJ
root O NOUN
planing O VERB
and O CCONJ
its O ADJ
effect O NOUN
on O ADP
clinical O ADJ
parameters O NOUN
like O ADP
plaque B-outcome NOUN
, O PUNCT
gingival B-outcome ADJ
scores, O NOUN
pocket B-outcome NOUN
depth I-outcome NOUN
, O PUNCT
and O CCONJ
clinical B-outcome ADJ
attachment I-outcome NOUN
level I-outcome NOUN
(CAL) I-outcome NOUN
. O PUNCT
MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
Ten O NUM
patients O NOUN
with O ADP
two O NUM
sites O NOUN
in O ADP
the O DET
contralateral O ADJ
quadrants O NOUN
having O VERB
probing O VERB
pocket O NOUN
depths O NOUN
(PPDs) O NOUN
of O ADP
>/=5 O ADJ
mm O NOUN
were O VERB
selected. O NOUN

Journal O ADJ
ID: O NOUN
9708388 O NUM

OBJECTIVE: O NOUN
to O PART
evaluate O VERB
the O DET
effectiveness O NOUN
of O ADP
menthol O NOUN
chewing O VERB
gum, O NOUN
in O ADP
the O DET
relief O NOUN
of O ADP
the O DET
intensity B-outcome NOUN
and Seperator CCONJ
discomfort B-outcome NOUN
of I-outcome ADP
the X NOUN
surgical X ADJ
patient's X NOUN
thirst E2-outcome ADV
in O ADP
the O DET
preoperative O ADJ
period. O NOUN

Title: O NOUN
Examining O VERB
diabetic O ADJ
heel O NOUN
ulcers O NOUN
through O ADP
an O DET
ecological O ADJ
lens: O NOUN
microbial O ADJ
community O NOUN
dynamics O NOUN
associated O VERB
with O ADP
healing O VERB
and O CCONJ
infection. O NOUN

There O PRON
were O VERB
slight O NOUN
transient O ADJ
increases O NOUN
in O ADP
scaling B-outcome VERB
and O CCONJ
burning B-outcome VERB
over O ADP
the O DET
first O ADV
four O NUM
weeks. O NOUN

METHODS: O NOUN
ECHELON-2 O NOUN
is O VERB
a O DET
double-blind, O NOUN
double-dummy, O NOUN
randomised, O NOUN
placebo-controlled, O NOUN
active-comparator O NOUN
phase O NOUN
3 O NUM
study. O NOUN

Title: O NOUN
Grip B-outcome NOUN
strength I-outcome NOUN
can O VERB
be O VERB
used O VERB
to O PART
evaluate O VERB
postoperative O ADJ
residual B-outcome ADJ
neuromuscular I-outcome ADJ
block I-outcome VERB
recovery I-outcome NOUN
in O ADP
patients O NOUN
undergoing O VERB
general O ADJ
anesthesia. O NOUN

Journal O ADJ
ID: O NOUN
9308586 O NUM

TRIAL O NOUN
REGISTRATION: O NOUN
This O DET
study O NOUN
was O VERB
retrospectively O ADV
registered O VERB
in O ADP
the O DET
Iranian O ADJ
website O ADV
( O PUNCT
www.irct.ir O NOUN
) O PUNCT
for O ADP
registration O NOUN
of O ADP
clinical O ADJ
trials O NOUN
( O PUNCT
IRCT20170513033941N37 O NOUN
). O NOUN

DISCUSSION: O NOUN
This O DET
study O NOUN
will O VERB
provide O VERB
data O NOUN
on O ADP
the O DET
efficacy O NOUN
of O ADP
repeated O VERB
PZQ O NOUN
treatment O NOUN
on O ADP
the O DET
clearance O NOUN
of O ADP
S.mansoni O NOUN
as O ADP
measured O VERB
by O ADP
several O ADJ
diagnostic O ADJ
techniques. O NUM

RESULTS:: O NOUN
There O PRON
is O VERB
good O ADJ
agreement O NOUN
when O ADP
comparing O VERB
radiographer O ADP
contours O NOUN
to O PART
the O DET
gold-standard O NOUN
for O ADP
all O DET
three O NUM
imaging O VERB
types O NOUN
with O ADP
Dice O NOUN
similarity O NOUN
co-efficient O NOUN
0.91-0.94, O NUM
Cohen's O NOUN
kappa O NOUN
0.85-0.91, O NUM
Hausdorff O NOUN
distance O NOUN
4.6-7.6 O NUM
mm O NOUN
and O CCONJ
mean O NOUN
distance O NOUN
between O ADP
contours O NOUN
0.9-1.2 O NUM
mm. O NOUN

The O DET
MMP-9 B-outcome NOUN
conversion I-outcome NOUN
rate O NOUN
of O ADP
group O NOUN
A O DET
(76.92%) O PUNCT
was O VERB
significantly O ADV
higher O ADJ
than O ADP
that O ADP
of O ADP
group O NOUN
B O NOUN
(38.46%, O NOUN
p O NOUN
= O SYM
0.005). O NUM

Results: O NOUN
Among O ADP
1458 O NUM
enrolled O VERB
patients O NOUN
(mean O NUM
[SD] O PUNCT
age, O NOUN
58 O NUM
[16] O PUNCT
years; O NOUN
599 O NUM
women O NOUN
[41%]), O NOUN
1353 O NUM
(93%) O PUNCT
completed O VERB
the O DET
study O NOUN
and O CCONJ
were O VERB
included O VERB
in O ADP
the O DET
final O ADJ
analysis. O NOUN

RESULTS: O NOUN
Comparison O NOUN
of O ADP
baseline O NOUN
and O CCONJ
12-month O NOUN
follow-up O NOUN
showed O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
overall O ADJ
TF1-9 B-outcome NOUN
prevalence O NOUN
by O ADP
balozi O NOUN
between O ADP
control O NOUN
and O CCONJ
treatment O NOUN
arms. O ADJ

The O DET
associations O NOUN
between O ADP
any O DET
2 O NUM
groups O NOUN
of O ADP
continuous O ADJ
variables O NOUN
will O VERB
be O VERB
tested O VERB
using O VERB
the O DET
t O NOUN
test O NOUN
or O CCONJ
the O DET
Mann-Whitney O NOUN
U O NOUN
test O NOUN
and O CCONJ
that O ADP
of O ADP
2 O NUM
groups O NOUN
of O ADP
categorical O ADJ
variables O NOUN
with O ADP
chi-square O NOUN
or O CCONJ
Fishers O NOUN
exact O NOUN
test O NOUN
where O ADP
appropriate. O NOUN

DISCUSSION: O NOUN
Our O ADJ
study O NOUN
suggests O NOUN
a O DET
beneficial O ADJ
effect O NOUN
of O ADP
oral O ADJ
glutamine O NOUN
supplementation O NOUN
for O ADP
the O DET
prevention O NOUN
from O ADP
radiation-induced O VERB
injury B-outcome NOUN
and O CCONJ
body B-outcome NOUN
weight I-outcome NOUN
loss O NOUN
in O ADP
advanced O VERB
NSCLC O NOUN
patients O NOUN
who O ADP
receiving O VERB
CCRT. O NOUN

RESULTS: O NOUN
The O DET
mean O NOUN
length B-outcome NOUN
of I-outcome ADP
hospital I-outcome NOUN
stay I-outcome NOUN
for O ADP
the O DET
intercostal O ADJ
drainage O NOUN
group O NOUN
in O ADP
the O DET
intensive O ADJ
care O NOUN
unit O NOUN
was O VERB
1.5 O NUM
day O NOUN
(1.0 O PUNCT
to O PART
2.0 O NUM
days) O NOUN
and O CCONJ
2.0 O NUM
days O NOUN
(25.1 O ADJ
to O PART
3.0 O NUM
days) O NOUN
for O ADP
the O DET
traditional O ADJ
chest O NOUN
drainage O NOUN
group O NOUN
(p=0.060). O NUM

The O DET
trial O NOUN
was O VERB
halted O VERB
after O ADP
an O DET
interim O ADJ
safety O NOUN
analysis O NOUN
(n=11) O NOUN
due O ADJ
to O PART
excess O ADJ
grade O NOUN
3 O NUM
neutropenia B-outcome NOUN
, O PUNCT
dose B-outcome NOUN
reductions I-outcome NOUN
and O CCONJ
treatment B-outcome NOUN
delays I-outcome NOUN
. O PUNCT
Grade O NOUN
3 O NUM
or O CCONJ
4 O NUM
neutropenia B-outcome NOUN
was O VERB
observed O VERB
in O ADP
64% O NUM
of O ADP
patients. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

A O DET
high O ADJ
Gleason O PROPN
score O NOUN
and O CCONJ
the O DET
presence O NOUN
of O ADP
extracapsular O ADJ
extension O NOUN
in O ADP
the O DET
radical O NOUN
prostatectomy O NOUN
specimens O NOUN
were O VERB
highly O ADV
predictive O ADJ
of O ADP
death B-outcome NOUN
from I-outcome ADP
prostate I-outcome NOUN
cancer I-outcome NOUN
. O PUNCT
(Funded O PUNCT
by O ADP
the O DET
Swedish O NOUN
Cancer O NOUN
Society O NOUN
and O CCONJ
others.). O NOUN

Journal O ADJ
ID: O NOUN
8303003 O NUM

In O ADP
this O DET
study, O NOUN
we O PRON
aimed O VERB
to O PART
determine O NOUN
the O DET
safety O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
ixazomib O NOUN
as O ADP
maintenance O NOUN
therapy O NOUN
following O VERB
ASCT. O NOUN

One O NUM
patient O NOUN
in O ADP
the O DET
gemcitabine O NOUN
group O NOUN
died B-outcome VERB
from O ADP
toxic B-outcome ADJ
effects O NOUN
( O PUNCT
interstitial B-outcome ADJ
pneumonitis I-outcome NOUN
). O NOUN

Patients O NOUN
in O ADP
group O NOUN
D O NOUN
received O VERB
intravenous O ADJ
infusion O NOUN
of O ADP
dexmedetomidine(1 O NOUN
mug/kg) O NOUN
20 O NUM
min O NOUN
before O ADP
anesthesia O NOUN
induction, O NOUN
followed O VERB
by O ADP
intravenous O ADJ
pumping O VERB
of O ADP
dexmedetomidine(0.2 O NOUN
mug.kg(-1).h(-1)) O NOUN
intraoperatively. O NOUN

In O ADP
addition, O NOUN
for O ADP
the O DET
upper O ADJ
50th O ADJ
percentile O ADJ
group, O NOUN
the O DET
adjusted O VERB
mean O NOUN
post-supplementation O NOUN
baseline O NOUN
hydroxyproline B-outcome NOUN
(HYP) I-outcome NOUN
for O ADP
the O DET
high O ADJ
dose O NOUN
group O NOUN
(1.5 O NOUN
+/- O SYM
0.3 O NUM
mug.mL(- O NOUN
1)) O NOUN
was O VERB
significantly O ADV
less O ADV
than O ADP
both O CCONJ
the O DET
low O ADJ
dose O NOUN
(2.4 O NOUN
+/- O SYM
0.3 O NUM
mug.mL(- O NOUN
1); O NOUN
p O NOUN
= O SYM
0.034) O NUM
and O CCONJ
placebo O NOUN
(2.4 O NOUN
+/- O SYM
0.3 O NUM
mug.mL(- O NOUN
1), O NUM
p O NOUN
= O SYM
0.024) O NOUN
groups. O NOUN

METHODS: O NOUN
Older O ADJ
breast O NOUN
cancer O NOUN
survivors O NOUN
were O VERB
randomized O VERB
into O ADP
two O NUM
groups: O NOUN
combined O VERB
training: O NOUN
resistance O NOUN
+ O SYM
aerobic O ADJ
exercise O NOUN
program O NOUN
for O ADP
nine O NUM
months O NOUN
(n O NOUN
= O SYM
18) O NOUN
or O CCONJ
control O NOUN
group O NOUN
(n O NOUN
= O SYM
18). O NUM

Cumulative O ADJ
opioid B-outcome NOUN
requirements I-outcome NOUN
after O ADP
48 O NUM
hours O NOUN
were O VERB
similar O ADJ
between O ADP
the O DET
groups. O NOUN

Among O ADP
the O DET
440 O NUM
patients O NOUN
randomized O VERB
(mean O NUM
age, O NOUN
60.5 O NUM
years; O NOUN
15% O ADJ
women), O NOUN
the O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
achieved O NOUN
in O ADP
396 O NUM
patients O NOUN
(90%), O NOUN
17 O NUM
(3.9%) O NUM
withdrew, O ADJ
and O CCONJ
all O DET
others O NOUN
were O VERB
followed O VERB
up O ADP
to O PART
3 O NUM
months. O NOUN

RESULTS: O NOUN
Truckers O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
were O VERB
significantly O ADV
more O ADV
likely O ADV
to O PART
test B-outcome NOUN
for Seperator ADP
HIV I-outcome NOUN
compared O VERB
to O PART
those O DET
in O ADP
the O DET
enhanced O VERB
SOC O NOUN
(OR O NOUN
= O SYM
2.7, O NOUN
p O NOUN
= O SYM
0.009). O NUM

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

METHODS: O NOUN
APPAC O NOUN
II O NUM
trial O NOUN
is O VERB
a O DET
multicentre, O NOUN
open-label, O ADV
non-inferiority O NOUN
randomised O VERB
controlled O VERB
trial O NOUN
comparing O VERB
per O ADP
oral O ADJ
(p.o.) O NOUN

Adult O NOUN
patients O NOUN
with O ADP
CT-scan O NOUN
diagnosed O VERB
uncomplicated O VERB
acute O ADJ
appendicitis O NOUN
will O VERB
be O VERB
enrolled O VERB
in O ADP
nine O NUM
Finnish O NOUN
hospitals. O NOUN

METHODS: O NOUN
A O DET
hundred O NUM
of O ADP
healthy O ADJ
parturients O NOUN
undergoing O VERB
elective O ADJ
cesarean O NOUN
section O NOUN
under O ADP
combined O VERB
spinal-epidural O ADJ
anesthesia O NOUN
(CSEA) O PUNCT
were O VERB
enrolled O VERB
in O ADP
this O DET
randomized, O NOUN
double-blinded, O NOUN
dose-ranging O VERB
study. O NOUN

J O NOUN
Strength O NOUN
Cond O ADP
Res O NOUN
33(1): O NOUN
225-233, O NUM
2019-Upper O NOUN
limb O NOUN
strength O NOUN
deficits O NOUN
are O VERB
frequently O ADV
observed O VERB
following O VERB
breast O NOUN
cancer O NOUN
(BC) O NOUN
and O CCONJ
its O ADJ
treatments. O NOUN

Title: O NOUN
IQOS(TM) O NOUN
vs. O CCONJ
e-Cigarette O NOUN
vs. O CCONJ
Tobacco O NOUN
Cigarette: O NOUN
A O DET
Direct O ADJ
Comparison O NOUN
of O ADP
Short-Term O NOUN
Effects O NOUN
after O ADP
Overnight-Abstinence. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
0313225 O NUM

METHODS: O NOUN
In O ADP
this O DET
study, O NOUN
80 O NUM
patients O NOUN
who O ADP
underwent O VERB
neuro O VERB
intervention O NOUN
with O ADP
MEP O NOUN
monitoring O VERB
were O VERB
randomly O ADV
assigned O VERB
into O ADP
2 O NUM
groups. O NOUN

MPH-ER O NOUN
was O VERB
well O ADV
tolerated B-outcome VERB
. O PUNCT
Conclusion: O NOUN
Fluvoxamine O NOUN
combined O VERB
with O ADP
MPH-ER O NOUN
is O VERB
effective O ADJ
in O ADP
the O DET
treatment O NOUN
of O ADP
refractory O ADJ
obsessive-compulsive O ADJ
disorder. O NOUN

Title: O NOUN
Study O NOUN
on O ADP
the O DET
safety O NOUN
of O ADP
Polygala O NOUN
tenuifolia O NOUN
Willdenow O NOUN
root O NOUN
extract O NOUN
powder O NOUN
(BT-11) O NOUN
in O ADP
young O ADJ
person O NOUN
aged O VERB
from O ADP
9 O NUM
to O PART
19 O NUM
years O NOUN
old. O NUM

Journal O ADJ
ID: O NOUN
8610224 O NUM

Grade O NOUN
3 O NUM
systemic B-outcome ADJ
solicited I-outcome VERB
AE I-outcome NOUN
occurred O VERB
in O ADP
5.4% O NOUN
and O CCONJ
2.9% O NOUN
of O ADP
the O DET
participants O NOUN
in O ADP
the O DET
Havrix O NOUN
group O NOUN
after O ADP
the O DET
1st O ADJ
and O CCONJ
2nd O ADJ
doses, O ADJ
respectively. O NOUN

After O ADP
eight O NUM
weeks, O NOUN
body B-outcome NOUN
weight I-outcome NOUN
, O PUNCT
body B-outcome NOUN
fat I-outcome NOUN
, O PUNCT
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
, O PUNCT
wrist B-outcome NOUN
circumference I-outcome NOUN
, O PUNCT
thigh B-outcome NOUN
circumference I-outcome NOUN
, O PUNCT
calf B-outcome NOUN
circumference I-outcome NOUN
, O PUNCT
mid-arm B-outcome NOUN
circumference I-outcome NOUN
, O PUNCT
and O CCONJ
triceps B-outcome ADP
skinfolds I-outcome NOUN
decreased O VERB
significantly O ADV
in O ADP
both O CCONJ
the O DET
groups. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrials.gov O NOUN
NCT01277302 O NOUN
. O PUNCT

INTRODUCTION: O NOUN
Joint O NOUN
hypermobility O NOUN
is O VERB
common O ADJ
in O ADP
childhood O NOUN
and O CCONJ
can O VERB
be O VERB
associated O VERB
with O ADP
musculoskeletal O ADJ
pain O NOUN
and O CCONJ
dysfunction. O NOUN

Journal O ADJ
ID: O NOUN
8109496 O NUM

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[pubmed] O PUNCT

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
incidence O NOUN
of O ADP
patient O NOUN
involuntary B-outcome ADJ
movement I-outcome NOUN
and O CCONJ
spontaneous B-outcome ADJ
respiration I-outcome NOUN
, O PUNCT
the O DET
mean O NOUN
MEP B-outcome NOUN
amplitude I-outcome ADJ
, O PUNCT
coefficient O NOUN
of O ADP
variation O NOUN
(CV), O NOUN
the O DET
incidence O NOUN
of O ADP
MEP B-outcome NOUN
stimulus I-outcome NOUN
change I-outcome NOUN
and O CCONJ
train-of-four B-outcome ADV
(TOF) I-outcome ADV
count I-outcome NOUN
were O VERB
compared. O NOUN

Moreover, O NOUN
the O DET
WSP-MR O NOUN
group O NOUN
demonstrated O VERB
a O DET
5% O NOUN
decrease O NOUN
in O ADP
body B-outcome NOUN
weight I-outcome NOUN
, O PUNCT
body B-outcome NOUN
fat I-outcome NOUN
, O PUNCT
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
, O PUNCT
and O CCONJ
mid-arm B-outcome NOUN
circumference I-outcome NOUN
and O CCONJ
a O DET
3.5% O NOUN
decrease O NOUN
in O ADP
glycated B-outcome VERB
hemoglobin I-outcome NOUN
levels O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Journal-Name:Journal O ADJ
of O ADP
clinical O ADJ
psychopharmacology O NOUN

Thus, O NOUN
the O DET
aim O ADP
of O ADP
this O DET
study O NOUN
is O VERB
to O PART
explore O ADP
the O DET
impact O NOUN
of O ADP
the O DET
application O NOUN
of O ADP
OPEP O NOUN
device O NOUN
(acapella) O PUNCT
in O ADP
lung O NOUN
cancer O NOUN
patients O NOUN
undergoing O VERB
video-assisted O VERB
thorascopic O ADJ
surgery O NOUN
(VATS). O NOUN

The O DET
intention-to-treat O NOUN
analysis O NOUN
showed O VERB
a O DET
difference O NOUN
in O ADP
the O DET
risk O NOUN
of O ADP
definitive O ADJ
treatment B-outcome NOUN
failure I-outcome NOUN
(oral O ADJ
group O NOUN
vs. O CCONJ
intravenous O ADJ
group) O ADJ
of O ADP
-1.4 O NUM
percentage O NOUN
points O NOUN
(90% O PUNCT
confidence O NOUN
interval O NOUN
[CI], O VERB
-4.9 O NUM
to O PART
2.2; O ADP
95% O NOUN
CI, O NOUN
-5.6 O VERB
to O PART
2.9), O NUM
indicating O VERB
noninferiority. O ADJ

METHODS: O NOUN
Sixty-six O NUM
female O NOUN
patients O NOUN
with O ADP
American O ADJ
Society O NOUN
of O ADP
Anesthesiologists O NOUN
I, O ADJ
II, O NOUN
or O CCONJ
III, O NOUN
aged O VERB
18 O NUM
to O PART
65 O NUM
years O NOUN
who O ADP
were O VERB
scheduled O VERB
for O ADP
laparoscopic O ADJ
hysterectomy O NOUN
for O ADP
benign O ADJ
gynecologic O ADJ
pathologies O NOUN
were O VERB
recruited O VERB
in O ADP
this O DET
randomized, O NOUN
controlled, O NOUN
observer-blinded O VERB
trial. O NOUN

All O DET
outcomes O NOUN
were O VERB
measured O VERB
at O ADP
baseline, O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
2-week, O NUM
and O CCONJ
1-month O NOUN
follow-up O NOUN
period. O NOUN

OBJECTIVE: O NOUN
This O DET
study O NOUN
aimed O VERB
to O PART
evaluate O VERB
the O DET
effectiveness O NOUN
of O ADP
Kinesio O NOUN
tape O NOUN
(KT) O NOUN
on O ADP
lower O ADJ
limb O NOUN
muscle B-outcome NOUN
activation I-outcome NOUN
pattern O NOUN
in O ADP
children O NOUN
with O ADP
developmental O ADJ
coordination O NOUN
disorder O ADP
(DCD) O NOUN
during O ADP
walking. O NOUN

The O DET
outcome O NOUN
assessor O NOUN
was O VERB
blinded; O NOUN
however, O ADV
it O PRON
was O VERB
not O ADV
feasible O ADJ
to O PART
blind O PUNCT
either O CCONJ
operator O NOUN
or O CCONJ
patients. O NOUN

Methods: O NOUN
By O ADP
theoretically O ADV
analyzing O VERB
the O DET
influential O ADJ
factors O NOUN
for O ADP
children's O NOUN
unintentional O ADJ
injury O NOUN
risk O NOUN
behaviors, O NOUN
children's O NOUN
cognitive O ADJ
development O NOUN
characteristics O NOUN
and O CCONJ
the O DET
social O ADJ
learning O VERB
theory, O ADJ
an O DET
intervention O NOUN
protocol O NOUN
was O VERB
established O VERB
on O ADP
the O DET
basis O NOUN
of O ADP
changing O VERB
the O DET
unintentional O ADJ
injury O NOUN
attribution O NOUN
and O CCONJ
negative O ADJ
information O NOUN
transmission O NOUN
of O ADP
risk O NOUN
behavior O NOUN
consequences. O NOUN

Primary O ADJ
endpoint O NOUN
was O VERB
comparison O NOUN
of O ADP
mean O NOUN
change O NOUN
in O ADP
serum O NOUN
hydroxymethylglutaryl-CoA B-outcome NOUN
reductase I-outcome NOUN
enzyme I-outcome NOUN
(HMGCR) I-outcome PUNCT
levels O NOUN
and O CCONJ
lipid O NOUN
indices O NOUN
of O ADP
both O CCONJ
groups O NOUN
and O CCONJ
their O ADJ
correlation O NOUN
with O ADP
each O DET
other. O NOUN

Serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
were O VERB
reported O VERB
in O ADP
124 O NUM
patients O NOUN
(20.2%) O NUM
in O ADP
the O DET
guided O VERB
and O CCONJ
130 O NUM
(21.0%) O PUNCT
in O ADP
the O DET
usual O ADJ
care O NOUN
group. O VERB

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
disease-free B-outcome ADJ
survival I-outcome NOUN
. O PUNCT
Secondary O ADJ
end O NOUN
points O NOUN
included O VERB
overall B-outcome ADJ
survival I-outcome NOUN
and O CCONJ
safety. O ADJ

Results: O NOUN
After O ADP
intervention, O ADP
the O DET
observation O NOUN
group O NOUN
had O VERB
significantly O ADV
higher O ADJ
forced B-outcome VERB
expiratory I-outcome ADJ
volume I-outcome NOUN
in Seperator ADP
1 I-outcome NUM
second I-outcome ADJ
(FEV(1) I-outcome PUNCT
), O NUM
forced B-outcome VERB
vital I-outcome ADJ
capacity I-outcome NOUN
(FVC) I-outcome PUNCT
, O PUNCT
arterial B-outcome ADJ
partial I-outcome ADJ
pressure I-outcome NOUN
of I-outcome ADP
oxygen I-outcome NOUN
(PaO(2) I-outcome PUNCT
) O PUNCT
, O PUNCT
and O CCONJ
six-minute O NOUN
walk B-outcome NOUN
distance I-outcome NOUN
than O ADP
the O DET
control O NOUN
group O NOUN
(P<0.05) O NOUN
, O PUNCT
while O ADP
there O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
in O ADP
FEV(1)/FVC B-outcome NOUN
and O CCONJ
partial B-outcome ADJ
pressure I-outcome NOUN
of I-outcome ADP
carbon I-outcome NOUN
dioxide I-outcome NOUN
(P>0.05) O PUNCT
. O PUNCT

One O NUM
patient O NOUN
(4%) O NUM
died B-outcome VERB
from O ADP
sepsis B-outcome NOUN
in O ADP
the O DET
context O NOUN
of O ADP
neutropenic B-outcome ADJ
fever I-outcome NOUN
, O PUNCT
infection B-outcome NOUN
, O PUNCT
and O CCONJ
haemorrhage B-outcome NOUN
in O ADP
the O DET
5-day O NOUN
group, O NOUN
and O CCONJ
in O ADP
the O DET
10-day O NOUN
group O NOUN
six O NUM
patients O NOUN
(14%) O PUNCT
died B-outcome VERB
from O ADP
infection B-outcome NOUN
. O PUNCT
Early O ADJ
mortality B-outcome NOUN
was O VERB
similar O ADJ
in O ADP
the O DET
two O NUM
groups. O NOUN

Journal-Name:The O ADJ
bone O NOUN
& O CCONJ
joint O NOUN
journal O ADJ

At O ADP
the O DET
end O NOUN
of O ADP
follow-up, O ADP
patients O NOUN
showed O VERB
normal O ADJ
levels O NOUN
of O ADP
vitamin O NOUN
D, O ADJ
with O ADP
increased O VERB
calcium B-outcome NOUN
levels I-outcome NOUN
and O CCONJ
decreased O VERB
bone B-outcome NOUN
turnover I-outcome ADV
. O PUNCT
Waist B-outcome NOUN
circumference I-outcome NOUN
also O ADV
decreased. O NOUN

The O DET
intended O VERB
sample O NOUN
size O NOUN
is O VERB
552 O NUM
patients. O NOUN

Late-onset O NOUN
sepsis B-outcome NOUN
occurred O VERB
in O ADP
414 O NUM
of O ADP
1389 O NUM
infants O NOUN
(29.8%) O PUNCT
in O ADP
the O DET
faster-increment O NOUN
group O NOUN
and O CCONJ
434 O NUM
of O ADP
1397 O NUM
(31.1%) O NUM
in O ADP
the O DET
slower-increment O ADJ
group O NOUN
(adjusted O PUNCT
risk O NOUN
ratio, O NOUN
0.96; O NOUN
95% O NOUN
CI, O NOUN
0.86 O NUM
to O PART
1.07). O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
control O NOUN
and O CCONJ
treatment O NOUN
groups O NOUN
all O DET
showed O VERB
elevated O VERB
serum O NOUN
levels O NOUN
of O ADP
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
23 I-outcome NUM
(FGF23) I-outcome NOUN
, O PUNCT
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
receptor I-outcome NOUN
(FGFRs) I-outcome NOUN
and O CCONJ
Klotho B-outcome NOUN
protein I-outcome NOUN
compared O VERB
with O ADP
the O DET
normal O ADJ
subjects O NOUN
(P O NUM
&lt; O NOUN
0.01); O NUM
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
23 I-outcome NUM
(FGF23) I-outcome NOUN
, O PUNCT
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
receptor I-outcome NOUN
(FGFRs) I-outcome NOUN
and O CCONJ
Klotho B-outcome NOUN
levels O NOUN
were O VERB
significantly O ADV
reduced O VERB
in O ADP
the O DET
treatment O NOUN
group O NOUN
(P O NUM
&lt; O NOUN
0.05) O NUM
but O CCONJ
remained O VERB
unchanged O VERB
in O ADP
the O DET
control O NOUN
group O NOUN
(P&gt;0.05), O NOUN
showing O VERB
significant O ADJ
differences O NOUN
between O ADP
the O DET
two O NUM
groups. O NOUN

Publication O NOUN
date: O NOUN
2018/12/12 O ADJ
00:00 O NOUN
[accepted] O ADV

RESULTS: O NOUN
The O DET
D-group O NOUN
increased O VERB
their O ADJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
more O ADV
than O ADP
the O DET
C-group O NOUN
at O ADP
12 O NUM
wk. O DET

Reports O NOUN
of O ADP
CHW O NOUN
household O NOUN
contact O NOUN
and O CCONJ
assessments O NOUN
of O ADP
CHW O NOUN
quality O NOUN
were O VERB
obtained O VERB
in O ADP
the O DET
endline O NOUN
KPC O NOUN
household O NOUN
survey, O ADJ
and O CCONJ
household O NOUN
contacts O NOUN
measured O VERB
in O ADP
monthly O ADV
submitted O VERB
reports O NOUN
were O VERB
also O ADV
tabulated. O NOUN

OBJECTIVE: O NOUN
The O DET
study O NOUN
sought O NOUN
to O PART
compare O NOUN
the O DET
efficacy O NOUN
of O ADP
a O DET
lower O ADJ
loading O VERB
dose O NOUN
of O ADP
prasugrel O NOUN
with O ADP
conventional O ADJ
loading O VERB
dose O NOUN
of O ADP
prasugrel O NOUN
in O ADP
Indian O NOUN
patients. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

There O PRON
were O VERB
statistically O ADV
significant O ADJ
differences O NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
at O ADP
2 O NUM
weeks O NOUN
and O CCONJ
4 O NUM
weeks O NOUN
after O ADP
treatment, O NOUN
including O VERB
the O DET
modified O VERB
Ashworth O NOUN
Scale O NOUN
(MAS) O NOUN
score, O NOUN
Gross B-outcome NOUN
Motor I-outcome NOUN
Function I-outcome NOUN
Measure O NOUN
(GMFM) O NOUN
score, O NOUN
plantar B-outcome NOUN
area I-outcome NOUN
and O CCONJ
plantar B-outcome NOUN
pressure I-outcome NOUN
(P O NUM
< O SYM
.05). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

Journal-Name:Medicine O NOUN

A O DET
randomized O VERB
clinical O ADJ
trial. O NOUN

METHODS: O NOUN
The O DET
research O NOUN
is O VERB
a O DET
prospective O ADJ
comparative O ADJ
randomized O VERB
study. O NOUN

Within O ADP
30 O NUM
days O NOUN
of O ADP
surgery, O NOUN
4 O NUM
patients O NOUN
(0.65%) O NOUN
in O ADP
the O DET
guided O VERB
group O NOUN
and O CCONJ
19 O NUM
(3.07%) O NUM
in O ADP
the O DET
usual O ADJ
care O NOUN
group O NOUN
died. O NOUN

Journal O ADJ
ID: O NOUN
8610224 O NUM

Title: O NOUN
Application O NOUN
of O ADP
intrapulmonary O ADJ
wire O NOUN
combined O VERB
with O ADP
intrapleural O ADJ
fibrin O NOUN
glue O ADJ
in O ADP
preoperative O ADJ
localization O NOUN
of O ADP
small O ADJ
pulmonary O ADJ
nodules. O NOUN

Title: O NOUN
[Surgical O ADJ
treatment O NOUN
strategy O NOUN
for O ADP
the O DET
"shell" O NOUN
phenomenon O NOUN
after O ADP
thoracolumbar O ADV
fracture]. O NOUN

In O ADP
2 O NUM
randomized O VERB
controlled O VERB
trials O NOUN
(RCTs) O PUNCT
of O ADP
stressed O VERB
community O NOUN
adults, O ADP
mindfulness O ADV
skills O NOUN
were O VERB
dismantled O VERB
into O ADP
2 O NUM
structurally O ADV
equivalent O ADJ
interventions: O NOUN
(a) O PUNCT
training O VERB
in O ADP
both O CCONJ
monitoring O VERB
and O CCONJ
acceptance O NOUN
(Monitor O NOUN
+ O SYM
Accept) O DET
and O CCONJ
(b) O NUM
training O VERB
in O ADP
monitoring O VERB
only O ADV
(Monitor O NOUN
Only) O NOUN
without O ADP
acceptance O NOUN
training. O NOUN

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
213 O NUM
patients O NOUN
(95.1%) O NOUN
completed O VERB
the O DET
study. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Moreover, O NOUN
the O DET
change O NOUN
in O ADP
ICAM1 O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
correlated O VERB
positively O ADV
with O ADP
the O DET
intake O NOUN
of O ADP
FF O NOUN
(P O NUM
< O SYM
0.05) O NUM
and O CCONJ
negatively O ADV
with O ADP
the O DET
intake O NOUN
of O ADP
LF O NOUN
(P O NUM
< O SYM
0.05), O NUM
independently O ADV
of O ADP
study O NOUN
group. O VERB

We O PRON
designed O VERB
a O DET
prospective O ADJ
randomized O VERB
study O NOUN
to O PART
assess O NOUN
the O DET
impact O NOUN
of O ADP
glutamine O NOUN
(GLN) O NOUN
supplementation O NOUN
in O ADP
preventing O VERB
CCRT-induced O VERB
toxicities B-outcome NOUN
of O ADP
advanced O VERB
NSCLC O NOUN
patients. O NOUN

BACKGROUND: O NOUN
Pregnancy O NOUN
has O VERB
been O VERB
identified O VERB
as O ADP
a O DET
contributor O NOUN
to O PART
obesity. O ADP

This O DET
single-blind O NOUN
preliminary O ADJ
randomized-controlled O VERB
study O NOUN
investigated O VERB
the O DET
effects O NOUN
of O ADP
a O DET
MBI O NOUN
on O ADP
anxio-depressive B-outcome ADJ
symptoms I-outcome NOUN
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
and O CCONJ
memory B-outcome NOUN
, O PUNCT
compared O VERB
to O PART
a O DET
psychoeducation-based O VERB
intervention O NOUN
in O ADP
older O ADJ
adults O NOUN
with O ADP
aMCI. O ADJ

The O DET
assessors O NOUN
were O VERB
masked O VERB
as O ADP
to O PART
group O NOUN
allocation. O NOUN

There O PRON
were O VERB
no O DET
statistically O ADV
significant O ADJ
effects O NOUN
for O ADP
pedaling O VERB
adherence B-outcome NOUN
. O PUNCT
Conclusions O NOUN
show O VERB
an O DET
important O ADJ
role O NOUN
for O ADP
live O ADJ
music O ADJ
therapy O NOUN
intervention O NOUN
on O ADP
observed O VERB
pain B-outcome NOUN
while O ADP
engaged O VERB
in O ADP
co-treatment O NOUN
during O ADP
this O DET
lower O ADJ
extremity O NOUN
ROM O NOUN
exercise. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
preintravenous O ADJ
injection O NOUN
of O ADP
parecoxib, O NOUN
combined O VERB
with O ADP
transversus O NOUN
abdominis O NOUN
plane O ADJ
block O VERB
in O ADP
strategy O NOUN
of O ADP
enhanced O VERB
recovery B-outcome NOUN
after O ADP
radical O NOUN
resection O NOUN
of O ADP
colorectal O ADJ
cancer. O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
In O ADP
this O DET
preliminary O ADJ
analysis O NOUN
of O ADP
an O DET
ongoing O VERB
trial, O NOUN
an O DET
intervention O NOUN
that O ADP
encouraged O VERB
an O DET
energy-reduced O VERB
Mediterranean O NOUN
diet O NOUN
and O CCONJ
physical O ADJ
activity, O ADP
compared O VERB
with O ADP
advice O NOUN
to O PART
follow O VERB
an O DET
energy-unrestricted O VERB
Mediterranean O NOUN
diet, O ADV
resulted O VERB
in O ADP
a O DET
significantly O ADV
greater O ADJ
increase O NOUN
in O ADP
diet O NOUN
adherence B-outcome NOUN
after O ADP
12 O NUM
months. O NOUN

Publication O NOUN
date: O NOUN
['2019/10/11 O NOUN
06:00' O NUM

Colorectal O ADJ
cancer O NOUN
(CRC) O NOUN
is O VERB
the O DET
third O ADJ
leading O VERB
cause O ADP
of O ADP
cancer-related O VERB
death O NOUN
in O ADP
the O DET
United O VERB
States O NOUN
and O CCONJ
emerging O VERB
evidence O NOUN
supports O NOUN
that O ADP
increased O VERB
consumption O NOUN
of O ADP
legumes, O NOUN
such O ADJ
as O ADP
navy O ADJ
beans, O NOUN
can O VERB
reduce O VERB
risk. O NOUN

Title: O NOUN
Treatment B-outcome NOUN
response I-outcome NOUN
to O PART
indacaterol/glycopyrronium O NOUN
versus O CCONJ
salmeterol/fluticasone O NOUN
in O ADP
exacerbating O VERB
COPD O NOUN
patients O NOUN
by O ADP
gender: O NOUN
a O DET
post-hoc O NOUN
analysis O NOUN
in O ADP
the O DET
FLAME O NOUN
study. O NOUN

CONCLUSION: O NOUN
Training O VERB
using O VERB
a O DET
gelatin-based O VERB
cervical O ADJ
spine O NOUN
phantom O NOUN
helps O ADJ
novices O NOUN
acquire O NOUN
the O DET
skills B-outcome NOUN
necessary O ADJ
to O PART
perform O NOUN
ultrasound-guided O VERB
cervical O ADJ
medial O ADJ
branch O NOUN
blocks. O NOUN

TRIAL O NOUN
REGISTER: O NOUN
NCT01511276 O NOUN
(clinicaltrials.gov), O PUNCT
prospectively O ADV
registered. O NOUN

CONCLUSIONS: O NOUN
A O DET
BCL O NOUN
can O VERB
improve O VERB
tear B-outcome NUM
film I-outcome NOUN
stability I-outcome NOUN
and O CCONJ
lessen O NOUN
dry B-outcome ADJ
eye I-outcome NOUN
discomfort I-outcome NOUN
immediately O ADV
after O ADP
phacoemulsification. O NOUN

Journal O ADJ
ID: O NOUN
0374675 O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
cognitive O ADJ
outcome O NOUN
was O VERB
occurrence O NOUN
of O ADP
adjudicated O VERB
probable O ADJ
dementia B-outcome NOUN
. O PUNCT
Secondary O ADJ
cognitive O ADJ
outcomes O NOUN
included O VERB
adjudicated O VERB
mild O ADJ
cognitive B-outcome ADJ
impairment I-outcome NOUN
and O CCONJ
a O DET
composite O NOUN
outcome O NOUN
of O ADP
mild O ADJ
cognitive B-outcome ADJ
impairment I-outcome NOUN
or Seperator CCONJ
probable I-outcome ADJ
dementia I-outcome NOUN
. O PUNCT
Results: O NOUN
Among O ADP
9361 O NUM
randomized O VERB
participants O NOUN
(mean O NUM
age, O NOUN
67.9 O NUM
years; O NOUN
3332 O NUM
women O NOUN
[35.6%]), O NOUN
8563 O NUM
(91.5%) O NOUN
completed O VERB
at O ADP
least O ADV
1 O NUM
follow-up O NOUN
cognitive O ADJ
assessment. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
microbiologically O ADV
confirmed O VERB
or O CCONJ
clinically O ADV
suspected O VERB
late-onset O NOUN
infection B-outcome NOUN
(occurring O VERB
>72 O PUNCT
h O NOUN
after O ADP
birth), O NOUN
which O ADP
was O VERB
assessed O VERB
in O ADP
all O DET
participants O NOUN
for O ADP
whom O ADP
primary O ADJ
outcome O NOUN
data O NOUN
was O VERB
available O ADJ
by O ADP
calculating O VERB
the O DET
relative O ADJ
risk O NOUN
ratio O NOUN
with O ADP
95% O NOUN
CI O NOUN
between O ADP
the O DET
two O NUM
groups. O NOUN

The O DET
effective O ADJ
concentration B-outcome NOUN
values O NOUN
for O ADP
remifentanil O NOUN
TCI O NOUN
were O VERB
determined O VERB
using O VERB
sequential O ADJ
method O NOUN
and O CCONJ
probit O NOUN
analysis. O NOUN

Publication O NOUN
date: O NOUN
2018/12/21 O NOUN
06:00 O ADP
[entrez] O ADP

There O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
VAS O NOUN
scores O NOUN
and O CCONJ
recognition O NOUN
thresholds O NOUN
for O ADP
four O NUM
basic O ADJ
tastes B-outcome NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
before O ADP
treatment. O NOUN

We O PRON
investigated O VERB
whether O ADP
prophylactic O ADJ
use O NOUN
of O ADP
carvedilol O NOUN
can O VERB
prevent O NOUN
doxorubicin-induced O VERB
cardiotoxicity B-outcome NOUN
and O CCONJ
whether O ADP
any O DET
observed O VERB
effect O NOUN
is O VERB
dose O NOUN
related. O NOUN

The O DET
trial O NOUN
is O VERB
registered O VERB
with O ADP
the O DET
International O ADJ
Standard O NOUN
Randomised O VERB
Controlled O VERB
Trial O NOUN
Number O NOUN
88261002. O NUM

Oxidative B-outcome ADJ
stress I-outcome NOUN
, O PUNCT
antioxidant B-outcome NOUN
status I-outcome NOUN
, O PUNCT
and O CCONJ
muscle B-outcome NOUN
damage I-outcome NOUN
were O VERB
assessed O VERB
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
30 O NUM
days O NOUN
of O ADP
chocolate O NOUN
intake. O VERB

CONCLUSIONS: O NOUN
A O DET
diet O NOUN
intervention O NOUN
that O ADP
produced O VERB
clinically O ADV
relevant O ADJ
postpartum O NOUN
weight O NOUN
loss O NOUN
also O ADV
resulted O VERB
in O ADP
increased O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
and O CCONJ
was O VERB
cost-effective. O ADJ

RESULTS: O NOUN
0.2% O NOUN
bio-adhesive O ADJ
chlorhexidine O NOUN
gel O NOUN
used O VERB
after O ADP
mandibular O ADJ
third O ADJ
molar O ADJ
removal O NOUN
reduced O VERB
incidence O NOUN
of O ADP
alveolar B-outcome ADJ
osteitis I-outcome NOUN
by O ADP
10% O ADP
in O ADP
comparison O NOUN
to O PART
control O NOUN
group O NOUN
with O ADP
statistically O ADV
significant O ADJ
difference, O NOUN
i.e., O NUM
p=0.044.. O NOUN
CONCLUSIONS: O NOUN
2.3 O NUM
times O NOUN
reduction O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
alveolar B-outcome ADJ
osteitis I-outcome NOUN
was O VERB
observed O VERB
after O ADP
use O NOUN
of O ADP
0.2% O NOUN
bio-adhesive O ADJ
chlorhexidine O NOUN
gel. O NOUN

CONSLUSIONS: O NOUN
Kangfuxin O NOUN
liquid O ADV
combined O VERB
with O ADP
Garlicin O NOUN
Capsules O NOUN
can O VERB
improve O VERB
the O DET
therapeutic O ADJ
effect O NOUN
of O ADP
ROU O NOUN
and O CCONJ
repair B-outcome NOUN
of I-outcome ADP
local I-outcome ADJ
damaged I-outcome VERB
mucosa I-outcome NOUN
in O ADP
children, O NOUN
increasing O VERB
the O DET
immune O ADJ
function O NOUN
of O ADP
children. O NOUN

Some O DET
participants O NOUN
used O VERB
the O DET
information O NOUN
from O ADP
the O DET
poster O NOUN
to O PART
encourage B-outcome NOUN
other Seperator ADJ
caregivers I-outcome NOUN
to O PART
use O NOUN
the O DET
ABHR O NOUN
("after O NUM
explaining O VERB
to O PART
them, O NUM
they O PRON
liked O VERB
it"). O NOUN

All O DET
patients O NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
treated O VERB
for O ADP
a O DET
total O ADJ
of O ADP
10 O NUM
days. O NOUN

Title: O NOUN
Preoperative O ADJ
celecoxib O NOUN
analgesia O NOUN
is O VERB
more O ADV
efficient O ADJ
and O CCONJ
equally O ADV
tolerated B-outcome VERB
compared O VERB
to O PART
postoperative O ADJ
celecoxib O NOUN
analgesia O NOUN
in O ADP
knee O NOUN
osteoarthritis O NOUN
patients O NOUN
undergoing O VERB
total O ADJ
knee O NOUN
arthroplasty: O NOUN
A O DET
randomized, O NOUN
controlled O VERB
study. O NOUN

Subjects O NOUN
exercised O VERB
significantly O ADV
longer O ADJ
(PC O NOUN
= O SYM
66.7 O NUM
+/- O SYM
16.3 O NUM
min, O NOUN
CON O NOUN
= O SYM
45.7 O NUM
+/- O SYM
9.5 O NUM
min) O ADJ
and O CCONJ
at O ADP
lower O ADJ
rectal B-outcome ADJ
temperature I-outcome NOUN
(approximately O ADV
0.5 O NUM
+/- O SYM
0.5 O NUM
degrees O NOUN
C) O NOUN
and O CCONJ
heart B-outcome NOUN
rate I-outcome NOUN
(approximately O ADV
10 O NUM
+/- O SYM
7 O NUM
bpm) O NOUN
following O VERB
PC. O NOUN

Journal O ADJ
ID: O NOUN
2985213R O NOUN

The O DET
intervention O NOUN
contained O VERB
35 O NUM
g O NOUN
of O ADP
cooked O VERB
navy O ADJ
bean O NOUN
or O CCONJ
macronutrient O ADJ
matched O VERB
meals O NOUN
and O CCONJ
snacks O NOUN
with O ADP
0 O NUM
g O NOUN
of O ADP
navy O ADJ
beans O NOUN
for O ADP
the O DET
control O NOUN
group O NOUN
(n O NOUN
= O SYM
18). O NUM

Journal O ADJ
ID: O NOUN
0255562 O NUM

In O ADP
addition, O NOUN
patients O NOUN
were O VERB
assigned O VERB
to O PART
receive O VERB
a O DET
single O ADJ
300-mg O NUM
dose O NOUN
of O ADP
tafenoquine O NOUN
on O ADP
day O NOUN
1 O NUM
or O CCONJ
2 O NUM
(260 O PUNCT
patients), O NOUN
placebo O NOUN
(133 O NOUN
patients), O NOUN
or O CCONJ
a O DET
15-mg O NOUN
dose O NOUN
of O ADP
primaquine O NOUN
once O ADP
daily O ADJ
for O ADP
14 O NUM
days O NOUN
(129 O NUM
patients). O ADJ

The O DET
primary O ADJ
outcomes O NOUN
are O VERB
implantation B-outcome NOUN
and O CCONJ
clinical B-outcome ADJ
pregnancy I-outcome NOUN
rates. O NOUN

Publication O NOUN
date: O NOUN
2019/02/08 O NOUN
06:00 O ADP
[entrez] O ADP

Title: O NOUN
[Evaluation O NOUN
of O ADP
peer O NOUN
support O NOUN
education O NOUN
mode O NOUN
for O ADP
type B-outcome NOUN
2 I-outcome NUM
diabetes I-outcome NOUN
control I-outcome NOUN
in O ADP
rural O ADJ
residents]. O ADJ

They O PRON
were O VERB
randomly O ADV
allocated O VERB
into O ADP
two O NUM
groups: O NOUN
PAR-G O NOUN
(BiPAP O NOUN
in O ADP
PAR O NOUN
for O ADP
one O NUM
hour), O NOUN
and O CCONJ
1PO-G O NUM
(BIPAP O PUNCT
for O ADP
one O NUM
hour O NOUN
on O ADP
the O DET
1PO). O NUM

OBJECTIVE: O NOUN
To O PART
explore O ADP
the O DET
clinical O ADJ
and O CCONJ
programmatic O ADJ
feasibility O NOUN
of O ADP
using O VERB
800 O NUM
mug O NUM
of O ADP
sublingual O ADJ
misoprostol O NOUN
to O PART
prevent O NOUN
and O CCONJ
treat O NOUN
postpartum B-outcome NOUN
hemorrhage I-outcome NOUN
(PPH) I-outcome PUNCT
during O ADP
home O NOUN
delivery. O VERB

Peri-implant O ADJ
mucosal O ADJ
stability O NOUN
was O VERB
generally O ADV
observed. O NOUN

Likewise, O NOUN
significant O ADJ
differences O NOUN
between O ADP
groups O NOUN
were O VERB
observed O VERB
throughout O ADV
the O DET
study O NOUN
in O ADP
the O DET
group-by-time O NOUN
interaction O NOUN
and O CCONJ
changes O NOUN
of O ADP
haemoglobin B-outcome NOUN
(GC: O NUM
-2.89 O NUM
+/- O SYM
2.29% O NOUN
vs. O CCONJ
VD3G: O NOUN
0.71 O NUM
+/- O SYM
1.91%; O NOUN
p O NOUN
= O SYM
0.009), O NUM
hematocrit B-outcome NOUN
(CG: O NUM
-1.57 O NUM
+/- O SYM
2.49% O NOUN
vs. O CCONJ
VD3G: O NOUN
1.16 O NUM
+/- O SYM
1.81%; O NOUN
p O NOUN
= O SYM
0.019) O NUM
and O CCONJ
transferrin B-outcome NOUN
(CG: O NUM
0.67 O NUM
+/- O SYM
4.88% O PUNCT
vs. O CCONJ
VD3G: O NOUN
6.51 O NUM
+/- O SYM
4.36%; O NOUN
p O NOUN
= O SYM
0.007). O NUM

Title: O NOUN
A O DET
randomized, O NOUN
double O ADV
blind, O NOUN
placebo O NOUN
controlled, O NOUN
multicenter O NOUN
clinical O ADJ
trial O NOUN
to O PART
assess O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
Emblica O NOUN
officinalis O NOUN
extract O NOUN
in O ADP
patients O NOUN
with O ADP
dyslipidemia. O NOUN

Result:The O NOUN
clinical O ADJ
manifestations O NOUN
of O ADP
60 O NUM
patients O NOUN
mainly O ADV
included O VERB
nasal B-outcome ADJ
obstruction I-outcome NOUN
81.67%, O NOUN
accompanied O VERB
by O ADP
fever B-outcome NOUN
, O PUNCT
headache B-outcome NOUN
, O PUNCT
nosebleed B-outcome NOUN
and O CCONJ
runny B-outcome NOUN
nose I-outcome NOUN
. O PUNCT
Forty-one O NUM
patients68.33% O NOUN
had O VERB
only O ADV
one O NUM
site O NOUN
of O ADP
lesion B-outcome NOUN
, O PUNCT
and O CCONJ
21 O NUM
patients35.00% O NOUN
had O VERB
multiple O ADJ
sites O NOUN
of O ADP
lesions B-outcome NOUN
. O PUNCT
In O ADP
terms O NOUN
of O ADP
total O ADJ
remission B-outcome NOUN
rate, O NOUN
it O PRON
was O VERB
significantly O ADV
higher O ADJ
in O ADP
group O NOUN
A O DET
than O ADP
that O ADP
in O ADP
group O NOUN
B93.33% O NOUN
vs. O CCONJ
66.67%, O NOUN
P<0.05. O NOUN

OBJECTIVES: O NOUN
To O PART
determine O NOUN
if O ADP
intermittent O ADJ
exercise-heat O NOUN
exposures O NOUN
(IHE) O PUNCT
every O DET
fifth O ADJ
day O NOUN
sustain O NOUN
heat B-outcome NOUN
acclimation I-outcome NOUN
(HA) I-outcome PUNCT
adaptations O NOUN
25 O NUM
days O NOUN
after O ADP
initial O ADJ
HA. O NOUN

BACKGROUND: O NOUN
Occupational O ADJ
radiation O NOUN
exposureis O NOUN
a O DET
growing O VERB
problem O ADP
due O ADJ
to O PART
increasing O VERB
number O NOUN
and O CCONJ
complexity O NOUN
of O ADP
interventional O ADJ
procedures. O NOUN

CONCLUSION: O NOUN
CrCo-Ti O NOUN
rods O NOUN
have O VERB
the O DET
ability O NOUN
to O PART
produce O VERB
higher O ADJ
correction B-outcome NOUN
rates O NOUN
in O ADP
AIS O NOUN
compared O VERB
to O PART
Ti-Ti O NOUN
rod O NOUN
of O ADP
the O DET
same O ADJ
diameter. O NOUN

CONCLUSIONS: O NOUN
In O ADP
summary, O ADJ
the O DET
findings O NOUN
of O ADP
this O DET
study O NOUN
showed O VERB
that O ADP
NMES O NOUN
therapy O NOUN
may O VERB
not O ADV
benefit O NUM
patients O NOUN
with O ADP
CUR O NOUN
following O VERB
TBI. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Journal-Name:Zhongguo O NOUN
xiu O NOUN
fu O ADP
chong O ADJ
jian O NOUN
wai O CCONJ
ke O NOUN
za O ADP
zhi O NUM
= O SYM
Zhongguo O NOUN
xiufu O VERB
chongjian O NOUN
waike O ADP
zazhi O NOUN
= O SYM
Chinese O NOUN
journal O ADJ
of O ADP
reparative O ADJ
and O CCONJ
reconstructive O ADJ
surgery O NOUN

Fish O NOUN
and O CCONJ
seafood O NOUN
consumption O NOUN
and O CCONJ
omega-3 O NOUN
PUFA O NOUN
intake O NOUN
were O VERB
assessed O VERB
through O ADP
a O DET
validated O VERB
food-frequency O NOUN
questionnaire. O NOUN

Funded O VERB
by O ADP
the O DET
National O ADJ
Cancer O NOUN
Institute O NOUN
and O CCONJ
others; O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02066181 O NOUN
.). O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Patients O NOUN
receiving O VERB
dexmedetomidine O NOUN
vs O CCONJ
propofol O NOUN
had O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
delirium B-outcome NOUN
(17% O PUNCT
vs O CCONJ
21%; O NUM
difference, O NOUN
-4% O NUM
[95% O NOUN
CI, O NOUN
-18% O NOUN
to O PART
10%]; O ADJ
P O NOUN
= O SYM
.54; O PUNCT
HR, O NOUN
0.8 O NUM
[95% O NOUN
CI, O NOUN
0.4-1.9]). O NUM

Results: O NOUN
The O DET
PFOA O NOUN
group O NOUN
had O VERB
less O ADV
ankle O NOUN
dorsiflexion O NOUN
(odds O NOUN
ratio O NOUN
6.7, O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
2.46-18.2), O NUM
greater O ADJ
midfoot O NOUN
height O NOUN
mobility O NOUN
(5.2, O NOUN
1.78-15.14) O ADJ
and O CCONJ
width O NOUN
mobility O NOUN
(4.3, O NOUN
1.33-14.39, O NUM
and O CCONJ
greater O ADJ
foot O NOUN
mobility O NOUN
magnitude O NOUN
(8.4, O NOUN
2.32-30.69) O NOUN
than O ADP
controls. O NOUN

BACKGROUND: O NOUN
Implantation O NOUN
failure O NOUN
is O VERB
the O DET
main O ADJ
factor O NOUN
affecting O VERB
the O DET
success O NOUN
rate O NOUN
of O ADP
in O ADP
vitro O ADV
fertilization O NOUN
(IVF) O NOUN
procedures. O NOUN

A O DET
definitive O ADJ
trial O NOUN
is O VERB
warranted. O NOUN

This O DET
may O VERB
necessitate O NOUN
an O DET
alternative O ADJ
therapy O NOUN
for O ADP
this O DET
group O NOUN
of O ADP
patients. O NOUN

Title: O NOUN
Hybrid O NOUN
Minimally O ADV
Invasive O ADJ
Esophagectomy O NOUN
for O ADP
Esophageal O ADJ
Cancer. O ADV

The O DET
cumulative O ADJ
opioid B-outcome NOUN
dose I-outcome NOUN
administered O VERB
at O ADP
6, O NOUN
12, O NUM
24, O NUM
and O CCONJ
48 O NUM
h O NOUN
after O ADP
surgery O NOUN
were O VERB
recorded. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

CONCLUSIONS: O NOUN
Probing O VERB
combined O VERB
with O ADP
tobramycin/dexamethasone O NOUN
eye O NOUN
drops O NOUN
was O VERB
effective O ADJ
and O CCONJ
easy-to-perform B-outcome NOUN
in O ADP
the O DET
clinic, O NOUN
and O CCONJ
it O PRON
may O VERB
be O VERB
a O DET
better O ADJ
choice O NOUN
for O ADP
persistent O ADJ
CNLDO. O NOUN

Results: O NOUN
19 O NUM
patients O NOUN
were O VERB
randomly O ADV
distributed O VERB
in O ADP
57.89% O NOUN
in O ADP
the O DET
G2 O NOUN
and O CCONJ
42.11% O NOUN
in O ADP
the O DET
G1. O NOUN

The O DET
minimal O ADJ
clinically O ADV
important O ADJ
between O ADP
group O NOUN
difference O NOUN
in O ADP
mean O NOUN
Roland-Morris O NOUN
Disability B-outcome NOUN
Questionnaire O PROPN
(RMDQ) O NOUN
score O NOUN
was O VERB
predefined O VERB
as O ADP
4. O NUM

In O ADP
this O DET
post-hoc O NOUN
analysis, O NOUN
gender-based O VERB
baseline O NOUN
differences O NOUN
and O CCONJ
treatment O NOUN
outcomes O NOUN
between O ADP
indacaterol/glycopyrronium O NOUN
110/50 O NOUN
mug O NUM
once O ADP
daily O ADJ
(IND/GLY) O NOUN
and O CCONJ
salmeterol/fluticasone O NOUN
50/500 O NOUN
twice O ADV
daily O ADJ
(SFC) O PUNCT
were O VERB
assessed O VERB
in O ADP
terms O NOUN
of O ADP
rate O NOUN
of O ADP
exacerbations B-outcome NOUN
, O PUNCT
time-to-first B-outcome ADV
exacerbation I-outcome NOUN
, O PUNCT
lung B-outcome NOUN
function I-outcome NOUN
, O PUNCT
health B-outcome NOUN
status, O NOUN
and O CCONJ
rescue B-outcome NOUN
medication I-outcome NOUN
use I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
This O DET
post-hoc O NOUN
analysis O NOUN
included O VERB
2557 O NUM
men O NOUN
and O CCONJ
805 O NUM
women. O NOUN

There O PRON
was O VERB
significant O ADJ
pain B-outcome NOUN
relief I-outcome NOUN
in O ADP
the O DET
group O NOUN
receiving O VERB
Triamcinolone O NOUN
at O ADP
two O NUM
and O CCONJ
six O NUM
week O NOUN
but O CCONJ
not O ADV
in O ADP
twelve O NUM
weeks. O NOUN

However, O ADV
the O DET
higher O ADJ
number O NOUN
of O ADP
premature O ADJ
withdrawals B-outcome NOUN
in O ADP
the O DET
TENS O NOUN
group O NOUN
may O VERB
be O VERB
due O ADJ
to O PART
early O ADJ
withdrawal B-outcome NOUN
of O ADP
patients O NOUN
who O ADP
did O VERB
not O ADV
experience O NOUN
improvement O NOUN
of O ADP
their O ADJ
symptoms. O NOUN

The O DET
contribution O NOUN
of O ADP
MAT O NOUN
components O NOUN
and O CCONJ
of O ADP
ruminations' O NOUN
reduction O NOUN
to O PART
intervention O NOUN
efficacy O NOUN
were O VERB
examined. O NOUN

Title: O NOUN
The O DET
acute O ADJ
effects O NOUN
of O ADP
dietary O ADJ
carbohydrate O NOUN
reduction O NOUN
on O ADP
postprandial O ADJ
responses O NOUN
of O ADP
non-esterified B-outcome VERB
fatty I-outcome ADJ
acids I-outcome NOUN
and O CCONJ
triglycerides B-outcome NOUN
: O PUNCT
a O DET
randomized O VERB
trial. O NOUN

RESULTS: O NOUN
We O PRON
observed O VERB
a O DET
significant O ADJ
effect O NOUN
of O ADP
the O DET
treatment O NOUN
in O ADP
both O CCONJ
the O DET
physical B-outcome ADJ
and Seperator CCONJ
task X ADJ
subscales X NOUN
of X ADP
the X NOUN
global B-outcome ADJ
quality I-outcome NOUN
of I-outcome ADP
life E3-outcome NOUN
(GQoL) O NOUN
(P O NUM
= O SYM
.01 O NUM
and O CCONJ
P O NOUN
= O SYM
.04, O PUNCT
respectively) O NOUN
and O CCONJ
also O ADV
in O ADP
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
specific O ADJ
for O ADP
CD O NOUN
(P O NUM
</=.0001) O NOUN
but O CCONJ
not O ADV
in O ADP
pain B-outcome NOUN
score O NOUN
(P O NUM
= O SYM
.28). O PUNCT

Title: O NOUN
Bilateral O ADJ
versus O CCONJ
Single O NOUN
Internal-Thoracic-Artery O DET
Grafts O NOUN
at O ADP
10 O NUM
Years. O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study, O NOUN
Journal O ADJ
Article, O ADJ
Multicenter O NOUN
Study, O NOUN
Randomized O VERB
Controlled O VERB
Trial, O NOUN
Research O NOUN
Support, O NOUN
Non-U.S. O NOUN
Gov't, O NOUN

IRCT. O NOUN

Journal-Name:Nutrients O NOUN

Journal O ADJ
ID: O NOUN
8900488 O NUM

CLINICAL O ADJ
TRIAL O NOUN
REGISTRATION: O NOUN
Australian O ADJ
New O ADJ
Zealand O NOUN
Clinical O ADJ
Trials O NOUN
Registry O NOUN
(ANZCTR) O NOUN
registration O NOUN
number O NOUN
ACTRN12618000368235 O ADJ
. O PUNCT

METHODS: O NOUN
Forty-four O NUM
adults O NOUN
with O ADP
Diagnostic O ADJ
and O CCONJ
Statistical O ADJ
Manual O ADJ
of O ADP
Mental O ADJ
Disorders, O NOUN
Fifth O NOUN
Edition O NOUN
diagnosis O NOUN
of O ADP
ADHD O NOUN
participated O VERB
in O ADP
a O DET
randomized, O NOUN
double-blind, O NOUN
placebo-controlled, O NOUN
12-week O NOUN
trial O NOUN
of O ADP
15 O NUM
mg O NOUN
of O ADP
L-methylfolate O NOUN
in O ADP
combination O NOUN
with O ADP
osmotic-release O NOUN
oral O ADJ
system O NOUN
methylphenidate. O NOUN

The O DET
aim O ADP
of O ADP
this O DET
split-mouth, O NOUN
randomized O VERB
controlled O VERB
clinical O ADJ
trial O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
efficacy O NOUN
of O ADP
low-level O NOUN
laser O NOUN
therapy O NOUN
(LLLT) O PUNCT
and O CCONJ
photodynamic O ADJ
therapy O NOUN
(PDT) O NOUN
as O ADP
an O DET
adjunct O ADP
to O PART
scaling O VERB
and O CCONJ
root O NOUN
planing O VERB
(SRP) O NOUN
in O ADP
treatment O NOUN
of O ADP
chronic O ADJ
periodontitis. O NOUN

CONCLUSION: O NOUN
The O DET
results O NOUN
of O ADP
the O DET
present O ADJ
study O NOUN
and O CCONJ
other O ADJ
experimental O ADJ
and O CCONJ
clinical O ADJ
trials O NOUN
confirmed O VERB
that O ADP
the O DET
administration O NOUN
of O ADP
the O DET
scorpion O NOUN
antivenom O NOUN
by O ADP
intravenous O ADJ
route O NOUN
has O VERB
a O DET
lower O ADJ
incidence O NOUN
of O ADP
systemic O ADJ
toxicity B-outcome NOUN
, O PUNCT
a O DET
better O ADJ
outcome O NOUN
of O ADP
fatal B-outcome ADJ
complication O NOUN
resulted O VERB
from O ADP
envenomation O NOUN
especially O ADV
cardiogenic B-outcome ADJ
shock I-outcome NOUN
, O PUNCT
decreased O VERB
need B-outcome NOUN
for Seperator ADP
ICU I-outcome NOUN
facilities O NOUN
and O CCONJ
mechanical B-outcome ADJ
ventilation I-outcome NOUN
, O PUNCT
shorter O ADJ
hospital B-outcome NOUN
stay I-outcome NOUN
, O PUNCT
and O CCONJ
better O ADJ
overall O ADJ
outcome O NOUN
than O ADP
the O DET
intramuscular O ADJ
route. O NOUN

Exclusion O NOUN
criteria O NOUN
were O VERB
presence O NOUN
of O ADP
a O DET
severe O ADJ
congenital O ADJ
anomaly, O NOUN
anticipated O VERB
enteral O ADJ
fasting O VERB
for O ADP
longer O ADJ
than O ADP
14 O NUM
days, O NOUN
or O CCONJ
no O DET
realistic O ADJ
prospect O VERB
of O ADP
survival. O NOUN

kg(-1).h(-1) O NOUN
for O ADP
patients O NOUN
in O ADP
group O NOUN
D. O NOUN
The O DET
operation B-outcome NOUN
time I-outcome NOUN
, O PUNCT
liquid B-outcome ADV
input I-outcome NOUN
and Seperator CCONJ
output S1-outcome NOUN
during O ADP
operation, O NOUN
the O DET
number O NOUN
of O ADP
patient O NOUN
controlled O VERB
analgesia B-outcome NOUN
(PCA) O PUNCT
pressings O NOUN
after O ADP
operation O NOUN
were O VERB
recorded. O NOUN

For O ADP
normal O ADJ
breathing, O NOUN
the O DET
adequate O ADJ
protection B-outcome NOUN
rates O NOUN
before O ADP
and O CCONJ
after O ADP
training O VERB
were O VERB
62 O NUM
(0-100) O NUM
vs O CCONJ
100 O NUM
(90-100) O NOUN
for O ADP
cup-type, O NOUN
100 O NUM
(0-100) O NUM
vs O CCONJ
100 O NUM
(100-100) O NOUN
for O ADP
fold-type, O NOUN
and O CCONJ
19 O NUM
(0-100) O NUM
vs O CCONJ
100 O NUM
(44-100) O NOUN
for O ADP
valve-type O NOUN
(all O PUNCT
P O NOUN
< O SYM
.05). O NUM

Both O CCONJ
groups O NOUN
participated O VERB
in O ADP
the O DET
follow-up O NOUN
of O ADP
three O NUM
months. O NOUN

The O DET
objective O ADP
responses B-outcome NOUN
are O VERB
ongoing. O NOUN

BACKGROUND: O NOUN
A O DET
lumbar O ADJ
herniated O VERB
intervertebral O ADJ
disc O NOUN
(LHIVD) O PUNCT
is O VERB
a O DET
common O ADJ
problem O ADP
that O ADP
usually O ADV
causes O NOUN
low O ADJ
back O ADP
pain O NOUN
and O CCONJ
radiating O VERB
pain. O NOUN

Regression O NOUN
analyses O NOUN
were O VERB
conducted O VERB
to O PART
test O NOUN
for O ADP
differences O NOUN
by O ADP
sponsorship O NOUN
condition O NOUN
on O ADP
the O DET
respective O ADJ
outcome O NOUN
measures. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

No O DET
changes O NOUN
in O ADP
insulin B-outcome NOUN
or O CCONJ
triglycerides B-outcome NOUN
were O VERB
observed O VERB
during O ADP
the O DET
ingestion O NOUN
period. O NOUN

METHODS: O NOUN
(1) O PUNCT
Clinical O ADJ
research: O NOUN
the O DET
patients O NOUN
needed O VERB
sedative O NOUN
undergoing O VERB
mechanical O ADJ
ventilation O NOUN
admitted O VERB
to O PART
intensive O ADJ
care O NOUN
unit O NOUN
(ICU) O PUNCT
of O ADP
Qingdao O NOUN
Municipal O ADJ
Hospital O NOUN
from O ADP
January O NOUN
2016 O NUM
to O PART
January O NOUN
2018 O NUM
were O VERB
enrolled. O NOUN

No O DET
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
were O VERB
reported. O NOUN

Objective: O NOUN
To O PART
assess O NOUN
the O DET
effect O NOUN
of O ADP
a O DET
nutritional O ADJ
and O CCONJ
physical O ADJ
activity O NOUN
education O NOUN
program O NOUN
on O ADP
dietary B-outcome ADJ
quality I-outcome NOUN
. O PUNCT
Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Preliminary O ADJ
exploratory O ADJ
interim O ADJ
analysis O NOUN
of O ADP
an O DET
ongoing O VERB
randomized O VERB
trial. O NOUN

The O DET
trial O NOUN
was O VERB
stopped O VERB
early O ADJ
for O ADP
benefit O NUM
on O ADP
its O ADJ
primary O ADJ
outcome O NOUN
(a O PUNCT
composite O NOUN
of O ADP
cardiovascular B-outcome ADJ
events) O NOUN
and O CCONJ
all-cause B-outcome NOUN
mortality I-outcome NOUN
on O ADP
August O NOUN
20, O NUM
2015. O NUM

Title: O NOUN
A O DET
Feasibility O NOUN
RCT O NOUN
Evaluating O VERB
a O DET
Play-Informed, O NOUN
Caregiver-Implemented, O NOUN
Home-Based O VERB
Intervention O NOUN
to O PART
Improve O NOUN
the O DET
Play B-outcome NOUN
of O ADP
Children O NOUN
Who O ADP
Are O VERB
HIV O NOUN
Positive. O NOUN

Meal O ADJ
replacements O NOUN
(MRs) O NOUN
are O VERB
portion- O NOUN
and O CCONJ
calorie-controlled O VERB
meals, O ADJ
which O ADP
make O VERB
the O DET
food O NOUN
environment O NOUN
part O NOUN
of O ADP
an O DET
individual's O NOUN
weight O NOUN
loss O NOUN
regimen. O NOUN

After O ADP
consumption, O NOUN
participants O NOUN
were O VERB
monitored O VERB
throughout O ADV
a O DET
45-min O NOUN
ingestion O NOUN
period, O NOUN
then O ADV
completed O VERB
a O DET
repeated O VERB
Wingate O NOUN
protocol, O NOUN
and O CCONJ
were O VERB
then O ADV
monitored O VERB
throughout O ADV
a O DET
45-min O NOUN
recovery O NOUN
period. O NOUN

Publication O NOUN
date: O NOUN
2018/12/24 O NUM
06:00 O ADP
[pubmed] O PUNCT

BACKGROUND: O NOUN
In O ADP
this O DET
randomized, O NOUN
double-blind, O NOUN
parallel-group O NOUN
trial, O NOUN
we O PRON
aimed O VERB
to O PART
explore O ADP
the O DET
effectiveness O NOUN
of O ADP
trigger O ADP
point O NOUN
dry O ADJ
needling O VERB
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
tension-type O NOUN
headache O NOUN
in O ADP
reducing O VERB
headache B-outcome NOUN
frequency, I-outcome NOUN
intensity I-outcome NOUN
and Seperator CCONJ
duration S1-outcome NOUN
, O PUNCT
and O CCONJ
improvement O NOUN
of O ADP
health-related B-outcome VERB
quality I-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
. O PUNCT
METHODS: O NOUN
The O DET
168 O NUM
patients O NOUN
in O ADP
2 O NUM
neurology O NOUN
clinics O NOUN
with O ADP
chronic O ADJ
tension-type O NOUN
headache. O NOUN

Journal-Name:Medicine O NOUN

Title: O NOUN
The O DET
efficacy O NOUN
of O ADP
cervical O ADJ
spine O NOUN
phantoms O NOUN
for O ADP
improving O VERB
resident O ADJ
proficiency B-outcome NOUN
in O ADP
performing O VERB
ultrasound-guided O VERB
cervical O ADJ
medial O ADJ
branch O NOUN
block: O NOUN
A O DET
prospective, O NOUN
randomized, O NOUN
comparative O ADJ
study. O NOUN

Hence O ADV
this O DET
operative O ADJ
procedure O NOUN
is O VERB
worthy O NOUN
of O ADP
popularization. O ADV

Funded O VERB
by O ADP
Paratek O NOUN
Pharmaceuticals; O NOUN
OPTIC O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02531438 O NOUN
.). O NOUN

Precooling, O NOUN
exertional O ADJ
heatstroke O NOUN
risk O NOUN
factors, O NOUN
and O CCONJ
postexercise O NOUN
cooling O VERB
rates. O NOUN

The O DET
primary O ADJ
outcome O NOUN
of O ADP
the O DET
study O NOUN
will O VERB
be O VERB
the O DET
difference O NOUN
in O ADP
cure B-outcome NOUN
rate O NOUN
of O ADP
intense O ADJ
versus O CCONJ
standard O ADJ
treatment O NOUN
with O ADP
PZQ O NOUN
on O ADP
individuals O NOUN
with O ADP
a O DET
confirmed O VERB
S.mansoni O NOUN
infection O NOUN
measured O VERB
by O ADP
KK. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Australian O ADJ
New O ADJ
Zealand O NOUN
Clinical O ADJ
Trial O NOUN
Registry; O NOUN
ACTRN12617000249358 O ADP
; O PUNCT
Date O NOUN
registered: O NOUN
17/02/2017. O NOUN

METHOD: O NOUN
A O DET
prospective O ADJ
randomised, O NOUN
single O ADJ
centre O NOUN
parallel O ADJ
group O NOUN
trial O NOUN
comparing O VERB
an O DET
8-week O NOUN
individualised O VERB
multidisciplinary O ADJ
intervention O NOUN
programme O NOUN
(bespoke O PUNCT
physiotherapy O NOUN
and O CCONJ
occupational O ADJ
therapy O NOUN
in O ADP
the O DET
clinical, O ADJ
home O NOUN
and O CCONJ
school O NOUN
environment) O NOUN
with O ADP
current O ADJ
standard O ADJ
management O NOUN
(advice, O NOUN
information O NOUN
and O CCONJ
therapy O NOUN
referral O ADJ
if O ADP
deemed O VERB
necessary). O NOUN

87.3 O NUM
+/- O SYM
7.7 O NUM
kg) O NOUN
with O ADP
at O ADP
least O ADV
2 O NUM
years O NOUN
of O ADP
experience O NOUN
in O ADP
resistance O NOUN
training. O NOUN

The O DET
area O NOUN
of O ADP
images O NOUN
that O ADP
give O ADJ
confidence O NOUN
for O ADP
sinus O NOUN
surgery O NOUN
at O ADP
one O NUM
time O NOUN
was O VERB
higher O ADJ
for O ADP
standard-dose O NOUN
MDCT O NOUN
protocol O NOUN
technique O NOUN
than O ADP
low-dose O NOUN
MDCT O NOUN
protocol O NOUN
method. O NOUN

RESULTS: O NOUN
The O DET
levels O NOUN
of O ADP
APN O NOUN
and O CCONJ
AdipoR1 O VERB
were O VERB
significantly O ADV
decreased O VERB
in O ADP
T2DM O NOUN
group O NOUN
and O CCONJ
T2DM O NOUN
+ O SYM
MVC O NOUN
group O NOUN
compared O VERB
with O ADP
NC O NOUN
group, O NOUN
with O ADP
the O DET
lowest O ADV
value O NOUN
in O ADP
T2DM O NOUN
+ O SYM
MVC O NOUN
group O NOUN
(all O PUNCT
P<0.01). O NOUN

Objective: O NOUN
To O PART
investigate O NOUN
the O DET
clinical O ADJ
effect O NOUN
of O ADP
nursing O VERB
intervention O NOUN
for O ADP
respiratory O ADJ
function O NOUN
exercise O NOUN
in O ADP
patients O NOUN
with O ADP
silicosis O NOUN
complicated O VERB
by O ADP
stable O ADJ
chronic O ADJ
obstructive O ADJ
pulmonary O ADJ
disease O NOUN
(COPD) O NUM
. O PUNCT

J. O NOUN
Radiol. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
Efficacy O NOUN
of O ADP
antibiotic O ADJ
treatment O NOUN
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain O NOUN
and O CCONJ
Modic O NOUN
changes O NOUN
(the O NOUN
AIM O NOUN
study): O NUM
double O ADV
blind, O NOUN
randomised, O NOUN
placebo O NOUN
controlled, O NOUN
multicentre O NOUN
trial. O NOUN

PURPOSE: O NOUN
This O DET
report O NOUN
assesses O NOUN
functional B-outcome ADJ
mobility I-outcome NOUN
in O ADP
children O NOUN
with O ADP
neurological O ADJ
impairments O NOUN
and O CCONJ
documented O VERB
gross O ADJ
motor O NOUN
delays, O NOUN
before O ADP
and O CCONJ
after O ADP
receiving O VERB
either O CCONJ
hippotherapy O NOUN
or O CCONJ
standard O ADJ
outpatient O ADJ
physical O ADJ
therapy O NOUN
(PT). O NUM

Weaknesses O NOUN
in O ADP
the O DET
CHW O NOUN
intervention O NOUN
severely O ADV
limited O VERB
the O DET
extent O NOUN
to O PART
which O ADP
the O DET
PCBHIS O NOUN
could O VERB
be O VERB
used O VERB
to O PART
observe O NOUN
trends O NOUN
in O ADP
mortality O NOUN
and O CCONJ
morbidity. O NOUN

Villages O NOUN
will O VERB
be O VERB
grouped O VERB
into O ADP
blocks, O NOUN
with O ADP
blocks O NOUN
transitioned O VERB
monthly O ADV
from O ADP
control O NOUN
(no O PUNCT
repellent) O NOUN
to O PART
intervention O NOUN
states O NOUN
(to O PUNCT
receive O VERB
repellent) O NOUN
across O ADP
14 O NUM
monthly O ADV
intervals O NOUN
in O ADP
random O NOUN
order). O NOUN

CONCLUSIONS: O NOUN
Phacoemulsification O NOUN
in O ADP
eyes O NOUN
with O ADP
mild-to-moderate O ADJ
primary O ADJ
open-angle O NOUN
glaucoma O NOUN
results O NOUN
in O ADP
early O ADJ
endothelial B-outcome ADJ
cell I-outcome NOUN
loss O NOUN
(ECL), O NUM
with O ADP
Endothelial B-outcome ADJ
Cell I-outcome NOUN
Density I-outcome NOUN
(ECD) I-outcome NOUN
stabilizing O VERB
after O ADP
3 O NUM
months O NOUN
and O CCONJ
no O DET
effect O NOUN
on O ADP
other O ADJ
endothelial B-outcome ADJ
stress I-outcome NOUN
markers O NOUN
up O ADP
to O PART
2 O NUM
years O NOUN
postoperatively. O NOUN

METHODS: O NOUN
Ninety O NOUN
patients O NOUN
with O ADP
ASA O NOUN
I O NUM
or O CCONJ
II, O NOUN
who O ADP
underwent O VERB
cesarean O NOUN
section, O NOUN
were O VERB
randomized O VERB
into O ADP
2 O NUM
groups: O NOUN
group O NOUN
D O NOUN
(bupivacaine O NUM
+ O SYM
5 O NUM
mug O NUM
Dex) O NOUN
and O CCONJ
group O NOUN
C O NOUN
(bupivacaine O NUM
+ O SYM
the O DET
same O ADJ
volume O NOUN
of O ADP
saline). O ADJ

The O DET
6-month O NOUN
values O NOUN
of O ADP
the O DET
resin O NOUN
infiltration O NOUN
group O NOUN
were O VERB
statistically O ADV
lower O ADJ
than O ADP
those O DET
of O ADP
the O DET
fluoride O NOUN
varnish O NOUN
group O NOUN
(P O NUM
= O SYM
0.028, O NUM
P O NOUN
< O SYM
0.05). O NOUN

Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Randomized, O NOUN
blinded, O NOUN
placebo-controlled, O NOUN
4-group O NOUN
trial O NOUN
in O ADP
6 O NUM
Danish O NOUN
hospitals O NOUN
with O ADP
90-day O NOUN
follow-up O NOUN
that O ADP
included O VERB
556 O NUM
patients O NOUN
undergoing O VERB
total O ADJ
hip O NOUN
arthroplasty O NOUN
(THA) O NUM
from O ADP
December O NOUN
2015 O NUM
to O PART
October O ADJ
2017. O NUM

BACKGROUND: O NOUN
We O PRON
evaluated O VERB
the O DET
effectiveness O NOUN
and O CCONJ
cost-effectiveness O NOUN
of O ADP
a O DET
loyalty O NOUN
scheme O NOUN
based O VERB
intervention O NOUN
involving O VERB
rewards O NOUN
for O ADP
increasing O VERB
physical B-outcome ADJ
activity I-outcome NOUN
in O ADP
public O ADJ
sector O NOUN
employees. O NUM

Change O NOUN
in O ADP
serum O NOUN
hydroxymethylglutaryl-CoA B-outcome NOUN
reductase I-outcome NOUN
enzyme I-outcome NOUN
(HMGCR) I-outcome PUNCT
levels O NOUN
correlated O VERB
more O ADV
with O ADP
change O NOUN
in O ADP
lipid B-outcome NOUN
indices O NOUN
of O ADP
DR O NOUN
group. O VERB

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

RESULTS: O NOUN
The O DET
combination O NOUN
of O ADP
data O NOUN
sources O NOUN
revealed O VERB
four O NUM
themes O NOUN
and O CCONJ
16 O NUM
sub-themes. O NOUN

This O DET
study O NOUN
was O VERB
done O NOUN
with O ADP
the O DET
goal O NOUN
of O ADP
comparing O VERB
the O DET
effect O NOUN
of O ADP
Ginger O NOUN
and O CCONJ
Novafen O NOUN
on O ADP
the O DET
menstrual B-outcome ADJ
pain I-outcome NOUN
. O PUNCT
MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
This O DET
crossover O NOUN
clinical O ADJ
trial O NOUN
study O NOUN
was O VERB
done O NOUN
in O ADP
Iran O NOUN
on O ADP
168 O NUM
single O ADJ
girl O NOUN
students O NOUN
18-26 O NUM
years O NOUN
old O ADJ
in O ADP
Babol O NOUN
University O NOUN
of O ADP
Medical O ADJ
Sciences O NOUN
with O ADP
primary O ADJ
menstrual O ADJ
pain. O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
incidence O NOUN
of O ADP
postoperative O ADJ
in-hospital O NOUN
delirium B-outcome NOUN
by O ADP
the O DET
Confusion O NOUN
Assessment O NOUN
Method. O NOUN

PMID: O NOUN
31618539 O NUM

The O DET
exercise O NOUN
protocol O NOUN
promoted O VERB
slight O NOUN
muscle B-outcome NOUN
damage I-outcome NOUN
, O PUNCT
reflected O VERB
in O ADP
significant O ADJ
increases O NOUN
in O ADP
total O ADJ
creatine B-outcome NOUN
kinase I-outcome NOUN
in O ADP
all O DET
subjects O NOUN
after O ADP
exercise. O NOUN

Journal-Name:American O NOUN
journal O ADJ
of O ADP
orthodontics O NOUN
and O CCONJ
dentofacial O ADJ
orthopedics O NOUN
: O PUNCT
official O ADJ
publication O NOUN
of O ADP
the O DET
American O ADJ
Association O NOUN
of O ADP
Orthodontists, O NOUN
its O ADJ
constituent O ADP
societies, O NOUN
and O CCONJ
the O DET
American O ADJ
Board O NOUN
of O ADP
Orthodontics O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

RESULTS: O NOUN
Of O ADP
the O DET
68 O NUM
Veterans O NOUN
who O ADP
were O VERB
self- O NOUN
or O CCONJ
provider-referred O VERB
to O PART
the O DET
program, O NOUN
25 O NUM
(36.7%) O NUM
were O VERB
ineligible O ADJ
due O ADJ
to O PART
(i) O PUNCT
absence O NOUN
of O ADP
a O DET
PTSD O NOUN
diagnosis O NOUN
(n O NOUN
= O SYM
3); O NOUN
participation O NOUN
in O ADP
ongoing O VERB
intense O ADJ
psychotherapy O NOUN
(n O NOUN
= O SYM
4) O NOUN
or O CCONJ
inpatient O NOUN
substance O NOUN
abuse O NOUN
program O NOUN
(n O NOUN
= O SYM
2); O NUM
current O ADJ
resident O ADJ
of O ADP
the O DET
Domiciliary O ADJ
(n O NOUN
= O SYM
8) O ADV
and O CCONJ
inability O NOUN
to O PART
participate O NOUN
due O ADJ
to O PART
distance O NOUN
of O ADP
residence O NOUN
from O ADP
the O DET
VA O NOUN
(n O NOUN
= O SYM
8). O NOUN

In O ADP
IHE O NOUN
only, O NOUN
post-exercise O NOUN
Tre B-outcome PUNCT
and O CCONJ
perceptual B-outcome ADJ
responses I-outcome NOUN
at O ADP
Post O ADV
HA O NOUN
and O CCONJ
+25d O NOUN
were O VERB
lower O ADJ
than O ADP
Pre O NOUN
HA O NOUN
(p</=0.01). O NUM

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

CONCLUSIONS: O NOUN
Physical B-outcome ADJ
and O CCONJ
psychological B-outcome ADJ
statuses O NOUN
of O ADP
elderly O NOUN
housebound O VERB
were O VERB
significantly O ADV
improved O VERB
by O ADP
Baduanjin O NOUN
training O VERB
combined O VERB
with O ADP
CBT. O NOUN

In O ADP
part O NOUN
B, O NOUN
patients O NOUN
without O ADP
recent O ADJ
attacks O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
once-monthly O ADV
injections O NOUN
of O ADP
one O NUM
of O ADP
two O NUM
doses O NOUN
of O ADP
givosiran O NOUN
(0.35 O PUNCT
or O CCONJ
1.0 O NUM
mg O NOUN
per O ADP
kilogram) O NOUN
or O CCONJ
placebo O NOUN
(total O ADJ
of O ADP
two O NUM
injections O NOUN
28 O NUM
days O NOUN
apart). O NOUN

In O ADP
group O NOUN
A O DET
simultaneous O ADJ
MMC O NOUN
repair O NOUN
and O CCONJ
VP O NOUN
shunting O VERB
was O VERB
performed O VERB
while O ADP
in O ADP
group O NOUN
B O NOUN
MMC O NOUN
repair O NOUN
was O VERB
done O NOUN
in O ADP
first O ADV
and O CCONJ
VP O NOUN
shunting O VERB
was O VERB
done O NOUN
two O NUM
weeks O NOUN
postoperatively.. O NOUN
RESULTS: O NOUN
In O ADP
this O DET
study O NOUN
mean O NOUN
age O NOUN
in O ADP
Group O NOUN
A O DET
was O VERB
1 O NUM
years O NOUN
with O ADP
SD+/-2.77 O ADP
while O ADP
mean O NOUN
age O NOUN
in O ADP
Group O NOUN
B O NOUN
was O VERB
1 O NUM
years O NOUN
with O ADP
SD+/-3.12. O NOUN

Objective: O NOUN
To O PART
evaluate O VERB
the O DET
effectiveness O NOUN
of O ADP
SuperPATH O NOUN
approach O NOUN
in O ADP
total O ADJ
hip O NOUN
arthroplasty O NOUN
(THA) O NUM
compared O VERB
with O ADP
conventional O ADJ
posterolateral O ADJ
approach. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

RESULTS: O NOUN
In O ADP
the O DET
LASIK O NOUN
group, O NOUN
central B-outcome ADJ
epithelial I-outcome ADJ
thickness I-outcome NOUN
increased O VERB
from O ADP
52.38 O NUM
+/- O SYM
2.57 O NUM
mum O NOUN
to O PART
57.00 O NUM
+/- O SYM
4.23 O NUM
mum O NOUN
and O CCONJ
remained O VERB
almost O ADV
stable O ADJ
at O ADP
this O DET
level O NOUN
for O ADP
up O ADP
to O PART
24 O NUM
months. O NOUN

Additionally, O NOUN
both O CCONJ
groups O NOUN
will O VERB
receive O VERB
the O DET
same O ADJ
acupuncture O NOUN
treatment O NOUN
once O ADP
a O DET
week O NOUN
for O ADP
6 O NUM
weeks O NOUN
as O ADP
a O DET
concurrent O ADJ
treatment. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrials.gov, O NOUN
NCT01465698 O NOUN
November O NOUN
7, O NUM
2011 O NUM
(prospective). O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
brief O ADJ
group O NOUN
intervention O NOUN
in O ADP
the O DET
harmful O ADJ
alcohol O NOUN
use O NOUN
in O ADP
primary O ADJ
health O NOUN
care. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
7909660 O NUM

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[entrez] O ADP

Hybrid O NOUN
surgery O NOUN
comprised O VERB
a O DET
two-field O NOUN
abdominal-thoracic O ADJ
operation O NOUN
(also O ADV
called O VERB
an O DET
Ivor-Lewis O NOUN
procedure) O NOUN
with O ADP
laparoscopic O ADJ
gastric O ADJ
mobilization O NOUN
and O CCONJ
open O ADJ
right O ADJ
thoracotomy. O NOUN

Conclusion: O NOUN
Nursing O VERB
intervention O NOUN
can O VERB
effectively O ADV
improve O VERB
forced B-outcome VERB
expiratory I-outcome ADJ
volume I-outcome NOUN
in Seperator ADP
1 I-outcome NUM
second I-outcome ADJ
(FEV(1) I-outcome PUNCT
, O PUNCT
forced B-outcome VERB
vital I-outcome ADJ
capacity I-outcome NOUN
(FVC) I-outcome PUNCT
, O PUNCT
arterial B-outcome ADJ
partial I-outcome ADJ
pressure I-outcome NOUN
of I-outcome ADP
oxygen I-outcome NOUN
(PaO(2) I-outcome PUNCT
, O PUNCT
and O CCONJ
6-minute O NOUN
walking B-outcome VERB
distance I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
silicosis O NOUN
complicated O VERB
by O ADP
stable O ADJ
COPD. O NOUN

High O ADJ
ECOG O NOUN
scores, O NOUN
cancer O NOUN
localization O NOUN
to O PART
the O DET
right O ADJ
side O NOUN
of O ADP
colon O NOUN
and O CCONJ
lymph O NOUN
node O NOUN
metastasis O NOUN
were O VERB
associated O VERB
with O ADP
increased O VERB
risk O NOUN
of O ADP
death B-outcome NOUN
and O CCONJ
all O DET
remained O VERB
independent O ADJ
factors O NOUN
affecting O VERB
overall B-outcome ADJ
survival I-outcome NOUN
. O PUNCT
The O DET
most O DET
common O ADJ
grade O NOUN
3/4 O PUNCT
treatment-related O VERB
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
hypertension B-outcome NOUN
and O CCONJ
hand-foot B-outcome NOUN
skin I-outcome NOUN
syndrome I-outcome NOUN
. O PUNCT
Apatinib O ADP
treatment O NOUN
for O ADP
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
who O ADP
had O VERB
failed O VERB
chemotherapy O NOUN
achieved O NOUN
better O ADJ
disease B-outcome NOUN
control I-outcome NOUN
and O CCONJ
prolonged O VERB
progression-free B-outcome ADJ
survival I-outcome NOUN
relative O ADJ
to O PART
untreated O VERB
controls. O NOUN

Music O ADJ
therapy O NOUN
is O VERB
used O VERB
as O ADP
a O DET
nonpharmacologic O ADJ
intervention O NOUN
for O ADP
pain O NOUN
management O NOUN
and O CCONJ
to O PART
promote O VERB
rehabilitation O NOUN
exercise O NOUN
adherence. O NOUN

Title: O NOUN
Three-Year O ADP
Prospective O ADJ
Randomized O VERB
Comparative O ADJ
Assessment O NOUN
of O ADP
Anterior O ADJ
Maxillary O ADJ
Single O NOUN
Implants O NOUN
with O ADP
Different O ADJ
Abutment O NOUN
Interfaces. O NOUN

Advances O NOUN
in O ADP
knowledge: O NOUN
Our O ADJ
work O NOUN
is O VERB
relevant O ADJ
for O ADP
MRI O NOUN
sequence O NOUN
choice O NOUN
and O CCONJ
development O NOUN
of O ADP
the O DET
roles O NOUN
of O ADP
the O DET
interprofessional O ADJ
team O NOUN
in O ADP
the O DET
advancement O ADJ
of O ADP
MRI-guided O VERB
radiotherapy. O NOUN

METHODS: O NOUN
Patients O NOUN
who O ADP
started O VERB
riociguat O NOUN
treatment O NOUN
(1.0-2.5 O NOUN
mg O NOUN
tid) O NOUN
within O ADP
the O DET
trials O NOUN
phase O NOUN
II, O NOUN
PATENT, O NOUN
PATENTplus, O NOUN
EAS, O NOUN
CHEST O NOUN
and O CCONJ
continued O NOUN
treatment O NOUN
for O ADP
3-12 O NUM
months O NOUN
were O VERB
included O VERB
in O ADP
this O DET
study. O NOUN

Title: O NOUN
A O DET
Randomized O VERB
Trial O NOUN
of O ADP
Endometrial O ADJ
Scratching O VERB
before O ADP
In O ADP
Vitro O ADV
Fertilization. O NOUN

RESULTS: O NOUN
Compared O VERB
to O PART
the O DET
control O NOUN
condition, O NOUN
unhealthy O NOUN
food O NOUN
sponsorship O NOUN
promoted O VERB
higher O ADJ
awareness B-outcome ADV
of, O NOUN
and O CCONJ
more O ADV
favourable O ADJ
attitudes B-outcome NOUN
towards, O NOUN
unhealthy O NOUN
food O NOUN
sponsor O ADP
brands. O NOUN

PURPOSE: O NOUN
The O DET
goal O NOUN
of O ADP
this O DET
investigation O NOUN
was O VERB
to O PART
define O NOUN
time-dependent O ADJ
peri-implant B-outcome ADJ
tissue I-outcome NOUN
changes O NOUN
at O ADP
implants O NOUN
with O ADP
different O ADJ
abutment O NOUN
interface O NOUN
designs. O VERB

Title: O NOUN
Changes O NOUN
in O ADP
Unilateral O ADJ
Upper B-outcome NOUN
Limb I-outcome NOUN
Muscular I-outcome ADJ
Strength I-outcome NOUN
and O CCONJ
Electromyographic B-outcome ADJ
Activity O NOUN
After O ADP
a O DET
16-Week O NOUN
Strength O NOUN
Training O VERB
Intervention O NOUN
in O ADP
Survivors O NOUN
of O ADP
Breast O NOUN
Cancer. O ADV

CONCLUSIONS: O NOUN
In O ADP
summary, O ADJ
we O PRON
demonstrated O VERB
that O ADP
10 O NUM
weeks O NOUN
of O ADP
NMES O NOUN
therapy O NOUN
was O VERB
efficacious O ADJ
in O ADP
patients O NOUN
with O ADP
UIAS. O NOUN

Importance: O NOUN
Intraoperative O ADJ
electroencephalogram O NOUN
(EEG) O PUNCT
waveform O NOUN
suppression, O NOUN
often O ADV
suggesting O VERB
excessive O ADJ
general O ADJ
anesthesia, O NOUN
has O VERB
been O VERB
associated O VERB
with O ADP
postoperative O ADJ
delirium. O NOUN

Journal O ADJ
ID: O NOUN
101599229 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
research O NOUN
sample O NOUN
includes O NOUN
3489 O NUM
girls, O ADJ
with O ADP
about O ADV
25 O NUM
girls O NOUN
per O ADP
school O NOUN
on O ADP
average. O ADJ

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Intra-abdominal B-outcome ADJ
fat I-outcome NOUN
loss O NOUN
was O VERB
not O ADV
significantly O ADV
larger O ADJ
in O ADP
the O DET
exercise O NOUN
plus O CCONJ
diet O NOUN
group O NOUN
(- O NOUN
3.8 O NUM
cm(2), O ADV
95%CI O NOUN
-9.0; O PUNCT
1.3). O NUM

At O ADP
D29, O NOUN
intention-to-treat O NOUN
efficacy O NOUN
in O ADP
the O DET
AmBisome O NOUN
arm O NOUN
was O VERB
70% O NUM
(95% O PUNCT
CI O NOUN
45-87%) O NUM
in O ADP
the O DET
unadjusted O VERB
analysis, O NOUN
and O CCONJ
50% O NUM
(95% O PUNCT
CI O NOUN
27-73%) O NUM
in O ADP
the O DET
adjusted O VERB
analysis, O NOUN
while O ADP
in O ADP
the O DET
combination O NOUN
arm, O ADJ
it O PRON
was O VERB
81% O NUM
(95% O PUNCT
CI O NOUN
67-90%) O ADP
and O CCONJ
67% O ADJ
(95% O PUNCT
CI O NOUN
48-82%) O PUNCT
respectively. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Title: O NOUN
Caplacizumab O NOUN
Treatment O NOUN
for O ADP
Acquired O VERB
Thrombotic O ADJ
Thrombocytopenic O ADJ
Purpura. O NOUN

The O DET
SPT-SMV O NOUN
experimental O ADJ
group O NOUN
received O VERB
SMV O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
each O DET
SPT O NOUN
session. O NOUN

We O PRON
evaluated O VERB
the O DET
use O NOUN
of O ADP
bilateral O ADJ
internal-thoracic-artery O ADV
grafts O NOUN
for O ADP
CABG. O NOUN

In O ADP
experimental O ADJ
group, O NOUN
patients O NOUN
received O VERB
delayed-start O NOUN
GnRH O NOUN
antagonist O NOUN
protocol O NOUN
with O ADP
estrogen O NOUN
priming O VERB
followed O VERB
by O ADP
early O ADJ
follicular-phase O NOUN
GnRH O NOUN
antagonist O NOUN
treatment O NOUN
for O ADP
7 O NUM
days O NOUN
before O ADP
ovarian O ADJ
stimulation O NOUN
with O ADP
gonadotropin O NOUN
and O CCONJ
in O ADP
control O NOUN
group, O NOUN
patients O NOUN
treated O VERB
with O ADP
estrogen O NOUN
priming O VERB
antagonist O NOUN
protocol. O NOUN

SETTING: O NOUN
University O NOUN
laboratory O NOUN
setting. O NOUN

METHODS: O NOUN
This O DET
randomized O VERB
crossover O NOUN
study O NOUN
evaluated O VERB
23 O NUM
healthcare O NOUN
providers. O ADP

Publication O NOUN
date: O NOUN
2018/10/28 O NOUN
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[pubmed] O PUNCT

BACKGROUND: O NOUN
Guidelines O NOUN
recommend O NOUN
macrolides O NOUN
and O CCONJ
fluoroquinolones O NOUN
in O ADP
patients O NOUN
hospitalized O VERB
with O ADP
community-acquired O VERB
pneumonia O NOUN
(CAP), O PUNCT
but O CCONJ
their O ADJ
use O NOUN
has O VERB
been O VERB
associated O VERB
with O ADP
cardiac O ADJ
events. O NOUN

SAI O NOUN
were O VERB
classified O VERB
as O ADP
lacunar O NOUN
infarction O NOUN
and O CCONJ
non-lacunar O NOUN
infarction. O NOUN

Title: O NOUN
Efficacy O NOUN
of O ADP
an O DET
ocular O ADJ
bandage O NOUN
contact O NOUN
lens O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
dry O ADJ
eye O NOUN
after O ADP
phacoemulsification. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

Use O PUNCT
of O ADP
hyaluronan-based O VERB
sperm O NOUN
selection O NOUN
for O ADP
ICSI O NOUN
(so-called O VERB
physiological O ADJ
ICSI O NOUN
[PICSI]) O NOUN
is O VERB
reported O VERB
to O PART
reduce O VERB
the O DET
proportion O NOUN
of O ADP
pregnancies O NOUN
that O ADP
end O NOUN
in O ADP
miscarriage. O NOUN

The O DET
primary O ADJ
outcome O NOUN
of O ADP
this O DET
trial O NOUN
is O VERB
clinical B-outcome ADJ
pregnancy I-outcome NOUN
rate. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Multicenter O NOUN
Study, O NOUN
Randomized O VERB
Controlled O VERB
Trial, O NOUN
Research O NOUN
Support, O NOUN
Non-U.S. O NOUN
Gov't, O NOUN

Method O NOUN
A O DET
prospective, O NOUN
randomized, O NOUN
double O ADV
blind, O NOUN
placebo O NOUN
control O NOUN
trial O NOUN
was O VERB
carried O VERB
out O ADP
in O ADP
community O NOUN
after O ADP
obtaining O VERB
the O DET
ethical O ADJ
clearance O NOUN
from O ADP
the O DET
IRC. O NOUN

Finally, O NOUN
endometrial B-outcome ADJ
thickness I-outcome NOUN
, O PUNCT
chemical, B-outcome ADJ
clinical, B-outcome ADJ
and Seperator CCONJ
ongoing B-outcome VERB
pregnancy E1-outcome NOUN
rates O NOUN
were O VERB
compared O VERB
between O ADP
two O NUM
groups. O NOUN

These O DET
meetings, O NOUN
called O VERB
Community O NOUN
Health O NOUN
Data O NOUN
Review O NOUN
(CHDR) O NUM
meetings, O NOUN
were O VERB
attended O VERB
by O ADP
community O NOUN
leaders, O NOUN
including O VERB
members O NOUN
of O ADP
the O DET
Ward O NOUN
Development O NOUN
Committee O NOUN
(WDC) O ADJ
and O CCONJ
Health O NOUN
Management O NOUN
Committee O NOUN
(HMC), O NUM
by O ADP
the O DET
CHW O NOUN
Peer O NOUN
Supervisors, O NOUN
and O CCONJ
by O ADP
representatives O NOUN
of O ADP
the O DET
Peripheral O ADJ
Health O NOUN
Unit. O NOUN

CONCLUSION: O NOUN
These O DET
data O NOUN
suggest O VERB
that O ADP
a O DET
single O ADJ
round O ADJ
of O ADP
MDA O NOUN
may O VERB
not O ADV
be O VERB
sufficient O ADJ
to O PART
decrease O NOUN
trachomatous B-outcome ADJ
inflammation-follicular I-outcome ADJ
levels O NOUN
below O ADP
5% O NOUN
when O ADP
TF1-9 O NOUN
is O VERB
between O ADP
5 O NUM
and O CCONJ
9.9% O NOUN
at O ADP
baseline. O NOUN

METHODS: O NOUN
A O DET
randomized, O NOUN
cross-over O NOUN
trial O NOUN
of O ADP
eight O NUM
weeks O NOUN
combined O VERB
aerobic O ADJ
and O CCONJ
resistance O NOUN
training O VERB
on O ADP
body B-outcome NOUN
composition I-outcome NOUN
assessed O VERB
by O ADP
Dual O ADJ
Energy O NOUN
X-ray O NOUN
Absorptiometry O NOUN
was O VERB
performed. O NOUN

A O DET
mindfulness-based O VERB
intervention O NOUN
(MBI) O NOUN
represents O NOUN
a O DET
promising O VERB
non-pharmacological O ADJ
framework O NOUN
for O ADP
Alzheimer's O NOUN
disease O NOUN
prevention. O NOUN

Similar O ADJ
changes O NOUN
were O VERB
observed O VERB
in O ADP
some O DET
slight O NOUN
or O CCONJ
more O ADV
serious O ADJ
unintentional O ADJ
injuries B-outcome NOUN
(P=0.030). O NUM

In O ADP
recent O ADJ
years, O NOUN
enamel O NOUN
matrix O NOUN
derivatives O NOUN
(EMDs) O NOUN
have O VERB
been O VERB
used O VERB
for O ADP
their O ADJ
regenerative O ADJ
potential O ADJ
in O ADP
periodontics. O NOUN

Journal-Name:Medicine O NOUN

It O PRON
was O VERB
also O ADV
registered O VERB
after O ADP
completion O NOUN
at O ADP
ClinicalTrials.gov O NOUN
( O PUNCT
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT03662165): O NOUN
https://clinicaltrials.gov/ct2/show/NCT03662165?term=NCT03662165&type=Intr&cond=H O NOUN
IV&rank=1 O NUM

Conclusion: O NOUN
The O DET
approach O NOUN
in O ADP
both O CCONJ
selecting O VERB
the O DET
patients O NOUN
participating O VERB
in O ADP
the O DET
study O NOUN
and O CCONJ
analyzing O VERB
the O DET
data O NOUN
in O ADP
this O DET
randomized O VERB
clinical O ADJ
trial O NOUN
allows O NOUN
us O PRON
to O PART
conclude O NOUN
that O ADP
cryotherapy O NOUN
is O VERB
an O DET
aid O VERB
of O ADP
clinical O ADJ
procedures O NOUN
to O PART
clean O NOUN
and O CCONJ
shape O NOUN
the O DET
canals O NOUN
to O PART
reduce O VERB
the O DET
occurrence O NOUN
of O ADP
postendodontic O ADJ
pain B-outcome NOUN
and O CCONJ
the O DET
need B-outcome NOUN
for Seperator ADP
medication I-outcome NOUN
in O ADP
patients O NOUN
presenting O VERB
with O ADP
a O DET
diagnosis O NOUN
of O ADP
vital O ADJ
pulp. O NOUN

RESULTS: O NOUN
The O DET
proportion O NOUN
of O ADP
patients O NOUN
reporting O VERB
severe O ADJ
pain B-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
a O DET
pain O NOUN
score O NOUN
of O ADP
between O ADP
7 O NUM
and O CCONJ
10, O NUM
on O ADP
postoperative O ADJ
day O NOUN
number O NOUN
2 O NUM
(POD O NOUN
2) O NOUN
were O VERB
21% O NUM
for O ADP
the O DET
single-shot O NOUN
group, O NOUN
14% O NOUN
for O ADP
the O DET
24-hour O NOUN
block O VERB
group, O NOUN
and O CCONJ
12% O NUM
for O ADP
the O DET
48-hour O NOUN
block O VERB
group O NOUN
(p O PUNCT
= O SYM
0.05). O NOUN

The O DET
same O ADJ
tools O NOUN
were O VERB
used O VERB
at O ADP
two, O NOUN
six O NUM
and O CCONJ
at O ADP
twelve O NUM
weeks O NOUN
post O ADV
injection O NOUN
to O PART
evaluate O VERB
the O DET
functional B-outcome ADJ
outcome O NOUN
and O CCONJ
pain B-outcome NOUN
. O PUNCT
Result O NOUN
One O NUM
hundred O NUM
and O CCONJ
seventeen O ADV
patients O NOUN
were O VERB
available O ADJ
for O ADP
analysis O NOUN
among O ADP
which, O NOUN
55(48.7%) O NUM
patients O NOUN
received O VERB
Triamcinolone O NOUN
and O CCONJ
58(51.3%) O NUM
received O VERB
placebo. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Preoperative O ADJ
analgesia O NOUN
group O NOUN
also O ADV
exhibited O VERB
decreased O VERB
patient's O NOUN
global B-outcome ADJ
assessment I-outcome NOUN
(PGA) O PUNCT
score O NOUN
compared O VERB
to O PART
postoperative O ADJ
analgesia O NOUN
group O NOUN
at O ADP
2 O NUM
hours, O NOUN
6 O NUM
hours, O NOUN
12 O NUM
hours, O NOUN
24 O NUM
hours, O NOUN
and O CCONJ
48 O NUM
hours O NOUN
post O ADV
operation. O ADV

At O ADP
23 O NUM
years, O NOUN
a O DET
mean O NOUN
of O ADP
2.9 O NUM
extra O ADJ
years O NOUN
of O ADP
life O NOUN
were O VERB
gained O VERB
with O ADP
radical O NOUN
prostatectomy. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Acute O ADJ
GU B-outcome NOUN
Toxicities I-outcome NOUN
were O VERB
more O ADV
common O ADJ
in O ADP
the O DET
MHF O NOUN
than O ADP
the O DET
EHF O NOUN
group O NOUN
(85 O PUNCT
vs. O CCONJ
57%, O NUM
p O NOUN
= O SYM
0.009), O NUM
but O CCONJ
late O ADJ
GI B-outcome NOUN
and Seperator CCONJ
GU B-outcome NOUN
toxicities E1-outcome NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
groups. O NOUN

In O ADP
the O DET
SMILE O NOUN
eyes, O NOUN
it O PRON
increased O VERB
from O ADP
52.52 O NUM
+/- O SYM
3.01 O NUM
mum O NOUN
to O PART
57.15 O NUM
+/- O SYM
4.57 O NUM
mum O NOUN
and O CCONJ
also O ADV
remained O VERB
stable O ADJ
for O ADP
up O ADP
to O PART
24 O NUM
months. O NOUN

Statistical O ADJ
analyses O NOUN
included O VERB
t O NOUN
tests, O NOUN
a O DET
Poisson O NOUN
regression O NOUN
model, O NOUN
and O CCONJ
analysis O NOUN
of O ADP
covariance O NOUN
(ANCOVA) O NUM
using O VERB
STATA. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

CONCLUSION: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
study O NOUN
found O VERB
that O ADP
lactulose O ADV
is O VERB
efficacious O ADJ
for O ADP
Chinese O NOUN
children O NOUN
with O ADP
chronic O ADJ
constipation O NOUN
after O ADP
6-weeks O NOUN
of O ADP
treatment. O NOUN

CONCLUSIONS: O NOUN
Single-dose O NUM
tafenoquine O NOUN
resulted O VERB
in O ADP
a O DET
significantly O ADV
lower O ADJ
risk O NOUN
of O ADP
P. O NOUN
vivax O NOUN
recurrence O NOUN
than O ADP
placebo O NOUN
in O ADP
patients O NOUN
with O ADP
phenotypically O ADV
normal O ADJ
G6PD O NOUN
activity. O NOUN
( O PUNCT

Publication O NOUN
date: O NOUN
2019/03/07 O ADV
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
date: O NOUN
2019/02/20 O ADJ
06:00 O ADP
[entrez] O ADP

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
overall B-outcome ADJ
survival I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
647 O NUM
patients O NOUN
underwent O VERB
randomization O NOUN
from O ADP
December O NOUN
2008 O NUM
through O ADP
January O NOUN
2012, O NUM
were O VERB
assigned O VERB
to O PART
undergo O NOUN
lymphadenectomy O NOUN
(323 O NUM
patients) O NOUN
or O CCONJ
not O ADV
undergo O NOUN
lymphadenectomy O NOUN
(324), O ADV
and O CCONJ
were O VERB
included O VERB
in O ADP
the O DET
analysis. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

BACKGROUND: O NOUN
Amyotrophic O ADJ
Lateral O ADJ
Sclerosis O NOUN
(ALS) O PUNCT
is O VERB
a O DET
rapid O ADJ
progressive O ADJ
neurodegenerative O ADJ
disease, O NOUN
characterized O VERB
by O ADP
a O DET
selective O ADJ
loss O NOUN
of O ADP
motor O NOUN
neurons, O PUNCT
brain O NOUN
stem O NOUN
and O CCONJ
spinal O ADJ
cord O NOUN
which O ADP
leads O NOUN
to O PART
deterioration O NOUN
of O ADP
motor O NOUN
abilities. O NOUN

Journal-Name:The O ADJ
western O NOUN
journal O ADJ
of O ADP
emergency O NOUN
medicine O NOUN

Electromyography-measured O VERB
eyestrain B-outcome NOUN
was O VERB
less O ADV
with O ADP
toric O ADJ
versus O CCONJ
spherical O ADJ
contact O NOUN
lenses O NOUN
at O ADP
fitting O VERB
(least-square O NOUN
ratio O NOUN
of O ADP
toric O ADJ
over O ADP
spherical=0.72; O NOUN
P=0.0019) O NOUN
but O CCONJ
not O ADV
at O ADP
follow-up O NOUN
(ratio=0.86; O NUM
P=0.11). O NOUN

The O DET
patients O NOUN
were O VERB
followed O VERB
up O ADP
for O ADP
12 O NUM
weeks O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
study O NOUN
medication O NOUN
was O VERB
assessed O VERB
by O ADP
analyzing O VERB
lipid B-outcome NOUN
profile. O NOUN

To O PART
improve O VERB
the O DET
success O NOUN
rate, O NOUN
probing O VERB
combined O VERB
with O ADP
tobramycin/dexamethasone O NOUN
ointment O NOUN
is O VERB
considered O VERB
effective. O ADJ

Publication O NOUN
date: O NOUN
2019/01/29 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
Perceived O VERB
Stress B-outcome NOUN
Scale], O NOUN
Center O NOUN
for O ADP
Epidemiologic O ADJ
Studies O NOUN
Depression B-outcome NOUN
Scale], O NOUN
and O CCONJ
Positive B-outcome ADJ
and Seperator CCONJ
Negative B-outcome ADJ
Affect E1-outcome NOUN
Scale O NOUN
were O VERB
used O VERB
to O PART
measure O NOUN
stress B-outcome NOUN
, O PUNCT
depressive B-outcome ADJ
symptoms I-outcome NOUN
, O PUNCT
and O CCONJ
positive B-outcome ADJ
and Seperator CCONJ
negative B-outcome ADJ
affect E1-outcome NOUN
, O PUNCT
respectively. O NOUN

Relocating O VERB
away O ADJ
from O ADP
family O NOUN
and O CCONJ
country O NOUN
for O ADP
treatment, O NOUN
adjusting O VERB
to O PART
life O NOUN
with O ADP
a O DET
chronic O ADJ
condition O NOUN
and O CCONJ
time O NOUN
lost O VERB
to O PART
dialysis O NOUN
cause O ADP
grief O NOUN
and O CCONJ
sadness O ADV
which O ADP
have O VERB
immense O NOUN
impact O NOUN
on O ADP
quality O NOUN
of O ADP
life O NOUN
and O CCONJ
challenges O NOUN
treatment O NOUN
adherence. O NOUN

BACKGROUND: O NOUN
Chronic O ADJ
obstructive O ADJ
pulmonary O ADJ
disease O NOUN
(COPD) O NUM
is O VERB
a O DET
serious O ADJ
lung O NOUN
disease O NOUN
for O ADP
individuals O NOUN
in O ADP
middle O ADJ
age O NOUN
and O CCONJ
especially O ADV
in O ADP
old O ADJ
people. O NOUN

The O DET
G1 O NOUN
presented O VERB
a O DET
higher O ADJ
average O NOUN
hospital B-outcome NOUN
stay I-outcome NOUN
in O ADP
relation O NOUN
to O PART
the O DET
G2, O NOUN
such O ADJ
differences O NOUN
were O VERB
not O ADV
significant O ADJ
(p> O NUM
0.05). O NOUN

The O DET
level O NOUN
of O ADP
activity O NOUN
has O VERB
been O VERB
assessed O VERB
on O ADP
the O DET
basis O NOUN
of O ADP
a O DET
questionnaire O NOUN
and O CCONJ
body O NOUN
posture O ADJ
assessments O NOUN
were O VERB
done O NOUN
using O VERB
a O DET
plumb O NOUN
line, O NOUN
pediscoliometer, O ADV
digital O ADJ
inclinometer. O NOUN

Before O ADP
crossover, O NOUN
the O DET
objective O ADP
response B-outcome NOUN
rate O NOUN
was O VERB
33% O NOUN
(95% O PUNCT
CI, O NOUN
20 O NUM
to O PART
48) O NOUN
in O ADP
the O DET
sorafenib O NOUN
group O NOUN
and O CCONJ
20% O NUM
(95% O PUNCT
CI, O NOUN
8 O NUM
to O PART
38) O NOUN
in O ADP
the O DET
placebo O NOUN
group. O VERB

There O PRON
were O VERB
no O DET
differences O NOUN
in O ADP
the O DET
live B-outcome ADJ
birth I-outcome NOUN
rates O NOUN
between O ADP
Group O NOUN
1 O NUM
and O CCONJ
Group O NOUN
2 O NUM
by O ADP
intention-to-treat O NOUN
(14/34, O PUNCT
41.2% O NUM
versus O CCONJ
21/37, O NUM
56.8%, O NUM
p O NOUN
= O SYM
0.19) O NUM
or O CCONJ
per-protocol O NOUN
(14/26, O PUNCT
53.8% O NUM
versus O CCONJ
19/31, O ADV
61.3%, O NUM
p O NOUN
= O SYM
0.57) O NUM
analyses. O NOUN

A O DET
follow-up O NOUN
extension O NOUN
was O VERB
then O ADV
done, O ADJ
with O ADP
the O DET
primary O ADJ
endpoint O NOUN
cumulative O ADJ
incidence O NOUN
of O ADP
chronic B-outcome ADJ
graft-versus-host I-outcome ADV
disease I-outcome NOUN
(cGVHD) I-outcome NOUN
. O PUNCT
Enrolment O ADJ
has O VERB
been O VERB
completed O VERB
for O ADP
both O CCONJ
studies. O NOUN

There O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
HIV B-outcome NOUN
testing I-outcome VERB
between O ADP
those O DET
in O ADP
the O DET
enhanced O VERB
SOC O NOUN
and O CCONJ
the O DET
SOC O NOUN
groups. O NOUN

CONCLUSION: O NOUN
RADPAD O NOUN
significantly O ADV
reduces O NOUN
radiation B-outcome NOUN
exposure I-outcome NOUN
to O PART
the O DET
primary O ADJ
operator O NOUN
during O ADP
prolonged O VERB
complex O NOUN
PCI O NOUN
procedures. O NOUN

beta-Eudesmol, O NOUN
an O DET
oxygenated O VERB
sesquiterpene, O NOUN
is O VERB
reported O VERB
to O PART
accumulate O VERB
in O ADP
a O DET
particular O NOUN
hop O NOUN
cultivar. O NOUN

The O DET
tear B-outcome NUM
film I-outcome NOUN
break-up I-outcome NOUN
time I-outcome NOUN
was O VERB
higher O ADJ
at O ADP
2 O NUM
weeks O NOUN
and O CCONJ
at O ADP
1 O NUM
month O NOUN
in O ADP
group O NOUN
A. O PROPN
The O DET
Schirmer O NOUN
I O NUM
test O NOUN
and O CCONJ
ocular B-outcome ADJ
surface I-outcome NOUN
disease I-outcome NOUN
index O NOUN
scores O NOUN
were O VERB
also O ADV
better O ADJ
in O ADP
group O NOUN
A O DET
for O ADP
up O ADP
to O PART
2 O NUM
months. O NOUN

Journal O ADJ
ID: O NOUN
8216186 O NUM

Mean O NOUN
central B-outcome ADJ
corneal I-outcome ADJ
thickness I-outcome NOUN
(CCT) I-outcome PUNCT
was O VERB
similar O ADJ
at O ADP
baseline O NOUN
(550 O ADV
+/- O SYM
35 O NUM
mum) O NOUN
and O CCONJ
at O ADP
12 O NUM
months O NOUN
(551 O NOUN
+/- O SYM
37 O NUM
mum) O NOUN
and O CCONJ
24 O NUM
months O NOUN
(555 O NUM
+/- O SYM
35 O NUM
mum). O NOUN

antibiotics O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
CT-scan O NOUN
confirmed O VERB
uncomplicated O VERB
acute O ADJ
appendicitis. O NOUN

Journal-Name:JAMA O NOUN

Title: O NOUN
Randomized O VERB
phase O NOUN
II/III O NOUN
trial O NOUN
of O ADP
neoadjuvant O ADJ
chemotherapy O NOUN
with O ADP
gemcitabine O NOUN
and O CCONJ
S-1 O NOUN
versus O CCONJ
upfront O ADP
surgery O NOUN
for O ADP
resectable O ADJ
pancreatic O ADJ
cancer O NOUN
(Prep-02/JSAP05). O NUM

Funded O VERB
by O ADP
the O DET
Netherlands O NOUN
Organization O NOUN
for O ADP
Health O NOUN
Research O NOUN
and O CCONJ
Development O NOUN
and O CCONJ
others; O NOUN
LEAP O NOUN
Current O ADJ
Controlled O VERB
Trials O NOUN
number, O ADV
ISRCTN30518857 O NOUN
.). O NOUN

Journal O ADJ
ID: O NOUN
8102988 O NUM

Additionally, O NOUN
30 O NUM
healthy O ADJ
people O NOUN
were O VERB
selected O VERB
as O ADP
control O NOUN
group O NOUN
(NC O PUNCT
group). O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Trial O NOUN
registered O VERB
at O ADP
ClinicalTrials.gov O NOUN
with O ADP
protocol O NOUN
number O NOUN
Medical O ADJ
College O NOUN
of O ADP
Wisconsin O NOUN
PRO00019269 O NOUN
on O ADP
11/29/2018 O NOUN
(Retrospectively O ADV
registered). O ADP

Publication O NOUN
date: O NOUN
2019/01/11 O NOUN
00:00 O NOUN
[accepted] O ADV

In O ADP
this O DET
randomized O VERB
controlled O VERB
trial, O NOUN
we O PRON
assessed O VERB
the O DET
effects O NOUN
of O ADP
a O DET
WSP O NOUN
formula O NOUN
on O ADP
body B-outcome NOUN
weight I-outcome NOUN
management O NOUN
in O ADP
58 O NUM
white-collar O ADJ
workers O NOUN
through O ADP
MR O NOUN
to O PART
elucidate O NOUN
the O DET
effects O NOUN
of O ADP
this O DET
WSP-MR O NOUN
on O ADP
factors O NOUN
leading O VERB
to O PART
overweight. O NOUN

The O DET
dose B-outcome NOUN
of O ADP
propofol O NOUN
and O CCONJ
remifentanil O NOUN
were O VERB
also O ADV
statisticed. O NOUN

CONCLUSION: O NOUN
The O DET
application O NOUN
of O ADP
preoperative O ADJ
localization O NOUN
of O ADP
small O ADJ
nodules O NOUN
by O ADP
placing O VERB
wire O NOUN
and O CCONJ
intrapleural O ADJ
fibrin O NOUN
glue O ADJ
improves O NOUN
the O DET
success O NOUN
[rate] O NOUN
of O ADP
resection B-outcome NOUN
, O PUNCT
reduces O NOUN
operation B-outcome NOUN
time I-outcome NOUN
and O CCONJ
the O DET
risk O NOUN
of O ADP
the O DET
operation B-outcome NOUN
, O PUNCT
and O CCONJ
lowers O NOUN
the O DET
difficulty B-outcome NOUN
of O ADP
finding O VERB
pathological O ADJ
specimens O NOUN
after O ADP
the O DET
operation. O ADV

RESULTS: O NOUN
Both O CCONJ
groups O NOUN
showed O VERB
a O DET
significant O ADJ
increase O NOUN
in O ADP
noggin B-outcome NOUN
serum O NOUN
levels O NOUN
(denosumab O PUNCT
p O NOUN
< O SYM
0.001; O NOUN
placebo O NOUN
p O NOUN
< O SYM
0.0001). O NUM

Publication O NOUN
date: O NOUN
['2019/10/17 O NOUN
06:00' O NUM

Clinical O ADJ
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
similar O ADJ
in O ADP
both O CCONJ
groups. O NOUN

Journal-Name:Medicine O NOUN

Publication O NOUN
date: O NOUN
2018/12/06 O NOUN
00:00 O NOUN
[accepted] O ADV

This O DET
study O NOUN
aimed O VERB
to O PART
evaluate O VERB
the O DET
effects O NOUN
of O ADP
a O DET
12-week O NOUN
high-intensity O NOUN
interval O NOUN
exercise O NOUN
(HIIT) O NOUN
training O VERB
program O NOUN
involving O VERB
suspension O NOUN
exercises O NOUN
(TRX) O NOUN
on O ADP
the O DET
muscle B-outcome NOUN
strength I-outcome NOUN
, O PUNCT
body B-outcome NOUN
composition I-outcome NOUN
, O PUNCT
gait B-outcome NOUN
speed I-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
of O ADP
older O ADJ
adults. O NOUN

This O DET
increase O NOUN
was O VERB
higher O ADJ
in O ADP
women O NOUN
who O ADP
conceived O VERB
in O ADP
PRP O NOUN
group O NOUN
(p O PUNCT
value: O NOUN
0.031). O NUM

GovNCT01996241 O NOUN
. O PUNCT

Title: O NOUN
Comparison O NOUN
Of O ADP
Simultaneous O ADJ
Versus O CCONJ
Delayed O VERB
Ventriculoperitoneal O NOUN
Shunting O VERB
In O ADP
Patients O NOUN
Undergoing O VERB
Meningocoele O PROPN
Repair O NOUN
In O ADP
Terms O NOUN
Of O ADP
Infection B-outcome NOUN
. O PUNCT

OBJECTIVE: O NOUN
The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
determine O NOUN
the O DET
effect O NOUN
of O ADP
vitamin O NOUN
D O NOUN
and O CCONJ
probiotic O ADJ
co-administration O NOUN
on O ADP
mental B-outcome ADJ
health I-outcome NOUN
, O PUNCT
hormonal B-outcome ADJ
, O PUNCT
inflammatory B-outcome ADJ
and O CCONJ
oxidative B-outcome ADJ
stress I-outcome NOUN
parameters O NOUN
in O ADP
women O NOUN
with O ADP
polycystic O ADJ
ovary O NOUN
syndrome O NOUN
(PCOS). O PUNCT

METHODS: O NOUN
In O ADP
this O DET
randomized, O NOUN
crossover, O NOUN
counterbalanced O VERB
study, O NOUN
12 O NUM
subjects O NOUN
(6 O ADV
men, O NOUN
6 O NUM
women; O ADJ
age O NOUN
= O SYM
22 O NUM
+/- O SYM
2 O NUM
yr; O NOUN
mass O NOUN
= O SYM
73.5 O NUM
+/- O SYM
7.9 O NUM
kg; O NOUN
height O NOUN
= O SYM
171 O NUM
+/- O SYM
7 O NUM
cm) O NOUN
underwent O VERB
15 O NUM
min O NOUN
of O ADP
CWI O NOUN
(10.0 O PUNCT
+/- O SYM
0.03 O NUM
degrees O NOUN
C) O NOUN
in O ADP
an O DET
environmental O ADJ
chamber O NOUN
(38.6 O PUNCT
+/- O SYM
0.6 O NUM
degrees O NOUN
C; O NOUN
36 O NUM
+/- O SYM
2% O NUM
humidity). O NOUN

Thermal B-outcome ADJ
sensation I-outcome NOUN
significantly O ADV
differed O VERB
between O ADP
conditions O NOUN
only O ADV
at O ADP
pre-exercise O NOUN
(PC O NOUN
= O SYM
3 O NUM
+/- O SYM
1, O NOUN
CON O NOUN
= O SYM
5 O NUM
+/- O SYM
0.5).DISCUSSION: O ADP
PC O NOUN
delayed O VERB
severe B-outcome ADJ
hyperthermia I-outcome NOUN
and O CCONJ
mitigated O VERB
dehydration B-outcome NOUN
without O ADP
affecting O VERB
thermal B-outcome ADJ
perception I-outcome NOUN
or O CCONJ
cooling B-outcome VERB
rates O NOUN
posthyperthermia. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
anteversion B-outcome NOUN
and O CCONJ
abduction B-outcome NOUN
between O ADP
2 O NUM
groups O NOUN
( O PUNCT
P>0.05) O NOUN
according O ADJ
to O PART
the O DET
X-ray O NOUN
film O NOUN
at O ADP
1 O NUM
year. O NOUN

CONCLUSION: O NOUN
This O DET
study O NOUN
presents O NOUN
novel O ADJ
and O CCONJ
important O ADJ
findings O NOUN
when O ADP
selecting O VERB
interaction O NOUN
devices O NOUN
for O ADP
individuals O NOUN
with O ADP
ALS O NOUN
to O PART
access O NOUN
technology O NOUN
by O ADP
demonstrating O VERB
immediate O ADJ
performance B-outcome NOUN
benefits O NOUN
of O ADP
using O VERB
a O DET
touchscreen O NUM
device, O NOUN
such O ADJ
as O ADP
improvement O NOUN
of O ADP
motor B-outcome NOUN
skills I-outcome NOUN
. O PUNCT
There O PRON
were O VERB
possible O ADJ
transferable O ADJ
skills O NOUN
obtained O VERB
when O ADP
using O VERB
virtual O ADJ
systems O NOUN
which O ADP
may O VERB
allow O ADP
flexibility O NOUN
and O CCONJ
enable O ADJ
individuals O NOUN
to O PART
maintain O NOUN
performance O NOUN
overtime. O ADJ

The O DET
corneal B-outcome ADJ
fluorescein I-outcome NOUN
staining I-outcome VERB
grades O NOUN
in O ADP
group O NOUN
A O DET
were O VERB
significantly O ADV
lower O ADJ
until O ADP
4 O NUM
months. O NOUN

Ethical O ADJ
approval O ADJ
for O ADP
the O DET
study O NOUN
was O VERB
obtained O VERB
from O ADP
the O DET
LUTH's O NOUN
Health O NOUN
Research O NOUN
and O CCONJ
Ethics O NOUN
Committee O NOUN
(Approval O NOUN
number: O NOUN
ADM/DCST/HREC/APP/2438; O NOUN
30th O ADV
August O NOUN
2018). O NUM

The O DET
postoperative O ADJ
mean B-outcome NOUN
arterial I-outcome ADJ
pressure I-outcome NOUN
(MAP) I-outcome NOUN
, O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
and O CCONJ
pulse B-outcome NOUN
oxygen I-outcome NOUN
saturation I-outcome NOUN
(SpO(2)) I-outcome PUNCT
in O ADP
the O DET
ward O NOUN
were O VERB
recorded O VERB
with O ADP
a O DET
multi-function O NOUN
monitor O NOUN
on O ADP
first O ADV
night O NOUN
after O ADP
surgery. O VERB

Publication O NOUN
Type: O NOUN
Clinical O ADJ
Trial, O NOUN
Phase O NOUN
III O NUM

METHODS: O NOUN
One O NUM
hundred O NUM
twenty-four O NOUN
eligible O ADJ
patients O NOUN
with O ADP
AGC O NOUN
were O VERB
included O VERB
in O ADP
this O DET
randomized O VERB
controlled O VERB
trial. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
(p O PUNCT
= O SYM
0.774) O NUM
difference, O NOUN
however, O ADV
between O ADP
the O DET
low O ADJ
dose O NOUN
and O CCONJ
placebo O NOUN
groups. O NOUN

Results: O NOUN
There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
general O ADJ
data O NOUN
and O CCONJ
Pittsburgh O NOUN
sleep B-outcome NOUN
quality I-outcome NOUN
index O NOUN
scale O NOUN
scores O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
of O ADP
patients O NOUN
(all O PUNCT
P>0.05). O NOUN

Journal-Name:International O ADJ
journal O ADJ
of O ADP
environmental O ADJ
research O NOUN
and O CCONJ
public O ADJ
health O NOUN

Our O ADJ
results O NOUN
were O VERB
estimated O VERB
as O ADP
good O ADJ
or O CCONJ
very O ADV
good O ADJ
in O ADP
93% O ADJ
of O ADP
patients. O NOUN

CONCLUSIONS: O NOUN
This O DET
retrospective O ADJ
analysis O NOUN
found O VERB
that O ADP
better O ADJ
BCVA, O NOUN
greater O ADJ
total O ADJ
macular O ADJ
volume, O NOUN
and O CCONJ
presence O NOUN
of O ADP
subretinal O ADJ
fluid O NOUN
at O ADP
baseline O NOUN
were O VERB
associated O VERB
with O ADP
more O ADV
rapid O ADJ
vision B-outcome NOUN
gains. O NOUN

There O PRON
were O VERB
formed O VERB
two O NUM
groups O NOUN
or O CCONJ
patients: O NOUN
the O DET
first O ADV
group O NOUN
involved O VERB
45 O NUM
patients O NOUN
- O PUNCT
were O VERB
treated O VERB
with O ADP
nicorandil O NOUN
(Cordinic, O PUNCT
PIQ-FHARMA O NOUN
LLC) O NOUN
(the O NOUN
main O ADJ
group) O ADJ
the O DET
other O ADJ
group O NOUN
included O VERB
43 O NUM
patients O NOUN
who O ADP
were O VERB
treated O VERB
by O ADP
the O DET
standard O ADJ
therapy O NOUN
(the O NOUN
comparison O NOUN
group). O NOUN

CONCLUSIONS: O NOUN
QCA O NOUN
has O VERB
potential O ADJ
for O ADP
an O DET
in-depth O NOUN
analysis O NOUN
of O ADP
complex O NOUN
interventions O NOUN
as O ADP
it O PRON
can O VERB
rely O ADV
on O ADP
small O ADJ
to O PART
medium O NOUN
sample O NOUN
sizes O NOUN
and O CCONJ
analyze O NOUN
pathways O NOUN
to O PART
success O NOUN
and O CCONJ
non-success O NOUN
separately. O NOUN

The O DET
levels O NOUN
of O ADP
CD3(+) B-outcome NOUN
, O PUNCT
CD4(+) B-outcome NOUN
, O PUNCT
CD4(+)/CD8(+) B-outcome NOUN
in O ADP
group O NOUN
A O DET
were O VERB
significantly O ADV
higher O ADJ
than O ADP
those O DET
in O ADP
group O NOUN
A O DET
after O ADP
treatment O NOUN
(P<0.05), O PUNCT
the O DET
levels O NOUN
of O ADP
CD8+ B-outcome NOUN
was O VERB
significant O ADJ
lower O ADJ
than O ADP
in O ADP
group O NOUN
B O NOUN
(P<0.05). O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

The O DET
trial O NOUN
was O VERB
registered O VERB
retrospectively O ADV
with O ADP
ISRCTN O NOUN
( O PUNCT
ISRCTN86573140 O VERB
). O NOUN

Journal-Name:Medicine O NOUN

The O DET
addition O NOUN
of O ADP
tazarotene O NOUN
affords O NOUN
sustained O VERB
benefits O NOUN
posttreatment. O NOUN

Conditioning O VERB
regimens O NOUN
were O VERB
cyclophosphamide O NOUN
120 O NUM
mg/kg O NOUN
with O ADP
either O CCONJ
total O ADJ
body O NOUN
irradiation O NOUN
(12 O PUNCT
Gy) O NOUN
or O CCONJ
busulfan O NOUN
(12.8 O NOUN
mg/kg O NOUN
intravenously O ADV
or O CCONJ
16 O NUM
mg/kg O NOUN
orally), O NOUN
with O ADP
or O CCONJ
without O ADP
etoposide O NOUN
(30-60 O NUM
mg/kg). O NOUN

They O PRON
were O VERB
randomly O ADV
divided O VERB
into O ADP
placebo, O NOUN
D1, O ADJ
and O CCONJ
D2 O NOUN
groups, O NOUN
respectively. O NOUN

RESULTS: O NOUN
There O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
with O ADP
respect O NOUN
to O PART
the O DET
best-corrected B-outcome VERB
visual I-outcome ADJ
acuity I-outcome NOUN
(BCVA) I-outcome NUM
between O ADP
the O DET
groups O NOUN
at O ADP
any O DET
time O NOUN
point. O NOUN

Adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
including O VERB
incidence O NOUN
and O CCONJ
severity B-outcome NOUN
of I-outcome ADP
febrile B-outcome NOUN
neutropenia E2-outcome NOUN
(41 O NOUN
[18%] O NUM
patients O NOUN
in O ADP
the O DET
A+CHP O ADV
group O NOUN
and O CCONJ
33 O NUM
[15%] O NUM
in O ADP
the O DET
CHOP O VERB
group) O ADJ
and O CCONJ
peripheral B-outcome ADJ
neuropathy I-outcome NOUN
(117 O NUM
[52%] O NUM
in O ADP
the O DET
A+CHP O ADV
group O NOUN
and O CCONJ
124 O NUM
[55%] O NUM
in O ADP
the O DET
CHOP O VERB
group), O NOUN
were O VERB
similar O ADJ
between O ADP
groups. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

The O DET
final O ADJ
date O NOUN
for O ADP
follow-up O NOUN
of O ADP
cognitive O ADJ
outcomes O NOUN
was O VERB
July O NOUN
22, O NUM
2018. O NUM

RESULTS: O NOUN
In O ADP
the O DET
per-protocol O NOUN
population, O NOUN
MRSA B-outcome NOUN
infection I-outcome NOUN
occurred O VERB
in O ADP
98 O NUM
of O ADP
1063 O NUM
participants O NOUN
(9.2%) O PUNCT
in O ADP
the O DET
education O NOUN
group O NOUN
and O CCONJ
in O ADP
67 O NUM
of O ADP
1058 O NUM
(6.3%) O NOUN
in O ADP
the O DET
decolonization O NOUN
group; O ADJ
84.8% O NUM
of O ADP
the O DET
MRSA B-outcome NOUN
infections I-outcome NOUN
led O VERB
to O PART
hospitalization B-outcome NOUN
. O PUNCT
Infection B-outcome NOUN
from O ADP
any O DET
cause O ADP
occurred O VERB
in O ADP
23.7% O NUM
of O ADP
the O DET
participants O NOUN
in O ADP
the O DET
education O NOUN
group O NOUN
and O CCONJ
19.6% O NOUN
of O ADP
those O DET
in O ADP
the O DET
decolonization O NOUN
group; O ADJ
85.8% O NUM
of O ADP
the O DET
infections B-outcome NOUN
led O VERB
to O PART
hospitalization B-outcome NOUN
. O PUNCT
The O DET
hazard O NOUN
of O ADP
MRSA B-outcome NOUN
infection I-outcome NOUN
was O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
decolonization O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
education O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
0.70; O NUM
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.52 O NUM
to O PART
0.96; O NOUN
P=0.03; O NOUN
number O NOUN
needed O VERB
to O PART
treat O NOUN
to O PART
prevent O NOUN
one O NUM
infection B-outcome NOUN
, O PUNCT
30; O NUM
95% O NOUN
CI, O NOUN
18 O NUM
to O PART
230); O NOUN
this O DET
lower O ADJ
hazard O NOUN
led O VERB
to O PART
a O DET
lower O ADJ
risk O NOUN
of O ADP
hospitalization B-outcome NOUN
due I-outcome ADJ
to I-outcome PART
MRSA I-outcome NOUN
infection I-outcome NOUN
(hazard O PUNCT
ratio, O NOUN
0.71; O NOUN
95% O NOUN
CI, O NOUN
0.51 O NUM
to O PART
0.99). O PUNCT

RESULTS: O NOUN
A O DET
majority O NOUN
(71%) O NUM
of O ADP
men O NOUN
wanted B-outcome VERB
children I-outcome NOUN
in O ADP
the O DET
future. O NOUN

CONCLUSIONS: O NOUN
The O DET
findings O NOUN
of O ADP
the O DET
current O ADJ
study O NOUN
demonstrate O VERB
that O ADP
consumption O NOUN
of O ADP
900 O NUM
mg O NOUN
of O ADP
PSE O NOUN
improved O VERB
specific O ADJ
measures O NOUN
of O ADP
reactive B-outcome ADJ
agility I-outcome NOUN
in O ADP
a O DET
young, O NOUN
active O ADJ
population. O ADV

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

Future O NOUN
research O NOUN
will O VERB
benefit O NUM
from O ADP
longer O ADJ
study O NOUN
durations O NOUN
with O ADP
larger O ADJ
numbers O NOUN
of O ADP
participants. O NOUN

Although O ADP
there O PRON
is O VERB
strong O ADJ
evidence O NOUN
that O ADP
topical O ADJ
repellents O NOUN
protect O VERB
against O ADP
mosquito O ADV
bites, O NOUN
evidence O NOUN
is O VERB
not O ADV
well O ADV
established O VERB
for O ADP
the O DET
effectiveness O NOUN
of O ADP
repellents O NOUN
distributed O VERB
as O ADP
part O NOUN
of O ADP
malaria O NOUN
control O NOUN
activities O NOUN
in O ADP
protecting O VERB
against O ADP
episodes O NOUN
of O ADP
malaria. O NOUN

By O ADP
the O DET
end O NOUN
of O ADP
the O DET
10-year O NOUN
follow-up, O ADP
11 O NUM
patients O NOUN
(36.7%) O NUM
in O ADP
the O DET
CC O NOUN
group O NOUN
had O VERB
experienced O VERB
local B-outcome ADJ
recurrence I-outcome NOUN
versus O CCONJ
11 O NUM
patients O NOUN
(36.7%) O NUM
in O ADP
the O DET
RC O NOUN
group O NOUN
(P O NUM
> O SYM
0.999). O NUM

Importance: O NOUN
Postoperative O ADJ
delirium O NOUN
is O VERB
common O ADJ
following O VERB
cardiac O ADJ
surgery O NOUN
and O CCONJ
may O VERB
be O VERB
affected O VERB
by O ADP
choice O NOUN
of O ADP
analgesic O ADP
and O CCONJ
sedative. O ADJ

Neither O CCONJ
coefficient O NOUN
of O ADP
variation O NOUN
nor O CCONJ
percentage O NOUN
of O ADP
hexagonal O ADJ
cells O NOUN
changed O VERB
significantly O ADV
from O ADP
baseline O NOUN
at O ADP
any O DET
time O NOUN
point. O NOUN

We O PRON
investigated O VERB
SPC O NOUN
and O CCONJ
the O DET
status O NOUN
of O ADP
MSI O NOUN
and O CCONJ
Epstein-Barr O NOUN
virus O NOUN
(EBV) O PUNCT
as O ADP
combinatory O ADJ
biomarkers O NOUN
to O PART
predict O VERB
the O DET
prognosis O NOUN
and O CCONJ
responsiveness O NOUN
of O ADP
adjuvant O NOUN
chemotherapy O NOUN
for O ADP
stage O NOUN
II/III O NOUN
gastric O ADJ
cancer. O NOUN

Interventions: O NOUN
Participants O NOUN
were O VERB
randomized O VERB
to O PART
receive O VERB
paracetamol O NOUN
(acetaminophen) O ADV
1000 O NUM
mg O NOUN
plus O CCONJ
ibuprofen O NOUN
400 O NUM
mg O NOUN
(n O NOUN
= O SYM
136; O NUM
PCM O NOUN
+ O SYM
IBU), O NOUN
paracetamol O NOUN
1000 O NUM
mg O NOUN
plus O CCONJ
matched O VERB
placebo O NOUN
(n O NOUN
= O SYM
142; O NUM
PCM), O NOUN
ibuprofen O NOUN
400 O NUM
mg O NOUN
plus O CCONJ
matched O VERB
placebo O NOUN
(n O NOUN
= O SYM
141; O NOUN
IBU), O NOUN
or O CCONJ
half-strength O NOUN
paracetamol O NOUN
500 O NUM
mg O NOUN
plus O CCONJ
ibuprofen O NOUN
200 O NUM
mg O NOUN
(n O NOUN
= O SYM
140; O NUM
HS-PCM O NOUN
+ O SYM
IBU) O ADJ
orally O ADV
every O DET
6 O NUM
hours O NOUN
for O ADP
24 O NUM
hours O NOUN
postoperatively, O NOUN
starting O VERB
1 O NUM
hour O NOUN
before O ADP
surgery. O VERB

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Funded O VERB
by O ADP
R&D O NOUN
Unicancer O NOUN
and O CCONJ
others; O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT01526135 O NOUN
; O PUNCT
EudraCT O NOUN
number, O ADV
2011-002026-52 O NUM
.). O NOUN

Title: O NOUN
Green O NOUN
tea O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
for O ADP
treatment O NOUN
of O ADP
acute O ADJ
uncomplicated O VERB
cystitis O NOUN
in O ADP
women: O NOUN
A O DET
randomized O VERB
clinical O ADJ
trial. O NOUN

Title: O NOUN
The O DET
analgesic O ADP
efficacy O NOUN
of O ADP
oblique O ADJ
subcostal O ADJ
transversus O NOUN
abdominis O NOUN
plane O ADJ
block O VERB
after O ADP
laparoscopic O ADJ
hysterectomy: O NOUN
A O DET
randomized, O NOUN
controlled, O NOUN
observer-blinded O VERB
study. O NOUN

The O DET
Quality B-outcome NOUN
of I-outcome ADP
Life I-outcome NOUN
Short O NOUN
Form O NOUN
(KDQOL-SF) O NUM
questionnaire O NOUN
was O VERB
completed O VERB
by O ADP
all O DET
participants O NOUN
at O ADP
the O DET
beginning O VERB
of O ADP
the O DET
trial O NOUN
and O CCONJ
two O NUM
months O NOUN
after O ADP
completion O NOUN
of O ADP
the O DET
intervention. O NOUN

The O DET
effectiveness O NOUN
of O ADP
Bosinji, O ADP
one O NUM
of O ADP
the O DET
herbal O ADJ
medicines O NOUN
used O VERB
for O ADP
low O ADJ
back O ADP
pain O NOUN
and O CCONJ
radiating O VERB
pain O NOUN
in O ADP
patient O NOUN
with O ADP
LHIVD, O ADJ
has O VERB
been O VERB
reported O VERB
in O ADP
several O ADJ
studies; O PUNCT
however, O ADV
little O DET
clinical O ADJ
evidence O NOUN
is O VERB
available O ADJ
owing O ADJ
to O PART
the O DET
methodological O ADJ
limitations O NOUN
in O ADP
previous O ADJ
studies. O NOUN

In O ADP
comparison O NOUN
to O PART
moderately-severe O ADV
health O NOUN
warnings, O ADP
highly-severe O ADJ
health O NOUN
warnings O NOUN
increased O VERB
avoidance B-outcome NOUN
and O CCONJ
reactance B-outcome NOUN
and O CCONJ
were O VERB
perceived O VERB
as O ADP
more O ADV
effective O ADJ
and O CCONJ
increased O VERB
motivation B-outcome NOUN
to O PART
drink O NOUN
less. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Participants O NOUN
completed O VERB
1 O NUM
week O NOUN
of O ADP
pre- O ADJ
and O CCONJ
post-testing, O NOUN
and O CCONJ
4 O NUM
days O NOUN
per O ADP
week O NOUN
of O ADP
strength O NOUN
and O CCONJ
conditioning O VERB
training O VERB
for O ADP
5 O NUM
weeks. O NOUN

NCT01709253 O NOUN
; O PUNCT
registered O VERB
October O ADJ
18, O NUM
2012; O NOUN
retrospectively O ADV
registered). O ADP

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
decolonization O NOUN
group O NOUN
had O VERB
lower O ADJ
likelihoods O NOUN
of O ADP
clinically O ADV
judged O VERB
infection B-outcome NOUN
from O ADP
any O DET
cause O ADP
(hazard O PUNCT
ratio, O NOUN
0.83; O NOUN
95% O NOUN
CI, O NOUN
0.70 O NUM
to O PART
0.99) O NUM
and O CCONJ
infection-related B-outcome VERB
hospitalization I-outcome NOUN
(hazard O PUNCT
ratio, O NOUN
0.76; O NUM
95% O NOUN
CI, O NOUN
0.62 O NUM
to O PART
0.93); O NUM
treatment O NOUN
effects O NOUN
for O ADP
secondary O ADJ
outcomes O NOUN
should O VERB
be O VERB
interpreted O VERB
with O ADP
caution O NOUN
owing O ADJ
to O PART
a O DET
lack O NOUN
of O ADP
prespecified O VERB
adjustment O NOUN
for O ADP
multiple O ADJ
comparisons. O NOUN

METHODS: O NOUN
The O DET
study O NOUN
was O VERB
conducted O VERB
in O ADP
96 O NUM
sub-village O NOUN
units O NOUN
(balozis) O NUM
in O ADP
the O DET
Kongwa O NOUN
district O ADP
of O ADP
Tanzania O NOUN
which O ADP
were O VERB
predicted O VERB
from O ADP
prior O ADJ
prevalence O NOUN
surveys O NOUN
to O PART
have O VERB
TF O NOUN
between O ADP
5 O NUM
and O CCONJ
9.9%. O NUM

The O DET
time O NOUN
required O VERB
for O ADP
a O DET
change O NOUN
in O ADP
TOFr O NOUN
values O NOUN
from O ADP
0.25 O NUM
to O PART
0.75 O NUM
and O CCONJ
0.9 O NUM
was O VERB
evaluated. O NOUN

We O PRON
looked O VERB
at O ADP
HIV B-outcome NOUN
testing I-outcome VERB
over O ADP
a O DET
2-month O NOUN
study O NOUN
period O NOUN
following O VERB
the O DET
first O ADV
text. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Secondary O ADJ
analyses O NOUN
included O VERB
the O DET
progression B-outcome NOUN
of O ADP
symptoms, O NOUN
as O ADP
measured O VERB
by O ADP
the O DET
UPDRS O NOUN
score, O NOUN
between O ADP
weeks O NOUN
4 O NUM
and O CCONJ
40 O NUM
and O CCONJ
the O DET
noninferiority O NOUN
of O ADP
early O ADJ
initiation O NOUN
of O ADP
treatment O NOUN
to O PART
delayed O VERB
initiation O NOUN
between O ADP
weeks O NOUN
44 O NUM
and O CCONJ
80, O NUM
with O ADP
a O DET
noninferiority O NOUN
margin O ADP
of O ADP
0.055 O NUM
points O NOUN
per O ADP
week. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

PSE O NOUN
also O ADV
significantly O ADV
increased O VERB
hits B-outcome NOUN
(treatment O NUM
effect, O NOUN
p O NOUN
= O SYM
0.020) O NUM
at O ADP
Day O NOUN
30 O NUM
(PSE O NUM
vs. O CCONJ
PLA: O NOUN
19.25 O NUM
+/- O SYM
1.84 O NUM
vs. O CCONJ
18.45 O NUM
+/- O SYM
1.48 O NUM
hits; O NOUN
p O NOUN
= O SYM
0.007) O NOUN
and O CCONJ
Day O NOUN
90 O NUM
(PSE O NUM
vs. O CCONJ
PLA: O NOUN
19.39 O NUM
+/- O SYM
1.90 O NUM
vs. O CCONJ
18.66 O NUM
+/- O SYM
1.64 O NUM
hits; O NOUN
p O NOUN
= O SYM
0.026) O NUM
for O ADP
the O DET
multi-directional O ADJ
test O NOUN
with O ADP
footplates. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Compared O VERB
with O ADP
clomifene O NOUN
citrate O NOUN
alone, O NOUN
the O DET
combined O VERB
treatment O NOUN
improved O VERB
cervical B-outcome ADJ
mucus I-outcome NOUN
score, O NOUN
follicle B-outcome NOUN
development I-outcome NOUN
rate, O NOUN
single B-outcome ADJ
follicle I-outcome NOUN
ovulation I-outcome NOUN
rate, O NOUN
endometrial B-outcome ADJ
thickness I-outcome NOUN
, O PUNCT
positive O ADJ
rate O NOUN
of O ADP
three B-outcome NUM
lines I-outcome NOUN
sign I-outcome ADV
, O PUNCT
and O CCONJ
follicle-stimulating B-outcome VERB
hormone I-outcome NOUN
level. O NOUN

Journal-Name:PLoS O NOUN
neglected O VERB
tropical O ADJ
diseases O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

INTRODUCTION: O NOUN
Halitosis O NOUN
is O VERB
the O DET
term O NOUN
used O VERB
to O PART
describe O NOUN
any O DET
unpleasant O ADJ
odor O NOUN
relative O ADJ
to O PART
expired O VERB
air O NOUN
regardless O ADV
of O ADP
its O ADJ
source. O NOUN

NCT: O NOUN
03200197. O NUM

The O DET
degree O NOUN
of O ADP
injured O VERB
vertebra B-outcome NOUN
compression I-outcome NOUN
, O PUNCT
VAS O NOUN
score, O NOUN
and O CCONJ
Oswestry O NOUN
disability B-outcome NOUN
index O NOUN
(ODI) O NOUN
score O NOUN
were O VERB
significantly O ADV
improved O VERB
in O ADP
both O CCONJ
groups O NOUN
at O ADP
immediate O ADJ
after O ADP
operation O NOUN
and O CCONJ
last O NOUN
follow-up O NOUN
( O PUNCT
P<0.05). O NOUN

In O ADP
the O DET
present O ADJ
study, O NOUN
we O PRON
evaluated O VERB
the O DET
Trimethylamine B-outcome NOUN
N-oxide I-outcome NOUN
(TMAO) I-outcome NOUN
-reducing O VERB
effect O NOUN
of O ADP
a O DET
novel O ADJ
nutraceutical O ADJ
formulation O NOUN
containing O VERB
grape O NOUN
pomace O NOUN
extract O NOUN
in O ADP
humans O NOUN
(Taurisolo((R))). O NOUN

The O DET
participants O NOUN
were O VERB
randomized O VERB
into O ADP
intervention O NOUN
group O NOUN
(IG) O NOUN
and O CCONJ
control O NOUN
group O NOUN
(CG). O NUM

Patients O NOUN
were O VERB
assigned O VERB
to O PART
receive O VERB
20 O NUM
mg/m(2) O NOUN
decitabine O NOUN
intravenously O ADV
for O ADP
5 O NUM
or O CCONJ
10 O NUM
consecutive O ADJ
days O NOUN
as O ADP
induction O NOUN
therapy, O NOUN
every O DET
4-8 O NUM
weeks O NOUN
for O ADP
up O ADP
to O PART
three O NUM
cycles. O NUM

Compared O VERB
with O ADP
women O NOUN
whose O ADP
inability O NOUN
to O PART
procreate O VERB
is O VERB
caused O VERB
by O ADP
simple O NOUN
tubal O ADJ
infertility, O ADJ
women O NOUN
with O ADP
endometriosis O NOUN
often O ADV
have O VERB
lower O ADJ
pregnancy O NOUN
rates O NOUN
following O VERB
in O ADP
vitro O ADV
fertilization/intracytoplasmic O ADJ
sperm O NOUN
injection O NOUN
(IVF/ICSI). O NUM

We O PRON
profiled O VERB
the O DET
microbiome O NOUN
of O ADP
a O DET
longitudinal O ADJ
sample O NOUN
series O NOUN
of O ADP
28 O NUM
people O NOUN
with O ADP
diabetes O NOUN
and O CCONJ
DFUs O NOUN
of O ADP
the O DET
heel O NOUN
in O ADP
an O DET
attempt O NOUN
to O PART
better O ADJ
characterize O NOUN
the O DET
relationship O NOUN
between O ADP
healing, O NOUN
infection O NOUN
and O CCONJ
the O DET
microbiome. O NOUN

Final O ADJ
outcome O NOUN
for O ADP
presence O NOUN
of O ADP
rheumatic B-outcome ADJ
fever/rheumatic I-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
(RF/RHD) I-outcome NOUN
or O CCONJ
other O ADJ
heart B-outcome NOUN
Diseases I-outcome NOUN
was O VERB
recorded O VERB
after O ADP
examination O NOUN
at O ADP
nearest O ADJ
primary O ADJ
health O NOUN
centers O NOUN
and/or O CCONJ
at O ADP
Indira O NOUN
Gandhi O NOUN
Medical O ADJ
College O NOUN
Hospital, O ADJ
Shimla. O NOUN

As O ADP
predicted, O NOUN
across O ADP
2 O NUM
RCTs, O NOUN
Monitor O NOUN
+ O SYM
Accept O ADV
training O VERB
increased O VERB
positive B-outcome ADJ
affect I-outcome NOUN
compared O VERB
with O ADP
both O CCONJ
Monitor O NOUN
Only O ADV
and O CCONJ
control O NOUN
groups. O NOUN

Title: O NOUN
Cost-effectiveness O NOUN
analysis O NOUN
of O ADP
a O DET
placebo-controlled O VERB
randomized O VERB
trial O NOUN
evaluating O VERB
the O DET
effectiveness O NOUN
of O ADP
arthroscopic O ADJ
subacromial O ADJ
decompression O NOUN
in O ADP
patients O NOUN
with O ADP
subacromial O ADJ
shoulder O NOUN
pain. O NOUN

RESULTS: O NOUN
Following O VERB
similar O ADJ
dehydration O NOUN
(~ O PUNCT
2%DeltaBW), O NUM
MW O NOUN
had O VERB
no O DET
differential O ADJ
(p O PUNCT
> O SYM
0.05) O NUM
impact O NOUN
on O ADP
any O DET
measure O NOUN
of O ADP
rehydration. O NOUN

Day O NOUN
1, O NOUN
8 O NUM
mg O NOUN
orally O ADV
Days O NOUN
2-4). O ADP

Journal O ADJ
ID: O NOUN
100967802 O NUM

To O PART
evaluates O NOUN
the O DET
eye-lens O NOUN
radiation O NOUN
exposure O NOUN
of O ADP
workers O NOUN
during O ADP
medical O ADJ
interventional O ADJ
procedures O NOUN
and O CCONJ
surgery O NOUN
in O ADP
a O DET
military O ADJ
hospital O NOUN
as O ADP
well O ADV
as O ADP
of O ADP
the O DET
equine O ADJ
veterinarians. O ADV

Our O ADJ
incentive O ADJ
level O NOUN
may O VERB
have O VERB
been O VERB
too O ADV
low O ADJ
to O PART
incentivise O NOUN
change, O NOUN
despite O ADP
being O VERB
designed O VERB
a O DET
priori O ADV
by O ADP
a O DET
Contingent O ADJ
Valuation O NOUN
Survey. O NOUN

The O DET
two O NUM
groups O NOUN
were O VERB
compared O VERB
in O ADP
terms O NOUN
of O ADP
pulmonary B-outcome ADJ
function I-outcome NOUN
, O PUNCT
blood B-outcome NOUN
gas I-outcome NOUN
parameters, O NOUN
and O CCONJ
six-minute O NOUN
walk B-outcome NOUN
distance I-outcome NOUN
before O ADP
intervention O NOUN
and O CCONJ
after O ADP
2 O NUM
months O NOUN
of O ADP
intervention. O NOUN

The O DET
first B-outcome ADV
out-of-bed I-outcome VERB
activity I-outcome NOUN
time I-outcome NOUN
, O PUNCT
first B-outcome ADV
anus I-outcome NOUN
exhaust I-outcome ADV
time I-outcome NOUN
, O PUNCT
and O CCONJ
hospital B-outcome NOUN
stay I-outcome NOUN
time I-outcome NOUN
of O ADP
the O DET
parecoxib O NOUN
+ O SYM
TAP O NOUN
group O NOUN
were O VERB
significantly O ADV
shorter O ADJ
than O ADP
those O DET
of O ADP
the O DET
other O ADJ
groups, O NOUN
while O ADP
the O DET
control O NOUN
group O NOUN
was O VERB
all O DET
significantly O ADV
higher O ADJ
than O ADP
the O DET
other O ADJ
groups. O NOUN

The O DET
test O NOUN
groups O NOUN
showed O VERB
significantly O ADV
higher O ADJ
reductions O NOUN
in O ADP
Gingival B-outcome ADJ
Index], O NOUN
probing B-outcome VERB
depth I-outcome NOUN
, O PUNCT
and O CCONJ
clinical B-outcome ADJ
attachment I-outcome NOUN
level I-outcome NOUN
as O ADP
well O ADV
as O ADP
reductions O NOUN
in O ADP
Porphyromonas B-outcome NOUN
gingivalis I-outcome NOUN
and O CCONJ
Aggregatibacter B-outcome NOUN
actinomycetemcomitans I-outcome NOUN
counts O NOUN
at O ADP
1-, O NOUN
3-, O ADJ
6-, O NOUN
and O CCONJ
9-month O NOUN
follow-ups O NOUN
when O ADP
compared O VERB
with O ADP
the O DET
control O NOUN
group. O VERB

RESULTS: O NOUN
Vitamin O NOUN
D O NOUN
and O CCONJ
probiotic O ADJ
co-supplementation, O NOUN
compared O VERB
with O ADP
the O DET
placebo, O NOUN
significantly O ADV
improved O VERB
beck O NOUN
depression B-outcome NOUN
inventory O ADJ
[beta O NOUN
(difference O NOUN
in O ADP
the O DET
mean O NOUN
of O ADP
outcomes O NOUN
measures O NOUN
between O ADP
treatment O NOUN
groups) O NOUN
- O PUNCT
0.58; O NOUN
95% O NOUN
CI, O NOUN
- O PUNCT
1.15, O ADP
- O PUNCT
0.02; O NUM
P O NOUN
= O SYM
0.04], O NOUN
general B-outcome ADJ
health I-outcome NOUN
questionnaire O NOUN
scores O NOUN
(beta O NUM
- O PUNCT
0.93; O ADP
95% O NOUN
CI, O NOUN
- O PUNCT
1.78, O ADP
- O PUNCT
0.08; O NUM
P O NOUN
= O SYM
0.03) O NUM
and O CCONJ
depression B-outcome NOUN
, O PUNCT
anxiety B-outcome NOUN
and O CCONJ
stress B-outcome NOUN
scale O NOUN
scores O NOUN
(beta O NUM
- O PUNCT
0.90; O NOUN
95% O NOUN
CI, O NOUN
- O PUNCT
1.67, O PUNCT
- O PUNCT
0.13; O NOUN
P O NOUN
= O SYM
0.02). O NOUN

CONCLUSIONS: O NOUN
We O PRON
found O VERB
that O ADP
hybrid O NOUN
minimally O ADV
invasive O ADJ
esophagectomy O NOUN
resulted O VERB
in O ADP
a O DET
lower O ADJ
incidence O NOUN
of O ADP
intraoperative O ADJ
and O CCONJ
postoperative O ADJ
major O ADJ
complications B-outcome NOUN
, O PUNCT
specifically O ADV
pulmonary B-outcome ADJ
complications I-outcome NOUN
, O PUNCT
than O ADP
open O ADJ
esophagectomy, O NOUN
without O ADP
compromising O VERB
overall B-outcome ADJ
and Seperator CCONJ
disease-free B-outcome ADJ
survival E1-outcome NOUN
over O ADP
a O DET
period O NOUN
of O ADP
3 O NUM
years. O NOUN
( O PUNCT

Publication O NOUN
date: O NOUN
2019/03/01 O NOUN
06:00 O ADP
[medline] O NOUN

BACKGROUND: O NOUN
Pharmacologic O ADJ
angiotensin O NOUN
axis O NOUN
blockade O NOUN
(AAB) O PUNCT
has O VERB
been O VERB
associated O VERB
with O ADP
profound O NOUN
hypotension O NOUN
following O VERB
anesthetic O ADJ
induction O NOUN
with O ADP
propofol. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
Comparison O NOUN
of O ADP
the O DET
immunogenicity B-outcome NOUN
and O CCONJ
safety O NOUN
of O ADP
3 O NUM
inactivated O VERB
hepatitis O NOUN
A O DET
vaccines O NOUN
in O ADP
Korean O NOUN
children O NOUN
aged O VERB
12 O NUM
to O PART
18 O NUM
months: O NOUN
An O DET
open-label, O ADV
randomized, O NOUN
prospective, O NOUN
multicenter O NOUN
study. O NOUN

Music O ADJ
therapy O NOUN
sessions O NOUN
lasting O VERB
30-45 O NUM
min O NOUN
were O VERB
individually O ADV
delivered O VERB
weekly O ADV
using O VERB
receptive O ADJ
techniques. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

BACKGROUND: O NOUN
Infections O NOUN
acquired O VERB
in O ADP
hospital O NOUN
are O VERB
an O DET
important O ADJ
cause O ADP
of O ADP
morbidity O NOUN
and O CCONJ
mortality O NOUN
in O ADP
very O ADV
preterm O NOUN
infants. O NOUN

BACKGROUND O NOUN
AND O CCONJ
PURPOSE: O NOUN
Self-efficacy O NOUN
is O VERB
considered O VERB
as O ADP
one O NUM
of O ADP
the O DET
influential O ADJ
parameters O NOUN
affecting O VERB
the O DET
health O NOUN
of O ADP
patients. O NOUN

The O DET
white O ADP
sclera O NOUN
slice O NOUN
could O VERB
be O VERB
seen O VERB
under O ADP
the O DET
conjunctiva, O NOUN
thereby O ADV
affecting O VERB
the O DET
cosmetic B-outcome ADJ
appearance I-outcome NOUN
. O PUNCT
CONCLUSION: O NOUN
The O DET
cornea O NOUN
slice O NOUN
acquired O VERB
from O ADP
SMILE O NOUN
surgery O NOUN
can O VERB
effectively O ADV
prevent O NOUN
drainage B-outcome NOUN
tube I-outcome NOUN
exposure I-outcome NOUN
. O PUNCT
Moreover, O NOUN
it O PRON
is O VERB
easy B-outcome NOUN
to I-outcome PART
acquire I-outcome NOUN
, O PUNCT
safe, O NOUN
and O CCONJ
cheaper B-outcome ADV
, O PUNCT
giving O VERB
the O DET
patient O NOUN
a O DET
better O ADJ
cosmetic B-outcome ADJ
appearance I-outcome NOUN
. O PUNCT

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
determine O NOUN
the O DET
therapeutic O ADJ
benefits O NOUN
of O ADP
soft O NOUN
non-manipulative O ADJ
osteopathic O ADJ
techniques O NOUN
in O ADP
patients O NOUN
with O ADP
CD. O NOUN

For O ADP
flexion B-outcome NOUN
and O CCONJ
abduction B-outcome NOUN
activity, O ADP
SuperPATH O NOUN
group O NOUN
at O ADP
1 O NUM
and O CCONJ
3 O NUM
days O NOUN
after O ADP
operation O NOUN
were O VERB
better O ADJ
than O ADP
the O DET
control O NOUN
group O NOUN
( O PUNCT
P<0.05), O NOUN
while O ADP
no O DET
significant O ADJ
difference O NOUN
was O VERB
found O VERB
between O ADP
2 O NUM
groups O NOUN
at O ADP
14 O NUM
days, O NOUN
3 O NUM
months, O NOUN
6 O NUM
months, O NOUN
and O CCONJ
1 O NUM
year O NOUN
after O ADP
operation O NOUN
( O PUNCT
P>0.05). O NOUN

Objective: O NOUN
The O DET
aim O ADP
of O ADP
this O DET
clinical O ADJ
trial O NOUN
was O VERB
to O PART
assess O NOUN
whether O ADP
controlled O VERB
irrigation O NOUN
with O ADP
three O NUM
different O ADJ
irrigation O NOUN
regimens O NOUN
with O ADP
different O ADJ
temperature O NOUN
would O VERB
result O VERB
in O ADP
reduction O NOUN
of O ADP
post-endodontic O ADJ
pain B-outcome NOUN
after O ADP
one-visit O NOUN
root O NOUN
canal O NOUN
treatment O NOUN
(RCT). O NOUN

T O NOUN
Kujala O NOUN
score O ADJ
increased O VERB
from O ADP
70.77 O NUM
points O NOUN
preoperatively O ADV
to O PART
94.32 O NUM
postoperatively O ADV
(P O NUM
< O SYM
.001). O PUNCT

METHODS: O NOUN
Ten O NUM
physically O ADV
active O ADJ
males O NOUN
(25.1 O ADJ
+/- O SYM
3.9 O NUM
years; O NOUN
weight O NOUN
78.71 O NUM
+/- O SYM
9.53 O NUM
kg; O NOUN
height O NOUN
177.2 O NUM
+/- O SYM
4.6 O NUM
cm; O NOUN
body O NOUN
fat O NOUN
15.5 O NUM
+/- O SYM
3.13%) O NUM
participated O VERB
in O ADP
this O DET
study. O NOUN

CONCLUSIONS: O NOUN
We O PRON
conclude O NOUN
that O ADP
weight B-outcome NOUN
loss O NOUN
of O ADP
6-7% O ADJ
with O ADP
diet O NOUN
or O CCONJ
with O ADP
exercise O NOUN
plus O CCONJ
diet O NOUN
reduced O VERB
both O CCONJ
subcutaneous B-outcome ADJ
and Seperator CCONJ
intra-abdominal B-outcome ADJ
fat E1-outcome NOUN
. O PUNCT
Only O ADV
subcutaneous B-outcome ADJ
fat I-outcome NOUN
statistically O ADV
significantly O ADV
reduced O VERB
to O PART
a O DET
larger O ADJ
extent O NOUN
when O ADP
exercise O NOUN
is O VERB
combined O VERB
with O ADP
a O DET
small O ADJ
caloric O ADJ
restriction. O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Complications B-outcome NOUN
were O VERB
comparable O ADJ
between O ADP
treatment O NOUN
groups. O NOUN

Title: O NOUN
Reduction O NOUN
of O ADP
postendodontic O ADJ
pain B-outcome NOUN
after O ADP
one-visit O NOUN
root O NOUN
canal O NOUN
treatment O NOUN
using O VERB
three O NUM
irrigating O VERB
regimens O NOUN
with O ADP
different O ADJ
temperature. O NOUN

Medication O NOUN
adherence B-outcome NOUN
and O CCONJ
occurrence O NOUN
of O ADP
adverse B-outcome ADJ
outcomes I-outcome NOUN
( O PUNCT
adverse B-outcome ADJ
drug I-outcome NOUN
reactions I-outcome NOUN
, O PUNCT
readmission B-outcome NOUN
, O PUNCT
emergency B-outcome NOUN
department I-outcome NOUN
visits I-outcome NOUN
, O PUNCT
and O CCONJ
death B-outcome NOUN
) O PUNCT
were O VERB
assessed O VERB
at O ADP
the O DET
follow-up O NOUN
visit, O NOUN
30 O NUM
days O NOUN
after O ADP
discharge. O ADJ

Conclusion: O NOUN
Further O ADV
trials O NOUN
are O VERB
needed O VERB
to O PART
determine O NOUN
optimal O ADJ
treatment O NOUN
protocols O NOUN
for O ADP
various O ADJ
UI O NOUN
types O NOUN
and O CCONJ
to O PART
evaluate O VERB
long-term O NOUN
outcomes O NOUN
of O ADP
the O DET
ExMI O NOUN
treatment. O NOUN

RESULTS: O NOUN
Fifty-two O NUM
eyes O NOUN
from O ADP
26 O NUM
patients O NOUN
(mean O NUM
age, O NOUN
57.7 O NUM
years) O NOUN
were O VERB
included. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

No O DET
significant O ADJ
ToP O NOUN
item O NOUN
changes O NOUN
were O VERB
found O VERB
in O ADP
the O DET
conventional O ADJ
group. O VERB

CBT-i O NOUN
group O NOUN
is O VERB
superior O ADJ
in O ADP
improving O VERB
sleep B-outcome NOUN
onset I-outcome NOUN
latency I-outcome NOUN
(SOL) I-outcome NOUN
and O CCONJ
sleep B-outcome NOUN
efficiency I-outcome NOUN
(SE) I-outcome NOUN
. O PUNCT
Combination O NOUN
regimen O NOUN
in O ADP
our O ADJ
study O NOUN
can O VERB
significantly O ADV
reduce O VERB
the O DET
doses B-outcome NOUN
of O ADP
medication. O NOUN

Journal O ADJ
ID: O NOUN
100968547 O NUM

Publication O NOUN
date: O NOUN
2018/12/27 O NOUN
00:00 O NOUN
[accepted] O ADV

Journal O ADJ
ID: O NOUN
0255562 O NUM

Secondary O ADJ
outcomes O NOUN
were O VERB
clinical O ADJ
and O CCONJ
MRI O NOUN
measures O NOUN
of O ADP
disease B-outcome NOUN
activity I-outcome NOUN
, O PUNCT
physical B-outcome ADJ
function I-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
. O PUNCT
Results: O NOUN
Of O ADP
200 O NUM
patients O NOUN
randomized O VERB
(133 O NOUN
women O NOUN
[67%]; O NOUN
mean O NOUN
[SD] O PUNCT
age, O NOUN
61.6 O NUM
[10.5] O NOUN
years; O NOUN
median O ADJ
baseline O NOUN
DAS28-CRP, O NOUN
1.9 O NUM
[interquartile O NOUN
range, O VERB
1.7-2.2]; O NUM
van O NOUN
der O NOUN
Heijde-modified O VERB
Sharp O NOUN
score, O NOUN
18.0 O NUM
[interquartile O NOUN
range, O VERB
7.0-42.5]), O NOUN
76 O NUM
patients O NOUN
(76%) O PUNCT
in O ADP
the O DET
MRI-guided O VERB
group O NOUN
and O CCONJ
95 O NUM
(95%) O NOUN
in O ADP
the O DET
conventional O ADJ
group O NOUN
completed O VERB
the O DET
study. O NOUN

Publication O NOUN
date: O NOUN
2019/02/18 O NOUN
00:00 O NOUN
[accepted] O ADV

Within O ADP
24 O NUM
h O NOUN
after O ADP
operation, O NOUN
the O DET
sufentanil B-outcome NOUN
consumption I-outcome NOUN
in O ADP
group O NOUN
D[(35.86+/-8.65)mug]was O NOUN
significantly O ADV
less O ADV
than O ADP
that O ADP
in O ADP
group O NOUN
C[(59.53+/-15.26) O NOUN
mug, O NOUN
t=7.061, O NOUN
P<0.05], O NOUN
and O CCONJ
the O DET
number O NOUN
of O ADP
patient O NOUN
controlled O VERB
analgesia B-outcome NOUN
pressing O VERB
in O ADP
group O NOUN
D(2.15+/-1.38) O NOUN
was O VERB
obviously O ADV
less O ADV
than O ADP
that O ADP
in O ADP
group O NOUN
C(5.85+/-2.16, O NOUN
t=4.971, O NOUN
P<0.05). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Journal O ADJ
of O ADP
vector O NOUN
borne O NOUN
diseases O NOUN

After O ADP
12 O NUM
months, O NOUN
patients O NOUN
receiving O VERB
riociguat O NOUN
therapy O NOUN
showed O VERB
a O DET
significant O ADJ
reduction O NOUN
in O ADP
right B-outcome ADJ
atrial I-outcome ADJ
(- X NOUN
2.6 X NUM
+/- X SYM
4.4 X NUM
cm2, X NOUN
95% X NOUN
CI X NOUN
-3.84, X NOUN
- X PUNCT
1.33; X NOUN
p X NOUN
< X SYM
0.001, X NUM
n X NOUN
= X SYM
49) X NOUN
and Seperator CCONJ
right B-outcome ADJ
ventricular I-outcome ADJ
(RV) I-outcome NOUN
area E1-outcome NOUN
(- O NOUN
3.5 O NUM
+/- O SYM
5.2 O NUM
cm2, O NOUN
95% O NOUN
CI O NOUN
-5.1, O NUM
- O PUNCT
1.9; O NOUN
p O NOUN
< O SYM
0.001; O NOUN
n O NOUN
= O SYM
44), O NUM
RV B-outcome NOUN
thickness I-outcome NOUN
(- O NOUN
0.76 O NUM
+/- O SYM
2.2 O NUM
mm, O NOUN
95% O NOUN
CI O NOUN
-1.55, O NOUN
0.03; O NOUN
n O NOUN
= O SYM
32), O NUM
and O CCONJ
a O DET
significant O ADJ
increase O NOUN
in O ADP
TAPSE B-outcome NOUN
(2.95 O NUM
+/- O SYM
4.78 O NUM
mm, O NOUN
95% O NOUN
CI O NOUN
1.52, O NUM
4.39; O NOUN
n O NOUN
= O SYM
45) O NOUN
and O CCONJ
RV B-outcome NOUN
fractional I-outcome ADJ
area I-outcome NOUN
change O NOUN
(8.12 O PUNCT
+/- O SYM
8.87 O NUM
mm, O NOUN
95% O NOUN
CI O NOUN
4.61, O NOUN
11.62; O NOUN
n O NOUN
= O SYM
27). O NOUN

METHODS: O NOUN
Patients O NOUN
admitted O VERB
from O ADP
Weifang O NOUN
People's O NOUN
Hospital O NOUN
from O ADP
January O NOUN
2015 O NUM
to O PART
December O NOUN
2016 O NUM
who O ADP
received O VERB
TKA O NOUN
were O VERB
injected O VERB
with O ADP
20 O NUM
mg/kg O NOUN
TXA O NOUN
by O ADP
IV O NUM
before O ADP
TKA O NOUN
(n O NOUN
= O SYM
50), O NOUN
3.0 O NUM
g O NOUN
TXA O NOUN
by O ADP
IA O NOUN
after O ADP
TKA O NOUN
(n O NOUN
= O SYM
50), O NOUN
or O CCONJ
combination O NOUN
of O ADP
20 O NUM
mg/kg O NOUN
TXA O NOUN
by O ADP
IV O NUM
before O ADP
TKA O NOUN
and O CCONJ
3.0 O NUM
g O NOUN
TXA O NOUN
by O ADP
IA O NOUN
after O ADP
TKA O NOUN
(n O NOUN
= O SYM
50). O NOUN

Angle B-outcome NOUN
change I-outcome NOUN
was O VERB
3.29+/-6.60 O NUM
for O ADP
kyphosis O NOUN
angle O NOUN
and O CCONJ
0.59+/-7.76 O NUM
for O ADP
lordosis O NOUN
angle. O NOUN

T O NOUN
Diabetes O NOUN
Management O NOUN
Self-Efficacy B-outcome NOUN
Scale O NOUN
was O VERB
completed O VERB
at O ADP
baseline O NOUN
6-month O NOUN
and O CCONJ
12-month. O NUM

Participants O NOUN
included O VERB
44 O NUM
adults O NOUN
with O ADP
serotonin O NOUN
reuptake O NOUN
inhibitor O NOUN
treatment-refractory O NOUN
OCD O NOUN
and O CCONJ
they O PRON
received O VERB
a O DET
stable O ADJ
fluvoxamine O NOUN
pharmacotherapy O NOUN
with O ADP
Yale-Brown O NOUN
Obsessive B-outcome ADJ
Compulsive I-outcome ADJ
Scale O NOUN
(Y-BOCS) O NUM
scores O NOUN
higher O ADJ
than O ADP
20. O NUM

PATIENTS O NOUN
AND O CCONJ
METHODS: O NOUN
A O DET
phase O NOUN
II O NUM
trial O NOUN
(planned O PUNCT
n=58) O NOUN
using O VERB
second-line O NOUN
therapy O NOUN
for O ADP
metastatic O ADJ
colorectal O ADJ
cancer O NOUN
with O ADP
either O CCONJ
oxaliplatin-based O VERB
(mFOLFOX6) O NOUN
or O CCONJ
irinotecan-based O VERB
(FOLFIRI) O NUM
combination O NOUN
chemotherapy O NOUN
and O CCONJ
100 O NUM
mg O NOUN
erlotinib O NOUN
daily O ADJ
on O ADP
days O NOUN
3-8 O NUM
after O ADP
each O DET
infusion O NOUN
(days O NUM
1 O NUM
and O CCONJ
2) O NOUN
every O DET
14 O NUM
days. O NOUN

Journal O ADJ
ID: O NOUN
100884618 O NUM

OBJECTIVE: O NOUN
Menstrual O ADJ
pain O NOUN
is O VERB
a O DET
periodic O ADJ
pain O NOUN
which O ADP
happens O NOUN
during O ADP
the O DET
days O NOUN
of O ADP
menses. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

This O DET
study O NOUN
was O VERB
aimed O VERB
to O PART
compare O NOUN
the O DET
prophylactic O ADJ
effects O NOUN
of O ADP
paracetamol O NOUN
and O CCONJ
dexmedetomidine O NOUN
for O ADP
controlling O VERB
hemodynamics B-outcome NOUN
during O ADP
surgery O NOUN
and O CCONJ
postoperative O ADJ
pain B-outcome NOUN
. O PUNCT
METHODS: O NOUN
The O DET
study O NOUN
population O NOUN
consisted O VERB
of O ADP
132 O NUM
patients O NOUN
aged O VERB
18 O NUM
to O PART
70 O NUM
years O NOUN
and O CCONJ
from O ADP
both O CCONJ
genders, O NOUN
who O ADP
were O VERB
candidates O NOUN
for O ADP
emergency O NOUN
cholecystectomy O NOUN
or O CCONJ
elective O ADJ
surgery. O VERB

Journal O ADJ
ID: O NOUN
9114501 O NUM

Methods: O NOUN
This O DET
was O VERB
a O DET
prospective, O NOUN
randomized, O NOUN
parallel-arm O NOUN
study O NOUN
of O ADP
70 O NUM
fourth-year O NOUN
medical O ADJ
students O NOUN
to O PART
either O CCONJ
simulation O NOUN
(SIM) O NOUN
or O CCONJ
standard O ADJ
training O VERB
(STD) O PUNCT
over O ADP
an O DET
eight-month O NOUN
period. O NOUN

Journal O ADJ
ID: O NOUN
101249598 O NUM

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
is O VERB
to O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
intervention O NOUN
of O ADP
intensive O ADJ
education O NOUN
on O ADP
hand O NOUN
hygiene O NOUN
on O ADP
hand B-outcome NOUN
food I-outcome NOUN
mouth I-outcome NOUN
disease I-outcome NOUN
(HFMD) I-outcome PUNCT
. O PUNCT
We O PRON
randomized O VERB
64 O NUM
villages O NOUN
into O ADP
intervention O NOUN
and O CCONJ
control O NOUN
groups O NOUN
in O ADP
Handan, O ADV
Hebei O NOUN
province, O NOUN
China. O NOUN

Sixteen O NUM
subjects O NOUN
with O ADP
well-controlled O VERB
T2DM O NOUN
(median O PUNCT
HbA1c O NOUN
47 O NUM
mmol/mol, O NOUN
(37-67 O NOUN
mmol/mol) O NOUN
and O CCONJ
BMI O NOUN
30 O NUM
+/- O SYM
4.4 O NUM
kg/m(2)) O NOUN
participated O VERB
in O ADP
the O DET
study. O NOUN

BACKGROUND: O NOUN
The O DET
increasing O VERB
multidrug O NOUN
resistance O NOUN
among O ADP
gram-negative O ADJ
uropathogens O NOUN
necessitates O NOUN
new O ADJ
treatments O NOUN
for O ADP
serious O ADJ
infections. O NOUN

RESULTS: O NOUN
Endometrial B-outcome ADJ
thickness I-outcome NOUN
increased O VERB
significantly O ADV
to O PART
8.67 O NUM
+/- O SYM
0.64 O NUM
in O ADP
PRP O NOUN
group O NOUN
than O ADP
in O ADP
controls O NOUN
(p O PUNCT
= O SYM
0.001). O NUM

In O ADP
the O DET
secondary O ADJ
analysis, O NOUN
the O DET
difference O NOUN
in O ADP
the O DET
mean O NOUN
Roland-Morris O NOUN
Disability B-outcome NOUN
Questionnaire O PROPN
(RMDQ) O NOUN
score O NOUN
between O ADP
the O DET
groups O NOUN
was O VERB
-2.3 O NOUN
(-4.2 O ADV
to-0.4, O NOUN
P=0.02) O NOUN
for O ADP
patients O NOUN
with O ADP
type O NOUN
1 O NUM
Modic O NOUN
changes O NOUN
and O CCONJ
-0.1 O ADV
(-2.7 O NOUN
to O PART
2.6, O NOUN
P=0.95) O NOUN
for O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
Modic O NOUN
changes. O NOUN

CONCLUSIONS: O NOUN
Overall, O NOUN
the O DET
co-administration O NOUN
of O ADP
vitamin O NOUN
D O NOUN
and O CCONJ
probiotic O ADJ
for O ADP
12 O NUM
weeks O NOUN
to O PART
women O NOUN
with O ADP
PCOS O NOUN
had O VERB
beneficial O ADJ
effects O NOUN
on O ADP
mental B-outcome ADJ
health I-outcome NOUN
parameters, O NOUN
serum O NOUN
total O ADJ
testosterone B-outcome NOUN
, O PUNCT
hirsutism B-outcome NOUN
, O PUNCT
high-sensitivity B-outcome NOUN
C-reactive I-outcome ADJ
protein I-outcome NOUN
(hs-CRP) I-outcome NOUN
, O PUNCT
plasma O NOUN
total O ADJ
antioxidant B-outcome NOUN
capacity O NOUN
(TAC), O NUM
glutathione B-outcome NOUN
(GSH) I-outcome PUNCT
and O CCONJ
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
levels. O NOUN

Further O ADV
process O NOUN
evaluations O NOUN
of O ADP
multi-component O ADJ
school-based O VERB
PA O NOUN
interventions O NOUN
are O VERB
warranted O VERB
to O PART
develop O VERB
the O DET
limited O VERB
evidence O NOUN
base. O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
695 O NUM
men O NOUN
with O ADP
localized O VERB
prostate O NOUN
cancer O NOUN
to O PART
watchful O ADJ
waiting O VERB
or O CCONJ
radical O NOUN
prostatectomy O NOUN
from O ADP
October O ADJ
1989 O NUM
through O ADP
February O ADJ
1999 O NUM
and O CCONJ
collected O VERB
follow-up O NOUN
data O NOUN
through O ADP
2017. O NUM

However, O ADV
anesthesia O NOUN
induction O NOUN
time O NOUN
by O ADP
timing O VERB
remifentanil O NOUN
administration O NOUN
was O VERB
not O ADV
identified. O NOUN

RESULTS: O NOUN
The O DET
independent O ADJ
t-test O NOUN
showed O VERB
a O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
mean O NOUN
total O ADJ
score O NOUN
of O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
and O CCONJ
its O ADJ
various O ADJ
dimensions O NOUN
( O PUNCT
vasomotor B-outcome NOUN
, O PUNCT
psychosocial B-outcome ADJ
, O PUNCT
physical B-outcome ADJ
, O PUNCT
and O CCONJ
sexual B-outcome ADJ
dimensions) O NOUN
after O ADP
the O DET
intervention O NOUN
between O ADP
the O DET
aromatherapy O NOUN
and O CCONJ
placebo O NOUN
groups O NOUN
(P<0.001). O NOUN

In O ADP
addition, O NOUN
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
also O ADV
assessed O VERB
during O ADP
the O DET
period O NOUN
of O ADP
this O DET
study. O NOUN

CONCLUSIONS: O NOUN
This O DET
study O NOUN
demonstrates O NOUN
the O DET
safety O NOUN
of O ADP
BT-11 O NOUN
in O ADP
the O DET
adolescent O NOUN
by O ADP
showing O VERB
no O DET
apparent O ADJ
adverse B-outcome ADJ
reactions I-outcome NOUN
related O VERB
to O PART
it. O NOUN

Title: O NOUN
Evaluation O NOUN
of O ADP
the O DET
safety O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
a O DET
new O ADJ
hemostatic O ADJ
powder O NOUN
using O VERB
a O DET
quantitative O ADJ
surface B-outcome NOUN
bleeding I-outcome VERB
severity O NOUN
scale. O ADJ

METHODS: O NOUN
Eligible O ADJ
patients O NOUN
were O VERB
aged O VERB
60 O NUM
years O NOUN
or O CCONJ
older O ADJ
with O ADP
acute O ADJ
myeloid O NOUN
leukaemia O NOUN
but O CCONJ
unsuitable O ADJ
for O ADP
intensive O ADJ
chemotherapy O NOUN
(or O NUM
<60 O NOUN
years O NOUN
if O ADP
unsuitable O ADJ
for O ADP
intensive O ADJ
chemotherapy O NOUN
with O ADP
an O DET
anthracycline O NOUN
plus O CCONJ
cytarabine). O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
length B-outcome NOUN
of I-outcome ADP
stay I-outcome NOUN
between O ADP
2 O NUM
groups O NOUN
( O PUNCT
t=0.474, O NOUN
P=0.640). O NOUN

Patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
7, O NUM
9, O NOUN
11, O NUM
13 O NUM
or O CCONJ
15 O NUM
mg O NOUN
intrathecal O ADJ
hyperbaric O ADJ
ropivacaine O NOUN
respectively. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
http://www.clinicaltrials.gov O NOUN
Unique O ADJ
identifier: O NOUN
NCT00979589 O NOUN
. O PUNCT

Journal-Name:Complementary O ADJ
therapies O NOUN
in O ADP
clinical O ADJ
practice O NOUN

BACKGROUND: O NOUN
Radical O ADJ
prostatectomy O NOUN
reduces O NOUN
mortality O NOUN
among O ADP
men O NOUN
with O ADP
clinically O ADV
detected O VERB
localized O VERB
prostate O NOUN
cancer, O NOUN
but O CCONJ
evidence O NOUN
from O ADP
randomized O VERB
trials O NOUN
with O ADP
long-term O NOUN
follow-up O NOUN
is O VERB
sparse. O NOUN

Title: O NOUN
Phase O NOUN
1 O NUM
Trial O NOUN
of O ADP
an O DET
RNA O NOUN
Interference O NOUN
Therapy O NOUN
for O ADP
Acute O ADJ
Intermittent O ADJ
Porphyria. O NOUN

Publication O NOUN
date: O NOUN
2019/02/13 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
This O DET
is O VERB
the O DET
first O ADV
prognostic O ADJ
factor O NOUN
analysis O NOUN
in O ADP
NSCLC O NOUN
performed O VERB
on O ADP
data O NOUN
from O ADP
a O DET
large O ADJ
prospective O ADJ
study. O NOUN

METHODS: O NOUN
Clinical O ADJ
and O CCONJ
randomized O VERB
trial O NOUN
with O ADP
follow-up O NOUN
of O ADP
three O NUM
months. O NOUN

We O PRON
have O VERB
shown O VERB
that O ADP
a O DET
diet O NOUN
intervention O NOUN
postpartum O NOUN
produced O VERB
a O DET
2-y O NOUN
weight O NOUN
loss O NOUN
of O ADP
8%. O NOUN

In O ADP
the O DET
primary O ADJ
analysis, O NOUN
the O DET
mean O NOUN
microvascular B-outcome ADJ
obstruction I-outcome NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
the O DET
20-mg O NOUN
alteplase O NOUN
and O CCONJ
placebo O NOUN
groups O NOUN
(3.5% O NOUN
vs O CCONJ
2.3%; O NOUN
estimated O VERB
difference, O NOUN
1.16%; O NOUN
95% O NOUN
CI, O NOUN
-0.08% O NOUN
to O PART
2.41%; O NOUN
P O NOUN
= O SYM
.32) O NOUN
nor O CCONJ
in O ADP
the O DET
analysis O NOUN
of O ADP
10-mg O NOUN
alteplase O NOUN
vs O CCONJ
placebo O NOUN
groups O NOUN
(2.6% O NOUN
vs O CCONJ
2.3%; O NOUN
estimated O VERB
difference, O NOUN
0.29%; O NOUN
95% O NOUN
CI, O NOUN
-0.76% O NUM
to O PART
1.35%; O NOUN
P O NOUN
= O SYM
.74). O PUNCT

Results O NOUN
The O DET
mean O NOUN
age O NOUN
of O ADP
the O DET
participants O NOUN
was O VERB
85.2 O NUM
years. O NOUN

The O DET
clinical O ADJ
value O NOUN
of O ADP
OPEP O NOUN
has O VERB
been O VERB
widely O ADV
discussed O VERB
in O ADP
chronic O ADJ
obstructive O ADJ
pulmonary O ADJ
disease, O NOUN
bronchiectasis O NOUN
as O ADP
well O ADV
as O ADP
pulmonary O ADJ
cyst. O NOUN

Publication O NOUN
date: O NOUN
2018/09/05 O NOUN
00:00 O NOUN
[accepted] O ADV

Except O ADP
for O ADP
the O DET
number O NOUN
of O ADP
infarctions, O NOUN
size O NOUN
and O CCONJ
location O NOUN
should O VERB
also O ADV
be O VERB
considered O VERB
to O PART
stratify O NOUN
risk O NOUN
of O ADP
stroke O NOUN
recurrence O NOUN
in O ADP
minor O ADJ
stroke. O NOUN

Eligible O ADJ
infants O NOUN
were O VERB
randomly O ADV
assigned O VERB
(1:1) O NOUN
to O PART
receive O VERB
either O CCONJ
enteral O ADJ
bovine O ADJ
lactoferrin O NOUN
(150 O NUM
mg/kg O NOUN
per O ADP
day; O NOUN
maximum O NOUN
300 O NUM
mg/day; O ADV
lactoferrin O NOUN
group) O ADJ
or O CCONJ
sucrose O NOUN
(same O NUM
dose; O NOUN
control O NOUN
group) O ADJ
once O ADP
daily O ADJ
until O ADP
34 O NUM
weeks' O ADP
postmenstrual O NOUN
age. O ADJ

BACKGROUND: O NOUN
Endotracheal O ADP
intubation O NOUN
for O ADP
general O ADJ
anesthesia O NOUN
causes O NOUN
postoperative O ADJ
sore O ADV
throat O NOUN
(POST). O NOUN

Publication O NOUN
date: O NOUN
2018/10/31 O NOUN
00:00 O NOUN
[accepted] O ADV

No O DET
further O ADV
group O NOUN
differences O NOUN
were O VERB
found. O NOUN

Title: O NOUN
Bag-Mask O NOUN
Ventilation O NOUN
during O ADP
Tracheal O ADJ
Intubation O NOUN
of O ADP
Critically O ADV
Ill O NOUN
Adults. O NOUN

PATIENTS O NOUN
OR O CCONJ
OTHER O ADJ
PARTICIPANTS: O NOUN
Seventy-two O NUM
elite O ADP
asymptomatic O ADJ
overhead O ADP
athletes O NOUN
(age O NOUN
= O SYM
17.00 O NUM
+/- O SYM
4.09 O NUM
years, O NOUN
height O NOUN
= O SYM
1.75 O NUM
+/- O SYM
0.11 O NUM
m, O NOUN
mass O NOUN
= O SYM
67.26 O NUM
+/- O SYM
15.25 O NUM
kg, O NOUN
body O NOUN
mass O NOUN
index O NOUN
= O SYM
21.80 O NUM
+/- O SYM
3.00). O NOUN

Journal O ADJ
ID: O NOUN
0014171 O NUM

Result/Key O NOUN
findings. O NOUN

Three O NUM
patients O NOUN
died B-outcome VERB
in O ADP
group O NOUN
A O DET
and O CCONJ
11 O NUM
patients O NOUN
died B-outcome VERB
in O ADP
group O NOUN
B O NOUN
during O ADP
the O DET
3-year O NOUN
follow-up. O PUNCT

Findings O NOUN
will O VERB
contribute O NOUN
to O PART
a O DET
better O ADJ
understanding O VERB
of O ADP
the O DET
optimal O ADJ
distribution O NOUN
mechanisms O NOUN
of O ADP
repellent, O NOUN
context O NOUN
specific O ADJ
effectiveness O NOUN
and O CCONJ
inform O NOUN
policy O NOUN
makers O NOUN
and O CCONJ
implementers O NOUN
of O ADP
malaria O NOUN
elimination O NOUN
programs O NOUN
in O ADP
the O DET
GMS. O NOUN

The O DET
secondary O ADJ
aim O ADP
was O VERB
to O PART
examine O NOUN
if O ADP
serum O NOUN
25(OH)D B-outcome NUM
is O VERB
a O DET
predictor O NOUN
of O ADP
testosterone B-outcome NOUN
and O CCONJ
cortisol B-outcome NOUN
levels. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Medicine O NOUN

Journal O ADJ
ID: O NOUN
101090220 O NUM

The O DET
subjects O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
received O VERB
ET O NOUN
plus O CCONJ
montelukast, O NOUN
while O ADP
the O DET
participants O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
received O VERB
montelukast O NOUN
alone. O NOUN

Decompression O NOUN
could O VERB
be O VERB
cost-effective O ADJ
in O ADP
the O DET
longer-term, O NOUN
but O CCONJ
results O NOUN
of O ADP
this O DET
analysis O NOUN
are O VERB
sensitive O ADJ
to O PART
the O DET
assumptions O NOUN
made O VERB
about O ADV
how O ADP
costs O NOUN
and O CCONJ
QALYs O NOUN
are O VERB
extrapolated O VERB
beyond O ADP
the O DET
follow-up O NOUN
of O ADP
the O DET
trial. O NOUN

The O DET
effects O NOUN
were O VERB
analyzed O VERB
by O ADP
the O DET
time B-outcome NOUN
to I-outcome PART
end I-outcome NOUN
the Seperator DET
task I-outcome NOUN
after O ADP
overcoming O VERB
the O DET
learning O VERB
curve O NOUN
which O ADP
is O VERB
determined O VERB
by O ADP
several O ADJ
performance B-outcome NOUN
parameters. O NOUN

Journal O ADJ
ID: O NOUN
9424324 O NUM

A O DET
nonsignificant O ADJ
elevation O NOUN
of O ADP
serum O NOUN
norepinephrine B-outcome NOUN
and O CCONJ
epinephrine B-outcome NOUN
levels O NOUN
was O VERB
observed O VERB
in O ADP
the O DET
methohexital O ADJ
group, O NOUN
while O ADP
serum O NOUN
arginine B-outcome NOUN
vasopressin I-outcome NOUN
and O CCONJ
angiotensin B-outcome NOUN
II I-outcome NUM
levels O NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
groups. O NOUN

Journal-Name: O NOUN
The O DET
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

CONCLUSIONS: O NOUN
We O PRON
have O VERB
developed O VERB
an O DET
automated, O VERB
accurate, O NOUN
and O CCONJ
precise O ADJ
assay O NOUN
for O ADP
the O DET
determination O NOUN
of O ADP
belatacept O ADV
serum O NOUN
concentrations. O NUM

Talbot O NOUN
Advisors, O NOUN
Anna O ADP
Maria, O NOUN
FL. O NOUN

Primary O ADJ
endpoint O NOUN
was O VERB
the O DET
ratio B-outcome NOUN
of I-outcome ADP
operator I-outcome NOUN
received I-outcome VERB
dose I-outcome NOUN
in X PUNCT
mrem X NOUN
to I-outcome PART
total I-outcome ADJ
radiation I-outcome NOUN
in O ADP
Gyat O ADJ
the O DET
end O NOUN
of O ADP
the O DET
procedure O NOUN
which O ADP
was O VERB
designated O VERB
''Relative O ADJ
operator O NOUN
exposure'', O NOUN
with O ADP
or O CCONJ
without O ADP
RADPAD. O NOUN

Patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
in O ADP
a O DET
3:2 O NOUN
ratio O NOUN
to O PART
oral O ADJ
ixazomib O NOUN
or O CCONJ
matching O VERB
placebo O NOUN
on O ADP
days O NOUN
1, O NOUN
8, O NOUN
and O CCONJ
15 O NUM
in O ADP
28-day O NOUN
cycles O NOUN
for O ADP
2 O NUM
years O NOUN
following O VERB
induction, O NOUN
high-dose O NOUN
therapy, O NOUN
and O CCONJ
transplantation. O ADV

Reactive B-outcome ADJ
agility I-outcome NOUN
, O PUNCT
our O ADJ
primary O ADJ
outcome, O ADJ
was O VERB
determined O VERB
by O ADP
measuring O VERB
the O DET
number O NOUN
of O ADP
hits B-outcome NOUN
and O CCONJ
average O NOUN
reaction B-outcome NOUN
time I-outcome NOUN
(ART) O NOUN
on O ADP
a O DET
Makoto O NOUN
Arena O NOUN
II, O NOUN
a O DET
360(0) O NUM
audio-visual O ADJ
device O NOUN
that O ADP
measures O NOUN
stationary, B-outcome NOUN
lateral, B-outcome NOUN
and Seperator CCONJ
multi-directional B-outcome ADJ
active I-outcome ADJ
choice I-outcome NOUN
reaction I-outcome NOUN
performance E4-outcome NOUN
. O PUNCT
Safety O NOUN
was O VERB
evaluated O VERB
using O VERB
complete O ADJ
blood B-outcome NOUN
count I-outcome NOUN
, O PUNCT
comprehensive O ADJ
metabolic B-outcome ADJ
panel I-outcome NOUN
, O PUNCT
and O CCONJ
blood B-outcome NOUN
lipids I-outcome NOUN
. O PUNCT
Measurements O NOUN
were O VERB
evaluated O VERB
on O ADP
days O NOUN
7, O NUM
30, O NUM
and O CCONJ
90 O NUM
of O ADP
supplementation. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

However, O ADV
no O DET
studies O NOUN
have O VERB
yet O ADV
documented O VERB
the O DET
utility O NOUN
of O ADP
and O CCONJ
student O NOUN
response O NOUN
to O PART
videoconference O NOUN
meetings O NOUN
for O ADP
mid-clerkship O NOUN
feedback O NOUN
(MCF) O NOUN
sessions O NOUN
required O VERB
by O ADP
the O DET
Liaison O NOUN
Committee O NOUN
on O ADP
Medical O ADJ
Education O NOUN
(LCME). O NOUN

During O ADP
the O DET
trial O NOUN
treatment O NOUN
period, O NOUN
three O NUM
patients O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
died B-outcome VERB
. O PUNCT
One O NUM
patient O NOUN
in O ADP
the O DET
caplacizumab O NOUN
group O NOUN
died B-outcome VERB
from O ADP
cerebral O ADJ
ischemia O NOUN
after O ADP
the O DET
end O NOUN
of O ADP
the O DET
treatment O NOUN
period. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
lowest O ADV
oxygen B-outcome NOUN
saturation I-outcome NOUN
observed O VERB
during O ADP
the O DET
interval O NOUN
between O ADP
induction O NOUN
and O CCONJ
2 O NUM
minutes O NOUN
after O ADP
tracheal O ADJ
intubation. O ADV

The O DET
data O NOUN
was O VERB
analyzed O VERB
via O ADP
SPSS-21 O NOUN
using O VERB
descriptive O ADJ
statistics O NOUN
such O ADJ
as O ADP
mean, O NOUN
standard O ADJ
deviation, O NOUN
and O CCONJ
frequency; O NOUN
and O CCONJ
inferential O ADJ
statistics O NOUN
such O ADJ
as O ADP
Chi O NOUN
Squared, O NOUN
Kruskal O NOUN
Wallis O NOUN
test, O NUM
and O CCONJ
Friedman O NOUN
test. O NOUN

Title: O NOUN
Cobalt O NOUN
chromium-Titanium O NOUN
rods O NOUN
versus O CCONJ
Titanium-Titanium O NOUN
rods O NOUN
for O ADP
treatment O NOUN
of O ADP
adolescent O NOUN
idiopathic O ADJ
scoliosis; O ADJ
which O ADP
type O NOUN
of O ADP
rod O NOUN
has O VERB
better O ADJ
postoperative O ADJ
outcomes? O NOUN

The O DET
survey O NOUN
also O ADV
collected O VERB
data O NOUN
on O ADP
these O DET
demographic O ADJ
variables: O NOUN
the O DET
name O NOUN
of O ADP
the O DET
faculty O NOUN
member O NOUN
with O ADP
whom O ADP
the O DET
student O NOUN
met; O NOUN
student O NOUN
gender, O NOUN
age, O NOUN
and O CCONJ
interest O NOUN
in O ADP
EM; O NOUN
location O NOUN
prior O ADJ
to O PART
meeting; O ADJ
meeting-method O NOUN
preference; O ADJ
and O CCONJ
number O NOUN
of O ADP
EM O NOUN
shifts O NOUN
completed. O NOUN

For O ADP
dexmedetomidine O NOUN
vs O CCONJ
propofol, O NOUN
only O ADV
breakthrough O NOUN
analgesia O NOUN
was O VERB
significantly O ADV
different O ADJ
(median, O NOUN
328.8 O NUM
vs O CCONJ
397.5 O NUM
microg; O NOUN
difference, O NOUN
-69 O NUM
[95% O NOUN
CI, O NOUN
-155 O NUM
to O PART
-4]; O NOUN
P O NOUN
= O SYM
.04). O PUNCT

The O DET
rates O NOUN
of O ADP
dyskinesia B-outcome ADJ
and O CCONJ
levodopa-related O VERB
fluctuations O NOUN
in O ADP
motor B-outcome NOUN
response I-outcome NOUN
did O VERB
not O ADV
differ O VERB
significantly O ADV
between O ADP
the O DET
two O NUM
groups. O NOUN

Publication O NOUN
date: O NOUN
2019/01/04 O VERB
06:00 O ADP
[entrez] O ADP

INTERPRETATION: O CCONJ
Enteral O ADJ
supplementation O NOUN
with O ADP
bovine O ADJ
lactoferrin O NOUN
does O VERB
not O ADV
reduce O VERB
the O DET
risk O NOUN
of O ADP
late-onset O NOUN
infection B-outcome NOUN
in O ADP
very O ADV
preterm O NOUN
infants. O NOUN

CONCLUSION: O NOUN
Both O CCONJ
drugs O NOUN
reduced O VERB
menstrual B-outcome ADJ
pain I-outcome NOUN
. O PUNCT
Ginger O NOUN
as O ADP
well O ADV
as O ADP
Novafen O NOUN
is O VERB
effective O ADJ
in O ADP
relieving O VERB
pain B-outcome NOUN
in O ADP
girls O NOUN
with O ADP
primary O ADJ
dysmenorrhea O ADJ
. O PUNCT

Further O ADV
controlled O VERB
prospective O ADJ
studies O NOUN
are O VERB
needed O VERB
to O PART
confirm O NOUN
these O DET
results. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Prospectively O ADV
registered O VERB
at O ADP
ClinicalTrials. O NOUN

OBJECTIVE: O NOUN
To O PART
evaluate O VERB
performance B-outcome NOUN
on O ADP
a O DET
computer O NOUN
task O NOUN
in O ADP
individuals O NOUN
with O ADP
ALS O NOUN
using O VERB
three O NUM
different O ADJ
commonly O ADV
used O VERB
non-immersive O ADJ
devices. O ADJ

This O DET
was O VERB
an O DET
educational O ADJ
tool O NOUN
which O ADP
aimed O VERB
to O PART
remind O VERB
mothers O NOUN
in O ADP
rural O ADJ
Uganda O ADP
to O PART
clean O NOUN
their O ADJ
hands O NOUN
to O PART
prevent O NOUN
neonatal O ADJ
infection. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
date: O NOUN
2019/01/22 O ADJ
06:00 O ADP
[medline] O NOUN

Title: O NOUN
Effects O NOUN
of O ADP
Instruction O NOUN
on O ADP
Parent O NOUN
Competency B-outcome NOUN
During O ADP
Infant O NOUN
Handling O VERB
in O ADP
a O DET
Neonatal O ADJ
Intensive O ADJ
Care O NOUN
Unit. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
date: O NOUN
2019/01/29 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSIONS: O NOUN
In O ADP
well-controlled O VERB
T2DM O NOUN
a O DET
modest O ADJ
reduction O NOUN
of O ADP
dietary O ADJ
carbohydrate O NOUN
with O ADP
a O DET
corresponding O VERB
increase O NOUN
in O ADP
protein O NOUN
and O CCONJ
fat O NOUN
acutely O ADV
reduced O VERB
postprandial O ADJ
serum O NOUN
non-esterified B-outcome VERB
fatty I-outcome ADJ
acid I-outcome NOUN
suppression O NOUN
and O CCONJ
increased O VERB
serum O NOUN
triglyceride B-outcome NOUN
(TG) I-outcome NOUN
responses O NOUN
after O ADP
a O DET
breakfast O NOUN
meal O ADJ
but O CCONJ
had O VERB
the O DET
opposite O ADJ
effect O NOUN
after O ADP
a O DET
lunch O NOUN
meal. O NOUN

BACKGROUND/AIMS: O NOUN
The O DET
present O ADJ
study O NOUN
aimed O VERB
to O PART
investigate O NOUN
the O DET
serum O NOUN
levels O NOUN
of O ADP
adiponectin O NOUN
(APN) O NUM
and O CCONJ
adiponectin O NOUN
receptor O NOUN
1 O NUM
(AdipoR1) O NOUN
in O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
mellitus O NOUN
(T2DM) O NOUN
combined O VERB
with O ADP
macrovascular O ADJ
complications O NOUN
(MVC), O NUM
as O ADP
well O ADV
as O ADP
their O ADJ
correlation O NOUN
with O ADP
clinical O ADJ
parameters. O NOUN

METHODS: O NOUN
Participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
the O DET
CART O NOUN
group O NOUN
that O ADP
performed O VERB
combined O VERB
aerobic O ADJ
and O CCONJ
resistance O NOUN
exercise O NOUN
of O ADP
moderate O ADJ
intensity O NOUN
[aerobic O NOUN
exercise O NOUN
50-80% O NUM
of O ADP
HRmax O NOUN
(maximum O NOUN
heart O NOUN
rate) O NOUN
and O CCONJ
resistance O NOUN
exercises O NOUN
at O ADP
50-80% O NUM
of O ADP
1 O NUM
Repetition O NOUN
Maximum O NOUN
(RM)], O NOUN
5 O NUM
times/week O DET
for O ADP
4 O NUM
weeks, O NOUN
or O CCONJ
to O PART
the O DET
control O NOUN
group O NOUN
that O ADP
followed O VERB
conventional O ADJ
treatment O NOUN
without O ADP
any O DET
supervised O VERB
exercise O NOUN
intervention. O NOUN

This O DET
will O VERB
help O VERB
to O PART
determine O NOUN
if O ADP
routine O ADJ
selenium O NOUN
supplementation O NOUN
in O ADP
HIV-infected O VERB
pregnant O ADJ
women O NOUN
will O VERB
contribute O NOUN
to O PART
the O DET
improvement O NOUN
in O ADP
the O DET
major O ADJ
adverse B-outcome ADJ
pregnancy I-outcome NOUN
outcomes I-outcome NOUN
such O ADJ
as O ADP
preterm B-outcome NOUN
birth I-outcome NOUN
and O CCONJ
low B-outcome ADJ
birth I-outcome NOUN
weight I-outcome NOUN
and O CCONJ
the O DET
HIV B-outcome NOUN
disease I-outcome NOUN
surrogate O ADJ
markers O NOUN
such O ADJ
as O ADP
CD4+ B-outcome NOUN
cells I-outcome NOUN
count I-outcome NOUN
and O CCONJ
viral B-outcome ADJ
load I-outcome NOUN
. O PUNCT
TRIAL O NOUN
REGISTRATION: O NOUN
PACTR, O ADJ
PACTR201809756724274. O NOUN

In O ADP
conclusion, O NOUN
cashews O NOUN
provide O VERB
fewer O ADJ
calories O NOUN
than O ADP
the O DET
values O NOUN
predicted O VERB
by O ADP
the O DET
Atwater O ADV
factors, O NOUN
as O ADP
found O VERB
on O ADP
current O ADJ
food O NOUN
labels. O NOUN

In O ADP
SAT, O NOUN
when O ADP
compared O VERB
with O ADP
the O DET
control O NOUN
group, O NOUN
the O DET
effect O NOUN
of O ADP
FF O NOUN
on O ADP
decreasing O VERB
IL1RN O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
was O VERB
significant O ADJ
(P O NUM
< O SYM
0.03). O NUM

PMP O NOUN
supplementation O NOUN
for O ADP
eight O NUM
weeks O NOUN
reduced O VERB
reactive B-outcome ADJ
oxygen I-outcome NOUN
species I-outcome NOUN
(ROS) I-outcome PUNCT
and O CCONJ
prevented O VERB
DNA B-outcome NOUN
damage I-outcome NOUN
without O ADP
altering O VERB
endogenous O ADJ
antioxidant O NOUN
system. O NOUN

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
388 O NUM
subjects O NOUN
were O VERB
included O VERB
in O ADP
the O DET
primary O ADJ
efficacy O NOUN
analysis. O NOUN

MAIN O ADJ
OUTCOME O NOUN
MEASURE(S): O NOUN
We O PRON
evaluated O VERB
all O DET
groups O NOUN
for O ADP
observable O ADJ
scapular B-outcome ADJ
dyskinesis I-outcome NOUN
using O VERB
the O DET
scapular O ADJ
dyskinesis O NOUN
test, O NUM
scapular B-outcome ADJ
upward I-outcome ADJ
rotation I-outcome NOUN
using O VERB
a O DET
digital O ADJ
inclinometer, O NOUN
and O CCONJ
pectoralis B-outcome NOUN
minor I-outcome ADJ
length I-outcome NOUN
using O VERB
the O DET
pectoralis O NOUN
minor O ADJ
index O NOUN
at O ADP
baseline, O NOUN
immediately O ADV
after O ADP
taping, O NOUN
and O CCONJ
at O ADP
60 O NUM
to O PART
72 O NUM
hours O NOUN
after O ADP
taping. O NOUN

Baseline O NOUN
characteristics O NOUN
differed O VERB
between O ADP
genders, O NOUN
with O ADP
women O NOUN
being O VERB
younger, O NOUN
having O VERB
better O ADJ
lung O NOUN
function O NOUN
and O CCONJ
more O ADV
often O ADV
experiencing O VERB
>/=2 O NOUN
exacerbations O NOUN
in O ADP
the O DET
previous O ADJ
year. O NOUN

Nervous O ADJ
tissues O NOUN
may O VERB
be O VERB
less O ADV
prone O NOUN
to O PART
low O ADJ
DHA B-outcome NOUN
levels O NOUN
after O ADP
infancy, O ADJ
or O CCONJ
higher O ADJ
doses O NOUN
might O VERB
be O VERB
required O VERB
to O PART
impact O NOUN
neurological B-outcome ADJ
functions I-outcome NOUN
. O PUNCT
In O ADP
situations O NOUN
of O ADP
minimal O ADJ
dietary O ADJ
DHA, O NOUN
endogenous O ADJ
synthesis O NOUN
of O ADP
DHA O NOUN
from O ADP
alpha-linolenic O ADJ
acid O NOUN
could O VERB
relevantly O ADV
contribute O NOUN
to O PART
DHA B-outcome NOUN
status. O NOUN

At O ADP
the O DET
end O NOUN
of O ADP
4-week O NOUN
follow-up, O ADP
there O PRON
were O VERB
also O ADV
no O DET
significant O ADJ
differences O NOUN
regarding O VERB
the O DET
post-voiding B-outcome VERB
residual I-outcome ADJ
urine I-outcome NOUN
volume I-outcome NOUN
(PV-VRU) I-outcome PUNCT
(P O NUM
= O SYM
.42), O PUNCT
voided B-outcome VERB
volume I-outcome NOUN
(P O NUM
= O SYM
.71), O PUNCT
maximum B-outcome NOUN
urinary I-outcome ADJ
flow I-outcome NOUN
rate O NOUN
(Qmax) O PUNCT
(P O NUM
= O SYM
.24), O PUNCT
and O CCONJ
Barthel O PROPN
Index O NOUN
(BI) O NOUN
scores O NOUN
(P O NUM
= O SYM
.75) O ADP
between O ADP
2 O NUM
groups. O NOUN

To O PART
ensure O NOUN
adequate O ADJ
input O NOUN
and O CCONJ
secure O ADJ
implementation, O ADP
study O NOUN
design O NOUN
and O CCONJ
results O NOUN
will O VERB
be O VERB
reviewed O VERB
with O ADP
relevant O ADJ
stakeholders, O NOUN
including O VERB
the O DET
children's O NOUN
families, O NOUN
and O CCONJ
provincial O ADJ
and O CCONJ
regional O ADJ
decision-makers. O NOUN

Measures O NOUN
included O VERB
a O DET
composite O NOUN
strength B-outcome NOUN
score O NOUN
(bench O NUM
press O NOUN
+ O SYM
squat). O NOUN

FINDINGS: O ADJ
Between O ADP
Jan O NOUN
24, O NUM
2013, O NUM
and O CCONJ
Nov O NOUN
7, O NUM
2016, O NUM
601 O NUM
patients O NOUN
assessed O VERB
for O ADP
eligibility, O NOUN
of O ADP
whom O ADP
452 O NUM
patients O NOUN
were O VERB
enrolled O VERB
and O CCONJ
226 O NUM
were O VERB
randomly O ADV
assigned O VERB
to O PART
both O CCONJ
the O DET
A+CHP O ADV
group O NOUN
and O CCONJ
the O DET
CHOP O VERB
group. O VERB

RESULTS: O NOUN
The O DET
diet O NOUN
and O CCONJ
exercise O NOUN
plus O CCONJ
diet O NOUN
group O NOUN
lost O VERB
6.1 O NUM
and O CCONJ
6.9% O NOUN
body B-outcome NOUN
weight I-outcome NOUN
, O PUNCT
respectively. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Consequently, O NOUN
the O DET
overall B-outcome ADJ
pain I-outcome NOUN
decreased O VERB
in O ADP
EMLA O NOUN
group O NOUN
and O CCONJ
TPI O NOUN
group O NOUN
(P O NUM
= O SYM
.023). O PUNCT

BACKGROUND: O NOUN
This O DET
study O NOUN
investigated O VERB
the O DET
effectiveness O NOUN
and O CCONJ
safety O NOUN
of O ADP
exercise O NOUN
training O VERB
(ET) O NOUN
as O ADP
an O DET
adjunctive O ADJ
therapy O NOUN
to O PART
montelukast O NOUN
for O ADP
children O NOUN
with O ADP
mild O ADJ
asthma O NOUN
(MA). O PUNCT

Journal O ADJ
ID: O NOUN
8910750 O NUM

The O DET
HIIT O NOUN
and O CCONJ
MICT O NOUN
groups O NOUN
were O VERB
offered O VERB
three O NUM
exercise O NOUN
sessions O NOUN
per O ADP
week O NOUN
for O ADP
the O DET
first O ADV
12 O NUM
weeks. O NOUN

PMID: O NOUN
31618331 O NUM

The O DET
drainage B-outcome NOUN
volume I-outcome NOUN
on O ADP
the O DET
1st O ADJ
day O NOUN
and O CCONJ
the O DET
2nd O ADJ
to O PART
4th O ADP
day O NOUN
after O ADP
operation O NOUN
in O ADP
the O DET
AGS O NOUN
group O NOUN
was O VERB
less O ADV
than O ADP
that O ADP
in O ADP
the O DET
control O NOUN
group O NOUN
(P O NUM
= O SYM
.015, O PUNCT
P O NOUN
= O SYM
.010). O PUNCT

RESULTS: O NOUN
The O DET
mean O NOUN
age O NOUN
in O ADP
the O DET
2 O NUM
groups O NOUN
was O VERB
similar O ADJ
and O CCONJ
almost O ADV
equal O ADJ
to O PART
52 O NUM
years; O NOUN
there O PRON
was O VERB
no O DET
difference O NOUN
in O ADP
the O DET
sex O NOUN
ratios O NOUN
in O ADP
both O CCONJ
groups O NOUN
(P O NUM
> O SYM
.05). O NUM

Segmental O ADJ
muscle O NOUN
vibration O NOUN
(SMV) O NOUN
is O VERB
one O NUM
of O ADP
the O DET
interventions O NOUN
that O ADP
incorporate O VERB
sensory O ADJ
stimulation O NOUN
to O PART
improve O VERB
motor O NOUN
cortical O ADJ
excitability. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Intensive O ADJ
vs O CCONJ
Standard O NOUN
Blood O NOUN
Pressure O NOUN
Control O NOUN
on O ADP
Probable O ADJ
Dementia B-outcome NOUN
: O PUNCT
A O DET
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

METHODS: O NOUN
An O DET
open-label, O ADV
randomised O VERB
controlled O VERB
trial O NOUN
will O VERB
be O VERB
conducted O VERB
in O ADP
school-aged O VERB
children O NOUN
(5 O PUNCT
to O PART
18 O NUM
years) O NOUN
from O ADP
the O DET
region O NOUN
of O ADP
Taabo, O ADP
Cote O NOUN
d'Ivoire, O NOUN
an O DET
area O NOUN
endemic O ADJ
for O ADP
S. O NOUN
mansoni. O NOUN

No O DET
clinically O ADV
significant O ADJ
alterations O NOUN
in O ADP
the O DET
alpha- B-outcome NOUN
and Seperator CCONJ
beta- B-outcome NOUN
diversity I-outcome NOUN
of I-outcome ADP
gut I-outcome NOUN
microbiota E4-outcome NOUN
and O CCONJ
associated O VERB
metabolic O ADJ
pathways O NOUN
were O VERB
evident. O NOUN

Blood O NOUN
samples O NOUN
were O VERB
taken O VERB
immediately O ADV
before, O NOUN
immediately O ADV
after O ADP
and O CCONJ
30 O NUM
min O NOUN
post-exercise O NOUN
to O PART
determine O NOUN
plasma O NOUN
albumin B-outcome NOUN
, O PUNCT
total O ADJ
protein B-outcome NOUN
, O PUNCT
glucose B-outcome NOUN
, O PUNCT
oxidative B-outcome ADJ
stress I-outcome NOUN
and O CCONJ
muscle B-outcome NOUN
damage I-outcome NOUN
markers. O NOUN

Compared O VERB
with O ADP
before O ADP
treatment, O NOUN
serum O NOUN
SOD B-outcome NOUN
level O NOUN
were O VERB
all O DET
increased O VERB
and O CCONJ
malondialdehyde B-outcome NOUN
(MDA) I-outcome NOUN
level O NOUN
were O VERB
all O DET
decreased O VERB
in O ADP
the O DET
three O NUM
groups O NOUN
after O ADP
treatment O NOUN
P<0.05. O NOUN

The O DET
main O ADJ
goal O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
assess O NOUN
the O DET
effects O NOUN
of O ADP
caffeine O NOUN
supplementation O NOUN
on O ADP
time B-outcome NOUN
under Seperator ADP
tension I-outcome NOUN
(TUT) I-outcome PUNCT
and O CCONJ
the O DET
number O NOUN
of O ADP
performed O VERB
repetitions B-outcome NOUN
(REP) I-outcome PUNCT
. O PUNCT
The O DET
second O ADJ
objective O ADP
was O VERB
to O PART
determine O NOUN
the O DET
effects O NOUN
of O ADP
CAF O NOUN
supplementation O NOUN
on O ADP
power B-outcome NOUN
(P) I-outcome NUM
and O CCONJ
movement B-outcome NOUN
velocity I-outcome NOUN
(V) I-outcome NUM
during O ADP
the O DET
bench O NOUN
press O NOUN
movement. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrial.gov O NOUN
: O PUNCT
NCT01015716 O ADJ
, O PUNCT
registration O NOUN
data O NOUN
14.12.2010 O NOUN
(Prospectively O ADV
registered). O ADP

(1) O PUNCT
Background: O NOUN
Spirulina O NOUN
(Arthrospira) O PUNCT
maxima O NOUN
has O VERB
shown O VERB
beneficial O ADJ
effects O NOUN
such O ADJ
as O ADP
being O VERB
anti-dyslipidemic, O NOUN
antiviral, O ADJ
antioxidant O NOUN
and O CCONJ
antihypertensive. O NOUN

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
investigate O NOUN
the O DET
influence O NOUN
of O ADP
5-minute O NOUN
SMV O NOUN
application O NOUN
along O ADV
with O ADP
supervised O VERB
physical O ADJ
therapy O NOUN
(SPT) O NUM
on O ADP
improving O VERB
activities B-outcome NOUN
of I-outcome ADP
daily I-outcome ADJ
living I-outcome VERB
and O CCONJ
motor B-outcome NOUN
recovery I-outcome NOUN
on O ADP
the O DET
hemiparetic O ADJ
upper O ADJ
extremity O NOUN
in O ADP
patients O NOUN
with O ADP
stroke. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Our O ADJ
aim O ADP
is O VERB
to O PART
assess O NOUN
the O DET
effectiveness O NOUN
of O ADP
a O DET
multifactorial O ADJ
intervention O NOUN
to O PART
improve O VERB
adherence O NOUN
to O PART
the O DET
MD, O ADV
diet O NOUN
quality O NOUN
and O CCONJ
biomedical O ADJ
parameters. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

BACKGROUND: O NOUN
Belatacept O NOUN
(Nulojix; O PUNCT
Bristol-Myers O NOUN
Squibb, O NOUN
New O ADJ
York, O ADJ
NY) O NOUN
is O VERB
a O DET
biological O ADJ
immunosuppressive O ADJ
drug O NOUN
used O VERB
for O ADP
the O DET
prophylaxis O NOUN
of O ADP
acute O ADJ
rejection O NOUN
after O ADP
renal O ADJ
transplantation. O ADV

5-year O ADJ
overall B-outcome ADJ
survival I-outcome NOUN
, O PUNCT
relapse-free B-outcome ADJ
survival I-outcome NOUN
, O PUNCT
and O CCONJ
non-relapse B-outcome VERB
mortality I-outcome NOUN
did O VERB
not O ADV
differ O VERB
significantly O ADV
between O ADP
groups. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Participants O NOUN
assigned O VERB
to O PART
both O CCONJ
conditions O NOUN
experienced O VERB
similar O ADJ
benefits O NOUN
regarding O VERB
anxio-depressive B-outcome ADJ
symptoms I-outcome NOUN
and O CCONJ
aging-related O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
. O PUNCT
General O NOUN
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
and O CCONJ
memory B-outcome NOUN
remained O VERB
unchanged. O NOUN

Intraoperative O ADJ
measures O NOUN
included O VERB
anesthetic B-outcome ADJ
concentration, O NOUN
EEG B-outcome NOUN
suppression I-outcome NOUN
, O PUNCT
and O CCONJ
hypotension B-outcome NOUN
. O PUNCT
Adverse B-outcome ADJ
events I-outcome NOUN
included O VERB
undesirable B-outcome ADJ
intraoperative I-outcome ADJ
movement I-outcome NOUN
, O PUNCT
intraoperative B-outcome ADJ
awareness I-outcome ADV
with Seperator ADP
recall I-outcome NOUN
, O PUNCT
postoperative O ADJ
nausea B-outcome NOUN
and Seperator CCONJ
vomiting I-outcome VERB
, O PUNCT
medical O ADJ
complications B-outcome NOUN
, O PUNCT
and O CCONJ
death B-outcome NOUN
. O PUNCT
Results: O NOUN
Of O ADP
the O DET
1232 O NUM
randomized O VERB
patients O NOUN
(median O PUNCT
age, O NOUN
69 O NUM
years O NOUN
[range, O NOUN
60 O NUM
to O PART
95]; O NOUN
563 O NUM
women O NOUN
[45.7%]), O ADJ
1213 O NUM
(98.5%) O NOUN
were O VERB
assessed O VERB
for O ADP
the O DET
primary O ADJ
outcome. O NOUN

If O ADP
patients O NOUN
were O VERB
found O VERB
to O PART
have O VERB
reflux-related O VERB
heartburn, O NOUN
we O PRON
randomly O ADV
assigned O VERB
them O PRON
to O PART
receive O VERB
surgical O ADJ
treatment O NOUN
(laparoscopic O ADJ
Nissen O ADJ
fundoplication), O NOUN
active O ADJ
medical O ADJ
treatment O NOUN
(omeprazole O PUNCT
plus O CCONJ
baclofen, O NOUN
with O ADP
desipramine O NOUN
added O VERB
depending O VERB
on O ADP
symptoms), O NOUN
or O CCONJ
control O NOUN
medical O ADJ
treatment O NOUN
(omeprazole O PUNCT
plus O CCONJ
placebo). O NOUN

Slightly O ADV
over O ADP
one-quarter O NOUN
were O VERB
veterans O NOUN
of O ADP
the O DET
OEF/OIF O NOUN
wars. O ADV

There O PRON
was O VERB
also O ADV
a O DET
significant O ADJ
-decrease O NOUN
in O ADP
creatine B-outcome NOUN
phosphokinase-MB I-outcome NOUN
after O ADP
24 O NUM
hours O NOUN
in O ADP
the O DET
nicorandil O NOUN
group O NOUN
(2.7 O NOUN
ng/L) O NUM
compared O VERB
to O PART
the O DET
control O NOUN
group O NOUN
(2.0 O NOUN
ng/L), O NOUN
p O NOUN
= O SYM
0.008. O NUM

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT01206062. O NOUN

Journal-Name:The O ADJ
Tohoku O NOUN
journal O ADJ
of O ADP
experimental O ADJ
medicine O NOUN

Information O NOUN
will O VERB
be O VERB
useful O ADJ
for O ADP
educators, O NOUN
community O NOUN
stakeholders O NOUN
and O CCONJ
policy O NOUN
makers O NOUN
interested O VERB
in O ADP
developing O VERB
programs O NOUN
to O PART
promote O VERB
students' O NOUN
out-of-school O NOUN
physical B-outcome ADJ
activity I-outcome NOUN
. O PUNCT
TRIAL O NOUN
REGISTRATION: O NOUN
ISRCTN39374060 O NOUN
. O PUNCT

The O DET
smaller O ADJ
sample O NOUN
size O NOUN
for O ADP
women O NOUN
may O VERB
account O VERB
for O ADP
some O DET
observed O VERB
discrepancies O NOUN
in O ADP
treatment B-outcome NOUN
responses I-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
Although O ADP
there O PRON
were O VERB
gender O NOUN
differences O NOUN
in O ADP
baseline O NOUN
characteristics, O ADJ
IND/GLY O NOUN
demonstrated O VERB
similar O ADJ
trends O NOUN
for O ADP
exacerbation B-outcome NOUN
prevention O NOUN
and O CCONJ
lung B-outcome NOUN
function I-outcome NOUN
improvement O NOUN
in O ADP
men O NOUN
and O CCONJ
women O NOUN
with O ADP
moderate-to-very-severe O NOUN
COPD O NOUN
and O CCONJ
a O DET
history O NOUN
of O ADP
exacerbations O NOUN
compared O VERB
with O ADP
SFC. O NOUN

The O DET
Physical O ADJ
Activity O NOUN
Loyalty O NOUN
Scheme O ADV
(PAL) O NOUN
intervention O NOUN
was O VERB
based O VERB
on O ADP
high-street O NOUN
loyalty O NOUN
cards O NOUN
where O ADP
participants O NOUN
earned O VERB
points O NOUN
for O ADP
minutes O NOUN
of O ADP
activity B-outcome NOUN
that O ADP
could O VERB
be O VERB
redeemed O VERB
for O ADP
rewards, O NOUN
complemented O VERB
by O ADP
evidence-based O VERB
behaviour O NOUN
change O NOUN
techniques. O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

It O PRON
involves O NOUN
the O DET
use O NOUN
of O ADP
a O DET
non-toxic O ADJ
dye, O PUNCT
called O VERB
photosensitizer O NOUN
(FS), O NOUN
and O CCONJ
a O DET
light O NOUN
source O NOUN
of O ADP
a O DET
specific O ADJ
wavelength O NOUN
in O ADP
the O DET
presence O NOUN
of O ADP
the O DET
environmental O ADJ
oxygen. O NOUN

The O DET
scores O NOUN
of O ADP
unintentional O ADJ
injury O NOUN
risk B-outcome NOUN
behavior I-outcome NOUN
before O ADP
intervention, O ADP
3 O NUM
months O NOUN
and O CCONJ
6 O NUM
months O NOUN
after O ADP
intervention, O ADP
and O CCONJ
the O DET
frequency O NOUN
before O ADP
intervention O NOUN
and O CCONJ
6 O NUM
months O NOUN
after O ADP
intervention, O ADP
were O VERB
collected O VERB
and O CCONJ
compared. O NOUN

Participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
in O ADP
a O DET
1:1 O ADJ
ratio O NOUN
to O PART
either O CCONJ
endometrial O ADJ
scratching O VERB
(by O NOUN
pipelle O ADJ
biopsy O NOUN
between O ADP
day O NOUN
3 O NUM
of O ADP
the O DET
cycle O NOUN
preceding O VERB
the O DET
embryo-transfer O NOUN
cycle O NOUN
and O CCONJ
day O NOUN
3 O NUM
of O ADP
the O DET
embryo-transfer O NOUN
cycle) O NOUN
or O CCONJ
no O DET
intervention. O NOUN

Lean B-outcome ADJ
tissue I-outcome NOUN
mass I-outcome NOUN
increased O VERB
by O ADP
a O DET
median O ADJ
of O ADP
1.59 O NUM
kg O NOUN
and O CCONJ
fat B-outcome NOUN
mass I-outcome NOUN
decreased O VERB
by O ADP
a O DET
median O ADJ
of O ADP
1.52 O NUM
kg O NOUN
in O ADP
the O DET
exercising O VERB
group. O VERB

Journal O ADJ
ID: O NOUN
101265111 O NUM

Publication O NOUN
date: O NOUN
['2019/10/11 O NOUN
06:00' O NUM

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal O ADJ
ID: O NOUN
101212761 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
intraoperative O ADJ
or O CCONJ
postoperative O ADJ
complication B-outcome NOUN
of O ADP
grade O NOUN
II O NUM
or O CCONJ
higher O ADJ
according O ADJ
to O PART
the O DET
Clavien-Dindo O NOUN
classification O NOUN
(indicating O VERB
major O ADJ
complication B-outcome NOUN
leading O VERB
to O PART
intervention) O NOUN
within O ADP
30 O NUM
days. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/02/27 O NOUN
06:00 O ADP
[medline] O NOUN

Patients O NOUN
aged O VERB
11 O NUM
years O NOUN
or O CCONJ
older, O ADV
in O ADP
the O DET
permanent O ADJ
dentition, O NOUN
and O CCONJ
about O ADV
to O PART
start O NOUN
fixed O VERB
orthodontic O ADJ
treatment O NOUN
in O ADP
these O DET
6 O NUM
centers O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
have O VERB
either O CCONJ
resin-modified O VERB
glass O NOUN
ionomer O NOUN
cement O NOUN
or O CCONJ
light-cured O VERB
composite O NOUN
for O ADP
bonding O VERB
brackets, O NOUN
forward O ADV
of O ADP
the O DET
first O ADV
molars. O NOUN

The O DET
primary O ADJ
endpoint O NOUN
was O VERB
the O DET
response B-outcome NOUN
rate O NOUN
compared O VERB
to O PART
the O DET
historical O ADJ
response O NOUN
rate. O NOUN


METHODS: O NOUN
In O ADP
a O DET
multicenter, O NOUN
randomized O VERB
trial O NOUN
conducted O VERB
in O ADP
seven O NUM
intensive O ADJ
care O NOUN
units O NOUN
in O ADP
the O DET
United O VERB
States, O NOUN
we O PRON
randomly O ADV
assigned O VERB
adults O NOUN
undergoing O VERB
tracheal O ADJ
intubation O NOUN
to O PART
receive O VERB
either O CCONJ
ventilation O NOUN
with O ADP
a O DET
bag-mask O ADJ
device O NOUN
or O CCONJ
no O DET
ventilation O NOUN
between O ADP
induction O NOUN
and O CCONJ
laryngoscopy. O NOUN

21 O NUM
patients O NOUN
(10.29%), O NOUN
were O VERB
lost O VERB
to O PART
follow O VERB
up. O ADV

Conjunctiva B-outcome NOUN
melted I-outcome VERB
and O CCONJ
drainage B-outcome NOUN
tube I-outcome NOUN
exposed I-outcome VERB
in O ADP
0 O NUM
eyes O NOUN
(0%) O NOUN
in O ADP
the O DET
corneal O ADJ
graft O NOUN
group O NOUN
and O CCONJ
2 O NUM
eyes O NOUN
(1.6%) O PUNCT
in O ADP
the O DET
scleral O ADJ
group. O VERB

This O DET
paper's O ADJ
objective O ADP
is O VERB
to O PART
fill O NOUN
that O ADP
lack. O NOUN

PURPOSE: O NOUN
Many O ADJ
studies O NOUN
have O VERB
demonstrated O VERB
the O DET
advantage O NOUN
of O ADP
maintaining O VERB
intraoperative O ADJ
deep O ADJ
neuromuscular O ADJ
block O VERB
(NMB) O ADV
with O ADP
sugammadex. O NOUN

CONCLUSION: O NOUN
Under O ADP
the O DET
conditions O NOUN
of O ADP
the O DET
present O ADJ
study, O NOUN
the O DET
95% O NOUN
effective O ADJ
dose B-outcome NOUN
of O ADP
intrathecal O ADJ
hyperbaric O ADJ
ropivacaine O NOUN
for O ADP
successful B-outcome ADJ
spinal I-outcome ADJ
anesthesia I-outcome NOUN
for O ADP
cesarean O NOUN
section O NOUN
in O ADP
healthy O ADJ
parturient O ADJ
receiving O VERB
prophylactic O ADJ
infusion O NOUN
of O ADP
phenylephrine O NOUN
was O VERB
15.2 O NUM
mg. O NOUN

However, O ADV
in O ADP
patients O NOUN
with O ADP
a O DET
low O ADJ
BMI, O NUM
the O DET
LBW O NOUN
protocol O NOUN
delivered O VERB
a O DET
significantly O ADV
higher O ADJ
dose B-outcome NOUN
than O ADP
the O DET
TBW O NOUN
protocol O NOUN
(620.7 O PUNCT
vs O CCONJ
600.0 O NUM
mg O NOUN
iodine/kg, O NOUN
P O NOUN
< O SYM
0.001). O NUM

Ferric B-outcome ADJ
reducing I-outcome VERB
ability O NOUN
of O ADP
plasma O NOUN
and O CCONJ
vitamin B-outcome NOUN
C I-outcome NOUN
levels O NOUN
in O ADP
AA O NOUN
cohort O NOUN
significantly O ADV
increased O VERB
after O ADP
exercise O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

METHODS: O NOUN
The O DET
study O NOUN
generated O VERB
five O NUM
data O NOUN
sets. O NOUN

In O ADP
addition, O NOUN
no O DET
statistical O ADJ
significance O NOUN
between O ADP
the O DET
placebo O NOUN
and O CCONJ
the O DET
treatment O NOUN
groups O NOUN
for O ADP
any O DET
secondary O ADJ
outcomes O NOUN
were O VERB
detected. O NOUN

The O DET
risk O NOUN
ratio O NOUN
adjusted O VERB
for O ADP
minimisation O NOUN
factors O NOUN
was O VERB
0.95 O NUM
(95% O PUNCT
CI O NOUN
0.86-1.04; O NUM
p=0.233). O NOUN

Journal-Name:Maturitas O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

antibiotic O ADJ
monotherapy O NOUN
with O ADP
intravenous O ADJ
(i.v.) O NOUN

Date O NOUN
of O ADP
registration: O NOUN
September O NOUN
2009. O NUM

p<0.001). O NOUN

Among O ADP
these, O NOUN
glasses B-outcome NOUN
ownership I-outcome NOUN
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
school O NOUN
year O NOUN
was O VERB
68.6% O NUM
among O ADP
1252 O NUM
treatment O NOUN
group O NOUN
students O NOUN
(82 O PUNCT
schools), O NOUN
and O CCONJ
26.4% O NUM
(p O PUNCT
< O SYM
0.01) O NUM
among O ADP
1461 O NUM
controls O NOUN
(82 O PUNCT
schools). O NOUN

OBJECTIVE: O NOUN
To O PART
observe O NOUN
the O DET
effect O NOUN
of O ADP
Ronghuang O NOUN
granule O NOUN
on O ADP
serum O NOUN
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
23 I-outcome NUM
(FGF23) I-outcome NOUN
, O PUNCT
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
receptor I-outcome NOUN
(FGFRs) I-outcome NOUN
and O CCONJ
Klotho B-outcome NOUN
protein I-outcome NOUN
levels O NOUN
in O ADP
non-dialysis O NOUN
patients O NOUN
with O ADP
chronic O ADJ
kidney O NOUN
disease-mineral O ADJ
and O CCONJ
bone O NOUN
disorder O ADP
(CKD-MBD) O NOUN
and O CCONJ
kidney O NOUN
deficiency O NOUN
and O CCONJ
damp O NOUN
heat O NOUN
syndrome. O NOUN

We O PRON
performed O VERB
a O DET
subset O NOUN
analysis O NOUN
of O ADP
73 O NUM
patients O NOUN
who O ADP
underwent O VERB
pancreatectomy. O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
In O ADP
this O DET
blinded O VERB
randomized O VERB
trial, O NOUN
70 O NUM
patients O NOUN
were O VERB
assigned O VERB
to O PART
receive O VERB
four O NUM
500mg O NOUN
capsules O NOUN
of O ADP
green O ADV
tea O NOUN
or O CCONJ
starch O NOUN
as O ADP
placebo O NOUN
daily O ADJ
for O ADP
three O NUM
days O NOUN
along O ADV
with O ADP
trimethoprim-sulfamethoxazole. O NUM

Results O NOUN
of O ADP
the O DET
Active O ADJ
Schools: O NOUN
Skelmersdale O NOUN
(AS:Sk) O PUNCT
multi-component O ADJ
pilot O NOUN
intervention O NOUN
indicated O VERB
no O DET
significant O ADJ
positive O ADJ
change O NOUN
to O PART
child O NOUN
PA O NOUN
levels. O NOUN

Achaogen, O VERB
South O NOUN
San O NOUN
Francisco, O ADV
CA. O NOUN

RESULTS: O NOUN
Ulcer B-outcome NOUN
healing I-outcome VERB
time I-outcome NOUN
(3.5+/-0.6) O NOUN
d, O NOUN
duration B-outcome NOUN
of I-outcome ADP
pain I-outcome NOUN
(3.1+/-0.3)d O PUNCT
in O ADP
group O NOUN
A O DET
were O VERB
shorter O ADJ
than O ADP
in O ADP
group O NOUN
B O NOUN
(P<0.05); O NOUN
treatment O NOUN
efficiency O NOUN
was O VERB
96.08% O NOUN
in O ADP
group O NOUN
A, O NOUN
88.24% O NOUN
in O ADP
group O NOUN
B( O NOUN
chi(2)=6.264, O ADV
P<0.05). O NOUN

CONCLUSION: O NOUN
In O ADP
low O ADJ
risk O NOUN
pregnancies, O NOUN
routine O ADJ
ultrasonography O NOUN
in O ADP
the O DET
third O ADJ
trimester O NOUN
along O ADV
with O ADP
clinically O ADV
indicated O VERB
ultrasonography O NOUN
was O VERB
associated O VERB
with O ADP
higher O ADJ
antenatal O ADJ
detection O NOUN
of O ADP
small B-outcome ADJ
for Seperator ADP
gestational I-outcome ADJ
age I-outcome NOUN
fetuses I-outcome NOUN
but O CCONJ
not O ADV
with O ADP
a O DET
reduced O VERB
incidence O NOUN
of O ADP
severe B-outcome ADJ
adverse I-outcome ADJ
perinatal I-outcome ADJ
outcomes I-outcome NOUN
compared O VERB
with O ADP
usual O ADJ
care O NOUN
alone. O NOUN

The O DET
selected O VERB
subjects O NOUN
will O VERB
be O VERB
divided O VERB
into O ADP
3 O NUM
groups: O NOUN
G1: O NOUN
aPDT; O NOUN
G2: O NOUN
scraper, O ADV
and O CCONJ
G3: O NOUN
aPDT O NOUN
and O CCONJ
scraper. O NOUN

Phytonutrients O NOUN
and O CCONJ
vitamin O NOUN
and O CCONJ
mineral O NOUN
supplementation O NOUN
have O VERB
been O VERB
reported O VERB
to O PART
provide O VERB
increased O VERB
antioxidant O NOUN
capacity O NOUN
in O ADP
humans; O NOUN
however, O ADV
there O PRON
is O VERB
still O ADV
controversy. O NOUN

INTERVENTIONS: O NOUN
Patients O NOUN
were O VERB
randomised O VERB
to O PART
three O NUM
months O NOUN
of O ADP
oral O ADJ
treatment O NOUN
with O ADP
either O CCONJ
750 O NUM
mg O NOUN
amoxicillin O NOUN
or O CCONJ
placebo O NOUN
three O NUM
times O NOUN
daily. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
survival B-outcome NOUN
without O ADP
moderate O ADJ
or O CCONJ
severe O ADJ
neurodevelopmental B-outcome ADJ
disability I-outcome NOUN
at O ADP
24 O NUM
months. O NOUN

Asthma O NOUN
among O ADP
children O NOUN
and O CCONJ
adolescents, O NOUN
its O ADJ
relations O NOUN
with O ADP
physical O ADJ
activity O NOUN
(PA) O NOUN
and O CCONJ
PA O NOUN
relations O NOUN
with O ADP
body O NOUN
posture O ADJ
were O VERB
and O CCONJ
are O VERB
still O ADV
being O VERB
investigated. O NOUN

The O DET
poster O NOUN
will O VERB
be O VERB
adapted O VERB
into O ADP
a O DET
sticker O NOUN
format O NUM
on O ADP
the O DET
ABHR O NOUN
bottle. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Journal O ADJ
ID: O NOUN
100968562 O NUM

Publication O NOUN
date: O NOUN
2018/12/21 O NOUN
06:00 O ADP
[entrez] O ADP

METHODS: O NOUN
A O DET
cluster O NOUN
randomised O VERB
wait-list O NOUN
controlled O VERB
trial O NOUN
in O ADP
public O ADJ
sector O NOUN
organisations O NOUN
in O ADP
Northern O NOUN
Ireland. O NOUN

Publication O NOUN
date: O NOUN
2019/02/27 O NOUN
06:00 O ADP
[medline] O NOUN

In O ADP
the O DET
experimental O ADJ
group, O NOUN
the O DET
patients O NOUN
performed O VERB
relaxation O NOUN
techniques O NOUN
once O ADP
a O DET
day O NOUN
for O ADP
30min O NOUN
over O ADP
two O NUM
months. O NOUN

ED95 O NOUN
of O ADP
spinal O ADJ
bupivacaine O NOUN
was O VERB
calculated O VERB
using O VERB
logistic O ADJ
regression O NOUN
model. O NOUN

Publication O NOUN
date: O NOUN
2019/02/20 O ADJ
06:00 O ADP
[medline] O NOUN

OUTCOME O NOUN
MEASURES: O NOUN
Image O NOUN
analysis O NOUN
was O VERB
performed O VERB
by O ADP
the O DET
workstation. O ADV
[ O PUNCT

We O PRON
evaluated O VERB
the O DET
prognostic O ADJ
value O NOUN
of O ADP
histopathological O ADJ
measures O NOUN
with O ADP
a O DET
Cox O NOUN
proportional-hazards O NOUN
model. O NOUN

The O DET
1-year O NOUN
abstinence B-outcome NOUN
rate O NOUN
was O VERB
18.0% O NUM
in O ADP
the O DET
e-cigarette O NOUN
group, O NOUN
as O ADP
compared O VERB
with O ADP
9.9% O NOUN
in O ADP
the O DET
nicotine-replacement O ADJ
group O NOUN
(relative O ADJ
risk, O NOUN
1.83; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
1.30 O NUM
to O PART
2.58; O NOUN
P<0.001). O NUM

Journal O ADJ
ID: O NOUN
101150032 O NUM

However, O ADV
there O PRON
is O VERB
a O DET
paucity O NOUN
of O ADP
research O NOUN
exploring O VERB
the O DET
potential O ADJ
benefit O NUM
of O ADP
FODMAP O ADV
strategies O NOUN
to O PART
support O NOUN
healthy, O NOUN
recreational O ADJ
athletes O NOUN
who O ADP
experience O NOUN
GI O NOUN
issues O NOUN
during O ADP
training. O NOUN

SafeWalker(R) O ADV
supports O NOUN
the O DET
body O NOUN
weight O NOUN
whilst O ADP
securing O VERB
postural O ADJ
stability O NOUN
without O ADP
relying O VERB
on O ADP
upper O ADJ
body O NOUN
strength O NOUN
or O CCONJ
high O ADJ
cognitive O ADJ
demand. O NOUN

The O DET
number O NOUN
of O ADP
women O NOUN
that O ADP
would O VERB
need O NOUN
to O PART
be O VERB
treated O VERB
to O PART
prevent O NOUN
the O DET
occurrence O NOUN
of O ADP
a O DET
fracture O NOUN
in O ADP
1 O NUM
woman O NOUN
was O VERB
15. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal-Name:Brazilian O ADP
oral O ADJ
research O NOUN

When O ADP
sex O NOUN
was O VERB
considered, O VERB
females O NOUN
had O VERB
lower O ADJ
urine B-outcome NOUN
volume I-outcome NOUN
[UV] I-outcome NOUN
, O PUNCT
elevated O VERB
urine B-outcome NOUN
osmolality I-outcome NOUN
(UOsm) I-outcome PUNCT
(p O PUNCT
< O SYM
0.05), O NUM
trends O NOUN
for O ADP
higher O ADJ
Delta O NOUN
Body B-outcome NOUN
Weight I-outcome NOUN
[BW] I-outcome NOUN
), O NUM
urine B-outcome NOUN
specific I-outcome ADJ
gravity I-outcome NOUN
[USG] I-outcome NOUN
, O PUNCT
but O CCONJ
similar O ADJ
salivary B-outcome ADJ
osmolality I-outcome NOUN
(SOsm) I-outcome PUNCT
. O PUNCT
Analysis O NOUN
of O ADP
beverages O NOUN
and O CCONJ
urine O NOUN
for O ADP
antioxidant B-outcome NOUN
potential I-outcome ADJ
(AP) I-outcome NOUN
revealed O VERB
a O DET
four-fold O NOUN
greater O ADJ
antioxidant B-outcome NOUN
potential I-outcome ADJ
(AP) I-outcome NOUN
in O ADP
MW, O NOUN
which O ADP
increased O VERB
peak O NOUN
urine O NOUN
antioxidant B-outcome NOUN
potential I-outcome ADJ
(AP) I-outcome NOUN
(9.4 O NOUN
+/- O SYM
0.7 O NUM
vs. O CCONJ
7.6 O NUM
+/- O SYM
1.0 O NUM
mmol, O NOUN
MW O NOUN
vs. O CCONJ
control, O NOUN
p O NOUN
< O SYM
0.05). O NOUN

In O ADP
this O DET
study O NOUN
(APEX, O PUNCT
Part O NOUN
I), O NOUN
we O PRON
evaluated O VERB
the O DET
efficacy/safety O NOUN
outcomes O NOUN
of O ADP
DMF O NOUN
in O ADP
a O DET
predominantly O ADV
East O ADV
Asian O ADJ
population O NOUN
of O ADP
patients O NOUN
with O ADP
RRMS. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Electroencephalography-Guided O VERB
Anesthetic O ADJ
Administration O NOUN
on O ADP
Postoperative O ADJ
Delirium B-outcome NOUN
Among O ADP
Older O ADJ
Adults O NOUN
Undergoing O VERB
Major O ADP
Surgery: O NOUN
The O DET
ENGAGES O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

RESULTS: O NOUN
In O ADP
the O DET
primary O ADJ
analysis O NOUN
of O ADP
the O DET
total O ADJ
cohort O NOUN
at O ADP
one O NUM
year, O ADV
the O DET
difference O NOUN
in O ADP
the O DET
mean O NOUN
Roland-Morris O NOUN
Disability B-outcome NOUN
Questionnaire O PROPN
(RMDQ) O NOUN
score O NOUN
between O ADP
the O DET
amoxicillin O NOUN
group O NOUN
and O CCONJ
the O DET
placebo O NOUN
group O NOUN
was O VERB
-1.6 O ADJ
(95% O PUNCT
confidence O NOUN
interval O NOUN
-3.1 O NUM
to O PART
0.0, O NOUN
P=0.04). O ADV

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Compared O VERB
with O ADP
the O DET
general O ADJ
anesthesia O NOUN
group, O NOUN
the O DET
first O ADV
night O NOUN
of O ADP
total B-outcome ADJ
sleep I-outcome NOUN
time I-outcome NOUN
in O ADP
the O DET
spinal O ADJ
anesthesia O NOUN
group O NOUN
was O VERB
significantly O ADV
shorter[(357.2+/-83.4)min O NOUN
vs O CCONJ
(275.1+/-64.8)min, O NOUN
t=-9.635, O NUM
P<0.05], O NOUN
while O ADP
the O DET
rate O NOUN
of O ADP
wakefulness B-outcome ADV
, O PUNCT
total B-outcome ADJ
sleep I-outcome NOUN
time I-outcome NOUN
, O PUNCT
overall B-outcome ADJ
sleep I-outcome NOUN
quality I-outcome NOUN
, O PUNCT
daytime B-outcome NOUN
mood I-outcome NOUN
and O CCONJ
daytime B-outcome NOUN
physical I-outcome ADJ
function I-outcome NOUN
were O VERB
significantly O ADV
higher[(25.9%, O NOUN
22.2%, O NUM
25.9%, O NUM
18.5%18.5%) O NUM
vs O CCONJ
(51.7%, O NUM
51.7%, O NOUN
55.2%, O NUM
48.3%44.8%), O NOUN
chi(2)=3.901, O NOUN
5.192, O NOUN
4.941, O NUM
5.523 O NOUN
and O CCONJ
4.437, O NUM
all O DET
P<0.05], O NOUN
and O CCONJ
the O DET
cases O NOUN
of O ADP
postoperative O ADJ
urinary B-outcome ADJ
retention I-outcome NOUN
and O CCONJ
lower B-outcome ADJ
limb I-outcome NOUN
discomfort I-outcome NOUN
were O VERB
significantly O ADV
higher[(8 O ADV
and O CCONJ
6) O NOUN
vs O CCONJ
(1 O NOUN
and O CCONJ
0), O NUM
all O DET
P<0.05]. O NOUN
Conclusion: O NOUN
Both O CCONJ
anesthesia O NOUN
methods O NOUN
can O VERB
be O VERB
safely O ADV
and O CCONJ
effectively O ADV
applied O VERB
to O PART
middle-aged O NOUN
and O CCONJ
elderly O NOUN
patients O NOUN
with O ADP
lower O ADJ
extremity O NOUN
varicose O ADJ
veins O NOUN
surgery, O NOUN
but O CCONJ
patients O NOUN
with O ADP
general O ADJ
anesthesia O NOUN
show O VERB
fewer O ADJ
adverse B-outcome ADJ
reactions I-outcome NOUN
on O ADP
the O DET
first O ADV
night O NOUN
after O ADP
surgery O NOUN
and O CCONJ
have O VERB
better O ADJ
sleep B-outcome NOUN
quality I-outcome NOUN
. O PUNCT

Clinical O ADJ
safety O NOUN
assessment O NOUN
failed O VERB
to O PART
show O VERB
toxicity O NOUN
and O CCONJ
adverse B-outcome ADJ
effects I-outcome NOUN
. O PUNCT
Therefore, O NOUN
herbal O ADJ
congee O ADP
containing O VERB
the O DET
combined O VERB
extract O NOUN
of O ADP
M. O NOUN
alba O NOUN
and O CCONJ
P. O NOUN
odoratum O NOUN
leaves O NOUN
is O VERB
the O DET
potential O ADJ
functional O ADJ
food O NOUN
that O ADP
can O VERB
decrease O NOUN
the O DET
risk O NOUN
of O ADP
osteoporosis. O NOUN

A O DET
community-based O VERB
randomized O VERB
controlled O VERB
trial O NOUN
was O VERB
conducted O VERB
on O ADP
the O DET
selected O VERB
students O NOUN
once O ADP
a O DET
week O NOUN
for O ADP
5 O NUM
consecutive O ADJ
weeks. O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
12-month O NOUN
change O NOUN
in O ADP
adherence B-outcome NOUN
based O VERB
on O ADP
the O DET
energy-reduced O VERB
Mediterranean O NOUN
diet O NOUN
(er-MedDiet) O PUNCT
score O NOUN
(range, O NOUN
0-17; O NUM
higher O ADJ
scores O NOUN
indicate O VERB
greater O ADJ
adherence; O ADJ
minimal O ADJ
clinically O ADV
important O ADJ
difference, O NOUN
1 O NUM
point). O NOUN

Catheter O NOUN
complications B-outcome NOUN
, O PUNCT
analyzed O VERB
as O ADP
a O DET
secondary O ADJ
end O NOUN
point, O NOUN
were O VERB
more O ADV
common O ADJ
in O ADP
the O DET
intravenous O ADJ
group O NOUN
(9.4% O PUNCT
vs. O CCONJ
1.0%). O NOUN

Patients O NOUN
who O ADP
enrolled O VERB
in O ADP
SHORE O DET
fulfilled O VERB
eligibility O NOUN
criteria O NOUN
per O ADP
protocol O NOUN
(N O PUNCT
= O SYM
202). O NUM

T O NOUN
Numeric O ADJ
rating O VERB
scale O NOUN
(NRS) O NOUN
was O VERB
used O VERB
to O PART
assess O NOUN
pain B-outcome NOUN
in O ADP
the O DET
post-anesthesia O NOUN
care O NOUN
unit O NOUN
(PACU). O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
amount O NOUN
of O ADP
microvascular B-outcome ADJ
obstruction I-outcome NOUN
(% O PUNCT
left B-outcome ADV
ventricular I-outcome ADJ
mass I-outcome NOUN
) O PUNCT
demonstrated O VERB
by O ADP
contrast-enhanced O VERB
cardiac O ADJ
magnetic O ADJ
resonance O NOUN
imaging O VERB
(MRI) O PUNCT
conducted O VERB
from O ADP
days O NOUN
2 O NUM
through O ADP
7 O NUM
after O ADP
enrollment. O NOUN

The O DET
effect O NOUN
of O ADP
the O DET
combined O VERB
intervention O NOUN
exceeded O VERB
that O ADP
of O ADP
CBT O NOUN
or O CCONJ
Baduanjin O NOUN
alone. O NOUN

BACKGROUND: O NOUN
Dyslipidemia O NOUN
is O VERB
one O NUM
of O ADP
the O DET
most O DET
frequently O ADV
implicated O VERB
risk O NOUN
factors O NOUN
for O ADP
development O NOUN
of O ADP
atherosclerosis. O NOUN

Pre- O NOUN
to O PART
postintervention O NOUN
overall O ADJ
Test O NOUN
of O ADP
Playfulness B-outcome ADV
(ToP) O ADV
scores O NOUN
improved O VERB
marginally O ADV
for O ADP
the O DET
PICIHBI O NOUN
group O NOUN
(n O NOUN
= O SYM
12) O NOUN
and O CCONJ
the O DET
conventional O ADJ
group O NOUN
(n O NOUN
= O SYM
12). O ADV

In O ADP
this O DET
study O NOUN
62 O NUM
subjects O NOUN
were O VERB
randomly O ADV
selected O VERB
for O ADP
the O DET
yoga O NOUN
group O NOUN
and O CCONJ
control O NOUN
groups. O NOUN

Funded O VERB
by O ADP
Vanderbilt O NOUN
Institute O NOUN
for O ADP
Clinical O ADJ
and O CCONJ
Translational O ADJ
Research O NOUN
and O CCONJ
others; O NOUN
PreVent O ADJ
ClinicalTrials.gov O NOUN
number, O ADV
NCT03026322.). O NOUN

Couples O NOUN
were O VERB
randomly O ADV
assigned O VERB
(1:1) O NOUN
with O ADP
an O DET
online O ADP
system O NOUN
to O PART
receive O VERB
either O CCONJ
PICSI O NOUN
or O CCONJ
a O DET
standard O ADJ
ICSI O NOUN
procedure. O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

In O ADP
the O DET
other O ADJ
group, O NOUN
each O DET
had O VERB
a O DET
different O ADJ
color. O ADV

A O DET
single O ADJ
trained O VERB
operator O NOUN
performed O VERB
the O DET
CT O NOUN
in O ADP
a O DET
single O ADJ
visit O NOUN
in O ADP
cases O NOUN
without O ADP
periapical O ADJ
or O CCONJ
interradicular O ADJ
radiolucency O NOUN
(PIR) O PUNCT
or O CCONJ
in O ADP
multiple O ADJ
visits O NOUN
in O ADP
cases O NOUN
with O ADP
PIR. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
median O ADJ
plasma O NOUN
Nitrotyrosine B-outcome NOUN
(NT) I-outcome NOUN
concentrations O NOUN
(pg/ml) O NUM
following O VERB
surgery O NOUN
(POP1) O PUNCT
were O VERB
significantly O ADV
lower O ADJ
in O ADP
patients O NOUN
with O ADP
cancer O NOUN
versus O CCONJ
patients O NOUN
with O ADP
benign O ADJ
disease O NOUN
(5.3 O NOUN
vs. O CCONJ
7.6, O NOUN
p=0.008). O NOUN

Patients O NOUN
were O VERB
divided O VERB
into O ADP
2 O NUM
groups. O NOUN

BACKGROUND: O NOUN
The O DET
lack O NOUN
of O ADP
surveillance O NOUN
system O NOUN
is O VERB
a O DET
major O ADJ
barrier O NOUN
in O ADP
prevention O NOUN
and O CCONJ
control O NOUN
of O ADP
rheumatic O ADJ
fever/rheumatic O ADJ
heart O NOUN
disease O NOUN
(RF/RHD). O PUNCT

Ten O NUM
SAEs B-outcome NOUN
were O VERB
observed O VERB
within O ADP
the O DET
treatment O NOUN
period, O NOUN
and O CCONJ
4 O NUM
deaths B-outcome NOUN
unrelated O VERB
to O PART
the O DET
study O NOUN
medication. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

BACKGROUND: O NOUN
Single O NOUN
acute O ADJ
infarction O NOUN
(SAI) O NUM
usually O ADV
had O VERB
lower O ADJ
risk O NOUN
of O ADP
stroke O NOUN
recurrence O NOUN
than O ADP
multiple O ADJ
acute O ADJ
infarctions O NOUN
(MAIs) O ADV
in O ADP
minor O ADJ
stroke. O NOUN

The O DET
44 O NUM
patients O NOUN
were O VERB
randomly O ADV
assigned O VERB
into O ADP
a O DET
study O NOUN
group O NOUN
and O CCONJ
a O DET
control O NOUN
group, O NOUN
with O ADP
22 O NUM
patiencs O NOUN
in O ADP
each O DET
group. O VERB

In O ADP
the O DET
analysis O NOUN
of O ADP
the O DET
risk O NOUN
of O ADP
the O DET
primary O ADJ
end O NOUN
point, O NOUN
the O DET
noninferiority O NOUN
margin O ADP
was O VERB
7.5 O NUM
percentage O NOUN
points. O NOUN

Journal-Name:Journal O ADJ
of O ADP
ovarian O ADJ
research O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

Secondary O ADJ
analyses O NOUN
and O CCONJ
sensitivity O NOUN
analyses O NOUN
supported O VERB
this O DET
finding. O NOUN

OBJECTIVE: O NOUN
We O PRON
conducted O VERB
this O DET
study O NOUN
to O PART
compare O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
entecavir O NOUN
and O CCONJ
tenofovir O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
treatment-naive O ADJ
HBV O NOUN
e O NOUN
antigen O NOUN
(HBeAg)-positive O ADJ
patients O NOUN
with O ADP
chronic O ADJ
hepatitis O NOUN
B O NOUN
(CHB) O NOUN
for O ADP
144 O NUM
weeks. O NOUN

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
the O DET
time B-outcome NOUN
to I-outcome PART
first I-outcome ADV
occurrence I-outcome NOUN
of I-outcome ADP
a Seperator DET
nonvertebral I-outcome ADJ
or Seperator CCONJ
vertebral I-outcome ADJ
fragility I-outcome NOUN
fracture I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
At O ADP
baseline, O NOUN
the O DET
mean O NOUN
(+/-SD) O NOUN
age O NOUN
was O VERB
71+/-5 O NOUN
years, O NOUN
the O DET
T O NOUN
score O NOUN
at O ADP
the O DET
femoral O ADJ
neck O NOUN
was O VERB
-1.6+/-0.5, O NOUN
and O CCONJ
the O DET
median O ADJ
10-year O NOUN
risk O NOUN
of O ADP
hip O NOUN
fracture O NOUN
was O VERB
2.3%. O NUM

The O DET
duration O NOUN
of O ADP
total B-outcome ADJ
hospital I-outcome NOUN
stay I-outcome NOUN
and O CCONJ
postoperative B-outcome ADJ
hospital I-outcome NOUN
stay I-outcome NOUN
in O ADP
the O DET
AG O NOUN
(10.86+/-5.64, O ADV
5.09+/-4.55) O NOUN
d O NOUN
were O VERB
significantly O ADV
shorter O ADJ
than O ADP
that O ADP
in O ADP
the O DET
CG O NOUN
(10.86+/-5.64, O ADV
5.09+/-4.55) O NOUN
d O NOUN
(P=0.01, O PUNCT
P=0.01). O NOUN

Therefore, O NOUN
a O DET
novel O ADJ
system O NOUN
for O ADP
patient O NOUN
classification O NOUN
(category O PUNCT
14) O PUNCT
was O VERB
developed O VERB
in O ADP
the O DET
present O ADJ
study O NOUN
based O VERB
on O ADP
these O DET
two O NUM
indices O NOUN
to O PART
assist O NOUN
in O ADP
predicting O VERB
the O DET
prognosis O NOUN
and O CCONJ
therapeutic O ADJ
response. O NOUN

Journal-Name:American O NOUN
journal O ADJ
of O ADP
orthodontics O NOUN
and O CCONJ
dentofacial O ADJ
orthopedics O NOUN
: O PUNCT
official O ADJ
publication O NOUN
of O ADP
the O DET
American O ADJ
Association O NOUN
of O ADP
Orthodontists, O NOUN
its O ADJ
constituent O ADP
societies, O NOUN
and O CCONJ
the O DET
American O ADJ
Board O NOUN
of O ADP
Orthodontics O NOUN

There O PRON
were O VERB
significant O ADJ
improvements O NOUN
in O ADP
household O NOUN
purchasing B-outcome VERB
of I-outcome ADP
vegetables I-outcome NOUN
and Seperator CCONJ
whole I-outcome ADJ
grains S2-outcome NOUN
, O PUNCT
in O ADP
individual O ADJ
intakes B-outcome NOUN
of I-outcome ADP
refined I-outcome VERB
grains I-outcome NOUN
, Seperator PUNCT
healthy I-outcome ADJ
proteins S2-outcome NOUN
, O PUNCT
whole-fat O PUNCT
dairies O NOUN
, O PUNCT
legumes O NOUN
, O PUNCT
100% O NOUN
fruit O NOUN
juices O NOUN
, O PUNCT
and O CCONJ
sweets O NOUN
and O CCONJ
snacks O NOUN
; O PUNCT
and O CCONJ
in O ADP
the O DET
individual O ADJ
frequency O NOUN
of O ADP
intake B-outcome NOUN
of I-outcome ADP
fruits I-outcome NOUN
and Seperator CCONJ
cold I-outcome NOUN
cuts/cured I-outcome VERB
meats S2-outcome NOUN
within O ADP
the O DET
intervention O NOUN
group O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Publication O NOUN
date: O NOUN
2019/03/01 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Recruitment O NOUN
was O VERB
stopped O VERB
after O ADP
inclusion O NOUN
of O ADP
19 O NUM
and O CCONJ
39 O NUM
patients O NOUN
in O ADP
monotherapy O NOUN
and O CCONJ
combination O NOUN
arms O NOUN
respectively, O NOUN
as O ADP
per O ADP
pre-specified O VERB
stopping O VERB
rules. O NUM

Three O NUM
models O NOUN
of O ADP
eye-lens O NOUN
dosemeters O NOUN
(Dosilab, O PUNCT
Landauer O NOUN
and O CCONJ
IRSN) O NUM
were O VERB
assessed O VERB
in O ADP
term O NOUN
of O ADP
ergonomics B-outcome NOUN
. O PUNCT
The O DET
annual O NOUN
estimation O NOUN
of O ADP
eye-lens B-outcome NOUN
doses I-outcome NOUN
did O VERB
not O ADV
reach O NOUN
the O DET
annual O NOUN
dose O NOUN
limit O NOUN
of O ADP
20 O NUM
mSv O NOUN
revised O VERB
by O ADP
the O DET
ICRP, O ADP
ranged O VERB
from O ADP
0.00 O NUM
to O PART
18.12 O NUM
mSv O NOUN
with O ADP
a O DET
mean O NOUN
of O ADP
0.96 O NUM
+/- O SYM
2.28 O NUM
mSv. O ADJ

RESULTS: O NOUN
119 O NUM
children O NOUN
aged O VERB
5 O NUM
to O PART
16 O NUM
years, O NOUN
with O ADP
symptomatic O ADJ
hypermobility O NOUN
were O VERB
randomised O VERB
to O PART
receive O VERB
an O DET
individualised O VERB
multidisciplinary O ADJ
intervention O NOUN
(I) O PUNCT
(n O NOUN
= O SYM
59) O NOUN
or O CCONJ
standard O ADJ
management O NOUN
(S) O PUNCT
(n O NOUN
= O SYM
60). O NOUN

Publication O NOUN
date: O NOUN
['2019/10/18 O NOUN
06:00' O NUM

The O DET
primary O ADJ
outcomes O NOUN
were O VERB
hospitalized B-outcome VERB
death I-outcome NOUN
, O PUNCT
severe B-outcome ADJ
disability I-outcome NOUN
at O ADP
15 O NUM
months O NOUN
of O ADP
age, O NOUN
neonatal B-outcome ADJ
behavioral I-outcome ADJ
neurological I-outcome ADJ
assessment O NOUN
(NBNA) O NOUN
score O NOUN
at O ADP
28 O NUM
days O NOUN
of O ADP
age, O NOUN
and O CCONJ
Bayley O PROPN
scales O NOUN
of O ADP
infant B-outcome NOUN
development I-outcome NOUN
(BSID) O NUM
score O NOUN
(including O PUNCT
mental B-outcome ADJ
development I-outcome NOUN
index O NOUN
(MDI) O NOUN
score O NOUN
and O CCONJ
psychomotor B-outcome NOUN
development I-outcome NOUN
index O NOUN
(PDI) O PUNCT
score) O NOUN
at O ADP
15 O NUM
months O NOUN
of O ADP
age O NOUN
at O ADP
follow-up. O PUNCT

BACKGROUND: O NOUN
Vaccination O NOUN
has O VERB
a O DET
huge O NOUN
public O ADJ
health O NOUN
impact. O NOUN

Title: O NOUN
Tafenoquine O NOUN
versus O CCONJ
Primaquine O NOUN
to O PART
Prevent O NOUN
Relapse B-outcome NOUN
of O ADP
Plasmodium O NOUN
vivax O NOUN
Malaria. O NOUN

T O NOUN
Yale-Brown O NOUN
Obsessive B-outcome ADJ
Compulsive I-outcome ADJ
Scale O NOUN
(Y-BOCS)], O NOUN
Hamilton O ADV
Anxiety B-outcome NOUN
Scale O NOUN
(HAMA) O PUNCT
were O VERB
used O VERB
to O PART
assess O NOUN
the O DET
efficacy, O NOUN
Pittsburgh O NOUN
Sleep B-outcome NOUN
Quality I-outcome NOUN
Index O NOUN
(PSQI) O NOUN
was O VERB
used O VERB
to O PART
evaluate O VERB
the O DET
sleep B-outcome NOUN
quality I-outcome NOUN
, O PUNCT
and O CCONJ
Treatment O NOUN
Emergent O ADJ
Symptom O NOUN
Scale O NOUN
(TESS) O ADP
was O VERB
used O VERB
to O PART
evaluate O VERB
the O DET
side B-outcome NOUN
effects I-outcome NOUN
. O PUNCT
Data O NOUN
were O VERB
analyzed O VERB
in O ADP
the O DET
intention-to-treat O NOUN
sample. O NOUN

Three O NUM
patients O NOUN
did O VERB
not O ADV
complete O ADJ
the O DET
study, O NOUN
leaving O VERB
156 O NUM
patients O NOUN
for O ADP
final O ADJ
analysis. O NOUN

In O ADP
one O NUM
group, O NOUN
all O DET
four O NUM
eye O NOUN
drops O NOUN
were O VERB
transparent. O NOUN

Changes O NOUN
in O ADP
unilateral O ADJ
upper B-outcome ADJ
limb I-outcome NOUN
muscular I-outcome ADJ
strength I-outcome NOUN
and O CCONJ
Electromyographic B-outcome ADJ
Activity I-outcome NOUN
after O ADP
a O DET
16-week O NOUN
strength O NOUN
training O VERB
intervention O NOUN
in O ADP
survivors O NOUN
of O ADP
breast O NOUN
cancer. O NOUN

Aortic O ADJ
enhancement B-outcome NOUN
during O ADP
the O DET
hepatic O ADJ
arterial O ADJ
phase O NOUN
and O CCONJ
hepatic O ADJ
enhancement O NOUN
during O ADP
the O DET
portal O NOUN
venous O ADJ
phase O NOUN
was O VERB
compared. O NOUN

Feasibility B-outcome NOUN
outcomes O NOUN
included O VERB
rates O NOUN
of O ADP
recruitment B-outcome NOUN
, O PUNCT
retention B-outcome NOUN
, O PUNCT
outcome B-outcome NOUN
completion I-outcome NOUN
, O PUNCT
and O CCONJ
exercise B-outcome NOUN
attendance I-outcome NOUN
. O PUNCT
Data O NOUN
were O VERB
collected O VERB
on O ADP
cardiorespiratory B-outcome ADJ
fitness I-outcome ADP
(e.g., O NOUN
peak B-outcome NOUN
oxygen I-outcome NOUN
uptake I-outcome NOUN
), O NUM
disease B-outcome NOUN
activity I-outcome NOUN
, O PUNCT
fatigue B-outcome NOUN
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
and O CCONJ
intervention O NOUN
acceptability B-outcome NOUN
(via O PUNCT
interviews). O NUM

BACKGROUND: O NOUN
Omadacycline, O NOUN
a O DET
new O ADJ
once-daily O ADV
aminomethylcycline O NOUN
antibiotic O ADJ
agent O NOUN
that O ADP
can O VERB
be O VERB
administered O VERB
intravenously O ADV
or O CCONJ
orally, O NOUN
reaches O NOUN
high O ADJ
concentrations O NOUN
in O ADP
pulmonary O ADJ
tissues O NOUN
and O CCONJ
is O VERB
active O ADJ
against O ADP
common O ADJ
pathogens O NOUN
that O ADP
cause O ADP
community-acquired O VERB
bacterial O ADJ
pneumonia. O NOUN

Awareness B-outcome ADV
about Seperator ADV
fertility I-outcome NOUN
and O CCONJ
lifestyle-related B-outcome VERB
factors I-outcome NOUN
were O VERB
the O DET
main O ADJ
outcomes, O NOUN
measured O VERB
through O ADP
a O DET
questionnaire O NOUN
before O ADP
the O DET
intervention O NOUN
and O CCONJ
through O ADP
a O DET
telephone O NOUN
survey O NOUN
after O ADP
three O NUM
months. O NOUN

Electromyography O NOUN
was O VERB
used O VERB
to O PART
objectively O ADV
evaluate O VERB
eyestrain B-outcome NOUN
. O PUNCT
Linear O ADJ
mixed O VERB
models O NOUN
were O VERB
used O VERB
to O PART
assess O NOUN
differences O NOUN
between O ADP
toric O ADJ
and O CCONJ
spherical O ADJ
contact O NOUN
lenses. O ADJ

In O ADP
the O DET
control O NOUN
group, O NOUN
no O DET
changes O NOUN
were O VERB
observed O VERB
with O ADP
the O DET
exception O NOUN
of O ADP
an O DET
increase O NOUN
of O ADP
sNox2-dp B-outcome PUNCT
, O PUNCT
H2O2 B-outcome NOUN
, O PUNCT
and O CCONJ
myoglobin B-outcome NOUN
. O PUNCT
A O DET
simple O NOUN
linear O ADJ
regression O NOUN
analysis O NOUN
showed O VERB
that O ADP
sNox2-dp B-outcome PUNCT
was O VERB
associated O VERB
with O ADP
a O DET
significant O ADJ
increase O NOUN
in O ADP
muscle B-outcome NOUN
damage I-outcome NOUN
biomarker O NOUN
release O NOUN
(p O PUNCT
= O SYM
0.001). O NUM

PATIENTS: O NOUN
A O DET
total O ADJ
of O ADP
97 O NUM
patients O NOUN
suffering O VERB
from O ADP
LBP. O NOUN

A O DET
total O ADJ
of O ADP
136 O NUM
patients O NOUN
with O ADP
FS O NOUN
were O VERB
recruited O VERB
and O CCONJ
then O ADV
were O VERB
equally O ADV
randomly O ADV
allocated O VERB
into O ADP
a O DET
treatment O NOUN
group O NOUN
(n O NOUN
= O SYM
68) O NOUN
and O CCONJ
a O DET
sham O NOUN
group O NOUN
(n O NOUN
= O SYM
68). O ADP

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Preoperative O ADJ
administration O NOUN
of O ADP
celecoxib O NOUN
exhibits O NOUN
better O ADJ
efficacy O NOUN
and O CCONJ
equal O ADJ
safety O NOUN
profiles O NOUN
compared O VERB
to O PART
postoperative O ADJ
administration O NOUN
of O ADP
celecoxib O NOUN
in O ADP
knee O NOUN
OA O NOUN
patients O NOUN
undergoing O VERB
TKA. O NOUN

Further O ADV
studies O NOUN
are O VERB
needed O VERB
to O PART
determine O NOUN
whether O ADP
multiple O ADJ
arterial O ADJ
grafts O NOUN
provide O VERB
better O ADJ
outcomes O NOUN
than O ADP
a O DET
single O ADJ
internal-thoracic-artery O ADV
graft. O VERB
( O PUNCT

Journal-Name:BMC O NOUN
psychology O NOUN

RESULTS: O NOUN
Forced B-outcome VERB
vital I-outcome ADJ
capacity I-outcome NOUN
(FVC) I-outcome PUNCT
, O PUNCT
maximum B-outcome NOUN
voluntary I-outcome ADJ
ventilation I-outcome NOUN
(MVV) I-outcome PUNCT
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
, O PUNCT
and O CCONJ
self-reported O VERB
health B-outcome NOUN
status O NOUN
were O VERB
significantly O ADV
increased O VERB
(P O NUM
< O SYM
.05) O NOUN
in O ADP
the O DET
group O NOUN
receiving O VERB
joint O NOUN
Baduanjin O NOUN
and O CCONJ
CBT O NOUN
intervention O NOUN
at O ADP
3 O NUM
months O NOUN
and O CCONJ
6 O NUM
months, O NOUN
as O ADP
compared O VERB
to O PART
the O DET
Baduanjin O NOUN
only O ADV
group O NOUN
or O CCONJ
the O DET
CBT O NOUN
only O ADV
group. O VERB

Journal-Name:Medicine O NOUN

CONCLUSIONS: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
study O NOUN
showed O VERB
that O ADP
verum O NOUN
TENS O NOUN
may O VERB
benefit O NUM
patients O NOUN
with O ADP
acute O ADJ
tinnitus O NOUN
after O ADP
4 O NUM
weeks O NOUN
of O ADP
treatment. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
This O DET
trial O NOUN
has O VERB
been O VERB
assigned O VERB
the O DET
following O VERB
registry O NOUN
number: O NOUN
NCT03006406 O NOUN
. O PUNCT

Publication O NOUN
date: O NOUN
2018/12/18 O ADJ
00:00 O NOUN
[accepted] O ADV

However, O ADV
no O DET
differences O NOUN
between O ADP
groups O NOUN
were O VERB
observed O VERB
in O ADP
the O DET
group-by-time O NOUN
interaction O NOUN
of O ADP
the O DET
hormonal B-outcome ADJ
parameters O NOUN
(p O PUNCT
> O SYM
0.05). O NOUN

Of O ADP
these, O NOUN
95 O NUM
(52%) O PUNCT
patients O NOUN
were O VERB
excluded O VERB
because O ADP
they O PRON
no O DET
longer O ADJ
met O VERB
study O NOUN
criteria O NOUN
and O CCONJ
80 O NUM
(43%) O NUM
patients O NOUN
entered O VERB
the O DET
placebo O NOUN
lead-in O NOUN
phase. O NOUN

We O PRON
describe O NOUN
an O DET
operations O NOUN
research O NOUN
(OR) O NOUN
Study O NOUN
and O CCONJ
assessment O NOUN
of O ADP
one O NUM
form O NOUN
of O ADP
community O NOUN
engagement, O NOUN
the O DET
development O NOUN
and O CCONJ
implementation O NOUN
of O ADP
a O DET
participatory O NOUN
community-based O VERB
health O NOUN
information O NOUN
system O NOUN
(PCBHIS), O NUM
in O ADP
slum O NOUN
communities O NOUN
in O ADP
Freetown, O NOUN
Sierra O NOUN
Leone. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Significant O ADJ
differences O NOUN
were O VERB
also O ADV
observed O VERB
in O ADP
mean O NOUN
velocity O NOUN
during O ADP
the O DET
eccentric O ADJ
phase O NOUN
of O ADP
movement O NOUN
(0.690 O NOUN
m/s O NOUN
in O ADP
the O DET
GCAF O NOUN
to O PART
0.609 O NUM
in O ADP
GCON O NOUN
with O ADP
p O NOUN
= O SYM
0.002). O NUM

Key O NOUN
secondary O ADJ
outcomes O NOUN
included O VERB
a O DET
composite O NOUN
of O ADP
TTP-related B-outcome VERB
death I-outcome NOUN
, O PUNCT
recurrence B-outcome NOUN
of O ADP
TTP, O NOUN
or O CCONJ
a O DET
thromboembolic B-outcome ADJ
event I-outcome NOUN
during O ADP
the O DET
trial O NOUN
treatment O NOUN
period; O NOUN
recurrence B-outcome NOUN
of O ADP
TTP O NOUN
at O ADP
any O DET
time O NOUN
during O ADP
the O DET
trial; O NOUN
refractory B-outcome ADJ
TTP I-outcome NOUN
; O PUNCT
and O CCONJ
normalization B-outcome NOUN
of I-outcome ADP
organ-damage I-outcome NOUN
markers. O NOUN

SETTING: O NOUN
60 O NUM
midwifery O NOUN
practices O NOUN
in O ADP
the O DET
Netherlands. O NOUN

These O DET
results O NOUN
show O VERB
that O ADP
the O DET
amla O NOUN
extract O NOUN
used O VERB
in O ADP
the O DET
study O NOUN
is O VERB
potentially O ADV
a O DET
hypoglycaemic O ADJ
as O ADP
well. O NOUN

The O DET
CD8+ O NOUN
T O NOUN
cells O NOUN
were O VERB
isolated O VERB
from O ADP
the O DET
peripheral O ADJ
blood O NOUN
and O CCONJ
their O ADJ
phenotype O NOUN
was O VERB
analyzed O VERB
by O ADP
flow O NOUN
cytometry. O VERB

Periods O NOUN
of O ADP
unilateral O ADJ
strength O NOUN
training O VERB
should O VERB
be O VERB
implemented O VERB
into O ADP
periodized O VERB
RT O NOUN
programs O NOUN
in O ADP
this O DET
cohort. O NOUN

In O ADP
this O DET
randomized, O NOUN
prospective O ADJ
trial, O NOUN
we O PRON
explore O ADP
differences O NOUN
in O ADP
live B-outcome ADJ
birth I-outcome NOUN
rates O NOUN
and O CCONJ
incidence O NOUN
of O ADP
ovarian B-outcome ADJ
hyperstimulation I-outcome NOUN
syndrome I-outcome NOUN
(OHSS) I-outcome NUM
in O ADP
high-responder O NOUN
patients O NOUN
undergoing O VERB
in O ADP
vitro O ADV
fertilization O NOUN
(IVF) O NOUN
receiving O VERB
low O ADJ
dose O NOUN
hCG O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
GnRH-agonist O NOUN
(dual O PUNCT
trigger) O NOUN
or O CCONJ
hCG O NOUN
adjuvant O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
oocyte O NOUN
retrieval. O NOUN

Publication O NOUN
date: O NOUN
2019/02/14 O NOUN
06:00 O ADP
[medline] O NOUN

Therefore, O NOUN
it O PRON
can O VERB
be O VERB
concluded O VERB
that O ADP
MBCT O NOUN
is O VERB
effective O ADJ
on O ADP
illness B-outcome NOUN
perceptions I-outcome NOUN
and O CCONJ
psychological B-outcome ADJ
syndrome I-outcome NOUN
and O CCONJ
can O VERB
be O VERB
used O VERB
as O ADP
an O DET
MBI O NOUN
method O NOUN
to O PART
reduce O VERB
the O DET
illness B-outcome NOUN
perceptions I-outcome NOUN
in O ADP
people O NOUN
with O ADP
RA. O NOUN

Title: O NOUN
The O DET
effectiveness O NOUN
of O ADP
a O DET
multidisciplinary O ADJ
intervention O NOUN
strategy O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
symptomatic O ADJ
joint O NOUN
hypermobility O NOUN
in O ADP
childhood: O NOUN
a O DET
randomised, O NOUN
single O ADJ
Centre O NOUN
parallel O ADJ
group O NOUN
trial O NOUN
(The O ADJ
Bendy O NOUN
Study). O NOUN

Before O ADP
program O NOUN
implementation, O ADP
the O DET
schools O NOUN
were O VERB
stratified O VERB
by O ADP
sub-county O NOUN
and O CCONJ
randomized O VERB
to O PART
one O NUM
of O ADP
four O NUM
study O NOUN
arms O NOUN
(35 O VERB
schools O NOUN
per O ADP
arm): O ADJ
1) O NUM
control, O NOUN
2) O NOUN
disposable O ADJ
sanitary O ADJ
pads O NOUN
distribution, O NOUN
2) O NOUN
reproductive O ADJ
health O NOUN
education, O VERB
and O CCONJ
4) O NOUN
sanitary O ADJ
pad O NOUN
distribution O NOUN
and O CCONJ
reproductive O ADJ
health O NOUN
education. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

Funded O VERB
by O ADP
the O DET
Health O NOUN
Research O NOUN
Council O NOUN
of O ADP
New O ADJ
Zealand; O NOUN
Australian O ADJ
New O ADJ
Zealand O NOUN
Clinical O ADJ
Trials O NOUN
Registry O NOUN
number, O ADV
ACTRN12609000593235 O NOUN
.). O NOUN

Publication O NOUN
date: O NOUN
2018/06/14 O PUNCT
00:00 O NOUN
[accepted] O ADV

The O DET
duration B-outcome NOUN
of I-outcome ADP
analgesia I-outcome NOUN
was O VERB
230.5 O NUM
+/- O SYM
40.5 O NUM
minutes O NOUN
in O ADP
Dex O NOUN
group O NOUN
and O CCONJ
145.1 O NUM
+/- O SYM
28.5 O NUM
minutes O NOUN
in O ADP
Control O NOUN
group, O NOUN
respectively O ADV
(P O NUM
< O SYM
.001). O PUNCT

Publication O NOUN
date: O NOUN
2018/08/29 O PUNCT
00:00 O NOUN
[accepted] O ADV

RESULTS: O NOUN
Significant O ADJ
time O NOUN
x O SYM
group O NOUN
interactions O NOUN
and O CCONJ
moderate O ADJ
to O PART
high O ADJ
effect O NOUN
sizes O NOUN
were O VERB
found O VERB
for O ADP
physical B-outcome ADJ
functioning I-outcome VERB
, O PUNCT
physical B-outcome ADJ
health I-outcome NOUN
, O PUNCT
bodily B-outcome ADV
pain I-outcome NOUN
, O PUNCT
general B-outcome ADJ
health I-outcome NOUN
perception I-outcome NOUN
, O PUNCT
vitality B-outcome NOUN
, O PUNCT
social B-outcome ADJ
functioning I-outcome VERB
, O PUNCT
fatigue B-outcome NOUN
, O PUNCT
sleep B-outcome NOUN
disturbance I-outcome NOUN
, O PUNCT
body B-outcome NOUN
image I-outcome NOUN
, O PUNCT
and O CCONJ
upset B-outcome ADV
by O ADP
hair O NOUN
loss, O NOUN
favoring O VERB
the O DET
exercise O NOUN
group. O VERB

For O ADP
a O DET
better O ADJ
application O NOUN
of O ADP
TXA O NOUN
function, O ADP
we O PRON
explored O VERB
the O DET
effect O NOUN
of O ADP
intravenous O ADJ
injection O NOUN
(IV) O NUM
of O ADP
TXA O NOUN
combined O VERB
with O ADP
intra-articular O ADJ
injection O NOUN
(IA) O NOUN
of O ADP
TXA O NOUN
in O ADP
patients O NOUN
after O ADP
TKA. O NOUN

Short- O ADV
and O CCONJ
long-term O NOUN
wound B-outcome NOUN
complications I-outcome NOUN
were O VERB
not O ADV
improved O VERB
with O ADP
NPWT. O ADV

Journal O ADJ
ID: O NOUN
101224380 O NUM

antibiotic O ADJ
therapy O NOUN
followed O VERB
by O ADP
p.o. O NOUN

Haematology O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
red B-outcome ADJ
blood I-outcome NOUN
cell I-outcome NOUN
count I-outcome NOUN
and O CCONJ
haematocrit B-outcome NOUN
of O ADP
the O DET
AGS O NOUN
group O NOUN
before O ADP
operation O NOUN
were O VERB
lower O ADJ
than O ADP
those O DET
in O ADP
the O DET
control O NOUN
group O NOUN
(P O NUM
= O SYM
.039, O NOUN
P O NOUN
= O SYM
.029), O PUNCT
but O CCONJ
there O PRON
was O VERB
no O DET
difference O NOUN
after O ADP
operation O NOUN
(P O NUM
>.05). O NUM

Publication O NOUN
date: O NOUN
2018/12/07 O NOUN
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Median O ADJ
end-tidal O ADP
volatile O ADP
anesthetic B-outcome ADJ
concentration O NOUN
was O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
guided O VERB
group O NOUN
than O ADP
the O DET
usual O ADJ
care O NOUN
group O NOUN
(0.69 O NUM
vs O CCONJ
0.80 O NUM
minimum O NOUN
alveolar B-outcome ADJ
concentration; O NOUN
difference, O NOUN
-0.11 O NUM
[95% O NOUN
CI, O NOUN
-0.13 O NUM
to O PART
-0.10), O NOUN
and O CCONJ
median O ADJ
cumulative O ADJ
time B-outcome NOUN
with Seperator ADP
EEG I-outcome NOUN
suppression I-outcome NOUN
was O VERB
significantly O ADV
less O ADV
(7 O NOUN
vs O CCONJ
13 O NUM
minutes; O NOUN
difference, O NOUN
-6.0 O ADJ
[95% O NOUN
CI, O NOUN
-9.9 O NUM
to O PART
-2.1]). O NUM

RESULTS: O NOUN
At O ADP
the O DET
end O NOUN
of O ADP
6 O NUM
weeks, O NOUN
and O CCONJ
12 O NUM
weeks, O NOUN
UGPRF O NOUN
showed O VERB
more O ADV
promising O VERB
outcome O NOUN
results O NOUN
in O ADP
pain B-outcome NOUN
relief I-outcome NOUN
, O PUNCT
as O ADP
measured O VERB
by O ADP
VAS O NOUN
(P O NUM
<.01), O PUNCT
improvement O NOUN
of O ADP
shoulder B-outcome NOUN
disorder I-outcome ADP
, O PUNCT
as O ADP
assessed O VERB
by O ADP
shoulder B-outcome NOUN
pain I-outcome NOUN
and O CCONJ
disability B-outcome NOUN
index O NOUN
(SPADI) O NOUN
score O NOUN
( O PUNCT
pain B-outcome NOUN
, O PUNCT
P O NOUN
<.01; O NUM
disability B-outcome NOUN
, O PUNCT
P O NOUN
<.01; O NUM
total, O ADJ
P O NOUN
<.01), O PUNCT
and O CCONJ
enhancement O NOUN
of O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
as O ADP
measured O VERB
by O ADP
the O DET
Short O NOUN
Form-36 O NOUN
questionnaire O NOUN
(SF-36) O NOUN
scale O NOUN
(PCS, O NOUN
P O NOUN
<.01; O NUM
MCS, O NOUN
P O NOUN
<.01), O PUNCT
compared O VERB
with O ADP
sham O NOUN
UGPRF O NOUN
in O ADP
this O DET
study. O NOUN

BACKGROUND: O NOUN
Desmoid O NOUN
tumors O NOUN
(also O ADV
referred O VERB
to O PART
as O ADP
aggressive O ADJ
fibromatosis) O NOUN
are O VERB
connective O ADJ
tissue O NOUN
neoplasms O NOUN
that O ADP
can O VERB
arise O VERB
in O ADP
any O DET
anatomical O ADJ
location O NOUN
and O CCONJ
infiltrate O NOUN
the O DET
mesentery, O NOUN
neurovascular O ADJ
structures, O NOUN
and O CCONJ
visceral O ADJ
organs. O NOUN

Publication O NOUN
date: O NOUN
2019/02/09 O NOUN
06:00 O ADP
[medline] O NOUN

Surveys O NOUN
with O ADP
established O VERB
validity O NOUN
and O CCONJ
reliability O NOUN
were O VERB
used O VERB
to O PART
measure O NOUN
self-efficacy B-outcome NOUN
to O PART
cope O NOUN
with O ADP
stress, O NOUN
emotional O ADJ
coping B-outcome VERB
response, O NOUN
and O CCONJ
social B-outcome ADJ
support I-outcome NOUN
for O ADP
stress O NOUN
management. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
live B-outcome ADJ
birth I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
1364 O NUM
women O NOUN
underwent O VERB
randomization. O NOUN

Estimates O NOUN
from O ADP
regression-adjusted O VERB
treatment O NOUN
effects O NOUN
indicate O VERB
that O ADP
the O DET
average O NOUN
PTSD B-outcome NOUN
severity I-outcome NOUN
score O NOUN
was O VERB
reduced O VERB
by O ADP
9.7 O NUM
points O NOUN
(p O PUNCT
= O SYM
0.01), O NUM
or O CCONJ
14.3% O NUM
from O ADP
pre- O ADJ
to O PART
post-intervention. O ADJ

KT O NOUN
could O VERB
be O VERB
incorporated O VERB
into O ADP
gait O NOUN
re-education O NOUN
programmes O NOUN
to O PART
facilitate O VERB
muscle O NOUN
contraction O NOUN
in O ADP
these O DET
children. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
death B-outcome NOUN
from I-outcome ADP
any Seperator DET
cause I-outcome ADP
at O ADP
10 O NUM
years. O NOUN

Pain B-outcome NOUN
VAS O NOUN
scores O NOUN
at O ADP
rest O NOUN
and O CCONJ
at O ADP
flexion O NOUN
were O VERB
both O CCONJ
lower O ADJ
in O ADP
preoperative O ADJ
analgesia O NOUN
group O NOUN
compared O VERB
to O PART
postoperative O ADJ
analgesia O NOUN
group O NOUN
at O ADP
2 O NUM
hours, O NOUN
6 O NUM
hours, O NOUN
12 O NUM
hours, O NOUN
and O CCONJ
24 O NUM
hours O NOUN
post O ADV
operation. O ADV

Study O NOUN
models O NOUN
and O CCONJ
cephalograms O NOUN
were O VERB
taken O VERB
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
12 O NUM
months O NOUN
of O ADP
treatment. O NOUN

wash-out O ADP
period, O NOUN
19 O NUM
healthy O ADJ
women O NOUN
performed O VERB
30 O NUM
min O NOUN
moderate-intensity O NOUN
cycling O VERB
after O ADP
ingesting O VERB
1000 O NUM
mg O NOUN
of O ADP
ascorbic O ADJ
acid O NOUN
(AA) O NOUN
or O CCONJ
placebo. O NOUN

METHODS: O NOUN
We O PRON
studied O VERB
40 O NUM
morbidly O ADV
obese O NOUN
individuals O NOUN
aged O VERB
between O ADP
25 O NUM
and O CCONJ
55 O NUM
years O NOUN
who O ADP
underwent O VERB
pulmonary O ADJ
function O NOUN
test O NOUN
and O CCONJ
chest O NOUN
X-ray O NOUN
preoperatively, O ADJ
and O CCONJ
on O ADP
the O DET
day O NOUN
of O ADP
discharge O NOUN
(2nd O PUNCT
day O NOUN
after O ADP
surgery). O NOUN

Furthermore, O NOUN
in O ADP
both O CCONJ
groups, O NOUN
mean B-outcome NOUN
arterial I-outcome ADJ
pressure I-outcome NOUN
and O CCONJ
preoperative O ADJ
PR B-outcome NOUN
interval I-outcome NOUN
were O VERB
similar O ADJ
at O ADP
various O ADJ
times. O NOUN

Such O ADJ
information O NOUN
provides O NOUN
important O ADJ
knowledge O NOUN
that O ADP
may O VERB
help O VERB
to O PART
inform O NOUN
decisions O NOUN
of O ADP
municipalities, O NOUN
employers O NOUN
and O CCONJ
other O ADJ
public O ADJ
health O NOUN
decision O NOUN
makers, O NOUN
when O ADP
and O CCONJ
if O ADP
implementing O VERB
weight O NOUN
loss O NOUN
interventions. O NOUN

The O DET
participants O NOUN
consumed O VERB
either O CCONJ
two O NUM
packs O NOUN
a O DET
day O NOUN
for O ADP
a O DET
total O ADJ
of O ADP
132 O NUM
g O NOUN
of O ADP
WSP O NOUN
(WSP-MR O PUNCT
group) O ADJ
or O CCONJ
a O DET
normal O ADJ
diet O NOUN
daily O ADJ
(non-WSP O PUNCT
group) O ADJ
for O ADP
eight O NUM
weeks. O NOUN

METHODS: O NOUN
Subjects O NOUN
were O VERB
randomized O VERB
to O PART
receive O VERB
HP O NOUN
(256 O NUM
subjects) O NOUN
or O CCONJ
G O NOUN
+ O SYM
T O NOUN
(132 O NUM
subjects) O NOUN
for O ADP
treatment O NOUN
of O ADP
minimal, O ADJ
mild, O NOUN
or O CCONJ
moderate O ADJ
bleeding B-outcome VERB
at O ADP
20 O NUM
investigational O ADJ
sites. O NOUN

The O DET
objective O ADP
of O ADP
this O DET
controlled O VERB
clinical O ADJ
study O NOUN
is O VERB
to O PART
verify O NOUN
the O DET
effect O NOUN
of O ADP
aPDT O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
halitosis O NOUN
by O ADP
evaluating O VERB
the O DET
formation O NOUN
of O ADP
volatile O ADP
sulphur O NOUN
compounds O NOUN
with O ADP
gas O NOUN
chromatography O NOUN
and O CCONJ
microbiological O ADJ
analysis O NOUN
before O ADP
and O CCONJ
after O ADP
treatment. O NOUN

Thus, O NOUN
a O DET
double-blinded O VERB
randomized, O NOUN
placebo-controlled O VERB
trial O NOUN
was O VERB
conducted O VERB
to O PART
determine O NOUN
whether O ADP
nifedipine, O NOUN
a O DET
calcium O NOUN
channel O NOUN
blocker O NOUN
with O ADP
potent O ADJ
smooth O NOUN
muscle O NOUN
relaxing O VERB
activity O NOUN
and O CCONJ
an O DET
excellent O ADJ
safety O NOUN
profile, O NOUN
can O VERB
improve O VERB
the O DET
outcome O NOUN
of O ADP
patients O NOUN
undergoing O VERB
ET O NOUN
treatments. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODS: O NOUN
In O ADP
this O DET
crossover, O NOUN
randomized O VERB
controlled O VERB
trial, O NOUN
elbow B-outcome NOUN
proprioception I-outcome NOUN
, O PUNCT
pain B-outcome NOUN
severity I-outcome NOUN
, O PUNCT
pain-free B-outcome ADJ
grip I-outcome NOUN
strength I-outcome NOUN
, O PUNCT
and O CCONJ
finger B-outcome NOUN
dexterity I-outcome NOUN
were O VERB
measured O VERB
in O ADP
50 O NUM
participants O NOUN
with O ADP
a O DET
diagnosis O NOUN
of O ADP
lateral O ADJ
elbow O NOUN
tendinopathy. O NOUN

Journal O ADJ
ID: O NOUN
9425194 O NUM

Publication O NOUN
date: O NOUN
2019/03/01 O NOUN
06:00 O ADP
[medline] O NOUN

In O ADP
contrast, O NOUN
children O NOUN
reported O VERB
that O ADP
the O DET
activities O NOUN
outside O ADP
of O ADP
the O DET
classroom O NOUN
were O VERB
preferred B-outcome VERB
. O PUNCT
Future O NOUN
school-based O VERB
PA O NOUN
interventions O NOUN
should O VERB
aim O ADP
to O PART
achieve O NOUN
a O DET
balance O NOUN
between O ADP
routine O ADJ
PA O NOUN
at O ADP
a O DET
set O NOUN
time O NOUN
and O CCONJ
PA O NOUN
that O ADP
is O VERB
flexible O ADJ
and O CCONJ
adaptable. O NOUN

Title: O NOUN
Proton O NOUN
Pump O ADV
Inhibitor O NOUN
Ameliorates O NOUN
Taste B-outcome NOUN
Disturbance I-outcome NOUN
among O ADP
Patients O NOUN
with O ADP
Laryngopharyngeal O ADJ
Reflux: O NOUN
A O DET
Randomized O VERB
Controlled O VERB
Study. O NOUN

Publication O NOUN
date: O NOUN
2019/03/12 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
with O ADP
normal O ADJ
G6PD O NOUN
enzyme O NOUN
activity, O ADP
the O DET
decline O NOUN
in O ADP
hemoglobin B-outcome NOUN
level O NOUN
with O ADP
tafenoquine O NOUN
did O VERB
not O ADV
differ O VERB
significantly O ADV
from O ADP
that O ADP
with O ADP
primaquine. O NOUN

If O ADP
endometrial B-outcome ADJ
thickness I-outcome NOUN
failed O VERB
to O PART
increase O NOUN
after O ADP
48 O NUM
h, O NOUN
PRP O NOUN
infusion O NOUN
was O VERB
repeated O VERB
in O ADP
the O DET
same O ADJ
cycle. O NOUN

All O DET
the O DET
clinical O ADJ
and O CCONJ
biochemical O ADJ
parameters O NOUN
were O VERB
routinely O ADV
evaluated O VERB
before O ADP
and O CCONJ
after O ADP
treatment. O NOUN

Title: O NOUN
Physiological, O ADJ
hyaluronan-selected O VERB
intracytoplasmic O ADJ
sperm O NOUN
injection O NOUN
for O ADP
infertility O NOUN
treatment O NOUN
(HABSelect): O NOUN
a O DET
parallel, O ADV
two-group, O NOUN
randomised O VERB
trial. O NOUN

Journal-Name:The O ADJ
bone O NOUN
& O CCONJ
joint O NOUN
journal O ADJ

Journal-Name:JAMA O NOUN

The O DET
objective O ADP
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
assess O NOUN
if O ADP
a O DET
combination O NOUN
of O ADP
a O DET
lower O ADJ
dose O NOUN
of O ADP
AmBisome O NOUN
with O ADP
miltefosine O NOUN
would O VERB
show O VERB
acceptable O ADJ
efficacy O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
treatment. O NOUN

Evaluation O NOUN
of O ADP
grip B-outcome NOUN
strength I-outcome NOUN
can O VERB
be O VERB
used O VERB
as O ADP
an O DET
additional O ADJ
strategy O NOUN
to O PART
evaluate O VERB
postoperative O ADJ
residual B-outcome ADJ
neuromuscular I-outcome ADJ
blockade I-outcome NOUN
. O PUNCT

DISCUSSION: O NOUN
The O DET
results O NOUN
of O ADP
this O DET
trial O NOUN
will O VERB
be O VERB
used O VERB
to O PART
establish O NOUN
clinical O ADJ
evidence O NOUN
regarding O VERB
the O DET
use O NOUN
of O ADP
Bosinji O NOUN
with O ADP
acupuncture O NOUN
treatment O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
patients O NOUN
with O ADP
LHIVD. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Low-Dose O NOUN
Intracoronary O ADJ
Alteplase O NOUN
During O ADP
Primary O ADJ
Percutaneous O ADJ
Coronary O ADJ
Intervention O NOUN
on O ADP
Microvascular B-outcome ADJ
Obstruction I-outcome NOUN
in O ADP
Patients O NOUN
With O ADP
Acute O ADJ
Myocardial O ADJ
Infarction: O NOUN
A O DET
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

We O PRON
assessed O VERB
a O DET
composite O NOUN
primary O ADJ
endpoint O NOUN
of O ADP
complete B-outcome ADJ
remission I-outcome NOUN
, O PUNCT
complete B-outcome ADJ
remission I-outcome NOUN
with Seperator ADP
incomplete I-outcome ADJ
platelet I-outcome NOUN
recovery I-outcome NOUN
(CRp) I-outcome NOUN
, O PUNCT
and O CCONJ
complete B-outcome ADJ
remission I-outcome NOUN
with Seperator ADP
incomplete I-outcome ADJ
haematological I-outcome ADJ
recovery I-outcome NOUN
(CRi) I-outcome NOUN
achieved O NOUN
at O ADP
any O DET
time O NOUN
and O CCONJ
assessed O VERB
by O ADP
intention O NOUN
to O PART
treat. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Hence, O NOUN
we O PRON
aimed O VERB
to O PART
identify O NOUN
which O ADP
combinations O NOUN
of O ADP
teacher O NOUN
and O CCONJ
implementation O NOUN
process O NOUN
characteristics O NOUN
affected O VERB
the O DET
emotional B-outcome ADJ
and Seperator CCONJ
social I-outcome ADJ
school I-outcome NOUN
experience I-outcome NOUN
(SCE) I-outcome PUNCT
of O ADP
pupils O NOUN
participating O VERB
in O ADP
a O DET
school-based O VERB
health O NOUN
promotion O NOUN
program. O NOUN

Objective: O NOUN
Netupitant O ADJ
is O VERB
a O DET
novel, O ADV
selective O ADJ
neurokinin-1 O NOUN
receptor O NOUN
antagonist O NOUN
used O VERB
for O ADP
prevention O NOUN
of O ADP
chemotherapy-induced O VERB
nausea O NOUN
and O CCONJ
vomiting, O NOUN
a O DET
distressing O VERB
side O NOUN
effect O NOUN
of O ADP
chemotherapy. O NOUN

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
early O ADJ
clinical B-outcome ADJ
response I-outcome NOUN
, O PUNCT
defined O VERB
as O ADP
survival B-outcome NOUN
with O ADP
improvement O NOUN
in O ADP
at O ADP
least O ADV
two O NUM
of O ADP
four O NUM
symptoms B-outcome NOUN
( O PUNCT
cough B-outcome NOUN
, O PUNCT
sputum B-outcome NOUN
production I-outcome NOUN
, O PUNCT
pleuritic B-outcome ADJ
chest I-outcome NOUN
pain I-outcome NOUN
, O PUNCT
and O CCONJ
dyspnea B-outcome NOUN
) O PUNCT
and O CCONJ
no O DET
worsening O VERB
of O ADP
symptoms B-outcome NOUN
at O ADP
72 O NUM
to O PART
120 O NUM
hours, O NOUN
without O ADP
receipt O NOUN
of O ADP
rescue B-outcome NOUN
antibacterial I-outcome ADJ
therapy I-outcome NOUN
. O PUNCT
A O DET
secondary O ADJ
end O NOUN
point O NOUN
was O VERB
investigator-assessed O VERB
clinical B-outcome ADJ
response I-outcome NOUN
at O ADP
a O DET
post-treatment O NOUN
evaluation O NOUN
5 O NUM
to O PART
10 O NUM
days O NOUN
after O ADP
the O DET
last O NOUN
dose, O NOUN
with O ADP
clinical O ADJ
response O NOUN
defined O VERB
as O ADP
resolution O NOUN
or O CCONJ
improvement O NOUN
in O ADP
signs B-outcome NOUN
or O CCONJ
symptoms B-outcome NOUN
to O PART
the O DET
extent O NOUN
that O ADP
further O ADV
antibacterial O ADJ
therapy O NOUN
was O VERB
unnecessary. O VERB

A O DET
total O ADJ
of O ADP
2048 O NUM
were O VERB
approached O VERB
for O ADP
participation O NOUN
in O ADP
the O DET
ICU, O ADJ
of O ADP
which O ADP
1458 O NUM
provided O ADJ
informed O VERB
consent. O NOUN

Publication O NOUN
date: O NOUN
2019/02/28 O NOUN
06:00 O ADP
[medline] O NOUN

The O DET
authors O NOUN
did O VERB
not O ADV
find O ADP
any O DET
statistically O ADV
significant O ADJ
differences O NOUN
between O ADP
all O DET
measured O VERB
variables O NOUN
for O ADP
the O DET
CG O NOUN
at O ADP
the O DET
initial O ADJ
and O CCONJ
final O ADJ
assessments. O NOUN

The O DET
nasopharyngeal O ADJ
temperature O NOUN
was O VERB
maintained O VERB
at O ADP
33.0-34.5 O NUM
centigrade O NOUN
and O CCONJ
the O DET
rectal O ADJ
temperature O NOUN
was O VERB
maintained O VERB
at O ADP
34.5-35.0 O NUM
centigrade. O NOUN

There O PRON
were O VERB
no O DET
significant O ADJ
between-group O NOUN
differences O NOUN
in O ADP
the O DET
rates O NOUN
of O ADP
ongoing B-outcome VERB
pregnancy I-outcome NOUN
, O PUNCT
clinical B-outcome ADJ
pregnancy I-outcome NOUN
, O PUNCT
multiple B-outcome ADJ
pregnancy I-outcome NOUN
, O PUNCT
ectopic B-outcome ADJ
pregnancy I-outcome NOUN
, O PUNCT
or O CCONJ
miscarriage B-outcome NOUN
. O PUNCT
The O DET
median O ADJ
score O NOUN
for O ADP
pain B-outcome NOUN
from O ADP
endometrial O ADJ
scratching O VERB
(on O PUNCT
a O DET
scale O NOUN
of O ADP
0 O NUM
to O PART
10, O NUM
with O ADP
higher O ADJ
scores O NOUN
indicating O VERB
worse O NOUN
pain) O NOUN
was O VERB
3.5 O NUM
(interquartile O NUM
range, O VERB
1.9 O NUM
to O PART
6.0). O NOUN

The O DET
Ocular B-outcome ADJ
Surface I-outcome NOUN
Disease I-outcome NOUN
Index O NOUN
(OSDI) O NOUN
questionnaire, O NOUN
evaluation O NOUN
of O ADP
subjective O ADJ
symptoms B-outcome NOUN
and O CCONJ
evaluation O NOUN
of O ADP
the O DET
best-corrected B-outcome VERB
visual I-outcome ADJ
acuity I-outcome NOUN
(BCVA) I-outcome NUM
were O VERB
conducted O VERB
preoperatively O ADV
and O CCONJ
postoperatively O ADV
on O ADP
days O NOUN
1, O NOUN
7, O NUM
14, O NUM
30 O NUM
and O CCONJ
90. O NOUN

3) O NOUN
Results: O NOUN
There O PRON
were O VERB
statistically O ADV
significant O ADJ
(p O PUNCT
< O SYM
0.05) O NUM
decreases O NOUN
in O ADP
systolic B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
sVCAM-1 B-outcome NOUN
, O PUNCT
sE-selectin B-outcome NOUN
and O CCONJ
endothelin-1 B-outcome NOUN
levels, O NOUN
and O CCONJ
increases O NOUN
in O ADP
glutathione B-outcome NOUN
peroxidase I-outcome NOUN
activity I-outcome NOUN
and O CCONJ
oxidized B-outcome VERB
glutathione I-outcome NOUN
levels. O NOUN
( O PUNCT

These O DET
and O CCONJ
other O ADJ
related O VERB
markers O NOUN
(holotranscobalamin, O NUM
methylmalonic O ADJ
acid O NOUN
and O CCONJ
homocysteine) O NOUN
have O VERB
been O VERB
linked O VERB
with O ADP
cognitive O ADJ
health. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Journal-Name:Clinical O ADJ
interventions O NOUN
in O ADP
aging O VERB

Patients O NOUN
were O VERB
enrolled O VERB
after O ADP
the O DET
diagnosis O NOUN
of O ADP
resectable O ADJ
or O CCONJ
borderline O NOUN
resectable O ADJ
by O ADP
portal O NOUN
vein O NOUN
involvement O NOUN
pancreatic O ADJ
cancer O NOUN
with O ADP
histological O ADJ
confirmation. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

BACKGROUND: O NOUN
This O DET
pilot O NOUN
study O NOUN
aimed O VERB
to O PART
evaluate O VERB
the O DET
feasibility B-outcome NOUN
effectiveness O NOUN
and O CCONJ
safety O NOUN
of O ADP
transcutaneous O ADJ
electrical O ADJ
nerve O NOUN
stimulation O NOUN
(TENS) O PUNCT
for O ADP
patients O NOUN
with O ADP
acute O ADJ
tinnitus. O NOUN

Although O ADP
the O DET
intervention O NOUN
successfully O ADV
altered O VERB
several O ADJ
hypothesised O VERB
mediating O VERB
constructs O NOUN
it O PRON
did O VERB
not O ADV
translate O NOUN
into O ADP
long-term O NOUN
behaviour O NOUN
change. O NOUN

Subpopulations O NOUN
of O ADP
T B-outcome NOUN
regulatory I-outcome ADJ
lymphocytes I-outcome NOUN
(Tregs) I-outcome NUM
( O PUNCT
CD4+ B-outcome NOUN
/ O SYM
CD25+ B-outcome DET
/ O SYM
CD127- B-outcome NUM
), O NUM
cytotoxic B-outcome ADJ
lymphocytes I-outcome NOUN
(CTLs) I-outcome NUM
( O PUNCT
CD8+ B-outcome NOUN
/ O SYM
TCRalphabeta+ B-outcome PUNCT
), O NUM
natural B-outcome ADJ
killer I-outcome NOUN
(NK) I-outcome ADV
cells I-outcome NOUN
( O PUNCT
CD3- B-outcome ADJ
/ O SYM
CD16+ B-outcome NOUN
/ O SYM
CD56+ B-outcome NOUN
) O PUNCT
and O CCONJ
TCRdeltagamma-positive B-outcome ADJ
(Tdeltagamma) I-outcome NUM
cells I-outcome NOUN
were O VERB
determined O VERB
by O ADP
means O NOUN
of O ADP
flow O NOUN
cytometry. O VERB

The O DET
primary O ADJ
endpoint O NOUN
is O VERB
overall B-outcome ADJ
survival I-outcome NOUN
; O PUNCT
secondary O ADJ
endpoints O NOUN
include O VERB
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
resection B-outcome NOUN
rate, O NOUN
recurrence-free B-outcome PUNCT
survival I-outcome NOUN
, O PUNCT
residual B-outcome ADJ
tumor I-outcome NOUN
status I-outcome NOUN
, O PUNCT
nodal B-outcome NOUN
metastases I-outcome NOUN
and O CCONJ
tumor B-outcome NOUN
marker I-outcome NOUN
kinetics I-outcome NOUN
. O PUNCT
The O DET
target O NOUN
sample O NOUN
size O NOUN
was O VERB
required O VERB
to O PART
be O VERB
at O ADP
least O ADV
163 O NUM
(alpha-error O NOUN
0.05; O NOUN
power O NOUN
0.8) O NOUN
in O ADP
both O CCONJ
arms. O ADJ

Journal-Name:Taiwanese O NOUN
journal O ADJ
of O ADP
obstetrics O NOUN
& O CCONJ
gynecology O NOUN

While O ADP
30% O NOUN
report O NOUN
working O VERB
full O ADJ
or O CCONJ
part O NOUN
time, O NOUN
45% O ADJ
were O VERB
retired O VERB
due O ADJ
to O PART
disability. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/01/28 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
results O NOUN
indicate O VERB
that O ADP
these O DET
vaccines O NOUN
were O VERB
safe O ADJ
and O CCONJ
immunogenic B-outcome ADJ
in O ADP
ethnic O ADJ
Korean O NOUN
children. O NOUN

There O PRON
was O VERB
no O DET
serious B-outcome ADJ
adverse I-outcome ADJ
event I-outcome NOUN
such O ADJ
as O ADP
arrhythmia, O NOUN
large O ADJ
vein O NOUN
thrombosis O NOUN
or O CCONJ
irreducible O ADJ
hypotension O NOUN
in O ADP
both O CCONJ
groups, O NOUN
and O CCONJ
there O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
general O ADJ
adverse B-outcome ADJ
events I-outcome NOUN
such O ADJ
as O ADP
sinus B-outcome NOUN
bradycardia I-outcome NOUN
, O PUNCT
scleredema B-outcome NOUN
, O PUNCT
blood B-outcome NOUN
glucose I-outcome NOUN
disorder I-outcome ADP
, O PUNCT
or O CCONJ
systemic B-outcome ADJ
infection I-outcome NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
[16.7% O ADP
(3/18) O PUNCT
vs. O CCONJ
11.1% O NUM
(2/18), O PUNCT
5.6% O NOUN
(1/18) O PUNCT
vs. O CCONJ
5.6% O NOUN
(1/18), O NUM
22.2% O NUM
(4/18) O PUNCT
vs. O CCONJ
11.1% O NUM
(2/18), O PUNCT
5.6% O NOUN
(1/18) O PUNCT
vs. O CCONJ
5.6% O NOUN
(1/18), O NUM
all O DET
P O NOUN
> O SYM
0.05]. O NUM
CONCLUSIONS: O NOUN
SBH O NOUN
treatment O NOUN
could O VERB
significantly O ADV
increase O NOUN
the O DET
neonatal B-outcome ADJ
behavioral I-outcome ADJ
neurological I-outcome ADJ
assessment O NOUN
score O NOUN
at O ADP
28 O NUM
days O NOUN
of O ADP
birth O NOUN
and O CCONJ
Bayley O PROPN
scales O NOUN
of O ADP
infant B-outcome NOUN
development I-outcome NOUN
score O NOUN
at O ADP
15 O NUM
months O NOUN
of O ADP
age, O NOUN
reduce O VERB
the O DET
incidence O NOUN
of O ADP
severe B-outcome ADJ
disability I-outcome NOUN
in O ADP
moderate O ADJ
and O CCONJ
severe O ADJ
HIE O NOUN
children, O NOUN
but O CCONJ
it O PRON
was O VERB
not O ADV
be O VERB
proved O VERB
that O ADP
SBH O NOUN
could O VERB
reduce O VERB
the O DET
mortality B-outcome NOUN
. O PUNCT
Compared O VERB
with O ADP
routine O ADJ
treatment, O NOUN
SBH O NOUN
treatment O NOUN
had O VERB
no O DET
significant O ADJ
superiority O NOUN
on O ADP
improving O VERB
the O DET
levels O NOUN
of O ADP
serum O NOUN
neuron-specific B-outcome ADJ
enolase I-outcome NOUN
and O CCONJ
S100 B-outcome NOUN
protein I-outcome NOUN
, O PUNCT
suggesting O VERB
that O ADP
SBH O NOUN
could O VERB
not O ADV
protect O VERB
the O DET
brain O NOUN
by O ADP
inhibiting O VERB
the O DET
apoptosis O NOUN
of O ADP
nerve O NOUN
cells O NOUN
and O CCONJ
promoting O VERB
the O DET
repair O NOUN
of O ADP
nerve O NOUN
cells. O NOUN

Both O CCONJ
MRI O NOUN
sequences O NOUN
scored O VERB
significantly O ADV
higher O ADJ
compared O VERB
to O PART
CT O NOUN
for O ADP
image O NOUN
quality O NOUN
and O CCONJ
confidence O NOUN
in O ADP
contouring, O NOUN
particularly O ADV
T2*W. O NOUN
This O DET
was O VERB
also O ADV
reflected O VERB
in O ADP
the O DET
shorter O ADJ
time O NOUN
for O ADP
contouring, O NOUN
measuring O VERB
15.4, O NOUN
9.6 O NUM
and O CCONJ
9.8 O NUM
min O NOUN
for O ADP
CT, O NOUN
T2W O NOUN
and O CCONJ
T2*W O NOUN
MRI O NOUN
respectively. O NOUN

All O DET
participants O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
three O NUM
groups, O NOUN
each O DET
using O VERB
a O DET
different O ADJ
device O NOUN
system O NOUN
(motion O NOUN
tracking, O PUNCT
finger O NOUN
motion O NOUN
control O NOUN
or O CCONJ
touchscreen) O ADV
to O PART
perform O NOUN
three O NUM
task O NOUN
phases O NOUN
( O PUNCT
acquisition B-outcome NOUN
, O PUNCT
retention B-outcome NOUN
and O CCONJ
transfer B-outcome NOUN
). O NOUN

And O CCONJ
there O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
mean B-outcome NOUN
arterial I-outcome ADJ
pressure I-outcome NOUN
, O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
, O PUNCT
pulse B-outcome NOUN
oxygen I-outcome NOUN
saturation I-outcome NOUN
and O CCONJ
bispectral O ADJ
index O NOUN
(BIS) O PUNCT
every O DET
2 O NUM
hours O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
from O ADP
20: O NOUN
00 O NUM
(the O NOUN
first O ADV
day) O NOUN
to O PART
6: O ADP
00 O NUM
(the O NOUN
second O ADJ
day)(all O NOUN
P>0.05). O NOUN

During O ADP
the O DET
final O ADJ
week O NOUN
of O ADP
each O DET
intervention O NOUN
phase, O NOUN
subjects O NOUN
collected O VERB
all O DET
feces O NOUN
and O CCONJ
urine O NOUN
produced, O NOUN
and O CCONJ
these O DET
were O VERB
also O ADV
analyzed O VERB
for O ADP
nitrogen B-outcome NOUN
(feces O NOUN
and O CCONJ
urine), O NOUN
energy B-outcome NOUN
(feces O NOUN
and O CCONJ
urine), O NOUN
and O CCONJ
fat B-outcome NOUN
(feces). O NOUN

Cost O NOUN
is O VERB
frequently O ADV
cited O VERB
as O ADP
an O DET
explanation O NOUN
for O ADP
both O CCONJ
of O ADP
these O DET
observations. O NOUN

Barriers O NOUN
were O VERB
regrouped O VERB
into O ADP
five O NUM
categories: O NOUN
structural O ADJ
factors O NOUN
(e.g., O NOUN
policies, O NOUN
social O ADJ
context, O NOUN
local O ADJ
workforce O ADP
development, O NOUN
and O CCONJ
physical O ADJ
aspects O NOUN
of O ADP
the O DET
environment), O NOUN
organizational O ADJ
factors O NOUN
(e.g., O NOUN
logistical O ADJ
issues O NOUN
for O ADP
the O DET
provision O NOUN
of O ADP
care O NOUN
and O CCONJ
collaboration O NOUN
within O ADP
and O CCONJ
across O ADP
healthcare O NOUN
organizations), O NOUN
provider O NOUN
factors O NOUN
(e.g., O NOUN
previous O ADJ
mental O ADJ
health O NOUN
experience O NOUN
and O CCONJ
personal O ADJ
characteristics), O NOUN
patient O NOUN
factors O NOUN
(e.g., O NOUN
beliefs O NOUN
about O ADV
the O DET
health O NOUN
system O NOUN
and O CCONJ
healthcare O NOUN
professionals, O NOUN
and O CCONJ
motivation O NOUN
to O PART
seek O NOUN
care), O NOUN
and O CCONJ
innovation O NOUN
factors O NOUN
(e.g., O NOUN
training O VERB
characteristics). O NOUN

Primary O ADJ
efficacy O NOUN
end O NOUN
point O NOUN
was O VERB
composite O NOUN
of O ADP
in-hospital B-outcome NOUN
death I-outcome NOUN
and O CCONJ
stent B-outcome NOUN
thrombosis I-outcome NOUN
at O ADP
96 O NUM
h, O NOUN
while O ADP
safety O NOUN
end O NOUN
point O NOUN
was O VERB
in-hospital B-outcome NOUN
bleeding I-outcome VERB
. O PUNCT
RESULTS: O NOUN
The O DET
two O NUM
groups O NOUN
did O VERB
not O ADV
differ O VERB
in O ADP
their O ADJ
baseline O NOUN
characteristics. O NOUN

The O DET
mean O NOUN
pain B-outcome NOUN
scale O NOUN
values O NOUN
on O ADP
first O ADV
postoperative O ADJ
was O VERB
4.24 O NUM
in O ADP
the O DET
drainage O NOUN
by O ADP
the O DET
same O ADJ
intercostal O ADJ
group O NOUN
and O CCONJ
3.95 O NUM
in O ADP
the O DET
traditional O ADJ
chest O NOUN
drainage O NOUN
(p=0.733). O PUNCT

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
degree O NOUN
of O ADP
injured O VERB
vertebra B-outcome NOUN
compression I-outcome NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
at O ADP
immediate O ADJ
after O ADP
operation O NOUN
( O PUNCT
P>0.05), O NOUN
but O CCONJ
which O ADP
was O VERB
significantly O ADV
higher O ADJ
in O ADP
the O DET
control O NOUN
group O NOUN
than O ADP
that O ADP
in O ADP
the O DET
treatment O NOUN
group O NOUN
at O ADP
last O NOUN
follow-up O NOUN
( O PUNCT
P<0.05). O NOUN

Mean O NOUN
change O NOUN
in O ADP
cry B-outcome NOUN
and Seperator CCONJ
fuss B-outcome NOUN
time E1-outcome NOUN
from O ADP
day O NOUN
0 O NUM
through O ADP
day O NOUN
28 O NUM
was O VERB
-163 O NUM
(99) O NOUN
minutes O NOUN
in O ADP
the O DET
probiotic O ADJ
and O CCONJ
-116 O NUM
(94) O NOUN
minutes O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.019). O NUM

TRIAL O NOUN
REGISTRATION: O NOUN
Brazilian O NOUN
Registry O NOUN
of O ADP
Clinical O ADJ
Trials O NOUN
(no. O PUNCT

Journal O ADJ
ID: O NOUN
0255562 O NUM

In O ADP
addition, O NOUN
the O DET
total O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(TBL), O NUM
hidden B-outcome NOUN
blood I-outcome NOUN
loss I-outcome NOUN
(HBL) I-outcome PUNCT
, O PUNCT
maximum O NOUN
hemoglobin B-outcome NOUN
(Hb) I-outcome PUNCT
drop, O NOUN
fibrinolytic B-outcome ADJ
activity, O ADP
as O ADP
well O ADV
as O ADP
incidence O NOUN
of O ADP
thromboembolism B-outcome NOUN
were O VERB
measured. O NOUN

METHOD: O NOUN
The O DET
double-blind O ADJ
study O NOUN
included O VERB
20 O NUM
members O NOUN
of O ADP
the O DET
Polish O ADV
Rowing O VERB
Team. O NOUN

This O DET
trial O NOUN
is O VERB
designed O VERB
to O PART
evaluate O VERB
the O DET
impact O NOUN
of O ADP
muscle O NOUN
relaxation O NOUN
during O ADP
laparoscopic O ADJ
subtotal O ADJ
gastrectomy O NOUN
on O ADP
the O DET
oncological O ADJ
benefits, O NOUN
particularly O ADV
in O ADP
obese O NOUN
patients O NOUN
with O ADP
gastric O ADJ
cancer. O NOUN

We O PRON
explored O VERB
characteristics O NOUN
of O ADP
NSCLC O NOUN
that O ADP
could O VERB
predict O VERB
disease-free B-outcome ADJ
survival I-outcome NOUN
(DFS) I-outcome NOUN
and O CCONJ
overall B-outcome ADJ
survival I-outcome NOUN
(OS) I-outcome NOUN
using O VERB
Cox O NOUN
regression O NOUN
models. O NOUN

Journal-Name:Journal O ADJ
of O ADP
cancer O NOUN
research O NOUN
and O CCONJ
therapeutics O NOUN

Journal-Name: O NOUN
Revista O NOUN
latino-americana O NOUN
de O ADP
enfermagem O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
baseline O NOUN
data O NOUN
of O ADP
gender, O NOUN
gestational O ADJ
age, O NOUN
birth O NOUN
weight, O NOUN
age, O NOUN
5-minure O NOUN
Apgar O PROPN
score O NOUN
or O CCONJ
SNAPPE O NOUN
II O NUM
score O NOUN
between O ADP
the O DET
two O NUM
groups, O NOUN
indicating O VERB
that O ADP
the O DET
baseline O NOUN
data O NOUN
of O ADP
the O DET
two O NUM
groups O NOUN
were O VERB
balanced O VERB
and O CCONJ
comparable. O NOUN

Yi O NOUN
xue O NOUN
ban O NOUN
= O SYM
Journal O ADJ
of O ADP
Central O ADJ
South O NOUN
University. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Title: O NOUN
Effectiveness O NOUN
and O CCONJ
cost-effectiveness O NOUN
of O ADP
a O DET
loyalty O NOUN
scheme O NOUN
for O ADP
physical B-outcome ADJ
activity I-outcome NOUN
behaviour O NOUN
change O NOUN
maintenance: O NOUN
results O NOUN
from O ADP
a O DET
cluster O NOUN
randomised O VERB
controlled O VERB
trial. O NOUN

Journal O ADJ
ID: O NOUN
101217089 O NUM

A O DET
P O NOUN
value O NOUN
of O ADP
less O ADV
than O ADP
.05 O NUM
was O VERB
considered O VERB
statistically O ADV
significant. O NOUN

Journal-Name:International O ADJ
journal O ADJ
of O ADP
sports O NOUN
medicine O NOUN

Background O NOUN
Very O ADV
little O DET
research O NOUN
has O VERB
been O VERB
done O NOUN
to O PART
simultaneously O ADV
investigate O NOUN
the O DET
effects O NOUN
of O ADP
Tai O NOUN
Chi O NOUN
(TC) O NOUN
on O ADP
depression O NOUN
and O CCONJ
heart O NOUN
rate O NOUN
variability O NOUN
(HRV). O NOUN

Eighty O PROPN
percent O NOUN
of O ADP
CI O NOUN
implants, O NOUN
61% O NUM
of O ADP
FI O NOUN
implants, O NOUN
and O CCONJ
84% O NOUN
of O ADP
PS O NOUN
implants O NOUN
were O VERB
observed O VERB
to O PART
have O VERB
a O DET
clinically O ADV
stable O ADJ
peri-implant B-outcome ADJ
mucosal I-outcome ADJ
zenith I-outcome ADP
position I-outcome NOUN
with O ADP
less O ADV
than O ADP
0.5 O NUM
mm O NOUN
of O ADP
measured O VERB
recession. O NOUN

In O ADP
addition, O NOUN
the O DET
groups O NOUN
were O VERB
dichotomized O VERB
at O ADP
the O DET
50th O ADJ
percentile O ADJ
based O VERB
on O ADP
pre-supplementation O NOUN
MVIC O NOUN
and O CCONJ
baseline O NOUN
HYP. O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
incident O ADJ
delirium B-outcome NOUN
during O ADP
postoperative O ADJ
days O NOUN
1 O NUM
through O ADP
5. O NUM

A O DET
total O ADJ
of O ADP
74 O NUM
patients O NOUN
who O ADP
have O VERB
low O ADJ
back O ADP
pain O NOUN
and O CCONJ
radiating O VERB
pain O NOUN
due O ADJ
to O PART
LHIVD O NOUN
will O VERB
be O VERB
recruited O VERB
and O CCONJ
randomly O ADV
allocated O VERB
to O PART
the O DET
experimental O ADJ
group O NOUN
and O CCONJ
control O NOUN
group. O VERB

Those O DET
in O ADP
the O DET
training O VERB
group O NOUN
received O VERB
a O DET
further O ADV
individual O ADJ
3-hour O NOUN
training O VERB
session, O NOUN
and O CCONJ
were O VERB
tested O VERB
again O ADV
after O ADP
1 O NUM
week O NOUN
(test-2). O PUNCT

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
overall O ADJ
remission B-outcome NOUN
rate O NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
(3.7% O PUNCT
vs O CCONJ
0%, O NUM
P O NOUN
= O SYM
.322). O NUM

Self-reported O VERB
life-time O NOUN
medical O ADJ
diagnosis O NOUN
of O ADP
depression B-outcome NOUN
or O CCONJ
use B-outcome NOUN
of I-outcome ADP
antidepressants I-outcome NOUN
was O VERB
considered O VERB
as O ADP
outcome. O NOUN

AIM: O NOUN
The O DET
purpose O NOUN
of O ADP
the O DET
study O NOUN
is O VERB
to O PART
prove O NOUN
the O DET
effectiveness O NOUN
of O ADP
pharmacological O ADJ
preconditioning O VERB
caused O VERB
by O ADP
nicorandil O NOUN
in O ADP
patients O NOUN
with O ADP
stable O ADJ
coronary O ADJ
heart O NOUN
disease O NOUN
(CHD) O PUNCT
during O ADP
the O DET
elective O ADJ
percutaneous O ADJ
coronary O ADJ
intervention O NOUN
(PCI). O PUNCT

Systemic O ADJ
hemodynamic B-outcome ADJ
data O NOUN
recorded O VERB
by O ADP
PRAM O NOUN
included O VERB
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
systolic B-outcome ADJ
(SBP) I-outcome PUNCT
and X NUM
mean X NOUN
(MBP) X PUNCT
blood I-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
stroke B-outcome NOUN
volume I-outcome NOUN
index O NOUN
(SVI), O PUNCT
cardiac B-outcome ADJ
index O NOUN
(CI), O ADJ
systemic B-outcome ADJ
vascular I-outcome ADJ
resistance I-outcome NOUN
index O NOUN
(SVRI), O PUNCT
the O DET
maximal O ADJ
slope O NOUN
of O ADP
systolic B-outcome ADJ
upstroke I-outcome NOUN
(dp/dtmax) O NUM
and O CCONJ
cardiac B-outcome ADJ
cycle I-outcome NOUN
efficiency O NOUN
(CCE) O PUNCT
after O ADP
sedation O NOUN
obtained, O NOUN
1, O NOUN
2, O NOUN
5 O NUM
min O NOUN
after O ADP
induction O NOUN
achieved, O NOUN
1, O NOUN
2, O NOUN
5 O NUM
and O CCONJ
10 O NUM
min O NOUN
after O ADP
intubation. O ADV

METHODS: O NOUN
Current O ADJ
soft O NOUN
contact O NOUN
lens O NOUN
wearers O NOUN
with O ADP
-0.75 O NUM
to O PART
-1.75 O NUM
D O NOUN
astigmatism O NOUN
in O ADP
each O DET
eye O NOUN
were O VERB
binocularly O ADV
fitted O VERB
with O ADP
toric O ADJ
(1-Day O PUNCT
ACUVUE O NOUN
MOIST O NOUN
for O ADP
astigmatism) O NOUN
and O CCONJ
spherical O ADJ
(1-Day O PUNCT
ACUVUE O NOUN
MOIST) O ADP
contact O NOUN
lenses O NOUN
in O ADP
random O NOUN
order. O NOUN

Title: O NOUN
The O DET
effects O NOUN
of O ADP
position O NOUN
on O ADP
gastric B-outcome ADJ
residual I-outcome ADJ
volume I-outcome NOUN
of O ADP
premature O ADJ
infants O NOUN
in O ADP
NICU. O NOUN

The O DET
study O NOUN
participants O NOUN
were O VERB
divided O VERB
randomly O ADV
into O ADP
two O NUM
groups: O NOUN
the O DET
supplemented O VERB
group O NOUN
ingested O VERB
caffeine O NOUN
before O ADP
exercise O NOUN
(GCAF), O NOUN
while O ADP
the O DET
control O NOUN
group O NOUN
was O VERB
given O VERB
a O DET
placebo O NOUN
(GCON). O NOUN

Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT02406677. O NOUN

Methods: O NOUN
In O ADP
this O DET
prospective O ADJ
study, O NOUN
one O NUM
hundred O NUM
patients O NOUN
undergoing O VERB
radical O NOUN
resection O NOUN
of O ADP
esophageal O ADJ
cancer O NOUN
in O ADP
Affiliated O VERB
Cancer O NOUN
Hospital O NOUN
of O ADP
Zhengzhou O NOUN
University O NOUN
from O ADP
January O NOUN
2016 O NUM
to O PART
October O ADJ
2017, O NUM
were O VERB
randomly O ADV
divided O VERB
into O ADP
control O NOUN
group O NOUN
(group O PUNCT
C) O NOUN
and O CCONJ
dexmedetomidine O NOUN
group O NOUN
(group O PUNCT
D), O NOUN
n=50. O ADJ

Preliminary O ADJ
evidence O NOUN
suggests O NOUN
that O ADP
patients' O NOUN
beliefs O NOUN
and O CCONJ
perceptions O NOUN
may O VERB
influence O NOUN
their O ADJ
prognosis. O NOUN

Journal-Name:Cellular O ADJ
physiology O NOUN
and O CCONJ
biochemistry O NOUN
: O PUNCT
international O ADJ
journal O ADJ
of O ADP
experimental O ADJ
cellular O ADJ
physiology, O NOUN
biochemistry, O ADP
and O CCONJ
pharmacology O NOUN

Main O ADJ
parameters O NOUN
setting O VERB
of O ADP
respirator: O NOUN
VCV O NOUN
group O NOUN
was O VERB
given O VERB
450, O NOUN
550, O NOUN
650 O NUM
mL O NOUN
preset O NOUN
VT, O NOUN
and O CCONJ
PCV O NOUN
group O NOUN
was O VERB
given O VERB
12, O NUM
16, O NOUN
20 O NUM
cmH2O O NOUN
(1 O NOUN
cmH2O O NOUN
= O SYM
0.098 O NUM
kPa) O NOUN
preset O NOUN
suction O NOUN
pressure. O NOUN

Statistical O ADJ
analyses O NOUN
will O VERB
be O VERB
carried O VERB
out O ADP
using O VERB
SPSS O ADV
version O NOUN
23.0 O NUM
for O ADP
Windows. O NOUN

Each O DET
quadrant O ADJ
was O VERB
categorized O VERB
into O ADP
control O NOUN
group O NOUN
(SRP O PUNCT
alone; O NOUN
two O NUM
quadrants O NOUN
per O ADP
patient), O NOUN
test O NOUN
group O NOUN
1 O NUM
(SRP O PUNCT
+ O SYM
PDT), O NOUN
and O CCONJ
test O NOUN
group O NOUN
2 O NUM
(SRP O PUNCT
+ O SYM
LLLT. O NOUN

Publication O NOUN
date: O NOUN
2018/12/19 O NOUN
00:00 O NOUN
[accepted] O ADV

Title: O NOUN
Effect O NOUN
of O ADP
Kinesio O NOUN
taping O VERB
on O ADP
electromyographic O ADJ
activity O NOUN
of O ADP
leg O NOUN
muscles O NOUN
during O ADP
gait O NOUN
in O ADP
children O NOUN
with O ADP
developmental O ADJ
coordination O NOUN
disorder: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Fluvoxamine O NOUN
and O CCONJ
MPH-ER O NOUN
were O VERB
given O VERB
to O PART
the O DET
study O NOUN
group, O NOUN
while O ADP
fluvoxamine O NOUN
and O CCONJ
placebo O NOUN
were O VERB
given O VERB
to O PART
the O DET
control O NOUN
group, O NOUN
with O ADP
8 O NUM
weeks O NOUN
of O ADP
the O DET
treatment O NOUN
course. O NOUN
[ O PUNCT

All O DET
subjects O NOUN
(20-45 O NOUN
years O NOUN
old), O NOUN
who O ADP
were O VERB
frequently O ADV
referred O VERB
to O PART
the O DET
private O ADJ
obstetrics O NOUN
and O CCONJ
gynecology O NOUN
clinics, O NOUN
were O VERB
initially O ADV
monitored O VERB
for O ADP
PMS O NOUN
and O CCONJ
depression. O NOUN

We O PRON
analyzed O VERB
44 O NUM
patients O NOUN
with O ADP
hypovitaminosis O NOUN
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
six O NUM
months O NOUN
of O ADP
two O NUM
different O ADJ
regimens O NOUN
of O ADP
administration: O NOUN
seven O NUM
drops O NOUN
(1750 O NOUN
IU)/day O NOUN
vs. O CCONJ
50,000 O NUM
IU/month. O NOUN

No O DET
significant O ADJ
differences O NOUN
were O VERB
noted O VERB
between O ADP
carvedilol O NOUN
and O CCONJ
placebo O NOUN
in O ADP
terms O NOUN
of O ADP
the O DET
development O NOUN
of O ADP
diastolic B-outcome ADJ
dysfunction I-outcome NOUN
, O PUNCT
clinically B-outcome ADV
overt I-outcome ADJ
heart I-outcome NOUN
failure I-outcome NOUN
or O CCONJ
death B-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
Carvedilol O NOUN
might O VERB
prevent O NOUN
deterioration O NOUN
in O ADP
left B-outcome ADV
ventricular I-outcome ADJ
ejection I-outcome NOUN
fraction I-outcome NOUN
(LVEF) I-outcome PUNCT
in O ADP
cancer O NOUN
patients O NOUN
treated O VERB
with O ADP
doxorubicin. O NOUN

These O DET
metabolites B-outcome NOUN
and O CCONJ
metabolic B-outcome ADJ
pathways O NOUN
represent O NOUN
an O DET
acute O ADJ
response O NOUN
to O PART
increased O VERB
navy O ADJ
bean O NOUN
intake, O NOUN
which O ADP
merit O NOUN
further O ADV
investigation O NOUN
for O ADP
improving O VERB
colonic O ADJ
health O NOUN
after O ADP
long-term O NOUN
consumption. O NOUN

Journal O ADJ
ID: O NOUN
101090633 O NUM

Journal-Name:Reproductive O ADJ
health O NOUN

At O ADP
6 O NUM
months, O NOUN
only O ADV
one O NUM
of O ADP
116 O NUM
patients O NOUN
(1%) O NOUN
assigned O VERB
to O PART
carvedilol O NOUN
had O VERB
an O DET
left B-outcome ADV
ventricular I-outcome ADJ
ejection I-outcome NOUN
fraction I-outcome NOUN
(LVEF) I-outcome PUNCT
<50% O PUNCT
compared O VERB
to O PART
four O NUM
of O ADP
the O DET
38 O NUM
assigned O VERB
to O PART
placebo O NOUN
(11%), O NOUN
(p=0.013). O PUNCT

The O DET
incidences O NOUN
of O ADP
postoperative O ADJ
pulmonary B-outcome ADJ
complications I-outcome NOUN
(PPCs) I-outcome PUNCT
and O CCONJ
atelectasis O NOUN
(2.9%, O NOUN
0.0%) O NUM
in O ADP
the O DET
AG O NOUN
were O VERB
significantly O ADV
lower O ADJ
than O ADP
that O ADP
in O ADP
the O DET
CG O NOUN
(20.6%, O NUM
14.7%)(P=0.03, O NOUN
P=0.03). O NOUN

Title: O NOUN
Does O VERB
the O DET
"delayed O PUNCT
start" O ADJ
protocol O NOUN
with O ADP
gonadotropin-releasing O VERB
hormone O NOUN
antagonist O NOUN
improve O VERB
the O DET
pregnancy B-outcome NOUN
outcome O NOUN
in O ADP
Bologna O NOUN
poor O ADJ
responders? O NOUN

Mean O NOUN
of O ADP
deformity B-outcome NOUN
correction I-outcome NOUN
rate O NOUN
was O VERB
91.49+/-10.67% O ADJ
using O VERB
CrCo-Ti O NOUN
rods O NOUN
versus O CCONJ
81.86+/-9.88% O NOUN
using O VERB
Ti-Ti O NOUN
rods O NOUN
(P-value=0.01). O PUNCT

Funded O VERB
by O ADP
the O DET
National O ADJ
Institute O NOUN
for O ADP
Health O NOUN
Research O NOUN
and O CCONJ
Cancer O NOUN
Research O NOUN
UK; O ADJ
Current O ADJ
Controlled O VERB
Trials O NOUN
number, O ADV
ISRCTN60477608 O ADP
.). O NOUN

BACKGROUND: O NOUN
Total O ADJ
hip O NOUN
replacement O NOUN
(THR) O PUNCT
is O VERB
often O ADV
accompanied O VERB
by O ADP
severe O ADJ
postoperative O ADJ
pain. O NOUN

BACKGROUND: O NOUN
Postprandial O ADJ
non-esterified O VERB
fatty O ADJ
acid O NOUN
(NEFA) O NUM
and O CCONJ
triglyceride O NOUN
(TG) O NOUN
responses O NOUN
are O VERB
increased O VERB
in O ADP
subjects O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes O NOUN
mellitus O NOUN
(T2DM) O NOUN
and O CCONJ
may O VERB
impair O NOUN
insulin O NOUN
action O NOUN
and O CCONJ
increase O NOUN
risk O NOUN
of O ADP
cardiovascular O ADJ
disease O NOUN
and O CCONJ
death. O ADP

Reduction O NOUN
in O ADP
radiation O NOUN
dose O NOUN
may O VERB
lead O NOUN
to O PART
a O DET
compromise O VERB
in O ADP
quality O NOUN
of O ADP
MDCT O NOUN
images O NOUN
and O CCONJ
have O VERB
chances O NOUN
of O ADP
postoperative O ADJ
complications. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Exhaled B-outcome VERB
CO I-outcome NOUN
(eCO) I-outcome PUNCT
measurements O NOUN
and O CCONJ
questionnaires O NOUN
were O VERB
repeatedly O ADV
administered O VERB
throughout O ADV
the O DET
session. O NOUN

The O DET
aim O ADP
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
compare O NOUN
the O DET
influence O NOUN
of O ADP
orlistat O NOUN
(IO), O PUNCT
metformin O NOUN
(IM), O PUNCT
or O CCONJ
calorie-restricted O VERB
diet O NOUN
(LC) O NOUN
on O ADP
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
, O PUNCT
with O ADP
special O ADJ
respect O NOUN
to O PART
insulin-resistance O NOUN
status. O NOUN

Journal-Name:The O ADJ
British O NOUN
journal O ADJ
of O ADP
radiology O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
very O ADV
preterm O NOUN
or O CCONJ
very-low-birth-weight O NOUN
infants O NOUN
to O PART
daily O ADJ
milk O NOUN
increments O NOUN
of O ADP
30 O NUM
ml O NOUN
per O ADP
kilogram O NOUN
of O ADP
body O NOUN
weight O NOUN
(faster O PUNCT
increment) O NOUN
or O CCONJ
18 O NUM
ml O NOUN
per O ADP
kilogram O NOUN
(slower O NUM
increment) O NOUN
until O ADP
reaching O VERB
full O ADJ
feeding O VERB
volumes. O ADP

Mean O NOUN
blood B-outcome NOUN
pressure I-outcome NOUN
(MBP) I-outcome PUNCT
, O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
and O CCONJ
SpO2 B-outcome NOUN
at O ADP
the O DET
time O NOUN
points O NOUN
from O ADP
T6 O NOUN
to O PART
T10 O NOUN
and O CCONJ
Observer's O NOUN
Assessment O NOUN
of O ADP
Alertness B-outcome ADP
/ O SYM
Sedation B-outcome NOUN
(OAA/S)], O NOUN
wavelet B-outcome NOUN
index O NOUN
[WLi], O NOUN
anxiety B-outcome NOUN
index O NOUN
[ANXi], O NOUN
comfortable B-outcome ADJ
index O NOUN
[CFi], O PUNCT
and O CCONJ
pain B-outcome NOUN
index O NOUN
[Pi] O NOUN
at O ADP
the O DET
time O NOUN
points O NOUN
from O ADP
T6 O NOUN
to O PART
T11 O NOUN
were O VERB
significantly O ADV
lower O ADJ
in O ADP
the O DET
sedation O NOUN
group O NOUN
(all O PUNCT
P O NOUN
&lt; O NOUN
0.05), O NUM
and O CCONJ
these O DET
parameters O NOUN
were O VERB
not O ADV
significantly O ADV
different O ADJ
between O ADP
the O DET
two O NUM
groups O NOUN
at O ADP
the O DET
other O ADJ
time O NOUN
points O NOUN
(all O PUNCT
P&gt;0.05). O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
similarity O NOUN
of O ADP
the O DET
simulators O NOUN
to O PART
the O DET
porcine O ADJ
larynx O ADJ
(P O NUM
= O SYM
.81). O PUNCT

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
101627676 O NUM

RESULTS: O NOUN
Statistically O ADV
significant O ADJ
and O CCONJ
different O ADJ
increases O NOUN
were O VERB
observed O VERB
in O ADP
the O DET
group-by-time O NOUN
interaction O NOUN
of O ADP
25(OH)D O NUM
in O ADP
VD3G O PUNCT
in O ADP
respect O NOUN
to O PART
CG O NOUN
during O ADP
the O DET
study O NOUN
(p O PUNCT
< O SYM
0.001; O NOUN
VD3G O PUNCT
(T1: O NUM
26.24 O NUM
+/- O SYM
8.18 O NUM
ng/mL O NOUN
vs. O CCONJ
T2: O NOUN
48.12 O NUM
+/- O SYM
10.88 O NUM
ng/mL) O NOUN
vs O CCONJ
CG O NOUN
(T1: O NUM
30.76 O NUM
+/- O SYM
6.95 O NUM
ng/mL O NOUN
vs. O CCONJ
T2: O NOUN
35.14 O NUM
+/- O SYM
7.96 O NUM
ng/mL). O NOUN

METHODS: O NOUN
The O DET
prospective, O NOUN
randomized, O NOUN
single-center O NOUN
study O NOUN
was O VERB
conducted O VERB
at O ADP
the O DET
Medical O ADJ
Department O NOUN
of O ADP
University O NOUN
Hospital O NOUN
Dubrava, O NOUN
Zagreb, O ADJ
between O ADP
April O NOUN
and O CCONJ
June O NOUN
2018. O NUM

Digestibility O NOUN
of O ADP
energy, O NOUN
fat, O ADP
protein, O NOUN
and O CCONJ
carbohydrate O NOUN
was O VERB
lower O ADJ
for O ADP
the O DET
cashew-containing O VERB
diet O NOUN
compared O VERB
to O PART
the O DET
control O NOUN
diet O NOUN
(92.9% O NOUN
vs. O CCONJ
94.9%, O NOUN
p O NOUN
< O SYM
0.0001 O NUM
for O ADP
energy; O ADP
96.1% O NOUN
vs. O CCONJ
97.8%, O NOUN
p O NOUN
= O SYM
0.0009 O NUM
for O ADP
fat; O NOUN
90.1% O NOUN
vs. O CCONJ
91.2%, O NOUN
p O NOUN
= O SYM
0.0012 O NUM
for O ADP
protein; O NOUN
92.9% O ADJ
vs. O CCONJ
94.9%, O NOUN
p O NOUN
< O SYM
0.0001 O NUM
for O ADP
carbohydrate; O NOUN
for O ADP
the O DET
cashew-containing O VERB
diet O NOUN
vs. O CCONJ
the O DET
control O NOUN
diet, O ADV
respectively). O NOUN

Within O ADP
7 O NUM
days O NOUN
after O ADP
surgery O NOUN
(or, O NOUN
if O ADP
the O DET
infection O NOUN
was O VERB
being O VERB
managed O VERB
without O ADP
surgery, O NOUN
within O ADP
7 O NUM
days O NOUN
after O ADP
the O DET
start O NOUN
of O ADP
antibiotic O ADJ
treatment), O NOUN
participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
receive O VERB
either O CCONJ
intravenous O ADJ
or O CCONJ
oral O ADJ
antibiotics O NOUN
to O PART
complete O ADJ
the O DET
first O ADV
6 O NUM
weeks O NOUN
of O ADP
therapy. O NOUN

High O ADJ
adherence O NOUN
was O VERB
defined O VERB
as O ADP
complying O VERB
with O ADP
5(-)6 O NOUN
targets; O NOUN
moderate O ADJ
adherence O NOUN
2(-)4 O NOUN
targets; O NOUN
low O ADJ
adherence O NOUN
0(-)1 O ADP
targets. O NOUN

The O DET
pancreaticoduodectomy B-outcome NOUN
rate O NOUN
was O VERB
68 O NUM
per O ADP
cent, O ADJ
whereas O ADP
27 O NUM
per O ADP
cent O NUM
of O ADP
patients O NOUN
underwent O VERB
distal B-outcome ADJ
or Seperator CCONJ
subtotal I-outcome ADJ
pancreatectomy I-outcome NOUN
, O PUNCT
and O CCONJ
4 O NUM
per O ADP
cent O NUM
total O ADJ
pancreatectomy B-outcome NOUN
. O PUNCT
Incisional B-outcome ADJ
hernia I-outcome NOUN
rates O NOUN
were O VERB
32 O NUM
per O ADP
cent O NUM
and O CCONJ
14 O NUM
per O ADP
cent O NUM
between O ADP
the O DET
SSD O NOUN
and O CCONJ
NPWT O NOUN
groups, O NOUN
respectively O ADV
(P O NUM
= O SYM
0.067). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Further O ADV
analysis O NOUN
of O ADP
the O DET
causes O NOUN
of O ADP
this O DET
asymmetry O NOUN
may O VERB
lead O NOUN
to O PART
more O ADV
accurate O ADJ
treatment O NOUN
of O ADP
PFM O NOUN
dysfunctions. O NOUN

Undesirable B-outcome ADJ
movement I-outcome NOUN
occurred O VERB
in O ADP
137 O NUM
patients O NOUN
(22.3%) O NUM
in O ADP
the O DET
guided O VERB
and O CCONJ
95 O NUM
(15.4%) O NOUN
in O ADP
the O DET
usual O ADJ
care O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2019/03/02 O ADJ
06:00 O ADP
[medline] O NOUN

Necrotizing B-outcome VERB
enterocolitis I-outcome NOUN
occurred O VERB
in O ADP
70 O NUM
of O ADP
1394 O NUM
infants O NOUN
(5.0%) O NUM
in O ADP
the O DET
faster-increment O NOUN
group O NOUN
and O CCONJ
78 O NUM
of O ADP
1399 O NUM
(5.6%) O PUNCT
in O ADP
the O DET
slower-increment O ADJ
group O NOUN
(adjusted O PUNCT
risk O NOUN
ratio, O NOUN
0.88; O NUM
95% O NOUN
CI, O NOUN
0.68 O NUM
to O PART
1.16). O NOUN

This O DET
study O NOUN
aimed O VERB
to O PART
compare O NOUN
the O DET
effect O NOUN
of O ADP
delayed-start O NOUN
GnRH O NOUN
antagonist O NOUN
protocol O NOUN
and O CCONJ
standard O ADJ
GnRH O NOUN
antagonist O NOUN
in O ADP
patients O NOUN
with O ADP
poor O ADJ
ovarian O ADJ
response O NOUN
(POR) O NOUN
undergoing O VERB
in O ADP
vitro O ADV
fertilization O NOUN
(IVF)/ O NOUN
intracytoplasmic O ADJ
sperm O NOUN
injection O NOUN
(ICSI). O NUM

The O DET
range B-outcome NOUN
of I-outcome ADP
motion I-outcome NOUN
, O PUNCT
functional B-outcome ADJ
score O NOUN
( O NOUN
Harris O NOUN
score]), O ADJ
visual O ADJ
analogue O NOUN
scale O NOUN
(VAS) O PUNCT
score, O NOUN
and O CCONJ
prosthesis B-outcome NOUN
position I-outcome NOUN
were O VERB
recorded. O NOUN

We O PRON
will O VERB
also O ADV
assess O NOUN
teachers' O ADV
autonomy-supportive B-outcome ADJ
techniques I-outcome NOUN
and Seperator CCONJ
behaviours S1-outcome NOUN
by O ADP
observation. O ADV

METHODS: O NOUN
In O ADP
this O DET
prospective O ADJ
study, O NOUN
patients O NOUN
with O ADP
intractable O ADJ
DED O NOUN
were O VERB
randomized O VERB
to O PART
a O DET
BTX-A O NOUN
(group O PUNCT
A) O NOUN
or O CCONJ
control O NOUN
group O NOUN
(group O PUNCT
B). O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

Therefore, O NOUN
treatment O NOUN
with O ADP
natural O ADJ
herbal O ADJ
medicine, O ADJ
non-synthetic O ADJ
drug, O NOUN
to O PART
reduce O VERB
primary B-outcome ADJ
dysmenorrhea I-outcome ADJ
is O VERB
recommended. O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

CONCLUSIONS: O NOUN
The O DET
application O NOUN
of O ADP
KT O NOUN
on O ADP
children O NOUN
with O ADP
DCD O NOUN
had O VERB
an O DET
increased O VERB
gastrocnemius B-outcome NOUN
medialis I-outcome NOUN
muscle I-outcome NOUN
activation I-outcome NOUN
during O ADP
stance O NOUN
phase. O NOUN

Mixed O VERB
model O NOUN
ANOVAs O NOUN
and O CCONJ
ANCOVAs O NOUN
were O VERB
used O VERB
to O PART
statistically O ADV
analyze O NOUN
the O DET
dependent O ADJ
variables O NOUN
for O ADP
the O DET
total O ADJ
groups O NOUN
(n O NOUN
= O SYM
21 O NUM
per O ADP
group) O ADJ
as O ADP
well O ADV
as O ADP
dichotomized O VERB
groups. O NOUN

BACKGROUND: O NOUN
This O DET
study O NOUN
assessed O VERB
the O DET
effectiveness O NOUN
and O CCONJ
safety O NOUN
of O ADP
ultrasound-guided O VERB
pulsed O VERB
radiofrequency O NOUN
(UGPRF) O NOUN
for O ADP
patients O NOUN
with O ADP
frozen O NOUN
shoulder O NOUN
(FS). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

The O DET
primary O ADJ
end O NOUN
point O NOUN
was O VERB
definitive O ADJ
treatment B-outcome NOUN
failure I-outcome NOUN
within O ADP
1 O NUM
year O NOUN
after O ADP
randomization. O NOUN

Journal-Name:Medicine O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

Title: O NOUN
Announcing O VERB
the O DET
availability O NOUN
of O ADP
oral O ADJ
HIV O NOUN
self-test O NOUN
kits O NOUN
via O ADP
text O VERB
message O NOUN
to O PART
increase O NOUN
HIV O NOUN
testing O VERB
among O ADP
hard-to-reach O ADJ
truckers O NOUN
in O ADP
Kenya: O NOUN
a O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Each O DET
diet O NOUN
was O VERB
consumed O VERB
on O ADP
two O NUM
consecutive O ADJ
days, O NOUN
separated O VERB
by O ADP
a O DET
wash-out O ADP
period. O NOUN

METHODS: O NOUN
We O PRON
intraoperatively O ADV
randomly O ADV
assigned O VERB
patients O NOUN
with O ADP
newly O ADV
diagnosed O VERB
advanced O VERB
ovarian O ADJ
cancer O NOUN
(International O ADJ
Federation O NOUN
of O ADP
Gynecology O NOUN
and O CCONJ
Obstetrics O NOUN
stage O NOUN
IIB O NOUN
through O ADP
IV) O NUM
who O ADP
had O VERB
undergone O VERB
macroscopically O ADV
complete O ADJ
resection O NOUN
and O CCONJ
had O VERB
normal O ADJ
lymph O NOUN
nodes O NOUN
both O CCONJ
before O ADP
and O CCONJ
during O ADP
surgery O NOUN
to O PART
either O CCONJ
undergo O NOUN
or O CCONJ
not O ADV
undergo O NOUN
lymphadenectomy. O NOUN

Exposure O NOUN
to O PART
sponsorship O NOUN
for O ADP
healthier O ADJ
foods O NOUN
produced O VERB
similar O ADJ
sponsorship O NOUN
effects O NOUN
for O ADP
healthier O ADJ
food O NOUN
sponsor O ADP
brands, O NOUN
as O ADP
well O ADV
as O ADP
prompting O VERB
a O DET
significant O ADJ
increase O NOUN
in O ADP
the O DET
proportion O NOUN
of O ADP
young O ADJ
adults O NOUN
showing O VERB
a O DET
preference B-outcome NOUN
for O ADP
these O DET
products. O NOUN

All O DET
patients O NOUN
received O VERB
cyclophosphamide O NOUN
750 O NUM
mg/m(2) O NOUN
and O CCONJ
doxorubicin O NOUN
50 O NUM
mg/m(2) O NOUN
on O ADP
day O NOUN
1 O NUM
of O ADP
each O DET
cycle O NOUN
intravenously O ADV
and O CCONJ
prednisone O ADJ
100 O NUM
mg O NOUN
once O ADP
daily O ADJ
on O ADP
days O NOUN
1 O NUM
to O PART
5 O NUM
of O ADP
each O DET
cycle O NOUN
orally, O NOUN
followed O VERB
by O ADP
either O CCONJ
brentuximab O NOUN
vedotin O NOUN
1.8 O NUM
mg/kg O NOUN
and O CCONJ
a O DET
placebo O NOUN
form O NOUN
of O ADP
vincristine O ADV
intravenously O ADV
(A+CHP O PUNCT
group) O ADJ
or O CCONJ
vincristine O ADV
1.4 O NUM
mg/m(2) O NOUN
and O CCONJ
a O DET
placebo O NOUN
form O NOUN
of O ADP
brentuximab O NOUN
vedotin O NOUN
intravenously O ADV
(CHOP O PUNCT
group) O ADJ
on O ADP
day O NOUN
1 O NUM
of O ADP
each O DET
cycle. O NOUN

PMID: O NOUN
31597806 O NUM

BACKGROUD: O NOUN
The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
effects O NOUN
of O ADP
trigger O ADP
point O NOUN
injection O NOUN
(TPI) O NOUN
and O CCONJ
eutectic O ADJ
mixture O NOUN
local O ADJ
anesthetics O NOUN
(EMLA) O NUM
cream O NOUN
on O ADP
the O DET
postoperative O ADJ
shoulder B-outcome NOUN
pain I-outcome NOUN
in O ADP
patients O NOUN
undergoing O VERB
total O ADJ
laparoscopic O ADJ
hysterectomy. O NOUN

The O DET
new O ADJ
lotion O NOUN
formulation O NOUN
was O VERB
well- B-outcome NOUN
tolerated I-outcome VERB
, O PUNCT
and O CCONJ
all O DET
treatment-related B-outcome VERB
AEs I-outcome NOUN
were O VERB
both O CCONJ
mild O ADJ
and O CCONJ
transient O ADJ
in O ADP
nature. O NOUN

Journal-Name:Medicine O NOUN

Few O ADJ
patients O NOUN
maintained O VERB
>/=75% O NUM
response B-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
Treatment O NOUN
with O ADP
galcanezumab O NOUN
120 O NUM
mg O NOUN
or O CCONJ
240 O NUM
mg O NOUN
demonstrated O VERB
statistically O ADV
significant O ADJ
and O CCONJ
clinically O ADV
meaningful O ADJ
persistence O NOUN
of O ADP
effect O NOUN
in O ADP
patients O NOUN
with O ADP
episodic O NOUN
migraine O NOUN
(>/=3 O NOUN
and O CCONJ
6 O NUM
consecutive O ADJ
months) O NOUN
and O CCONJ
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
migraine O NOUN
(for O PUNCT
3 O NUM
months). O NOUN

Furthermore, O NOUN
no O DET
adverse B-outcome ADJ
events I-outcome NOUN
related O VERB
to O PART
NES O NOUN
treatment O NOUN
were O VERB
detected. O NOUN

From O ADP
January O NOUN
2015 O NUM
to O PART
June O NOUN
2017, O NUM
42 O NUM
children O NOUN
with O ADP
moderate O ADJ
to O PART
severe O ADJ
HIE O NOUN
in O ADP
the O DET
neonatal O ADJ
intensive O ADJ
care O NOUN
unit O NOUN
(NICU) O NUM
of O ADP
the O DET
First O ADV
Affiliated O VERB
Hospital O NOUN
of O ADP
Bengbu O NOUN
Medical O ADJ
College O NOUN
were O VERB
enrolled, O NOUN
and O CCONJ
they O PRON
were O VERB
randomly O ADV
divided O VERB
into O ADP
SBH O NOUN
treatment O NOUN
group O NOUN
and O CCONJ
routine O ADJ
treatment O NOUN
group O NOUN
after O ADP
obtaining O VERB
the O DET
consent O NOUN
of O ADP
the O DET
guardian O ADJ
of O ADP
the O DET
children. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

CONCLUSIONS: O NOUN
Intraoperative O ADJ
propofol O NOUN
sedation O NOUN
can O VERB
alleviate O NOUN
the O DET
patients' O NOUN
anxiety B-outcome NOUN
, O PUNCT
improve O VERB
the O DET
comfort B-outcome NOUN
level, O NOUN
and O CCONJ
lessen O NOUN
physiological B-outcome ADJ
stress I-outcome NOUN
during O ADP
surgeries O NOUN
under O ADP
epidural O ADJ
anesthesia. O NOUN

However, O ADV
limited O VERB
studies O NOUN
to O PART
investigate O NOUN
the O DET
association O NOUN
of O ADP
health O NOUN
education O NOUN
via O ADP
Wechat O ADP
platform O NOUN
on O ADP
increased O VERB
the O DET
basic O ADJ
self-care O NOUN
skills O NOUN
and O CCONJ
glycemic O ADJ
control O NOUN
rate O NOUN
in O ADP
patients O NOUN
with O ADP
type O NOUN
2 O NUM
diabetes. O NOUN

The O DET
response B-outcome NOUN
rate O NOUN
was O VERB
18%. O NUM

Publication O NOUN
date: O NOUN
2019/03/05 O NOUN
06:00 O ADP
[medline] O NOUN

CONCLUSION: O NOUN
The O DET
findings O NOUN
of O ADP
this O DET
study O NOUN
suggested O VERB
that O ADP
normal O ADJ
recommended O VERB
dosages O NOUN
of O ADP
100 O NUM
mg O NOUN
CA O NOUN
+ O SYM
100 O NUM
mg O NOUN
C O NOUN
is O VERB
sufficient O ADJ
to O PART
promote O VERB
glucose B-outcome NOUN
sparing O VERB
at O ADP
rest, O NOUN
with O ADP
modest O ADJ
increases O NOUN
in O ADP
SNS B-outcome NOUN
activity I-outcome NOUN
; O PUNCT
however, O ADV
the O DET
individual O ADJ
role O NOUN
of O ADP
CA O NOUN
or O CCONJ
C O NOUN
in O ADP
this O DET
response O NOUN
can O AUX
not O ADV
be O VERB
determined. O NOUN

CONCLUSION: O NOUN
BTX-A O NOUN
injection O NOUN
into O ADP
the O DET
medial O ADJ
part O NOUN
of O ADP
eyelid O NOUN
improves O NOUN
dry B-outcome ADJ
eye I-outcome NOUN
signs I-outcome NOUN
and Seperator CCONJ
symptoms S2-outcome NOUN
and O CCONJ
reduces O NOUN
tear O NUM
cytokine B-outcome NOUN
levels. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Title: O NOUN
Effects O NOUN
of O ADP
selenium O NOUN
supplementation O NOUN
on O ADP
pregnancy B-outcome NOUN
outcome I-outcome NOUN
and O CCONJ
disease B-outcome NOUN
progression I-outcome NOUN
in O ADP
HIV-infected O VERB
pregnant O ADJ
women O NOUN
in O ADP
Lagos, O NOUN
Nigeria: O NOUN
Study O NOUN
protocol O NOUN
for O ADP
a O DET
randomised, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
trial. O NOUN

A O DET
2015 O NUM
review. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Title: O NOUN
The O DET
effects O NOUN
of O ADP
Shilajit O ADJ
supplementation O NOUN
on O ADP
fatigue-induced O VERB
decreases O NOUN
in O ADP
muscular B-outcome ADJ
strength I-outcome NOUN
and O CCONJ
serum O NOUN
hydroxyproline B-outcome NOUN
levels. O NOUN

County O NOUN
hospital-based O VERB
vision O NOUN
centers O NOUN
appear O VERB
effective O ADJ
in O ADP
delivering O VERB
childrens' O NOUN
glasses O NOUN
in O ADP
rural O ADJ
China. O NOUN

We O PRON
evaluated O VERB
the O DET
effects O NOUN
on O ADP
ADHD B-outcome NOUN
symptoms I-outcome NOUN
, O PUNCT
self-report O NOUN
on O ADP
the O DET
Behavior O NOUN
Rating O VERB
Inventory O ADJ
of O ADP
Executive B-outcome NOUN
Function I-outcome NOUN
of O ADP
executive B-outcome ADJ
function I-outcome NOUN
, O PUNCT
methylphenidate B-outcome NOUN
dosing I-outcome VERB
, O PUNCT
neuropsychological B-outcome ADJ
test O NOUN
measures, O NOUN
the O DET
Adult O NOUN
ADHD B-outcome NOUN
Self-report O NOUN
scale], O NUM
emotional B-outcome ADJ
dysregulation I-outcome NOUN
, O PUNCT
social B-outcome ADJ
adjustment I-outcome NOUN
, O PUNCT
and O CCONJ
work B-outcome NOUN
productivity I-outcome NOUN
, O PUNCT
as O ADP
well O ADV
as O ADP
moderating O VERB
effects O NOUN
of O ADP
body O NOUN
mass O NOUN
index, O NOUN
autoantibodies O NOUN
to O PART
folate O NOUN
receptors, O NOUN
and O CCONJ
select O NOUN
genetic O ADJ
polymorphisms. O NOUN

In O ADP
the O DET
AGS O NOUN
group, O NOUN
allogeneic B-outcome ADJ
blood I-outcome NOUN
was O VERB
infused O VERB
in O ADP
1 O NUM
case O NOUN
during O ADP
operation, O NOUN
and O CCONJ
no O DET
allogeneic B-outcome ADJ
blood I-outcome NOUN
was O VERB
infused O VERB
in O ADP
the O DET
other O ADJ
patients. O NOUN

Balozis O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
the O DET
intervention O NOUN
and O CCONJ
control O NOUN
arms. O ADJ

Electronic O ADJ
address: O NOUN
cedar@stanford.edu. O VERB

P O NOUN
<.05) O NOUN
CONCLUSIONS:: O NOUN
A O DET
single O ADJ
bolus O NOUN
injection O NOUN
of O ADP
oxycodone O NOUN
is O VERB
more O ADV
effective O ADJ
than O ADP
that O ADP
of O ADP
fentanyl O NOUN
in O ADP
the O DET
acute O ADJ
phase O NOUN
of O ADP
postoperative O ADJ
pain B-outcome NOUN
after O ADP
THR. O NOUN

Publication O NOUN
date: O NOUN
2018/12/21 O NOUN
00:00 O NOUN
[accepted] O ADV

Additional O ADJ
implications O NOUN
and O CCONJ
limitations O NOUN
are O VERB
discussed. O NOUN

Significance O ADV
testing O VERB
for O ADP
the O DET
primary O ADJ
outcome O NOUN
was O VERB
based O VERB
on O ADP
1-sided O VERB
testing. O NOUN

Publication O NOUN
date: O NOUN
2018/07/06 O NOUN
00:00 O NOUN
[accepted] O ADV

OBJECTIVE: O NOUN
To O PART
determine O NOUN
the O DET
efficacy O NOUN
of O ADP
TENS O NOUN
in O ADP
the O DET
treatment O NOUN
LBP O NOUN
when O ADP
associated O VERB
to O PART
a O DET
therapeutic O ADJ
education O NOUN
program O NOUN
(TEP). O PUNCT

Child O NOUN
engagement: O NOUN
enjoyment O ADJ
and O CCONJ
positive O ADJ
behaviour. O NOUN

To O PART
address O NOUN
these O DET
lacunas, O NOUN
a O DET
training O VERB
based O VERB
on O ADP
the O DET
Mental O ADJ
Health O NOUN
Gap O NOUN
Action O NOUN
Programme O NOUN
(mhGAP) O NOUN
Intervention O NOUN
Guide O NOUN
(IG) O NOUN
was O VERB
offered O VERB
to O PART
PCPs O NOUN
working O VERB
in O ADP
the O DET
Greater O ADJ
Tunis O NOUN
area O NOUN
between O ADP
February O ADJ
and O CCONJ
April O NOUN
2016. O NUM

CONCLUSIONS: O NOUN
Rigid O ADV
or O CCONJ
Kinesio O NOUN
taping O VERB
of O ADP
the O DET
shoulder O NOUN
and O CCONJ
scapular O ADJ
region O NOUN
improved O VERB
scapular B-outcome ADJ
dyskinesis I-outcome NOUN
and O CCONJ
pectoralis B-outcome NOUN
minor I-outcome ADJ
length I-outcome NOUN
but O CCONJ
did O VERB
not O ADV
alter O NOUN
scapular B-outcome ADJ
upward I-outcome ADJ
rotation I-outcome NOUN
. O PUNCT
Short-term O NOUN
rigid O NOUN
and O CCONJ
Kinesio O NOUN
taping O VERB
may O VERB
help O VERB
improve O VERB
scapular B-outcome ADJ
dyskinesis I-outcome NOUN
and O CCONJ
pectoralis B-outcome NOUN
minor I-outcome ADJ
length I-outcome NOUN
in O ADP
overhead O ADP
athletes. O ADV

T O NOUN
test O NOUN
was O VERB
performed O VERB
to O PART
compare O NOUN
the O DET
differences O NOUN
between O ADP
two O NUM
groups, O NOUN
and O CCONJ
the O DET
results O NOUN
were O VERB
corrected O VERB
using O VERB
Bonferroni O NOUN
method. O NOUN

After O ADP
interventions, O NOUN
the O DET
exercise O NOUN
group O NOUN
had O VERB
lower O ADJ
percentage O NOUN
body B-outcome NOUN
fat I-outcome NOUN
(%BF) O ADV
and O CCONJ
cardiometabolic B-outcome ADJ
risk O NOUN
markers, O NOUN
and O CCONJ
higher O ADJ
lean B-outcome ADJ
body I-outcome NOUN
mass I-outcome NOUN
(LM) I-outcome NUM
and O CCONJ
leg B-outcome NOUN
muscle I-outcome NOUN
strength I-outcome NOUN
compared O VERB
to O PART
the O DET
usual O ADJ
care O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

We O PRON
used O VERB
fuzzy-set O ADP
qualitative O ADJ
comparative O ADJ
analysis O NOUN
(fsQCA) O PUNCT
to O PART
identify O NOUN
combinations O NOUN
of O ADP
conditions O NOUN
that O ADP
were O VERB
associated O VERB
with O ADP
either O CCONJ
an O DET
increase O NOUN
or O CCONJ
no O DET
increase O NOUN
in O ADP
the O DET
outcome O NOUN
emotional B-outcome ADJ
and Seperator CCONJ
social I-outcome ADJ
school I-outcome NOUN
experience I-outcome NOUN
(SCE) I-outcome PUNCT
in O ADP
comparison O NOUN
to O PART
the O DET
control O NOUN
group O NOUN
at O ADP
20 O NUM
months O NOUN
post O ADV
intervention. O NOUN

OBJECTIVE: O NOUN
Data O NOUN
regarding O VERB
efficacy O NOUN
comparison O NOUN
of O ADP
daily O ADJ
regimen O NOUN
(DR) O NOUN
versus O CCONJ
every O DET
other O ADJ
day O NOUN
regimen O NOUN
(EODR) O NUM
atorvastatin O NOUN
therapy O NOUN
is O VERB
not O ADV
validated O VERB
by O ADP
estimation O NOUN
of O ADP
serum O NOUN
hydroxymethylglutaryl-CoA O NOUN
reductase O NOUN
(HMGCR) O PUNCT
levels O NOUN
and O CCONJ
HMGCR O ADV
correlation O NOUN
with O ADP
lipid O NOUN
indices. O ADJ

Journal O ADJ
ID: O NOUN
2985248R O NOUN

METHODS: O NOUN
This O DET
study O NOUN
employed O VERB
a O DET
prospective, O NOUN
randomized O VERB
study O NOUN
design O NOUN
to O PART
assess O NOUN
student's O NUM
learning B-outcome VERB
curve. O ADJ

Title: O NOUN
Oral O ADJ
ixazomib O NOUN
maintenance O NOUN
following O VERB
autologous O ADJ
stem O NOUN
cell O NOUN
transplantation O NOUN
(TOURMALINE-MM3): O NUM
a O DET
double-blind, O NOUN
randomised, O NOUN
placebo-controlled O VERB
phase O NOUN
3 O NUM
trial. O NOUN

Here, O NOUN
we O PRON
describe O NOUN
a O DET
simple O NOUN
method O NOUN
for O ADP
creating O VERB
a O DET
cervical O ADJ
spine O NOUN
phantom O NOUN
and O CCONJ
investigate O NOUN
whether O ADP
the O DET
use O NOUN
of O ADP
a O DET
gelatin-based O VERB
phantom O NOUN
is O VERB
associated O VERB
with O ADP
improved O VERB
proficiency B-outcome NOUN
in O ADP
performing O VERB
ultrasound-guided O VERB
cervical O ADJ
medial O ADJ
branch O NOUN
block. O NOUN

In O ADP
contrast, O NOUN
all O DET
active O ADJ
interventions O NOUN
in O ADP
Studies O NOUN
1 O NUM
and O CCONJ
2 O NUM
decreased O VERB
negative B-outcome ADJ
affect I-outcome NOUN
. O PUNCT
These O DET
studies O NOUN
provide O VERB
the O DET
first O ADV
experimental O ADJ
evidence O NOUN
that O ADP
developing O VERB
an O DET
orientation O NOUN
of O ADP
acceptance O NOUN
toward O ADP
present-moment O ADJ
experiences O NOUN
is O VERB
a O DET
central O ADJ
mechanism O NOUN
of O ADP
mindfulness O ADV
interventions O NOUN
for O ADP
boosting O VERB
positive B-outcome ADJ
emotions I-outcome NOUN
in O ADP
daily O ADJ
life. O NOUN
( O PUNCT

A O DET
total O ADJ
of O ADP
21 O NUM
patients O NOUN
(10.9%) O PUNCT
in O ADP
the O DET
bag-mask O ADJ
ventilation O NOUN
group O NOUN
had O VERB
severe B-outcome ADJ
hypoxemia I-outcome NOUN
, O PUNCT
as O ADP
compared O VERB
with O ADP
45 O NUM
patients O NOUN
(22.8%) O NOUN
in O ADP
the O DET
no-ventilation O NOUN
group O NOUN
(relative O ADJ
risk, O NOUN
0.48; O NUM
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.30 O NUM
to O PART
0.77). O NUM

The O DET
primary O ADJ
endpoint, O VERB
progression-free B-outcome ADJ
survival I-outcome NOUN
according O ADJ
to O PART
blinded O VERB
independent O ADJ
central O ADJ
review, O ADJ
was O VERB
analysed O VERB
by O ADP
intent-to-treat. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

In O ADP
the O DET
treatment O NOUN
group, O NOUN
1 O NUM
case O NOUN
had O VERB
incision B-outcome NOUN
fat I-outcome NOUN
liquefaction I-outcome NOUN
and O CCONJ
4 O NUM
cases O NOUN
had O VERB
bone B-outcome NOUN
cement I-outcome NOUN
leakage I-outcome NOUN
; O PUNCT
in O ADP
the O DET
control O NOUN
group, O NOUN
2 O NUM
cases O NOUN
had O VERB
screw B-outcome NOUN
loosening I-outcome VERB
and O CCONJ
1 O NUM
case O NOUN
had O VERB
unilateral O ADJ
connecting O VERB
rod B-outcome NOUN
rupture I-outcome NOUN
; O PUNCT
there O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
incidence O NOUN
of O ADP
complications B-outcome NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
( O PUNCT
chi O NOUN
(2)=0.504, O ADV
P=0.478). O NOUN

Publication O NOUN
date: O NOUN
2018/12/28 O NUM
06:00 O ADP
[medline] O NOUN

Title: O NOUN
Acute O ADJ
Effect O NOUN
of O ADP
Resistant O ADJ
Starch O NOUN
on O ADP
Food B-outcome NOUN
Intake I-outcome NOUN
, O PUNCT
Appetite B-outcome ADV
and O CCONJ
Satiety B-outcome NOUN
in O ADP
Overweight/Obese O NOUN
Males. O NOUN

All O DET
the O DET
included O VERB
patients O NOUN
were O VERB
equally O ADV
and O CCONJ
randomly O ADV
divided O VERB
into O ADP
a O DET
verum O NOUN
TENS O NOUN
group O NOUN
and O CCONJ
a O DET
sham O NOUN
TENS O NOUN
group, O NOUN
each O DET
group O NOUN
23 O NUM
participants. O NOUN

Efficacy O NOUN
assessments O NOUN
using O VERB
the O DET
validated O VERB
IGAxBSA O NOUN
composite O NOUN
tool. O NOUN

Diagnostic O ADJ
criteria O NOUN
for O ADP
the O DET
diagnosis O NOUN
of O ADP
patients O NOUN
with O ADP
RA O NOUN
were O VERB
all O DET
patients O NOUN
with O ADP
RA O NOUN
who O ADP
visited O VERB
the O DET
clinic O ADJ
of O ADP
Jam O NOUN
Rheumatology O NOUN
Centers O NOUN
and O CCONJ
met O VERB
other O ADJ
inclusion O NOUN
criteria O NOUN
in O ADP
Mashhad O ADJ
in O ADP
the O DET
spring O VERB
of O ADP
2018. O NUM

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Baseline O NOUN
characteristics O NOUN
were O VERB
detectable O ADJ
viral O ADJ
loads O NOUN
(median O PUNCT
7897 O NUM
copies/mL), O NOUN
low O ADJ
CD4(+) O NOUN
(median O PUNCT
410 O NUM
cells/microL), O NOUN
and O CCONJ
elevated O VERB
CD8(+) O NOUN
(median O PUNCT
930 O NUM
cells/microL) O NOUN
T O NOUN
cell O NOUN
counts. O NOUN

There O PRON
were O VERB
no O DET
differences O NOUN
in O ADP
the O DET
baseline O NOUN
characteristics O NOUN
and O CCONJ
outcome O NOUN
of O ADP
ovarian O ADJ
stimulation O NOUN
between O ADP
the O DET
two O NUM
groups. O NOUN

The O DET
objective O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
evaluate O VERB
the O DET
metabolizable O ADJ
energy O NOUN
in O ADP
cashew O NOUN
nuts. O NOUN

Journal O ADJ
ID: O NOUN
0421110 O NUM

Title: O NOUN
A O DET
randomized, O NOUN
double-blind, O NOUN
placebo-controlled O VERB
trial O NOUN
on O ADP
the O DET
efficacy O NOUN
of O ADP
tranexamic O ADJ
acid O NOUN
combined O VERB
with O ADP
rivaroxaban O ADJ
thromboprophylaxis O NOUN
in O ADP
reducing O VERB
blood B-outcome NOUN
loss I-outcome NOUN
after O ADP
primary O ADJ
cementless O NOUN
total O ADJ
hip O NOUN
arthroplasty. O NOUN

Subjects O NOUN
practiced O VERB
yoga O NOUN
over O ADP
two O NUM
months O NOUN
in O ADP
three O NUM
sessions, O DET
the O DET
duration O NOUN
of O ADP
each O DET
session O NOUN
was O VERB
60min. O NOUN

Results: O NOUN
Participant O ADJ
retention O NOUN
was O VERB
100% O NOUN
at O ADP
6 O NUM
months. O NOUN

Most O DET
participants O NOUN
were O VERB
women O NOUN
(>88%), O NOUN
with O ADP
a O DET
mean O NOUN
age O NOUN
of O ADP
35.3 O NUM
years, O NOUN
more O ADV
than O ADP
a O DET
high O ADJ
school O NOUN
education O NOUN
(>80%), O NOUN
a O DET
family O NOUN
composition O NOUN
of O ADP
at O ADP
least O ADV
three O NUM
members, O NOUN
and O CCONJ
a O DET
mean O NOUN
baseline O NOUN
body O NOUN
mass O NOUN
index O NOUN
(BMI) O PUNCT
of O ADP
34.5 O NUM
kg/m(2). O NOUN

Publication O NOUN
Type: O NOUN
Equivalence O NOUN
Trial O NOUN

Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Two-year, O ADV
randomized, O NOUN
multicenter O NOUN
trial O NOUN
conducted O VERB
at O ADP
9 O NUM
hospitals O NOUN
in O ADP
Denmark. O NOUN

RESULTS: O NOUN
There O PRON
were O VERB
49 O NUM
patients O NOUN
allocated O VERB
to O PART
receive O VERB
misoprostol O NOUN
and O CCONJ
38 O NUM
allocated O VERB
to O PART
receive O VERB
placebo; O ADV
the O DET
incidence O NOUN
of O ADP
a O DET
20 O NUM
g/L O NOUN
decrease O NOUN
in O ADP
hemoglobin B-outcome NOUN
was O VERB
similar O ADJ
between O ADP
the O DET
groups O NOUN
(20/43 O NOUN
[47%] O NUM
vs O CCONJ
19/33 O NOUN
[58%], O NOUN
respectively; O NOUN
P=0.335). O NOUN

CONCLUSIONS: O NOUN
Adjuvant O NOUN
therapy O NOUN
with O ADP
a O DET
modified O VERB
FOLFIRINOX O NOUN
regimen O NOUN
led O VERB
to O PART
significantly O ADV
longer O ADJ
survival B-outcome NOUN
than O ADP
gemcitabine O NOUN
among O ADP
patients O NOUN
with O ADP
resected O VERB
pancreatic O ADJ
cancer, O NOUN
at O ADP
the O DET
expense O NOUN
of O ADP
a O DET
higher O ADJ
incidence O NOUN
of O ADP
toxic B-outcome ADJ
effects. O NOUN
( O PUNCT

Journal O ADJ
ID: O NOUN
0255562 O NUM

The O DET
objective O ADP
of O ADP
this O DET
randomized O VERB
controlled O VERB
trial O NOUN
was O VERB
to O PART
assess O NOUN
whether O ADP
informing O VERB
truckers O NOUN
who O ADP
do O VERB
not O ADV
test O NOUN
for O ADP
HIV O NOUN
regularly O ADV
about O ADV
the O DET
availability O NOUN
of O ADP
HIV O NOUN
self-testing O VERB
kits O NOUN
at O ADP
roadside O NOUN
wellness O NOUN
centers O NOUN
in O ADP
Kenya O PROPN
using O VERB
text O VERB
messages O NOUN
would O VERB
increase O NOUN
HIV B-outcome NOUN
testing I-outcome VERB
rates O NOUN
compared O VERB
to O PART
the O DET
current O ADJ
program O NOUN
in O ADP
which O ADP
they O PRON
are O VERB
sent O ADJ
text O VERB
messages O NOUN
about O ADV
the O DET
availability O NOUN
of O ADP
HIV O NOUN
testing O VERB
in O ADP
general. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

Methods: O NOUN
A O DET
total O ADJ
of O ADP
60 O NUM
patients O NOUN
with O ADP
silicosis O NOUN
complicated O VERB
by O ADP
stable O ADJ
COPD O NOUN
who O ADP
were O VERB
hospitalized O VERB
in O ADP
Department O NOUN
of O ADP
Occupational O ADJ
Diseases, O NOUN
Laigang O NOUN
Hospital O NOUN
Affiliated O VERB
to O PART
Taishan O NOUN
Medical O ADJ
College, O PUNCT
from O ADP
August O NOUN
2017 O NUM
to O PART
April O NOUN
2018 O NUM
were O VERB
enrolled O VERB
and O CCONJ
randomly O ADV
divided O VERB
into O ADP
control O NOUN
group O NOUN
and O CCONJ
observation O NOUN
group, O NOUN
with O ADP
30 O NUM
patients O NOUN
in O ADP
each O DET
group. O VERB

FUNDING: O NOUN
Millennium O NOUN
Pharmaceuticals, O ADJ
a O DET
wholly O ADV
owned O VERB
subsidiary O NOUN
of O ADP
Takeda O NOUN
Pharmaceutical O NOUN
Company. O NOUN

Title: O NOUN
Using O VERB
physical O ADJ
education O NOUN
to O PART
promote O VERB
out-of O ADP
school O NOUN
physical O ADJ
activity O NOUN
in O ADP
lower O ADJ
secondary O ADJ
school O NOUN
students O NOUN
- O PUNCT
a O DET
randomized O VERB
controlled O VERB
trial O NOUN
protocol. O NOUN

BACKGROUND: O NOUN
Bisphosphonates O NOUN
prevent O NOUN
fractures O NOUN
in O ADP
patients O NOUN
with O ADP
osteoporosis, O PRON
but O CCONJ
their O ADJ
efficacy O NOUN
in O ADP
women O NOUN
with O ADP
osteopenia O NOUN
is O VERB
unknown. O NOUN

At O ADP
these O DET
time O NOUN
points: O NOUN
T(0)(the O NOUN
day O NOUN
before O ADP
operation), O NOUN
T(1)(immediate O NOUN
before O ADP
anesthesia O NOUN
induction), O NOUN
T(2)(1 O NOUN
h O NOUN
after O ADP
emergence), O NOUN
T(3)(24 O NOUN
h O NOUN
after O ADP
operation), O NOUN
T(4)(3 O NOUN
d O NOUN
after O ADP
operation), O NOUN
T(5)(7 O NOUN
d O NOUN
after O ADP
operation), O NOUN
T(6)(one O PRON
month O NOUN
after O ADP
operation), O NOUN
T(7)(3 O NOUN
months O NOUN
after O ADP
operation) O NOUN
and O CCONJ
T(8)(6 O NOUN
month O NOUN
after O ADP
operation) O NOUN
, O PUNCT
venous O ADJ
blood O NOUN
samples O NOUN
of O ADP
patients O NOUN
were O VERB
collected O VERB
for O ADP
detection O NOUN
of O ADP
epinephrine B-outcome NOUN
, O PUNCT
norepinephrine B-outcome NOUN
and O CCONJ
corticosterone B-outcome NOUN
. O PUNCT
The O DET
pain B-outcome NOUN
visual O ADJ
analogue O NOUN
scale(VSA) O NUM
was O VERB
used O VERB
to O PART
assess O NOUN
pain B-outcome NOUN
levels O NOUN
in O ADP
patients O NOUN
at O ADP
T(2), O NOUN
T(3), O NOUN
T(4), O NOUN
T(5), O NOUN
T(6), O NOUN
T(7), O NOUN
T(8). O NOUN

For O ADP
the O DET
evaluation O NOUN
of O ADP
the O DET
association O NOUN
of O ADP
the O DET
categorical O ADJ
variables O NOUN
the O DET
Chi-square O NOUN
test O NOUN
and O CCONJ
Fisher's O NOUN
Exact O NOUN
Test O NOUN
will O VERB
be O VERB
used. O NOUN

Journal-Name:Revista O NOUN
de O ADP
saude O NOUN
publica O NOUN

There O PRON
were O VERB
also O ADV
major O ADJ
re-structuring O VERB
of O ADP
several O ADJ
organisations O NOUN
which O ADP
presented O VERB
significant O ADJ
implementation O NOUN
challenges, O NOUN
and O CCONJ
technical O ADJ
limitations. O NOUN

DESIGN: O NOUN
A O DET
parallel O ADJ
group O NOUN
trial O NOUN
with O ADP
follow-up O NOUN
METHODS:: O NOUN
Thirty O NUM
young O ADJ
women O NOUN
were O VERB
divided O VERB
into O ADP
2 O NUM
groups: O NOUN
experimental O ADJ
(n O NOUN
= O SYM
15) O NOUN
and O CCONJ
control O NOUN
(n O NOUN
= O SYM
15). O NOUN

Amer.). O NOUN

Physical B-outcome ADJ
activity I-outcome NOUN
participation I-outcome NOUN
, O PUNCT
the O DET
primary O ADJ
outcome O NOUN
variable, O NOUN
and O CCONJ
psychological O ADJ
mediators O NOUN
from O ADP
the O DET
trans-contextual O ADJ
model O NOUN
will O VERB
be O VERB
measured O VERB
at O ADP
pre-trial, O ADJ
post-trial, O ADJ
and O CCONJ
at O ADP
one-, O NOUN
three- O NOUN
and O CCONJ
six-months O NOUN
post-trial. O NOUN

BACKGROUND: O NOUN
Upper O NOUN
extremity O NOUN
functional O ADJ
impairments O NOUN
are O VERB
common O ADJ
consequences O NOUN
of O ADP
stroke. O NOUN

The O DET
children O NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
treated O VERB
for O ADP
a O DET
total O ADJ
of O ADP
6 O NUM
weeks. O NOUN

Hence, O NOUN
the O DET
present O ADJ
study O NOUN
aims O NOUN
to O PART
establish O NOUN
the O DET
clinical O ADJ
evidence O NOUN
regarding O VERB
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
Bosinji O NOUN
in O ADP
improving O VERB
pain B-outcome NOUN
, O PUNCT
function B-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
in O ADP
LHIVD O NOUN
patients. O NOUN

Publication O NOUN
date: O NOUN
2019/02/26 O VERB
06:00 O ADP
[medline] O NOUN

Implementation O NOUN
of O ADP
multi-component O ADJ
PA O NOUN
interventions O NOUN
within O ADP
schools O NOUN
is O VERB
advocated O VERB
but O CCONJ
research O NOUN
has O VERB
showed O VERB
that O ADP
they O PRON
may O VERB
not O ADV
always O ADV
be O VERB
effective O ADJ
at O ADP
increasing O VERB
child O NOUN
PA. O NOUN

Mean O NOUN
arterial B-outcome ADJ
pressure I-outcome NOUN
(MAP), O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
peripheral B-outcome ADJ
capillary I-outcome NOUN
oxygen I-outcome NOUN
saturation I-outcome NOUN
SpO(2) I-outcome NOUN
, O PUNCT
partial B-outcome ADJ
pressure I-outcome NOUN
of I-outcome ADP
exhaled I-outcome VERB
carbon I-outcome NOUN
dioxide I-outcome NOUN
P(ET)CO(2) I-outcome NOUN
and O CCONJ
bispectral O ADJ
index O NOUN
(BIS) O PUNCT
were O VERB
recorded O VERB
after O ADP
entering O VERB
the O DET
operating O VERB
room(T(0)), O NOUN
after O ADP
anesthesia O NOUN
induction(T(1)), O NOUN
immediately O ADV
after O ADP
inserting O VERB
laryngeal O ADJ
mask O NOUN
airway O NOUN
or O CCONJ
tracheal O ADJ
tube(T(2)), O NOUN
fiberbronchoscopy O NOUN
inserting(T(3)), O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
the O DET
operation(T(4)), O NOUN
and O CCONJ
at O ADP
the O DET
recovery O NOUN
of O ADP
patients' O NOUN
consciousness(T(5)). O NOUN

Of O ADP
10 O NUM
key O ADJ
secondary O ADJ
end O NOUN
points, O NOUN
8 O NUM
were O VERB
null O ADJ
and O CCONJ
2 O NUM
showed O VERB
statistically O ADV
significant O ADJ
benefit O NUM
for O ADP
the O DET
MRI O NOUN
treat-to-target O NOUN
group. O VERB

During O ADP
pre-supplementation O NOUN
testing, O NOUN
the O DET
subjects O NOUN
performed O VERB
2 O NUM
pretest O NOUN
MVICs, O NOUN
2 O NUM
sets O NOUN
of O ADP
50 O NUM
maximal, O ADJ
bilateral, O ADP
concentric O ADJ
isokinetic O ADJ
leg O NOUN
extensions O NOUN
at O ADP
180 O NUM
degrees O NOUN
.s(- O PUNCT
1) O NUM
separated O VERB
by O ADP
2-min O NOUN
of O ADP
rest, O NOUN
and O CCONJ
2 O NUM
posttest O NOUN
MVICs. O ADJ

The O DET
RADPAD O NOUN
is O VERB
a O DET
lead-free O ADJ
sterile O ADJ
drape O NOUN
containing O VERB
bismuth O NOUN
and O CCONJ
barium O NOUN
that O ADP
reduces O NOUN
scatter O NOUN
radiation O NOUN
during O ADP
fluoroscopic O ADJ
procedures. O NOUN

The O DET
odds O NOUN
ratios O NOUN
(95% O PUNCT
CI) O NOUN
for O ADP
gestational B-outcome ADJ
diabetes I-outcome NOUN
mellitus I-outcome NOUN
(GDM) I-outcome NOUN
and O CCONJ
CMFCs O NOUN
in O ADP
women O NOUN
with O ADP
a O DET
high O ADJ
adherence O NOUN
were O VERB
0.35((0.18(-)0.67), O NOUN
p O NOUN
= O SYM
0.002) O NUM
and O CCONJ
0.23((0.11(-)0.48), O PUNCT
p O NOUN
< O SYM
0.001), O NUM
respectively. O NOUN

Moreover, O NOUN
further O ADV
studies O NOUN
should O VERB
allow O ADP
assessments O NOUN
of O ADP
the O DET
safety O NOUN
and O CCONJ
effectiveness O NOUN
of O ADP
pegbelfermin O NOUN
in O ADP
a O DET
larger O ADJ
number O NOUN
of O ADP
patients. O NOUN

Conclusion: O NOUN
Perioperative O ADJ
application O NOUN
of O ADP
dexmedetomidine O NOUN
can O VERB
effectively O ADV
decrease O NOUN
the O DET
perioperative O ADJ
stress B-outcome NOUN
response, O NOUN
obviously O ADV
cut O ADJ
down O ADJ
the O DET
perioperative O ADJ
opioid B-outcome NOUN
consumption I-outcome NOUN
, O PUNCT
and O CCONJ
prevent O NOUN
the O DET
transition O NOUN
from O ADP
postoperative O ADJ
acute B-outcome ADJ
pain I-outcome NOUN
to O PART
chronic B-outcome ADJ
pain I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
radical O NOUN
resection O NOUN
of O ADP
esophageal O ADJ
cancer O NOUN
under O ADP
combined O VERB
thoracoscope O NOUN
and O CCONJ
laparoscope. O NOUN

Conclusion: O NOUN
Therapeutic O ADJ
radiographer O ADP
prostate O NOUN
contours O NOUN
are O VERB
more O ADV
accurate, O NOUN
show O VERB
less O ADV
interobserver O ADV
variability O NOUN
and O CCONJ
are O VERB
more O ADV
confidently O ADV
and O CCONJ
quickly O NOUN
outlined O VERB
on O ADP
MRI O NOUN
compared O VERB
to O PART
CT, O NOUN
particularly O ADV
using O VERB
T2*W O NOUN
MRI. O NOUN

The O DET
first O ADV
lotion O NOUN
formulation O NOUN
of O ADP
tretinoin O NOUN
was O VERB
developed O VERB
using O VERB
novel O ADJ
polymerized O VERB
emulsion O NOUN
technology O NOUN
to O PART
provide O VERB
an O DET
important O ADJ
alternative O ADJ
option O NOUN
to O PART
treat O NOUN
these O DET
acne O NOUN
patients O NOUN
who O ADP
may O VERB
be O VERB
sensitive O ADJ
to O PART
the O DET
irritant O NOUN
effects O NOUN
of O ADP
other O ADJ
tretinoin O NOUN
formulations. O VERB

Pain B-outcome NOUN
visual O ADJ
analog O NOUN
scale O NOUN
(VAS), O NUM
patient's O NOUN
global B-outcome ADJ
assessment I-outcome NOUN
(PGA), O PUNCT
flexional B-outcome ADJ
angles I-outcome NOUN
, O PUNCT
patient-controlled O VERB
analgesia B-outcome NOUN
consumption I-outcome NOUN
, O PUNCT
percentage O NOUN
of O ADP
patients O NOUN
receiving O VERB
pethidine B-outcome NOUN
, O PUNCT
pethidine B-outcome NOUN
consumption I-outcome NOUN
, O PUNCT
and O CCONJ
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
assessed. O NOUN

Interpretation O NOUN
& O CCONJ
conclusion: O NOUN
: O PUNCT
Addition O NOUN
of O ADP
a O DET
third O ADJ
SP O NOUN
dose O NOUN
to O PART
the O DET
standard O ADJ
two-dose O NOUN
SP O NOUN
for O ADP
IPTp O NOUN
led O VERB
to O PART
improved O VERB
reductions O NOUN
in O ADP
the O DET
risk O NOUN
of O ADP
some O DET
adverse B-outcome ADJ
pregnancy I-outcome NOUN
outcomes I-outcome NOUN
. O PUNCT

The O DET
decrease O NOUN
in O ADP
albuminemia B-outcome NOUN
had O VERB
a O DET
direct O ADJ
correlation O NOUN
with O ADP
CRP O NOUN
levels, O NOUN
which O ADP
were O VERB
higher O ADJ
in O ADP
the O DET
G1. O NOUN

We O PRON
evaluated O VERB
the O DET
comparative O ADJ
effectiveness O NOUN
of O ADP
high-fidelity O NOUN
simulation O NOUN
training O VERB
vs. O CCONJ
standard O ADJ
manikin O NOUN
training O VERB
for O ADP
teaching O VERB
medical O ADJ
students O NOUN
the O DET
American O ADJ
Heart O NOUN
Association O NOUN
(AHA) O NUM
guidelines O NOUN
for O ADP
high-quality O NOUN
CPR. O NOUN

Both O CCONJ
T2W O NOUN
and O CCONJ
T2*W O NOUN
MRI O NOUN
show O VERB
reduced O VERB
interobserver O ADV
variability O NOUN
and O CCONJ
improved O VERB
accuracy O NOUN
compared O VERB
to O PART
CT, O NOUN
this O DET
was O VERB
statistically O ADV
significant O ADJ
for O ADP
T2*W O NOUN
imaging O VERB
compared O VERB
to O PART
CT O NOUN
across O ADP
all O DET
four O NUM
comparison O NOUN
metrics. O NOUN

This O DET
study O NOUN
evaluated O VERB
the O DET
efficacy O NOUN
of O ADP
amla O NOUN
(Emblica O NUM
officinalis) O NOUN
extract O NOUN
(composed O PUNCT
of O ADP
polyphenols, O NOUN
triterpenoids, O NOUN
oils O NOUN
etc. O NOUN

Conclusion O NOUN
We O PRON
demonstrated O VERB
the O DET
feasibility B-outcome NOUN
and O CCONJ
acceptability B-outcome NOUN
of O ADP
the O DET
use O NOUN
of O ADP
a O DET
robotic O ADJ
walking O VERB
aid O VERB
from O ADP
the O DET
perspective O ADJ
of O ADP
both O CCONJ
older O ADJ
individuals O NOUN
and O CCONJ
physiotherapists. O NOUN

The O DET
study O NOUN
included O VERB
204 O NUM
subjects O NOUN
between O ADP
25(-)70 O ADJ
years O NOUN
with O ADP
T2DM. O NOUN

INTERPRETATION: O CCONJ
Ixazomib O NUM
maintenance O NOUN
prolongs O NOUN
progression-free B-outcome ADJ
survival I-outcome NOUN
(PFS) I-outcome NOUN
and O CCONJ
represents O NOUN
an O DET
additional O ADJ
option O NOUN
for O ADP
post-transplant O NOUN
maintenance O NOUN
therapy O NOUN
in O ADP
patients O NOUN
with O ADP
newly O ADV
diagnosed O VERB
multiple O ADJ
myeloma. O ADV

Journal-Name:Nutrients O NOUN

At O ADP
the O DET
beginning O VERB
of O ADP
pain, O NOUN
in O ADP
the O DET
two O NUM
groups O NOUN
200 O NUM
mg O NOUN
capsule O NOUN
was O VERB
given O VERB
every O DET
6 O NUM
h O NOUN
for O ADP
two O NUM
serial O ADJ
cycles. O NUM

Conclusion:Rhodiola O NOUN
may O VERB
improve O VERB
the O DET
negative B-outcome ADJ
emotions I-outcome NOUN
such O ADJ
as O ADP
anxiety B-outcome NOUN
and O CCONJ
depression B-outcome NOUN
by O ADP
inhibiting O VERB
oxygen B-outcome NOUN
free I-outcome ADJ
radicals I-outcome NOUN
and O CCONJ
lipid B-outcome NOUN
peroxidation I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
OSA. O NOUN

Therefore, O NOUN
denosumab O NOUN
possibly O ADV
regulates O NOUN
noggin B-outcome NOUN
and O CCONJ
favours O NOUN
bone O NOUN
turnover O ADV
in O ADP
TDT O NOUN
patients O NOUN
with O ADP
osteoporosis O NOUN
through O ADP
a O DET
novel O ADJ
mechanism O NOUN
of O ADP
action. O NOUN

Journal O ADJ
ID: O NOUN
7511141 O NUM

Publication O NOUN
date: O NOUN
2018/12/21 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
Kaplan-Meier O NOUN
estimated O VERB
percentage O NOUN
of O ADP
patients O NOUN
who O ADP
were O VERB
free O ADJ
from O ADP
recurrence B-outcome NOUN
at O ADP
6 O NUM
months, O NOUN
defined O VERB
as O ADP
P. O NOUN
vivax O NOUN
clearance O NOUN
without O ADP
recurrent O ADP
parasitemia. O NOUN

Serum O NOUN
cytokines O NOUN
were O VERB
quantified, O NOUN
and O CCONJ
microbiota O NOUN
assessed O VERB
using O VERB
metagenomic O ADJ
sequencing. O NOUN

INTERVENTIONS: O NOUN
Patients O NOUN
were O VERB
subjected O VERB
to O PART
low-dose O NOUN
preoperative O ADJ
protocols O NOUN
of O ADP
MDCT O NOUN
(n O NOUN
= O SYM
144; O NUM
ldMDCT O NOUN
group) O ADJ
or O CCONJ
standard-dose O NOUN
preoperative O ADJ
protocols O NOUN
of O ADP
MDCT O NOUN
(n O NOUN
= O SYM
144; O NUM
sdMDCT O NOUN
group). O NOUN

The O DET
incidence O NOUN
of O ADP
undetectable O ADJ
MEP B-outcome NOUN
did O VERB
not O ADV
differ O VERB
as O ADP
measured O VERB
in O ADP
both O CCONJ
groups. O NOUN

In O ADP
the O DET
OSTAP O NOUN
group, O NOUN
the O DET
patients O NOUN
received O VERB
a O DET
bilateral O ADJ
OSTAP O NOUN
block O VERB
with O ADP
40 O NUM
mL O NOUN
of O ADP
0.375% O NUM
bupivacaine O NOUN
and O CCONJ
in O ADP
the O DET
Sham O NOUN
group O NOUN
received O VERB
an O DET
US-guided O VERB
bilateral O ADJ
OSTAP O NOUN
with O ADP
40 O NUM
mL O NOUN
of O ADP
0.9% O NOUN
saline. O NOUN

Despite O ADP
growing O VERB
interest O NOUN
in O ADP
natural O ADJ
rehydrating O VERB
beverages, O NOUN
no O DET
study O NOUN
has O VERB
examined O VERB
maple O NOUN
water O NOUN
(MW). O PUNCT

Journal-Name:Nutrients O NOUN

However, O ADV
although O ADP
it O PRON
was O VERB
not O ADV
sufficient O ADJ
to O PART
enhance O NOUN
muscle O NOUN
recovery O NOUN
observed O VERB
by O ADP
testosterone B-outcome NOUN
and O CCONJ
cortisol B-outcome NOUN
responses, O NOUN
it O PRON
was O VERB
observed O VERB
that O ADP
serum O NOUN
25(OH)D B-outcome NUM
levels O NOUN
could O VERB
be O VERB
a O DET
predictor O NOUN
of O ADP
anabolic B-outcome ADJ
and O CCONJ
catabolic B-outcome ADJ
hormones. O NUM

Conclusion O NOUN
PRAM O NOUN
provides O NOUN
meaningful O ADJ
and O CCONJ
direct O ADJ
monitoring O VERB
of O ADP
hemodynamics O NOUN
and O CCONJ
cardiac O ADJ
efficiency O NOUN
during O ADP
the O DET
dynamic O ADJ
period O NOUN
of O ADP
anesthetic O ADJ
induction O NOUN
in O ADP
children O NOUN
undergoing O VERB
cardiac O ADJ
surgery. O VERB

The O DET
results O NOUN
showed O VERB
that O ADP
there O PRON
was O VERB
a O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
mean O NOUN
scores O NOUN
of O ADP
pre-test O NOUN
(before O NUM
MBI) O NOUN
and O CCONJ
post-test O NOUN
(after O PUNCT
MBI) O NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
compared O VERB
to O PART
the O DET
control O NOUN
group, O NOUN
and O CCONJ
MBCT O NOUN
had O VERB
a O DET
significant O ADJ
effect O NOUN
on O ADP
the O DET
perception B-outcome NOUN
of I-outcome ADP
the Seperator DET
disease I-outcome NOUN
and O CCONJ
the O DET
psychological B-outcome ADJ
syndrome I-outcome NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
compared O VERB
to O PART
the O DET
control O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
0374675 O NUM

They O PRON
were O VERB
randomly O ADV
divided O VERB
into O ADP
volume O NOUN
controlled O VERB
ventilation O NOUN
(VCV) O NOUN
group O NOUN
and O CCONJ
pressure O NOUN
controlled O VERB
ventilation O NOUN
(PCV) O NOUN
group O NOUN
according O ADJ
to O PART
random O NOUN
number O NOUN
table. O ADJ

Title: O NOUN
Baseline O NOUN
characteristics O NOUN
associated O VERB
with O ADP
early O ADJ
visual B-outcome ADJ
acuity I-outcome NOUN
gains O NOUN
after O ADP
ranibizumab O ADJ
treatment O NOUN
for O ADP
retinal O ADJ
vein O NOUN
occlusion. O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

METHODS: O NOUN
Eighty-two O NUM
patients O NOUN
with O ADP
T1-3bN0M0 O NOUN
prostate O NOUN
cancer O NOUN
who O ADP
had O VERB
not O ADV
received O VERB
androgen-deprivation O NOUN
therapy O NOUN
were O VERB
randomized O VERB
to O PART
one O NUM
of O ADP
five O NUM
arms: O NOUN
Arm O NOUN
1, O NOUN
60 O NUM
cobalt O NOUN
gray O NOUN
equivalent O ADJ
(CGE)/20 O NOUN
fractions/5 O NOUN
weeks; O ADP
Arm O NOUN
2, O NOUN
54 O NUM
CGE/15 O NOUN
fractions/5 O NOUN
weeks; O ADP
Arm O NOUN
3, O NOUN
47 O NUM
CGE/10 O NOUN
fractions/5 O NOUN
weeks; O ADP
Arm O NOUN
4, O NOUN
35 O NUM
CGE/5 O NOUN
fractions/2.5 O NUM
weeks; O ADP
and O CCONJ
Arm O NOUN
5, O ADJ
35 O NUM
CGE/5 O NOUN
fractions/4 O NOUN
weeks. O NOUN

Journal-Name:BMC O NOUN
neurology O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Most O DET
fractures O NOUN
in O ADP
postmenopausal O ADJ
women O NOUN
occur O VERB
in O ADP
those O DET
with O ADP
osteopenia, O NOUN
so O ADV
therapies O NOUN
that O ADP
are O VERB
effective O ADJ
in O ADP
women O NOUN
with O ADP
osteopenia O NOUN
are O VERB
needed. O NOUN

The O DET
main O ADJ
group O NOUN
consisted O VERB
of O ADP
90 O NUM
children O NOUN
diagnosed O VERB
with O ADP
asthma O NOUN
and O CCONJ
allergies O NOUN
symptoms O NOUN
age O NOUN
9 O NUM
to O PART
12 O NUM
years O NOUN
old O ADJ
(x O PUNCT
= O SYM
10.75 O NUM
+/- O SYM
1.08). O NOUN

BACKGROUND: O NOUN
Few O ADJ
studies O NOUN
have O VERB
been O VERB
conducted O VERB
on O ADP
the O DET
utility O NOUN
of O ADP
cervical O ADJ
spine O NOUN
phantoms O NOUN
for O ADP
practicing O VERB
cervical O ADJ
procedures. O NOUN

Significant O ADJ
correlations O NOUN
were O VERB
found O VERB
between O ADP
depression B-outcome NOUN
and O CCONJ
parasympathetic B-outcome ADJ
modulation I-outcome NOUN
using O VERB
linear O ADJ
(r O NUM
= O SYM
- O PUNCT
0.687; O NUM
p O NOUN
= O SYM
0.028) O NUM
and O CCONJ
nonlinear O ADJ
analyses O NOUN
(r O NUM
= O SYM
- O PUNCT
0.689; O NOUN
p O NOUN
= O SYM
0.027) O NUM
in O ADP
MTG. O NOUN

Publication O NOUN
date: O NOUN
['2019/10/17 O NOUN
06:00' O NUM

However, O ADV
no O DET
significant O ADJ
differences O NOUN
in O ADP
bacteriological B-outcome ADJ
cure I-outcome NOUN
(P O NUM
= O SYM
.34), O PUNCT
clinical B-outcome ADJ
response I-outcome NOUN
(P O NUM
= O SYM
.11), O NOUN
and O CCONJ
safety O NOUN
were O VERB
found O VERB
between O ADP
2 O NUM
groups. O NOUN

RESULTS: O NOUN
For O ADP
the O DET
upper O ADJ
50th O ADJ
percentile O ADJ
group, O NOUN
the O DET
post-supplementation O NOUN
adjusted O VERB
mean O NOUN
percent O NOUN
decline O NOUN
in O ADP
maximal B-outcome ADJ
voluntary I-outcome ADJ
isometric I-outcome ADJ
contraction I-outcome NOUN
(MVIC) I-outcome NOUN
was O VERB
significantly O ADV
less O ADV
for O ADP
the O DET
high O ADJ
dose O NOUN
group O NOUN
(8.9 O PUNCT
+/- O SYM
2.3%) O NUM
than O ADP
the O DET
low O ADJ
dose O NOUN
(17.0 O PUNCT
+/- O SYM
2.4%; O NOUN
p O NOUN
= O SYM
0.022) O NUM
and O CCONJ
placebo O NOUN
(16.0 O PUNCT
+/- O SYM
2.4%; O NOUN
p O NOUN
= O SYM
0.044) O NUM
groups. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
between-group O NOUN
difference O NOUN
in O ADP
the O DET
mean O NOUN
change O NOUN
from O ADP
baseline O NOUN
to O PART
week O NOUN
80 O NUM
in O ADP
the O DET
total O ADJ
score O NOUN
on O ADP
the O DET
Unified O VERB
Parkinson's B-outcome NOUN
Disease I-outcome NOUN
Rating O VERB
Scale O NOUN
(UPDRS; O PUNCT
scores O NOUN
range O NOUN
from O ADP
0 O NUM
to O PART
176, O NOUN
with O ADP
higher O ADJ
scores O NOUN
signifying O VERB
more O ADV
severe O ADJ
disease). O NOUN

When O ADP
comparing O VERB
survey O NOUN
responses O NOUN
between O ADP
individuals O NOUN
who O ADP
met O VERB
online O ADP
and O CCONJ
in O ADP
person, O NOUN
we O PRON
did O VERB
not O ADV
detect O VERB
a O DET
difference O NOUN
in O ADP
demographics O NOUN
with O ADP
the O DET
exception O NOUN
of O ADP
preferred O VERB
meeting O VERB
method O NOUN
(p=0.0225). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Five O NUM
minutes O NOUN
before O ADP
taking O VERB
the O DET
Trier O NOUN
Social O ADJ
Stress O NOUN
Test O NOUN
(TSST) O NUM
as O ADP
a O DET
mental O ADJ
stressor, O NOUN
participants O NOUN
in O ADP
each O DET
group O NOUN
ingested O VERB
a O DET
beverage O ADP
containing O VERB
beta-Eudesmol, O NOUN
the O DET
active O ADJ
beverage, O CCONJ
or O CCONJ
a O DET
placebo O NOUN
beverage O ADP
that O ADP
did O VERB
not O ADV
contain O NOUN
beta-Eudesmol. O NOUN

The O DET
treatment O NOUN
lasted O VERB
for O ADP
2 O NUM
weeks. O NOUN

Title: O NOUN
Efficacy O NOUN
of O ADP
Curcumin O NOUN
as O ADP
an O DET
Adjunct O ADP
to O PART
Scaling O VERB
and O CCONJ
Root O ADJ
Planing O VERB
in O ADP
Chronic O ADJ
Periodontitis O NOUN
Patients: O NOUN
A O DET
Randomized O VERB
Controlled O VERB
Clinical O ADJ
Trial. O NOUN

The O DET
upper O ADJ
boundary O NOUN
of O ADP
the O DET
95% O NOUN
confidence O NOUN
interval, O ADP
when O ADP
comparing O VERB
short O ADJ
and O CCONJ
long O ADV
protocols, O NOUN
was O VERB
below O ADP
the O DET
pre-specified O VERB
margin O ADP
of O ADP
non-inferiority O NOUN
(p O PUNCT
= O SYM
0.027). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN
Research O NOUN
Support, O NOUN
Non-U.S. O NOUN
Gov't, O NOUN

They O PRON
had O VERB
lost O VERB
their O ADJ
ability O NOUN
to O PART
perform O NOUN
some O DET
basic O ADJ
living O VERB
activities. O NOUN

ID: O NOUN
ISRCTN13021107]. O NUM

All O DET
men O NOUN
received O VERB
standard O ADJ
care, O NOUN
and O CCONJ
men O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
(IG) O NOUN
also O ADV
received O VERB
oral O ADJ
and O CCONJ
written O ADP
RLP-based O VERB
information O NOUN
about O ADV
lifestyle O NOUN
and O CCONJ
fertility. O NOUN

Time B-outcome NOUN
to I-outcome PART
emergency I-outcome NOUN
medical I-outcome ADJ
services I-outcome NOUN
(EMS) I-outcome NUM
activation I-outcome NOUN
was O VERB
24.7 O NUM
seconds O NOUN
(s) O PUNCT
(95% O PUNCT
CI O NOUN
[15.7-40.8]) O NOUN
for O ADP
SIM O NOUN
group O NOUN
and O CCONJ
79.5 O NUM
s O NOUN
(95% O PUNCT
CI O NOUN
[44.8-119.6]) O PUNCT
for O ADP
STD O NOUN
group, O NOUN
p=0.007. O NUM

Therefore, O NOUN
in O ADP
this O DET
setting, O ADV
ATLG O NOUN
plus O CCONJ
standard O ADJ
GVHD O NOUN
prophylaxis O NOUN
should O VERB
be O VERB
preferred O VERB
over O ADP
the O DET
standard O ADJ
GVHD O NOUN
prophylaxis O NOUN
alone. O NOUN

We O PRON
hypothesized O VERB
that O ADP
this O DET
high-fidelity O NOUN
cricothyroidotomy O NOUN
simulator O NOUN
results O NOUN
in O ADP
increased O VERB
proficiency B-outcome NOUN
for O ADP
needle O NOUN
cricothyroidotomy O NOUN
compared O VERB
with O ADP
conventional O ADJ
simulators. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

Omadacycline O NOUN
also O ADV
was O VERB
noninferior O ADJ
to O PART
linezolid O NOUN
with O ADP
respect O NOUN
to O PART
investigator-assessed O VERB
clinical B-outcome ADJ
response I-outcome NOUN
at O ADP
the O DET
post-treatment O NOUN
evaluation O NOUN
in O ADP
the O DET
modified O VERB
intention-to-treat O NOUN
population O NOUN
(rate O NOUN
of O ADP
response, O NOUN
86.1% O NUM
and O CCONJ
83.6%, O NUM
respectively; O NOUN
difference, O NOUN
2.5 O NUM
percentage O NOUN
points; O NOUN
95% O NOUN
CI, O NOUN
-3.2 O NUM
to O PART
8.2) O NUM
and O CCONJ
in O ADP
the O DET
clinical O ADJ
per-protocol O NOUN
population O NOUN
(96.3% O PUNCT
and O CCONJ
93.5%, O NOUN
respectively; O NOUN
difference, O NOUN
2.8 O NUM
percentage O NOUN
points; O NOUN
95% O NOUN
CI, O NOUN
-1.0 O PUNCT
to O PART
6.9). O ADP

The O DET
amount O NOUN
of O ADP
postoperative O ADJ
pain B-outcome NOUN
was O VERB
measured O VERB
on O ADP
the O DET
basis O NOUN
of O ADP
visual O ADJ
analog O NOUN
scale, O NOUN
arterial B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
as O ADP
well O ADV
as O ADP
heart B-outcome NOUN
rate I-outcome NOUN
at O ADP
recovery O NOUN
and O CCONJ
4, O NOUN
12, O NUM
and O CCONJ
24 O NUM
hours O NOUN
after O ADP
surgery. O VERB

Journal-Name:Pediatric O ADJ
physical O ADJ
therapy O NOUN
: O PUNCT
the O DET
official O ADJ
publication O NOUN
of O ADP
the O DET
Section O NOUN
on O ADP
Pediatrics O NOUN
of O ADP
the O DET
American O ADJ
Physical O ADJ
Therapy O NOUN
Association O NOUN

Publication O NOUN
date: O NOUN
2018/09/21 O NOUN
00:00 O NOUN
[accepted] O ADV

Secondary O ADJ
endpoints O NOUN
include O VERB
post-intervention O NOUN
complications B-outcome NOUN
, O PUNCT
late O ADJ
recurrence B-outcome NOUN
of O ADP
acute O ADJ
appendicitis O NOUN
after O ADP
one O NUM
year, O ADV
duration B-outcome NOUN
of I-outcome ADP
hospital I-outcome NOUN
stay I-outcome NOUN
, O PUNCT
pain B-outcome NOUN
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
sick B-outcome NOUN
leave I-outcome NOUN
and O CCONJ
treatment B-outcome NOUN
costs I-outcome NOUN
. O PUNCT
Primary O ADJ
endpoint O NOUN
will O VERB
be O VERB
evaluated O VERB
in O ADP
two O NUM
stages: O NOUN
point O NOUN
estimates O NOUN
with O ADP
95% O NOUN
confidence O NOUN
interval O NOUN
(CI) O NOUN
will O VERB
be O VERB
calculated O VERB
for O ADP
both O CCONJ
groups O NOUN
and O CCONJ
proportion O NOUN
difference O NOUN
between O ADP
groups O NOUN
with O ADP
95% O NOUN
CI O NOUN
will O VERB
be O VERB
calculated O VERB
and O CCONJ
evaluated O VERB
based O VERB
on O ADP
6 O NUM
percentage O NOUN
point O NOUN
non-inferiority O NOUN
margin. O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

The O DET
use O NOUN
of O ADP
cadaver O ADV
allograft O NOUN
spares O NOUN
the O DET
hamstring B-outcome VERB
muscles I-outcome NOUN
and O CCONJ
reduces O NOUN
the O DET
time B-outcome NOUN
of I-outcome ADP
surgery I-outcome NOUN
. O PUNCT
Therefore, O NOUN
such O ADJ
study O NOUN
appears O NOUN
to O PART
be O VERB
useful O ADJ
because O ADP
it O PRON
provides O NOUN
valuable O ADJ
information O NOUN
that O ADP
would O VERB
help O VERB
to O PART
guide O NOUN
treatment O NOUN
of O ADP
this O DET
condition O NOUN
in O ADP
children. O NOUN

In O ADP
part O NOUN
C, O NOUN
all O DET
6 O NUM
patients O NOUN
who O ADP
were O VERB
assigned O VERB
to O PART
receive O VERB
once-monthly O ADV
injections O NOUN
of O ADP
givosiran O NOUN
had O VERB
sustained O VERB
reductions O NOUN
in O ADP
ALAS1 B-outcome NOUN
messenger I-outcome NOUN
RNA I-outcome NOUN
(mRNA) I-outcome ADV
, O PUNCT
delta B-outcome NOUN
aminolevulinic I-outcome ADJ
acid I-outcome NOUN
, O PUNCT
and O CCONJ
porphobilinogen B-outcome NOUN
levels O NOUN
to O PART
near O ADV
normal. O NOUN

The O DET
hazard O NOUN
ratio O NOUN
for O ADP
the O DET
risk O NOUN
of O ADP
recurrence B-outcome NOUN
was O VERB
0.30 O NUM
(95% O PUNCT
CI, O NOUN
0.22 O NUM
to O PART
0.40) O NUM
with O ADP
tafenoquine O NOUN
as O ADP
compared O VERB
with O ADP
placebo O NOUN
(P<0.001) O PUNCT
and O CCONJ
0.26 O NUM
(95% O PUNCT
CI, O NOUN
0.18 O NUM
to O PART
0.39) O NOUN
with O ADP
primaquine O NOUN
as O ADP
compared O VERB
with O ADP
placebo O NOUN
(P<0.001). O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Results: O NOUN
During O ADP
the O DET
study O NOUN
period, O NOUN
133 O NUM
third-year O NOUN
medical O ADJ
students O NOUN
responded O VERB
to O PART
the O DET
survey. O NOUN

Title: O NOUN
Resin O NOUN
infiltration O NOUN
technique O NOUN
and O CCONJ
fluoride O NOUN
varnish O NOUN
on O ADP
white O ADP
spot O NOUN
lesions O NOUN
in O ADP
children: O NOUN
Preliminary O ADJ
findings O NOUN
of O ADP
a O DET
randomized O VERB
clinical O ADJ
trial. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
time B-outcome NOUN
to I-outcome PART
normalization I-outcome NOUN
of I-outcome ADP
the Seperator DET
platelet I-outcome NOUN
count I-outcome NOUN
, O PUNCT
with O ADP
discontinuation O NOUN
of O ADP
daily O ADJ
plasma O NOUN
exchange O NOUN
within O ADP
5 O NUM
days O NOUN
thereafter. O NOUN

However, O ADV
no O DET
condition O NOUN
x O SYM
time O NOUN
interactions O NOUN
were O VERB
observed. O NOUN

This O DET
study O NOUN
was O VERB
conducted O VERB
to O PART
compare O NOUN
the O DET
simultaneous O ADJ
vs O CCONJ
delayed O VERB
ventriculoperitoneal O ADJ
shunting O VERB
in O ADP
children O NOUN
undergoing O VERB
myelomeningocele O NOUN
in O ADP
terms O NOUN
of O ADP
infection B-outcome NOUN
. O PUNCT
METHODS: O NOUN
This O DET
Randomized O VERB
Control O NOUN
Trial O NOUN
was O VERB
conducted O VERB
at O ADP
department O NOUN
of O ADP
Neurosurgery, O NOUN
Ayub O ADP
Medical O ADJ
College, O PUNCT
Abbottabad O ADV
from O ADP
7th O NOUN
March O NOUN
to O PART
7th O NOUN
June O NOUN
2016. O NUM

All O DET
patients O NOUN
received O VERB
parenteral O ADJ
intramuscular O ADJ
therapy O NOUN
of O ADP
1 O NUM
ml O NOUN
Vitamin O NOUN
B12 O NOUN
weekly O ADV
for O ADP
a O DET
total O ADJ
of O ADP
4 O NUM
weeks. O NOUN

This O DET
study O NOUN
aimed O VERB
to O PART
investigate O NOUN
the O DET
effect O NOUN
of O ADP
relaxation O NOUN
techniques O NOUN
on O ADP
self-efficacy B-outcome NOUN
of O ADP
patients O NOUN
suffering O VERB
from O ADP
cancer. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Results: O NOUN
The O DET
hysteroscopic O ADJ
findings O NOUN
were O VERB
available O ADJ
for O ADP
20 O NUM
patients O NOUN
in O ADP
group O NOUN
1 O NUM
and O CCONJ
28 O NUM
patients O NOUN
in O ADP
group O NOUN
2. O NUM

Both O CCONJ
groups O NOUN
during O ADP
the O DET
hospital O NOUN
stay O NOUN
received O VERB
the O DET
usual O ADJ
diabetes O NOUN
education. O NOUN

Approval O ADJ
from O ADP
ethical O ADJ
committee O NOUN
was O VERB
obtained. O NOUN

METHODS: O NOUN
Ninety-six O NUM
parents O NOUN
in O ADP
the O DET
NICU O NOUN
received O VERB
instruction. O NOUN

Assessment O NOUN
of O ADP
plaque B-outcome NOUN
index O NOUN
(PI)], O NOUN
gingival B-outcome ADJ
index O NOUN
(GI)], O NUM
probing B-outcome VERB
pocket I-outcome NOUN
depth I-outcome NOUN
, O PUNCT
and O CCONJ
clinical B-outcome ADJ
attachment I-outcome NOUN
levels I-outcome NOUN
(CAL) I-outcome NOUN
were O VERB
done O NOUN
at O ADP
the O DET
baseline O NOUN
and O CCONJ
at O ADP
the O DET
4th O ADP
week. O NOUN

RESULTS: O NOUN
The O DET
FOLFIRI/erlotinib O NOUN
arm O NOUN
met O VERB
the O DET
pre-specified O VERB
response B-outcome NOUN
rate O NOUN
criteria O NOUN
of O ADP
at O ADP
least O ADV
10% O ADP
to O PART
expand O NOUN
accrual O ADJ
to O PART
the O DET
intended O VERB
sample O NOUN
size. O NOUN

Two O NUM
patients O NOUN
presented O VERB
a O DET
serious B-outcome ADJ
adverse I-outcome ADJ
event I-outcome NOUN
during O ADP
the O DET
study O NOUN
(one O NOUN
in O ADP
each O DET
group) O ADJ
but O CCONJ
non-attributable O ADJ
to O PART
the O DET
treatment O NOUN
studied. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
IBU-alone O NOUN
group O NOUN
vs O CCONJ
HS-PCM O NOUN
+ O SYM
IBU O NOUN
(2 O PUNCT
mg O NOUN
[99.6% O NOUN
CI, O NOUN
-10 O NUM
to O PART
7]; O NUM
P O NOUN
= O SYM
.81). O PUNCT

BTX-A O NOUN
is O VERB
thus O ADV
a O DET
potential O ADJ
treatment O NOUN
option O NOUN
for O ADP
patients O NOUN
with O ADP
intractable O ADJ
DED. O NOUN

Journal-Name:Indian O NOUN
heart O NOUN
journal O ADJ

Efficacy O NOUN
of O ADP
school-based O VERB
surveillance O NOUN
was O VERB
evaluated O VERB
for O ADP
detection O NOUN
of O ADP
acute B-outcome ADJ
pharyngitis I-outcome NOUN
and O CCONJ
rheumatic B-outcome ADJ
fever/rheumatic I-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
(RF/RHD) I-outcome NOUN
in O ADP
Shimla O NOUN
district, O NOUN
HP. O NOUN

The O DET
incidence O NOUN
of O ADP
postoperative B-outcome ADJ
sore I-outcome ADV
throat I-outcome NOUN
was O VERB
monitored O VERB
at O ADP
0, O NUM
2, O NOUN
4, O NOUN
and O CCONJ
24 O NUM
hours O NOUN
postoperatively. O NOUN

Compliance B-outcome NOUN
rates O NOUN
varied O VERB
between O ADP
intervention-arms. O NOUN

Decreases O NOUN
in O ADP
savory B-outcome ADJ
and Seperator CCONJ
sweet I-outcome ADJ
snack I-outcome NOUN
intake I-outcome NOUN
were O VERB
associated O VERB
with O ADP
lower O ADJ
HOMA-IR B-outcome ADV
3(-)8 O ADJ
years O NOUN
later, O ADV
but O CCONJ
these O DET
associations O NOUN
disappeared O VERB
after O ADP
adjustment O NOUN
for O ADP
current O ADJ
lifestyle. O NOUN

Publication O NOUN
date: O NOUN
2019/02/15 O NOUN
06:00 O ADP
[medline] O NOUN

Title: O NOUN
Using O VERB
misoprostol O NOUN
to O PART
treat O NOUN
postpartum O NOUN
hemorrhage O NOUN
in O ADP
home O NOUN
deliveries O NOUN
attended O VERB
by O ADP
traditional O ADJ
birth O NOUN
attendants. O NOUN

No O DET
patients O NOUN
reported O VERB
intraoperative B-outcome ADJ
awareness I-outcome ADV
. O PUNCT
Postoperative O ADJ
nausea B-outcome NOUN
and Seperator CCONJ
vomiting I-outcome VERB
was O VERB
reported O VERB
in O ADP
48 O NUM
patients O NOUN
(7.8%) O PUNCT
in O ADP
the O DET
guided O VERB
and O CCONJ
55 O NUM
patients O NOUN
(8.9%) O NUM
in O ADP
the O DET
usual O ADJ
care O NOUN
group. O VERB

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

After O ADP
surgery, O NOUN
the O DET
intraocular B-outcome ADJ
pressure I-outcome NOUN
was O VERB
reduced O VERB
significantly O ADV
in O ADP
both O CCONJ
groups O NOUN
(P O NUM
< O SYM
.05). O NUM

Biochemical O ADJ
parameters O NOUN
including O VERB
fasting B-outcome VERB
plasma I-outcome NOUN
glucose I-outcome NOUN
(FPG) I-outcome NOUN
, O PUNCT
2-hour B-outcome NOUN
plasma I-outcome NOUN
glucose I-outcome NOUN
(2hPG) I-outcome PUNCT
, O PUNCT
glycosylated B-outcome VERB
hemoglobin I-outcome NOUN
A1c I-outcome ADV
(HbA1c) I-outcome NOUN
were O VERB
measured O VERB
among O ADP
the O DET
2 O NUM
groups O NOUN
at O ADP
baseline O NOUN
6-month O NOUN
and O CCONJ
12-month. O NUM
[ O PUNCT

Publication O NOUN
date: O NOUN
['2019/10/18 O NOUN
06:00' O NUM

Publication O NOUN
date: O NOUN
2019/03/09 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:Toxicon O NOUN
: O PUNCT
official O ADJ
journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
on O ADP
Toxinology O NOUN

Journal-Name:Nutrients O NOUN

While O ADP
Atorvastatin O ADP
80mg O NOUN
results O NOUN
in O ADP
LDL B-outcome NOUN
reduction O NOUN
as O ADP
50.11+/-15.85 O NUM
& O CCONJ
52.30+/-13.72. O NOUN

All O DET
together O ADV
219 O NUM
women O NOUN
were O VERB
randomized O VERB
within O ADP
each O DET
sub-study, O NOUN
of O ADP
whom O ADP
74 O NUM
and O CCONJ
68% O NUM
had O VERB
adequate O ADJ
questionnaire O NOUN
data O NOUN
at O ADP
6 O NUM
and O CCONJ
12 O NUM
months, O NOUN
respectively. O NOUN

AmBisome O NOUN
monotherapy O NOUN
at O ADP
40 O NUM
mg/kg O NOUN
is O VERB
recommended O VERB
by O ADP
the O DET
World O NOUN
Health O NOUN
Organization. O NOUN

The O DET
endpoints O NOUN
were O VERB
radiation-induced O VERB
esophagitis B-outcome NOUN
, O PUNCT
mucositis B-outcome NOUN
, O PUNCT
body B-outcome NOUN
weight I-outcome NOUN
loss, O NOUN
overall B-outcome ADJ
survival I-outcome NOUN
and O CCONJ
progression-free B-outcome ADJ
survival I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
The O DET
60 O NUM
patients O NOUN
with O ADP
NSCLC O NOUN
included O VERB
42 O NUM
men O NOUN
and O CCONJ
18 O NUM
women O NOUN
with O ADP
a O DET
mean O NOUN
age O NOUN
+/- O SYM
standard O ADJ
deviation O NOUN
of O ADP
60.3 O NUM
years O NOUN
+/- O SYM
18.2 O NUM
(range, O NOUN
44-78 O NUM
years).At O NOUN
a O DET
median O ADJ
follow-up O NOUN
of O ADP
26.4 O NUM
months O NOUN
(range O PUNCT
10.4-32.2), O NOUN
all O DET
patients O NOUN
tolerated B-outcome VERB
GLN O NOUN
well. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
24th O ADJ
hour O NOUN
tramadol B-outcome NOUN
consumption. O NOUN

as O ADP
found O VERB
in O ADP
the O DET
fresh O ADJ
wild O ADJ
amla O NOUN
fruit) O NOUN
in O ADP
patients O NOUN
with O ADP
dyslipidemia. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

We O PRON
aimed O VERB
to O PART
study O NOUN
whether O ADP
oxycodone O NOUN
can O VERB
be O VERB
an O DET
effective O ADJ
alternative O ADJ
for O ADP
fentanyl O NOUN
in O ADP
the O DET
management O NOUN
of O ADP
early O ADJ
postoperative O ADJ
pain B-outcome NOUN
after O ADP
total O ADJ
hip O NOUN
replacement. O NOUN

RESULTS: O NOUN
The O DET
intention-to-treat O NOUN
population O NOUN
included O VERB
386 O NUM
patients O NOUN
in O ADP
the O DET
omadacycline O NOUN
group O NOUN
and O CCONJ
388 O NUM
patients O NOUN
in O ADP
the O DET
moxifloxacin O NOUN
group. O VERB

METHODS: O NOUN
Sixty-nine O NUM
patients O NOUN
receiving O VERB
VATS O NOUN
lobectomy O NOUN
in O ADP
Department O NOUN
of O ADP
Thoracic O ADJ
Surgery, O NOUN
West O ADP
China O NOUN
Hospital, O ADJ
Sichuan O NOUN
University O NOUN
from O ADP
September O NOUN
15, O NUM
2017 O NUM
to O PART
January O NOUN
15, O NUM
2018 O NUM
were O VERB
randomly O ADV
divided O VERB
into O ADP
the O DET
acapella O ADP
group O NOUN
(AG) O NOUN
or O CCONJ
the O DET
control O NOUN
group O NOUN
(CG). O NUM

Title: O NOUN
Body O NOUN
posture O ADJ
and O CCONJ
physical O ADJ
activity O NOUN
in O ADP
children O NOUN
diagnosed O VERB
with O ADP
asthma O NOUN
and O CCONJ
allergies O NOUN
symptoms: O NOUN
A O DET
report O NOUN
from O ADP
randomized O VERB
observational O ADJ
studies. O NOUN

Publication O NOUN
date: O NOUN
2019/01/23 O NOUN
06:00 O ADP
[medline] O NOUN

After O ADP
adjustment O NOUN
for O ADP
confounders, O NOUN
the O DET
difference O NOUN
between O ADP
the O DET
groups O NOUN
was O VERB
not O ADV
significant O ADJ
(odds O NOUN
ratio O NOUN
0.88, O NUM
95% O NOUN
confidence O NOUN
interval O NOUN
0.70 O NUM
to O PART
1.20). O NOUN

However, O ADV
knowledge O NOUN
about O ADV
their O ADJ
effects O NOUN
on O ADP
hemodynamics O NOUN
and O CCONJ
cardiac O ADJ
efficiency O NOUN
remains O NOUN
limited O VERB
due O ADJ
largely O ADV
to O PART
the O DET
lack O NOUN
of O ADP
direct O ADJ
monitoring O VERB
method. O NOUN

Results: O NOUN
HP/TAZ O NOUN
lotion O NOUN
demonstrated O VERB
statistically O ADV
significant O ADJ
superiority O NOUN
at O ADP
week O NOUN
8 O NUM
(versus O NOUN
TAZ O NOUN
and O CCONJ
vehicle) O NOUN
and O CCONJ
week O NOUN
12 O NUM
(versus O NOUN
HP, O NOUN
TAZ, O NOUN
and O CCONJ
vehicle). O NOUN

Journal-Name:The O ADJ
Lancet. O NOUN

Various O ADJ
pharmacological O ADJ
agents, O NOUN
with O ADP
the O DET
exception O NOUN
of O ADP
calcium O NOUN
channel O NOUN
blockers, O NOUN
have O VERB
been O VERB
investigated O VERB
to O PART
improve O VERB
ET O NOUN
outcomes O NOUN
by O ADP
reducing O VERB
UC. O ADJ

Title: O NOUN
Spirometric B-outcome ADJ
changes O NOUN
during O ADP
exacerbations O NOUN
of O ADP
COPD: O NOUN
a O DET
post O ADV
hoc O NOUN
analysis O NOUN
of O ADP
the O DET
WISDOM O NOUN
trial. O NOUN

The O DET
current O ADJ
study O NOUN
combined O VERB
hedonic O ADJ
liking O VERB
with O ADP
non-hypothetical O ADJ
experimental O ADJ
auctions O NOUN
to O PART
measure O NOUN
consumer O NOUN
preferences B-outcome NOUN
for O ADP
bitter O NOUN
tasting O VERB
food O NOUN
and O CCONJ
identify O NOUN
individual O ADJ
socio-demographic O ADJ
and O CCONJ
psychographic O ADJ
characteristics O NOUN
that O ADP
influence O NOUN
bitter B-outcome NOUN
aversion I-outcome NOUN
. O PUNCT
Furthermore, O NOUN
the O DET
research O NOUN
analyzed O VERB
whether O ADP
consumer O NOUN
preferences B-outcome NOUN
for O ADP
bitter O NOUN
food O NOUN
were O VERB
influenced O VERB
by O ADP
sensory O ADJ
and O CCONJ
health-related O VERB
information. O NOUN

Journal-Name:Medicine O NOUN

Journal O ADJ
ID: O NOUN
100968551 O NUM

Furthermore, O NOUN
there O PRON
were O VERB
no O DET
statistically O ADV
significant O ADJ
differences O NOUN
between O ADP
all O DET
measured O VERB
variables O NOUN
for O ADP
the O DET
EG O NOUN
and O CCONJ
the O DET
CG O NOUN
at O ADP
the O DET
final O ADJ
assessment. O NOUN

There O PRON
were O VERB
173 O NUM
with O ADP
complete O ADJ
before-and O CCONJ
after-digital O ADJ
images O NOUN
of O ADP
the O DET
teeth. O NOUN

In O ADP
23 O NUM
research O NOUN
centers O NOUN
in O ADP
Spain, O ADV
6874 O NUM
men O NOUN
and O CCONJ
women O NOUN
aged O VERB
55 O NUM
to O PART
75 O NUM
years O NOUN
with O ADP
metabolic O ADJ
syndrome O NOUN
and O CCONJ
no O DET
cardiovascular O ADJ
disease O NOUN
were O VERB
enrolled O VERB
in O ADP
the O DET
trial O NOUN
between O ADP
September O NOUN
2013 O NUM
and O CCONJ
December O NOUN
2016, O NUM
with O ADP
final O ADJ
data O NOUN
collection O NOUN
in O ADP
March O NOUN
2019. O NUM

Patients O NOUN
in O ADP
group O NOUN
A O DET
were O VERB
treated O VERB
with O ADP
dimethyldiguanide O NOUN
combined O VERB
with O ADP
clomifene O NOUN
citrate, O NOUN
while O ADP
patients O NOUN
in O ADP
group O NOUN
B O NOUN
were O VERB
treated O VERB
with O ADP
clomifene O NOUN
citrate O NOUN
alone. O NOUN

This O DET
8-week O NOUN
trial O NOUN
includes O NOUN
four O NUM
two-weekly O NOUN
standard O ADJ
doses O NOUN
of O ADP
PZQ O NOUN
in O ADP
the O DET
"intense O PUNCT
treatment" O NOUN
intervention O NOUN
group O NOUN
and O CCONJ
one O NUM
standard O ADJ
dose O NOUN
of O ADP
PZQ O NOUN
in O ADP
the O DET
"standard O VERB
treatment" O NOUN
control O NOUN
group. O VERB

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Publication O NOUN
date: O NOUN
2018/12/15 O NOUN
06:00 O ADP
[entrez] O ADP

AIMS: O VERB
The O DET
aims O NOUN
of O ADP
this O DET
study O NOUN
were O VERB
to O PART
compare O NOUN
the O DET
use B-outcome NOUN
of I-outcome ADP
resources I-outcome NOUN
, O PUNCT
costs B-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
outcomes O NOUN
associated O VERB
with O ADP
subacromial O ADJ
decompression, O NOUN
arthroscopy O NOUN
only O ADV
(placebo O PUNCT
surgery), O NOUN
and O CCONJ
no O DET
treatment O NOUN
for O ADP
subacromial O ADJ
pain O NOUN
in O ADP
the O DET
United O VERB
Kingdom O NOUN
National O ADJ
Health O NOUN
Service O NOUN
(NHS), O NUM
and O CCONJ
to O PART
estimate O ADP
their O ADJ
cost-effectiveness. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
ISRCTN O NOUN
99322160 O NUM
, O PUNCT
01/10/2018. O NUM

Background: O NOUN
A O DET
unique O ADJ
fixed O VERB
combination O NOUN
halobetasol O NOUN
propionate O NOUN
0.01% O NOUN
and O CCONJ
tazarotene O NOUN
0.045% O NUM
(HP/TAZ) O PUNCT
lotion O NOUN
has O VERB
been O VERB
shown O VERB
to O PART
be O VERB
effective O ADJ
in O ADP
psoriasis O NOUN
using O VERB
Investigator O NOUN
Global O NOUN
Assessment O NOUN
(IGA) O NOUN
tools O NOUN
to O PART
assess O NOUN
erythema, O ADJ
plaque O NOUN
elevation, O NOUN
and O CCONJ
scaling. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

As O ADP
compared O VERB
to O PART
inhalational O ADJ
sevoflurane, O ADJ
intravenous O ADJ
sufentanil-midazolam O NOUN
exerts O NOUN
more O ADV
favorable O ADJ
effects O NOUN
on O ADP
systemic B-outcome ADJ
hemodynamics I-outcome NOUN
and O CCONJ
cardiac B-outcome ADJ
efficiency O NOUN
during O ADP
anesthetic O ADJ
induction O NOUN
in O ADP
this O DET
group O NOUN
of O ADP
patients. O NOUN

The O DET
primary O ADJ
outcome, O ADJ
hemoglobin B-outcome NOUN
decrease O NOUN
of O ADP
20 O NUM
g/L O NOUN
or O CCONJ
greater O ADJ
from O ADP
pre- O ADJ
to O PART
post-delivery O NOUN
assessment, O NOUN
was O VERB
compared O VERB
on O ADP
a O DET
modified O VERB
intention-to-treat O NOUN
basis. O NUM

For O ADP
the O DET
project O NOUN
manager, O NOUN
achieving O VERB
good O ADJ
scientific O ADJ
results O NOUN
was O VERB
highlighted O VERB
as O ADP
well. O NOUN

RESULTS: O NOUN
Of O ADP
the O DET
1218 O NUM
open O ADJ
fracture O NOUN
patients O NOUN
with O ADP
complete O ADJ
data O NOUN
available O ADJ
for O ADP
analysis, O NOUN
813 O NUM
(66.7%) O NUM
reported O VERB
moderate O ADJ
to O PART
extreme O NOUN
pain B-outcome NOUN
at O ADP
1 O NUM
yr. O PUNCT

There O PRON
is O VERB
no O DET
standard O ADJ
of O ADP
care. O NOUN

Title: O NOUN
Observation O NOUN
of O ADP
the O DET
curative O ADJ
effect O NOUN
of O ADP
device-guided O VERB
rehabilitation O NOUN
on O ADP
respiratory B-outcome ADJ
function I-outcome NOUN
in O ADP
stable O ADJ
patients O NOUN
with O ADP
chronic O ADJ
obstructive O ADJ
pulmonary O ADJ
disease. O NOUN

AIM O NOUN
OF O ADP
THE O DET
STUDY: O NOUN
To O PART
evaluate O VERB
the O DET
safety O NOUN
of O ADP
BT-11 O NOUN
in O ADP
human O NOUN
aged O VERB
from O ADP
9 O NUM
to O PART
19 O NUM
years O NOUN
old. O NUM

RESULTS: O NOUN
The O DET
volunteers O NOUN
had O VERB
a O DET
level O NOUN
of O ADP
education O NOUN
from O ADP
incomplete O ADJ
junior O NOUN
school O NOUN
to O PART
complete O ADJ
graduate O NOUN
course, O NOUN
with O ADP
16 O NUM
males O NOUN
(48%) O NOUN
and O CCONJ
18 O NUM
females O NOUN
(52%), O PUNCT
age O NOUN
range O NOUN
of O ADP
21 O NUM
to O PART
87 O NUM
years. O NOUN

Objective: O NOUN
The O DET
aim O ADP
of O ADP
the O DET
study O NOUN
was O VERB
to O PART
assess O NOUN
the O DET
effectiveness O NOUN
of O ADP
ExMI O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
stress O NOUN
UI O NOUN
in O ADP
women. O NOUN

Among O ADP
healthy O ADJ
children, O NOUN
percentages O NOUN
of O ADP
the O DET
participants O NOUN
were O VERB
higher O ADJ
in O ADP
active O ADJ
children O NOUN
than O ADP
in O ADP
inactive O ADJ
children. O NOUN

Journal O ADJ
ID: O NOUN
0255562 O NUM

Anti-CT694 B-outcome NOUN
responses I-outcome NOUN
increased O VERB
in O ADP
both O CCONJ
study O NOUN
arms O NOUN
(p O PUNCT
= O SYM
0.009 O NUM
for O ADP
control O NOUN
arm O NOUN
and O CCONJ
p O NOUN
= O SYM
0.04 O NUM
for O ADP
treatment O NOUN
arm). O ADP

The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
determine O NOUN
the O DET
effect O NOUN
of O ADP
pilates O NOUN
exercises O NOUN
on O ADP
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
of O ADP
CKD O NOUN
patients. O NOUN

RESULTS: O NOUN
A O DET
total O ADJ
of O ADP
23 O NUM
patients O NOUN
in O ADP
parts O NOUN
A O DET
and O CCONJ
B O NOUN
and O CCONJ
17 O NUM
patients O NOUN
in O ADP
part O NOUN
C O NOUN
underwent O VERB
randomization. O NOUN

Maintaining O VERB
vaccine O NOUN
coverage O NOUN
is O VERB
key O ADJ
to O PART
avoid O NOUN
the O DET
devastating O VERB
consequences O NOUN
of O ADP
resurgence. O NOUN

Scapular B-outcome ADJ
upward I-outcome ADJ
rotation I-outcome NOUN
did O VERB
not O ADV
change O NOUN
after O ADP
taping O VERB
in O ADP
any O DET
group O NOUN
(P O NUM
> O SYM
.05). O NUM

Journal O ADJ
ID: O NOUN
0135043 O NUM

Regression O NOUN
models O NOUN
that O ADP
show O VERB
the O DET
collaborative O ADJ
relationship O NOUN
between O ADP
mother O NOUN
and O CCONJ
child, O NOUN
and O CCONJ
their O ADJ
reciprocity O NOUN
in O ADP
the O DET
process O NOUN
of O ADP
adaptation O NOUN
were O VERB
proposed. O NOUN

Title: O NOUN
High-intensity O NOUN
interval O NOUN
training O VERB
and O CCONJ
moderate-intensity O NOUN
continuous O ADJ
training O VERB
in O ADP
adults O NOUN
with O ADP
Crohn's O NOUN
disease: O NOUN
a O DET
pilot O NOUN
randomised O VERB
controlled O VERB
trial. O NOUN


It O PRON
has O VERB
proven O VERB
properties O NOUN
like O ADP
anti-inflammatory, O NOUN
antioxidant, O NOUN
antimicrobial, O ADJ
hepatoprotective, O NOUN
immunostimulant, O NOUN
antiseptic, O NOUN
antimutagenic, O VERB
and O CCONJ
it O PRON
also O ADV
accelerates O NOUN
wound O NOUN
healing. O NOUN

Self-reported O VERB
pain B-outcome NOUN
measures, O NOUN
observed O VERB
pain B-outcome NOUN
measures, O NOUN
and O CCONJ
observed O VERB
measures O NOUN
of O ADP
pedaling O VERB
adherence B-outcome NOUN
were O VERB
collected O VERB
for O ADP
each O DET
participant. O NOUN

The O DET
current O ADJ
randomized, O NOUN
cross-over O NOUN
behavioral O ADJ
trial O NOUN
tried O VERB
to O PART
bridge O NOUN
the O DET
latter O NOUN
gaps. O NOUN

Objective: O NOUN
To O PART
determine O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
tretinoin O NOUN
0.05% O NUM
lotion O NOUN
in O ADP
treating O VERB
moderate-to-severe O ADV
acne O NOUN
in O ADP
a O DET
Hispanic O ADJ
population. O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Consumption O NOUN
of O ADP
WPI O NOUN
significantly O ADV
improved O VERB
active B-outcome ADJ
B12 I-outcome NOUN
and O CCONJ
folate B-outcome NOUN
status O NOUN
but O CCONJ
did O VERB
not O ADV
result O VERB
in O ADP
direct O ADJ
improvements O NOUN
in O ADP
cognitive B-outcome ADJ
function I-outcome NOUN
. O PUNCT
However, O ADV
there O PRON
was O VERB
evidence O NOUN
of O ADP
improvement O NOUN
in O ADP
reaction B-outcome NOUN
time I-outcome NOUN
(p O PUNCT
= O SYM
0.02) O NUM
and O CCONJ
reasoning B-outcome VERB
speed I-outcome NOUN
(p O PUNCT
= O SYM
0.04) O NUM
in O ADP
the O DET
SPI O NOUN
condition O NOUN
for O ADP
females. O ADP

The O DET
overall B-outcome ADJ
survival I-outcome NOUN
rates O NOUN
at O ADP
1, O NOUN
5, O ADJ
and O CCONJ
10 O NUM
years O NOUN
were O VERB
96.7%, O NOUN
53.3%, O NUM
and O CCONJ
43.3%, O NUM
respectively, O NOUN
in O ADP
the O DET
CC O NOUN
group, O NOUN
and O CCONJ
96.7%, O NOUN
43.3%, O NUM
and O CCONJ
33.3%, O NUM
respectively, O NOUN
in O ADP
the O DET
RC O NOUN
group O NOUN
(P O NUM
= O SYM
0.346). O NOUN

Osmotic-release O NOUN
oral O ADJ
system O NOUN
methylphenidate O NOUN
was O VERB
dose O NOUN
optimized O VERB
over O ADP
the O DET
first O ADV
6 O NUM
weeks. O NOUN

Publication O NOUN
date: O NOUN
2019/03/12 O NOUN
06:00 O ADP
[medline] O NOUN

Results: O NOUN
The O DET
improvement O NOUN
in O ADP
the O DET
Yale-Brown O NOUN
Obsessive B-outcome ADJ
Compulsive I-outcome ADJ
Scale O NOUN
(Y-BOCS) O NUM
total O ADJ
score, O NOUN
Yale-Brown O NOUN
Obsessive B-outcome ADJ
Compulsive I-outcome ADJ
Scale O NOUN
(Y-BOCS) O NUM
obsession B-outcome NOUN
subscale O NOUN
score O NOUN
and O CCONJ
Hamilton O ADV
Anxiety B-outcome NOUN
Scale O NOUN
(HAMA) O PUNCT
score O NOUN
were O VERB
more O ADV
prominent O ADJ
in O ADP
the O DET
study O NOUN
group O NOUN
than O ADP
those O DET
in O ADP
the O DET
control O NOUN
group O NOUN
(P<0.001). O NOUN

Publication O NOUN
date: O NOUN
2018/11/08 O ADP
00:00 O NOUN
[accepted] O ADV

CONCLUSION: O NOUN
PRP O NOUN
may O VERB
be O VERB
effective O ADJ
in O ADP
improving O VERB
the O DET
endometrial B-outcome ADJ
growth I-outcome NOUN
, O PUNCT
and O CCONJ
possibly O ADV
pregnancy B-outcome NOUN
outcomes I-outcome NOUN
in O ADP
women O NOUN
with O ADP
a O DET
thin O ADJ
endometrium. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

The O DET
pain B-outcome NOUN
scores O NOUN
of O ADP
both O CCONJ
groups O NOUN
were O VERB
significantly O ADV
reduced O VERB
after O ADP
treatment, O NOUN
and O CCONJ
the O DET
difference O NOUN
was O VERB
significant O ADJ
between O ADP
group O NOUN
A O DET
and O CCONJ
group O NOUN
B O NOUN
[(1.1+/-0.4) O NOUN
vs O CCONJ
(3.2+/- O PUNCT
0.6) O NUM
(P<0.05). O NOUN

CONCLUSIONS: O NOUN
These O DET
findings O NOUN
call O ADV
into O ADP
question O NOUN
the O DET
validity O NOUN
of O ADP
the O DET
self-affirmation O NOUN
manipulation, O NOUN
which O ADP
is O VERB
purported O VERB
to O PART
reduce O VERB
defensive B-outcome ADJ
reactions I-outcome NOUN
to O PART
threatening O VERB
warnings. O NOUN

The O DET
TBW O NOUN
group O NOUN
(n O NOUN
= O SYM
251) O NOUN
was O VERB
injected O VERB
with O ADP
600 O NUM
mg O NOUN
iodine/kg O DET
TBW. O NOUN

Functional B-outcome ADJ
outcomes O NOUN
were O VERB
not O ADV
associated O VERB
with O ADP
DHA O NOUN
status O NOUN
before O ADP
and O CCONJ
after O ADP
intervention O NOUN
and O CCONJ
remained O VERB
unchanged O VERB
by O ADP
supplementation. O NOUN

During O ADP
each O DET
session, O NOUN
participants O NOUN
used O VERB
one O NUM
of O ADP
three O NUM
products O NOUN
(cigarette, O PUNCT
e-cigarette, O PUNCT
or O CCONJ
IQOS(TM)) O NOUN
for O ADP
five O NUM
minutes. O ADJ

Eligible O ADJ
participants O NOUN
are O VERB
HIV-infected O VERB
pregnant O ADJ
women O NOUN
aged O VERB
15 O NUM
to O PART
49 O NUM
years O NOUN
and O CCONJ
have O VERB
a O DET
singleton O NOUN
gestation O NOUN
at O ADP
14 O NUM
to O PART
27 O NUM
weeks' O ADP
gestation. O NOUN

Objective: O NOUN
To O PART
determine O NOUN
whether O ADP
an O DET
MRI-guided O VERB
treat-to-target O NOUN
strategy O NOUN
vs O CCONJ
a O DET
conventional O ADJ
clinical O ADJ
treat-to-target O NOUN
strategy O NOUN
improves O NOUN
outcomes O NOUN
in O ADP
patients O NOUN
with O ADP
RA O NOUN
in O ADP
clinical O ADJ
remission. O ADV

There O PRON
was O VERB
a O DET
statistically O ADV
significant O ADJ
higher O ADJ
success B-outcome NOUN
rate O NOUN
regarding O VERB
complete O ADJ
success B-outcome NOUN
in O ADP
patients O NOUN
that O ADP
received O VERB
Ologen(R) O NOUN
implant O NOUN
(p O PUNCT
= O SYM
0.04). O NUM

No O DET
significant O ADJ
differences O NOUN
were O VERB
reported O VERB
between O ADP
dietary O ADJ
conditions O NOUN
for O ADP
plasma O NOUN
intestinal B-outcome ADJ
fatty I-outcome ADJ
acid I-outcome NOUN
binding I-outcome VERB
protein I-outcome NOUN
(I-FABP) I-outcome ADV
(P O NUM
> O SYM
0.05). O NOUN

Title: O NOUN
Optimising O VERB
the O DET
antibiotic O ADJ
treatment O NOUN
of O ADP
uncomplicated O VERB
acute O ADJ
appendicitis: O NOUN
a O DET
protocol O NOUN
for O ADP
a O DET
multicentre O NOUN
randomised O VERB
clinical O ADJ
trial O NOUN
(APPAC O PUNCT
II O NUM
trial). O NOUN

The O DET
secondary O ADJ
aim O ADP
was O VERB
to O PART
assess O NOUN
the O DET
non-inferiority O NOUN
of O ADP
the O DET
reduction O NOUN
of O ADP
blood B-outcome NOUN
loss I-outcome NOUN
of O ADP
the O DET
short O ADJ
protocol O NOUN
versus O CCONJ
the O DET
long O ADV
protocol. O NOUN

Title: O NOUN
Process O NOUN
evaluation O NOUN
of O ADP
a O DET
pilot O NOUN
multi-component O ADJ
physical O ADJ
activity O NOUN
intervention O NOUN
- O PUNCT
active O ADJ
schools: O NOUN
Skelmersdale. O NOUN

Journal-Name:Nutrients O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
study O NOUN
also O ADV
examines O NOUN
the O DET
cost O NOUN
effectiveness O NOUN
of O ADP
this O DET
therapy O NOUN
in O ADP
this O DET
setting O VERB
through O ADP
examination O NOUN
of O ADP
health O NOUN
care O NOUN
service O NOUN
utilisation O NOUN
across O ADP
groups O NOUN
during O ADP
the O DET
first O ADV
3 O NUM
months. O NOUN

Overall O ADV
incidence O NOUN
of O ADP
total O ADJ
side B-outcome NOUN
effects I-outcome NOUN
in O ADP
FZD O NOUN
and O CCONJ
CLA O NOUN
groups O NOUN
was O VERB
19.57% O NUM
and O CCONJ
13.98%, O NOUN
and O CCONJ
their O ADJ
severe B-outcome ADJ
side I-outcome NOUN
effects I-outcome NOUN
were O VERB
3.26% O NOUN
and O CCONJ
2.15%, O NUM
respectively O ADV
(P O NUM
> O SYM
.05). O NUM

The O DET
control O NOUN
group O NOUN
included O VERB
102 O NUM
healthy O ADJ
children O NOUN
at O ADP
the O DET
similar O ADJ
age O NOUN
(x O PUNCT
= O SYM
10.64 O NUM
+/- O SYM
1.1). O NOUN

Title: O NOUN
The O DET
Effects O NOUN
of O ADP
Adiponectin O NOUN
and O CCONJ
Adiponectin O NOUN
Receptor O NOUN
1 O NUM
Levels O NOUN
on O ADP
Macrovascular O ADJ
Complications O NOUN
Among O ADP
Patients O NOUN
with O ADP
Type O NOUN
2 O NUM
Diabetes O NOUN
Mellitus. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Adverse B-outcome ADJ
events I-outcome NOUN
of O ADP
grade O NOUN
3 O NUM
or O CCONJ
4 O NUM
occurred O VERB
in O ADP
75.9% O NUM
of O ADP
the O DET
patients O NOUN
in O ADP
the O DET
modified-FOLFIRINOX O NOUN
group O NOUN
and O CCONJ
in O ADP
52.9% O NUM
of O ADP
those O DET
in O ADP
the O DET
gemcitabine O NOUN
group. O VERB

The O DET
disease B-outcome NOUN
control I-outcome NOUN
rate O NOUN
of O ADP
the O DET
apatinib O ADP
group O NOUN
was O VERB
significantly O ADV
better O ADJ
than O ADP
that O ADP
of O ADP
the O DET
observation O NOUN
group O NOUN
(70.4% O NUM
vs O CCONJ
26.9%, O NUM
P O NOUN
= O SYM
.002). O PUNCT

Objective: O NOUN
To O PART
determine O NOUN
whether O ADP
a O DET
nurse-led O VERB
preventive, O ADJ
complex O NOUN
psychological O ADJ
intervention, O ADP
initiated O VERB
in O ADP
the O DET
ICU, O ADJ
reduces O NOUN
patient-reported O VERB
posttraumatic B-outcome ADJ
stress I-outcome NOUN
disorder I-outcome ADP
(PTSD) I-outcome ADV
symptom I-outcome NOUN
severity I-outcome NOUN
at O ADP
6 O NUM
months. O NOUN

Methods: O NOUN
From O ADP
March O NOUN
2017 O NUM
to O PART
June O NOUN
2018, O NUM
third-year O NOUN
medical O ADJ
students O NOUN
rotating O VERB
through O ADP
the O DET
mandatory, O NOUN
four-week O NOUN
emergency O NOUN
medicine O NOUN
(EM) O NOUN
clerkship O NOUN
at O ADP
a O DET
single O ADJ
medical O ADJ
school O NOUN
were O VERB
randomly O ADV
assigned O VERB
either O CCONJ
to O PART
a O DET
web-based O VERB
videoconference O NOUN
meeting O VERB
via O ADP
Google O NOUN
Hangouts, O NOUN
or O CCONJ
to O PART
a O DET
traditional O ADJ
in-person O NOUN
meeting O VERB
for O ADP
their O ADJ
MCF O NOUN
session. O NOUN

Depressive B-outcome ADJ
symptoms I-outcome NOUN
were O VERB
collected O VERB
by O ADP
the O DET
Beck O NOUN
Depression O NOUN
Inventory-II]. O ADP
Logistic O ADJ
regression O NOUN
models O NOUN
were O VERB
used O VERB
to O PART
estimate O ADP
the O DET
association O NOUN
between O ADP
seafood O NOUN
products O NOUN
and O CCONJ
omega-3 O NOUN
PUFA O NOUN
consumption O NOUN
and O CCONJ
depression B-outcome NOUN
. O PUNCT
Multiple O ADJ
linear O ADJ
regression O NOUN
models O NOUN
were O VERB
fitted O VERB
to O PART
assess O NOUN
the O DET
association O NOUN
between O ADP
fish O NOUN
and O CCONJ
long-chain O NOUN
(LC) O NOUN
omega-3 O NOUN
PUFA O NOUN
intake O NOUN
and O CCONJ
depressive B-outcome ADJ
symptoms I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
Out O ADP
of O ADP
6587 O NUM
participants, O NOUN
there O PRON
were O VERB
1367 O NUM
cases O NOUN
of O ADP
depression B-outcome NOUN
. O PUNCT
Total O ADJ
seafood O NOUN
consumption O NOUN
was O VERB
not O ADV
associated O VERB
with O ADP
depression B-outcome NOUN
. O PUNCT
The O DET
odds O NOUN
ratios O NOUN
(ORs) O NOUN
(95% O PUNCT
confidence O NOUN
intervals O NOUN
(CIs)) O NUM
for O ADP
the O DET
2nd, O NUM
3rd, O NUM
and O CCONJ
4th O ADP
quintiles O NOUN
of O ADP
consumption O NOUN
of O ADP
fatty O ADJ
fish O NOUN
were O VERB
0.77 O NUM
(0.63(-)0.94), O PUNCT
0.71 O NUM
(0.58(-)0.87), O PUNCT
and O CCONJ
0.78 O NUM
(0.64(-)0.96), O NUM
respectively, O NOUN
and O CCONJ
p O NOUN
for O ADP
trend O NOUN
= O SYM
0.759. O NUM

Interventions: O NOUN
Patients O NOUN
were O VERB
randomized O VERB
to O PART
1 O NUM
of O ADP
4 O NUM
groups O NOUN
receiving O VERB
postoperative O ADJ
analgesia O NOUN
with O ADP
IV O NUM
acetaminophen O ADV
or O CCONJ
placebo O NOUN
every O DET
6 O NUM
hours O NOUN
for O ADP
48 O NUM
hours O NOUN
and O CCONJ
postoperative O ADJ
sedation O NOUN
with O ADP
dexmedetomidine O NOUN
or O CCONJ
propofol O NOUN
starting O VERB
at O ADP
chest O NOUN
closure O NOUN
and O CCONJ
continued O NOUN
for O ADP
up O ADP
to O PART
6 O NUM
hours O NOUN
(acetaminophen O ADV
and O CCONJ
dexmedetomidine: O NOUN
n O NOUN
= O SYM
29; O NUM
placebo O NOUN
and O CCONJ
dexmedetomidine: O NOUN
n O NOUN
= O SYM
30; O NUM
acetaminophen O ADV
and O CCONJ
propofol: O NOUN
n O NOUN
= O SYM
31; O NOUN
placebo O NOUN
and O CCONJ
propofol: O NOUN
n O NOUN
= O SYM
30). O NOUN

The O DET
scores O NOUN
for O ADP
the O DET
HMCs O NOUN
improved O VERB
less O ADV
in O ADP
the O DET
intervention O NOUN
area O NOUN
than O ADP
in O ADP
the O DET
comparison O NOUN
area O NOUN
for O ADP
all O DET
six O NUM
components, O NOUN
but O CCONJ
none O NUM
of O ADP
these O DET
differences O NOUN
were O VERB
statistically O ADV
significant. O NOUN

Patients O NOUN
of O ADP
ldMDCT O NOUN
group O NOUN
with O ADP
large O ADJ
growth O NOUN
of O ADP
nasal O ADJ
polyps O NOUN
(P O NUM
= O SYM
.03, O PUNCT
q O NOUN
= O SYM
5.35) O NOUN
and O CCONJ
complete O ADJ
opacification O NOUN
of O ADP
sinuses O NOUN
(P O NUM
= O SYM
.03, O PUNCT
q O NOUN
= O SYM
7.94) O NUM
had O VERB
complications B-outcome NOUN
after O ADP
sinus O NOUN
surgeries. O NUM

Title: O NOUN
[Can O NOUN
Perioperative O ADJ
Oscillating O VERB
Positive O ADJ
Expiratory O ADJ
Pressure O NOUN
Practice O NOUN
Enhance O NOUN
Recovery B-outcome NOUN
in O ADP
Lung O NOUN
Cancer O NOUN
Patients O NOUN
Undergoing O VERB
Thorascopic O ADJ
Lobectomy? O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study O NOUN

Poor O ADJ
ovarian O ADJ
response O NOUN
was O VERB
defined O VERB
according O ADJ
to O PART
the O DET
Bologna O NOUN
criteria. O NOUN

Researchers O NOUN
were O VERB
masked O VERB
to O PART
allocation, O NOUN
but O CCONJ
participants O NOUN
were O VERB
not. O ADV

Interventions: O NOUN
Twenty O NUM
four O NUM
ICUs O NOUN
were O VERB
randomized O VERB
1:1 O ADJ
to O PART
the O DET
intervention O NOUN
or O CCONJ
control O NOUN
group. O VERB

Patients O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
the O DET
Surgiflo O NOUN
Haemostatic O ADJ
Matrix O NOUN
(SHM) O NOUN
group O NOUN
or O CCONJ
the O DET
AGS O NOUN
group O NOUN
(AGS) O NOUN
by O ADP
computer-generated O VERB
randomization O NOUN
codes. O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

There O PRON
is O VERB
a O DET
need O NOUN
of O ADP
future O NOUN
studies O NOUN
to O PART
demonstrate O VERB
the O DET
effectiveness O NOUN
of O ADP
the O DET
proposed O VERB
intervention O NOUN
in O ADP
endemic O ADJ
regions O NOUN
of O ADP
the O DET
state. O ADV

Journal O ADJ
ID: O NOUN
9420934 O NUM

There O PRON
are O VERB
no O DET
specific O ADJ
treatment O NOUN
drugs O NOUN
and O CCONJ
vaccine O NOUN
for O ADP
Hand O NOUN
Foot O NOUN
and O CCONJ
Mouth O NOUN
Disease O NOUN
(HFMD). O PUNCT

The O DET
median O ADJ
progression-free B-outcome ADJ
survival I-outcome NOUN
(PFS) I-outcome NOUN
was O VERB
significantly O ADV
longer O ADJ
for O ADP
apatinib O ADP
group O NOUN
than O ADP
for O ADP
observation O NOUN
group O NOUN
(2.0 O NOUN
vs. O CCONJ
1.1 O NUM
months; O NOUN
HR O NOUN
= O SYM
3.88; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
1.91-7.88; O NOUN
P O NOUN
< O SYM
.001). O PUNCT

This O DET
study O NOUN
aimed O VERB
to O PART
describe O NOUN
the O DET
playfulness B-outcome ADV
in O ADP
children O NOUN
with O ADP
HIV O NOUN
and O CCONJ
PHE O NOUN
on O ADP
HAART O NOUN
living O VERB
in O ADP
challenging O VERB
socioeconomic O ADJ
areas O NOUN
in O ADP
South O NOUN
Africa O PROPN
aged O VERB
6 O NUM
months O NOUN
to O PART
8 O NUM
years O NOUN
and O CCONJ
to O PART
evaluate O VERB
the O DET
feasibility B-outcome NOUN
and O CCONJ
preliminary O ADJ
effectiveness O NOUN
of O ADP
a O DET
play-informed, O NOUN
caregiver-implemented, O NOUN
home-based O VERB
intervention O NOUN
(PICIHBI) O NOUN
for O ADP
improving O VERB
play. O NOUN

Serum, O NOUN
peripheral O ADJ
blood O NOUN
mononuclear O ADJ
cells O NOUN
(PBMCs) O PUNCT
and O CCONJ
kidney O NOUN
biopsy O NOUN
specimens O NOUN
were O VERB
obtained O VERB
from O ADP
participants. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

This O DET
trial O NOUN
is O VERB
registered, O VERB
number O NOUN
ISRCTN99214271. O NOUN

Publication O NOUN
date: O NOUN
2019/01/23 O NOUN
06:00 O ADP
[entrez] O ADP

Parents, O NOUN
caregivers, O NOUN
and O CCONJ
outcome O NOUN
assessors O NOUN
were O VERB
unaware O VERB
of O ADP
group O NOUN
assignment. O NOUN

Outcomes O NOUN
were O VERB
measured O VERB
in O ADP
3 O NUM
randomized O VERB
conditions O NOUN
(no O PUNCT
brace, O NOUN
forearm O NOUN
band, O NOUN
or O CCONJ
elbow O NOUN
sleeve). O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
patients O NOUN
with O ADP
septic O ADJ
shock, O ADJ
a O DET
resuscitation O NOUN
strategy O NOUN
targeting O VERB
normalization O NOUN
of O ADP
capillary O NOUN
refill O NOUN
time, O NOUN
compared O VERB
with O ADP
a O DET
strategy O NOUN
targeting O VERB
serum O NOUN
lactate O VERB
levels, O NOUN
did O VERB
not O ADV
reduce O VERB
all-cause O NOUN
28-day O NOUN
mortality B-outcome NOUN
. O PUNCT
Trial O NOUN
Registration: O NOUN
ClinicalTrials.gov O NOUN
Identifier: O NOUN
NCT03078712. O NOUN

BACKGROUND: O NOUN
In O ADP
acquired O VERB
thrombotic O ADJ
thrombocytopenic O ADJ
purpura O NOUN
(TTP), O PUNCT
an O DET
immune-mediated O VERB
deficiency O NOUN
of O ADP
the O DET
von O ADP
Willebrand O NOUN
factor-cleaving O VERB
protease O NOUN
ADAMTS13 O NOUN
allows O NOUN
unrestrained O VERB
adhesion O NOUN
of O ADP
von O ADP
Willebrand O NOUN
factor O NOUN
multimers O NOUN
to O PART
platelets O NOUN
and O CCONJ
microthrombosis, O NOUN
which O ADP
result O VERB
in O ADP
thrombocytopenia, O NOUN
hemolytic O ADJ
anemia, O NOUN
and O CCONJ
tissue O NOUN
ischemia. O NOUN

The O DET
IG O NOUN
participants O NOUN
additionally O ADV
took O VERB
part O NOUN
in O ADP
a O DET
food O NOUN
workshop, O NOUN
five O NUM
walks O VERB
and O CCONJ
received O VERB
a O DET
smartphone O NOUN
application O NOUN
for O ADP
three O NUM
months. O NOUN

The O DET
eye-lens O NOUN
dosemeters O NOUN
were O VERB
placed O VERB
near O ADV
the O DET
eye O NOUN
closest O ADV
to O PART
the O DET
radiation O NOUN
source O NOUN
(Carinou, O NOUN
E., O NOUN
Ferrari, O NOUN
P., O NOUN
Bjelac, O NOUN
O. O ADV
C., O NOUN
Gingaume, O NOUN
M., O NOUN
Merce, O NOUN
M. O NOUN
S. O NOUN
and O CCONJ
O'Connor, O NOUN
U. O NOUN
Eye O NOUN
lens O NOUN
monitoring O VERB
for O ADP
interventional O ADJ
radiology O NOUN
personnel: O NOUN
dosemeters, O NOUN
calibration O NOUN
and O CCONJ
practical O ADJ
aspects O NOUN
of O ADP
H O NOUN
p O NOUN
(3) O PUNCT
monitoring. O NOUN

Title: O NOUN
Navy O ADJ
Beans O NOUN
Impact O NOUN
the O DET
Stool B-outcome NOUN
Metabolome I-outcome NOUN
and O CCONJ
Metabolic B-outcome ADJ
Pathways O NOUN
for O ADP
Colon O NOUN
Health O NOUN
in O ADP
Cancer O NOUN
Survivors. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Main O ADJ
outcome O NOUN
measures O NOUN
The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
feasibility B-outcome NOUN
and O CCONJ
acceptability B-outcome NOUN
of O ADP
rehabilitation O NOUN
sessions O NOUN
at O ADP
five O NUM
and O CCONJ
ten O NUM
days O NOUN
based O VERB
on O ADP
(i) O PUNCT
questionnaires O NOUN
completed O VERB
by O ADP
patient O NOUN
and O CCONJ
physiotherapist, O NOUN
(ii) O PUNCT
the O DET
number O NOUN
of O ADP
steps B-outcome NOUN
performed O VERB
during O ADP
sessions, O DET
(iii) O NUM
replacement B-outcome NOUN
of O ADP
a O DET
robotic O ADJ
session O NOUN
by O ADP
a O DET
conventional O ADJ
one. O PUNCT

The O DET
present O ADJ
study O NOUN
was O VERB
aimed O VERB
to O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
TEAS O NOUN
on O ADP
the O DET
effective O ADJ
concentration B-outcome NOUN
(EC50) O PUNCT
of O ADP
remifentanil O NOUN
suppressing O VERB
tracheal O ADJ
extubation O NOUN
response O NOUN
in O ADP
elderly O NOUN
patients. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
hand O NOUN
washing O VERB
and O CCONJ
personal O ADJ
hygiene O NOUN
on O ADP
hand B-outcome NOUN
food I-outcome NOUN
mouth I-outcome NOUN
disease I-outcome NOUN
: O PUNCT
A O DET
community O NOUN
intervention O NOUN
study. O NOUN

Journal-Name:Medicine O NOUN

METHODS: O NOUN
The O DET
trial O NOUN
will O VERB
adopt O NOUN
a O DET
waitlist-control O NOUN
design O NOUN
with O ADP
cluster-randomization O NOUN
by O ADP
school. O NOUN

DHA O NOUN
supplementation O NOUN
increased O VERB
plasma O NOUN
glycerophospholipid B-outcome ADP
DHA I-outcome NOUN
proportional O ADJ
to O PART
dose O NOUN
by O ADP
0.4% O NOUN
DHA O NOUN
per O ADP
1 O NUM
mg O NOUN
intake/kg O ADJ
bodyweight. O NOUN

Within O ADP
groups, O NOUN
there O PRON
were O VERB
also O ADV
significant O ADJ
differences O NOUN
at O ADP
different O ADJ
times O NOUN
(P O NUM
< O SYM
.05).The O NUM
rESWT O NOUN
combined O VERB
with O ADP
rehabilitation O NOUN
can O VERB
quickly O NOUN
and O CCONJ
effectively O ADV
relieve O NOUN
paralysis B-outcome NOUN
of O ADP
lower O ADJ
extremities, O NOUN
reduce O VERB
the O DET
tension B-outcome NOUN
of I-outcome ADP
hamstrings I-outcome NOUN
and Seperator CCONJ
calf I-outcome NOUN
muscles S2-outcome NOUN
, O PUNCT
relieve O NOUN
muscle B-outcome NOUN
spasm I-outcome NOUN
, O PUNCT
and O CCONJ
rapidly O ADV
improve O VERB
limb B-outcome NOUN
function I-outcome NOUN
in O ADP
children O NOUN
with O ADP
spastic O ADJ
cerebral O ADJ
palsy. O NOUN

METHODS: O NOUN
Using O VERB
a O DET
single-blind, O NOUN
counterbalanced, O NOUN
crossover O NOUN
design, O NOUN
we O PRON
compared O VERB
the O DET
rehydrating B-outcome VERB
efficacy O NOUN
of O ADP
MW O NOUN
vs. O CCONJ
maple-flavored O VERB
bottled O VERB
water O NOUN
(control) O NUM
in O ADP
26 O NUM
young O ADJ
healthy O ADJ
(22 O NOUN
+/- O SYM
4 O NUM
yrs., O ADP

BMI B-outcome NOUN
, O PUNCT
blood B-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
body B-outcome NOUN
composition I-outcome NOUN
, O PUNCT
pulse B-outcome NOUN
wave I-outcome NOUN
velocity I-outcome NOUN
, O PUNCT
glycemic B-outcome ADJ
parameters O NOUN
and O CCONJ
lipid B-outcome NOUN
profile O NOUN
were O VERB
assessed O VERB
3(-)8 O ADJ
years O NOUN
after O ADP
randomization. O NOUN

CONCLUSIONS: O NOUN
The O DET
Amla O NOUN
extract O NOUN
has O VERB
shown O VERB
significant O ADJ
potential O ADJ
in O ADP
reducing O VERB
total O ADJ
cholesterol B-outcome NOUN
(TC) O NOUN
and O CCONJ
triglyceride B-outcome NOUN
(TG) I-outcome NOUN
levels O NOUN
as O ADP
well O ADV
as O ADP
lipid B-outcome NOUN
ratios I-outcome NOUN
, O PUNCT
atherogenic B-outcome ADJ
index O NOUN
of O ADP
the O DET
plasma O NOUN
(AIP) O NUM
and O CCONJ
apoB/apo B-outcome NOUN
A-I I-outcome NOUN
in O ADP
dyslipidemic O ADJ
persons O NOUN
and O CCONJ
thus O ADV
has O VERB
scope O NOUN
to O PART
treat O NOUN
general O ADJ
as O ADP
well O ADV
as O ADP
diabetic O ADJ
dyslipidemia. O NOUN

We O PRON
assessed O VERB
the O DET
associations O NOUN
between O ADP
infarction O NOUN
patterns O NOUN
and O CCONJ
stroke B-outcome NOUN
recurrence O NOUN
using O VERB
multivariable O ADJ
Cox O NOUN
regression O NOUN
models. O NOUN

No O DET
other O ADJ
associations O NOUN
between O ADP
changes O NOUN
in O ADP
lifestyle B-outcome NOUN
or O CCONJ
body B-outcome NOUN
weight I-outcome NOUN
during O ADP
the O DET
first O ADV
six O NUM
months O NOUN
after O ADP
randomization O NOUN
with O ADP
cardiovascular B-outcome ADJ
health I-outcome NOUN
3(-)8 O ADJ
years O NOUN
later O ADV
were O VERB
observed. O NOUN

Title: O NOUN
Cardiac O ADJ
events O NOUN
after O ADP
macrolides O NOUN
or O CCONJ
fluoroquinolones O NOUN
in O ADP
patients O NOUN
hospitalized O VERB
for O ADP
community-acquired O VERB
pneumonia: O NOUN
post-hoc O NOUN
analysis O NOUN
of O ADP
a O DET
cluster-randomized O VERB
trial. O NOUN

Title: O NOUN
Radical O ADJ
Prostatectomy O NOUN
or O CCONJ
Watchful O ADJ
Waiting O VERB
in O ADP
Prostate O NOUN
Cancer O NOUN
- O PUNCT
29-Year O NOUN
Follow-up. O NOUN

Title: O NOUN
Omadacycline O NOUN
for O ADP
Acute O ADJ
Bacterial O ADJ
Skin O NOUN
and O CCONJ
Skin-Structure O NOUN
Infections. O ADV

In O ADP
a O DET
double-blind O ADJ
multicentric O ADJ
trial, O NOUN
109 O NUM
PKU O NOUN
patients O NOUN
were O VERB
randomized O VERB
to O PART
DHA O NOUN
doses O NOUN
from O ADP
0 O NUM
to O PART
7 O NUM
mg/kg&amp;day O NOUN
for O ADP
six O NUM
months. O NOUN

Secondary O ADJ
outcomes O NOUN
were O VERB
organ B-outcome NOUN
dysfunction I-outcome NOUN
at O ADP
72 O NUM
hours O NOUN
after O ADP
randomization, O NOUN
as O ADP
assessed O VERB
by O ADP
Sequential O ADJ
Organ B-outcome NOUN
Failure I-outcome NOUN
Assessment O NOUN
(SOFA) O NOUN
score O NOUN
(range, O NOUN
0 O NUM
[best] O NOUN
to O PART
24 O NUM
[worst]); O PUNCT
death B-outcome NOUN
within O ADP
90 O NUM
days; O NOUN
mechanical B-outcome ADJ
ventilation-, I-outcome NOUN
renal B-outcome ADJ
replacement I-outcome NOUN
therapy-, I-outcome PUNCT
and Seperator CCONJ
vasopressor- B-outcome ADJ
free I-outcome ADJ
days E2-outcome NOUN
within O ADP
28 O NUM
days; O NOUN
intensive B-outcome ADJ
care I-outcome NOUN
unit I-outcome NOUN
and Seperator CCONJ
hospital I-outcome NOUN
length I-outcome NOUN
of I-outcome ADP
stay I-outcome NOUN
. O PUNCT
Results: O NOUN
Among O ADP
424 O NUM
patients O NOUN
randomized O VERB
(mean O NUM
age, O NOUN
63 O NUM
years; O NOUN
226 O NUM
[53%] O NUM
women), O NOUN
416 O NUM
(98%) O ADV
completed O VERB
the O DET
trial. O NOUN

Journal O ADJ
ID: O NOUN
101273946 O NUM

As O ADP
the O DET
method O NOUN
of O ADP
blind O PUNCT
randomization O NOUN
envelope O NOUN
method O NOUN
was O VERB
used. O NOUN

RESULTS: O NOUN
Gastrocnemius B-outcome NOUN
medialis I-outcome NOUN
activation I-outcome NOUN
during O ADP
mid O NOUN
stance O NOUN
(23.46%MVIC, O NOUN
95% O NOUN
CI O NOUN
= O SYM
-32.53, O NOUN
-14.39) O NOUN
and O CCONJ
late O ADJ
stance O NOUN
phases O NOUN
(3.25%MVIC, O NUM
95% O NOUN
CI O NOUN
= O SYM
-5.67, O NOUN
-0.81) O NUM
of O ADP
gait O NOUN
increased O VERB
after O ADP
the O DET
application O NOUN
of O ADP
KT O NOUN
in O ADP
the O DET
KT O NOUN
group O NOUN
compared O VERB
to O PART
baseline O NOUN
values. O NUM

Title: O NOUN
Effect O NOUN
of O ADP
transcutaneous O ADJ
electrical O ADJ
acupoint O NOUN
stimulation O NOUN
on O ADP
the O DET
effective O ADJ
concentration B-outcome NOUN
(EC50) O PUNCT
of O ADP
remifentanil O NOUN
suppressing O VERB
responses B-outcome NOUN
to O PART
tracheal O ADJ
extubation O NOUN
in O ADP
elderly O NOUN
patients. O NOUN

METHODS: O NOUN
Sixteen O NUM
healthy O ADJ
volunteers O NOUN
were O VERB
randomly O ADV
assigned O VERB
in O ADP
a O DET
crossover O NOUN
design O NOUN
manner O NOUN
to O PART
either O CCONJ
a O DET
LOWFODMAP O NOUN
(16.06 O NOUN
+/- O SYM
1.79 O NUM
g.d(- O NOUN
1)) O NOUN
or O CCONJ
HIGHFODMAP O ADV
(38.65 O PUNCT
+/- O SYM
6.66 O NUM
g.d(- O NOUN
1)) O NOUN
diet O NOUN
for O ADP
7 O NUM
days, O NOUN
with O ADP
a O DET
one O NUM
week O NOUN
washout O ADV
period O NOUN
followed O VERB
by O ADP
a O DET
further O ADV
7 O NUM
days O NOUN
on O ADP
the O DET
alternate O VERB
diet. O NOUN

METHODS: O NOUN
The O DET
schools O NOUN
in O ADP
district O ADP
Shimla O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
intervention O NOUN
and O CCONJ
controlled O VERB
arm O NOUN
(442 O NUM
vs. O CCONJ
441 O NUM
schools). O NOUN

The O DET
participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
one O NUM
of O ADP
two O NUM
treatment O NOUN
groups O NOUN
for O ADP
dry O ADJ
needling O VERB
or O CCONJ
sham O NOUN
dry O ADJ
needling, O NOUN
delivered O VERB
in O ADP
3 O NUM
sessions O NOUN
a O DET
week O NOUN
for O ADP
2 O NUM
weeks. O NOUN

This O DET
double-blind, O NOUN
randomized, O NOUN
Phase O NOUN
II O NUM
study O NOUN
investigated O VERB
the O DET
dose-response O NOUN
of O ADP
oral O ADJ
netupitant O ADJ
in O ADP
Japanese O NOUN
patients O NOUN
receiving O VERB
highly O ADV
emetogenic O ADJ
chemotherapy. O NOUN

For O ADP
that O ADP
highly O ADV
selected O VERB
subgroup, O NOUN
surgery O NOUN
was O VERB
superior O ADJ
to O PART
medical O ADJ
treatment. O NOUN
( O PUNCT

None O NUM
of O ADP
the O DET
findings O NOUN
that O ADP
favored O VERB
the O DET
comparison O NOUN
area O NOUN
were O VERB
statistically O ADV
significant. O NOUN

Data O NOUN
analysis O NOUN
was O VERB
conducted O VERB
using O VERB
Chi-square, O NOUN
independent O ADJ
t-test, O NOUN
and O CCONJ
paired O VERB
t-test. O NOUN

The O DET
participants O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
two O NUM
groups O NOUN
receiving O VERB
the O DET
drugs O NOUN
Novafen O NOUN
and O CCONJ
Ginger. O NOUN

Compared O VERB
to O PART
MIIT O NOUN
and O CCONJ
CG, O NOUN
participants O NOUN
of O ADP
the O DET
HIIT O NOUN
group O NOUN
showed O VERB
significant O ADJ
post-intervention O NOUN
improvements O NOUN
in O ADP
BMI B-outcome NOUN
(p=.002 O NUM
and O CCONJ
p<.001, O NOUN
respectively) O NOUN
and O CCONJ
gait B-outcome NOUN
speed I-outcome NOUN
(p<.001 O PUNCT
for O ADP
both). O NUM

Additional O ADJ
studies O NOUN
that O ADP
use O NOUN
liver O NOUN
biopsies O NOUN
would O VERB
allow O ADP
for O ADP
the O DET
assessment O NOUN
of O ADP
pegbelfermin's O NOUN
effects O NOUN
on O ADP
liver O NOUN
histology. O NOUN

Journal O ADJ
ID: O NOUN
101150032 O NUM

Further O ADV
rigorous O ADJ
studies O NOUN
are O VERB
needed O VERB
to O PART
confirm O NOUN
and O CCONJ
extend O NOUN
these O DET
results. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
segmental O ADJ
muscle O NOUN
vibration O NOUN
on O ADP
upper B-outcome ADJ
extremity I-outcome NOUN
functional I-outcome ADJ
ability I-outcome NOUN
poststroke: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

The O DET
mean O NOUN
(SD) O NOUN
er-MedDiet O NUM
score O NOUN
was O VERB
8.5 O NUM
(2.6) O NOUN
at O ADP
baseline O NOUN
and O CCONJ
13.2 O NUM
(2.7) O NOUN
at O ADP
12 O NUM
months O NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
(increase, O NOUN
4.7 O NUM
[95% O NOUN
CI, O NOUN
4.6-4.8]) O NOUN
and O CCONJ
8.6 O NUM
(2.7) O NOUN
at O ADP
baseline O NOUN
and O CCONJ
11.1 O NUM
(2.8) O NOUN
at O ADP
12 O NUM
months O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
(increase, O NOUN
2.5 O NUM
[95% O NOUN
CI, O NOUN
2.3-2.6]) O NUM
(between-group O NOUN
difference, O NOUN
2.2 O NUM
[95% O NOUN
CI, O NOUN
2.1-2.4]; O NUM
P O NOUN
< O SYM
.001). O PUNCT

The O DET
number O NOUN
of O ADP
minor O ADJ
unintentional O ADJ
injuries B-outcome NOUN
in O ADP
the O DET
intervention O NOUN
group O NOUN
decreased O VERB
from O ADP
119 O NUM
to O PART
56, O NOUN
and O CCONJ
the O DET
number O NOUN
of O ADP
children O NOUN
suffering O VERB
2 O NUM
or O CCONJ
more O ADV
injuries O NOUN
dropped O VERB
from O ADP
34 O NUM
to O PART
10 O NUM
(P<0.001) O PUNCT
at O ADP
6 O NUM
months O NOUN
after O ADP
the O DET
intervention, O ADP
while O ADP
both O CCONJ
of O ADP
them O PRON
were O VERB
lower O ADJ
than O ADP
that O ADP
in O ADP
the O DET
control O NOUN
group O NOUN
(P=0.011). O NUM

Publication O NOUN
date: O NOUN
2018/12/10 O ADV
00:00 O NOUN
[accepted] O ADV

CONCLUSIONS: O NOUN
Ronghuang O NOUN
granule O NOUN
improves O NOUN
the O DET
clinical O ADJ
symptoms B-outcome NOUN
of O ADP
non-dialysis O NOUN
CKD-MBD O NOUN
patients O NOUN
with O ADP
kidney O NOUN
deficiency O NOUN
and O CCONJ
dampness O NOUN
heat O NOUN
syndrome O NOUN
by O ADP
reducing O VERB
serum O NOUN
levels O NOUN
of O ADP
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
23 I-outcome NUM
(FGF23) I-outcome NOUN
, O PUNCT
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
receptor I-outcome NOUN
(FGFRs) I-outcome NOUN
and O CCONJ
Klotho B-outcome NOUN
, O PUNCT
improving O VERB
calcium B-outcome NOUN
and Seperator CCONJ
phosphorus I-outcome NOUN
metabolism I-outcome NOUN
disorder I-outcome ADP
, O PUNCT
and O CCONJ
inhibiting O VERB
secondary B-outcome ADJ
hyperparathyroidism I-outcome NOUN
. O PUNCT

Few O ADJ
galcanezumab-treated O VERB
patients O NOUN
maintained O VERB
100% O NOUN
response B-outcome NOUN
. O PUNCT
In O ADP
patients O NOUN
with O ADP
chronic O ADJ
migraine, O ADJ
29% O NUM
of O ADP
galcanezumab-treated O VERB
patients O NOUN
maintained O VERB
>/=30% O NOUN
response B-outcome NOUN
all O DET
3 O NUM
months O NOUN
compared O VERB
to O PART
16% O NUM
of O ADP
placebo O NOUN
patients O NOUN
while O ADP
>/=50% O ADV
response B-outcome NOUN
was O VERB
maintained O VERB
in O ADP
16.8 O NUM
and O CCONJ
14.6% O NOUN
of O ADP
galcanezumab-treated O VERB
patients O NOUN
(120 O NUM
mg O NOUN
and O CCONJ
240 O NUM
mg) O NOUN
and O CCONJ
was O VERB
greater O ADJ
than O ADP
placebo O NOUN
(6.3%; O NOUN
p O NOUN
< O SYM
0.001). O NUM

We O PRON
therefore O ADV
assessed O VERB
the O DET
effects O NOUN
of O ADP
PPI O NOUN
or O CCONJ
a O DET
histamine O NOUN
H2 O NOUN
receptor O NOUN
antagonist O NOUN
(H2 O NUM
blocker) O NOUN
on O ADP
hypogeusia B-outcome NOUN
among O ADP
patients O NOUN
with O ADP
LPR. O NOUN

Registered O VERB
June O NOUN
16, O NOUN
2015. O NUM

Minor B-outcome ADJ
bleeding I-outcome VERB
was O VERB
significantly O ADV
less O ADV
in O ADP
group O NOUN
B O NOUN
[Bleeding O VERB
Academic O ADJ
Research O NOUN
Consortium O NOUN
1, O NOUN
A O DET
= O SYM
6.63% O NOUN
vs O CCONJ
B O NOUN
= O SYM
1.81%, O NUM
odds O NOUN
ratio O NOUN
(OR) O NOUN
= O SYM
3.86, O NUM
95% O NOUN
confidence O NOUN
interval O NOUN
(CI) O NOUN
= O SYM
1.06-14.08, O NOUN
P O NOUN
= O SYM
0.05]. O NUM
Major B-outcome ADP
bleeding I-outcome VERB
was O VERB
higher O ADJ
in O ADP
group O NOUN
A O DET
(A O PUNCT
= O SYM
3.61%, O NUM
vs O CCONJ
B O NOUN
= O SYM
1.81%, O NUM
OR O CCONJ
= O SYM
2.04, O ADV
95% O NOUN
CI O NOUN
= O SYM
0.50-8.29, O NUM
P O NOUN
= O SYM
0.50). O NUM

CONCLUSION: O NOUN
There O PRON
was O VERB
no O DET
clear O ADJ
benefit O NUM
of O ADP
the O DET
24-hour O NOUN
or O CCONJ
48-hour O NOUN
infusions O NOUN
over O ADP
the O DET
single-shot O NOUN
ACB O NOUN
for O ADP
the O DET
primary O ADJ
endpoint O NOUN
of O ADP
the O DET
study. O NOUN

The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
is O VERB
to O PART
investigate O NOUN
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
apatinib O ADP
in O ADP
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
for O ADP
whom O ADP
at O ADP
least O ADV
two O NUM
lines O NOUN
of O ADP
prior O ADJ
chemotherapy O NOUN
had O VERB
failed. O NOUN

Twelve O NUM
weeks O NOUN
later, O ADV
permanent O ADJ
crowns O VERB
were O VERB
placed O VERB
on O ADP
patient-specific O ADJ
abutments O NOUN
and O CCONJ
evaluated O VERB
at O ADP
6, O NOUN
12, O NUM
and O CCONJ
36 O NUM
months O NOUN
following O VERB
implant O NOUN
placement. O NOUN

Publication O NOUN
date: O NOUN
2019/01/17 O ADP
06:00 O ADP
[entrez] O ADP

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
gender, O NOUN
age, O NOUN
injury O NOUN
cause, O NOUN
Denis O NOUN
classification, O NOUN
fracture O NOUN
segment, O NOUN
the O DET
degree O NOUN
of O ADP
injured O VERB
vertebra O NOUN
compression, O NOUN
bone O NOUN
mineral O NOUN
density, O NOUN
and O CCONJ
American O ADJ
Spinal O ADJ
Cord O NOUN
Injury O NOUN
Association O NOUN
(ASIA) O NUM
classification O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
( O PUNCT
P>0.05). O NOUN

The O DET
allocation O NOUN
sequence O NOUN
was O VERB
concealed O VERB
by O ADP
using O VERB
a O DET
computer O NOUN
generated O VERB
number O NOUN
on O ADP
the O DET
prescription. O NOUN

Title: O NOUN
The O DET
effectiveness O NOUN
of O ADP
Mindfulness-Based O VERB
Cognitive O ADJ
Therapy O NOUN
on O ADP
the O DET
illness B-outcome NOUN
perception I-outcome NOUN
and O CCONJ
Psychological B-outcome ADJ
Symptoms I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
Rheumatoid O NOUN
Arthritis. O NOUN

Some O DET
cycles O NOUN
are O VERB
cancelled O VERB
due O ADJ
to O PART
inadequate O ADJ
endometrial O ADJ
growth O NOUN
in O ADP
ART. O NOUN

The O DET
mean O NOUN
and O CCONJ
standard O ADJ
deviation O NOUN
of O ADP
variables O NOUN
were O VERB
obtained O VERB
and O CCONJ
the O DET
normality O NOUN
of O ADP
data O NOUN
was O VERB
analyzed O VERB
using O VERB
the O DET
Kolmogorov-Smirnov O NOUN
test. O NOUN

In O ADP
conclusion, O NOUN
our O ADJ
data O NOUN
show O VERB
that O ADP
Taurisolo((R)) O NOUN
may O VERB
represent O NOUN
a O DET
novel O ADJ
and O CCONJ
useful O ADJ
natural O ADJ
remedy O NOUN
to O PART
reduce O VERB
prognostic O ADJ
markers O NOUN
for O ADP
incident O ADJ
cardiovascular O ADJ
events. O NOUN

Hydrocephalus O NOUN
is O VERB
a O DET
common O ADJ
condition O NOUN
associated O VERB
with O ADP
myelomeningocele. O NOUN

The O DET
primary O ADJ
comparison O NOUN
was O VERB
the O DET
alteplase O NOUN
20-mg O NOUN
group O NOUN
vs O CCONJ
the O DET
placebo O NOUN
group; O ADJ
if O ADP
not O ADV
significant, O NOUN
the O DET
alteplase O NOUN
10-mg O NOUN
group O NOUN
vs O CCONJ
the O DET
placebo O NOUN
group O NOUN
was O VERB
considered O VERB
a O DET
secondary O ADJ
analysis. O NOUN

Cite O NOUN
this O DET
article: O NOUN
Bone O NOUN
Joint O NOUN
J O NOUN
2019;101-B:340-347 O ADP

RESULTS: O NOUN
Plasma O NOUN
albumin B-outcome NOUN
and O CCONJ
total O ADJ
protein B-outcome NOUN
levels O NOUN
increased O VERB
immediately O ADV
after O ADP
exercise O NOUN
in O ADP
placebo O NOUN
alongside O ADP
slight O NOUN
reductions O NOUN
in O ADP
glucose B-outcome NOUN
(p O PUNCT
= O SYM
0.001). O NUM

Journal-Name:Nutrients O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
clinicaltrials.gov, O NOUN
NCT02518165 O NOUN
. O PUNCT

Journal O ADJ
ID: O NOUN
2985248R O NOUN

No O DET
adverse B-outcome ADJ
events I-outcome NOUN
occurred O VERB
in O ADP
either O CCONJ
group. O VERB

Clinical O ADJ
trial O NOUN
registration: O NOUN
JapicCTI-142 O NOUN
483. O NOUN

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
60 O NUM
cases O NOUN
were O VERB
recruited O VERB
during O ADP
August O NOUN
2016 O NUM
and O CCONJ
June O NOUN
2017 O NUM
according O ADJ
to O PART
the O DET
inclusion O NOUN
and O CCONJ
exclusion O NOUN
criteria. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2018/12/22 O NOUN
06:00 O ADP
[entrez] O ADP

OBJECTIVE: O NOUN
Compare O NOUN
the O DET
outcome O NOUN
of O ADP
spinal B-outcome ADJ
deformity I-outcome NOUN
correction I-outcome NOUN
between O ADP
Ti-Ti O NOUN
and O CCONJ
CrCo-Ti O NOUN
rods O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
spinal O ADJ
Adolescent O NOUN
Idiopathic O ADJ
Scoliosis O NOUN
(AIS) O NOUN
using O VERB
rods O NOUN
mentioned O VERB
with O ADP
all O DET
pedicle O NOUN
screws O NOUN
and O CCONJ
translation O NOUN
technique. O NOUN

Interventions: O NOUN
Patients O NOUN
were O VERB
randomly O ADV
allocated O VERB
(1:1) O NOUN
to O PART
an O DET
MRI-guided O VERB
vs O CCONJ
a O DET
conventional O ADJ
treat-to-target O NOUN
strategy. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
CM O NOUN
group O NOUN
(12.3% O NUM
increase) O NOUN
had O VERB
significantly O ADV
greater O ADJ
improvements O NOUN
in O ADP
composite O NOUN
strength B-outcome NOUN
from O ADP
pre- O ADJ
to O PART
post-test O NOUN
than O ADP
CHO O NOUN
(2.7% O NOUN
increase). O NOUN

Importance: O NOUN
A O DET
meta-analysis O NOUN
of O ADP
outcomes O NOUN
during O ADP
the O DET
6 O NUM
months O NOUN
after O ADP
intensive O ADJ
care O NOUN
unit O NOUN
(ICU) O PUNCT
discharge O NOUN
indicate O VERB
a O DET
prevalence O NOUN
for O ADP
clinically O ADV
important O ADJ
posttraumatic O ADJ
stress O NOUN
disorder O ADP
(PTSD) O ADV
symptoms O NOUN
of O ADP
25%. O NUM

Journal-Name:Journal O ADJ
of O ADP
Ayub O ADP
Medical O ADJ
College, O PUNCT
Abbottabad O ADV
: O PUNCT
JAMC O NOUN

Participants O NOUN
in O ADP
the O DET
experimental O ADJ
group O NOUN
participated O VERB
in O ADP
a O DET
24-week O NUM
TC O NOUN
training O VERB
program O NOUN
(three O NUM
60-min O NOUN
sessions O NOUN
per O ADP
week), O NOUN
whereas O ADP
individuals O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
maintained O VERB
their O ADJ
unaltered O VERB
lifestyle. O NOUN

Publication O NOUN
date: O NOUN
2018/12/19 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
date: O NOUN
2019/03/05 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/01/22 O ADJ
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
00:00 O NOUN
[accepted] O ADV

Age O NOUN
was O VERB
significantly O ADV
associated O VERB
with O ADP
endothelial B-outcome ADJ
cell I-outcome NOUN
loss O NOUN
(ECL) O ADV
after O ADP
cataract O NOUN
surgery O NOUN
(P O NUM
= O SYM
0.02), O NUM
but O CCONJ
baseline O NOUN
intraocular O ADJ
pressure, O NOUN
number O NOUN
of O ADP
glaucoma B-outcome NOUN
medications I-outcome NOUN
, O PUNCT
and O CCONJ
central B-outcome ADJ
corneal I-outcome ADJ
thickness I-outcome NOUN
(CCT) I-outcome PUNCT
were O VERB
not. O ADV

This O DET
study O NOUN
was O VERB
designed O VERB
to O PART
determine O NOUN
the O DET
effects O NOUN
of O ADP
ascorbic O ADJ
acid O NOUN
supplementation O NOUN
on O ADP
circulating O VERB
biomarkers O NOUN
of O ADP
oxidative B-outcome ADJ
stress I-outcome NOUN
and O CCONJ
muscle B-outcome NOUN
damage I-outcome NOUN
following O VERB
a O DET
single O ADJ
bout O NOUN
of O ADP
exercise. O NOUN

Background O NOUN
and O CCONJ
Objectives: O ADJ
The O DET
authors O NOUN
sought O NOUN
to O PART
assess O NOUN
the O DET
effect O NOUN
of O ADP
the O DET
use O NOUN
of O ADP
a O DET
new O ADJ
crosslinked O VERB
hyaluronan O ADJ
(NCH) O PUNCT
gel O NOUN
on O ADP
the O DET
prevention O NOUN
of O ADP
intrauterine B-outcome ADJ
adhesions I-outcome NOUN
(IUAs) I-outcome NUM
in O ADP
women O NOUN
underwent O VERB
curettage O NOUN
in O ADP
the O DET
second O ADJ
trimester. O NOUN

Background/aim: O NOUN
In O ADP
South O NOUN
Africa, O NOUN
contextual O ADJ
factors O NOUN
have O VERB
been O VERB
identified O VERB
as O ADP
barriers O NOUN
to O PART
outdoor, O NOUN
unstructured O VERB
play. O NOUN

These O DET
patients O NOUN
were O VERB
enrolled O VERB
at O ADP
17 O NUM
medical O ADJ
centres O NOUN
in O ADP
the O DET
USA. O NOUN

Journal O ADJ
ID: O NOUN
101291488 O NUM

Journal-Name:Lancet O NOUN
(London, O PUNCT
England) O NOUN

In O ADP
this O DET
phase O NOUN
2a O NOUN
study, O NOUN
we O PRON
aimed O VERB
to O PART
evaluate O VERB
the O DET
safety O NOUN
and O CCONJ
efficacy O NOUN
of O ADP
pegbelfermin O NOUN
in O ADP
patients O NOUN
with O ADP
non-alcoholic O ADJ
steatohepatitis. O NOUN

METHODS: O NOUN
We O PRON
performed O VERB
a O DET
multicenter, O NOUN
open-label, O ADV
randomized, O NOUN
controlled O VERB
trial O NOUN
involving O VERB
patients O NOUN
18 O NUM
to O PART
75 O NUM
years O NOUN
of O ADP
age O NOUN
with O ADP
resectable O ADJ
cancer O NOUN
of O ADP
the O DET
middle O ADJ
or O CCONJ
lower O ADJ
third O ADJ
of O ADP
the O DET
esophagus. O NOUN

Participants O NOUN
rated O VERB
their O ADJ
gastrointestinal B-outcome ADJ
symptoms I-outcome NOUN
on O ADP
an O DET
adapted O VERB
version O NOUN
of O ADP
the O DET
Irritable B-outcome ADJ
Bowel I-outcome NOUN
Syndrome-Severity I-outcome NOUN
Scoring O VERB
System O NOUN
(IBS-SSS) O PUNCT
questionnaire O NOUN
before O ADP
and O CCONJ
at O ADP
the O DET
end O NOUN
of O ADP
each O DET
dietary O ADJ
period. O NOUN

Journal O ADJ
ID: O NOUN
101248897 O NUM

Methods: O NOUN
Between O ADP
June O NOUN
2016 O NUM
and O CCONJ
September O NOUN
2017, O NUM
60 O NUM
patients O NOUN
who O ADP
underwent O VERB
curettage O NOUN
for O ADP
retained O VERB
placental O ADJ
tissue O NOUN
after O ADP
medically O ADV
induced O VERB
or O CCONJ
spontaneous O ADJ
pregnancy O NOUN
loss O NOUN
in O ADP
the O DET
second O ADJ
trimester O NOUN
were O VERB
enrolled O VERB
in O ADP
the O DET
study. O NOUN

METHODS: O NOUN
In O ADP
this O DET
randomized, O NOUN
single-blinded, O NOUN
and O CCONJ
controlled O VERB
study, O NOUN
total O ADJ
75 O NUM
patients O NOUN
were O VERB
randomly O ADV
allocated O VERB
to O PART
TPI O NOUN
group O NOUN
(n O NOUN
= O SYM
25), O NUM
EMLA O NOUN
group O NOUN
(n O NOUN
= O SYM
25), O NUM
and O CCONJ
control O NOUN
group O NOUN
(n O NOUN
= O SYM
25). O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
incremental O ADJ
vs O CCONJ
maximum O NOUN
bite O NOUN
advancement O ADJ
during O ADP
Herbst O NOUN
appliance O NOUN
therapy O NOUN
in O ADP
late O ADJ
adolescent O NOUN
and O CCONJ
young O ADJ
adult O NOUN
patients. O NOUN

Main O ADJ
Outcomes O NOUN
and O CCONJ
Measures: O NOUN
The O DET
primary O ADJ
clinical O ADJ
outcome O NOUN
was O VERB
posttraumatic B-outcome ADJ
stress I-outcome NOUN
disorder I-outcome ADP
(PTSD) I-outcome ADV
symptom I-outcome NOUN
severity I-outcome NOUN
among O ADP
survivors O NOUN
at O ADP
6 O NUM
months O NOUN
measured O VERB
using O VERB
the O DET
posttraumatic B-outcome ADJ
stress I-outcome NOUN
disorder I-outcome ADP
(PTSD) I-outcome ADV
symptom I-outcome NOUN
severity I-outcome NOUN
Scale-Self-Report O NOUN
questionnaire O NOUN
(score O PUNCT
range, O VERB
0-51, O NUM
with O ADP
higher O ADJ
scores O NOUN
indicating O VERB
greater O ADJ
symptom O NOUN
severity; O ADV
the O DET
minimal O ADJ
clinically O ADV
important O ADJ
difference O NOUN
was O VERB
considered O VERB
to O PART
be O VERB
4.2 O NUM
points). O NOUN

Ixazomib O NUM
is O VERB
ideally O ADV
suited O VERB
for O ADP
maintenance O NOUN
therapy O NOUN
given O VERB
its O ADJ
convenient O ADJ
once-weekly O NOUN
oral O ADJ
dosing O VERB
and O CCONJ
low O ADJ
toxicity O NOUN
profile. O NOUN

Title: O NOUN
Spirulina O NOUN
maxima O NOUN
Decreases O NOUN
Endothelial B-outcome ADJ
Damage I-outcome NOUN
and O CCONJ
Oxidative B-outcome ADJ
Stress I-outcome NOUN
Indicators O NOUN
in O ADP
Patients O NOUN
with O ADP
Systemic O ADJ
Arterial O ADJ
Hypertension: O NOUN
Results O NOUN
from O ADP
Exploratory O ADJ
Controlled O VERB
Clinical O ADJ
Trial. O NOUN

PURPOSE: O NOUN
The O DET
purpose O NOUN
of O ADP
this O DET
study O NOUN
is O VERB
to O PART
translate O NOUN
laboratory-based O VERB
research O NOUN
on O ADP
beverage-based O VERB
supplements O NOUN
to O PART
a O DET
naturalistic, O VERB
field O NOUN
setting O VERB
in O ADP
adolescent O NOUN
athletes. O ADV

METHODS: O NOUN
In O ADP
this O DET
mixed-methods O NOUN
pilot O NOUN
trial, O NOUN
participants O NOUN
with O ADP
quiescent O ADJ
or O CCONJ
mildly-active O ADJ
CD O NOUN
were O VERB
randomly O ADV
assigned O VERB
1:1:1 O ADJ
to O PART
HIIT, O NOUN
MICT O NOUN
or O CCONJ
usual O ADJ
care O NOUN
control, O NOUN
and O CCONJ
followed O VERB
up O ADP
for O ADP
6 O NUM
months. O NOUN

Serum O NOUN
levels O NOUN
of O ADP
Ca B-outcome NOUN
, O PUNCT
P B-outcome NOUN
, O PUNCT
parathyroid B-outcome NOUN
hormone I-outcome NOUN
(iPTH) I-outcome NUM
, O PUNCT
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
23 I-outcome NUM
(FGF23) I-outcome NOUN
, O PUNCT
fibroblast B-outcome NOUN
growth I-outcome NOUN
factor I-outcome NOUN
receptor I-outcome NOUN
(FGFRs) I-outcome NOUN
and O CCONJ
Klotho B-outcome NOUN
proteins I-outcome NOUN
were O VERB
detected O VERB
before O ADP
and O CCONJ
after O ADP
treatment. O NOUN

Chlorhexidine O NOUN
is O VERB
most O DET
widely O ADV
used O VERB
antiseptic O ADJ
which O ADP
is O VERB
thought O VERB
to O PART
be O VERB
helpful O ADJ
to O PART
prevent O NOUN
alveolar O ADJ
osteitis. O NOUN

BACKGROUND: O NOUN
Liver O NOUN
transplantation O NOUN
is O VERB
the O DET
best O ADP
treatment O NOUN
for O ADP
end-stage O NOUN
liver O NOUN
disease. O NOUN

The O DET
secondary O ADJ
outcome O NOUN
composite O NOUN
of O ADP
requirement O NOUN
of O ADP
hemodialysis B-outcome NOUN
, O PUNCT
death B-outcome NOUN
and O CCONJ
rehospitalization B-outcome NOUN
for Seperator ADP
heart I-outcome NOUN
failure I-outcome NOUN
was O VERB
not O ADV
statistically O ADV
significant O ADJ
(p: O NUM
0.646). O NUM

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
date: O NOUN
2019/03/06 O ADJ
06:00 O ADP
[medline] O NOUN

As O ADP
compared O VERB
with O ADP
the O DET
placebo O NOUN
group, O NOUN
women O NOUN
who O ADP
received O VERB
zoledronate O ADJ
had O VERB
a O DET
lower O ADJ
risk O NOUN
of O ADP
nonvertebral B-outcome ADJ
fragility I-outcome NOUN
fractures I-outcome NOUN
(hazard O PUNCT
ratio, O NOUN
0.66; O NOUN
P=0.001), O NOUN
symptomatic B-outcome ADJ
fractures I-outcome NOUN
(hazard O PUNCT
ratio, O NOUN
0.73; O NOUN
P=0.003), O NOUN
vertebral B-outcome ADJ
fractures I-outcome NOUN
(odds O NOUN
ratio, O NOUN
0.45; O NOUN
P=0.002), O NOUN
and O CCONJ
height B-outcome NOUN
loss I-outcome NOUN
(P<0.001). O NOUN

After O ADP
the O DET
12-week O NOUN
treatments, O ADV
the O DET
patients O NOUN
were O VERB
examined O VERB
for O ADP
changes O NOUN
of O ADP
TCM O NOUN
syndromes. O ADJ

Journal O ADJ
ID: O NOUN
101521595 O NUM

The O DET
safety O NOUN
of O ADP
BT-11 O NOUN
should O VERB
be O VERB
elucidated O VERB
in O ADP
younger O ADJ
person O NOUN
further. O NOUN

In O ADP
the O DET
intention-to-treat O NOUN
analysis O NOUN
at O ADP
10 O NUM
years, O NOUN
there O PRON
were O VERB
315 O NUM
deaths B-outcome NOUN
(20.3% O ADV
of O ADP
the O DET
patients) O NOUN
in O ADP
the O DET
bilateral-graft O NOUN
group O NOUN
and O CCONJ
329 O NUM
deaths O NOUN
(21.2%) O NUM
in O ADP
the O DET
single-graft O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
0.96; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.82 O NUM
to O PART
1.12; O NOUN
P=0.62). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Median O ADJ
progression-free B-outcome ADJ
survival I-outcome NOUN
was O VERB
48.2 O NUM
months O NOUN
(95% O PUNCT
CI O NOUN
35.2-not O NOUN
evaluable) O NOUN
in O ADP
the O DET
A+CHP O ADV
group O NOUN
and O CCONJ
20.8 O NUM
months O NOUN
(12.7-47.6) O NOUN
in O ADP
the O DET
CHOP O VERB
group O NOUN
(hazard O PUNCT
ratio O NOUN
0.71 O NUM
[95% O NOUN
CI O NOUN
0.54-0.93], O NOUN
p=0.0110). O NOUN

In B-outcome ADP
stent I-outcome NOUN
re-stenosis I-outcome NOUN
was O VERB
found O VERB
in O ADP
7 O NUM
of O ADP
85(8.2%) O NUM
in O ADP
the O DET
polymer-free O ADJ
group O NOUN
vs. O CCONJ
6 O NUM
of O ADP
98(6.12%) O ADP
in O ADP
the O DET
biodegradable O ADJ
polymer O NOUN
group. O VERB

During O ADP
the O DET
intervention O NOUN
period, O NOUN
rivaroxaban O ADJ
led O VERB
to O PART
a O DET
substantially O ADV
lower O ADJ
incidence O NOUN
of O ADP
such O ADJ
events, O NOUN
with O ADP
a O DET
low O ADJ
incidence O NOUN
of O ADP
major B-outcome ADJ
bleeding I-outcome VERB
. O PUNCT
(Funded O PUNCT
by O ADP
Janssen O NOUN
and O CCONJ
others; O NOUN
CASSINI O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT02555878.). O NOUN

Basis O NOUN
for O ADP
sample O NOUN
size O NOUN
calculation O NOUN
was O VERB
the O DET
rate O NOUN
of O ADP
MACE O NOUN
from O ADP
the O DET
ISAR O NOUN
TEST O NOUN
3 O NUM
trial O NOUN
in O ADP
which O ADP
the O DET
absolute O ADJ
difference O NOUN
was O VERB
10.25% O NOUN
with O ADP
a O DET
standard O ADJ
deviation O NOUN
of O ADP
0.24. O NUM

More O ADV
focus O NOUN
could O VERB
be O VERB
put O NOUN
into O ADP
an O DET
education O NOUN
tool O NOUN
for O ADP
other O ADJ
caregivers O NOUN
who O ADP
wish O NOUN
to O PART
hold O NOUN
the O DET
baby. O NOUN

Publication O NOUN
date: O NOUN
2019/01/18 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
toxicity B-outcome NOUN
was O VERB
manageable. O NOUN

RESULTS: O NOUN
24 O NUM
participants O NOUN
in O ADP
the O DET
Traditional O ADJ
group O NOUN
and O CCONJ
27 O NUM
in O ADP
the O DET
App O NOUN
group O NOUN
completed O VERB
the O DET
study. O NOUN

BACKGROUND: O NOUN
To O PART
combat O NOUN
emerging O VERB
drug O NOUN
resistance O NOUN
in O ADP
the O DET
Greater O ADJ
Mekong O NOUN
Sub-region O NOUN
(GMS) O NUM
the O DET
World O NOUN
Health O NOUN
Organization O NOUN
and O CCONJ
GMS O NOUN
countries O NOUN
have O VERB
committed O VERB
to O PART
eliminating O VERB
malaria O NOUN
in O ADP
the O DET
region O NOUN
by O ADP
2030. O NUM

It O PRON
was O VERB
observed O VERB
in O ADP
both O CCONJ
groups O NOUN
that, O NOUN
as O ADP
CRP B-outcome NOUN
levels O NOUN
increased, O NOUN
albumin B-outcome NOUN
levels O NOUN
decreased O VERB
significantly O ADV
(p O PUNCT
<0.01). O ADJ

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Pair-matched O VERB
participants O NOUN
were O VERB
randomized O VERB
into O ADP
a O DET
control O NOUN
group O NOUN
(CON; O PUNCT
n=7) O VERB
that O ADP
exercised O VERB
in O ADP
a O DET
temperate O NOUN
environment O NOUN
(24 O NOUN
degrees O NOUN
C, O NOUN
21%RH) O NUM
or O CCONJ
IHE O NOUN
group O NOUN
(n=9) O PUNCT
that O ADP
exercised O VERB
in O ADP
a O DET
hot O ADJ
environment O NOUN
(40 O NOUN
degrees O NOUN
C, O NOUN
40%RH) O NUM
every O DET
fifth O ADJ
day O NOUN
for O ADP
25 O NUM
days O NOUN
following O VERB
HA O NOUN
(+25d) O NOUN
with O ADP
out-of-laboratory O ADP
exercise B-outcome NOUN
intensity I-outcome NOUN
and Seperator CCONJ
duration S1-outcome NOUN
recorded. O NOUN

Journal O ADJ
ID: O NOUN
8610224 O NUM

CONCLUSION: O NOUN
Electrolyte-containing O VERB
MW, O NOUN
was O VERB
similar O ADJ
in O ADP
effectiveness O NOUN
to O PART
water, O NOUN
but O CCONJ
has O VERB
antioxidant B-outcome NOUN
properties. O NOUN

INTERVENTIONS: O NOUN
Routine O ADJ
care O NOUN
(TENS O PUNCT
group) O ADJ
or O CCONJ
routine O ADJ
care O NOUN
plus O CCONJ
a O DET
therapeutic O ADJ
education O NOUN
program O NOUN
(TENS-TEP O NUM
group) O ADJ
based O VERB
on O ADP
consultation O NOUN
support O NOUN
by O ADP
a O DET
pain O NOUN
resource O NOUN
nurse. O NOUN

Title: O NOUN
A O DET
multi-center, O NOUN
randomized O VERB
controlled O VERB
clinical O ADJ
trial O NOUN
of O ADP
the O DET
application O NOUN
of O ADP
a O DET
shortened O VERB
protocol O NOUN
of O ADP
long-acting O VERB
Triptorelin O NOUN
down-regulated O VERB
prior O ADJ
to O PART
IVF/ICSI O NOUN
among O ADP
patients O NOUN
with O ADP
endometriosis: O NOUN
A O DET
protocol. O NOUN

Journal-Name:Medicine O NOUN

FINDINGS: O ADJ
In O ADP
the O DET
original O ADJ
study, O NOUN
from O ADP
Dec O NOUN
14, O NUM
2006, O NUM
to O PART
Feb O NOUN
2, O NOUN
2012, O NUM
161 O NUM
patients O NOUN
were O VERB
enrolled O VERB
and O CCONJ
155 O NUM
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
the O DET
ATLG O NOUN
group O NOUN
(n=83) O PUNCT
or O CCONJ
to O PART
the O DET
non-ATLG O NOUN
group O NOUN
(n=72). O NOUN

Safety, O NOUN
pharmacokinetic, O VERB
pharmacodynamic, O VERB
and O CCONJ
exploratory O ADJ
efficacy O NOUN
outcomes O NOUN
were O VERB
evaluated. O NOUN

Publication O NOUN
Type: O NOUN
Comparative O ADJ
Study O NOUN

We O PRON
observed O VERB
a O DET
trend O NOUN
toward O ADP
decreased O VERB
incisional B-outcome ADJ
hernia I-outcome NOUN
rates O NOUN
in O ADP
patients O NOUN
treated O VERB
with O ADP
NPWT. O ADV

LEVEL O NOUN
OF O ADP
EVIDENCE: O NOUN
III. O NOUN

OBJECTIVE: O NOUN
To O PART
observe O NOUN
the O DET
preoperative O ADJ
sedation B-outcome NOUN
, O PUNCT
the O DET
status B-outcome NOUN
of I-outcome ADP
separation I-outcome NOUN
from I-outcome ADP
parents I-outcome NOUN
, O PUNCT
compliance B-outcome NOUN
with O ADP
the O DET
mask, O NOUN
hemodynamic B-outcome ADJ
parameters O NOUN
and O CCONJ
postoperative O ADJ
agitation B-outcome NOUN
of O ADP
intranasal O ADJ
dexmedetomidine O NOUN
(DEX) O NOUN
premedication O NOUN
on O ADP
children O NOUN
undergoing O VERB
dental O ADJ
rehabilitation O NOUN
under O ADP
general O ADJ
anesthesia. O NOUN

Title: O NOUN
The O DET
immediate O ADJ
sensorimotor B-outcome NOUN
effects O NOUN
of O ADP
elbow O NOUN
orthoses O NOUN
in O ADP
patients O NOUN
with O ADP
lateral O ADJ
elbow O NOUN
tendinopathy: O NOUN
a O DET
prospective O ADJ
crossover O NOUN
study. O NOUN

Interim O NOUN
analysis O NOUN
of O ADP
a O DET
randomized, O NOUN
double O ADV
blinded, O NOUN
placebo-controlled O VERB
trial. O NOUN

CONCLUSIONS: O NOUN
The O DET
results O NOUN
seem O VERB
to O PART
indicate O VERB
that O ADP
using O VERB
krill O NOUN
powder O NOUN
as O ADP
a O DET
source O NOUN
for O ADP
EPA O NOUN
and O CCONJ
DHA O NOUN
is O VERB
safe O ADJ
in O ADP
therapeutic O ADJ
dose O NOUN
and O CCONJ
the O DET
risk O NOUN
of O ADP
adverse B-outcome ADJ
events I-outcome NOUN
, O PUNCT
let O NOUN
alone O ADJ
serious O ADJ
ones, O NOUN
is O VERB
low. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

The O DET
mean O NOUN
age O NOUN
of O ADP
enrolled O VERB
subjects O NOUN
was O VERB
51 O NUM
years O NOUN
old O ADJ
[range: O NOUN
22 O NUM
to O PART
76]. O NUM
The O DET
majority O NOUN
was O VERB
male O NOUN
(90%). O PUNCT

DESIGN: O NOUN
Randomized O VERB
and O CCONJ
blinded O VERB
clinical O ADJ
trial. O NOUN

OBJECTIVES: O NOUN
To O PART
compare O NOUN
the O DET
effect O NOUN
of O ADP
toric O ADJ
versus O CCONJ
spherical O ADJ
soft O NOUN
contact O NOUN
lenses O NOUN
on O ADP
objective O ADP
measures O NOUN
of O ADP
visual B-outcome ADJ
performance O NOUN
using O VERB
visual O ADJ
acuity O NOUN
and O CCONJ
electromyography O NOUN
of O ADP
the O DET
orbicularis O NOUN
oculi O NOUN
muscle. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Major B-outcome ADP
bleeding I-outcome VERB
occurred O VERB
in O ADP
8 O NUM
of O ADP
405 O NUM
patients O NOUN
(2.0%) O NUM
in O ADP
the O DET
rivaroxaban O ADJ
group O NOUN
and O CCONJ
in O ADP
4 O NUM
of O ADP
404 O NUM
(1.0%) O NOUN
in O ADP
the O DET
placebo O NOUN
group O NOUN
(hazard O PUNCT
ratio, O NOUN
1.96; O NOUN
95% O NOUN
CI, O NOUN
0.59 O NUM
to O PART
6.49). O ADP

Funded O VERB
by O ADP
the O DET
National O ADJ
Institute O NOUN
for O ADP
Health O NOUN
Research; O NOUN
OVIVA O NOUN
Current O ADJ
Controlled O VERB
Trials O NOUN
number, O ADV
ISRCTN91566927 O NOUN
.). O NOUN

Suicidal O NOUN
ideation O NOUN
was O VERB
independently O ADV
associated O VERB
with O ADP
sexual O ADJ
abuse O NOUN
(AOR O NUM
11.9 O NUM
(3.0-47.0)) O NOUN
and O CCONJ
a O DET
lack O NOUN
of O ADP
parental O ADJ
emotional O ADJ
support O NOUN
(AOR O NUM
0.2 O NUM
(0.1-0.5)). O NUM

Dual O ADJ
trigger O ADP
may O VERB
be O VERB
preferable O ADJ
to O PART
reduce O VERB
the O DET
risk O NOUN
of O ADP
OHSS. O NOUN

BACKGROUND/AIM: O NOUN
Our O ADJ
hypothesis O NOUN
was O VERB
that O ADP
rectus O ADJ
sheath O NOUN
block O VERB
(RSB) O NOUN
analgesia O NOUN
could O VERB
enhance O NOUN
satisfaction B-outcome NOUN
following O VERB
midline O NOUN
laparotomy O NOUN
in O ADP
patients O NOUN
with O ADP
benign O ADJ
disease O NOUN
and O CCONJ
cancer O NOUN
patients. O NOUN

For O ADP
the O DET
representative O ADJ
of O ADP
the O DET
municipality O NOUN
the O DET
possible O ADJ
economical O ADJ
gain O VERB
of O ADP
the O DET
project O NOUN
was O VERB
in O ADP
focus. O NOUN

Funded O VERB
by O ADP
GlaxoSmithKline O NOUN
and O CCONJ
Medicines O NOUN
for O ADP
Malaria O NOUN
Venture; O NOUN
DETECTIVE O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT01376167 O NOUN
.). O NOUN

It O PRON
impacts O NOUN
physical, O NOUN
mental, O NOUN
and O CCONJ
social O ADJ
functioning O VERB
as O ADP
well O ADV
as O ADP
the O DET
quality O NOUN
of O ADP
life, O ADJ
often O ADV
leading O VERB
to O PART
depression. O NOUN

METHODS: O NOUN
In O ADP
this O DET
double-blind O ADJ
trial, O NOUN
we O PRON
randomly O ADV
assigned O VERB
adults O NOUN
with O ADP
acute O ADJ
bacterial O ADJ
skin O NOUN
and O CCONJ
skin-structure O NOUN
infections O NOUN
(in O NUM
a O DET
1:1 O ADJ
ratio) O NOUN
to O PART
receive O VERB
omadacycline O NOUN
(100 O NUM
mg O NOUN
given O VERB
intravenously O ADV
every O DET
12 O NUM
hours O NOUN
for O ADP
two O NUM
doses, O ADJ
then O ADV
100 O NUM
mg O NOUN
given O VERB
intravenously O ADV
every O DET
24 O NUM
hours) O NOUN
or O CCONJ
linezolid O NOUN
(600 O NUM
mg O NOUN
given O VERB
intravenously O ADV
every O DET
12 O NUM
hours). O NOUN

Treatment O NOUN
included O VERB
weekly O ADV
behavioral O ADJ
support O NOUN
for O ADP
at O ADP
least O ADV
4 O NUM
weeks. O NOUN

CONCLUSIONS: O NOUN
Under O ADP
the O DET
VCV O NOUN
mode, O NOUN
the O DET
oxygen O NOUN
flow O NOUN
outside O ADP
the O DET
atomization O NOUN
could O VERB
lead O NOUN
to O PART
the O DET
increase O NOUN
in O ADP
tidal B-outcome DET
volume I-outcome NOUN
of O ADP
the O DET
patient O NOUN
side, O NOUN
while O ADP
under O ADP
the O DET
PCV O NOUN
mode, O NOUN
the O DET
tidal B-outcome DET
volume I-outcome NOUN
and O CCONJ
peak B-outcome NOUN
airway I-outcome NOUN
pressure I-outcome NOUN
in O ADP
the O DET
patient O NOUN
side O NOUN
had O VERB
no O DET
significant O ADJ
change. O NOUN

Clinical B-outcome ADJ
attachment I-outcome NOUN
level I-outcome NOUN
was O VERB
improved O VERB
but O CCONJ
the O DET
results O NOUN
were O VERB
not O ADV
statically O ADV
significant. O NOUN

Gastrointestinal B-outcome ADJ
symptoms I-outcome NOUN
( O PUNCT
flatulence B-outcome NOUN
, O PUNCT
( O PUNCT
heartburn B-outcome ADP
and O CCONJ
diarrhea B-outcome NOUN
) O PUNCT
were O VERB
the O DET
most O DET
commonly O ADV
reported O VERB
among O ADP
those O DET
probably O ADV
related O VERB
to O PART
the O DET
test O NOUN
products. O NOUN

Lifestyle B-outcome NOUN
was O VERB
assessed O VERB
using O VERB
questionnaires O NOUN
and O CCONJ
weight B-outcome NOUN
was O VERB
measured O VERB
at O ADP
baseline, O NOUN
3 O NUM
and O CCONJ
6 O NUM
months O NOUN
after O ADP
randomization. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Before O ADP
and O CCONJ
at O ADP
2 O NUM
weeks, O NOUN
1 O NUM
month, O NOUN
2 O NUM
months, O NOUN
and O CCONJ
4 O NUM
months O NOUN
after O ADP
injection, O NOUN
dry B-outcome ADJ
eye I-outcome NOUN
signs I-outcome NOUN
; O PUNCT
tear B-outcome NUM
film I-outcome NOUN
break-up I-outcome NOUN
time I-outcome NOUN
(TBUT) I-outcome PUNCT
, O PUNCT
Schirmer O NOUN
I O NUM
test], O NUM
corneal B-outcome ADJ
fluorescein I-outcome NOUN
staining I-outcome VERB
(CFS) I-outcome NOUN
, O PUNCT
and O CCONJ
symptoms B-outcome NOUN
; O PUNCT
ocular B-outcome ADJ
surface I-outcome NOUN
disease I-outcome NOUN
index O NOUN
(OSDI)]; O NOUN
and O CCONJ
frequency O NOUN
of O ADP
lubricants B-outcome NOUN
were O VERB
assessed. O NOUN

Journal-Name:Cellular O ADJ
physiology O NOUN
and O CCONJ
biochemistry O NOUN
: O PUNCT
international O ADJ
journal O ADJ
of O ADP
experimental O ADJ
cellular O ADJ
physiology, O NOUN
biochemistry, O ADP
and O CCONJ
pharmacology O NOUN

Conclusions: O NOUN
HP/TAZ O NOUN
lotion O NOUN
was O VERB
associated O VERB
with O ADP
significant O ADJ
and O CCONJ
rapid O ADJ
reductions O NOUN
in O ADP
disease B-outcome NOUN
severity I-outcome NOUN
as O ADP
assessed O VERB
by O ADP
the O DET
IGAxBSA O NOUN
composite O NOUN
tool. O NOUN

PURPOSE/BACKGROUND: O NOUN
Interventions O NOUN
for O ADP
attention-deficit/hyperactivity O NOUN
disorder O ADP
(ADHD) O NUM
may O VERB
be O VERB
inadequate O ADJ
for O ADP
some O DET
patients. O NOUN

We O PRON
report O NOUN
unpublished O VERB
data O NOUN
on O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QoL) I-outcome NOUN
from O ADP
the O DET
original O ADJ
study O NOUN
and O CCONJ
the O DET
results O NOUN
of O ADP
a O DET
follow-up O NOUN
extension. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

RESULTS: O NOUN
In O ADP
the O DET
experimental O ADJ
group O NOUN
both O CCONJ
the O DET
Ober O NOUN
and O CCONJ
Thomas O NOUN
tests O NOUN
were O VERB
positive O ADJ
at O ADP
baseline O NOUN
in O ADP
most O DET
subjects. O NOUN

A O DET
number O NOUN
of O ADP
preventive O ADJ
methods O NOUN
have O VERB
been O VERB
tried. O NOUN

However, O ADV
it O PRON
is O VERB
unknown O VERB
if O ADP
these O DET
characteristics O NOUN
are O VERB
evident O ADJ
in O ADP
people O NOUN
with O ADP
PF O NOUN
osteoarthritis O NOUN
(OA), O NOUN
compared O VERB
to O PART
pain-free O ADJ
older O ADJ
adults. O NOUN

There O PRON
were O VERB
no O DET
statistically O ADV
significant O ADJ
changes O NOUN
in O ADP
the O DET
control O NOUN
group. O VERB

The O DET
subjects O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
the O DET
supplemented O VERB
group O NOUN
(n O NOUN
= O SYM
10), O NUM
receiving O VERB
150 O NUM
mg O NOUN
of O ADP
L-theanine O NOUN
extract O NOUN
for O ADP
6 O NUM
weeks, O NOUN
or O CCONJ
to O PART
the O DET
placebo O NOUN
group O NOUN
(n O NOUN
= O SYM
10). O NOUN

All O DET
rural O ADJ
primary O ADJ
schools O NOUN
(n O NOUN
= O SYM
164) O NOUN
in O ADP
the O DET
county O NOUN
were O VERB
invited O VERB
to O PART
participate. O NOUN

METHODS: O NOUN
The O DET
design O NOUN
for O ADP
the O DET
evaluation O NOUN
of O ADP
the O DET
Nia O NOUN
Project O NOUN
is O VERB
a O DET
longitudinal, O ADJ
cluster-randomized O VERB
controlled O VERB
trial O NOUN
consisting O VERB
of O ADP
a O DET
baseline O NOUN
survey O NOUN
with O ADP
a O DET
cohort O NOUN
of O ADP
Class O NOUN
7 O NUM
girls, O ADJ
a O DET
school O NOUN
quality O NOUN
survey, O ADJ
qualitative O ADJ
data O NOUN
collection, O NOUN
school O NOUN
attendance O NOUN
tracking, O PUNCT
and O CCONJ
an O DET
endline O NOUN
survey O NOUN
at O ADP
the O DET
completion O NOUN
of O ADP
the O DET
18-month O NOUN
intervention O NOUN
period O NOUN
with O ADP
the O DET
same O ADJ
cohort. O NOUN

Control O NOUN
group O NOUN
received O VERB
general O ADJ
education. O NOUN

Additionally, O NOUN
no O DET
significant O ADJ
differences O NOUN
regarding O VERB
all O DET
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
detected O VERB
between O ADP
2 O NUM
groups. O NOUN

The O DET
change O NOUN
in O ADP
Unified O VERB
Parkinson's B-outcome NOUN
Disease I-outcome NOUN
Rating O VERB
Scale O NOUN
(UPDRS) O NUM
score O NOUN
from O ADP
baseline O NOUN
to O PART
week O NOUN
80 O NUM
was O VERB
-1.0+/-13.1 O NOUN
points O NOUN
and O CCONJ
-2.0+/-13.0 O NOUN
points, O NOUN
respectively O ADV
(difference, O ADV
1.0 O NUM
point; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
-1.5 O NUM
to O PART
3.5; O NOUN
P=0.44); O NOUN
this O DET
finding O VERB
of O ADP
no O DET
significant O ADJ
between-group O NOUN
difference O NOUN
at O ADP
week O NOUN
80 O NUM
implies O NOUN
that O ADP
levodopa O NOUN
had O VERB
no O DET
disease-modifying O VERB
effect. O NOUN

Journal O ADJ
ID: O NOUN
100940562 O NUM

Metabolic B-outcome ADJ
function I-outcome NOUN
was O VERB
measured O VERB
through O ADP
blood O NOUN
glucose B-outcome NOUN
, O PUNCT
plasma O NOUN
insulin B-outcome NOUN
, O PUNCT
plasma O NOUN
triglycerides B-outcome NOUN
, O PUNCT
and O CCONJ
plasma O NOUN
catecholamines B-outcome NOUN
: O PUNCT
epinephrine B-outcome NOUN
(E) I-outcome NUM
and O CCONJ
norepinephrine B-outcome NOUN
(NE) I-outcome NOUN
. O PUNCT
Biomarkers O NOUN
were O VERB
taken O VERB
at O ADP
four O NUM
different O ADJ
time O NOUN
points; O NOUN
Ingestion O NOUN
period: O NOUN
baseline O NOUN
(I1), O ADV
post-ingestion O NOUN
period O NOUN
(I2); O PUNCT
Recovery O NOUN
period: O NOUN
immediately O ADV
post-exercise O NOUN
(R1), O PUNCT
post-recovery O NOUN
period O NOUN
(R2). O NOUN

Gains O NOUN
in O ADP
motor B-outcome NOUN
function I-outcome NOUN
in O ADP
both O CCONJ
groups O NOUN
suggest O VERB
that O ADP
undergoing O VERB
therapy, O NOUN
regardless O ADV
of O ADP
its O ADJ
type, O NOUN
might O VERB
be O VERB
a O DET
sufficient O ADJ
stimulus O NOUN
to O PART
produce O VERB
gains O NOUN
when O ADP
intensity O NOUN
is O VERB
adequately O ADV
adjusted. O NOUN

CONCLUSION: O NOUN
The O DET
RSB O NOUN
analgesia O NOUN
could O VERB
significantly O ADV
enhance O NOUN
patient O NOUN
satisfaction B-outcome NOUN
following O VERB
midline O NOUN
laparotomy. O NOUN

BACKGROUND: O NOUN
Today, O NOUN
the O DET
ever-expanding O VERB
technology O NOUN
is O VERB
inevitably O ADV
shadowing O VERB
on O ADP
all O DET
aspects O NOUN
of O ADP
human O NOUN
life. O NOUN

Our O ADJ
primary O ADJ
aim O ADP
was O VERB
to O PART
examine O NOUN
in O ADP
a O DET
randomized O VERB
controlled O VERB
setting O VERB
whether O ADP
diets O NOUN
enriched O VERB
in O ADP
fatty O ADJ
fish O NOUN
(FF), O NUM
lean O ADJ
fish O NOUN
(LF) O NOUN
or O CCONJ
ALA-rich O ADJ
camelina O NOUN
sativa O NOUN
oil O NOUN
(CSO) O PUNCT
differ O VERB
in O ADP
their O ADJ
effects O NOUN
on O ADP
the O DET
mRNA B-outcome NOUN
expression I-outcome NOUN
response O NOUN
of O ADP
selected O VERB
inflammation-related O VERB
genes O NOUN
in O ADP
peripheral O ADJ
blood O NOUN
mononuclear O ADJ
cells O NOUN
(PBMCs) O PUNCT
and O CCONJ
subcutaneous O ADJ
adipose O ADJ
tissue O NOUN
(SAT) O PUNCT
in O ADP
subjects O NOUN
with O ADP
impaired O VERB
fasting O VERB
glucose. O NOUN

Conclusions: O NOUN
No O DET
dose-response O NOUN
relationship O NOUN
of O ADP
netupitant O ADJ
in O ADP
terms O NOUN
of O ADP
overall O ADJ
complete B-outcome ADJ
response I-outcome NOUN
rate O NOUN
was O VERB
observed O VERB
in O ADP
this O DET
study. O NOUN

We O PRON
aimed O VERB
to O PART
examine O NOUN
the O DET
correlation O NOUN
between O ADP
grip B-outcome NOUN
strength I-outcome NOUN
and O CCONJ
train-of-four O ADV
ratio O NOUN
(TOFr) O NOUN
to O PART
examine O NOUN
whether O ADP
assessing O VERB
grip B-outcome NOUN
strength I-outcome NOUN
can O VERB
be O VERB
used O VERB
clinically O ADV
to O PART
monitor O NOUN
residual B-outcome ADJ
neuromuscular I-outcome ADJ
blockade I-outcome NOUN
. O PUNCT
METHODS: O NOUN
One O NUM
hundred O NUM
twenty O NUM
patients O NOUN
with O ADP
ASA O NOUN
I O NUM
or O CCONJ
II O NUM
scheduled O VERB
for O ADP
laparoscopic O ADJ
cholecystectomy O NOUN
under O ADP
general O ADJ
anesthesia O NOUN
were O VERB
enrolled O VERB
in O ADP
this O DET
study. O NOUN

Determining O VERB
whether O ADP
levodopa O NOUN
also O ADV
has O VERB
a O DET
disease-modifying O VERB
effect O NOUN
could O VERB
provide O VERB
guidance O NOUN
as O ADP
to O PART
when O ADP
in O ADP
the O DET
course O NOUN
of O ADP
the O DET
disease O NOUN
the O DET
treatment O NOUN
with O ADP
this O DET
drug O NOUN
should O VERB
be O VERB
initiated. O NOUN

Results: O NOUN
Patients O NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
followed O VERB
up O ADP
1 O NUM
year. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
when O ADP
baseline O NOUN
( O NOUN
DIAGNOdent O ADJ
pen O NOUN
(DD) O NOUN
values O NOUN
were O VERB
compared O VERB
(P O NUM
> O SYM
0.05). O NOUN

RESULTS: O NOUN
Thirty-four O NUM
patients O NOUN
completed O VERB
the O DET
study. O NOUN

Title: O NOUN
A O DET
randomized O VERB
placebo-controlled O VERB
trial O NOUN
of O ADP
delayed-release O NOUN
dimethyl O NOUN
fumarate O NOUN
in O ADP
patients O NOUN
with O ADP
relapsing-remitting O VERB
multiple O ADJ
sclerosis O NOUN
from O ADP
East O ADV
Asia O PROPN
and O CCONJ
other O ADJ
countries. O NUM

The O DET
study O NOUN
involved O VERB
192 O NUM
children. O NOUN

Journal-Name:Medicine O NOUN

PE O NOUN
teachers O NOUN
assigned O VERB
to O PART
the O DET
intervention O NOUN
condition O NOUN
will O VERB
receive O VERB
a O DET
two-week, O NOUN
12-h O NOUN
training O VERB
program O NOUN
comprising O VERB
basic O ADJ
information O NOUN
on O ADP
how O ADP
to O PART
promote O VERB
out-of-school O NOUN
physical B-outcome ADJ
activity I-outcome NOUN
and O CCONJ
theory-based O VERB
training O VERB
on O ADP
strategies O NOUN
to O PART
promote O VERB
students' O NOUN
autonomous O ADJ
motivation B-outcome NOUN
toward O ADP
physical O ADJ
activity. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Negative O ADJ
Pressure O NOUN
Wound O NOUN
Therapy O NOUN
on O ADP
Wound B-outcome NOUN
Complications I-outcome NOUN
Post-Pancreatectomy. O NOUN

INTRODUCTION: O NOUN
N95 O NOUN
or O CCONJ
higher O ADJ
filtering O VERB
respirators O NOUN
have O VERB
been O VERB
recommended O VERB
in O ADP
healthcare O NOUN
settings, O NOUN
although O ADP
there O PRON
is O VERB
still O ADV
a O DET
risk O NOUN
of O ADP
infection O NOUN
due O ADJ
to O PART
the O DET
improper O NOUN
selection O NOUN
and O CCONJ
wearing O VERB
of O ADP
respirators. O NOUN

CONCLUSIONS: O NOUN
Soft, O NOUN
non-manipulative O ADJ
osteopathic O ADJ
treatment O NOUN
is O VERB
effective O ADJ
in O ADP
improving O VERB
overall B-outcome ADJ
and Seperator CCONJ
physical-related B-outcome VERB
quality I-outcome NOUN
of I-outcome ADP
life E3-outcome NOUN
in O ADP
CD O NOUN
patients, O NOUN
regardless O ADV
of O ADP
the O DET
phase O NOUN
of O ADP
the O DET
disease. O NOUN

Thirty O NUM
patients O NOUN
(50%) O PUNCT
received O VERB
prophylactic O ADJ
powdered O VERB
GLN O NOUN
orally O ADV
at O ADP
a O DET
dose O NOUN
of O ADP
10 O NUM
g/8 O NOUN
h. O NOUN
The O DET
prescribed O VERB
radiation O NOUN
dose O NOUN
to O PART
the O DET
planning O VERB
target O NOUN
volume O NOUN
was O VERB
30 O NUM
Gy O NOUN
in O ADP
2-Gy O NUM
fractions. O NOUN

The O DET
secondary O ADJ
endpoints O NOUN
are O VERB
surgeon's O PUNCT
surgical B-outcome ADJ
condition I-outcome NOUN
score, O NOUN
patient's O NOUN
sedation B-outcome NOUN
score, O NOUN
and O CCONJ
surgical O ADJ
outcomes O NOUN
including O VERB
peak B-outcome NOUN
inspiratory I-outcome ADJ
pressure I-outcome NOUN
, O PUNCT
operation B-outcome NOUN
time I-outcome NOUN
, O PUNCT
postoperative O ADJ
pain B-outcome NOUN
, O PUNCT
and O CCONJ
morbidity B-outcome NOUN
. O PUNCT
DISCUSSION: O NOUN
This O DET
is O VERB
the O DET
first O ADV
study O NOUN
that O ADP
compares O NOUN
deep O ADJ
NMB O NOUN
with O ADP
moderate O ADJ
NMB O NOUN
during O ADP
laparoscopic O ADJ
gastrectomy O NOUN
in O ADP
obese O NOUN
patients O NOUN
with O ADP
gastric O ADJ
cancer. O NOUN

Publication O NOUN
date: O NOUN
2019/01/18 O NOUN
06:00 O ADP
[medline] O NOUN

Journal O ADJ
ID: O NOUN
101225531 O NUM

This O DET
study O NOUN
suggests O NOUN
that O ADP
epithelial O ADJ
remodeling O VERB
may O VERB
correlate O VERB
with O ADP
relative O ADJ
curvature O NOUN
changes O NOUN
resulting O VERB
after O ADP
both O CCONJ
techniques, O NOUN
rather O ADV
than O ADP
the O DET
obvious O ADJ
difference O NOUN
of O ADP
subepithelial O ADJ
corneal O ADJ
denervation O NOUN
changes. O NOUN

Title: O NOUN
Preventive O ADJ
effect O NOUN
of O ADP
ecabet O NOUN
sodium O NOUN
on O ADP
low-dose O NOUN
aspirin-induced O VERB
small B-outcome ADJ
intestinal I-outcome ADJ
mucosal I-outcome ADJ
injury I-outcome NOUN
: O PUNCT
a O DET
randomized, O NOUN
double-blind, O NOUN
pilot O NOUN
study. O NOUN

Journal-Name:Nigerian O NOUN
journal O ADJ
of O ADP
clinical O ADJ
practice O NOUN

However, O ADV
this O DET
is O VERB
the O DET
first O ADV
report O NOUN
about O ADV
the O DET
effects O NOUN
on O ADP
indicators O NOUN
of O ADP
endothelial B-outcome ADJ
damage I-outcome NOUN
. O PUNCT
More O ADV
research O NOUN
in O ADP
this O DET
field O NOUN
is O VERB
necessary O ADJ
to O PART
gain O VERB
an O DET
insight O NOUN
into O ADP
the O DET
effects O NOUN
of O ADP
Spirulina O NOUN
on O ADP
these O DET
indicators. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

We O PRON
found O VERB
that O ADP
the O DET
two O NUM
regimens O NOUN
were O VERB
equivalent; O NOUN
36 O NUM
out O ADP
of O ADP
44 O NUM
patients O NOUN
reached O VERB
the O DET
normal O ADJ
range O NOUN
of O ADP
vitamin O NOUN
D O NOUN
after O ADP
six O NUM
months O NOUN
of O ADP
treatment. O NOUN

Publication O NOUN
date: O NOUN
2019/01/18 O NOUN
06:00 O ADP
[entrez] O ADP

Current O ADJ
management O NOUN
is O VERB
delivered O VERB
by O ADP
a O DET
multidisciplinary O ADJ
team, O NOUN
but O CCONJ
evidence O NOUN
of O ADP
effectiveness O NOUN
is O VERB
limited. O NOUN

Age, O NOUN
sex, O NOUN
type O NOUN
of O ADP
femoral O ADJ
prosthesis, O ADV
and O CCONJ
the O DET
injection O NOUN
method O NOUN
of O ADP
TXA O NOUN
were O VERB
risk O NOUN
factors O NOUN
for O ADP
HBL O NOUN
of O ADP
patients O NOUN
after O ADP
receiving O VERB
TKA. O NOUN

Journal O ADJ
ID: O NOUN
8910750 O NUM

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

Thus, O NOUN
the O DET
present O ADJ
study O NOUN
was O VERB
conducted O VERB
with O ADP
the O DET
aim O ADP
to O PART
determine O NOUN
the O DET
effect O NOUN
of O ADP
lavender O NOUN
aromatherapy O NOUN
on O ADP
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(QOL) I-outcome PUNCT
of O ADP
postmenopausal O ADJ
women. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Otherwise, O NOUN
there O PRON
were O VERB
marginal O ADJ
benefits O NOUN
for O ADP
keeping O VERB
the O DET
indwelling O VERB
catheter O NOUN
for O ADP
48 O NUM
hours O NOUN
in O ADP
terms O NOUN
of O ADP
reducing O VERB
the O DET
number O NOUN
of O ADP
patients O NOUN
with O ADP
moderate O ADJ
pain B-outcome NOUN
and O CCONJ
improving O VERB
the O DET
quality B-outcome NOUN
of I-outcome ADP
pain I-outcome NOUN
management I-outcome NOUN
. O PUNCT
However, O ADV
all O DET
three O NUM
groups O NOUN
had O VERB
similar O ADJ
opioid B-outcome NOUN
usage I-outcome NOUN
, O PUNCT
length B-outcome NOUN
of I-outcome ADP
hospital I-outcome NOUN
stay I-outcome NOUN
, O PUNCT
and O CCONJ
functional B-outcome ADJ
outcomes. O ADJ

Despite O ADP
their O ADJ
growing O VERB
demographics O NOUN
in O ADP
the O DET
US, O ADP
there O PRON
are O VERB
few O ADJ
studies O NOUN
evaluating O VERB
acne O NOUN
treatment O NOUN
in O ADP
this O DET
population. O ADV

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
the O DET
age, O NOUN
MAS O NOUN
score, O NOUN
and O CCONJ
GMFM O NOUN
score O NOUN
between O ADP
the O DET
2 O NUM
groups O NOUN
before O ADP
treatment. O NOUN

In O ADP
the O DET
modified O VERB
localization O NOUN
group, O NOUN
all O DET
32 O NUM
patients O NOUN
succeeded O VERB
in O ADP
the O DET
localization B-outcome NOUN
, O PUNCT
and O CCONJ
the O DET
success B-outcome NOUN
rate O NOUN
was O VERB
100%. O ADP

Children O NOUN
with O ADP
spastic O ADJ
cerebral O ADJ
palsy O NOUN
6 O NUM
weeks O NOUN
after O ADP
multistage O NOUN
surgery O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
treatment O NOUN
group O NOUN
(received O PUNCT
rESWT O NOUN
and O CCONJ
conventional O ADJ
rehabilitation O NOUN
therapy) O NOUN
and O CCONJ
control O NOUN
group O NOUN
(received O PUNCT
conventional O ADJ
rehabilitation O NOUN
only). O NUM

Overjets B-outcome NOUN
were O VERB
reduced O VERB
by O ADP
7 O NUM
mm O NOUN
(SD, O NOUN
2.92) O NUM
in O ADP
the O DET
PT O NOUN
group O NOUN
and O CCONJ
6.5 O NUM
mm O NOUN
(SD, O NOUN
2.62) O NUM
in O ADP
the O DET
FT O NOUN
group, O NOUN
with O ADP
no O DET
statistical O ADJ
difference O NOUN
between O ADP
the O DET
groups O NOUN
(P O NUM
= O SYM
0.587; O NUM
95% O NOUN
CI, O NOUN
-1.01, O NOUN
1.78). O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

At O ADP
4, O NOUN
8, O NOUN
and O CCONJ
12 O NUM
weeks O NOUN
of O ADP
treatment, O NOUN
the O DET
patients O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
had O VERB
significantly O ADV
lowered O VERB
scores O NOUN
of O ADP
TCM B-outcome NOUN
syndromes I-outcome NOUN
compared O VERB
with O ADP
the O DET
score O NOUN
before O ADP
treatment O NOUN
(P O NUM
&lt; O NOUN
0.05 O NUM
or O CCONJ
0.01), O NUM
while O ADP
in O ADP
the O DET
control O NOUN
group, O NOUN
significant O ADJ
reduction O NOUN
of O ADP
the O DET
scores O NOUN
occurred O VERB
only O ADV
at O ADP
12 O NUM
weeks O NOUN
(P O NUM
&lt; O NOUN
0.05); O NUM
at O ADP
each O DET
of O ADP
the O DET
time O NOUN
points, O NOUN
the O DET
treatment O NOUN
group O NOUN
had O VERB
significantly O ADV
greater O ADJ
reductions O NOUN
in O ADP
the O DET
score O NOUN
than O ADP
the O DET
control O NOUN
group O NOUN
(P O NUM
&lt; O NOUN
0.01). O NOUN

The O DET
patients O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
received O VERB
UGPRF, O NOUN
while O ADP
the O DET
subjects O NOUN
in O ADP
the O DET
sham O NOUN
group O NOUN
underwent O VERB
sham O NOUN
UGPRF. O NOUN

The O DET
two O NUM
groups O NOUN
only O ADV
differ O VERB
by O ADP
the O DET
Simvastatin O NOUN
or O CCONJ
placebo O NOUN
administration O NOUN
regimen O NOUN
while O ADP
following O VERB
the O DET
same O ADJ
procedure, O NOUN
with O ADP
identical O ADJ
surgical O ADJ
instruments, O NOUN
and O CCONJ
medical O ADJ
and O CCONJ
nursing O VERB
skilled O VERB
staff. O NOUN

Sporting O VERB
organisations O NOUN
should O VERB
be O VERB
encouraged O VERB
to O PART
seek O NOUN
sponsorship O NOUN
from O ADP
companies O NOUN
who O ADP
produce O VERB
healthier O ADJ
food O NOUN
brands O NOUN
and O CCONJ
government-funded O VERB
social O ADJ
marketing O VERB
campaigns. O ADV

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Additionally O ADV
mean O NOUN
radiation B-outcome NOUN
dose I-outcome NOUN
per O ADP
shoot O NOUN
of O ADP
recorded O VERB
Left O ADV
anterior O ADJ
oblique O ADJ
(LAO) O NOUN
oriented O VERB
projections O NOUN
was O VERB
34.4+/-15.7mGyvs O NUM
24.9+/-12.9 O NUM
mGy O NOUN
for O ADP
a O DET
non O ADJ
LAO O NOUN
oriented O VERB
projection. O NOUN
( O PUNCT

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

IR O NOUN
premenopausal O ADJ
women O NOUN
show O VERB
significant O ADJ
increase O NOUN
in O ADP
insulin-like B-outcome ADJ
growth I-outcome NOUN
factor-1 I-outcome NOUN
serum O NOUN
concentrations O NOUN
regardless O ADV
the O DET
method O NOUN
of O ADP
intervention. O NOUN

In O ADP
conclusion, O NOUN
PPI O NOUN
could O VERB
ameliorate O VERB
hypogeusia B-outcome NOUN
by O ADP
improving O VERB
bitter, B-outcome NOUN
salty, B-outcome ADJ
and Seperator CCONJ
sour B-outcome NOUN
tastes E1-outcome NOUN
among O ADP
patients O NOUN
with O ADP
LPR. O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
Medication O NOUN
Co-payment O ADJ
Vouchers O NOUN
on O ADP
P2Y12 B-outcome NOUN
Inhibitor I-outcome NOUN
Use I-outcome PUNCT
and O CCONJ
Major B-outcome ADP
Adverse I-outcome ADJ
Cardiovascular I-outcome ADJ
Events I-outcome NOUN
Among O ADP
Patients O NOUN
With O ADP
Myocardial O ADJ
Infarction: O NOUN
The O DET
ARTEMIS O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

Publication O NOUN
date: O NOUN
2018/12/28 O NUM
06:00 O ADP
[entrez] O ADP

For O ADP
normal O ADJ
breathing, O NOUN
fit B-outcome NOUN
factors I-outcome NOUN
before O ADP
and O CCONJ
after O ADP
training O VERB
were O VERB
121 O NUM
(10-185) O NUM
vs O CCONJ
192 O NUM
(161-200) O PUNCT
for O ADP
cup-type, O NOUN
200 O NUM
(39-200) O NOUN
vs O CCONJ
200 O NUM
(200-200) O NOUN
for O ADP
fold-type, O NOUN
and O CCONJ
85 O NUM
(18-157) O PUNCT
vs O CCONJ
173 O NUM
(117-200) O PUNCT
for O ADP
valve-type. O NOUN

INTERPRETATION: O CCONJ
In O ADP
older O ADJ
patients O NOUN
with O ADP
newly O ADV
diagnosed O VERB
acute O ADJ
myeloid O NOUN
leukaemia, O NOUN
efficacy O NOUN
and O CCONJ
safety O NOUN
did O VERB
not O ADV
differ O VERB
by O ADP
the O DET
5-day O NOUN
or O CCONJ
the O DET
10-day O NOUN
decitabine O NOUN
schedule. O NOUN

Complications B-outcome NOUN
, O PUNCT
for O ADP
both O CCONJ
groups O NOUN
were O VERB
similar O ADJ
with O ADP
30% O NOUN
in O ADP
proposed O VERB
drainage O NOUN
and O CCONJ
25% O NUM
in O ADP
traditional O ADJ
approach O NOUN
(p=0.723). O PUNCT

One O NUM
participant O ADJ
was O VERB
lost B-outcome VERB
to I-outcome PART
follow-up I-outcome NOUN
. O PUNCT
Outcome B-outcome NOUN
completion I-outcome NOUN
rates O NOUN
ranged O VERB
from O ADP
89 O NUM
to O PART
97%. O NUM

Title: O NOUN
[Efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
selective O ADJ
brain O NOUN
hypothermia O NOUN
therapy O NOUN
on O ADP
neonatal O ADJ
hypoxic-ischemic O ADJ
encephalopathy]. O NOUN

The O DET
assay O NOUN
was O VERB
applied O VERB
in O ADP
a O DET
pilot O NOUN
pharmacokinetic O ADJ
study O NOUN
in O ADP
renal O ADJ
transplanted O VERB
patients O NOUN
receiving O VERB
belatacept O ADV
infusions. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Endothelial B-outcome ADJ
Cell I-outcome NOUN
Density I-outcome NOUN
(ECD) I-outcome NOUN
, O PUNCT
coefficient O NOUN
of O ADP
variation, O NOUN
and O CCONJ
percentage O NOUN
of O ADP
hexagonal B-outcome ADJ
cells I-outcome NOUN
were O VERB
evaluated O VERB
by O ADP
a O DET
central O ADJ
image O NOUN
analysis O NOUN
reading O VERB
center O NOUN
and O CCONJ
central B-outcome ADJ
corneal I-outcome ADJ
thickness I-outcome NOUN
(CCT) I-outcome PUNCT
was O VERB
evaluated O VERB
by O ADP
ultrasound O NOUN
pachymetry. O VERB

After O ADP
each O DET
fitting O VERB
and O CCONJ
at O ADP
1-week O NOUN
follow-up, O ADP
high- O ADV
and O CCONJ
low-contrast O NOUN
visual B-outcome ADJ
acuities I-outcome NOUN
were O VERB
measured. O NOUN

Results: O NOUN
P(ET)CO(2) B-outcome NOUN
in O ADP
group O NOUN
A O DET
at O ADP
T(0), O NOUN
T(1), O NOUN
T(2), O NOUN
T(3), O NOUN
T(4), O NOUN
T(5) O ADJ
were O VERB
(36.9+/-4.1), O NOUN
(36.3+/-4.7), O NOUN
(38.1+/-5.6), O NOUN
(40.4+/-4.0), O NOUN
(48.8+/-7.7), O NOUN
(45.3+/-7.6) O NOUN
mmHg, O NOUN
P(ET)CO(2) B-outcome NOUN
in O ADP
group O NOUN
B O NOUN
were O VERB
(38.6+/-4.4), O NOUN
(37.8+/-5.6), O ADV
(37.8+/-5.4), O NOUN
(37.4+/-6.7), O NOUN
(43.3+/-12.2), O PUNCT
(43.5+/-8.0) O PUNCT
mmHg, O NOUN
at O ADP
the O DET
end O NOUN
of O ADP
operation, O NOUN
the O DET
P(ET)CO(2) B-outcome NOUN
at O ADP
T(4) O NOUN
and O CCONJ
T(5) O ADJ
were O VERB
significantly O ADV
higher O ADJ
than O ADP
at O ADP
T(0) O NOUN
in O ADP
group O NOUN
A O DET
and O CCONJ
group O NOUN
B O NOUN
(F=14.582, O NOUN
12.651, O ADV
all O DET
P<0.05). O NOUN

Journal-Name:Zhonghua O NOUN
yi O ADP
xue O NOUN
za O ADP
zhi O NUM

Four O NUM
infants O NOUN
had O VERB
consent O NOUN
withdrawn O VERB
or O CCONJ
unconfirmed, O NOUN
leaving O VERB
1098 O NUM
infants O NOUN
in O ADP
the O DET
lactoferrin O NOUN
group O NOUN
and O CCONJ
1101 O NUM
in O ADP
the O DET
sucrose O NOUN
group. O VERB

CONCLUSION: O NOUN
Significant O ADJ
differences O NOUN
in O ADP
MBLs O NOUN
were O VERB
observed O VERB
at O ADP
different O ADJ
implant O NOUN
interfaces. O NUM

CONCLUSIONS: O NOUN
Our O ADJ
mixed O VERB
results O NOUN
pose O NOUN
challenges O NOUN
that O ADP
are O VERB
too O ADV
infrequently O ADV
exposed O VERB
in O ADP
public O ADJ
heath O NOUN
intervention O NOUN
trials. O NOUN

The O DET
patient's O NOUN
satisfaction B-outcome NOUN
with O ADP
anesthesia O NOUN
was O VERB
assessed O VERB
with O ADP
the O DET
Visual O ADJ
Analog O NOUN
Scale O NOUN
(VAS) O PUNCT
score O NOUN
on O ADP
the O DET
first O ADV
day O NOUN
after O ADP
the O DET
operation. O ADV

Title: O NOUN
Comparison O NOUN
the O DET
cost-efficacy O NOUN
of O ADP
furazolidone-based O VERB
versus O CCONJ
clarithromycin-based O VERB
quadruple O ADJ
therapy O NOUN
in O ADP
initial O ADJ
treatment O NOUN
of O ADP
Helicobacter O NOUN
pylori O NOUN
infection O NOUN
in O ADP
a O DET
variable O ADJ
clarithromycin O NOUN
drug-resistant O ADJ
region, O NOUN
a O DET
single-center, O NOUN
prospective, O NOUN
randomized, O NOUN
open-label O NOUN
study. O NOUN

Journal O ADJ
ID: O NOUN
100968555 O NUM

However, O ADV
there O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
social B-outcome ADJ
support I-outcome NOUN
for O ADP
stress O NOUN
management O NOUN
and O CCONJ
negative B-outcome ADJ
affect I-outcome NOUN
between O ADP
these O DET
two O NUM
groups. O NOUN

Title: O NOUN
Pilates O NOUN
exercises O NOUN
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
of O ADP
patients O NOUN
with O ADP
chronic O ADJ
kidney O NOUN
disease. O NOUN

Results: O NOUN
All O DET
patients O NOUN
were O VERB
followed O VERB
up O ADP
12-18 O NUM
months O NOUN
with O ADP
an O DET
average O NOUN
of O ADP
14.4 O NUM
months. O NOUN

All O DET
secondary O ADJ
endpoints O NOUN
were O VERB
met. O NOUN

Between O ADP
weeks O NOUN
4 O NUM
and O CCONJ
40, O NUM
the O DET
rate O NOUN
of O ADP
progression B-outcome NOUN
of O ADP
symptoms, O NOUN
as O ADP
measured O VERB
in O ADP
Unified O VERB
Parkinson's B-outcome NOUN
Disease I-outcome NOUN
Rating O VERB
Scale O NOUN
(UPDRS) O NUM
points O NOUN
per O ADP
week, O NOUN
was O VERB
0.04+/-0.23 O NOUN
in O ADP
the O DET
early-start O NOUN
group O NOUN
and O CCONJ
0.06+/-0.34 O NOUN
in O ADP
the O DET
delayed-start O NOUN
group O NOUN
(difference, O ADV
-0.02; O ADP
95% O NOUN
CI, O NOUN
-0.07 O NUM
to O PART
0.03). O NUM

Hydrocephalus O NOUN
is O VERB
seen O VERB
in O ADP
11.8% O NUM
of O ADP
children O NOUN
with O ADP
Myelomeningocele O NOUN
(MMC). O PUNCT

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

After O ADP
administration O NOUN
of O ADP
2 O NUM
doses, O ADJ
the O DET
seropositivity O NOUN
rates O NOUN
in O ADP
the O DET
Avaxim, O NOUN
Epaxal, O NOUN
and O CCONJ
Havrix O NOUN
groups O NOUN
were O VERB
all O DET
100% O NOUN
(95% O PUNCT
confidence O NOUN
intervals O NOUN
[CIs]: O NOUN
99.0-100, O NOUN
98.9-100, O NOUN
and O CCONJ
99.0-100, O NOUN
respectively; O NOUN
P O NOUN
< O SYM
.001). O PUNCT

In O ADP
addition, O NOUN
post-training, O NOUN
participants O NOUN
still O ADV
felt O ADP
uncomfortable O ADJ
with O ADP
certain O ADJ
aspects O NOUN
of O ADP
treatment O NOUN
and O CCONJ
the O DET
management O NOUN
of O ADP
some O DET
mental O ADJ
health O NOUN
conditions. O NOUN

HIV O NOUN
self-testing O VERB
may O VERB
be O VERB
a O DET
way O NOUN
to O PART
increase O NOUN
testing O VERB
rates O NOUN
in O ADP
this O DET
high-risk O NOUN
population. O ADV

Journal-Name:Japanese O NOUN
journal O ADJ
of O ADP
clinical O ADJ
oncology O NOUN

Journal-Name:Medicine O NOUN

OBJECTIVE: O NOUN
To O PART
assess O NOUN
the O DET
efficacy O NOUN
of O ADP
three O NUM
months O NOUN
of O ADP
antibiotic O ADJ
treatment O NOUN
compared O VERB
with O ADP
placebo O NOUN
in O ADP
patients O NOUN
with O ADP
chronic O ADJ
low O ADJ
back O ADP
pain, O NOUN
previous O ADJ
disc O NOUN
herniation, O NOUN
and O CCONJ
vertebral O ADJ
endplate O NOUN
changes O NOUN
(Modic O NUM
changes). O NUM

TRIAL O NOUN
REGISTRATION: O NOUN
ClinicalTrials.gov O NOUN
NCT02323412. O NOUN

Journal-Name:Zhonghua O NOUN
yi O ADP
xue O NOUN
za O ADP
zhi O NUM

Before O ADP
clinicians O NOUN
can O VERB
advocate O NOUN
PC O NOUN
as O ADP
an O DET
EHS O NOUN
prevention O NOUN
strategy, O NOUN
it O PRON
must O VERB
effectively O ADV
mitigate O NOUN
factors O NOUN
associated O VERB
with O ADP
EHS O NOUN
development O NOUN
while O ADP
not O ADV
lessening O VERB
the O DET
effectiveness O NOUN
of O ADP
EHS O NOUN
treatment. O NOUN

A O DET
total O ADJ
of O ADP
82 O NUM
children O NOUN
with O ADP
spastic O ADJ
cerebral O ADJ
palsy O NOUN
were O VERB
recruited, O NOUN
including O VERB
43 O NUM
children O NOUN
in O ADP
treatment O NOUN
group O NOUN
and O CCONJ
39 O NUM
children O NOUN
in O ADP
control O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
101160020 O NUM

Gastric B-outcome ADJ
residual I-outcome ADJ
volume I-outcome NOUN
before O ADP
and O CCONJ
one O NUM
hours O NOUN
after O ADP
feeding O VERB
was O VERB
measured O VERB
and O CCONJ
recorded O VERB
for O ADP
three O NUM
positions O NOUN
including O VERB
right-lateral, O NOUN
left-lateral, O NOUN
and O CCONJ
prone. O NOUN

The O DET
95% O NOUN
confidence O NOUN
interval O NOUN
for O ADP
the O DET
difference O NOUN
in O ADP
aortic O ADJ
and O CCONJ
hepatic O ADJ
enhancement B-outcome NOUN
between O ADP
the O DET
2 O NUM
protocols O NOUN
was O VERB
within O ADP
the O DET
range O NOUN
of O ADP
the O DET
predetermined O VERB
equivalence O NOUN
margins O NOUN
in O ADP
all O DET
BMI O NOUN
subgroups. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

This O DET
follows O NOUN
a O DET
4-week O NOUN
baseline O NOUN
period O NOUN
where O ADP
all O DET
villages O NOUN
do O VERB
not O ADV
receive O VERB
repellent. O NOUN

No O DET
adverse B-outcome ADJ
events I-outcome NOUN
were O VERB
recorded O VERB
in O ADP
both O CCONJ
groups. O NOUN

No O DET
change O NOUN
in O ADP
Pgp3-specific B-outcome NOUN
antibody I-outcome NOUN
responses I-outcome NOUN
were O VERB
observed O VERB
after O ADP
treatment O NOUN
in O ADP
the O DET
control O NOUN
or O CCONJ
treatment O NOUN
arms. O ADJ

RESULTS: O NOUN
CART O NOUN
group O NOUN
demonstrated O VERB
an O DET
increase O NOUN
in O ADP
HFnu B-outcome NOUN
, O PUNCT
TP B-outcome NOUN
, O PUNCT
SDNN B-outcome NOUN
, O PUNCT
and O CCONJ
RMSSD B-outcome NOUN
, O PUNCT
(p<0.05) O NOUN
along O ADV
with O ADP
a O DET
significant O ADJ
decrease O NOUN
in O ADP
LFnu B-outcome ADP
, O PUNCT
LF/HF B-outcome ADV
ratio I-outcome NOUN
, O PUNCT
systolic B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
, O PUNCT
and O CCONJ
diastolic B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
(p<0.05). O NOUN

MATERIAL O NOUN
AND O CCONJ
METHODS: O NOUN
The O DET
safety O NOUN
was O VERB
evaluated O VERB
in O ADP
randomly O ADV
assigned O VERB
subjects O NOUN
who O ADP
received O VERB
the O DET
test O NOUN
products O NOUN
(61 O NOUN
subjects O NOUN
in O ADP
BT-11 O NOUN
300mg O NUM
daily O ADJ
or O CCONJ
60 O NUM
subjects O NOUN
in O ADP
matching O VERB
placebo) O NOUN
for O ADP
12 O NUM
weeks. O NOUN

We O PRON
used O VERB
minimally O ADV
invasive O ADJ
technique O NOUN
pressure O NOUN
recording O VERB
analytical O ADJ
method O NOUN
(PRAM) O NUM
to O PART
directly O ADV
monitor O NOUN
hemodynamics B-outcome NOUN
and O CCONJ
cardiac B-outcome ADJ
efficiency O NOUN
and O CCONJ
compared O VERB
the O DET
effects O NOUN
of O ADP
the O DET
two O NUM
anesthetic O ADJ
regimens O NOUN
in O ADP
children O NOUN
undergoing O VERB
ventricular O ADJ
septal O ADJ
defect O NOUN
repair. O NOUN

Results O NOUN
will O VERB
be O VERB
disseminated O VERB
through O ADP
workshops, O NOUN
conferences O NOUN
and O CCONJ
peer-reviewed O VERB
publications. O NOUN

The O DET
presence O NOUN
of O ADP
acute O ADJ
uncomplicated O VERB
cystitis O NOUN
symptoms O NOUN
was O VERB
recorded O VERB
and O CCONJ
urinalysis O ADV
was O VERB
performed. O NOUN

Our O ADJ
finding O VERB
that O ADP
highly-severe O ADJ
health O NOUN
warnings O NOUN
increase O NOUN
avoidance B-outcome NOUN
and O CCONJ
reactance B-outcome NOUN
but O CCONJ
are O VERB
also O ADV
perceived O VERB
as O ADP
being O VERB
more O ADV
effective O ADJ
and O CCONJ
more O ADV
likely O ADV
to O PART
motivate B-outcome NOUN
people O NOUN
to O PART
drink O NOUN
less O ADV
will O VERB
inform O NOUN
future O NOUN
health O NOUN
warning O VERB
design O NOUN
and O CCONJ
have O VERB
implications O NOUN
for O ADP
health O NOUN
warning O VERB
label O NOUN
theory. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Conclusions O NOUN
The O DET
results O NOUN
of O ADP
this O DET
study O NOUN
indicated O VERB
that O ADP
TC O NOUN
may O VERB
alleviate O NOUN
depression B-outcome NOUN
of O ADP
the O DET
elderly O NOUN
through O ADP
modulating O VERB
autonomous O ADJ
nervous O ADJ
system O NOUN
or O CCONJ
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
parameters. O NOUN

The O DET
same O ADJ
evaluation O NOUN
was O VERB
used O VERB
18 O NUM
to O PART
30 O NUM
months O NOUN
postoperatively O ADV
to O PART
estimate O ADP
the O DET
results O NOUN
of O ADP
our O ADJ
treatment. O NOUN

Our O ADJ
findings O NOUN
confirm O NOUN
that O ADP
lactobacilli O NOUN
decrease O NOUN
cry B-outcome NOUN
and Seperator CCONJ
fuss B-outcome NOUN
time E1-outcome NOUN
and O CCONJ
provide O VERB
a O DET
dietary B-outcome ADJ
support I-outcome NOUN
in O ADP
exclusively O ADV
breastfed O NOUN
infants O NOUN
with O ADP
colic. O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
patients O NOUN
scheduled O VERB
for O ADP
CABG O NOUN
to O PART
undergo O NOUN
bilateral O ADJ
or O CCONJ
single O ADJ
internal-thoracic-artery O ADV
grafting. O NOUN

Accumulating O VERB
evidence O NOUN
suggests O NOUN
that O ADP
some O DET
single O ADJ
strains O NOUN
of O ADP
lactobacilli O NOUN
may O VERB
play O VERB
a O DET
positive O ADJ
dietary O ADJ
role O NOUN
in O ADP
attenuation O NOUN
of O ADP
colic O ADJ
in O ADP
exclusively O ADV
breastfed O NOUN
infants. O NOUN

We O PRON
hypothesized O VERB
that O ADP
Dex O NOUN
could O VERB
enhance O NOUN
the O DET
efficiency O NOUN
of O ADP
intrathecal O ADJ
bupivacaine O NOUN
for O ADP
spinal O ADJ
anesthesia O NOUN
in O ADP
cesarean O NOUN
section. O NOUN

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[entrez] O ADP

Importance: O NOUN
Microvascular O ADJ
obstruction O NOUN
commonly O ADV
affects O NOUN
patients O NOUN
with O ADP
acute O ADJ
ST-segment O NOUN
elevation O NOUN
myocardial O ADJ
infarction O NOUN
(STEMI) O PUNCT
and O CCONJ
is O VERB
associated O VERB
with O ADP
adverse O ADJ
outcomes. O ADJ

In O ADP
the O DET
PRP O NOUN
group O NOUN
(n O NOUN
= O SYM
40), O NOUN
in O ADP
addition O NOUN
to O PART
HRT, O NOUN
0.5-1 O NUM
cc O NOUN
of O ADP
PRP O NOUN
was O VERB
infused O VERB
into O ADP
the O DET
uterine O ADJ
cavity O NOUN
on O ADP
the O DET
13th O ADJ
day O NOUN
of O ADP
HRT O NOUN
cycle. O NOUN

In O ADP
this O DET
study, O NOUN
we O PRON
showed O VERB
that O ADP
supplementation O NOUN
with O ADP
a O DET
PMP O NOUN
significantly O ADV
improved O VERB
reactive B-outcome ADJ
oxygen I-outcome NOUN
species I-outcome NOUN
(ROS) I-outcome PUNCT
scavenging O VERB
activity O NOUN
and O CCONJ
prevented O VERB
DNA B-outcome NOUN
damage I-outcome NOUN
. O PUNCT
However, O ADV
additional O ADJ
research O NOUN
is O VERB
still O ADV
needed O VERB
to O PART
further O ADV
identify O NOUN
mechanisms O NOUN
of O ADP
actions O NOUN
and O CCONJ
the O DET
role O NOUN
of O ADP
circulating O VERB
phytonutrient O NOUN
metabolites. O NOUN

Thus, O NOUN
krill O NOUN
powder O NOUN
has O VERB
a O DET
lot O NOUN
of O ADP
potential O ADJ
in O ADP
improving O VERB
lipid O NOUN
and O CCONJ
metabolic O ADJ
profile O NOUN
and O CCONJ
reinforcing O VERB
the O DET
activity O NOUN
of O ADP
the O DET
antioxidant O NOUN
system. O NOUN

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

Bivariate O NOUN
and O CCONJ
multivariate O ADJ
logistic O ADJ
regression O NOUN
analysis O NOUN
assessed O VERB
correlates O NOUN
of O ADP
different O ADJ
indicators O NOUN
of O ADP
psychological O ADJ
distress. O NOUN

Netupitant O ADJ
was O VERB
well O ADV
tolerated B-outcome VERB
at O ADP
all O DET
doses O NOUN
without O ADP
clinically O ADV
harmful O ADJ
safety O NOUN
signals O NOUN
observed. O NOUN

A O DET
range O NOUN
of O ADP
studies O NOUN
showed O VERB
confusing O VERB
data O NOUN
about O ADV
the O DET
relationship O NOUN
between O ADP
obesity, O ADJ
weight O NOUN
reduction O NOUN
and O CCONJ
circulating O VERB
total O ADJ
insulin-like O ADJ
growth O NOUN
factor O NOUN
-1 O NUM
(IGF-1). O PUNCT

Methods: O NOUN
Between O ADP
March O NOUN
2017 O NUM
and O CCONJ
May O NOUN
2017, O NUM
24 O NUM
patients O NOUN
who O ADP
planned O VERB
to O PART
have O VERB
a O DET
unilateral O ADJ
THA O NOUN
were O VERB
enrolled O VERB
in O ADP
the O DET
study O NOUN
and O CCONJ
randomized O VERB
into O ADP
2 O NUM
groups. O NOUN

INTRODUCTION: O NOUN
In O ADP
this O DET
study, O NOUN
we O PRON
aimed O VERB
to O PART
compare O NOUN
the O DET
incidence O NOUN
of O ADP
new O ADJ
demineralized B-outcome VERB
lesions I-outcome NOUN
and O CCONJ
bond B-outcome NOUN
failures I-outcome NOUN
between O ADP
2 O NUM
groups O NOUN
of O ADP
participants O NOUN
wearing O VERB
fixed O VERB
orthodontic O ADJ
appliances O NOUN
bonded O VERB
with O ADP
either O CCONJ
light-cured O VERB
resin-modified O VERB
glass O NOUN
ionomer O NOUN
cement O NOUN
or O CCONJ
light-cured O VERB
composite. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Few O ADJ
studies O NOUN
have O VERB
described O VERB
belatacept O ADV
pharmacokinetics, O NOUN
and O CCONJ
the O DET
effect O NOUN
of O ADP
therapeutic O ADJ
drug O NOUN
monitoring O VERB
has O VERB
not O ADV
been O VERB
investigated. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Patients O NOUN
in O ADP
the O DET
chronomodulated O VERB
chemotherapy O NOUN
group O NOUN
(n O NOUN
= O SYM
30, O NUM
CC O NOUN
group) O ADJ
received O VERB
cisplatin O NOUN
at O ADP
80 O NUM
mg/m(2) O NOUN
through O ADP
intravenous O ADJ
infusion O NOUN
from O ADP
10:00 O NOUN
to O PART
22:00 O NOUN
and O CCONJ
5-fluorouracil O NOUN
(5-FU) O NOUN
at O ADP
1000 O NUM
mg/m(2) O NOUN
plus O CCONJ
citrovorum O NOUN
factor O NOUN
at O ADP
200 O NUM
mg/m(2) O NOUN
from O ADP
22:00 O NOUN
to O PART
10:00 O NOUN
each O DET
day O NOUN
for O ADP
3 O NUM
days. O NOUN

Among O ADP
the O DET
men O NOUN
in O ADP
the O DET
IG, O NOUN
76% O NUM
had O VERB
a O DET
positive B-outcome ADJ
experience I-outcome NOUN
of O ADP
the O DET
counselling, O NOUN
and O CCONJ
77% O NUM
had O VERB
received B-outcome VERB
new I-outcome ADJ
information I-outcome NOUN
. O PUNCT
CONCLUSION: O NOUN
The O DET
intervention O NOUN
managed O VERB
to O PART
increase O NOUN
different O ADJ
aspects O NOUN
of O ADP
men's O NOUN
fertility B-outcome NOUN
awareness I-outcome ADV
. O PUNCT
In O ADP
the O DET
future, O NOUN
the O DET
format O NUM
for O ADP
preconception O NOUN
care O NOUN
for O ADP
men O NOUN
needs O NOUN
further O ADV
development. O NOUN

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Post O ADV
hoc O NOUN
analysis O NOUN
of O ADP
the O DET
FLAME O NOUN
study. O NOUN

During O ADP
operations, O NUM
the O DET
ETView O NOUN
tubes O NOUN
provided O ADJ
continuous B-outcome ADJ
airway I-outcome NOUN
visualization I-outcome NOUN
in O ADP
all O DET
patients; O NOUN
a O DET
good O ADJ
view B-outcome NOUN
was O VERB
obtained O VERB
in O ADP
24/25 O VERB
patients O NOUN
in O ADP
VDT/VST, O ADJ
moderate O ADJ
in O ADP
4/12 O NOUN
patients O NOUN
in O ADP
VDT/VST, O ADJ
and O CCONJ
poor O ADJ
in O ADP
1/1 O ADP
patients O NOUN
in O ADP
VDT/VST. O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

13 O NUM
046 O NUM
women O NOUN
(intervention O PUNCT
n=7067, O NOUN
usual O ADJ
care O NOUN
n=5979) O NOUN
with O ADP
data O NOUN
based O VERB
on O ADP
the O DET
national O ADJ
Dutch O NOUN
perinatal O ADJ
registry O NOUN
or O CCONJ
hospital O NOUN
records O NOUN
were O VERB
included O VERB
in O ADP
the O DET
analyses. O NOUN

Peripheral O ADJ
perfusion-targeted O VERB
resuscitation O NOUN
was O VERB
associated O VERB
with O ADP
less O ADV
organ B-outcome NOUN
dysfunction I-outcome NOUN
at O ADP
72 O NUM
hours O NOUN
(mean O NUM
SOFA O NOUN
score, O NOUN
5.6 O NUM
[SD, O NOUN
4.3 O PUNCT
vs O CCONJ
6.6 O NUM
[SD, O NOUN
4.7]; O NUM
mean O NOUN
difference, O NOUN
-1.00 O NUM
[95% O NOUN
CI, O NOUN
-1.97 O NUM
to O PART
-0.02]; O NOUN
P O NOUN
= O SYM
.045). O NUM

The O DET
primary O ADJ
endpoint O NOUN
is O VERB
the O DET
number O NOUN
of O ADP
harvested B-outcome VERB
lymph I-outcome NOUN
nodes I-outcome NOUN
, O PUNCT
which O ADP
is O VERB
a O DET
critical O ADJ
index O NOUN
of O ADP
the O DET
quality O NOUN
of O ADP
surgery O NOUN
in O ADP
gastric O ADJ
cancer O NOUN
treatment. O NOUN

Journal-Name:BMC O NOUN
gastroenterology O NOUN

BACKGROUND: O NOUN
This O DET
randomized O VERB
controlled O VERB
trial O NOUN
evaluated O VERB
the O DET
effectiveness O NOUN
of O ADP
nerve O NOUN
electrical O ADJ
stimulation O NOUN
(NES) O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
chemotherapy-induced O VERB
nausea B-outcome NOUN
and O CCONJ
vomiting B-outcome VERB
(CINV) O PUNCT
in O ADP
patients O NOUN
with O ADP
advanced O VERB
gastric O ADJ
cancer O NOUN
(AGC). O PUNCT

Krill-derived O VERB
protein O NOUN
hydrolysates/peptides O NOUN
may O VERB
have O VERB
positive O ADJ
effect O NOUN
on O ADP
blood O NOUN
pressure O NOUN
and O CCONJ
astaxanthin O ADP
has O VERB
anti-oxidative O ADJ
and O CCONJ
anti-inflammatory O ADJ
properties. O NOUN

Publication O NOUN
date: O NOUN
2019/02/18 O NOUN
06:00 O ADP
[entrez] O ADP

Journal O ADJ
ID: O NOUN
101510759 O NUM

Title: O NOUN
Remote O ADV
ischemic O ADJ
preconditioning O VERB
for O ADP
prevention O NOUN
of O ADP
contrast B-outcome NOUN
induced I-outcome VERB
nephropathy I-outcome NOUN
-Insights O NUM
from O ADP
an O DET
Indian O NOUN
study. O NOUN

Several O ADJ
approved O VERB
inactivated O VERB
hepatitis O NOUN
A O DET
(HA) O PUNCT
vaccines O NOUN
are O VERB
available O ADJ
in O ADP
Korea. O NOUN

Publication O NOUN
date: O NOUN
2019/01/23 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
TFP O NOUN
group O NOUN
(n O NOUN
= O SYM
30) O NOUN
received O VERB
a O DET
single O ADJ
TFP O NOUN
25 O NUM
mug/ O NOUN
h O NOUN
to O PART
the O DET
anterior O ADJ
chest O NOUN
wall O NOUN
14 O NUM
h O NOUN
before O ADP
operation. O ADV

However, O ADV
the O DET
combination O NOUN
did O VERB
not O ADV
result O VERB
in O ADP
a O DET
clinically O ADV
important O ADJ
improvement O NOUN
over O ADP
ibuprofen O NOUN
alone, O NOUN
suggesting O VERB
that O ADP
ibuprofen O NOUN
alone O ADJ
may O VERB
be O VERB
a O DET
reasonable O ADJ
option O NOUN
for O ADP
early O ADJ
postoperative O ADJ
oral O ADJ
analgesia. O NOUN

Journal O ADJ
ID: O NOUN
101521595 O NUM

0.05). O NOUN

In O ADP
the O DET
Province O NOUN
of O ADP
Quebec, O NOUN
vaccine O NOUN
coverage O NOUN
in O ADP
young O ADJ
children O NOUN
are O VERB
sub-optimal, O ADJ
mostly O ADV
due O ADJ
to O PART
ambivalence O NOUN
toward O ADP
vaccine O NOUN
safety O NOUN
and O CCONJ
efficacy. O NOUN

BACKGROUND: O NOUN
This O DET
study O NOUN
aimed O VERB
to O PART
evaluate O VERB
the O DET
effectiveness O NOUN
of O ADP
neuromuscular O ADJ
electrical O ADJ
stimulation O NOUN
(NMES) O NUM
therapy O NOUN
for O ADP
chronic O ADJ
urinary O ADJ
retention O NOUN
(CUR) O NOUN
following O VERB
traumatic O ADJ
brain O NOUN
injury O NOUN
(TBI). O PUNCT

Title: O NOUN
The O DET
effect O NOUN
of O ADP
probiotics O NOUN
on O ADP
glycemic O ADJ
index. O NOUN

Final O ADJ
date O NOUN
of O ADP
follow-up O NOUN
was O VERB
January O NOUN
1, O NOUN
2018. O NUM

These O DET
findings O NOUN
were O VERB
potentially O ADV
explained O VERB
by O ADP
within-group O NOUN
significance O NOUN
for O ADP
the O DET
same O ADJ
variables O NOUN
for O ADP
the O DET
first O ADV
10 O NUM
min O NOUN
split O ADJ
(P O NUM
</= O NOUN
0.01), O NUM
and O CCONJ
for O ADP
distance O NOUN
covered O VERB
(P O NUM
= O SYM
0.01) O NUM
in O ADP
the O DET
second O ADJ
10-min O NOUN
split. O NOUN

RESULTS: O NOUN
The O DET
median O ADJ
time B-outcome NOUN
to I-outcome PART
normalization I-outcome NOUN
of I-outcome ADP
the Seperator DET
platelet I-outcome NOUN
count I-outcome NOUN
was O VERB
shorter O ADJ
with O ADP
caplacizumab O NOUN
than O ADP
with O ADP
placebo O NOUN
(2.69 O NUM
days O NOUN
[95% O NOUN
confidence O NOUN
interval O NOUN
{CI}, O NOUN
1.89 O NUM
to O PART
2.83 O NOUN
vs. O CCONJ
2.88 O NUM
days O NOUN
[95% O NOUN
CI, O NOUN
2.68 O NUM
to O PART
3.56], O NOUN
P=0.01), O NOUN
and O CCONJ
patients O NOUN
who O ADP
received O VERB
caplacizumab O NOUN
were O VERB
1.55 O NUM
times O NOUN
as O ADP
likely O ADV
to O PART
have O VERB
a O DET
normalization B-outcome NOUN
of I-outcome ADP
the Seperator DET
platelet I-outcome NOUN
count I-outcome NOUN
as O ADP
those O DET
who O ADP
received O VERB
placebo. O NOUN

Results O NOUN
heart B-outcome NOUN
rate I-outcome NOUN
(HR) I-outcome NOUN
, O PUNCT
systemic B-outcome ADJ
vascular I-outcome ADJ
resistance I-outcome NOUN
index O NOUN
(SVRI) O PUNCT
showed O VERB
a O DET
decrease O NOUN
in O ADP
Group O NOUN
SM O NOUN
but O CCONJ
an O DET
increase O NOUN
in O ADP
Group O NOUN
S O NOUN
(Ptime*group<0.0001) O PUNCT
in O ADP
the O DET
study O NOUN
period. O NOUN

Hydration B-outcome NOUN
indicators O NOUN
( O PUNCT
body B-outcome NOUN
weight I-outcome NOUN
(BW) I-outcome NOUN
, O PUNCT
salivary B-outcome ADJ
and Seperator CCONJ
urine B-outcome NOUN
osmolality E1-outcome NOUN
[SOsm/UOsm], O ADP
urine B-outcome NOUN
specific I-outcome ADJ
gravity I-outcome NOUN
[USG] I-outcome NOUN
, O PUNCT
urine B-outcome NOUN
volume I-outcome NOUN
[UV] I-outcome NOUN
, O PUNCT
urine B-outcome NOUN
color I-outcome NOUN
[UC] I-outcome NOUN
), O NUM
thirst B-outcome ADV
, O PUNCT
fatigue B-outcome NOUN
, O PUNCT
and O CCONJ
recovery B-outcome NOUN
( O PUNCT
heart B-outcome NOUN
rate I-outcome NOUN
[HR) I-outcome PUNCT
], O NOUN
and O CCONJ
HR B-outcome NOUN
variability I-outcome NOUN
[HRV] I-outcome NOUN
) O PUNCT
were O VERB
taken O VERB
at O ADP
baseline, O NOUN
post-exercise, O NOUN
0.5, O NOUN
1, O NOUN
and O CCONJ
2 O NUM
h O NOUN
post-consumption O NOUN
of O ADP
1 O NUM
L O NOUN
of O ADP
MW O NOUN
or O CCONJ
control. O NOUN

RESULTS: O NOUN
The O DET
95% O NOUN
effective O ADJ
dose B-outcome NOUN
of O ADP
intrathecal O ADJ
ropivacaine O NOUN
with O ADP
5 O NUM
mug O NUM
sufentanil O NOUN
for O ADP
successful O ADJ
anesthesia O NOUN
was O VERB
15.2 O NUM
mg O NOUN
(95%CI, O NOUN
13.5-18.8 O NUM
mg), O NOUN
when O ADP
receiving O VERB
prophylactic O ADJ
infusion O NOUN
of O ADP
phenylephrine. O NOUN

The O DET
plasma O NOUN
concentrations O NOUN
of O ADP
the O DET
NT O NOUN
marker O NOUN
were O VERB
measured O VERB
just O ADV
before, O NOUN
immediately O ADV
after O ADP
and O CCONJ
24 O NUM
h O NOUN
after O ADP
operation. O ADV

Changes O NOUN
in O ADP
the O DET
100-mm O NOUN
visual O ADJ
analogue O NOUN
scale O NOUN
(VAS) O PUNCT
for O ADP
low B-outcome ADJ
back I-outcome ADP
pain I-outcome NOUN
after O ADP
6 O NUM
weeks O NOUN
from O ADP
baseline O NOUN
will O VERB
be O VERB
assessed O VERB
as O ADP
the O DET
primary O ADJ
outcome. O NOUN

Safety O NOUN
was O VERB
assessed O VERB
in O ADP
all O DET
patients O NOUN
who O ADP
received O VERB
at O ADP
least O ADV
one O NUM
dose O NOUN
of O ADP
ixazomib O NOUN
or O CCONJ
placebo, O NOUN
according O ADJ
to O PART
treatment O NOUN
actually O ADV
received. O NOUN

While O ADP
the O DET
mhGAP-IG O NOUN
has O VERB
been O VERB
used O VERB
extensively O ADV
in O ADP
low- O ADJ
and O CCONJ
middle-income O NOUN
countries O NOUN
(LMICs) O PUNCT
to O PART
help O VERB
build O ADP
non-specialists' O NOUN
mental O ADJ
health O NOUN
capacity, O NOUN
little O DET
research O NOUN
has O VERB
focused O VERB
on O ADP
how O ADP
contextual O ADJ
factors O NOUN
interact O VERB
with O ADP
the O DET
implemented O VERB
training O VERB
program O NOUN
to O PART
influence O NOUN
its O ADJ
expected O VERB
outcomes. O ADJ

Secondary O ADJ
outcome O NOUN
was O VERB
time B-outcome NOUN
to I-outcome PART
emergency I-outcome NOUN
medical I-outcome ADJ
services I-outcome NOUN
(EMS) I-outcome NUM
activation I-outcome NOUN
. O PUNCT
We O PRON
analyzed O VERB
data O NOUN
via O ADP
Kruskal-Wallis O NOUN
rank O NOUN
sum O NOUN
test. O NOUN

All O DET
patients O NOUN
presented O VERB
with O ADP
a O DET
vital O ADJ
maxillary O ADJ
or O CCONJ
mandibular O ADJ
molar, O ADV
premolar, O ADV
or O CCONJ
front O NOUN
teeth O NOUN
designated O VERB
for O ADP
intentional O ADJ
endodontic O ADJ
RCT O NOUN
for O ADP
prosthetic O ADJ
reasons. O NOUN

BACKGROUND: O NOUN
Incidence O NOUN
of O ADP
end O NOUN
stage O NOUN
kidney O NOUN
disease O NOUN
(ESKD) O PUNCT
for O ADP
Indigenous O ADJ
Australians O NOUN
is O VERB
especially O ADV
high O ADJ
in O ADP
remote O ADV
and O CCONJ
very O ADV
remote O ADV
areas O NOUN
of O ADP
Australia O PROPN
(18 O NOUN
and O CCONJ
20 O NUM
times O NOUN
the O DET
rate O NOUN
of O ADP
comparable O ADJ
non-Indigenous O ADJ
people). O NOUN

Both O CCONJ
intervention O NOUN
groups O NOUN
aimed O VERB
for O ADP
equivalent O ADJ
weight O NOUN
loss O NOUN
(6-7%) O NUM
following O VERB
a O DET
calorie-restricted O VERB
diet O NOUN
(diet O NOUN
group) O ADJ
or O CCONJ
a O DET
partly O ADV
supervised O VERB
intensive O ADJ
exercise O NOUN
programme O NOUN
(4 O NOUN
h O NOUN
per O ADP
week) O NOUN
combined O VERB
with O ADP
a O DET
small O ADJ
caloric O ADJ
restriction O NOUN
(exercise O PUNCT
plus O CCONJ
diet O NOUN
group). O NOUN

Objective: O NOUN
Investigate O NOUN
beneficial O ADJ
and O CCONJ
harmful O ADJ
effects O NOUN
of O ADP
4 O NUM
nonopioid O NOUN
analgesics O NOUN
regimens. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Study O NOUN
design: O NOUN
Controlled O VERB
laboratory O NOUN
study; O ADJ
cross-sectional O ADJ
design. O NOUN

Funded O VERB
by O ADP
the O DET
AHRQ O NOUN
Healthcare-Associated O VERB
Infections O NOUN
Program O NOUN
and O CCONJ
others; O NOUN
ClinicalTrials.gov O NOUN
number, O ADV
NCT01209234 O NOUN
.). O NOUN

When O ADP
the O DET
intensity O NOUN
of O ADP
pain B-outcome NOUN
was O VERB
taken O VERB
into O ADP
consideration O NOUN
in O ADP
the O DET
analysis O NOUN
of O ADP
the O DET
EG, O NOUN
there O PRON
was O VERB
a O DET
significantly O ADV
greater O ADJ
increment O NOUN
in O ADP
the O DET
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
specific O ADJ
for O ADP
CD O NOUN
after O ADP
treatment O NOUN
in O ADP
people O NOUN
without O ADP
pain B-outcome NOUN
than O ADP
in O ADP
those O DET
with O ADP
pain B-outcome NOUN
(P O NUM
= O SYM
.02) O PUNCT
The O DET
improvements O NOUN
in O ADP
global B-outcome ADJ
quality I-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(GQoL) I-outcome NOUN
were O VERB
independent O ADJ
from O ADP
the O DET
disease O NOUN
status O NOUN
(P O NUM
= O SYM
.16). O NOUN

The O DET
primary O ADJ
outcomes O NOUN
were O VERB
success B-outcome NOUN
rate O NOUN
and O CCONJ
procedure B-outcome NOUN
time I-outcome NOUN
. O PUNCT
The O DET
secondary O ADJ
outcome O NOUN
was O VERB
a O DET
subjective O ADJ
measure O NOUN
of O ADP
the O DET
similarity O NOUN
of O ADP
the O DET
simulator O NOUN
to O PART
the O DET
porcine O ADJ
larynx. O NOUN

They O PRON
were O VERB
equally O ADV
divided O VERB
the O DET
NES O NOUN
group O NOUN
and O CCONJ
the O DET
sham O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
2985248R O NOUN

This O DET
study O NOUN
evaluated O VERB
the O DET
effectiveness O NOUN
of O ADP
two-dose O NOUN
versus O CCONJ
three-dose O NOUN
of O ADP
SP O NOUN
for O ADP
IPTp-SP O NOUN
in O ADP
the O DET
prevention O NOUN
of O ADP
low B-outcome ADJ
birth I-outcome NOUN
weight I-outcome NOUN
(LBW) I-outcome NUM
and O CCONJ
malaria B-outcome NOUN
parasitaemia I-outcome NOUN
. O PUNCT
Methods: O NOUN
: O PUNCT
An O DET
open, O ADV
randomized, O NOUN
controlled, O NOUN
longitudinal O ADJ
trial O NOUN
was O VERB
conducted O VERB
in O ADP
a O DET
secondary O ADJ
level O NOUN
hospital O NOUN
in O ADP
Nsukka O NUM
region O NOUN
of O ADP
Enugu O NOUN
State, O VERB
Nigeria. O NOUN

In O ADP
this O DET
regard, O NOUN
proper O ADJ
positioning O VERB
is O VERB
one O NUM
of O ADP
the O DET
key O ADJ
measures O NOUN
that O ADP
is O VERB
done O NOUN
by O ADP
nurses; O NOUN
still O ADV
there O PRON
is O VERB
a O DET
paucity O NOUN
of O ADP
studies O NOUN
in O ADP
this O DET
field O NOUN
and O CCONJ
the O DET
results O NOUN
of O ADP
these O DET
few O ADJ
studies O NOUN
are O VERB
an O DET
area O NOUN
of O ADP
ongoing O VERB
debates. O NOUN

METHODS: O NOUN
Ninety-two O NUM
patients O NOUN
scheduled O VERB
for O ADP
orthopedic O ADJ
lower O ADJ
extremity O NOUN
surgery O NOUN
under O ADP
general O ADJ
anesthesia O NOUN
were O VERB
randomly O ADV
assigned O VERB
into O ADP
1 O NUM
of O ADP
2 O NUM
groups. O NOUN

Journal-Name:Medicine O NOUN

Regression-adjusted O VERB
difference O NOUN
in O ADP
means O NOUN
were O VERB
used O VERB
to O PART
examine O NOUN
the O DET
intervention's O NOUN
effectiveness O NOUN
with O ADP
respect O NOUN
to O PART
PTSD B-outcome NOUN
symptomatology I-outcome NOUN
(primary O PUNCT
outcome) O PUNCT
as O ADP
well O ADV
as O ADP
depression B-outcome NOUN
, O PUNCT
perceptions B-outcome NOUN
of I-outcome ADP
cognitive I-outcome ADJ
failures I-outcome NOUN
, O PUNCT
social B-outcome ADJ
functioning I-outcome VERB
and O CCONJ
isolation B-outcome NOUN
, O PUNCT
and O CCONJ
health-related B-outcome VERB
quality I-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
(secondary O PUNCT
outcomes). O ADJ

Publication O NOUN
date: O NOUN
2018/12/15 O NOUN
06:00 O ADP
[pubmed] O PUNCT

Journal O ADJ
ID: O NOUN
9308586 O NUM

A O DET
total O ADJ
of O ADP
37 O NUM
patients O NOUN
(36%) O NOUN
in O ADP
the O DET
hybrid-procedure O NOUN
group O NOUN
had O VERB
a O DET
major O ADJ
intraoperative O ADJ
or O CCONJ
postoperative O ADJ
complication B-outcome NOUN
, O PUNCT
as O ADP
compared O VERB
with O ADP
67 O NUM
(64%) O PUNCT
in O ADP
the O DET
open-procedure O NOUN
group O NOUN
(odds O NOUN
ratio, O NOUN
0.31; O NOUN
95% O NOUN
confidence O NOUN
interval O NOUN
[CI], O VERB
0.18 O NUM
to O PART
0.55; O NOUN
P<0.001). O NUM

The O DET
prophylactic O ADJ
phenylephrine O NOUN
infusion O NOUN
(50 O PUNCT
mug/min) O NOUN
was O VERB
initiated O VERB
immediately O ADV
at O ADP
the O DET
same O ADJ
time O NOUN
of O ADP
spinal O ADJ
injection. O ADV

ClinicalTrials.gov O NOUN
number: O NOUN
NCT01782326 O NOUN
. O PUNCT

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Modelling O VERB
of O ADP
the O DET
predicted O VERB
species O NOUN
interactions O NOUN
in O ADP
a O DET
single O ADJ
DFU O NOUN
with O ADP
high O ADJ
diversity O NOUN
indicated O VERB
that O ADP
networks O NOUN
of O ADP
metabolic O ADJ
interactions O NOUN
may O VERB
exist O VERB
that O ADP
contribute O NOUN
to O PART
the O DET
formation O NOUN
of O ADP
stable O ADJ
communities. O NOUN

Health O NOUN
sciences O NOUN

Missing O VERB
end-point O NOUN
data O NOUN
(39 O ADV
participants, O NOUN
3.7%) O NUM
were O VERB
imputed. O NOUN

Journal-Name:Zhonghua O NOUN
yi O ADP
xue O NOUN
za O ADP
zhi O NUM

BACKGROUND: O NOUN
Overweight O NOUN
and O CCONJ
metabolic O ADJ
problems O NOUN
now O ADV
add O NOUN
to O PART
the O DET
burden O NOUN
of O ADP
illness O NOUN
in O ADP
patients O NOUN
with O ADP
Inflammatory O ADJ
Bowel O NOUN
Disease. O NOUN

Of O ADP
the O DET
560 O NUM
total O ADJ
metabolites B-outcome NOUN
identified O VERB
from O ADP
the O DET
cooked O VERB
navy O ADJ
beans, O NOUN
there O PRON
were O VERB
237 O NUM
possible O ADJ
navy B-outcome ADJ
bean-derived I-outcome VERB
metabolites I-outcome NOUN
that O ADP
were O VERB
identified O VERB
in O ADP
the O DET
stool O NOUN
of O ADP
participants O NOUN
consuming O VERB
navy O ADJ
beans, O NOUN
such O ADJ
as O ADP
N-methylpipecolate B-outcome NOUN
, O PUNCT
2-aminoadipate B-outcome NOUN
, O PUNCT
piperidine B-outcome NOUN
, O PUNCT
and O CCONJ
vanillate B-outcome NOUN
. O PUNCT
The O DET
microbial O ADJ
metabolism B-outcome NOUN
of I-outcome ADP
amino I-outcome ADJ
acids I-outcome NOUN
and Seperator CCONJ
fatty I-outcome ADJ
acids S2-outcome NOUN
were O VERB
also O ADV
identified O VERB
in O ADP
stool O NOUN
after O ADP
4 O NUM
weeks O NOUN
of O ADP
navy O ADJ
bean O NOUN
intake O NOUN
including O VERB
cadaverine B-outcome NOUN
, O PUNCT
hydantoin-5 B-outcome NOUN
propionic I-outcome ADJ
acid I-outcome NOUN
, O PUNCT
4-hydroxyphenylacetate B-outcome NOUN
, O PUNCT
and O CCONJ
caprylate B-outcome NOUN
. O PUNCT
The O DET
stool O NOUN
relative O ADJ
abundance O NOUN
of O ADP
ophthalmate B-outcome NUM
increased O VERB
5.25-fold O NOUN
for O ADP
navy O ADJ
bean O NOUN
consumers O NOUN
that O ADP
can O VERB
indicate O VERB
glutathione O NOUN
regulation, O NOUN
and O CCONJ
involving O VERB
cancer O NOUN
control O NOUN
mechanisms O NOUN
such O ADJ
as O ADP
detoxification O NOUN
of O ADP
xenobiotics, O NOUN
antioxidant O NOUN
defense, O NOUN
proliferation, O NOUN
and O CCONJ
apoptosis. O NOUN

Journal-Name:BMC O NOUN
surgery O NOUN

Observers O NOUN
recorded O VERB
time O NOUN
taken O VERB
for O ADP
contouring O VERB
and O CCONJ
scored O VERB
image O NOUN
quality O NOUN
and O CCONJ
confidence O NOUN
in O ADP
contouring. O NOUN

FUNDING: O NOUN
University O NOUN
of O ADP
Texas O ADP
MD O NOUN
Anderson O NOUN
Cancer O NOUN
Center O NOUN
and O CCONJ
National O ADJ
Cancer O NOUN
Institute O NOUN
Specialized O VERB
Programs O NOUN
of O ADP
Research O NOUN
Excellence. O NOUN

Journal-Name: O NOUN
Einstein O NOUN
(Sao O ADV
Paulo, O NOUN
Brazil) O NOUN

Objective: O NOUN
To O PART
evaluate O VERB
the O DET
intervention O NOUN
effects O NOUN
of O ADP
peer O NOUN
support O NOUN
education O NOUN
mode O NOUN
for O ADP
type B-outcome NOUN
2 I-outcome NUM
diabetes I-outcome NOUN
control I-outcome NOUN
in O ADP
rural O ADJ
residents. O NOUN

m(-2) O NOUN
and O CCONJ
0.42 O NUM
+/- O SYM
0.40 O NUM
degrees O NOUN
C, O NOUN
respectively, O NOUN
before O ADP
exercise. O NOUN

RESULTS: O NOUN
Significant O ADJ
difference O NOUN
of O ADP
HbA1c B-outcome NOUN
concentration O NOUN
and O CCONJ
Self-Efficacy B-outcome NOUN
were O VERB
found O VERB
between O ADP
intervention O NOUN
and O CCONJ
control O NOUN
groups O NOUN
at O ADP
6-month O NOUN
and O CCONJ
12-month O NOUN
(P O NUM
<.05). O NOUN

Activities B-outcome NOUN
of I-outcome ADP
daily I-outcome ADJ
living I-outcome VERB
(ADL) I-outcome PUNCT
, O PUNCT
self-evaluated O VERB
loneliness B-outcome NOUN
, O PUNCT
and O CCONJ
level O NOUN
of O ADP
depression B-outcome NOUN
were O VERB
significantly O ADV
lowered O VERB
(P O NUM
< O SYM
.05) O NOUN
in O ADP
the O DET
group O NOUN
receiving O VERB
joint O NOUN
Baduanjin O NOUN
and O CCONJ
CBT O NOUN
intervention O NOUN
at O ADP
3 O NUM
months O NOUN
and O CCONJ
6 O NUM
months, O NOUN
as O ADP
compared O VERB
to O PART
the O DET
Baduanjin O NOUN
only O ADV
group O NOUN
or O CCONJ
the O DET
CBT O NOUN
only O ADV
group. O VERB

A O DET
25% O NUM
and O CCONJ
50% O NUM
improvement O NOUN
in O ADP
IGAxBSA O NOUN
was O VERB
achieved O NOUN
within O ADP
1.9 O NUM
and O CCONJ
4.6 O NUM
weeks, O NOUN
respectively, O NOUN
and O CCONJ
47.5% O NOUN
of O ADP
patients O NOUN
achieved O NOUN
IGAxBSA-75 O NOUN
by O ADP
week O NOUN
8. O NUM

BACKGROUND: O NOUN
Primary O ADJ
care O NOUN
physicians O NOUN
(PCPs) O PUNCT
working O VERB
in O ADP
mental O ADJ
health O NOUN
care O NOUN
in O ADP
Tunisia O NOUN
often O ADV
lack O NOUN
knowledge O NOUN
and O CCONJ
skills O NOUN
needed O VERB
to O PART
adequately O ADV
address O NOUN
mental O ADJ
health-related O VERB
issues. O NOUN

Journal-Name: O NOUN
Revista O NOUN
da O NOUN
Associacao O NOUN
Medica O NOUN
Brasileira O NOUN
(1992) O PUNCT

On O ADP
the O DET
other O ADJ
hand, O NOUN
plasma O NOUN
C-reactive B-outcome ADJ
protein I-outcome NOUN
and O CCONJ
lactate B-outcome VERB
dehydrogenase I-outcome NOUN
remained O VERB
unchanged. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

We O PRON
collected O VERB
6484 O NUM
questionnaires, O NOUN
including O VERB
3583 O NUM
in O ADP
the O DET
intervention O NOUN
group O NOUN
[response O NOUN
rate: O NOUN
96% O ADJ
(3583/3726) O NOUN
and O CCONJ
2901 O NUM
in O ADP
the O DET
control O NOUN
group O NOUN
[response O NOUN
rate: O NOUN
90% O VERB
(2901/3224)]. O NOUN
We O PRON
observed O VERB
that O ADP
hand B-outcome NOUN
washing I-outcome VERB
habit I-outcome NOUN
of O ADP
children O NOUN
and O CCONJ
parent, O NOUN
knowledge B-outcome NOUN
of I-outcome ADP
hand I-outcome NOUN
food I-outcome NOUN
mouth I-outcome NOUN
disease I-outcome NOUN
of O ADP
parents, O NOUN
children's O NOUN
daily O ADJ
cleaning B-outcome VERB
habits I-outcome NOUN
scores O NOUN
improved O VERB
in O ADP
the O DET
intervention O NOUN
group O NOUN
and O CCONJ
higher O ADJ
than O ADP
that O ADP
in O ADP
the O DET
control O NOUN
group O NOUN
at O ADP
both O CCONJ
the O DET
end O NOUN
of O ADP
year O NOUN
1 O NUM
(April O NOUN
1-July O ADJ
31, O NUM
2011)and O NOUN
year O NOUN
2 O NUM
(April O NOUN
1-July O ADJ
31, O NUM
2012). O NOUN

The O DET
primary O ADJ
safety O NOUN
end O NOUN
point O NOUN
was O VERB
major B-outcome ADJ
bleeding I-outcome VERB
. O PUNCT
RESULTS: O NOUN
Of O ADP
1080 O NUM
enrolled O VERB
patients, O NOUN
49 O NUM
(4.5%) O NOUN
had O VERB
thrombosis O NOUN
at O ADP
screening O VERB
and O CCONJ
did O VERB
not O ADV
undergo O NOUN
randomization. O NOUN

METHODS: O NOUN
A O DET
prospective, O NOUN
randomized, O NOUN
double-blind O ADJ
study O NOUN
in O ADP
patients O NOUN
treated O VERB
with O ADP
doxorubicin, O NOUN
comparing O VERB
placebo O NOUN
(n=38) O NOUN
with O ADP
different O ADJ
doses O NOUN
of O ADP
carvedilol O NOUN
[6.25mg/day O PUNCT
(n=41), O NOUN
12.5mg/day O NUM
(n=38) O NOUN
or O CCONJ
25mg/day O NOUN
(n=37)]. O NUM
The O DET
primary O ADJ
endpoint O NOUN
was O VERB
the O DET
measured O VERB
change O NOUN
in O ADP
left B-outcome ADV
ventricular I-outcome ADJ
ejection I-outcome NOUN
fraction I-outcome NOUN
(LVEF) I-outcome PUNCT
from O ADP
baseline O NOUN
to O PART
6 O NUM
months. O NOUN

This O DET
clinical O ADJ
trial O NOUN
aimed O VERB
to O PART
determine O NOUN
whether O ADP
a O DET
structured O VERB
multidisciplinary, O NOUN
multisite O NOUN
intervention O NOUN
resulted O VERB
in O ADP
improved O VERB
clinical O ADJ
outcomes O NOUN
compared O VERB
with O ADP
standard O ADJ
care. O NOUN

Therefore, O NOUN
it O PRON
can O VERB
be O VERB
used O VERB
as O ADP
an O DET
alternative O ADJ
method O NOUN
for O ADP
patients O NOUN
who O ADP
are O VERB
willing O VERB
to O PART
use O NOUN
this O DET
technique. O NOUN

We O PRON
followed O VERB
a O DET
standard O ADJ
general O ADJ
anesthetic O ADJ
technique, O ADV
with O ADP
endotracheal O ADJ
intubation. O ADV

FGDs O NOUN
were O VERB
audio-recorded, O NOUN
transcribed O VERB
then O ADV
translated O VERB
into O ADP
English. O NOUN

Similarly, O NOUN
time-to-first B-outcome ADV
moderate/severe I-outcome ADV
exacerbation I-outcome NOUN
was O VERB
also O ADV
delayed O VERB
(hazard O PUNCT
ratio O NOUN
[95% O NOUN
CI]: O ADP
0.79 O NUM
[0.70-0.89] O ADJ
and O CCONJ
0.76 O NUM
[0.63-0.91] O NOUN
in O ADP
men O NOUN
and O CCONJ
women, O NOUN
respectively). O NOUN

Up O NOUN
to O PART
50% O NUM
of O ADP
reproductive-age O NOUN
women O NOUN
suffer O NOUN
from O ADP
pelvic O ADJ
pain. O NOUN

This O DET
is O VERB
a O DET
post O ADV
hoc O NOUN
analysis O NOUN
of O ADP
the O DET
St. O NOUN
Carlos O NOUN
gestational O ADJ
diabetes O NOUN
mellitus O NOUN
(GDM) O NOUN
Prevention O NOUN
Study. O NOUN

The O DET
evaluation O NOUN
of O ADP
the O DET
Nia O NOUN
Project O NOUN
is O VERB
one O NUM
of O ADP
the O DET
first O ADV
to O PART
analyze O NOUN
the O DET
individual O ADJ
and O CCONJ
combined O VERB
contributions O NOUN
of O ADP
sanitary O ADJ
pads O NOUN
and O CCONJ
provision O NOUN
of O ADP
comprehensive O ADJ
reproductive O ADJ
health O NOUN
education O NOUN
on O ADP
girls' O NOUN
education B-outcome NOUN
and O CCONJ
reproductive B-outcome ADJ
health I-outcome NOUN
outcomes. O ADJ

Results O NOUN
may O VERB
be O VERB
used O VERB
to O PART
tailor O ADV
structural, O ADJ
organizational, O ADJ
provider, O NOUN
patient, O NOUN
and O CCONJ
innovation O NOUN
factors O NOUN
prior O ADJ
to O PART
future O NOUN
implementations O NOUN
of O ADP
the O DET
mhGAP-based O VERB
training O VERB
in O ADP
Tunisia. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
The O DET
project O NOUN
is O VERB
approved O VERB
by O ADP
Iranian O ADJ
Registry O NOUN
of O ADP
Clinical O ADJ
Trial O NOUN
with O ADP
no. O ADV

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Initial O ADJ
forward O ADV
movement O NOUN
in O ADP
the O DET
IA O NOUN
group O NOUN
was O VERB
4 O NUM
to O PART
5 O NUM
mm O NOUN
and O CCONJ
was O VERB
followed O VERB
by O ADP
subsequent O ADJ
bimonthly O ADV
advancements O NOUN
of O ADP
2 O NUM
mm. O NOUN

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
00:00 O NOUN
[accepted] O ADV

Journal-Name:Journal O ADJ
of O ADP
Ayub O ADP
Medical O ADJ
College, O PUNCT
Abbottabad O ADV
: O PUNCT
JAMC O NOUN

Journal-Name:Journal O ADJ
of O ADP
science O NOUN
and O CCONJ
medicine O NOUN
in O ADP
sport O ADJ

Journal-Name:Radiation O NOUN
protection O NOUN
dosimetry O NOUN

Follow-on O NOUN
oral O ADJ
antibiotics O NOUN
were O VERB
permitted O VERB
in O ADP
both O CCONJ
groups. O NOUN

CONCLUSIONS: O NOUN
This O DET
study O NOUN
revealed O VERB
that O ADP
teachers O NOUN
believed O VERB
classroom O NOUN
based O VERB
activities O NOUN
were O VERB
most O DET
feasible B-outcome ADJ
and O CCONJ
acceptable B-outcome ADJ
due O ADJ
to O PART
the O DET
reduced O VERB
implementation O NOUN
barriers O NOUN
of O ADP
sufficient O ADJ
time O NOUN
and O CCONJ
space. O NOUN

Publication O NOUN
date: O NOUN
2018/11/26 O NOUN
00:00 O NOUN
[accepted] O ADV

However, O ADV
these O DET
do O VERB
not O ADV
consider O NOUN
changes O NOUN
in O ADP
Body O NOUN
Surface O NOUN
Area O NOUN
(BSA)]. O NOUN
The O DET
IGAxBSA O NOUN
composite O NOUN
tool O NOUN
is O VERB
a O DET
simple, O NOUN
effective, O NUM
validated O VERB
alternative O ADJ
for O ADP
measuring O VERB
improvement O NOUN
in O ADP
psoriasis O NOUN
severity. O DET

Title: O NOUN
To O PART
study O NOUN
the O DET
effect O NOUN
of O ADP
high O ADJ
dose O NOUN
Atorvastatin O ADP
40mg O NOUN
versus O CCONJ
80mg O NOUN
in O ADP
patients O NOUN
with O ADP
dyslipidemia. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Plasma O NOUN
Nitrotyrosine B-outcome NOUN
(NT) I-outcome NOUN
concentrations O NOUN
versus O CCONJ
patient O NOUN
satisfaction O NOUN
following O VERB
surgery O NOUN
are O VERB
significantly O ADV
correlated O VERB
in O ADP
benign O ADJ
disease O NOUN
and O CCONJ
cancer. O NOUN

The O DET
majority O NOUN
of O ADP
AEs B-outcome NOUN
were O VERB
mild O ADJ
and O CCONJ
transient. O NOUN

Methods: O NOUN
Post O ADV
hoc O NOUN
analysis O NOUN
of O ADP
212 O NUM
patients O NOUN
with O ADP
moderate-to-severe O ADV
plaque O NOUN
psoriasis O NOUN
randomized O VERB
(2:2:2:1) O NUM
to O PART
HP/TAZ O NOUN
lotion, O NOUN
HP, O NOUN
TAZ, O NOUN
or O CCONJ
vehicle O NOUN
once-daily O ADV
for O ADP
8 O NUM
weeks, O NOUN
with O ADP
a O DET
4-week O NOUN
posttreatment O NOUN
follow-up. O PUNCT

Overall, O NOUN
the O DET
group O NOUN
(n O NOUN
= O SYM
24) O NOUN
had O VERB
a O DET
median O ADJ
score O NOUN
of O ADP
0 O NUM
(lowest O NUM
item O NOUN
score) O NOUN
on O ADP
nine O NUM
of O ADP
24 O NUM
Test O NOUN
of O ADP
Playfulness B-outcome ADV
(ToP) O ADV
items O NOUN
and O CCONJ
only O ADV
had O VERB
a O DET
median O ADJ
score O NOUN
of O ADP
3 O NUM
(highest O NUM
score) O NOUN
on O ADP
two O NUM
items. O NOUN

In O ADP
FZD O NOUN
group, O NOUN
92 O NUM
patients O NOUN
were O VERB
treated O VERB
with O ADP
FZD O NOUN
plus O CCONJ
esomeprazole, O NOUN
bismuth O NOUN
potassium O NOUN
citrate, O NOUN
and O CCONJ
amoxicillin O NOUN
for O ADP
14 O NUM
days. O NOUN

The O DET
patients O NOUN
were O VERB
followed O VERB
up O ADP
for O ADP
6 O NUM
months. O NOUN

The O DET
disease-free B-outcome ADJ
survival I-outcome NOUN
rate O NOUN
at O ADP
3 O NUM
years O NOUN
was O VERB
39.7% O NUM
in O ADP
the O DET
modified-FOLFIRINOX O NOUN
group O NOUN
and O CCONJ
21.4% O NUM
in O ADP
the O DET
gemcitabine O NOUN
group. O VERB

Randomisation O NOUN
was O VERB
stratified O VERB
by O ADP
histological O ADJ
subtype O NOUN
according O ADJ
to O PART
local O ADJ
pathology O NOUN
assessment O NOUN
and O CCONJ
by O ADP
international O ADJ
prognostic O ADJ
index O NOUN
score. O NOUN

Complications B-outcome NOUN
regarding O VERB
opioids O NOUN
were O VERB
compared O VERB
between O ADP
groups. O NOUN

Publication O NOUN
date: O NOUN
2018/12/27 O NOUN
00:00 O NOUN
[accepted] O ADV

Difference O NOUN
in O ADP
detection O NOUN
rate O NOUN
between O ADP
intervention O NOUN
arm O NOUN
and O CCONJ
control O NOUN
arm O NOUN
was O VERB
compared O VERB
using O VERB
Z O NOUN
test. O NOUN

Title: O NOUN
Can O VERB
Reproductive O ADJ
Life O NOUN
Plan-based O VERB
counselling O VERB
increase O NOUN
men's O NOUN
fertility B-outcome NOUN
awareness I-outcome ADV
? O PUNCT

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

Following O VERB
8 O NUM
weeks O NOUN
of O ADP
supplementation, O NOUN
the O DET
subjects O NOUN
repeated O VERB
the O DET
pre-supplementation O NOUN
testing O VERB
procedures. O NOUN

BACKGROUND: O NOUN
Based O VERB
on O ADP
our O ADJ
pre-clinical O ADJ
data, O NOUN
we O PRON
hypothesized O VERB
that O ADP
sequencing O VERB
chemotherapy O NOUN
with O ADP
erlotinib O NOUN
would O VERB
increase O NOUN
the O DET
tumor O NOUN
response B-outcome NOUN
rate O NOUN
in O ADP
patients O NOUN
with O ADP
metastatic O ADJ
colorectal O ADJ
cancer. O NOUN

Data O NOUN
elicited O VERB
from O ADP
18 O NUM
participating O VERB
children O NOUN
via O ADP
a O DET
write O NOUN
draw, O NOUN
show O VERB
and O CCONJ
tell O NOUN
task O NOUN
included, O VERB
frequency O NOUN
counts O NOUN
of O ADP
most O DET
enjoyable O ADJ
intervention O NOUN
components, O NOUN
drawings, O ADJ
and O CCONJ
verbatim O ADV
data. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
researchregistry4264 O ADP
dated O VERB
1 O NUM
March O NOUN
2016 O NUM
(www.researchregistry.com). O PUNCT

BACKGROUND: O NOUN
We O PRON
performed O VERB
a O DET
prospective O ADJ
phase O NOUN
II O NUM
study O NOUN
to O PART
compare O NOUN
acute O ADJ
toxicity B-outcome NOUN
among O ADP
five O NUM
different O ADJ
hypofractionated O VERB
schedules O NOUN
using O VERB
proton O NOUN
therapy. O NOUN

Better O ADJ
baseline O NOUN
BCVA O NOUN
(> O PUNCT
50 O NUM
ETDRS O NOUN
letters/Snellen O NOUN
equivalent O ADJ
>/= O NOUN
20/100), O NUM
greater O ADJ
baseline O NOUN
total O ADJ
macular O ADJ
volume O NOUN
(> O PUNCT
9.99 O NUM
mm(3)), O NOUN
and O CCONJ
presence O NOUN
of O ADP
subretinal O ADJ
fluid O NOUN
at O ADP
baseline O NOUN
were O VERB
all O DET
associated O VERB
with O ADP
early O ADJ
improvement O NOUN
to O PART
20/40 O NOUN
or O CCONJ
better O ADJ
vision B-outcome NOUN
( O NOUN
Early O ADJ
Treatment O NOUN
Diabetic B-outcome ADJ
Retinopathy I-outcome NOUN
Study O NOUN
(ETDRS) O NOUN
equivalent O ADJ
>/= O NOUN
69 O NUM
letters; O NUM
P O NOUN
< O SYM
.0001, O NUM
P O NOUN
= O SYM
.02, O NOUN
and O CCONJ
P O NOUN
= O SYM
.03, O PUNCT
respectively). O NOUN

Patients O NOUN
were O VERB
operated O VERB
in O ADP
two O NUM
orthopedic O ADJ
centers. O NOUN

Title: O NOUN
The O DET
effect O NOUN
of O ADP
L-theanine O NOUN
supplementation O NOUN
on O ADP
the O DET
immune O ADJ
system O NOUN
of O ADP
athletes O NOUN
exposed O VERB
to O PART
strenuous O NOUN
physical O ADJ
exercise. O NOUN

Transcripts O NOUN
were O VERB
inductively O ADV
coded O VERB
using O VERB
ATLAS.ti(R) O NOUN
and O CCONJ
qualitatively O ADV
analysed O VERB
using O VERB
thematic O ADJ
content O NOUN
analysis. O NOUN

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

Patients O NOUN
in O ADP
the O DET
non-invasive O ADJ
ventilator O NOUN
group O NOUN
were O VERB
treated O VERB
with O ADP
continuous O ADJ
positive O ADJ
airway O NOUN
pressure O NOUN
CPAP O NOUN
for O ADP
3 O NUM
months, O NOUN
and O CCONJ
those O DET
in O ADP
the O DET
rhodiola O NOUN
rosea+non-invasive O ADJ
ventilator O NOUN
group O NOUN
were O VERB
treated O VERB
with O ADP
oral O ADJ
rhodiola O NOUN
capsules O NOUN
for O ADP
3 O NUM
months O NOUN
on O ADP
the O DET
basis O NOUN
of O ADP
CPAP, O NOUN
and O CCONJ
those O DET
in O ADP
the O DET
rhodiola O NOUN
rosea O NOUN
treatment O NOUN
group O NOUN
were O VERB
treated O VERB
with O ADP
pure O ADJ
oral O ADJ
rhodiola O NOUN
capsules O NOUN
for O ADP
3 O NUM
months. O NOUN

Results: O NOUN
Students O NOUN
in O ADP
the O DET
SIM O NOUN
group O NOUN
performed O VERB
CPR O NOUN
that O ADP
more O ADV
closely O ADV
adhered B-outcome VERB
to O PART
the O DET
AHA O NOUN
guidelines O NOUN
of O ADP
compression B-outcome NOUN
depth I-outcome NOUN
and O CCONJ
compression B-outcome NOUN
fraction I-outcome NOUN
. O PUNCT
Mean O NOUN
compression B-outcome NOUN
depth I-outcome NOUN
was O VERB
4.57 O NUM
centimeters O NOUN
(cm) O PUNCT
(95% O PUNCT
confidence O NOUN
interval O NOUN
[CI] O ADV
[4.30-4.82]) O ADP
for O ADP
SIM O NOUN
and O CCONJ
3.89 O NUM
cm O NOUN
(95% O PUNCT
CI O NOUN
[3.50-4.27]) O NOUN
for O ADP
STD, O NUM
p=0.02. O NOUN

CONCLUSION: O NOUN
In O ADP
conclusion, O NOUN
higher O ADJ
noggin B-outcome NOUN
levels O NOUN
reflected O VERB
more O ADV
BMP O NOUN
inhibition, O NOUN
since O ADP
our O ADJ
assay O NOUN
detects O NOUN
free O ADJ
bioactive O ADJ
noggin B-outcome NOUN
, O PUNCT
which O ADP
in O ADP
turn O NOUN
impaired O VERB
bone O NOUN
formation O NOUN
in O ADP
placebo O NOUN
group. O VERB

h(- O NOUN
1) O NUM
given O VERB
after O ADP
the O DET
Observer's O NOUN
Assessment O NOUN
of O ADP
Alertness B-outcome ADP
/ O SYM
Sedation B-outcome NOUN
(OAA/S) O PUNCT
score O NOUN
reached O VERB
2-3. O NOUN

At O ADP
baseline O NOUN
and O CCONJ
endline, O NOUN
knowledge, O NOUN
practice O NOUN
and O CCONJ
coverage O NOUN
(KPC) O NOUN
surveys O NOUN
measured O VERB
household O NOUN
health-related O VERB
behaviors O NOUN
and O CCONJ
care-seeking O VERB
behaviors. O DET

RESULTS: O NOUN
All O DET
the O DET
patients O NOUN
were O VERB
followed O VERB
up O ADP
for O ADP
at O ADP
least O ADV
1 O NUM
month. O NOUN

Perceived O VERB
exercise B-outcome NOUN
frequency X NOUN
(z X NOUN
= X SYM
2.309, X PUNCT
P X NOUN
= X SYM
0.02) X NUM
and X NOUN
intensity I-outcome NOUN
(z O NOUN
= O SYM
2.687, O ADJ
P O NOUN
= O SYM
0.007) O NOUN
was O VERB
significantly O ADV
improved O VERB
following O VERB
a O DET
short-term O NOUN
LOWFODMAP O NOUN
approach O NOUN
compared O VERB
to O PART
HIGHFODMAP. O NOUN

Journal-Name:Medicine O NOUN

CONCLUSIONS: O NOUN
The O DET
risk O NOUN
of O ADP
nonvertebral B-outcome ADJ
or Seperator CCONJ
vertebral B-outcome ADJ
fragility I-outcome NOUN
fractures E2-outcome NOUN
was O VERB
significantly O ADV
lower O ADJ
in O ADP
women O NOUN
with O ADP
osteopenia O NOUN
who O ADP
received O VERB
zoledronate O ADJ
than O ADP
in O ADP
women O NOUN
who O ADP
received O VERB
placebo. O NOUN
( O PUNCT

After O ADP
3 O NUM
days O NOUN
of O ADP
treatment, O NOUN
the O DET
serum O NOUN
neuron-specific B-outcome ADJ
enolase I-outcome NOUN
and O CCONJ
S100 B-outcome NOUN
protein I-outcome NOUN
levels O NOUN
in O ADP
both O CCONJ
groups O NOUN
were O VERB
significantly O ADV
decreased O VERB
as O ADP
compared O VERB
with O ADP
those O DET
before O ADP
treatment O NOUN
[NSE O PUNCT
(mug/L): O NOUN
30.15+/-15.18 O NUM
vs. O CCONJ
31.32+/-14.75, O NUM
S100 O NOUN
(ng/L): O NOUN
387.5 O NUM
(273.3, O PUNCT
573.0) O NUM
vs. O CCONJ
890.0 O NUM
(590.5, O NOUN
1 O NUM
162.5) O NUM
in O ADP
routine O ADJ
treatment O NOUN
group; O ADJ
NSE O NOUN
(mug/L): O NOUN
29.09+/-16.22 O NUM
vs. O CCONJ
32.25+/-15.43, O NUM
S100 O NOUN
(ng/L): O NOUN
402.5 O NUM
(302.2, O NOUN
580.5) O NUM
vs. O CCONJ
842.0 O NUM
(462.3, O PUNCT
1 O NUM
200.5) O NUM
in O ADP
SBH O NOUN
treatment O NOUN
group, O NOUN
all O DET
P O NOUN
< O SYM
0.05]. O NUM
There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
serum O NOUN
neuron-specific B-outcome ADJ
enolase I-outcome NOUN
or O CCONJ
S100 B-outcome NOUN
protein I-outcome NOUN
level O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
(all O PUNCT
P O NOUN
> O SYM
0.05). O NOUN

Patients O NOUN
received O VERB
IV O NUM
plus O CCONJ
IA O NOUN
TXA O NOUN
has O VERB
decreased O VERB
total O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(TBL), O NUM
hidden B-outcome NOUN
blood I-outcome NOUN
loss I-outcome NOUN
(HBL) I-outcome PUNCT
, O PUNCT
and O CCONJ
maximum O NOUN
hemoglobin B-outcome NOUN
(Hb) I-outcome PUNCT
drop O NOUN
than O ADP
those O DET
received O VERB
IV O NUM
TXA-alone O NOUN
and O CCONJ
IA O NOUN
TXA-alone, O NOUN
with O ADP
reductions O NOUN
in O ADP
FDP B-outcome NOUN
and O CCONJ
D-dimer B-outcome NOUN
, O PUNCT
indicating O VERB
that O ADP
IV O NUM
plus O CCONJ
IA O NOUN
TXA O NOUN
injection O NOUN
is O VERB
superior O ADJ
to O PART
prevent O NOUN
blood B-outcome NOUN
loss I-outcome NOUN
and O CCONJ
hyperfibrinolysis B-outcome NOUN
during O ADP
TKA. O NOUN

Before O ADP
treatment, O NOUN
2 O NUM
weeks O NOUN
and O CCONJ
1 O NUM
month O NOUN
after O ADP
treatment, O NOUN
the O DET
Gross B-outcome NOUN
Motor I-outcome NOUN
Function I-outcome NOUN
Measure X ADJ
(GMFM)], X NOUN
modified X VERB
Ashworth X NOUN
Scale X NOUN
(MAS)] X PUNCT
of I-outcome ADP
the Seperator DET
hamstrings I-outcome NOUN
and Seperator CCONJ
triceps I-outcome ADP
, O PUNCT
plantar B-outcome NOUN
area I-outcome NOUN
and O CCONJ
plantar B-outcome NOUN
pressure I-outcome NOUN
were O VERB
examined O VERB
for O ADP
efficacy O NOUN
assessment. O NOUN

In O ADP
the O DET
patient-level O NOUN
meta-analysis, O NOUN
the O DET
percentage O NOUN
of O ADP
patients O NOUN
who O ADP
were O VERB
free O ADJ
from O ADP
recurrence B-outcome NOUN
at O ADP
6 O NUM
months O NOUN
was O VERB
67.0% O NUM
(95% O PUNCT
CI, O NOUN
61.0 O NUM
to O PART
72.3) O NUM
among O ADP
the O DET
426 O NUM
patients O NOUN
in O ADP
the O DET
tafenoquine O NOUN
group O NOUN
and O CCONJ
72.8% O NUM
(95% O PUNCT
CI, O NOUN
65.6 O NUM
to O PART
78.8) O NUM
among O ADP
the O DET
214 O NUM
patients O NOUN
in O ADP
the O DET
primaquine O NOUN
group. O VERB

The O DET
patients O NOUN
in O ADP
the O DET
AG O NOUN
had O VERB
better O ADJ
forced B-outcome VERB
expiratory I-outcome ADJ
volume I-outcome NOUN
in O ADP
the O DET
first O ADV
second O ADJ
and O CCONJ
peak B-outcome NOUN
expiratory I-outcome ADJ
flow I-outcome NOUN
[(1.50+/-0.32) O NOUN
L,(252.06+/-75.27) O NOUN
L/min O NOUN
compared O VERB
with O ADP
the O DET
CG O NOUN
[(1.34+/-0.19) O NOUN
L, O NOUN
(216.94+/-49.72) O PUNCT
L/min O NOUN
(P=0.03, O NUM
P=0.03) O NOUN
at O ADP
discharge. O ADJ

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[entrez] O ADP

Both O CCONJ
effects O NOUN
remained O VERB
significant O ADJ
after O ADP
controlling O VERB
for O ADP
preferred O VERB
meeting O VERB
method O NOUN
(p<0.0001 O NOUN
and O CCONJ
p=0.0003, O NOUN
respectively) O NOUN
and O CCONJ
among O ADP
EM-bound O ADP
students O NOUN
(p=.0423 O PUNCT
and O CCONJ
p<0.0110, O NOUN
respectively). O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

The O DET
total O ADJ
irradiation O NOUN
dose O NOUN
in O ADP
each O DET
group O NOUN
was O VERB
70 O NUM
Gy O NOUN
for O ADP
the O DET
whole O ADJ
nasopharynx. O NOUN

However, O ADV
data O NOUN
from O ADP
randomized O VERB
trials O NOUN
are O VERB
limited. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

The O DET
follow-up O NOUN
was O VERB
conducted O VERB
during O ADP
the O DET
first O ADV
five O NUM
weeks O NOUN
of O ADP
life O NOUN
and O CCONJ
the O DET
evaluation O NOUN
was O VERB
carried O VERB
at O ADP
two O NUM
different O ADJ
times. O NOUN

PROTOCOL: O NOUN
The O DET
protocol O NOUN
is O VERB
available O ADJ
from O ADP
the O DET
corresponding O VERB
author O NOUN
on O ADP
request. O NOUN

Evidence O NOUN
of O ADP
Lack O NOUN
of O ADP
Benefit O NOUN
From O ADP
a O DET
Double-Blind, O NOUN
Placebo-Controlled, O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

During O ADP
a O DET
total O ADJ
median O ADJ
follow-up O NOUN
of O ADP
5.11 O NUM
years, O NOUN
adjudicated O VERB
probable O ADJ
dementia B-outcome NOUN
occurred O VERB
in O ADP
149 O NUM
participants O NOUN
in O ADP
the O DET
intensive O ADJ
treatment O NOUN
group O NOUN
vs O CCONJ
176 O NUM
in O ADP
the O DET
standard O ADJ
treatment O NOUN
group O NOUN
(7.2 O NOUN
vs O CCONJ
8.6 O NUM
cases O NOUN
per O ADP
1000 O NUM
person-years; O NOUN
hazard O NOUN
ratio O NOUN
[HR], O PUNCT
0.83; O NOUN
95% O NOUN
CI, O NOUN
0.67-1.04). O ADV

TRIAL O NOUN
REGISTRATION: O NOUN
Netherlands O NOUN
Trial O NOUN
Register O NOUN
NTR4367. O NOUN

Publication O NOUN
date: O NOUN
2019/03/06 O ADJ
06:00 O ADP
[medline] O NOUN

Notably, O NOUN
10 O NUM
g O NOUN
of O ADP
either O CCONJ
L-leucine O NOUN
or O CCONJ
L-isoleucine, O ADJ
administered O VERB
intragastrically O ADV
before O ADP
a O DET
mixed-nutrient O ADJ
drink, O NOUN
lowered O VERB
postprandial O ADJ
blood O NOUN
glucose, O NOUN
and O CCONJ
intraduodenal O ADJ
infusion O NOUN
of O ADP
L-leucine O NOUN
(at O NUM
a O DET
rate O NOUN
of O ADP
0.45 O NUM
kcal/min, O NOUN
total: O NOUN
9.9 O NUM
g) O NOUN
lowered O VERB
fasting O VERB
blood O NOUN
glucose O NOUN
and O CCONJ
reduced O VERB
energy O NOUN
intake O NOUN
from O ADP
a O DET
subsequent O ADJ
meal. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2019/01/29 O NOUN
06:00 O ADP
[medline] O NOUN

From O ADP
weeks O NOUN
12 O NUM
- O PUNCT
24, O NUM
the O DET
total O ADJ
number O NOUN
of O ADP
new O ADJ
gadolinium-enhancing B-outcome VERB
(Gd(+)) I-outcome NUM
lesions I-outcome NOUN
was O VERB
reduced O VERB
by O ADP
84% O NOUN
(p O PUNCT
< O SYM
0.0001) O NUM
in O ADP
DMF O NOUN
compared O VERB
with O ADP
placebo. O NOUN

Subjects O NOUN
and O CCONJ
Methods: O NOUN
Among O ADP
the O DET
children O NOUN
referred O VERB
to O PART
the O DET
our O ADJ
University, O ADJ
Faculty O NOUN
of O ADP
Dentistry, O PUNCT
Department O NOUN
of O ADP
Pediatric O ADJ
Dentistry, O PUNCT
23 O NUM
aged O VERB
between O ADP
8-14 O NUM
with O ADP
81 O NUM
anterior O ADJ
white B-outcome ADP
spot I-outcome NOUN
lesions I-outcome NOUN
were O VERB
included O VERB
in O ADP
the O DET
study. O NOUN

METHOD: O NOUN
59 O NUM
patients O NOUN
operated O VERB
for O ADP
spinal O ADJ
deformity O NOUN
(Lenke O NOUN
1 O NUM
or O CCONJ
2) O NOUN
AIS. O NOUN

The O DET
postprandial O ADJ
insulin B-outcome NOUN
and O CCONJ
GLP-1 B-outcome NOUN
responses O NOUN
were O VERB
not O ADV
significantly O ADV
different. O NOUN

Journal O ADJ
ID: O NOUN
0210174 O NUM

We O PRON
compared O VERB
the O DET
efficacy O NOUN
and O CCONJ
safety O NOUN
of O ADP
these O DET
two O NUM
schedules. O NOUN

MBCT O NOUN
as O ADP
an O DET
evidence-based O VERB
psychotherapeutic O ADJ
intervention O NOUN
and O CCONJ
Mindfulness-Based O VERB
Intervention O NOUN
(MBI), O PUNCT
is O VERB
an O DET
8-week O NOUN
course O NOUN
developed O VERB
for O ADP
patients O NOUN
with O ADP
relapsing O VERB
depression O NOUN
that O ADP
integrates O NOUN
mindfulness O ADV
meditation O NOUN
practices O NOUN
and O CCONJ
cognitive O ADJ
therapy. O NOUN

The O DET
assay O NOUN
was O VERB
successfully O ADV
applied O VERB
in O ADP
a O DET
pharmacokinetic O ADJ
study O NOUN
in O ADP
renal O ADJ
transplant O NOUN
recipients O NOUN
receiving O VERB
belatacept O ADV
infusions. O NOUN

The O DET
pattern O NOUN
of O ADP
FEV1 B-outcome NOUN
changes O NOUN
around O ADP
exacerbations O NOUN
was O VERB
similar O ADJ
in O ADP
the O DET
triple O NOUN
therapy O NOUN
and O CCONJ
dual O ADJ
bronchodilator O NOUN
groups, O NOUN
and O CCONJ
a O DET
similar O ADJ
pattern O NOUN
was O VERB
seen O VERB
in O ADP
moderate O ADJ
and O CCONJ
severe O ADJ
exacerbations O NOUN
when O ADP
analysed O VERB
separately. O NOUN

BACKGROUND: O NOUN
Endometriosis O NOUN
is O VERB
the O DET
major O ADJ
cause O ADP
of O ADP
progressive O ADJ
pelvic O ADJ
pain O NOUN
and O CCONJ
subfertility. O ADJ

In O ADP
addition, O NOUN
lavender O NOUN
essential O ADJ
oil O NOUN
has O VERB
been O VERB
shown O VERB
to O PART
have O VERB
positive O ADJ
effects O NOUN
on O ADP
some O DET
symptoms O NOUN
associated O VERB
with O ADP
menopause. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Significant O ADJ
improvements O NOUN
in O ADP
serum O NOUN
Ca B-outcome NOUN
, O PUNCT
P B-outcome NOUN
and O CCONJ
iPTH B-outcome NOUN
levels O NOUN
were O VERB
observed O VERB
at O ADP
4, O NOUN
8, O NOUN
and O CCONJ
12 O NUM
weeks O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
(P O NUM
&lt; O NOUN
0.05) O NUM
but O CCONJ
only O ADV
at O ADP
12 O NUM
weeks O NOUN
in O ADP
the O DET
control O NOUN
group O NOUN
(P O NUM
&lt; O NOUN
0.05). O NOUN

Journal-Name:Yonsei O NOUN
medical O ADJ
journal O ADJ

However, O ADV
based O VERB
on O ADP
the O DET
study O NOUN
protocols O NOUN
to O PART
ensure O NOUN
patient O NOUN
safety, O ADP
these O DET
randomised O VERB
studies O NOUN
used O VERB
mainly O ADV
broad-spectrum O NOUN
intravenous O ADJ
antibiotics O NOUN
requiring O VERB
additional O ADJ
hospital O NOUN
resources O NOUN
and O CCONJ
prolonged O VERB
hospital O NOUN
stay. O ADJ

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Publication O NOUN
date: O NOUN
['2019/10/10 O PUNCT
06:00' O NUM

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Recent O ADJ
studies O NOUN
have O VERB
shown O VERB
that O ADP
antibiotic O ADJ
therapy O NOUN
is O VERB
both O CCONJ
safe O ADJ
and O CCONJ
cost-effective O ADJ
for O ADP
a O DET
CT-scan O NOUN
confirmed O VERB
uncomplicated O VERB
acute O ADJ
appendicitis. O NOUN

INTRODUCTION: O NOUN
Deficient O ADJ
levels O NOUN
of O ADP
25-hydroxyvitamin O NOUN
D O NOUN
(25(OH)D) O NUM
(<30 O PUNCT
ng/mL) O NOUN
may O VERB
compromise O VERB
health O NOUN
and O CCONJ
athletic O ADJ
performance. O NOUN

Title: O NOUN
A O DET
prospective O ADJ
randomized O VERB
open-label O NOUN
study O NOUN
of O ADP
single O ADJ
injection O NOUN
versus O CCONJ
continuous O ADJ
adductor O NOUN
canal O NOUN
block O VERB
for O ADP
postoperative O ADJ
analgesia O NOUN
after O ADP
total O ADJ
knee O NOUN
arthroplasty. O NOUN

MATERIAL O NOUN
AND O CCONJ
METHODS: O NOUN
Thirty-six O NUM
elite O ADP
male O NOUN
rowers O NOUN
(27 O PUNCT
+/- O SYM
6 O NUM
years) O NOUN
were O VERB
assigned O VERB
to O PART
one O NUM
of O ADP
the O DET
two O NUM
groups O NOUN
randomly: O NOUN
1) O NUM
Control O NOUN
group O NOUN
(CG, O NOUN
n O NOUN
= O SYM
18, O NUM
height: O NOUN
181.05 O NUM
+/- O SYM
3.39 O NUM
cm O NOUN
and O CCONJ
body O NOUN
mass: O NOUN
77.02 O NUM
+/- O SYM
7.55 O NUM
kg), O NOUN
2) O NOUN
Group O NOUN
treated O VERB
with O ADP
3,000 O NUM
IU O NOUN
of O ADP
vitamin O NOUN
D3/day O NOUN
(VD3G, O NOUN
s O NOUN
= O SYM
18, O NUM
height: O NOUN
179.70 O NUM
+/- O SYM
9.07 O NUM
cm O NOUN
and O CCONJ
body O NOUN
mass: O NOUN
76.19 O NUM
+/- O SYM
10.07 O NUM
kg). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Publication O NOUN
date: O NOUN
2018/11/06 O NOUN
00:00 O NOUN
[accepted] O ADV

Group O NOUN
A O DET
consisted O VERB
patients O NOUN
who O ADP
received O VERB
Atorvastatin O ADP
40mg O NOUN
daily O ADJ
and O CCONJ
Group O NOUN
B O NOUN
Atorvastatin O ADP
80mg O NOUN
daily. O NOUN

Title: O NOUN
Precooling, O NOUN
Exertional O ADJ
Heatstroke O NOUN
Risk O NOUN
Factors, O NOUN
and O CCONJ
Postexercise O ADV
Cooling O VERB
Rates. O NOUN

Cost O NOUN
and O CCONJ
resource O NOUN
savings O NOUN
of O ADP
using O VERB
the O DET
app O CCONJ
compared O VERB
to O PART
face-to-face O NUM
counseling O VERB
may O VERB
make O VERB
it O PRON
a O DET
good O ADJ
option O NOUN
for O ADP
interventionists. O NOUN

Publication O NOUN
date: O NOUN
2019/01/01 O NOUN
06:00 O ADP
[medline] O NOUN

J O NOUN
Drugs O NOUN
Dermatol. O NOUN

We O PRON
conducted O VERB
a O DET
double-blinded, O NOUN
randomized, O NOUN
and O CCONJ
placebo-controlled O VERB
trial O NOUN
in O ADP
Addis O NOUN
Ababa, O NOUN
Ethiopia, O ADV
to O PART
investigate O NOUN
if O ADP
daily O ADJ
nutritional O ADJ
supplementation O NOUN
with O ADP
vitD(3) O NOUN
(5000 O NUM
IU) O NOUN
and O CCONJ
phenylbutyrate O NOUN
(PBA, O PUNCT
2 O NUM
x O SYM
500 O NUM
mg) O NOUN
could O VERB
mediate O VERB
beneficial O ADJ
effects O NOUN
in O ADP
treatment-naive O ADJ
HIV O NOUN
patients. O NOUN

CONCLUSIONS: O NOUN
For O ADP
high O ADJ
responder O VERB
patients O NOUN
receiving O VERB
GnRH-agonist O NOUN
trigger, O ADV
low O ADJ
dose O NOUN
hCG O NOUN
supplementation O NOUN
allowed O VERB
high O ADJ
pregnancy B-outcome NOUN
rates O NOUN
after O ADP
fresh O ADJ
embryo O NOUN
transfer, O NOUN
regardless O ADV
of O ADP
whether O ADP
it O PRON
was O VERB
given O VERB
at O ADP
the O DET
time O NOUN
of O ADP
trigger O ADP
or O CCONJ
at O ADP
oocyte O NOUN
retrieval. O NOUN

They O PRON
were O VERB
randomly O ADV
divided O VERB
into O ADP
group O NOUN
A O DET
and O CCONJ
group O NOUN
B, O NOUN
30 O NUM
cases O NOUN
in O ADP
each O DET
group. O VERB

The O DET
primary O ADJ
outcome O NOUN
was O VERB
the O DET
fit B-outcome NOUN
factor I-outcome NOUN
, O PUNCT
and O CCONJ
the O DET
secondary O ADJ
outcomes O NOUN
were O VERB
overall B-outcome ADJ
fit I-outcome NOUN
factor I-outcome NOUN
, O PUNCT
adequate O ADJ
protection B-outcome NOUN
rate, O NOUN
and O CCONJ
respiratory O ADJ
preference B-outcome NOUN
. O PUNCT
RESULTS: O NOUN
Fit B-outcome NOUN
factors I-outcome NOUN
, O PUNCT
overall B-outcome ADJ
fit I-outcome NOUN
factor I-outcome NOUN
, O PUNCT
and O CCONJ
adequate B-outcome ADJ
protection I-outcome NOUN
rate O NOUN
were O VERB
higher O ADJ
after O ADP
training O VERB
than O ADP
before O ADP
training O VERB
for O ADP
the O DET
3 O NUM
types O NOUN
of O ADP
respirators O NOUN
(all O PUNCT
P O NOUN
< O SYM
.05). O NUM

RESULTS: O NOUN
More O ADV
than O ADP
one O NUM
third O ADJ
of O ADP
girls O NOUN
(35.1%) O PUNCT
reported O VERB
having O VERB
no O DET
hope O NOUN
for O ADP
the O DET
future. O NOUN

At O ADP
6 O NUM
months, O NOUN
the O DET
mean O NOUN
Posttraumatic B-outcome ADJ
Stress I-outcome NOUN
Disorder I-outcome NOUN
(PTSD) I-outcome ADV
Symptom I-outcome NOUN
Scale]-Self-Report O ADJ
questionnaire O NOUN
score O NOUN
in O ADP
intervention O NOUN
ICUs O NOUN
was O VERB
11.8 O NUM
(baseline O NUM
period) O NOUN
compared O VERB
with O ADP
11.5 O NUM
(intervention O PUNCT
period) O NOUN
(difference, O ADV
-0.40 O NUM
[95% O NOUN
CI, O NOUN
-2.46 O NUM
to O PART
1.67]) O NOUN
and O CCONJ
in O ADP
control O NOUN
ICUs, O ADP
10.1 O NUM
(baseline O NUM
period) O NOUN
compared O VERB
with O ADP
10.2 O NUM
(intervention O PUNCT
period) O NOUN
(difference, O ADV
0.06 O NUM
[95% O NOUN
CI, O NOUN
-1.74 O NUM
to O PART
1.85]) O NOUN
between O ADP
periods. O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
assigned O VERB
female O NOUN
healthcare O NOUN
workers O NOUN
with O ADP
recurrent O ADP
non-specific O ADJ
LBP O NOUN
to O PART
one O NUM
of O ADP
four O NUM
study-arms: O NOUN
Combined O VERB
neuromuscular O ADJ
exercise O NOUN
and O CCONJ
back O ADP
care O NOUN
counseling; O VERB
Exercise; O NOUN
Counseling; O VERB
and O CCONJ
no O DET
intervention O NOUN
Control. O NOUN

Yoga O NOUN
decreased O VERB
the O DET
state O NOUN
of O ADP
depression B-outcome NOUN
and O CCONJ
diastolic B-outcome ADJ
pressure I-outcome NOUN
of O ADP
the O DET
subjects O NOUN
with O ADP
PMS O NOUN
complaining O VERB
from O ADP
depression. O NOUN

The O DET
95% O NOUN
effective O ADJ
dose B-outcome NOUN
was O VERB
calculated O VERB
with O ADP
Probit O NOUN
analysis. O NOUN

Publication O NOUN
date: O NOUN
2019/02/12 O ADJ
06:00 O ADP
[medline] O NOUN

Multidisciplinary O ADJ
interventions O NOUN
among O ADP
these O DET
workers O NOUN
have O VERB
improved O VERB
fear O ADJ
avoidance O NOUN
beliefs B-outcome NOUN
, O PUNCT
but O CCONJ
not O ADV
low B-outcome ADJ
back I-outcome ADP
pain I-outcome NOUN
(LBP) I-outcome PUNCT
and O CCONJ
related O VERB
sickness B-outcome NOUN
absences I-outcome NOUN
, O PUNCT
cost-effectiveness O NOUN
studies O NOUN
are O VERB
scarce. O NOUN

Rate O NOUN
of O ADP
main B-outcome ADJ
curve I-outcome NOUN
correction I-outcome NOUN
was O VERB
not O ADV
significantly O ADV
different O ADJ
considering O VERB
patients' O NOUN
gender O NOUN
(P-value0.657). O NUM

Adverse B-outcome ADJ
reactions I-outcome NOUN
were O VERB
analyzed O VERB
by O ADP
the O DET
incidence O NOUN
rate, O NOUN
type, O NOUN
and O CCONJ
severity. O DET

Journal-Name:Anticancer O NOUN
research O NOUN

We O PRON
evaluated O VERB
the O DET
effectiveness O NOUN
and O CCONJ
usefulness O ADJ
of O ADP
the O DET
single/double O ADJ
ETView O NOUN
TVT O NOUN
in O ADP
monitoring O VERB
the O DET
tracheal O ADJ
tube O NOUN
position O NOUN
during O ADP
general O ADJ
anesthesia O NOUN
undergoing O VERB
video-assisted O VERB
thoracoscopic O ADJ
lobectomy. O NOUN

CONCLUSION: O NOUN
Thus, O NOUN
the O DET
use O NOUN
of O ADP
BiPAP O ADJ
in O ADP
PAR O NOUN
can O VERB
promote O VERB
restoration O NOUN
of O ADP
expiratory B-outcome ADJ
reserve I-outcome NOUN
volume I-outcome NOUN
and O CCONJ
contribute O NOUN
to O PART
the O DET
reduction O NOUN
of O ADP
atelectasis. O NOUN

Objective O NOUN
To O PART
evaluate O VERB
the O DET
clinical O ADJ
outcome O NOUN
of O ADP
injecting O VERB
Triamcinolone O NOUN
acetenoid O NOUN
in O ADP
osteoarthritis O NOUN
of O ADP
knee O NOUN
in O ADP
a O DET
community O NOUN
set O NOUN
up O ADP
over O ADP
a O DET
randomized O VERB
double-blind O ADJ
placebo O NOUN
control O NOUN
trial. O NOUN

Publication O NOUN
date: O NOUN
2018/11/06 O NOUN
00:00 O NOUN
[accepted] O ADV

Comparing O VERB
MRI O NOUN
sequences O NOUN
reveals O NOUN
significantly O ADV
reduced O VERB
interobserver O ADV
variability O NOUN
and O CCONJ
significantly O ADV
improved O VERB
accuracy O NOUN
on O ADP
T2*W O NOUN
compared O VERB
to O PART
T2W O NOUN
MRI O NOUN
for O ADP
DSC O NOUN
and O CCONJ
Cohen's O NOUN
kappa. O NOUN

BACKGROUND: O NOUN
Various O ADJ
studies O NOUN
indicate O VERB
the O DET
negative O ADJ
effects O NOUN
of O ADP
menopausal O ADJ
symptoms O NOUN
and O CCONJ
complications O NOUN
on O ADP
the O DET
quality O NOUN
of O ADP
life O NOUN
(QOL) O PUNCT
of O ADP
women. O NOUN

Before O ADP
treatment, O NOUN
the O DET
average O NOUN
pain B-outcome NOUN
intensity I-outcome NOUN
in O ADP
Novafen O NOUN
and O CCONJ
Ginger O NOUN
users O NOUN
were O VERB
7.12 O NUM
+/- O SYM
2.32 O NUM
and O CCONJ
7.60 O NUM
+/- O SYM
1.84, O NUM
respectively O ADV
and O CCONJ
after O ADP
treatment O NOUN
pain B-outcome NOUN
intensity I-outcome NOUN
decreased O VERB
to O PART
3.10 O NUM
+/- O SYM
2.69 O NUM
and O CCONJ
2.97 O NUM
+/- O SYM
2.69, O NUM
respectively. O NOUN

METHOD: O NOUN
a O DET
randomized O VERB
controlled O VERB
trial, O NOUN
with O ADP
102 O NUM
patients O NOUN
in O ADP
the O DET
preoperative O ADJ
period, O NOUN
randomized O VERB
in O ADP
a O DET
control O NOUN
group, O NOUN
with O ADP
usual O ADJ
care, O NOUN
and O CCONJ
an O DET
experimental O ADJ
group, O NOUN
which O ADP
received O VERB
menthol O NOUN
gum, O NOUN
which O ADP
was O VERB
the O DET
study O NOUN
treatment O NOUN
variable. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

OBJECTIVE: O NOUN
Deterioration O NOUN
in O ADP
ventricular O ADJ
function O NOUN
is O VERB
often O ADV
observed O VERB
in O ADP
patients O NOUN
treated O VERB
with O ADP
anthracyclines O NOUN
for O ADP
cancer. O NOUN

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[entrez] O ADP

Non-esterified B-outcome VERB
fatty I-outcome ADJ
acid I-outcome NOUN
and O CCONJ
triglyceride B-outcome NOUN
were O VERB
evaluated O VERB
following O VERB
breakfast O NOUN
and O CCONJ
lunch. O NOUN

METHODS: O NOUN
This O DET
trial O NOUN
was O VERB
a O DET
multicenter O NOUN
(6 O ADV
centers: O NOUN
2 O NUM
teaching O VERB
hospitals, O NOUN
4 O NUM
specialist O NOUN
orthodontic O ADJ
practices), O NOUN
single-blinded, O NOUN
randomized O VERB
controlled O VERB
trial O NOUN
with O ADP
2 O NUM
parallel O ADJ
groups. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Spirometry, O ADV
SF-36 O NUM
health O NOUN
survey O NOUN
of O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
and O CCONJ
Lawton O NOUN
and O CCONJ
Brody O NOUN
Instrumental O ADJ
Activities B-outcome NOUN
of I-outcome ADP
Daily I-outcome ADJ
Living I-outcome VERB
Scale O NOUN
(IADL) O NUM
were O VERB
used O VERB
to O PART
collect O NOUN
physical B-outcome ADJ
health I-outcome NOUN
data, O NOUN
and O CCONJ
self-evaluation O NOUN
of O ADP
overall B-outcome ADJ
health I-outcome NOUN
status, O NOUN
self-evaluation O NOUN
of O ADP
loneliness B-outcome NOUN
, O PUNCT
and O CCONJ
short-form O NOUN
geriatric O ADJ
depression B-outcome NOUN
scale O NOUN
(GDS-15) O ADV
were O VERB
used O VERB
to O PART
collect O NOUN
mental B-outcome ADJ
health I-outcome NOUN
data O NOUN
at O ADP
baseline, O NOUN
3 O NUM
months, O NOUN
and O CCONJ
6 O NUM
months O NOUN
after O ADP
intervention. O NOUN

Teacher O NOUN
verbatim O ADV
data O NOUN
was O VERB
collected O VERB
from O ADP
3 O NUM
interviews, O ADJ
and O CCONJ
18 O NUM
researcher O ADP
observations O NOUN
were O VERB
recorded O VERB
using O VERB
field O NOUN
notes. O ADV

Overall, O NOUN
throat B-outcome NOUN
or Seperator CCONJ
mouth I-outcome NOUN
irritation I-outcome NOUN
was O VERB
reported O VERB
more O ADV
frequently O ADV
in O ADP
the O DET
e-cigarette O NOUN
group O NOUN
(65.3%, O PUNCT
vs. O CCONJ
51.2% O NUM
in O ADP
the O DET
nicotine-replacement O ADJ
group) O ADJ
and O CCONJ
nausea B-outcome NOUN
more O ADV
frequently O ADV
in O ADP
the O DET
nicotine-replacement O ADJ
group O NOUN
(37.9%, O PUNCT
vs. O CCONJ
31.3% O NUM
in O ADP
the O DET
e-cigarette O NOUN
group). O NOUN

Patients O NOUN
were O VERB
injected O VERB
with O ADP
BTX-A O NOUN
or O CCONJ
normal O ADJ
saline O NOUN
in O ADP
the O DET
medial O ADJ
part O NOUN
of O ADP
the O DET
upper O ADJ
and O CCONJ
lower O ADJ
eyelids. O NOUN

METHODS: O NOUN
Sixteen O NUM
non-heat O NOUN
acclimatized O VERB
men O NOUN
heat O NOUN
acclimated O VERB
during O ADP
10-11 O NUM
days O NOUN
of O ADP
exercise O NOUN
in O ADP
the O DET
heat O NOUN
(40 O NOUN
degrees O NOUN
C, O NOUN
40% O NUM
RH). O NOUN

Publication O NOUN
date: O NOUN
2019/01/01 O NOUN
06:00 O ADP
[medline] O NOUN

Similar O ADJ
results O NOUN
were O VERB
observed O VERB
in O ADP
patients O NOUN
who O ADP
underwent O VERB
CyPass O NOUN
micro-stent O ADJ
implantation O NOUN
accompanying O VERB
phacoemulsification. O NOUN

The O DET
experimental O ADJ
group O NOUN
had O VERB
a O DET
statistically O ADV
significant O ADJ
reduction O NOUN
(p O PUNCT
< O SYM
0.01) O NUM
of O ADP
about O ADV
10 O NUM
points O NOUN
in O ADP
Audit O NOUN
score O NOUN
after O ADP
the O DET
brief O ADJ
group O NOUN
intervention O NOUN
[before O NOUN
BGI O NOUN
= O SYM
15.89 O NUM
(SD O NOUN
= O SYM
6.62) O ADP
- O PUNCT
hazardous B-outcome ADJ
use I-outcome NOUN
; O PUNCT
after O ADP
BGI O NOUN
= O SYM
6.40 O NUM
(SD O NOUN
= O SYM
5.05) O NOUN
- O PUNCT
low O ADJ
hazardous B-outcome ADJ
use I-outcome NOUN
maintaining O VERB
the O DET
low O ADJ
hazardous B-outcome ADJ
use I-outcome NOUN
in O ADP
follow-up O NOUN
[6.69 O NOUN
(SD O NOUN
= O SYM
6.38) O NOUN
- O PUNCT
low O ADJ
hazardous B-outcome ADJ
use I-outcome NOUN
]. O NOUN
The O DET
control O NOUN
group O NOUN
had O VERB
a O DET
statistically O ADV
significant O ADJ
reduction O NOUN
(p O PUNCT
</= O NOUN
0.01) O NUM
of O ADP
about O ADV
three O NUM
points O NOUN
in O ADP
Audit O NOUN
score O NOUN
[before O NOUN
BGI O NOUN
= O SYM
13.11 O NUM
(SD O NOUN
= O SYM
4.54) O NOUN
- O PUNCT
hazardous B-outcome ADJ
use I-outcome NOUN
; O PUNCT
after O ADP
BGI O NOUN
= O SYM
9.83 O NUM
(SD O NOUN
= O SYM
5.54) O NUM
- O PUNCT
hazardous B-outcome ADJ
use I-outcome NOUN
and O CCONJ
in O ADP
follow-up O NOUN
presented O VERB
the O DET
mean O NOUN
score O NOUN
of O ADP
13.00 O NUM
(SD O NOUN
= O SYM
5.70), O NUM
indicative O ADJ
of O ADP
hazardous B-outcome ADJ
use I-outcome NOUN
. O PUNCT
Differences O NOUN
between O ADP
the O DET
two O NUM
groups O NOUN
(experimental O ADJ
group O NOUN
versus O CCONJ
control O NOUN
group) O ADJ
in O ADP
reduction O NOUN
of O ADP
consumption B-outcome NOUN
were O VERB
statistically O ADV
significant O ADJ
(p O PUNCT
</= O NOUN
0.01). O NOUN

Clinical O ADJ
changes O NOUN
were O VERB
defined O VERB
as O ADP
improvements O NOUN
on O ADP
the O DET
Fugl-Meyer O NOUN
motor B-outcome NOUN
assessment O NOUN
(FMA) O NOUN
and O CCONJ
Wolf O NOUN
motor B-outcome NOUN
function I-outcome NOUN
test O NOUN
(WMFT)]. O PUNCT
Results: O NOUN
All O DET
participants O NOUN
adhered O VERB
to O PART
FT/ST O ADV
without O ADP
adverse B-outcome ADJ
effects I-outcome NOUN
, O PUNCT
and O CCONJ
comparable O ADJ
Borg O ADJ
rating O VERB
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
ratings O NOUN
were O VERB
noted O VERB
between O ADP
groups O NOUN
throughout O ADV
the O DET
training O VERB
(P>/=0.42). O NUM

METHODS: O NOUN
A O DET
total O ADJ
of O ADP
60 O NUM
T2DM O NOUN
patients O NOUN
were O VERB
divided O VERB
into O ADP
2 O NUM
groups O NOUN
according O ADJ
to O PART
the O DET
presence O NOUN
of O ADP
MVC: O NOUN
T2DM O NOUN
+ O SYM
MVC O NOUN
group O NOUN
(n=30) O NUM
and O CCONJ
T2DM O NOUN
group O NOUN
(n=30). O NOUN

Publication O NOUN
date: O NOUN
2019/02/16 O NOUN
06:00 O ADP
[medline] O NOUN

Title: O NOUN
Foot O NOUN
and O CCONJ
ankle O NOUN
characteristics O NOUN
and O CCONJ
dynamic O ADJ
knee O NOUN
valgus O NOUN
in O ADP
individuals O NOUN
with O ADP
patellofemoral O ADJ
osteoarthritis. O NOUN

There O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
generated O VERB
power B-outcome NOUN
and O CCONJ
velocity B-outcome NOUN
in O ADP
the O DET
CON O NOUN
phase O NOUN
of O ADP
the O DET
movement O NOUN
between O ADP
the O DET
GCAF O NOUN
and O CCONJ
GCON. O NOUN

CONCLUSIONS: O NOUN
Among O ADP
patients O NOUN
referred O VERB
to O PART
VA O NOUN
gastroenterology O NOUN
clinics O NOUN
for O ADP
PPI-refractory O ADJ
heartburn, O NOUN
systematic O ADJ
workup O NOUN
revealed O VERB
truly O ADV
PPI-refractory O ADJ
and O CCONJ
reflux-related O VERB
heartburn O ADP
in O ADP
a O DET
minority O NOUN
of O ADP
patients. O NOUN

However, O ADV
self-testing O VERB
is O VERB
only O ADV
a O DET
partial O ADJ
solution O NOUN
to O PART
increasing O VERB
testing B-outcome VERB
rates O NOUN
in O ADP
this O DET
hard O NOUN
to O PART
reach O NOUN
population. O ADV

Publication O NOUN
date: O NOUN
2019/02/15 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:The O ADJ
western O NOUN
journal O ADJ
of O ADP
emergency O NOUN
medicine O NOUN

Journal O ADJ
ID: O NOUN
100891112 O NUM

The O DET
median O ADJ
overall B-outcome ADJ
survival I-outcome NOUN
was O VERB
54.4 O NUM
months O NOUN
in O ADP
the O DET
modified-FOLFIRINOX O NOUN
group O NOUN
and O CCONJ
35.0 O NUM
months O NOUN
in O ADP
the O DET
gemcitabine O NOUN
group O NOUN
(stratified O PUNCT
hazard O NOUN
ratio O NOUN
for O ADP
death B-outcome NOUN
, O PUNCT
0.64; O NOUN
95% O NOUN
CI, O NOUN
0.48 O NUM
to O PART
0.86; O NOUN
P=0.003). O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
critically O ADV
ill O ADJ
patients O NOUN
in O ADP
the O DET
ICU, O ADJ
a O DET
nurse-led O VERB
preventive, O ADJ
complex O NOUN
psychological O ADJ
intervention O NOUN
did O VERB
not O ADV
significantly O ADV
reduce O VERB
patient-reported O VERB
posttraumatic B-outcome ADJ
stress I-outcome NOUN
disorder I-outcome ADP
(PTSD) I-outcome ADV
symptom I-outcome NOUN
severity I-outcome NOUN
at O ADP
6 O NUM
months. O NOUN

Clinical O ADJ
interventions O NOUN
to O PART
address O NOUN
greater O ADJ
foot O NOUN
mobility O NOUN
may O VERB
be O VERB
relevant O ADJ
for O ADP
PFOA. O NOUN

Publication O NOUN
date: O NOUN
2019/02/26 O VERB
06:00 O ADP
[medline] O NOUN

Methods: O NOUN
This O DET
was O VERB
a O DET
prospective O ADJ
study O NOUN
conducted O VERB
from O ADP
November O NOUN
2017 O NUM
to O PART
March O NOUN
2018. O NUM

Further O ADV
study O NOUN
of O ADP
pegbelfermin O NOUN
is O VERB
warranted O VERB
in O ADP
patients O NOUN
with O ADP
non-alcoholic O ADJ
steatohepatitis. O NOUN

Journal-Name:Journal O ADJ
of O ADP
music O ADJ
therapy O NOUN

Publication O NOUN
date: O NOUN
2018/08/02 O ADJ
00:00 O NOUN
[accepted] O ADV

Publication O NOUN
date: O NOUN
2019/01/12 O ADJ
06:00 O ADP
[medline] O NOUN

BACKGROUND: O NOUN
Multiple O ADJ
arterial O ADJ
grafts O NOUN
may O VERB
result O VERB
in O ADP
longer O ADJ
survival O NOUN
than O ADP
single O ADJ
arterial O ADJ
grafts O NOUN
after O ADP
coronary-artery O NOUN
bypass O NOUN
grafting O VERB
(CABG) O PUNCT
surgery. O VERB

In O ADP
Group O NOUN
A O DET
(12%) O NUM
patients O NOUN
had O VERB
infection B-outcome NOUN
and O CCONJ
(88%) O NOUN
whereas O ADP
in O ADP
Group O NOUN
B O NOUN
(20%) O NOUN
patients O NOUN
had O VERB
infection B-outcome NOUN
and O CCONJ
(80%) O NOUN
patients O NOUN
did O VERB
n't O ADV
had O VERB
infection B-outcome NOUN
. O PUNCT
CONCLUSIONS: O NOUN
Simultaneous O ADJ
VP O NOUN
shunting O VERB
was O VERB
more O ADV
effective O ADJ
than O ADP
delayed O VERB
VP O NOUN
shunting O VERB
in O ADP
children O NOUN
undergoing O VERB
myelomeningocele O NOUN
in O ADP
terms O NOUN
of O ADP
infection B-outcome NOUN
. O PUNCT

Publication O NOUN
date: O NOUN
2019/01/05 O NOUN
06:00 O ADP
[medline] O NOUN

All O DET
the O DET
patients O NOUN
were O VERB
given O VERB
routine O ADJ
treatment O NOUN
combined O VERB
with O ADP
traditional O ADJ
Chinese O NOUN
medicine O NOUN
retention O NOUN
enema, O ADP
and O CCONJ
the O DET
patients O NOUN
in O ADP
the O DET
treatment O NOUN
group O NOUN
received O VERB
additional O ADJ
Ronghuang O NOUN
granule O NOUN
treatment O NOUN
(3 O NOUN
times O NOUN
a O DET
day). O NOUN

This O DET
is O VERB
the O DET
first O ADV
experimental O ADJ
evidence O NOUN
of O ADP
beta-Eudesmol O NOUN
effect O NOUN
for O ADP
mental O ADJ
stress O NOUN
in O ADP
human. O NOUN

Journal O ADJ
ID: O NOUN
8102988 O NUM

Furthermore, O NOUN
glycolysis B-outcome NOUN
and O CCONJ
tricarboxylic B-outcome ADJ
acid I-outcome NOUN
(TCA) I-outcome PUNCT
cycle I-outcome NOUN
was O VERB
perturbed, O NOUN
and O CCONJ
increased O VERB
dihydroxyacetone B-outcome NOUN
phosphate I-outcome NOUN
(DHAP) I-outcome NUM
and O CCONJ
decreased O VERB
succinyl-CoA B-outcome NOUN
synthetase I-outcome NOUN
(SCS) I-outcome PUNCT
respectively O ADV
in O ADP
these O DET
two O NUM
metabolic O ADJ
pathways O NOUN
were O VERB
identified O VERB
as O ADP
potential O ADJ
biomarkers O NOUN
for O ADP
tubular O ADJ
injury O NOUN
in O ADP
DKD. O NOUN

Journal-Name:Journal O ADJ
of O ADP
physiology O NOUN
and O CCONJ
pharmacology O NOUN
: O PUNCT
an O DET
official O ADJ
journal O ADJ
of O ADP
the O DET
Polish O ADV
Physiological O ADJ
Society O NOUN

Journal O ADJ
ID: O NOUN
0332203 O NUM

Title: O NOUN
Effects O NOUN
of O ADP
Vitamin O NOUN
D O NOUN
Supplementation O NOUN
on O ADP
Haematological B-outcome ADJ
Values O NOUN
and O CCONJ
Muscle B-outcome NOUN
Recovery I-outcome NOUN
in O ADP
Elite O ADP
Male O NOUN
Traditional O ADJ
Rowers. O NOUN

The O DET
experimental O ADJ
group O NOUN
(G1) O PUNCT
was O VERB
indicated O VERB
from O ADP
the O DET
entrance O NOUN
a O DET
diet O NOUN
hyperproteic O NOUN
low O ADJ
in O ADP
colecistokinetics O NOUN
diet, O ADV
and O CCONJ
to O PART
the O DET
control O NOUN
group O NOUN
(G2) O NUM
nothing O VERB
by O ADP
mouth. O NOUN

METHODS: O NOUN
In O ADP
this O DET
double-blind, O NOUN
controlled O VERB
trial, O NOUN
we O PRON
randomly O ADV
assigned O VERB
145 O NUM
patients O NOUN
with O ADP
TTP O NOUN
to O PART
receive O VERB
caplacizumab O NOUN
(10-mg O NOUN
intravenous O ADJ
loading O VERB
bolus, O NOUN
followed O VERB
by O ADP
10 O NUM
mg O NOUN
daily O ADJ
subcutaneously) O NOUN
or O CCONJ
placebo O NOUN
during O ADP
plasma O NOUN
exchange O NOUN
and O CCONJ
for O ADP
30 O NUM
days O NOUN
thereafter. O NOUN

After O ADP
adjusting O VERB
for O ADP
pancreatic O ADJ
fistula O NOUN
and O CCONJ
delayed O VERB
gastric O ADJ
emptying, O NOUN
no O DET
statistically O ADV
significant O ADJ
differences O NOUN
in O ADP
the O DET
primary O ADJ
outcomes O NOUN
were O VERB
observed. O NOUN

The O DET
implantation B-outcome NOUN
rate O NOUN
and O CCONJ
per-cycle O NOUN
clinical B-outcome ADJ
pregnancy I-outcome NOUN
rate O NOUN
were O VERB
significantly O ADV
higher O ADJ
in O ADP
PRP O NOUN
group O NOUN
(p O PUNCT
= O SYM
0.002 O NUM
and O CCONJ
0.044, O NOUN
respectively O ADV
(p O PUNCT
= O SYM
0.002). O NUM

Samples O NOUN
were O VERB
stable O ADJ
during O ADP
storage O NOUN
at O ADP
4 O NUM
degrees O NOUN
C O NOUN
for O ADP
15 O NUM
days O NOUN
and O CCONJ
during O ADP
2 O NUM
freeze-thaw O NOUN
cycles. O NUM

In O ADP
this O DET
clinical O ADJ
trial, O NOUN
we O PRON
evaluated O VERB
the O DET
effectiveness O NOUN
of O ADP
platelet-rich O NOUN
plasma O NOUN
(PRP) O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
thin O ADJ
endometrium. O NOUN

OBJECTIVE: O NOUN
In O ADP
view O NOUN
of O ADP
the O DET
high O ADJ
incidence O NOUN
of O ADP
polycystic O ADJ
ovary O NOUN
syndrome O NOUN
(PCOS) O PUNCT
and O CCONJ
the O DET
unsatisfactory O ADJ
therapeutic O ADJ
effects O NOUN
of O ADP
dimethyldiguanide O NOUN
or O CCONJ
clomifene O NOUN
citrate O NOUN
alone, O NOUN
our O ADJ
study O NOUN
aimed O VERB
to O PART
investigate O NOUN
the O DET
therapeutic O ADJ
effects O NOUN
of O ADP
dimethyldiguanide O NOUN
combined O VERB
with O ADP
clomifene O NOUN
citrate O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
PCOS. O NOUN

Journal O ADJ
ID: O NOUN
8611905 O NUM

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

L(- O NOUN
1)). O NOUN

Journal O ADJ
ID: O NOUN
101147696 O NUM

The O DET
primary O ADJ
outcomes O NOUN
were O VERB
safety O NOUN
and O CCONJ
the O DET
absolute O ADJ
change O NOUN
in O ADP
hepatic B-outcome ADJ
fat I-outcome NOUN
fraction I-outcome NOUN
after O ADP
16 O NUM
weeks O NOUN
of O ADP
treatment. O NOUN

Other O ADJ
potential O ADJ
moments O NOUN
for O ADP
hand B-outcome NOUN
hygiene I-outcome NOUN
were O VERB
introduced O VERB
by O ADP
participants, O NOUN
such O ADJ
as O ADP
after O ADP
tending O VERB
to O PART
domestic O ADJ
animals O NOUN
and O CCONJ
gardening. O NOUN

The O DET
relationship O NOUN
of O ADP
marginal O ADJ
bone O NOUN
responses O NOUN
and O CCONJ
peri-implant O ADJ
mucosal O ADJ
stability O NOUN
requires O NOUN
further O ADV
evaluation. O ADV

Journal O ADJ
ID: O NOUN
0374675 O NUM

Patients O NOUN
and O CCONJ
Methods: O NOUN
Between O ADP
2003 O NUM
and O CCONJ
2004, O NUM
60 O NUM
patients O NOUN
with O ADP
pathologically O ADV
confirmed O VERB
NPC O NOUN
were O VERB
included O VERB
and O CCONJ
randomly O ADV
assigned O VERB
to O PART
two O NUM
groups. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Clinical O ADJ
Trials O NOUN
NCT01839708 O NOUN
; O PUNCT
registered O VERB
February O ADJ
28, O NUM
2013. O NUM

The O DET
analysis O NOUN
of O ADP
which O ADP
was O VERB
conducted O VERB
before O ADP
PCI O NOUN
and O CCONJ
24 O NUM
hours O NOUN
after O ADP
the O DET
surgery. O VERB

Considerations O NOUN
for O ADP
feasibility O NOUN
and O CCONJ
effectiveness, O NOUN
including O VERB
barriers O NOUN
to O PART
attendance, O NOUN
are O VERB
discussed. O NOUN

However, O ADV
higher O ADJ
frequencies O NOUN
of O ADP
all O DET
adverse B-outcome ADJ
outcomes I-outcome NOUN
were O VERB
consistently O ADV
observed O VERB
in O ADP
the O DET
control O NOUN
group. O VERB

METHODS: O NOUN
From O ADP
October O ADJ
2015 O NUM
to O PART
December O NOUN
2017, O NUM
a O DET
total O ADJ
of O ADP
79 O NUM
patients, O NOUN
who O ADP
received O VERB
preoperative O ADJ
localization O NOUN
of O ADP
small O ADJ
pulmonary O ADJ
nodules O NOUN
and O CCONJ
surgical O ADJ
treatment O NOUN
in O ADP
the O DET
Department O NOUN
of O ADP
Thoracic O ADJ
Surgery O NOUN
of O ADP
Hohhot O NOUN
First O ADV
Hospital, O ADJ
were O VERB
enrolled O VERB
into O ADP
this O DET
study. O NOUN

EBV-encoded O VERB
small O ADJ
RNA O NOUN
in O ADP
situ O ADV
hybridization O NOUN
was O VERB
performed O VERB
to O PART
define O NOUN
EBV O NOUN
status. O NOUN

METHODS: O NOUN
This O DET
was O VERB
a O DET
post-hoc O NOUN
analysis O NOUN
of O ADP
a O DET
cluster-randomized O VERB
trial O NOUN
as O ADP
a O DET
cohort O NOUN
study; O ADJ
including O VERB
patients O NOUN
with O ADP
a O DET
working O VERB
diagnosis O NOUN
of O ADP
CAP O NOUN
admitted O VERB
to O PART
non-ICU O NOUN
wards O NOUN
without O ADP
a O DET
cardiac O ADJ
event O NOUN
on O ADP
admission. O NOUN

The O DET
physiological B-outcome ADJ
adaptive I-outcome ADJ
mode I-outcome NOUN
( O PUNCT
activity B-outcome NOUN
and O CCONJ
exercise B-outcome NOUN
and O CCONJ
neonatal B-outcome ADJ
nutrition I-outcome NOUN
) O PUNCT
and O CCONJ
the O DET
interdependence B-outcome NOUN
adaptive I-outcome ADJ
mode I-outcome NOUN
(appropriate O NOUN
affection B-outcome NOUN
and O CCONJ
proper O ADJ
development B-outcome NOUN
); O PUNCT
and O CCONJ
statistically O ADV
significant O ADJ
differences O NOUN
were O VERB
found O VERB
in O ADP
favor O NOUN
of O ADP
the O DET
experimental O ADJ
group. O VERB

Publication O NOUN
date: O NOUN
2019/01/31 O NOUN
06:00 O ADP
[entrez] O ADP

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Compared O VERB
with O ADP
the O DET
control O NOUN
group, O NOUN
the O DET
combination O NOUN
therapy O NOUN
in O ADP
the O DET
experiment O NOUN
group O NOUN
could O VERB
significantly O ADV
improve O VERB
the O DET
6MWT O ADV
(P O NUM
= O SYM
.0094), O NUM
CAT O NOUN
(P O NUM
= O SYM
.0071) O PUNCT
and O CCONJ
BODE O NOUN
index O NOUN
(P O NUM
= O SYM
.0064) O PUNCT
as O ADP
well O ADV
as O ADP
the O DET
changes O NOUN
of O ADP
6MWT O ADV
(P O NUM
< O SYM
.01), O PUNCT
CAT O NOUN
(P O NUM
< O SYM
.01), O PUNCT
and O CCONJ
BODE O NOUN
index O NOUN
(P O NUM
< O SYM
.01) O PUNCT
before O ADP
and O CCONJ
after O ADP
treatment. O NOUN

There O PRON
was O VERB
no O DET
significant O ADJ
difference O NOUN
in O ADP
major B-outcome ADJ
adverse I-outcome ADJ
cardiovascular I-outcome ADJ
events I-outcome NOUN
(MACE) I-outcome PUNCT
at O ADP
1 O NUM
year O NOUN
between O ADP
intervention O NOUN
and O CCONJ
usual O ADJ
care O NOUN
groups O NOUN
(unadjusted O VERB
cumulative O ADJ
incidence, O NOUN
10.2% O NUM
vs O CCONJ
10.6%; O ADJ
P O NOUN
= O SYM
.65; O NUM
adjusted O VERB
difference, O NOUN
0.66% O NUM
[95% O NOUN
CI, O NOUN
-0.73% O ADV
to O PART
2.06%]; O ADJ
adjusted O VERB
hazard O NOUN
ratio, O NOUN
1.07 O NUM
[95% O NOUN
CI, O NOUN
0.93 O NUM
to O PART
1.25]). O ADJ

Journal-Name:Journal O ADJ
of O ADP
the O DET
International O ADJ
Society O NOUN
of O ADP
Sports O NOUN
Nutrition O NOUN

A O DET
sociodemographic O ADJ
questionnaire O NOUN
and O CCONJ
the O DET
Alcohol B-outcome NOUN
Use I-outcome PUNCT
Disorders I-outcome NOUN
Identification O NOUN
Test O NOUN
(Audit) O PUNCT
were O VERB
applied. O NOUN

RESULTS: O NOUN
Methohexital O ADJ
resulted O VERB
in O ADP
less O ADV
hypotension B-outcome NOUN
compared O VERB
with O ADP
propofol O NOUN
(P O NUM
= O SYM
.01), O PUNCT
although O ADP
the O DET
degree O NOUN
of O ADP
refractory B-outcome ADJ
hypotension I-outcome NOUN
was O VERB
similar O ADJ
(P O NUM
= O SYM
.37). O PUNCT

The O DET
eligible O ADJ
women O NOUN
were O VERB
randomly O ADV
allocated O VERB
into O ADP
an O DET
experimental O ADJ
and O CCONJ
control O NOUN
groups. O NOUN

RESULTS: O NOUN
Among O ADP
the O DET
401 O NUM
patients O NOUN
enrolled, O NOUN
the O DET
median O ADJ
lowest O ADV
oxygen B-outcome NOUN
saturation I-outcome NOUN
was O VERB
96% O ADJ
(interquartile O NUM
range, O VERB
87 O NUM
to O PART
99) O NOUN
in O ADP
the O DET
bag-mask O ADJ
ventilation O NOUN
group O NOUN
and O CCONJ
93% O ADJ
(interquartile O NUM
range, O VERB
81 O NUM
to O PART
99) O NOUN
in O ADP
the O DET
no-ventilation O NOUN
group O NOUN
(P O NUM
= O SYM
0.01). O NOUN

Title: O NOUN
National O ADJ
quality O NOUN
improvement O NOUN
programmes O NOUN
need O NOUN
time O NOUN
and O CCONJ
resources O NOUN
to O PART
have O VERB
an O DET
impact. O NOUN

Publication O NOUN
date: O NOUN
2018/12/15 O NOUN
06:00 O ADP
[entrez] O ADP

Journal-Name:BMC O NOUN
public O ADJ
health O NOUN

In O ADP
addition, O NOUN
all O DET
subjects O NOUN
were O VERB
required O VERB
to O PART
undergo O NOUN
indwelling O VERB
urinary O ADJ
catheter O NOUN
throughout O ADV
the O DET
study O NOUN
period. O NOUN

Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
patients O NOUN
undergoing O VERB
THA, O NOUN
paracetamol O NOUN
plus O CCONJ
ibuprofen O NOUN
significantly O ADV
reduced O VERB
morphine B-outcome NOUN
consumption I-outcome NOUN
compared O VERB
with O ADP
paracetamol O NOUN
alone O ADJ
in O ADP
the O DET
first O ADV
24 O NUM
hours O NOUN
after O ADP
surgery; O NOUN
there O PRON
was O VERB
no O DET
statistically O ADV
significant O ADJ
increase O NOUN
in O ADP
SAEs B-outcome NOUN
in O ADP
the O DET
pooled O VERB
groups O NOUN
receiving O VERB
ibuprofen O NOUN
alone O ADJ
vs O CCONJ
with O ADP
paracetamol O NOUN
alone. O NOUN

CONCLUSION: O NOUN
Drainage O NOUN
by O ADP
the O DET
same O ADJ
thoracotomy O NOUN
intercostal O ADJ
space O NOUN
was O VERB
feasible O ADJ
and O CCONJ
results O NOUN
30 O NUM
days O NOUN
after O ADP
surgery O NOUN
were O VERB
not O ADV
inferior O ADJ
to O PART
those O DET
of O ADP
the O DET
traditional O ADJ
chest O NOUN
drainage O NOUN
approach. O NOUN

['2018/12/21 O NOUN
06:00' O NUM

Title: O NOUN
Comparison O NOUN
of O ADP
effective O ADJ
teaching O VERB
methods O NOUN
to O PART
achieve O NOUN
skill B-outcome ADV
acquisition O NOUN
using O VERB
a O DET
robotic O ADJ
virtual O ADJ
reality O NOUN
simulator: O NOUN
Expert O NOUN
proctoring O VERB
versus O CCONJ
an O DET
educational O ADJ
video O ADJ
versus O CCONJ
independent O ADJ
training. O NOUN

Title: O NOUN
Daily O ADJ
Nutritional O ADJ
Supplementation O NOUN
with O ADP
Vitamin O NOUN
D(3) O NOUN
and O CCONJ
Phenylbutyrate O NOUN
to O PART
Treatment-Naive O ADJ
HIV O NOUN
Patients O NOUN
Tested O VERB
in O ADP
a O DET
Randomized O VERB
Placebo-Controlled O VERB
Trial. O NOUN

To O PART
analyze O NOUN
if O ADP
25(OH)D O NUM
was O VERB
a O DET
good O ADJ
predictor O NOUN
of O ADP
testosterone B-outcome NOUN
, O PUNCT
cortisol B-outcome NOUN
, O PUNCT
and O CCONJ
testosterone/cortisol B-outcome NOUN
ratio I-outcome NOUN
a O DET
stepwise O ADV
regression O NOUN
model O NOUN
was O VERB
performed. O NOUN

Title: O NOUN
Promoting O VERB
vaccination O NOUN
in O ADP
the O DET
province O NOUN
of O ADP
Quebec: O ADV
the O DET
PromoVaQ O NOUN
randomized O VERB
controlled O VERB
trial O NOUN
protocol. O NOUN

METHODS: O NOUN
In O ADP
this O DET
double-blind, O NOUN
phase O NOUN
3 O NUM
trial, O NOUN
we O PRON
randomly O ADV
assigned O VERB
87 O NUM
patients O NOUN
with O ADP
progressive, O NOUN
symptomatic, O NOUN
or O CCONJ
recurrent O ADP
desmoid O NOUN
tumors O NOUN
to O PART
receive O VERB
either O CCONJ
sorafenib O NOUN
(400-mg O NOUN
tablet O NOUN
once O ADP
daily) O CCONJ
or O CCONJ
matching O VERB
placebo. O NOUN

Among O ADP
patients O NOUN
who O ADP
underwent O VERB
lymphadenectomy, O NOUN
the O DET
median O ADJ
number O NOUN
of O ADP
removed O VERB
nodes B-outcome NOUN
was O VERB
57 O NUM
(35 O VERB
pelvic O ADJ
and O CCONJ
22 O NUM
paraaortic O ADJ
nodes). O NOUN

Publication O NOUN
date: O NOUN
2019/01/11 O NOUN
06:00 O ADP
[entrez] O ADP

METHODS: O NOUN
Healthy O NOUN
volunteers O NOUN
were O VERB
enrolled O VERB
randomly O ADV
into O ADP
one O NUM
of O ADP
two O NUM
groups O NOUN
with O ADP
the O DET
following O VERB
drug O NOUN
regimens O NOUN
for O ADP
2 O NUM
weeks: O NOUN
group O NOUN
A, O NOUN
low-dose O NOUN
aspirin O NOUN
once O ADP
per O ADP
day O NOUN
and O CCONJ
group O NOUN
B, O NOUN
low-dose O NOUN
aspirin O NOUN
and O CCONJ
4.0 O NUM
g O NOUN
of O ADP
ecabet O NOUN
sodium. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
daily O ADJ
stool B-outcome NOUN
frequency. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

All O DET
patients O NOUN
were O VERB
randomly O ADV
selected O VERB
to O PART
receive O VERB
standard O ADJ
anesthesia O NOUN
induction O NOUN
with O ADP
either O CCONJ
0.6 O NUM
mg.kg O NOUN
rocuronium O NOUN
or O CCONJ
0.2 O NUM
mg.kg O NOUN
cisatracurium. O NOUN

h(-1)), O NOUN
but O CCONJ
did O VERB
not O ADV
affect O NOUN
ratings O NOUN
of O ADP
perceived B-outcome VERB
exertion I-outcome NOUN
or O CCONJ
CWI O NOUN
cooling B-outcome VERB
rates O NOUN
(PC O NOUN
= O SYM
0.18 O NUM
+/- O SYM
0.14 O NUM
degrees O NOUN
C O NOUN
. O PUNCT

METHODS: O NOUN
This O DET
study O NOUN
was O VERB
designed O VERB
as O ADP
a O DET
randomized, O NOUN
double-blind, O NOUN
sham O NOUN
control O NOUN
trial. O NOUN

Tafenoquine O NOUN
was O VERB
associated O VERB
with O ADP
asymptomatic O ADJ
declines O NOUN
in O ADP
hemoglobin O NOUN
levels, O NOUN
which O ADP
resolved O VERB
without O ADP
intervention. O NOUN

MACE B-outcome NOUN
at O ADP
1 O NUM
year O NOUN
were O VERB
comparable O ADJ
in O ADP
both O CCONJ
the O DET
groups O NOUN
3 O NUM
of O ADP
85(3.52%) O NUM
in O ADP
the O DET
polymer-free O ADJ
group O NOUN
and O CCONJ
3 O NUM
of O ADP
98(3.06%) O ADV
in O ADP
the O DET
biodegradable O ADJ
polymer O NOUN
group, O NOUN
p O NOUN
= O SYM
0.859. O NUM

Curcumin O NOUN
can O VERB
be O VERB
used O VERB
as O ADP
an O DET
effective O ADJ
alternative O ADJ
local O ADJ
drug O NOUN
delivery O NOUN
agent. O NOUN

Further O ADV
studies O NOUN
with O ADP
larger O ADJ
sample O NOUN
sizes O NOUN
are O VERB
needed O VERB
to O PART
confirm O NOUN
these O DET
findings. O NOUN

Subepithelial O ADJ
connective O ADJ
tissue O NOUN
grafts O NOUN
(SCTGs) O NOUN
with O ADP
a O DET
coronally O ADV
advanced O VERB
flap O NOUN
(CAF) O PUNCT
are O VERB
accepted O VERB
as O ADP
the O DET
gold O NOUN
standard O ADJ
for O ADP
covering O VERB
denuded O VERB
root O NOUN
surfaces. O NOUN

Journal O ADJ
ID: O NOUN
1307333 O NUM

Objectives: O ADJ
To O PART
compare O NOUN
foot O NOUN
and O CCONJ
ankle O NOUN
mobility, O NOUN
foot O NOUN
posture, O NOUN
and O CCONJ
dynamic O ADJ
knee O NOUN
valgus, O NOUN
measured O VERB
as O ADP
the O DET
frontal O ADJ
plane O ADJ
projection O NOUN
angle O NOUN
(FPPA) O PUNCT
during O ADP
single-leg O ADJ
squatting, O NOUN
between O ADP
individuals O NOUN
with O ADP
and O CCONJ
without O ADP
PFOA. O NOUN

We O PRON
hypothesize O NOUN
that O ADP
school O NOUN
students O NOUN
receiving O VERB
the O DET
teacher-delivered O VERB
intervention O NOUN
to O PART
promote O VERB
autonomous O ADJ
motivation O NOUN
toward O ADP
physical O ADJ
activity O NOUN
will O VERB
exhibit O NOUN
greater O ADJ
participation B-outcome NOUN
in O ADP
physical O ADJ
activities O NOUN
outside O ADP
of O ADP
school, O NOUN
relative O ADJ
to O PART
students O NOUN
receiving O VERB
a O DET
control O NOUN
intervention. O NOUN

The O DET
prevalence O NOUN
of O ADP
halitosis O NOUN
in O ADP
the O DET
population O NOUN
is O VERB
approximately O ADV
30%, O NUM
of O ADP
which O ADP
80 O NUM
to O PART
90% O VERB
of O ADP
the O DET
cases O NOUN
originate O ADJ
in O ADP
the O DET
oral O ADJ
cavity O NOUN
resulting O VERB
from O ADP
proteolytic O ADJ
degradation O NOUN
by O ADP
gram O NOUN
negative O ADJ
anaerobic O ADJ
bacteria. O NOUN

In O ADP
the O DET
high-dose O NOUN
remifentanil O NOUN
(HR) O NOUN
group O NOUN
(n O NOUN
= O SYM
46), O NOUN
remifentanil O NOUN
was O VERB
infused O VERB
at O ADP
a O DET
rate O NOUN
of O ADP
0.25 O NUM
mug/kg/min O NOUN
and O CCONJ
subsequently O ADV
increased O VERB
or O CCONJ
decreased O VERB
by O ADP
0.05 O NUM
mug/kg/min O NOUN
per O ADP
clinical O ADJ
demand. O NOUN

The O DET
primary O ADJ
outcome O NOUN
was O VERB
assessed O VERB
by O ADP
the O DET
post-voiding B-outcome VERB
residual I-outcome ADJ
urine I-outcome NOUN
volume I-outcome NOUN
(PV-VRU) I-outcome PUNCT
. O PUNCT
The O DET
secondary O ADJ
outcomes O NOUN
were O VERB
evaluated O VERB
by O ADP
the O DET
voided B-outcome VERB
volume I-outcome NOUN
, O PUNCT
maximum B-outcome NOUN
urinary I-outcome ADJ
flow I-outcome NOUN
rate O NOUN
(Qmax), O NUM
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
as O ADP
assessed O VERB
by O ADP
Barthel O PROPN
Index O NOUN
(BI) O NOUN
scale. O ADJ

MAIN O ADJ
OUTCOME O NOUN
MEASURES: O NOUN
EIFEL O NOUN
and O CCONJ
Dallas O NOUN
Pain B-outcome NOUN
Questionnaire O NOUN
scores. O NOUN

Minor O ADJ
stroke O NOUN
were O VERB
categorized O VERB
into O ADP
SAI O NOUN
and O CCONJ
MAIs O NOUN
by O ADP
infarction O NOUN
numbers O NOUN
in O ADP
diffusion O NOUN
weighted O VERB
imaging. O NOUN

The O DET
incidence O NOUN
of O ADP
postoperative O ADJ
nausea B-outcome NOUN
, O PUNCT
vomiting B-outcome VERB
, O PUNCT
drowsiness B-outcome ADV
, O PUNCT
and O CCONJ
headache B-outcome NOUN
was O VERB
similar O ADJ
between O ADP
the O DET
groups. O NOUN

Participants O NOUN
completed O VERB
a O DET
laboratory O NOUN
30-min O NOUN
rowing O VERB
time-trial, O NOUN
followed O VERB
by O ADP
3x30-seconds O NOUN
(s) O PUNCT
maximal O ADJ
sprint O NOUN
efforts O NOUN
at O ADP
days O NOUN
0, O NUM
14 O NUM
and O CCONJ
28 O NUM
(T1-T3). O PUNCT

After O ADP
suitable O ADJ
training, O NOUN
patients O NOUN
performed O VERB
daily O ADJ
spirometry O NOUN
at O ADP
home O NOUN
using O VERB
a O DET
portable, O NOUN
battery-operated O VERB
spirometer. O NOUN

Patient-reported O VERB
persistence B-outcome NOUN
with O ADP
P2Y12 O NOUN
inhibitors O NOUN
at O ADP
1 O NUM
year O NOUN
was O VERB
higher O ADJ
in O ADP
the O DET
intervention O NOUN
group O NOUN
than O ADP
in O ADP
the O DET
control O NOUN
group O NOUN
(unadjusted O VERB
rates, O NOUN
5340/6135 O ADJ
[87.0%] O NOUN
vs O CCONJ
3324/3967 O PUNCT
[83.8%], O NOUN
respectively; O NOUN
P O NOUN
< O SYM
.001; O NOUN
adjusted O VERB
difference, O NOUN
2.3% O NOUN
[95% O NOUN
CI, O NOUN
0.4% O NOUN
to O PART
4.1%]; O NOUN
adjusted O VERB
odds O NOUN
ratio, O NOUN
1.19 O NUM
[95% O NOUN
CI, O NOUN
1.02 O NUM
to O PART
1.40]). O NOUN

Title: O NOUN
Effect O NOUN
of O ADP
nerve O NOUN
electrical O ADJ
stimulation O NOUN
for O ADP
treating O VERB
chemotherapy-induced O VERB
nausea B-outcome NOUN
and O CCONJ
vomiting B-outcome VERB
in O ADP
patients O NOUN
with O ADP
advanced O VERB
gastric O ADJ
cancer: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Intervention O NOUN
ICUs O NOUN
(n O NOUN
= O SYM
12; O NUM
669 O NUM
participants) O NOUN
delivered O VERB
usual O ADJ
care O NOUN
during O ADP
a O DET
baseline O NOUN
period O NOUN
followed O VERB
by O ADP
an O DET
intervention O NOUN
period. O NOUN

It O PRON
correlates O NOUN
well O ADV
with O ADP
the O DET
Psoriasis O NOUN
Area O NOUN
and O CCONJ
Severity O NOUN
Index O NOUN
(PASI) O PUNCT
and O CCONJ
demonstrates O NOUN
sensitivity O NOUN
to O PART
changes O NOUN
from O ADP
baseline O NOUN
in O ADP
patients O NOUN
with O ADP
both O CCONJ
mild O ADJ
and O CCONJ
moderately O ADV
severe O ADJ
disease. O NOUN

Mitochondrial B-outcome ADJ
fragmentation I-outcome NOUN
was O VERB
specifically O ADV
presented O VERB
in O ADP
tubules, O NOUN
but O CCONJ
not O ADV
in O ADP
podocytes O NOUN
of O ADP
DKD O NOUN
patients. O NOUN

CONCLUSIONS: O NOUN
Omadacycline O NOUN
was O VERB
noninferior O ADJ
to O PART
moxifloxacin O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
community-acquired O VERB
bacterial O ADJ
pneumonia O NOUN
in O ADP
adults. O NOUN
( O PUNCT

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

To O PART
compare O NOUN
the O DET
means O NOUN
the O DET
student O NOUN
t O NOUN
test O NOUN
and O CCONJ
analysis O NOUN
of O ADP
variance O NOUN
(ANOVA) O NUM
will O VERB
be O VERB
used O VERB
and O CCONJ
to O PART
analyse O NOUN
the O DET
correlation O NOUN
between O ADP
the O DET
continuous O ADJ
variables O NOUN
the O DET
correlation O NOUN
test O NOUN
by O ADP
Pearson O NOUN
will O VERB
be O VERB
applied. O NOUN

Title: O NOUN
Effectiveness O NOUN
of O ADP
neuromuscular O ADJ
electrical O ADJ
stimulation O NOUN
therapy O NOUN
in O ADP
patients O NOUN
with O ADP
urinary O ADJ
incontinence O NOUN
after O ADP
stroke: O NOUN
A O DET
randomized O VERB
sham O NOUN
controlled O VERB
trial. O NOUN

Title: O NOUN
Traditional O ADJ
chest O NOUN
drainage O NOUN
versus O CCONJ
drainage O NOUN
by O ADP
thoracotomy: O NOUN
a O DET
prospective O ADJ
randomized O VERB
study. O NOUN

So O ADV
we O PRON
tried O VERB
tobramycin/dexamethasone O NOUN
eye O NOUN
drops O NOUN
as O ADP
a O DET
replacement. O NOUN

Title: O NOUN
Hydrogen O NOUN
gas O NOUN
restores O NOUN
exhausted O VERB
CD8+ B-outcome NOUN
T I-outcome NOUN
cells I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
advanced O VERB
colorectal O ADJ
cancer O NOUN
to O PART
improve O VERB
prognosis. O NOUN

Constant O NOUN
score O NOUN
for O ADP
function B-outcome NOUN
, O PUNCT
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
using O VERB
SF-36], O NOUN
simple O NOUN
shoulder O NOUN
test O NOUN
(SST) O PUNCT
and O CCONJ
the O DET
Disabilities B-outcome NOUN
of I-outcome ADP
the Seperator DET
Arm I-outcome NOUN
, Seperator PUNCT
Shoulder I-outcome ADV
, Seperator PUNCT
and Seperator CCONJ
Hand S3-outcome NOUN
(DASH) O NUM
score O NOUN
were O VERB
also O ADV
calculated O VERB
at O ADP
six, O ADV
12 O NUM
and O CCONJ
24 O NUM
weeks O NOUN
of O ADP
follow-up. O PUNCT

Fisher's O NOUN
exact O NOUN
test O NOUN
was O VERB
used O VERB
to O PART
verify O NOUN
the O DET
differences O NOUN
between O ADP
categorical O ADJ
variables. O NUM

Publication O NOUN
date: O NOUN
2019/01/08 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

METHODS: O NOUN
From O ADP
September O NOUN
2014 O NUM
to O PART
September O NOUN
2015, O NUM
60 O NUM
patients O NOUN
diagnosed O VERB
with O ADP
NSCLC O NOUN
were O VERB
included O VERB
to O PART
the O DET
study. O NOUN

These O DET
results O NOUN
indicate O VERB
that O ADP
polyphenol-rich O ADJ
nutrient O NOUN
supplementation O NOUN
by O ADP
means O NOUN
of O ADP
dark O ADJ
chocolate O NOUN
positively O ADV
modulates O NOUN
redox B-outcome NOUN
status O NOUN
and O CCONJ
reduced O VERB
exercise-induced O VERB
muscular B-outcome ADJ
injury I-outcome NOUN
biomarkers O NOUN
in O ADP
elite O ADP
football O NOUN
athletes. O ADV

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
date: O NOUN
2019/02/28 O NOUN
06:00 O ADP
[medline] O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

Of O ADP
the O DET
185 O NUM
enrolled O VERB
patients, O NOUN
180 O NUM
completed O VERB
the O DET
study. O NOUN

Journal-Name:Medicine O NOUN

Journal O ADJ
ID: O NOUN
9113221 O NUM

a O DET
randomized O VERB
clinical O ADJ
trial. O NOUN

No O DET
statistically O ADV
significant O ADJ
difference O NOUN
(P O NUM
> O SYM
0.05) O NUM
among O ADP
the O DET
groups O NOUN
was O VERB
found O VERB
regarding O VERB
degree O NOUN
or O CCONJ
duration O NOUN
of O ADP
pain B-outcome NOUN
. O PUNCT
There O PRON
was O VERB
no O DET
statistically O ADV
significant O ADJ
difference O NOUN
(P O NUM
> O SYM
0.05) O NUM
among O ADP
the O DET
4(o)C O NOUN
and O CCONJ
2.5(o)C O CCONJ
groups. O NOUN

However, O ADV
there O PRON
are O VERB
limited O VERB
data O NOUN
on O ADP
the O DET
time O NOUN
course O NOUN
of O ADP
changes O NOUN
in O ADP
forced O VERB
expiratory O ADJ
volume O NOUN
in O ADP
1 O NUM
s O NOUN
(FEV1) O NOUN
preceding O VERB
the O DET
first O ADV
reported O VERB
symptom O NOUN
and O CCONJ
after O ADP
the O DET
start O NOUN
of O ADP
an O DET
exacerbation. O ADJ

Journal-Name:Oxidative O ADJ
medicine O NOUN
and O CCONJ
cellular O ADJ
longevity O NOUN

Participants O NOUN
were O VERB
selected O VERB
based O VERB
on O ADP
specific O ADJ
inclusion O NOUN
and O CCONJ
exclusion O NOUN
criteria, O NOUN
and O CCONJ
randomly O ADV
allocated O VERB
into O ADP
two O NUM
groups: O NOUN
Group O NOUN
1 O NUM
(G1) O PUNCT
- O PUNCT
iodoform O NOUN
paste O NOUN
(iodoform O NUM
+ O SYM
camphorated O VERB
parachlorophenol O NOUN
+ O SYM
ointment O NOUN
comprising O VERB
prednisolone O NOUN
acetate O NOUN
5.0 O NUM
mg O NOUN
and O CCONJ
rifamycin O NOUN
1.5 O NUM
mg); O NOUN
Group O NOUN
2 O NUM
(G2) O NUM
- O PUNCT
Calen(R)/ZO O NUM
paste. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

2019;18(1):32-38. O NUM

Title: O NOUN
Effect O NOUN
of O ADP
Intravenous O ADJ
Acetaminophen O ADV
vs O CCONJ
Placebo O NOUN
Combined O VERB
With O ADP
Propofol O NOUN
or O CCONJ
Dexmedetomidine O NOUN
on O ADP
Postoperative O ADJ
Delirium B-outcome NOUN
Among O ADP
Older O ADJ
Patients O NOUN
Following O VERB
Cardiac O ADJ
Surgery: O NOUN
The O DET
DEXACET O NOUN
Randomized O VERB
Clinical O ADJ
Trial. O NOUN

All O DET
patients O NOUN
who O ADP
were O VERB
randomly O ADV
assigned O VERB
to O PART
groups O NOUN
and O CCONJ
received O VERB
the O DET
study O NOUN
drug O NOUN
or O CCONJ
placebo O NOUN
were O VERB
included O VERB
in O ADP
the O DET
primary O ADJ
analyses. O NOUN

The O DET
reported O VERB
adverse B-outcome ADJ
events I-outcome NOUN
in O ADP
the O DET
groups O NOUN
were O VERB
compared O VERB
as O ADP
primary O ADJ
endpoint O NOUN
and O CCONJ
haematological B-outcome ADJ
safety O NOUN
parameters O NOUN
and O CCONJ
changes O NOUN
in O ADP
systolic B-outcome ADJ
and Seperator CCONJ
diastolic B-outcome ADJ
pressure E1-outcome NOUN
and O CCONJ
blood O NOUN
total O ADJ
and O CCONJ
lipoprotein B-outcome NOUN
lipids B-outcome NOUN
were O VERB
measured O VERB
as O ADP
secondary O ADJ
end O NOUN
points. O NOUN

Journal O ADJ
ID: O NOUN
101234168 O NUM

The O DET
treatment O NOUN
sessions O NOUN
lasted O VERB
for O ADP
15 O NUM
minutes, O NOUN
and O CCONJ
occurred O VERB
three O NUM
times O NOUN
a O DET
week, O NOUN
for O ADP
4 O NUM
weeks. O NOUN

Collectively, O NOUN
the O DET
present O ADJ
results O NOUN
suggested O VERB
that O ADP
hydrogen O NOUN
gas O NOUN
reverses O NOUN
imbalances O NOUN
toward O ADP
PD1+ B-outcome NOUN
CD8+ I-outcome NOUN
T I-outcome NOUN
cells I-outcome NOUN
to O PART
provide O VERB
an O DET
improved O VERB
prognosis. O NOUN

METHODS: O NOUN
We O PRON
randomly O ADV
divided O VERB
529 O NUM
patients O NOUN
(279 O PUNCT
men, O NOUN
250 O NUM
women; O ADJ
median O ADJ
age, O NOUN
66 O NUM
years) O NOUN
scheduled O VERB
for O ADP
hepatic O ADJ
dynamic O ADJ
computed O VERB
tomography O NOUN
into O ADP
2 O NUM
groups. O NOUN

Self-reported O VERB
responses B-outcome NOUN
to O PART
the O DET
pictorial O ADJ
health O NOUN
warning O VERB
labels O NOUN
were O VERB
then O ADV
measured, O NOUN
including O VERB
avoidance B-outcome NOUN
, O PUNCT
reactance B-outcome NOUN
, O PUNCT
effectiveness, O NOUN
susceptibility B-outcome NOUN
and O CCONJ
motivation B-outcome NOUN
to O PART
drink O NOUN
less. O NOUN

The O DET
experimental O ADJ
group O NOUN
underwent O VERB
the O DET
Brief O ADP
Group O NOUN
Intervention, O VERB
which O ADP
had O VERB
four O NUM
group O NOUN
sessions, O DET
with O ADP
weekly O ADV
meetings. O NOUN

Intensive O ADJ
physical O ADJ
exercise O NOUN
may O VERB
cause O ADP
increase O NOUN
oxidative O ADJ
stress O NOUN
and O CCONJ
muscular O ADJ
injury O NOUN
in O ADP
elite O ADP
football O NOUN
athletes. O ADV

Therefore, O NOUN
exercise O NOUN
training O VERB
in O ADP
combined O VERB
form O NOUN
(aerobic O PUNCT
and O CCONJ
resistance) O NOUN
may O VERB
be O VERB
incorporated O VERB
in O ADP
the O DET
management O NOUN
programs O NOUN
of O ADP
the O DET
patients O NOUN
suffering O VERB
from O ADP
hypertension O NOUN
in O ADP
order O NOUN
to O PART
augment O ADP
improvement O NOUN
in O ADP
their O ADJ
cardiac O ADJ
autonomic O ADJ
control. O NOUN

All O DET
patients O NOUN
that O ADP
were O VERB
operated O VERB
returned O VERB
to O PART
full B-outcome ADJ
activity I-outcome NOUN
. O PUNCT
However, O ADV
median O ADJ
duration B-outcome NOUN
of I-outcome ADP
operation I-outcome NOUN
was O VERB
longer O ADJ
and O CCONJ
lasted O VERB
1 O NUM
hour O NOUN
and O CCONJ
55 O NUM
minutes. O ADJ

Fifty O NUM
patients O NOUN
(56%) O NOUN
in O ADP
the O DET
amoxicillin O NOUN
group O NOUN
experienced O VERB
at O ADP
least O ADV
one O NUM
drug O NOUN
related O VERB
adverse B-outcome ADJ
event I-outcome NOUN
compared O VERB
with O ADP
31 O NUM
(34%) O NOUN
in O ADP
the O DET
placebo O NOUN
group. O VERB

Publication O NOUN
date: O NOUN
2018/02/01 O NOUN
00:00 O NOUN
[accepted] O ADV

Pilot O NOUN
study. O NOUN

BACKGROUND: O NOUN
Krill O NOUN
powder O NOUN
is O VERB
rich O ADJ
in O ADP
bioactive O ADJ
ingredients O NOUN
such O ADJ
as O ADP
eicosapentaenoic O ADJ
acid O NOUN
(EPA), O NOUN
docosahexaenoic O VERB
acid O NOUN
(DHA), O PUNCT
phospholipids, O NOUN
protein O NOUN
and O CCONJ
astaxanthin. O NOUN

A O DET
3-way O NOUN
repeated O VERB
measures O NOUN
ANOVA O NOUN
was O VERB
employed O VERB
for O ADP
main O ADJ
analyses, O NOUN
with O ADP
Bonferonni O NOUN
post-hoc O NOUN
assessment O NOUN
(P O NUM
</= O NOUN
0.05). O NOUN

The O DET
intervention O NOUN
will O VERB
be O VERB
guided O VERB
by O ADP
the O DET
trans-contextual O ADJ
model O NOUN
explaining O VERB
the O DET
processes O NOUN
by O ADP
which O ADP
PE O NOUN
teachers' O ADV
support O NOUN
for O ADP
autonomous O ADJ
motivation O NOUN
in O ADP
the O DET
classroom O NOUN
promotes O NOUN
students' O NOUN
motivation B-outcome NOUN
to O PART
engage O NOUN
in O ADP
out-of-school O NOUN
physical O ADJ
activity. O NOUN

In O ADP
the O DET
follow-up O NOUN
study, O NOUN
which O ADP
started O VERB
on O ADP
Feb O NOUN
7, O NUM
2017, O NUM
and O CCONJ
was O VERB
completed O VERB
on O ADP
June O NOUN
30, O NUM
2017, O NUM
61 O NUM
patients O NOUN
were O VERB
included O VERB
in O ADP
the O DET
ATLG O NOUN
group O NOUN
and O CCONJ
53 O NUM
were O VERB
included O VERB
in O ADP
the O DET
non-ATLG O NOUN
group. O VERB

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
The O DET
120 O NUM
elderly O NOUN
housebound O VERB
were O VERB
randomly O ADV
divided O VERB
into O ADP
3 O NUM
intervention O NOUN
groups: O NOUN
Baduanjin O NOUN
training, O NOUN
Baduanjin O NOUN
training O VERB
combined O VERB
with O ADP
CBT, O NOUN
and O CCONJ
CBT. O NOUN

STD O NOUN
group O NOUN
learned O VERB
identical O ADJ
content O NOUN
using O VERB
a O DET
low-fidelity O NOUN
Resusci O NOUN
Anne(R) O ADJ
CPR O NOUN
manikin. O NOUN

METHODS: O NOUN
We O PRON
enrolled O VERB
adults O NOUN
who O ADP
were O VERB
being O VERB
treated O VERB
for O ADP
bone O NOUN
or O CCONJ
joint O NOUN
infection O NOUN
at O ADP
26 O NUM
U.K. O ADJ
centers. O NOUN

Title: O NOUN
Long-term O NOUN
results O NOUN
of O ADP
a O DET
phase O NOUN
II O NUM
study O NOUN
of O ADP
hypofractionated O VERB
proton O NOUN
therapy O NOUN
for O ADP
prostate O NOUN
cancer: O NOUN
moderate O ADJ
versus O CCONJ
extreme O NOUN
hypofractionation. O NOUN

Objective: O NOUN
To O PART
evaluate O VERB
the O DET
effect O NOUN
of O ADP
intensive O ADJ
blood O NOUN
pressure O NOUN
control O NOUN
on O ADP
risk O NOUN
of O ADP
dementia B-outcome NOUN
. O PUNCT
Design, O NOUN
Setting, O ADV
and O CCONJ
Participants: O NOUN
Randomized O VERB
clinical O ADJ
trial O NOUN
conducted O VERB
at O ADP
102 O NUM
sites O NOUN
in O ADP
the O DET
United O VERB
States O NOUN
and O CCONJ
Puerto O NOUN
Rico O NOUN
among O ADP
adults O NOUN
aged O VERB
50 O NUM
years O NOUN
or O CCONJ
older O ADJ
with O ADP
hypertension O NOUN
but O CCONJ
without O ADP
diabetes O NOUN
or O CCONJ
history O NOUN
of O ADP
stroke. O NOUN

Journal O ADJ
ID: O NOUN
100968547 O NUM

This O DET
study O NOUN
will O VERB
assess O NOUN
the O DET
effect O NOUN
of O ADP
selenium O NOUN
supplementation O NOUN
on O ADP
major O ADJ
pregnancy B-outcome NOUN
outcomes I-outcome NOUN
and O CCONJ
disease B-outcome NOUN
progression I-outcome NOUN
among O ADP
HIV-infected O VERB
pregnant O ADJ
women O NOUN
in O ADP
Lagos, O NOUN
Nigeria. O NOUN

MATERIALS O NOUN
AND O CCONJ
METHODS: O NOUN
Young O ADJ
adults O NOUN
in O ADP
the O DET
age O NOUN
group O NOUN
between O ADP
18 O NUM
and O CCONJ
25 O NUM
years O NOUN
with O ADP
diagnosis O NOUN
of O ADP
halitosis O NOUN
will O VERB
be O VERB
included O VERB
in O ADP
this O DET
research. O NOUN

Primary O ADJ
outcome O NOUN
data O NOUN
were O VERB
available O ADJ
for O ADP
249 O NUM
(54.4%) O NUM
intervention O NOUN
and O CCONJ
236 O NUM
(59.6%) O NOUN
control O NOUN
participants. O NOUN

Publication O NOUN
date: O NOUN
2018/12/16 O NOUN
00:00 O NOUN
[accepted] O ADV

Dehydration O NOUN
impairs O NOUN
physiological O ADJ
function O NOUN
and O CCONJ
physical O ADJ
performance, O NOUN
thus O ADV
understanding O VERB
effective O ADJ
rehydration O NOUN
strategies O NOUN
is O VERB
paramount. O NOUN

Title: O NOUN
Prophylactic O ADJ
use O NOUN
of O ADP
carvedilol O NOUN
to O PART
prevent O NOUN
ventricular B-outcome ADJ
dysfunction I-outcome NOUN
in O ADP
patients O NOUN
with O ADP
cancer O NOUN
treated O VERB
with O ADP
doxorubicin. O NOUN

Publication O NOUN
date: O NOUN
2019/01/10 O ADV
06:00 O ADP
[entrez] O ADP

The O DET
data O NOUN
collection O NOUN
tools O NOUN
were O VERB
the O DET
Menopause-Specific O ADJ
Quality B-outcome NOUN
of I-outcome ADP
Life I-outcome NOUN
Questionnaire O PROPN
(MENQOL) O NUM
and O CCONJ
a O DET
demographic O ADJ
characteristics O NOUN
questionnaire. O NOUN

BACKGROUND: O NOUN
Multidetector O NOUN
computed O VERB
tomography O NOUN
(MDCT) O NUM
images O NOUN
for O ADP
rhinosinusitis O NOUN
may O VERB
have O VERB
a O DET
risk O NOUN
of O ADP
radiation O NOUN
hazards. O NOUN

Flushing B-outcome VERB
and O CCONJ
flushing-related B-outcome VERB
symptoms I-outcome NOUN
, O PUNCT
and O CCONJ
gastrointestinal B-outcome ADJ
events I-outcome NOUN
were O VERB
adverse B-outcome ADJ
events I-outcome NOUN
related O VERB
to O PART
DMF O NOUN
treatment. O NOUN

Athens O NOUN
Insomnia B-outcome NOUN
Scale O NOUN
(AIS) O NOUN
was O VERB
recorded O VERB
at O ADP
18: O NOUN
00 O NUM
at O ADP
the O DET
second O ADJ
day O NOUN
after O ADP
surgery. O VERB

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
primary O ADJ
outcome, O ADJ
perioperative O ADJ
real O ADJ
blood B-outcome NOUN
loss I-outcome NOUN
(RBL), O PUNCT
was O VERB
evaluated O VERB
at O ADP
72 O NUM
hours O NOUN
postoperatively. O NOUN

METHODS: O NOUN
In O ADP
the O DET
original O ADJ
open-label O NOUN
study, O NOUN
patients O NOUN
with O ADP
acute O ADJ
myeloid O NOUN
and O CCONJ
lymphoblastic O ADJ
leukaemia O NOUN
in O ADP
first O ADV
or O CCONJ
subsequent O ADJ
remission, O NOUN
having O VERB
sibling O VERB
HLA-identical O ADJ
allogeneic O ADJ
peripheral O ADJ
blood O NOUN
stem-cell O NOUN
transplantation, O NOUN
were O VERB
randomly O ADV
assigned O VERB
(1:1) O NOUN
to O PART
receive O VERB
ATLG O NOUN
plus O CCONJ
standard O ADJ
GVHD O NOUN
prophylaxis O NOUN
with O ADP
ciclosporin O NOUN
and O CCONJ
short-term O NOUN
methotrexate O NOUN
(ATLG O PUNCT
group) O ADJ
or O CCONJ
standard O ADJ
GVHD O NOUN
prophylaxis O NOUN
without O ADP
ATLG O NOUN
(non-ATLG O PUNCT
group). O NOUN

The O DET
secondary O ADJ
efficacy O NOUN
endpoints O NOUN
were O VERB
assessed O VERB
by O ADP
the O DET
Tinnitus B-outcome NOUN
Handicap I-outcome NOUN
Inventory O ADJ
(THI)], O NOUN
12-Item O NOUN
Short O NOUN
Form O NOUN
Health B-outcome NOUN
Survey O NOUN
(SF-12) O NOUN
questionnaire], O NUM
and O CCONJ
adverse B-outcome ADJ
events I-outcome NOUN
. O PUNCT
All O DET
outcome O NOUN
efficacy O NOUN
endpoints O NOUN
were O VERB
measured O VERB
at O ADP
baseline O NOUN
and O CCONJ
after O ADP
4 O NUM
weeks O NOUN
of O ADP
treatment. O NOUN

Only O ADV
3 O NUM
(4.4%) O NUM
Veterans O NOUN
declined O VERB
participation O NOUN
due O ADJ
to O PART
lack O NOUN
of O ADP
interest. O NOUN

BACKGROUND: O NOUN
beta-alanine O NOUN
(betaA) O NOUN
supplementation O NOUN
has O VERB
been O VERB
shown O VERB
to O PART
increase O NOUN
intramuscular O ADJ
carnosine O NOUN
content O NOUN
and O CCONJ
subsequent O ADJ
high-intensity O NOUN
performance O NOUN
in O ADP
events O NOUN
lasting O VERB
< O SYM
4 O NUM
minutes O NOUN
(min), O NOUN
which O ADP
may O VERB
be O VERB
dependent O ADJ
on O ADP
total, O ADJ
as O ADP
opposed O VERB
to O PART
daily, O NOUN
dose. O NOUN

Title: O NOUN
Treatment O NOUN
with O ADP
a O DET
5-day O NOUN
versus O CCONJ
a O DET
10-day O NOUN
schedule O NOUN
of O ADP
decitabine O NOUN
in O ADP
older O ADJ
patients O NOUN
with O ADP
newly O ADV
diagnosed O VERB
acute O ADJ
myeloid O NOUN
leukaemia: O NOUN
a O DET
randomised O VERB
phase O NOUN
2 O NUM
trial. O NOUN

Tafenoquine O NOUN
showed O VERB
efficacy O NOUN
for O ADP
the O DET
radical O NOUN
cure B-outcome NOUN
of O ADP
P. O NOUN
vivax O NOUN
malaria, O NOUN
although O ADP
tafenoquine O NOUN
was O VERB
not O ADV
shown O VERB
to O PART
be O VERB
noninferior O ADJ
to O PART
primaquine. O NOUN
( O PUNCT

OBJECTIVE: O NOUN
To O PART
investigate O NOUN
the O DET
effect O NOUN
of O ADP
combined O VERB
aerobic O ADJ
and O CCONJ
resistance O NOUN
training O VERB
(CART) O PUNCT
on O ADP
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
in O ADP
sedentary, O ADJ
hypertensive O ADJ
women. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Total O ADJ
distance B-outcome NOUN
(m), O PUNCT
average O NOUN
power B-outcome NOUN
(W), O NUM
relative O ADJ
average O NOUN
power B-outcome NOUN
(W.kg(- O PUNCT
1)), O NOUN
cardio-respiratory B-outcome NOUN
measures O NOUN
and O CCONJ
perceived B-outcome VERB
exertion I-outcome NOUN
were O VERB
assessed O VERB
for O ADP
each O DET
10-min O NOUN
split. O NOUN

Title: O NOUN
Lactulose O NOUN
for O ADP
the O DET
treatment O NOUN
of O ADP
Chinese O NOUN
children O NOUN
with O ADP
chronic O ADJ
constipation: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Title: O NOUN
A O DET
randomized-controlled O VERB
trial O NOUN
pilot O NOUN
study O NOUN
examining O VERB
the O DET
effect O NOUN
of O ADP
extracorporeal O ADJ
magnetic O ADJ
innervation O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
stress O NOUN
urinary O ADJ
incontinence O NOUN
in O ADP
women. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

They O PRON
then O ADV
underwent O VERB
ET O NOUN
and O CCONJ
were O VERB
observed O VERB
for O ADP
adverse B-outcome ADJ
events I-outcome NOUN
for O ADP
another O DET
30 O NUM
minutes O NOUN
post-ET. O NOUN

Treated O VERB
teeth O NOUN
were O VERB
restored O VERB
with O ADP
composite O NOUN
resin O NOUN
immediately O ADV
after O ADP
the O DET
root O NOUN
canal O NOUN
filling. O NOUN

Quantitative O ADJ
fit O NOUN
tests O NOUN
(QNFTs) O PUNCT
were O VERB
performed O VERB
before O ADP
and O CCONJ
after O ADP
training O VERB
using O VERB
three O NUM
types O NOUN
of O ADP
N95 O NOUN
or O CCONJ
higher O ADJ
filter O NOUN
respirators O NOUN
(cup-type, O NOUN
fold-type, O NOUN
valve-type). O NOUN

Journal O ADJ
ID: O NOUN
101153627 O NUM

Additionally, O NOUN
a O DET
39% O NUM
reduction O NOUN
in O ADP
atherogenic B-outcome ADJ
index O NOUN
of O ADP
the O DET
plasma O NOUN
(AIP) O NUM
(p O PUNCT
= O SYM
0.0177) O NUM
was O VERB
also O ADV
noted O VERB
in O ADP
amla O NOUN
group. O VERB

TRIAL O NOUN
REGISTRATION: O NOUN
The O DET
study O NOUN
was O VERB
registered O VERB
at O ADP
clinicaltrials.gov O NOUN
ID: O NOUN
NCT02472951. O NOUN

RESULTS: O NOUN
The O DET
number O NOUN
of O ADP
school O NOUN
children O NOUN
reported O VERB
from O ADP
intervention O NOUN
group O NOUN
was O VERB
significantly O ADV
higher O ADJ
than O ADP
in O ADP
control O NOUN
due O ADJ
to O PART
suspected O VERB
symptoms O NOUN
of O ADP
acute B-outcome ADJ
pharyngitis I-outcome NOUN
and O CCONJ
or O CCONJ
rheumatic B-outcome ADJ
fever/rheumatic I-outcome ADJ
heart I-outcome NOUN
disease I-outcome NOUN
(RF/RHD) I-outcome NOUN
were O VERB
65 O NUM
(2.84/1000) O NOUN
and O CCONJ
15 O NUM
(0.60/1000), O NOUN
respectively O ADV
(p<0.01). O NOUN

DESIGN: O NOUN
Randomized, O NOUN
double-blind O ADJ
(patients O NOUN
and O CCONJ
evaluators O NOUN
blind), O NOUN
controlled, O NOUN
trial. O NOUN

Journal-Name:The O ADJ
journal O ADJ
of O ADP
headache O NOUN
and O CCONJ
pain O NOUN

Vaccination O NOUN
coverage O NOUN
will O VERB
be O VERB
assessed O VERB
at O ADP
3-years O NOUN
of O ADP
age, O NOUN
thus O ADV
the O DET
trial O NOUN
is O VERB
expected O VERB
to O PART
be O VERB
completed O VERB
in O ADP
March O NOUN
2019. O NUM

We O PRON
deductively O ADV
selected O VERB
five O NUM
conditions O NOUN
based O VERB
on O ADP
the O DET
Consolidated O VERB
Framework O NOUN
for O ADP
Implementation O NOUN
Research: O NOUN
teachers' O ADV
perceived O VERB
self-efficacy B-outcome NOUN
, O PUNCT
teachers' O ADV
expectations B-outcome NOUN
of O ADP
the O DET
benefits O NOUN
of O ADP
the O DET
intervention, O ADP
teachers' O ADV
previous O ADJ
knowledge B-outcome NOUN
about O ADV
the O DET
intervention, O ADP
dosage B-outcome NOUN
of I-outcome ADP
physical I-outcome ADJ
activity I-outcome NOUN
breaks I-outcome NOUN
, O PUNCT
and O CCONJ
quality B-outcome NOUN
of I-outcome ADP
the Seperator DET
implementation I-outcome NOUN
. O PUNCT
RESULTS: O NOUN
We O PRON
identified O VERB
five O NUM
different O ADJ
pathways O NOUN
that O ADP
led O VERB
to O PART
no O DET
increase O NOUN
in O ADP
the O DET
pupils' O NOUN
outcome O NOUN
(parameters O NOUN
of O ADP
fit: O ADP
consistency O NOUN
94%, O PUNCT
coverage O NOUN
66%). O NOUN

Demographic O ADJ
characteristics O NOUN
and O CCONJ
hormonal O ADJ
profiles O NOUN
of O ADP
the O DET
patients O NOUN
did O VERB
not O ADV
differ O VERB
between O ADP
groups. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Title: O NOUN
A O DET
randomized O VERB
trial O NOUN
of O ADP
trigger O ADP
point O NOUN
dry O ADJ
needling O VERB
versus O CCONJ
sham O NOUN
needling O VERB
for O ADP
chronic O ADJ
tension-type O NOUN
headache. O NOUN

METHODS: O NOUN
A O DET
total O ADJ
number O NOUN
of O ADP
120 O NUM
type O NOUN
2 O NUM
diabetes O NOUN
patients O NOUN
were O VERB
randomized O VERB
into O ADP
intervention O NOUN
(health O NOUN
education O NOUN
by O ADP
Wechat O ADP
platform O NOUN
plus O CCONJ
usual O ADJ
care) O NOUN
and O CCONJ
the O DET
control O NOUN
group O NOUN
(usual O ADJ
care). O NOUN

The O DET
same O ADJ
multidisciplinary O ADJ
protocol O NOUN
for O ADP
detecting O VERB
and O CCONJ
managing O VERB
fetal O ADJ
growth O NOUN
restriction O NOUN
was O VERB
used O VERB
in O ADP
both O CCONJ
strategies. O NOUN

Prerandomization O NOUN
procedures O NOUN
excluded O VERB
288 O NUM
patients: O NOUN
42 O NUM
had O VERB
relief O NOUN
of O ADP
their O ADJ
heartburn O ADP
during O ADP
the O DET
2-week O NOUN
omeprazole O NOUN
trial, O NOUN
70 O NUM
did O VERB
not O ADV
complete O ADJ
trial O NOUN
procedures, O NOUN
54 O NUM
were O VERB
excluded O VERB
for O ADP
other O ADJ
reasons, O NOUN
23 O NUM
had O VERB
non-GERD O NOUN
esophageal O ADJ
disorders, O NOUN
and O CCONJ
99 O NUM
had O VERB
functional O ADJ
heartburn O ADP
(not O ADV
due O ADJ
to O PART
GERD O NOUN
or O CCONJ
other O ADJ
histopathologic, O SYM
motility, O ADJ
or O CCONJ
structural O ADJ
abnormality). O NOUN

CONCLUSIONS: O NOUN
A O DET
self-administered O VERB
rehabilitation O NOUN
program O NOUN
for O ADP
painful O NOUN
shoulder O NOUN
was O VERB
non-inferior O ADJ
than O ADP
usual O ADJ
physical O ADJ
therapy. O NOUN

Trial O NOUN
Registration O NOUN
Date: O NOUN
August O NOUN
22, O NUM
2017. O NUM

The O DET
comparison O NOUN
between O ADP
two O NUM
doses O NOUN
revealed O VERB
a O DET
non-significant O ADJ
difference O NOUN
(p=.118 O NUM
& O CCONJ
p=.149 O NOUN
respectively). O NOUN

The O DET
primary O ADJ
clinical O ADJ
outcome O NOUN
was O VERB
the O DET
variation O NOUN
in O ADP
thirst B-outcome ADV
intensity I-outcome NOUN
, O PUNCT
evaluated O VERB
by O ADP
the O DET
Numeral O ADJ
Verbal O ADV
Scale], O NOUN
and O CCONJ
the O DET
secondary, O NOUN
the O DET
variation O NOUN
of O ADP
the O DET
discomfort B-outcome NOUN
of I-outcome ADP
thirst I-outcome ADV
, O PUNCT
evaluated O VERB
by O ADP
the O DET
Perioperative O ADJ
Thirst B-outcome ADV
Discomfort I-outcome NOUN
Scale]. O NOUN
Mann-Whitney O NOUN
test O NOUN
was O VERB
used O VERB
to O PART
compare O NOUN
measures O NOUN
between O ADP
groups. O NOUN

Exercise B-outcome NOUN
intensity I-outcome NOUN
during O ADP
out-of-lab O NOUN
exercise O NOUN
and O CCONJ
+25d O NOUN
post-exercise O NOUN
heart B-outcome NOUN
rate I-outcome NOUN
were O VERB
correlated O VERB
(r=-0.89, O NOUN
p=0.02) O ADJ
in O ADP
IHE. O NOUN

Publication O NOUN
date: O NOUN
2019/02/09 O NOUN
06:00 O ADP
[medline] O NOUN

Journal-Name:Journal O ADJ
of O ADP
drugs O NOUN
in O ADP
dermatology O NOUN
: O PUNCT
JDD O NOUN

BACKGROUND: O NOUN
Acute O ADJ
bacterial O ADJ
skin O NOUN
and O CCONJ
skin-structure O NOUN
infections O NOUN
are O VERB
associated O VERB
with O ADP
substantial O ADJ
morbidity O NOUN
and O CCONJ
health O NOUN
care O NOUN
costs. O NOUN

Primary O ADJ
outcome O NOUN
was O VERB
current O ADJ
pain B-outcome NOUN
intensity I-outcome NOUN
(100-mm O NOUN
visual O ADJ
analog O NOUN
scale); O NOUN
secondary O ADJ
outcome O NOUN
measures O NOUN
included O VERB
function B-outcome NOUN
( O NOUN
Oswestry O NOUN
Disability B-outcome NOUN
Index]), O NOUN
pain B-outcome NOUN
on O ADP
movement O NOUN
( O PUNCT
Pain B-outcome NOUN
on O ADP
Movement O NOUN
Questionnaire), O NOUN
perceived B-outcome VERB
change X NOUN
in X NOUN
health I-outcome NOUN
status I-outcome NOUN
, O PUNCT
pressure B-outcome NOUN
pain I-outcome NOUN
threshold, O NOUN
mechanical B-outcome ADJ
detection I-outcome NOUN
threshold, O NOUN
and O CCONJ
vibration B-outcome NOUN
detection I-outcome NOUN
threshold. O NOUN

The O DET
primary O ADJ
endpoints O NOUN
were O VERB
low B-outcome ADJ
birth I-outcome NOUN
weight I-outcome NOUN
(LBW) I-outcome NUM
, O PUNCT
peripheral, B-outcome ADJ
and Seperator CCONJ
placental B-outcome ADJ
parasitaemia E1-outcome NOUN
, O PUNCT
while O ADP
the O DET
secondary O ADJ
endpoints O NOUN
were O VERB
maternal B-outcome ADJ
anaemia I-outcome NOUN
, O PUNCT
pre-term B-outcome NOUN
birth I-outcome NOUN
, O PUNCT
clinical B-outcome ADJ
malaria I-outcome NOUN
and O CCONJ
adverse B-outcome ADJ
effects I-outcome NOUN
of O ADP
SP. O NOUN

CONCLUSIONS: O NOUN
Exercise O NOUN
once O ADP
a O DET
week O NOUN
for O ADP
6 O NUM
months O NOUN
combined O VERB
with O ADP
five O NUM
sessions O NOUN
of O ADP
back O ADP
care O NOUN
counseling O VERB
after O ADP
working O VERB
hours O NOUN
in O ADP
real-life O NOUN
settings O NOUN
effectively O ADV
reduced O VERB
the O DET
intensity B-outcome NOUN
of I-outcome ADP
low I-outcome ADJ
back I-outcome ADP
pain I-outcome NOUN
, O PUNCT
work B-outcome NOUN
interference I-outcome NOUN
due O ADJ
to O PART
LBP, O NOUN
and O CCONJ
fear B-outcome ADJ
of I-outcome ADP
pain I-outcome NOUN
, O PUNCT
but O CCONJ
was O VERB
not O ADV
cost-effective. O ADJ

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Multicenter O NOUN
Study, O NOUN
Pragmatic O NOUN
Clinical O ADJ
Trial, O NOUN
Randomized O VERB
Controlled O VERB
Trial, O NOUN
Research O NOUN
Support, O NOUN
Non-U.S. O NOUN
Gov't, O NOUN

Though O ADP
much O DET
of O ADP
this O DET
risk O NOUN
is O VERB
mitigated O VERB
with O ADP
trigger O ADP
using O VERB
gonadotropin O NOUN
releasing-hormone O NOUN
(GnRH) O NUM
agonist O NOUN
alone, O NOUN
it O PRON
may O VERB
result O VERB
in O ADP
lower O ADJ
birth O NOUN
rates. O NOUN

The O DET
primary O ADJ
outcome O NOUN
included O VERB
symptoms B-outcome NOUN
severity I-outcome NOUN
and O CCONJ
appetite B-outcome NOUN
. O PUNCT
The O DET
secondary O ADJ
outcomes O NOUN
included O VERB
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
, O PUNCT
as O ADP
measured O VERB
by O ADP
the O DET
MD O NOUN
Anderson O NOUN
Symptom O NOUN
Inventory O ADJ
(MDASI) O NUM
score, O NOUN
and O CCONJ
functional B-outcome ADJ
impairment I-outcome NOUN
, O PUNCT
as O ADP
evaluated O VERB
by O ADP
the O DET
Karnofsky O NOUN
score. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

And O CCONJ
the O DET
safety O NOUN
of O ADP
berberine O NOUN
was O VERB
assessed. O NOUN

BACKGROUND: O NOUN
Given O VERB
the O DET
documented O VERB
decline O NOUN
in O ADP
levels O NOUN
of O ADP
physical O ADJ
activity O NOUN
in O ADP
early O ADJ
adolescence, O NOUN
promoting O VERB
physical O ADJ
activity O NOUN
in O ADP
young O ADJ
people O NOUN
is O VERB
a O DET
priority O NOUN
for O ADP
health O NOUN
promotion. O NOUN

The O DET
primary O ADJ
endpoint O NOUN
was O VERB
progression-free B-outcome ADJ
survival I-outcome NOUN
(PFS) I-outcome NOUN
by O ADP
intention-to-treat O NOUN
analysis. O NOUN

RESULTS: O NOUN
Comparison O NOUN
of O ADP
the O DET
median O ADJ
iodine O NOUN
dose B-outcome NOUN
in O ADP
patients O NOUN
with O ADP
a O DET
normal O ADJ
or O CCONJ
high O ADJ
BMI O NOUN
showed O VERB
that O ADP
it O PRON
was O VERB
significantly O ADV
lower O ADJ
under O ADP
the O DET
LBW O NOUN
protocol O NOUN
than O ADP
the O DET
TBW O NOUN
protocol O NOUN
(558.2 O PUNCT
and O CCONJ
507.0 O NUM
mg O NOUN
iodine/kg, O NOUN
P O NOUN
< O SYM
0.001, O NUM
respectively). O NOUN

Publication O NOUN
date: O NOUN
2019/02/20 O ADJ
06:00 O ADP
[medline] O NOUN

All O DET
eye O NOUN
drops O NOUN
were O VERB
placed O VERB
in O ADP
identical, O ADJ
unlabelled O VERB
vials. O NOUN

Date O NOUN
of O ADP
enrolment O ADJ
of O ADP
the O DET
first O ADV
participant O ADJ
to O PART
the O DET
trial: O NOUN
02/02/2016. O NUM

Twenty-eight O NUM
patients O NOUN
undergoing O VERB
painless O NOUN
fiberbronchoscopy O NOUN
in O ADP
Hangzhou O NOUN
First O ADV
People's O NOUN
Hospital O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
2 O NUM
groups(n=14): O NOUN
supraglottic O ADJ
tracheal O ADJ
tube O NOUN
ventilation(group O ADJ
A) O NOUN
and O CCONJ
modified O VERB
laryngeal O ADJ
mask O NOUN
airway(group O NOUN
B). O NOUN

Methods: O NOUN
A O DET
random O NOUN
cluster O NOUN
sampling O VERB
method O NOUN
has O VERB
been O VERB
used, O NOUN
including O VERB
300 O NUM
rural O ADJ
residents O NOUN
aged O VERB
above O ADP
18 O NUM
years O NOUN
old O ADJ
from O ADP
three O NUM
villages O NOUN
(184 O NUM
in O ADP
control O NOUN
group, O NOUN
116 O NUM
in O ADP
intervention O NOUN
group), O NOUN
in O ADP
order O NOUN
to O PART
proceed O NOUN
the O DET
physical O ADJ
check-up O VERB
and O CCONJ
health O NOUN
education O NOUN
programs. O NOUN

Seventeen O NUM
patients O NOUN
(17%) O NUM
in O ADP
the O DET
MRI-guided O VERB
treat-to-target O NOUN
group O NOUN
and O CCONJ
6 O NUM
patients O NOUN
(6%) O ADV
in O ADP
the O DET
conventional O ADJ
treat-to-target O NOUN
group O NOUN
experienced O VERB
serious B-outcome ADJ
adverse I-outcome ADJ
events I-outcome NOUN
. O PUNCT
Conclusions O NOUN
and O CCONJ
Relevance: O NOUN
Among O ADP
patients O NOUN
with O ADP
RA O NOUN
in O ADP
clinical O ADJ
remission, O NOUN
an O DET
MRI-guided O VERB
treat-to-target O NOUN
strategy O NOUN
compared O VERB
with O ADP
a O DET
conventional O ADJ
treat-to-target O NOUN
strategy O NOUN
did O VERB
not O ADV
result O VERB
in O ADP
improved O VERB
disease B-outcome NOUN
activity I-outcome NOUN
remission I-outcome NOUN
rates O NOUN
or O CCONJ
reduce O VERB
radiographic B-outcome ADJ
progression I-outcome NOUN
. O PUNCT
These O DET
findings O NOUN
do O VERB
not O ADV
support O NOUN
the O DET
use O NOUN
of O ADP
an O DET
MRI-guided O VERB
strategy O NOUN
for O ADP
treating O VERB
patients O NOUN
with O ADP
RA. O NOUN

Journal-Name:Nutrients O NOUN

Journal O ADJ
ID: O NOUN
8109958 O NUM

Serum O NOUN
cortisol B-outcome NOUN
level O NOUN
was O VERB
measured O VERB
before O ADP
anesthesia O NOUN
and O CCONJ
at O ADP
the O DET
end O NOUN
of O ADP
operation O NOUN
to O PART
calculate O NOUN
the O DET
changes O NOUN
in O ADP
cortisol O NOUN
level. O NOUN

RESULTS: O NOUN
In O ADP
the O DET
intention-to-treat O NOUN
population, O NOUN
the O DET
percentage O NOUN
of O ADP
patients O NOUN
who O ADP
were O VERB
free O ADJ
from O ADP
recurrence B-outcome NOUN
at O ADP
6 O NUM
months O NOUN
was O VERB
62.4% O NUM
in O ADP
the O DET
tafenoquine O NOUN
group O NOUN
(95% O PUNCT
confidence O NOUN
interval O NOUN
[CI], O VERB
54.9 O NUM
to O PART
69.0), O NOUN
27.7% O NUM
in O ADP
the O DET
placebo O NOUN
group O NOUN
(95% O PUNCT
CI, O NOUN
19.6 O NUM
to O PART
36.6), O NUM
and O CCONJ
69.6% O ADP
in O ADP
the O DET
primaquine O NOUN
group O NOUN
(95% O PUNCT
CI, O NOUN
60.2 O NUM
to O PART
77.1). O NUM

Title: O NOUN
Effectiveness O NOUN
of O ADP
part-time O NOUN
vs O CCONJ
full-time O NOUN
wear O ADJ
protocols O NOUN
of O ADP
Twin-block O NOUN
appliance O NOUN
on O ADP
dental B-outcome ADJ
and O CCONJ
skeletal B-outcome ADJ
changes: O NOUN
A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Publication O NOUN
date: O NOUN
2018/12/31 O NOUN
06:00 O ADP
[entrez] O ADP

RESULTS: O NOUN
In O ADP
PBMCs, O NOUN
LF O NOUN
decreased O VERB
ICAM1 O NOUN
mRNA B-outcome NOUN
expression I-outcome NOUN
(P O NUM
< O SYM
0.05), O NUM
which O ADP
was O VERB
different O ADJ
(P O NUM
= O SYM
0.06, O NUM
Bonferroni O NOUN
correction) O NOUN
from O ADP
the O DET
observed O VERB
increase O NOUN
in O ADP
the O DET
FF O NOUN
group O NOUN
(P O NUM
< O SYM
0.05). O NOUN

GLN O NOUN
supplementation O NOUN
appeared O VERB
to O PART
significantly O ADV
delay O NOUN
acute O ADJ
radiation-induced O VERB
esophagitis B-outcome NOUN
(ARIE) O NUM
onset O NOUN
for O ADP
5.8 O NUM
days O NOUN
(18.2 O ADV
days O NOUN
vs O CCONJ
12.4 O NUM
days; O NOUN
P O NOUN
= O SYM
.027) O PUNCT
and O CCONJ
reduced O VERB
incidence O NOUN
of O ADP
weight B-outcome NOUN
loss O NOUN
(20% O PUNCT
vs O CCONJ
73.3%; O NUM
P O NOUN
= O SYM
.01). O PUNCT

Interobserver O ADV
reliability O NOUN
showed O VERB
excellent O ADJ
agreement O NOUN
based O VERB
on O ADP
the O DET
intraclass O NOUN
correlation O NOUN
coefficient, O NOUN
and O CCONJ
moderate O ADJ
to O PART
almost O ADV
perfect O NOUN
agreement O NOUN
by O ADP
kappa O NOUN
statistics. O NOUN

Publication O NOUN
date: O NOUN
2019/02/13 O NOUN
06:00 O ADP
[medline] O NOUN

Of O ADP
these, O NOUN
105 O NUM
completed O VERB
follow O VERB
up O ADP
at O ADP
12 O NUM
months. O NOUN

Journal O ADJ
ID: O NOUN
100968562 O NUM

According O ADJ
to O PART
the O DET
random O NOUN
number O NOUN
table O ADJ
method, O NOUN
the O DET
patients O NOUN
were O VERB
randomly O ADV
divided O VERB
into O ADP
non-invasive O ADJ
ventilator O NOUN
group, O NOUN
rhodiola O NOUN
rosea+non-invasive O ADJ
ventilator O NOUN
group O NOUN
and O CCONJ
rhodiola O NOUN
rosea O NOUN
group, O NOUN
with O ADP
30 O NUM
cases O NOUN
in O ADP
each O DET
group. O VERB

Serious O ADJ
postoperative O ADJ
complications B-outcome NOUN
occurred O VERB
more O ADV
frequently O ADV
in O ADP
the O DET
lymphadenectomy O NOUN
group O NOUN
(e.g., O NOUN
incidence O NOUN
of O ADP
repeat O NOUN
laparotomy, O NOUN
12.4% O NUM
vs. O CCONJ
6.5% O NOUN
[P O PUNCT
= O SYM
0.01]; O NUM
mortality B-outcome NOUN
within O ADP
60 O NUM
days O NOUN
after O ADP
surgery, O NOUN
3.1% O NOUN
vs. O CCONJ
0.9% O NOUN
[P O PUNCT
= O SYM
0.049]). O ADJ

Journal O ADJ
ID: O NOUN
101234168 O NUM

At O ADP
the O DET
16-week O NOUN
follow-up, O ADP
significant O ADJ
group O NOUN
by O ADP
time O NOUN
interaction O NOUN
effects O NOUN
were O VERB
observed O VERB
in O ADP
percentage O NOUN
body B-outcome NOUN
fat I-outcome NOUN
(%BF) O ADV
(beta O NUM
= O SYM
-1.52, O NOUN
95%CI O NOUN
= O SYM
-2.58(-)-0.45), O NOUN
lean B-outcome ADJ
body I-outcome NOUN
mass I-outcome NOUN
(LM) I-outcome NUM
(beta O NUM
= O SYM
1.20, O NUM
95%CI O NOUN
= O SYM
0.12(-)2.29), O NUM
diastolic B-outcome ADJ
blood I-outcome NOUN
pressure I-outcome NOUN
(beta O NUM
= O SYM
-5.24, O ADJ
95%CI O NOUN
= O SYM
-9.66(-)-0.83), O NOUN
high-sensitivity B-outcome NOUN
C-reactive I-outcome ADJ
protein I-outcome NOUN
(beta O NUM
= O SYM
-1.67, O NOUN
95%CI O NOUN
= O SYM
-2.77(-)-1.01), O NOUN
and O CCONJ
wall O NOUN
sit O NOUN
test O NOUN
score O NOUN
(beta O NUM
= O SYM
50.74, O NOUN
95%CI O NOUN
= O SYM
32.30(-)69.18). O NOUN

Title: O NOUN
A O DET
Randomized O VERB
Trial O NOUN
to O PART
Evaluate O NOUN
the O DET
Effect O NOUN
of O ADP
Toric O ADJ
Versus O CCONJ
Spherical O NOUN
Contact O NOUN
Lenses O NOUN
on O ADP
Vision B-outcome NOUN
and O CCONJ
Eyestrain B-outcome NOUN
. O PUNCT

Both O CCONJ
LOCF O NOUN
and O CCONJ
BOCF O NOUN
showed O VERB
similar O ADJ
results O NOUN
but O CCONJ
lower O ADJ
effect O NOUN
sizes. O NOUN

CONCLUSIONS: O NOUN
The O DET
TFP O NOUN
(25 O NOUN
mug/h) O NOUN
affixed O VERB
14 O NUM
h O NOUN
before O ADP
surgery O NOUN
reached O VERB
a O DET
higher O ADJ
constant B-outcome NOUN
concentration I-outcome NOUN
than O ADP
the O DET
same O ADJ
dose O NOUN
setting O VERB
of O ADP
a O DET
constant O NOUN
IV O NUM
infusion O NOUN
of O ADP
fentanyl O NOUN
after O ADP
surgery. O VERB

Journal O ADJ
ID: O NOUN
101090552 O NUM

BACKGROUND: O NOUN
Mothers O NOUN
in O ADP
Motion O NOUN
(MIM), O ADV
a O DET
community-based O VERB
intervention O NOUN
program, O NOUN
was O VERB
designed O VERB
to O PART
help O VERB
young, O NOUN
low-income O NOUN
women O NOUN
with O ADP
overweight O NUM
or O CCONJ
obesity O NOUN
prevent O NOUN
further O ADV
weight O NOUN
gain O VERB
by O ADP
promoting O VERB
stress O NOUN
management, O NOUN
healthy O ADJ
eating, O NOUN
and O CCONJ
physical O ADJ
activity. O NOUN

The O DET
initial O ADJ
dose O NOUN
of O ADP
bupivacaine O NOUN
in O ADP
the O DET
2 O NUM
groups O NOUN
was O VERB
4 O NUM
mg, O NOUN
and O CCONJ
the O DET
subsequent O ADJ
dose O NOUN
for O ADP
the O DET
following O VERB
patient O NOUN
was O VERB
depended O VERB
on O ADP
the O DET
probability O NOUN
of O ADP
the O DET
current O ADJ
dose. O NOUN

Results: O NOUN
Smoking O VERB
a O DET
cigarette O NOUN
for O ADP
five O NUM
minutes O NOUN
resulted O VERB
in O ADP
a O DET
significant O ADJ
increase O NOUN
of O ADP
exhaled B-outcome VERB
CO I-outcome NOUN
, O PUNCT
whereas O ADP
using O VERB
an O DET
IQOS(TM) O NOUN
resulted O VERB
in O ADP
a O DET
small O ADJ
but O CCONJ
reliable O ADJ
increase O NOUN
(0.3 O NOUN
ppm). O NOUN

Cholesterol B-outcome NOUN
reduction O NOUN
is O VERB
achieved O NOUN
without O ADP
concomitant O ADJ
reduction O NOUN
of O ADP
Coenzyme B-outcome NOUN
Q10 I-outcome NOUN
(CoQ10) I-outcome PUNCT
, O PUNCT
in O ADP
contrast O NOUN
to O PART
what O DET
is O VERB
observed O VERB
with O ADP
statins. O NUM

Title: O NOUN
The O DET
effect O NOUN
of O ADP
enamel O NOUN
matrix O NOUN
derivatives O NOUN
on O ADP
root B-outcome NOUN
coverage I-outcome NOUN
: O PUNCT
a O DET
12-month O NOUN
follow-up O NOUN
of O ADP
a O DET
randomized O VERB
clinical O ADJ
trial. O NOUN

Title: O NOUN
Clinical O ADJ
Outcome O NOUN
following O VERB
Intra-articular O ADJ
Triamcinolone O NOUN
Injection O NOUN
in O ADP
Osteoarthritic O ADJ
Knee O NOUN
at O ADP
the O DET
Community: O NOUN
A O DET
Randomized O VERB
Double O ADV
Blind O NOUN
Placebo O NOUN
Controlled O VERB
Trial. O NOUN

Delirium B-outcome NOUN
during O ADP
postoperative O ADJ
days O NOUN
1 O NUM
to O PART
5 O NUM
occurred O VERB
in O ADP
157 O NUM
of O ADP
604 O NUM
patients O NOUN
(26.0%) O NUM
in O ADP
the O DET
guided O VERB
group O NOUN
and O CCONJ
140 O NUM
of O ADP
609 O NUM
patients O NOUN
(23.0%) O NOUN
in O ADP
the O DET
usual O ADJ
care O NOUN
group O NOUN
(difference, O ADV
3.0% O NOUN
[95% O NOUN
CI, O NOUN
-2.0% O NUM
to O PART
8.0%]; O NOUN
P O NOUN
= O SYM
.22). O NUM

Larger O ADJ
studies O NOUN
with O ADP
longer O ADJ
follow-up O NOUN
periods O NOUN
may O VERB
be O VERB
required O VERB
to O PART
confirm O NOUN
these O DET
findings. O NOUN

This O DET
study, O NOUN
therefore, O NOUN
attempted O VERB
to O PART
explore O ADP
the O DET
effects O NOUN
of O ADP
TC O NOUN
on O ADP
depression B-outcome NOUN
and O CCONJ
on O ADP
heart B-outcome NOUN
rate I-outcome NOUN
variability I-outcome NOUN
(HRV) I-outcome NUM
parameters. O NOUN

We O PRON
aimed O VERB
to O PART
study O NOUN
the O DET
radiation B-outcome NOUN
exposure I-outcome NOUN
reduction O NOUN
to O PART
operators O NOUN
with O ADP
the O DET
use O NOUN
of O ADP
RADPAD O NOUN
and O CCONJ
also O ADV
measureradiation O NOUN
doses O NOUN
in O ADP
different O ADJ
angiographic O ADJ
projections. O NOUN

Title: O NOUN
Standard-dose O ADJ
versus O CCONJ
low-dose O NOUN
multidetector O NOUN
computed O VERB
tomography O NOUN
examinations O NOUN
in O ADP
patients O NOUN
with O ADP
uncontrolled O VERB
chronic O ADJ
rhinosinusitis: O NOUN
A O DET
randomized, O NOUN
controlled O VERB
trial. O NOUN

Publication O NOUN
date: O NOUN
2019/01/13 O NOUN
00:00 O NOUN
[accepted] O ADV

Journal O ADJ
ID: O NOUN
101521595 O NUM

The O DET
effect O NOUN
on O ADP
humans O NOUN
has O VERB
not O ADV
been O VERB
elucidated, O NOUN
therefore, O NOUN
we O PRON
investigated O VERB
the O DET
effects O NOUN
of O ADP
beta-Eudesmol O NOUN
on O ADP
reducing O VERB
objective O ADP
and O CCONJ
subjective O ADJ
markers O NOUN
related O VERB
to O PART
sympathetic B-outcome ADJ
nerve I-outcome NOUN
activity I-outcome NOUN
after O ADP
the O DET
application O NOUN
of O ADP
mental O ADJ
stress O NOUN
in O ADP
healthy O ADJ
participants. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article, O ADJ
Randomized O VERB
Controlled O VERB
Trial, O NOUN

Journal-Name: O NOUN
JAMA O NOUN

Publication O NOUN
date: O NOUN
['2019/10/10 O PUNCT
06:00' O NUM

Likewise, O NOUN
triglyceride B-outcome NOUN
net O ADJ
AUC O NOUN
was O VERB
increased O VERB
by O ADP
80 O NUM
+/- O SYM
28 O NUM
mumol/Lx270 O NOUN
min O NOUN
(p O PUNCT
= O SYM
0.012) O NUM
after O ADP
breakfast O NOUN
but O CCONJ
reduced O VERB
by O ADP
320 O NUM
+/- O SYM
60 O NUM
mumol/Lx180 O NOUN
min O NOUN
(p O PUNCT
< O SYM
0.001) O NUM
after O ADP
lunch O NOUN
on O ADP
the O DET
CRHP O NOUN
compared O VERB
with O ADP
CD O NOUN
diet. O NOUN

Title: O NOUN
The O DET
Effect O NOUN
of O ADP
Whey O NOUN
and O CCONJ
Soy O NOUN
Protein O NOUN
Isolates O NOUN
on O ADP
Cognitive B-outcome ADJ
Function I-outcome NOUN
in O ADP
Older O ADJ
Australians O NOUN
with O ADP
Low O ADJ
Vitamin O NOUN
B12: O NOUN
A O DET
Randomised O VERB
Controlled O VERB
Crossover O NOUN
Trial. O NOUN

The O DET
EIFEL O NOUN
score O NOUN
and O CCONJ
the O DET
Dallas O NOUN
Pain B-outcome NOUN
Questionnaire O NOUN
score O NOUN
had O VERB
a O DET
similar O ADJ
evolution O NOUN
over O ADP
time O NOUN
between O ADP
groups O NOUN
(P O NUM
= O SYM
.18 O PUNCT
and O CCONJ
P O NOUN
= O SYM
.50 O NUM
respectively). O NOUN

RESULTS: O NOUN
left B-outcome ADV
ventricular I-outcome ADJ
ejection I-outcome NOUN
fraction I-outcome NOUN
(LVEF) I-outcome PUNCT
decreased O VERB
from O ADP
62+/-5% O NOUN
at O ADP
baseline O NOUN
to O PART
58+/-7% O NOUN
at O ADP
6-months O NOUN
(p=0.002) O NOUN
in O ADP
patients O NOUN
assigned O VERB
to O PART
placebo O NOUN
but O CCONJ
no O DET
statistically O ADV
significant O ADJ
changes O NOUN
were O VERB
observed O VERB
in O ADP
any O DET
of O ADP
the O DET
3 O NUM
carvedilol O NOUN
groups. O NOUN

METHODS: O NOUN
Post O ADV
hoc O NOUN
analysis O NOUN
of O ADP
baseline O NOUN
patient O NOUN
characteristics O NOUN
in O ADP
the O DET
randomized, O NOUN
open-label, O ADV
vision O NOUN
examiner-masked O VERB
SHORE O DET
phase O NOUN
4 O NUM
study O NOUN
that O ADP
compared O VERB
monthly O ADV
versus O CCONJ
pro O ADJ
re O NOUN
nata O NOUN
dosing O VERB
of O ADP
ranibizumab O ADJ
in O ADP
patients O NOUN
with O ADP
branch O NOUN
and O CCONJ
central O ADJ
RVO. O NOUN

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

The O DET
total O ADJ
sleep B-outcome NOUN
time I-outcome NOUN
(TST) O PUNCT
and O CCONJ
daytime B-outcome NOUN
dysfunction I-outcome NOUN
(DF) I-outcome NOUN
in O ADP
PSQI O NOUN
significantly O ADV
decreased O VERB
at O ADP
week O NOUN
8 O NUM
(both O NOUN
P<0.05). O NOUN
( O PUNCT

OBJECTIVE: O NOUN
This O DET
study O NOUN
aims O NOUN
to O PART
investigate O NOUN
the O DET
accuracy O NOUN
of O ADP
the O DET
preoperative O ADJ
localization B-outcome NOUN
of O ADP
small O ADJ
nodules O NOUN
by O ADP
computerized O VERB
tomography O NOUN
(CT)-guided O PUNCT
placing O VERB
wire O NOUN
and O CCONJ
intrapleural O ADJ
fibrin O NOUN
glue O ADJ
near O ADV
the O DET
nodules O NOUN
at O ADP
3 O NUM
days O NOUN
before O ADP
the O DET
operation. O ADV

The O DET
intervention O NOUN
period O NOUN
was O VERB
from O ADP
April O NOUN
1 O NUM
to O PART
July O NOUN
31, O NUM
2011 O NUM
and O CCONJ
April O NOUN
1 O NUM
to O PART
July O NOUN
31, O NUM
2012. O NUM

The O DET
rate O NOUN
of O ADP
wearing B-outcome VERB
glasses I-outcome NOUN
was O VERB
55.2% O NUM
in O ADP
the O DET
treatment O NOUN
group O NOUN
and O CCONJ
23.4% O NUM
(p O PUNCT
< O SYM
0.01) O NUM
among O ADP
the O DET
control O NOUN
group. O VERB

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
Type: O NOUN
Clinical O ADJ
Trial, O NOUN
Phase O NOUN
II O NUM

The O DET
control O NOUN
group O NOUN
received O VERB
the O DET
placebo O NOUN
(distilled O PUNCT
water) O NOUN
in O ADP
the O DET
same O ADJ
manner O NOUN
as O ADP
the O DET
intervention O NOUN
group. O VERB

METHODS: O NOUN
We O PRON
conducted O VERB
a O DET
pragmatic, O NOUN
multicenter, O NOUN
open-label, O ADV
randomized, O NOUN
controlled O VERB
trial. O NOUN

Journal O ADJ
ID: O NOUN
100967802 O NUM

Introduction: O NOUN
Research O NOUN
from O ADP
Philip O ADV
Morris O NOUN
International's O NOUN
science O NOUN
division O NOUN
on O ADP
its O ADJ
Heat-not-Burn O NOUN
product O NOUN
IQOS(TM) O NOUN
focused O VERB
on O ADP
its O ADJ
chemical, O ADJ
toxicological, O ADJ
clinical, O ADJ
and O CCONJ
behavioral O ADJ
aspects. O NOUN

The O DET
participants O NOUN
were O VERB
randomly O ADV
assigned O VERB
to O PART
either O CCONJ
the O DET
resin O NOUN
infiltration O NOUN
group O NOUN
or O CCONJ
the O DET
fluoride O NOUN
varnish O NOUN
group. O VERB

TRIAL O NOUN
REGISTRATION O NOUN
NUMBER: O NOUN
UMIN-CTR O NOUN
Study O NOUN
Design: O NOUN
trial O NOUN
number: O NOUN
UMIN000022032. O NOUN

The O DET
aim O ADP
of O ADP
this O DET
study O NOUN
was O VERB
to O PART
collect O NOUN
data O NOUN
on O ADP
safety O NOUN
and O CCONJ
tolerability B-outcome NOUN
of O ADP
krill O NOUN
powder O NOUN
in O ADP
humans O NOUN
and O CCONJ
simultaneously O ADV
gain O VERB
efficacy O NOUN
data O NOUN
by O ADP
measuring O VERB
the O DET
risk O NOUN
factors O NOUN
for O ADP
cardiovascular O ADJ
disease. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
The O DET
trial O NOUN
was O VERB
registered O VERB
prospectively O ADV
with O ADP
the O DET
national O ADJ
database O NOUN
at O ADP
the O DET
Clinical O ADJ
Research O NOUN
Network O NOUN
(UKCRN O NOUN
Portfolio O NOUN
9366). O NOUN

This O DET
study O NOUN
therefore O ADV
aimed O VERB
to O PART
assess O NOUN
whether O ADP
a O DET
short-term O NOUN
LOWFODMAP O NOUN
diet O NOUN
improved O VERB
exercise-related O VERB
GI B-outcome NOUN
symptoms I-outcome NOUN
and O CCONJ
the O DET
perceived O VERB
ability B-outcome NOUN
to O PART
exercise O NOUN
in O ADP
recreational O ADJ
runners. O NOUN

A O DET
total O ADJ
of O ADP
18 O NUM
of O ADP
102 O NUM
patients O NOUN
(18%) O NOUN
in O ADP
the O DET
hybrid-procedure O NOUN
group O NOUN
had O VERB
a O DET
major O ADJ
pulmonary B-outcome ADJ
complication I-outcome NOUN
, O PUNCT
as O ADP
compared O VERB
with O ADP
31 O NUM
of O ADP
103 O NUM
(30%) O PUNCT
in O ADP
the O DET
open-procedure O NOUN
group. O VERB

Title: O NOUN
Effect O NOUN
of O ADP
lavender O NOUN
aromatherapy O NOUN
through O ADP
inhalation O NOUN
on O ADP
quality B-outcome NOUN
of I-outcome ADP
life I-outcome NOUN
among O ADP
postmenopausal O ADJ
women O NOUN
covered O VERB
by O ADP
a O DET
governmental O ADJ
health O NOUN
center O NOUN
in O ADP
Isfahan, O CCONJ
Iran: O NOUN
A O DET
single-blind O NOUN
clinical O ADJ
trial. O NOUN

Regression O NOUN
multivariate O ADJ
analysis O NOUN
showed O VERB
that O ADP
cortisol B-outcome NOUN
and O CCONJ
testosterone B-outcome NOUN
levels O NOUN
were O VERB
associated O VERB
with O ADP
25(OH)D B-outcome NUM
levels O NOUN
(p O PUNCT
< O SYM
0.05). O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

RESULTS: O NOUN
Thirty-four O NUM
subjects O NOUN
high-responder O NOUN
patients O NOUN
were O VERB
randomized O VERB
to O PART
receive O VERB
low-dose O NOUN
hCG O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
GnRH-agonist O NOUN
trigger O ADP
(Group O PUNCT
1) O NUM
and O CCONJ
37 O NUM
received O VERB
low-dose O NOUN
hCG O NOUN
at O ADP
the O DET
time O NOUN
of O ADP
oocyte O NOUN
retrieval O ADV
(Group O PUNCT
2). O NOUN

Title: O NOUN
[Nursing O VERB
intervention O NOUN
for O ADP
respiratory O ADJ
function O NOUN
exercise O NOUN
in O ADP
patients O NOUN
with O ADP
silicosis O NOUN
complicated O VERB
by O ADP
stable O ADJ
chronic O ADJ
obstructive O ADJ
pulmonary O ADJ
disease]. O NOUN

BACKGROUND: O NOUN
Nutrition O NOUN
cares O NOUN
are O VERB
of O ADP
the O DET
main O ADJ
measures O NOUN
to O PART
save O ADP
premature O ADJ
infants. O NOUN

Outcomes O NOUN
after O ADP
16 O NUM
weeks O NOUN
are O VERB
amount O NOUN
and O CCONJ
distribution B-outcome NOUN
of I-outcome ADP
abdominal B-outcome ADJ
fat E2-outcome NOUN
, O PUNCT
measured O VERB
by O ADP
magnetic O ADJ
resonance O NOUN
imaging O VERB
(MRI) O PUNCT
with O ADP
the O DET
use O NOUN
of O ADP
the O DET
three-point O NOUN
IDEAL O ADV
Dixon O NOUN
method. O NOUN

Journal O ADJ
ID: O NOUN
2985248R O NOUN

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

The O DET
degree O NOUN
of O ADP
injured O VERB
vertebra B-outcome NOUN
compression I-outcome NOUN
, O PUNCT
visual O ADJ
analogue O NOUN
scale O NOUN
(VAS) O PUNCT
score, O NOUN
and O CCONJ
Oswestry O NOUN
disability B-outcome NOUN
index O NOUN
(ODI) O NOUN
score O NOUN
at O ADP
preoperation, O NOUN
immediate O ADJ
after O ADP
operation, O NOUN
and O CCONJ
last O NOUN
follow-up O NOUN
were O VERB
calculated O VERB
and O CCONJ
compared O VERB
between O ADP
the O DET
two O NUM
groups. O NOUN

Subjects O NOUN
were O VERB
fed O VERB
a O DET
fully O ADV
controlled O VERB
base O NOUN
diet O NOUN
for O ADP
4 O NUM
weeks O NOUN
with O ADP
either O CCONJ
no O DET
additions O NOUN
or O CCONJ
with O ADP
the O DET
addition O NOUN
of O ADP
42 O NUM
g/day O NOUN
(1.5 O NOUN
servings) O NOUN
of O ADP
cashew O NOUN
nuts, O NOUN
with O ADP
the O DET
final O ADJ
treatment O NOUN
diets O NOUN
being O VERB
isocaloric. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

Body O NOUN
posture O ADJ
is O VERB
directly O ADV
related O VERB
to O PART
PA O NOUN
and O CCONJ
the O DET
lack O NOUN
of O ADP
activity O NOUN
affects O NOUN
disturbances O NOUN
within O ADP
posturometric O ADJ
parameters. O NOUN

Primary O ADJ
endpoint O NOUN
is O VERB
the O DET
success B-outcome NOUN
of O ADP
the O DET
randomised O VERB
treatment, O NOUN
defined O VERB
as O ADP
resolution B-outcome NOUN
of I-outcome ADP
acute I-outcome ADJ
appendicitis I-outcome NOUN
resulting O VERB
in O ADP
discharge B-outcome NOUN
from I-outcome ADP
the Seperator DET
hospital I-outcome NOUN
without O ADP
the O DET
need O NOUN
for O ADP
surgical B-outcome ADJ
intervention I-outcome NOUN
and O CCONJ
no O DET
recurrent B-outcome ADP
appendicitis I-outcome NOUN
during O ADP
one-year O NOUN
follow-up. O PUNCT

Sixty O NUM
patients O NOUN
completed O VERB
the O DET
study. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Journal O ADJ
ID: O NOUN
7501160 O NUM

Missing O VERB
values O NOUN
were O VERB
imputed O VERB
by O ADP
linear O ADJ
interpolation O NOUN
(intermittent), O PUNCT
backfilling O VERB
(beginning) O NOUN
or O CCONJ
carry O NOUN
forward O ADV
(end). O PUNCT

The O DET
primary O ADJ
efficacy O NOUN
endpoints O NOUN
were O VERB
measured O VERB
by O ADP
urodynamic B-outcome ADJ
values, O NOUN
and O CCONJ
Overactive B-outcome ADJ
Bladder I-outcome NOUN
Symptom I-outcome NOUN
Score O NOUN
(OABSS)]. O NOUN
The O DET
secondary O ADJ
efficacy O NOUN
endpoints O NOUN
were O VERB
assessed O VERB
by O ADP
International O ADJ
Consultation O NOUN
on O ADP
Incontinence B-outcome NOUN
Questionnaire-Short O NOUN
Form O NOUN
(ICIQ-SF) O NUM
score, O NOUN
Barthel O PROPN
Index O NOUN
(BI) O NOUN
scale, O NOUN
and O CCONJ
adverse B-outcome ADJ
events I-outcome NOUN
. O PUNCT
All O DET
outcomes O NOUN
were O VERB
evaluated O VERB
at O ADP
baseline O NOUN
and O CCONJ
at O ADP
the O DET
end O NOUN
of O ADP
10 O NUM
weeks O NOUN
treatment. O NOUN

TRIAL O NOUN
REGISTRATION: O NOUN
Current O ADJ
Controlled O VERB
Trials O NOUN
ChiCTR-INR-16008863 O NOUN
(Date O PUNCT
of O ADP
registration: O NOUN
20 O NUM
July O NOUN
2016). O NOUN

Title: O NOUN
Efficacy O NOUN
of O ADP
a O DET
nootropic O ADJ
spearmint O NOUN
extract O NOUN
on O ADP
reactive B-outcome ADJ
agility I-outcome NOUN
: O PUNCT
a O DET
randomized, O NOUN
double-blind, O NOUN
placebo-controlled, O NOUN
parallel O ADJ
trial. O NOUN

Aerosp O NOUN
Med O NOUN
Hum O NOUN
Perform. O NOUN

Journal O ADJ
ID: O NOUN
101147696 O NUM

Two O NUM
operative O ADJ
procedures O NOUN
were O VERB
evaluated; O NOUN
a O DET
fascia O NOUN
lata O NOUN
allograft O NOUN
and O CCONJ
an O DET
autologous O ADJ
gracilis O NOUN
graft. O VERB

Journal-Name:Medicine O NOUN

METHODS:: O NOUN
Five O NUM
therapeutic O ADJ
radiographers O NOUN
contoured O VERB
the O DET
prostate O NOUN
individually O ADV
on O ADP
CT, O NOUN
T2 O NOUN
weighted O VERB
(T2W) O NOUN
and O CCONJ
T2* O NOUN
weighted O VERB
(T2*W) O NUM
imaging O VERB
for O ADP
10 O NUM
patients. O NOUN

Journal O ADJ
ID: O NOUN
101578780 O NUM

These O DET
have O VERB
been O VERB
shown O VERB
to O PART
be O VERB
immunogenic O ADJ
and O CCONJ
safe O ADJ
in O ADP
European O NOUN
children; O NOUN
however, O ADV
their O ADJ
immunogenicity O NOUN
and O CCONJ
safety O NOUN
have O VERB
not O ADV
been O VERB
investigated O VERB
among O ADP
Korean O NOUN
children. O NOUN

Antimicrobial O ADJ
photodynamic O ADJ
therapy O NOUN
(aPDT) O NOUN
has O VERB
been O VERB
widely O ADV
used O VERB
with O ADP
very O ADV
satisfactory O ADJ
results O NOUN
in O ADP
the O DET
health O NOUN
sciences. O NOUN

Publication O NOUN
date: O NOUN
2017/11/15 O NOUN
00:00 O NOUN
[accepted] O ADV

Recovery O NOUN
of O ADP
TOFr O NOUN
from O ADP
0.25 O NUM
to O PART
0.75 O NUM
and O CCONJ
from O ADP
0.25 O NUM
to O PART
0.9 O NUM
was O VERB
longer O ADJ
in O ADP
patients O NOUN
treated O VERB
with O ADP
rocuronium O NOUN
than O ADP
in O ADP
those O DET
treated O VERB
with O ADP
cisatracurium O NOUN
(both O NOUN
P O NOUN
<.001). O NUM

Journal-Name:The O ADJ
New O ADJ
England O NOUN
journal O ADJ
of O ADP
medicine O NOUN

The O DET
difference O NOUN
in O ADP
morphine B-outcome NOUN
consumption I-outcome NOUN
was O VERB
not O ADV
statistically O ADV
significant O ADJ
for O ADP
the O DET
PCM O NOUN
+ O SYM
IBU O NOUN
group O NOUN
vs O CCONJ
HS-PCM O NOUN
+ O SYM
IBU O NOUN
(8 O NOUN
mg O NOUN
[99.6% O NOUN
CI, O NOUN
-2 O NUM
to O PART
16]; O NOUN
P O NOUN
= O SYM
.005) O PUNCT
or O CCONJ
for O ADP
the O DET
PCM-alone O NOUN
group O NOUN
vs O CCONJ
IBU O NOUN
alone O ADJ
(10 O NOUN
mg O NOUN
[99.6% O NOUN
CI, O NOUN
-2 O NUM
to O PART
16]; O NOUN
P O NOUN
= O SYM
.004) O PUNCT
after O ADP
adjustment O NOUN
for O ADP
multiple O ADJ
comparisons O NOUN
and O CCONJ
2 O NUM
co-primary O ADJ
outcomes. O ADJ

RESULTS: O NOUN
A O DET
repeated O VERB
measures O NOUN
ANOVA O NOUN
revealed O VERB
significant O ADJ
time-dependent O ADJ
increases O NOUN
in O ADP
plasma O NOUN
epinephrine B-outcome NOUN
(E) I-outcome NUM
and O CCONJ
norepinephrine B-outcome NOUN
(NE) I-outcome NOUN
at O ADP
I2 O NOUN
only O ADV
in O ADP
the O DET
CA O NOUN
+ O SYM
C O NOUN
trial O NOUN
(p O PUNCT
< O SYM
0.05), O NUM
and O CCONJ
a O DET
significant O ADJ
decrease O NOUN
in O ADP
blood O NOUN
glucose B-outcome NOUN
at O ADP
I2 O NOUN
in O ADP
the O DET
PLA O NOUN
trial O NOUN
(p O PUNCT
< O SYM
0.05); O NUM
however, O ADV
no O DET
meaningful O ADJ
changes O NOUN
in O ADP
glucose B-outcome NOUN
was O VERB
observed O VERB
following O VERB
CA O NOUN
+ O SYM
C O NOUN
ingestion. O NOUN

Publication O NOUN
date: O NOUN
2018/07/27 O ADV
00:00 O NOUN
[accepted] O ADV

Title: O NOUN
Effectiveness O NOUN
of O ADP
repellent O NOUN
delivered O VERB
through O ADP
village O NOUN
health O NOUN
volunteers O NOUN
on O ADP
malaria B-outcome NOUN
incidence O NOUN
in O ADP
villages O NOUN
in O ADP
South-East O NOUN
Myanmar: O NOUN
a O DET
stepped-wedge O NOUN
cluster-randomised O VERB
controlled O VERB
trial O NOUN
protocol. O NOUN

Journal-Name:Cornea O NOUN

The O DET
likelihood O NOUN
for O ADP
cost-effectiveness, O NOUN
based O VERB
on O ADP
a O DET
willingness O ADP
to O PART
pay O NOUN
50,000 O NUM
USD O NOUN
per O ADP
QALY, O NOUN
was O VERB
0.77-1.00. O PUNCT

There O PRON
were O VERB
no O DET
significant O ADJ
differences O NOUN
in O ADP
the O DET
other O ADJ
6 O NUM
secondary O ADJ
outcomes. O ADJ

and O CCONJ
1 O NUM
y, O NOUN
with O ADP
pronounced O VERB
differences O NOUN
for O ADP
the O DET
dimensions O NOUN
general B-outcome ADJ
health I-outcome NOUN
and O CCONJ
mental B-outcome ADJ
health I-outcome NOUN
, O PUNCT
and O CCONJ
the O DET
mental B-outcome ADJ
component O NOUN
summary O NOUN
score O NOUN
(all O PUNCT
p O NOUN
< O SYM
0.05). O NOUN

Publication O NOUN
date: O NOUN
2019/02/23 O NOUN
06:00 O ADP
[medline] O NOUN

Patients O NOUN
who O ADP
received O VERB
caplacizumab O NOUN
needed O VERB
less O ADV
plasma B-outcome NOUN
exchange I-outcome NOUN
and O CCONJ
had O VERB
a O DET
shorter O ADJ
hospitalization B-outcome NOUN
than O ADP
those O DET
who O ADP
received O VERB
placebo. O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
LBW O NOUN
protocol O NOUN
can O VERB
avoid O NOUN
iodine O NOUN
overdosing B-outcome VERB
, O PUNCT
especially O ADV
in O ADP
patients O NOUN
with O ADP
a O DET
high O ADJ
BMI. O NOUN

OBJECTIVES: O NOUN
We O PRON
describe O NOUN
a O DET
research O NOUN
protocol O NOUN
and O CCONJ
lessons O NOUN
learned O VERB
from O ADP
a O DET
partnership O NOUN
between O ADP
Johns O NOUN
Hopkins O NOUN
Health O NOUN
System O NOUN
and O CCONJ
11 O NUM
CBOs. O NOUN

Journal O ADJ
ID: O NOUN
101125284 O NUM

The O DET
primary O ADJ
efficacy O NOUN
end O NOUN
point O NOUN
was O VERB
a O DET
composite O NOUN
of O ADP
objectively O ADV
confirmed O VERB
proximal B-outcome ADJ
deep-vein I-outcome NOUN
thrombosis I-outcome NOUN
in Seperator ADP
a Seperator DET
lower I-outcome ADJ
limb I-outcome NOUN
, O PUNCT
pulmonary B-outcome ADJ
embolism I-outcome NOUN
, O PUNCT
symptomatic B-outcome ADJ
deep-vein I-outcome NOUN
thrombosis I-outcome NOUN
in Seperator ADP
an Seperator DET
upper I-outcome ADJ
limb I-outcome NOUN
or O CCONJ
distal B-outcome ADJ
deep-vein I-outcome NOUN
thrombosis I-outcome NOUN
in Seperator ADP
a Seperator DET
lower I-outcome ADJ
limb I-outcome NOUN
, O PUNCT
and O CCONJ
death B-outcome NOUN
from I-outcome ADP
venous I-outcome ADJ
thromboembolism I-outcome NOUN
and O CCONJ
was O VERB
assessed O VERB
up O ADP
to O PART
day O NOUN
180. O NOUN

The O DET
subsequent O ADJ
dose O NOUN
of O ADP
spinal O ADJ
bupivacaine O NOUN
was O VERB
determined O VERB
by O ADP
the O DET
improved O VERB
up-down O VERB
allocation O NOUN
method. O NOUN

Participants O NOUN
(55% O PUNCT
female) O NOUN
consumed O VERB
50 O NUM
g O NOUN
whey O NOUN
(WPI; O NUM
active) O ADJ
or O CCONJ
soy O ADJ
protein O NOUN
isolate O VERB
(SPI; O NOUN
control) O NOUN
for O ADP
eight O NUM
weeks. O NOUN

Australian O ADJ
adults O NOUN
(N O PUNCT
= O SYM
1132) O NOUN
aged O VERB
18-24 O NUM
years O NOUN
were O VERB
recruited O VERB
via O ADP
a O DET
national O ADJ
online O ADP
panel. O NOUN

Journal O ADJ
ID: O NOUN
101153626 O NUM

Physical O ADJ
exercise O NOUN
remains O NOUN
a O DET
potentially O ADV
useful O ADJ
adjunct O ADP
therapy O NOUN
in O ADP
CD. O NOUN
[ O PUNCT

PMID: O NOUN
31596415 O NUM

CONCLUSIONS: O NOUN
L-Methylfolate O NOUN
was O VERB
associated O VERB
with O ADP
no O DET
change O NOUN
in O ADP
efficacy O NOUN
on O ADP
measures O NOUN
relevant O ADJ
to O PART
neuropsychiatric B-outcome ADJ
function I-outcome NOUN
in O ADP
adults O NOUN
with O ADP
ADHD, O ADJ
other O ADJ
than O ADP
suggestion O NOUN
of O ADP
reduced O VERB
efficacy O NOUN
of O ADP
methylphenidate. O NOUN

Publication O NOUN
date: O NOUN
['2019/10/17 O NOUN
06:00' O NUM

The O DET
primary O ADJ
outcome O NOUN
was O VERB
sustained O VERB
abstinence B-outcome NOUN
for O ADP
1 O NUM
year, O ADV
which O ADP
was O VERB
validated O VERB
biochemically O ADV
at O ADP
the O DET
final O ADJ
visit. O NOUN

Increases O NOUN
in O ADP
serum O NOUN
creatinine B-outcome NOUN
levels O NOUN
of O ADP
0.5 O NUM
mg O NOUN
or O CCONJ
more O ADV
per O ADP
deciliter O NOUN
(>/=40 O NUM
mumol O NOUN
per O ADP
liter) O NOUN
above O ADP
baseline O NOUN
occurred O VERB
in O ADP
7.0% O NOUN
of O ADP
patients O NOUN
in O ADP
the O DET
plazomicin O NOUN
group O NOUN
and O CCONJ
in O ADP
4.0% O NOUN
in O ADP
the O DET
meropenem O NOUN
group. O VERB

Title: O NOUN
Effectiveness O NOUN
of O ADP
Adjunctive O ADJ
Use O PUNCT
of O ADP
Low-Level O NUM
Laser O NOUN
Therapy O NOUN
and O CCONJ
Photodynamic O ADJ
Therapy O NOUN
After O ADP
Scaling O VERB
and O CCONJ
Root O ADJ
Planing O VERB
in O ADP
Patients O NOUN
with O ADP
Chronic O ADJ
Periodontitis. O NOUN

It O PRON
is O VERB
currently O ADV
unknown O VERB
whether O ADP
these O DET
unilateral O ADJ
deficits O NOUN
can O VERB
be O VERB
corrected O VERB
by O ADP
a O DET
standard O ADJ
bilateral O ADJ
strength O NOUN
training O VERB
intervention. O NOUN

Publication O NOUN
Type: O NOUN
Randomized O VERB
Controlled O VERB
Trial O NOUN

Title: O NOUN
A O DET
randomized O VERB
trial O NOUN
of O ADP
AmBisome O NOUN
monotherapy O NOUN
and O CCONJ
AmBisome O NOUN
and O CCONJ
miltefosine O NOUN
combination O NOUN
to O PART
treat O NOUN
visceral O ADJ
leishmaniasis O NOUN
in O ADP
HIV O NOUN
co-infected O VERB
patients O NOUN
in O ADP
Ethiopia. O NOUN

L(- O NOUN
1); O NOUN
betaA2: O NOUN
9.2 O NUM
+/- O SYM
1.1 O NUM
mmol. O NOUN

Journal-Name:Clinical O ADJ
interventions O NOUN
in O ADP
aging O VERB

Publication O NOUN
date: O NOUN
2018/12/14 O NOUN
06:00 O ADP
[entrez] O ADP

The O DET
changes O NOUN
of O ADP
Self-rating O VERB
depression B-outcome NOUN
scale O NOUN
(SDS) O PUNCT
and O CCONJ
self-rating O VERB
anxiety B-outcome NOUN
scale O NOUN
SAS O NUM
before O ADP
and O CCONJ
after O ADP
the O DET
three O NUM
groups O NOUN
were O VERB
compared, O NOUN
and O CCONJ
the O DET
changes O NOUN
of O ADP
serum O NOUN
SOD O NOUN
and O CCONJ
MDA O NOUN
were O VERB
detected O VERB
by O ADP
immunoenzyme-linked O VERB
adsorption O NOUN
for O ADP
comparative O ADJ
analysis. O NOUN

OBJECTIVE: O NOUN
The O DET
assessment O NOUN
of O ADP
pelvis O NOUN
reposition O NOUN
exercise O NOUN
efficacy O NOUN
in O ADP
the O DET
treatment O NOUN
of O ADP
pelvic O ADJ
floor O NOUN
muscles O NOUN
(PFM) O PUNCT
asymmetry. O VERB

The O DET
aim O ADP
of O ADP
this O DET
split-mouth O NOUN
and O CCONJ
randomized O VERB
controlled O VERB
study O NOUN
was O VERB
to O PART
assess O NOUN
the O DET
clinical O ADJ
and O CCONJ
aesthetical O ADJ
impacts O NOUN
of O ADP
EMD O NOUN
application O NOUN
in O ADP
combination O NOUN
with O ADP
SCTG+CAF O NUM
in O ADP
patients O NOUN
with O ADP
Miller's O NOUN
Class O NOUN
I O NUM
and O CCONJ
II O NUM
gingival O ADJ
recessions O NOUN
in O ADP
contralateral O ADJ
canines O NOUN
of O ADP
the O DET
maxilla. O NOUN

Journal O ADJ
ID: O NOUN
101090633 O NUM

BACKGROUND: O NOUN
The O DET
management O NOUN
of O ADP
acute O ADJ
esophageal O ADJ
variceal O ADJ
bleeding O VERB
remains O NOUN
a O DET
clinical O ADJ
challenge. O NOUN

Publication O NOUN
Type: O NOUN
Multicenter O NOUN
Study O NOUN

The O DET
number O NOUN
of O ADP
mature B-outcome ADJ
follicles I-outcome NOUN
and O CCONJ
cervical B-outcome ADJ
mucus I-outcome NOUN
score], O NUM
follicular B-outcome ADJ
development I-outcome NOUN
rate O NOUN
and O CCONJ
single B-outcome ADJ
follicle I-outcome NOUN
ovulation I-outcome NOUN
rate, O NOUN
cycle B-outcome NOUN
pregnancy I-outcome NOUN
rate, O NOUN
early B-outcome ADJ
miscarriage I-outcome NOUN
rate, O NOUN
ovulation B-outcome NOUN
rate, O NOUN
endometrial B-outcome ADJ
thickness I-outcome NOUN
, O PUNCT
positive O ADJ
rate O NOUN
of O ADP
three B-outcome NUM
lines I-outcome NOUN
sign I-outcome ADV
, O PUNCT
follicle B-outcome NOUN
stimulating I-outcome VERB
hormone I-outcome NOUN
level O NOUN
and O CCONJ
luteinizing B-outcome VERB
hormone I-outcome NOUN
level O NOUN
were O VERB
compared O VERB
between O ADP
the O DET
two O NUM
groups. O NOUN

Publication O NOUN
date: O NOUN
2018/12/22 O NOUN
06:00 O ADP
[entrez] O ADP

RESULTS: O NOUN
The O DET
3-year O NOUN
assessment O NOUN
included O VERB
45 O NUM
conical O ADJ
interface O NOUN
(CI), O ADJ
34 O NUM
flat-to-flat O NOUN
interface O NOUN
(FI), O PUNCT
and O CCONJ
32 O NUM
platform-switched O VERB
interface O NOUN
(PS) O NOUN
implants O NOUN
in O ADP
111 O NUM
participants. O NOUN

Localization B-outcome NOUN
accuracy, O NOUN
operation B-outcome NOUN
time I-outcome NOUN
and O CCONJ
difficulty B-outcome NOUN
in O ADP
postoperative O ADJ
seeking O VERB
for O ADP
pathological O ADJ
specimens O NOUN
were O VERB
compared O VERB
between O ADP
these O DET
2 O NUM
groups. O NOUN

6.9% O NOUN
reported O VERB
feeling O VERB
down, O ADJ
depressed O VERB
or O CCONJ
hopeless O ADV
in O ADP
the O DET
past O NOUN
2 O NUM
weeks. O NOUN

The O DET
primary O ADJ
end O NOUN
points O NOUN
were O VERB
composite O NOUN
cure B-outcome NOUN
( O PUNCT
clinical B-outcome ADJ
cure I-outcome NOUN
and Seperator CCONJ
microbiologic I-outcome ADJ
eradication I-outcome NOUN
) O PUNCT
at O ADP
day O NOUN
5 O NUM
and O CCONJ
at O ADP
the O DET
test-of-cure O NOUN
visit O NOUN
(15 O PUNCT
to O PART
19 O NUM
days O NOUN
after O ADP
initiation O NOUN
of O ADP
therapy) O NOUN
in O ADP
the O DET
microbiologic O ADJ
modified O VERB
intention-to-treat O NOUN
population. O ADV

In O ADP
addition, O NOUN
subjects O NOUN
were O VERB
monitored O VERB
for O ADP
eligible O ADJ
and O CCONJ
ineligible O ADJ
criteria. O NOUN

The O DET
primary O ADJ
endpoint O NOUN
was O VERB
cumulative O ADJ
incidence O NOUN
of O ADP
chronic B-outcome ADJ
graft-versus-host I-outcome ADV
disease I-outcome NOUN
(cGVHD) I-outcome NOUN
at O ADP
2 O NUM
years. O NOUN

CONCLUSIONS: O NOUN
The O DET
application O NOUN
of O ADP
OPEP O NOUN
device O NOUN
during O ADP
the O DET
perioperative O ADJ
period O NOUN
was O VERB
valuable O ADJ
in O ADP
decreasing O VERB
pulmonary B-outcome ADJ
complications I-outcome NOUN
and O CCONJ
enhancing O VERB
recovery B-outcome NOUN
for O ADP
lung O NOUN
cancer O NOUN
patients O NOUN
receiving O VERB
VATS O NOUN
lobectomy. O NOUN

Mean O NOUN
wear B-outcome ADJ
durations I-outcome NOUN
were O VERB
8.78 O NUM
hours O NOUN
a O DET
day O NOUN
in O ADP
the O DET
PT O NOUN
group O NOUN
and O CCONJ
12.38 O NUM
hours O NOUN
in O ADP
the O DET
FT O NOUN
group. O VERB

Using O VERB
a O DET
theory-based O VERB
approach, O NOUN
we O PRON
hypothesized O VERB
that O ADP
learning O VERB
acceptance O NOUN
skills O NOUN
in O ADP
mindfulness O ADV
interventions O NOUN
helps O ADJ
people O NOUN
notice O NOUN
more O ADV
positive O ADJ
experiences O NOUN
in O ADP
daily O ADJ
life, O ADJ
and O CCONJ
tested O VERB
whether O ADP
removing O VERB
acceptance O NOUN
training O VERB
from O ADP
mindfulness O ADV
interventions O NOUN
would O VERB
eliminate O NOUN
intervention-related O VERB
boosts O NOUN
in O ADP
positive O ADJ
affect. O NOUN

BACKGROUND: O NOUN
The O DET
management O NOUN
of O ADP
complex O NOUN
orthopedic O ADJ
infections O NOUN
usually O ADV
includes O NOUN
a O DET
prolonged O VERB
course O NOUN
of O ADP
intravenous O ADJ
antibiotic O ADJ
agents. O NOUN

Journal-Name:Journal O ADJ
of O ADP
cardiac O ADJ
surgery O NOUN

Publication O NOUN
Type: O NOUN
Journal O ADJ
Article O NOUN

The O DET
general O ADJ
clinical O ADJ
data O NOUN
of O ADP
the O DET
two O NUM
groups O NOUN
including O VERB
gender, O NOUN
gestational O ADJ
age, O NOUN
birth O NOUN
weight, O NOUN
age, O NOUN
5-minute O NOUN
neonatal O ADJ
asphyxia O NOUN
score O NOUN
(Apgar O NOUN
score), O NOUN
score O NOUN
for O ADP
neonatal O ADJ
acute O ADJ
physiology O NOUN
perinatal O ADJ
extension O NOUN
version O NOUN
II O NUM
(SNAPPE O NOUN
II) O NOUN
were O VERB
collected. O NOUN

A O DET
randomized O VERB
controlled O VERB
trial. O NOUN

Journal O ADJ
ID: O NOUN
101303164 O NUM

Journal O ADJ
ID: O NOUN
0372541 O NUM

Journal O ADJ
ID: O NOUN
101521595 O NUM

CONCLUSION: O NOUN
There O PRON
was O VERB
a O DET
strong O ADJ
correlation O NOUN
between O ADP
grip B-outcome NOUN
strength I-outcome NOUN
and O CCONJ
TOFr O NOUN
during O ADP
recovery O NOUN
from O ADP
general O ADJ
anesthesia. O NOUN

Secondary O ADJ
endpoints: O NOUN
longitudinal O ADJ
HIV B-outcome NOUN
viral I-outcome ADJ
load I-outcome NOUN
, O PUNCT
T B-outcome NOUN
cell I-outcome NOUN
counts I-outcome NOUN
, O PUNCT
body B-outcome NOUN
mass I-outcome NOUN
index I-outcome NOUN
(BMI) I-outcome PUNCT
, O PUNCT
middle-upper-arm B-outcome NOUN
circumference I-outcome NOUN
(MUAC) I-outcome NUM
, O PUNCT
and O CCONJ
25(OH)D(3) B-outcome NOUN
levels O NOUN
in O ADP
plasma. O NOUN

Patients O NOUN
in O ADP
both O CCONJ
groups O NOUN
improved O VERB
significantly O ADV
after O ADP
treatment O NOUN
in O ADP
Barthel O PROPN
index O NOUN
(BI)], O NOUN
elbow B-outcome NOUN
range I-outcome NOUN
of I-outcome ADP
motion I-outcome NOUN
(ROM) I-outcome NOUN
, O PUNCT
and O CCONJ
elbow B-outcome NOUN
muscles I-outcome NOUN
strength I-outcome NOUN
. O PUNCT
However, O ADV
muscle B-outcome NOUN
tone I-outcome NOUN
in O ADP
elbow O NOUN
joint O NOUN
of O ADP
the O DET
hemiplegic O ADJ
upper O ADJ
extremity O NOUN
improved O VERB
significantly O ADV
after O ADP
SMV O NOUN
only O ADV
in O ADP
the O DET
experimental O ADJ
group O NOUN
(SPT-SMV). O NOUN

CONCLUSION: O NOUN
The O DET
findings O NOUN
of O ADP
this O DET
study O NOUN
showed O VERB
that O ADP
UGPRF O NOUN
may O VERB
benefit O NUM
for O ADP
patients O NOUN
with O ADP
FS O NOUN
after O ADP
12 O NUM
weeks O NOUN
treatment. O NOUN

Electronic O ADJ
randomization O NOUN
was O VERB
undertaken, O ADJ
with O ADP
group O NOUN
allocation O NOUN
concealed O VERB
using O VERB
opaque, O ADV
sealed O VERB
envelopes. O NUM

At O ADP
baseline O NOUN
and O CCONJ
12-month O NOUN
follow-up, O ADP
ocular O ADJ
exams O NOUN
for O ADP
trachoma B-outcome NOUN
, O PUNCT
ocular O ADJ
swabs O NOUN
for O ADP
detection O NOUN
of O ADP
chlamydial B-outcome ADJ
DNA I-outcome NOUN
, O PUNCT
and O CCONJ
finger O NOUN
prick O NOUN
blood O NOUN
for O ADP
analysis O NOUN
of O ADP
anti-chlamydial B-outcome ADJ
antibody I-outcome NOUN
were O VERB
taken. O NOUN

